PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Schneeweiss, S; Walker, AM; Glynn, RJ; Maclure, M; Dormuth, C; Soumerai, SB				Schneeweiss, S; Walker, AM; Glynn, RJ; Maclure, M; Dormuth, C; Soumerai, SB			Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BRITISH-COLUMBIA; PRESCRIPTION DRUGS; PROPENSITY SCORE; COST; MEDICAID; CARDIOLOGISTS; EXPENDITURES; MORTALITY; PAYMENT; EVENTS	Background: In January 1997, reference pricing for angiotensin-converting-enzyme (ACE) inhibitors for patients 65 years of age or older was introduced in British Columbia, Canada. For medications within a specific class, insurance covers the cost up to the reference price, and patients pay the extra cost of more expensive medications. Although reference pricing may reduce the costs of prescription drugs, there is concern that patients may switch to less effective medications or stop treatment. Methods: We analyzed data from the Ministry of Health on all 37,362 residents of British Columbia who were 65 or older and were enrolled in the provincial health insurance program, received ACE inhibitors priced higher than the reference price of $27 a month in 1996, and were potentially affected by the new policy. We identified 5353 residents who switched to an ACE inhibitor not subject to cost sharing during the first six months and compared them with 27,938 residents who received only ACE inhibitors subject to cost sharing. Results: Reference pricing for ACE inhibitors was not associated with changes in the rates of visits to physicians, hospitalizations, admissions to long-term care facilities, or mortality. The probability of stopping antihypertensive therapy decreased as compared with the probability before the change in policy (relative risk, 0.76; 95 percent confidence interval, 0.65 to 0.89). Eighteen percent of patients who had been prescribed ACE inhibitors subject to cost sharing switched to lower-priced alternatives. As compared with patients who did not switch, those who did had a moderate transitory increase in the rates of visits to physicians (rate ratio, 1.11; 95 percent confidence interval, 1.07 to 1.15) and hospital admissions through the emergency room (rate ratio, 1.19; 95 percent confidence interval, 0.99 to 1.42) during the two months after switching, but not subsequently. Conclusions: We found little evidence that when reference pricing for ACE inhibitors was introduced in British Columbia, patients stopped treatment for hypertension or that health care utilization and costs increased. (N Engl J Med 2002;346:822-9.) Copyright (C) 2002 Massachusetts Medical Society.	Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; British Columbia Minist Hlth, Victoria, BC, Canada; Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA; Harvard Pilgrim Hlth Care, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care	Schneeweiss, S (corresponding author), Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 221 Longwood Ave, Boston, MA 02115 USA.	schneeweiss@post.harvard.edu	Schneeweiss, Sebastian/C-2125-2013	Schneeweiss, Sebastian/0000-0003-2575-467X; Dormuth, Colin/0000-0001-8577-8783	AHRQ HHS [R03 HS09855, R01 HS10881] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R03HS009855, R01HS010881] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		ANDERSON GM, 1993, INQUIRY-J HEALTH CAR, V30, P199; Boulet AP, 1997, CAN J CARDIOL, V13, P46; Bourgault C, 1999, CAN MED ASSOC J, V161, P255; Diehr P, 1999, ANNU REV PUBL HEALTH, V20, P125, DOI 10.1146/annurev.publhealth.20.1.125; ESTEVE J, 1994, IARC SCI PUBL, V128, P62; GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450; GARG R, 1995, JAMA-J AM MED ASSOC, V274, P462; Gill N J, 2000, Can J Clin Pharmacol, V7, P109; GILLINGS D, 1981, AM J PUBLIC HEALTH, V71, P38, DOI 10.2105/AJPH.71.1.38; Glynn RJ, 1996, BMJ-BRIT MED J, V312, P364; GOODMAN SN, 1994, ANN INTERN MED, V121, P200, DOI 10.7326/0003-4819-121-3-199408010-00008; GOODMAN SN, 1995, ANN INTERN MED, V122, P478, DOI 10.7326/0003-4819-122-6-199503150-00029; Hallas J, 1996, EPIDEMIOLOGY, V7, P478, DOI 10.1097/00001648-199609000-00005; HARRIS BL, 1990, MED CARE, V28, P907, DOI 10.1097/00005650-199010000-00005; Holbrook A, 1997, CAN J CARDIOL, V13, P689; HOSMER DW, 2000, WILEY PS TX, P1; Huskamp HA, 2000, HEALTH AFFAIR, V19, P8, DOI 10.1377/hlthaff.19.2.8; Iglehart JK, 2001, NEW ENGL J MED, V344, P1010, DOI 10.1056/NEJM200103293441311; *INT CLASS DIS, 1992, ICD 9 CM; Kane NM, 1997, HEALTH POLICY, V41, pS71, DOI 10.1016/S0168-8510(97)00048-1; KENNEDY P, 1988, GUIDE ECONOMETRICS, P123; Levit K, 1998, HEALTH AFFAIR, V17, P99, DOI 10.1377/hlthaff.17.6.99; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; LEWIS EJ, 1994, NEW ENGL J MED, V330, P152; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502; McLaughlin PR, 1997, CAN J CARDIOL, V13, P31; Mitler LK, 2000, J CLIN EPIDEMIOL, V53, P1030, DOI 10.1016/S0895-4356(00)00221-3; NELSON AA, 1984, MED CARE, V22, P724, DOI 10.1097/00005650-198408000-00004; *PHARM, 1997, ANT INF REF DRUG PRI; REEDER CE, 1985, INQUIRY-J HEALTH CAR, V22, P396; ROEMER MI, 1975, MED CARE, V13, P457, DOI 10.1097/00005650-197506000-00002; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Rubin DB, 2000, J AM STAT ASSOC, V95, P573, DOI 10.2307/2669400; Schneeweiss S, 1998, HEALTH POLICY, V44, P253, DOI 10.1016/S0168-8510(98)00023-2; Schneeweiss S, 2001, HEALTH POLICY, V55, P97, DOI 10.1016/S0168-8510(00)00120-2; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; SOUMERAI SB, 1987, NEW ENGL J MED, V317, P550, DOI 10.1056/NEJM198708273170906; STEINHAUER J, 1999, NY TIMES        1029; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; Thomas M, 1998, LANCET, V352, P1830, DOI 10.1016/S0140-6736(05)79893-7; VENEY JE, 1991, EVALUATION DECISIO 5; VONKORFF M, 1992, J CLIN EPIDEMIOL, V45, P197, DOI 10.1016/0895-4356(92)90016-G; Williams JI, 1996, INVENTORY STUDIES AC; ZELEN M, 1991, BIOMETRICS, V47, P778	46	145	146	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2002	346	11					822	829		10.1056/NEJMsa003087	http://dx.doi.org/10.1056/NEJMsa003087			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529YM	11893794	Green Published, Green Submitted			2022-12-28	WOS:000174328900006
J	Barco, A; Alarcon, JM; Kandel, ER				Barco, A; Alarcon, JM; Kandel, ER			Expression of constitutively active CREB protein facilitates the late phase of long-term potentiation by enhancing synaptic capture	CELL			English	Article							ELEMENT-BINDING PROTEIN; FAMILY TRANSCRIPTION FACTOR; CAMP-RESPONSIVE ELEMENT; TARGETED MUTATION; GENE-EXPRESSION; CRITICAL PERIOD; MEMORY STORAGE; CA1 REGION; LTP; HIPPOCAMPUS	Restricted and regulated expression in mice of VP16-CREB, a constitutively active form of CRES, in hippocampal CA1 neurons lowers the threshold for eliciting a persistent late phase of long-term potentiation (L-LTP) in the Schaffer collateral pathway. This L-LTP has unusual properties in that its induction is not dependent on transcription. Pharmacological and two-pathway experiments suggest a model in which VP16-CREB activates the transcription of CRE-driven genes and leads to a cell-wide distribution of proteins that prime the synapses for subsequent synapse-specific capture of L-LTP by a weak stimulus. Our analysis indicates that synaptic capture of CRE-driven gene products may be sufficient for consolidation of LTP and provides insight into the molecular mechanisms of synaptic tagging and synapse-specific potentiation.	Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University	Kandel, ER (corresponding author), Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, 1051 Riverside Dr, New York, NY 10032 USA.		Barco, Angel/C-3062-2008; Barco, Angel/ABF-1864-2021	Barco, Angel/0000-0002-0653-3751; Barco, Angel/0000-0002-0653-3751				Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Abel T, 1998, SCIENCE, V279, P338, DOI 10.1126/science.279.5349.338; Ausubel F. M., 1999, SHORT PROTOCOLS MOL; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Blendy JA, 1996, EMBO J, V15, P1098, DOI 10.1002/j.1460-2075.1996.tb00447.x; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; FREY U, 1995, NEUROSCIENCE, V67, P799, DOI 10.1016/0306-4522(95)00117-2; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Frey U, 1998, NEUROPHARMACOLOGY, V37, P545, DOI 10.1016/S0028-3908(98)00040-9; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gass P, 1998, LEARN MEMORY, V5, P274; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; Huang Y Y, 1994, Learn Mem, V1, P74; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Lu YF, 1999, J NEUROSCI, V19, P10250; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MATTHIES H, 1993, NEUROREPORT, V4, P712, DOI 10.1097/00001756-199306000-00028; Mayford M, 1999, TRENDS GENET, V15, P463, DOI 10.1016/S0168-9525(99)01846-6; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; O'Dell T J, 1994, Learn Mem, V1, P129; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; Rammes G, 2000, EUR J NEUROSCI, V12, P2534, DOI 10.1046/j.1460-9568.2000.00108.x; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Staubli U, 1996, J NEUROSCI, V16, P853; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Taubenfeld SM, 1999, NAT NEUROSCI, V2, P309, DOI 10.1038/7217; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; WISDEN W, 1994, IN SITU HYBRIDIZATIO, P9; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Zhuo M, 1999, P NATL ACAD SCI USA, V96, P4650, DOI 10.1073/pnas.96.8.4650	49	412	430	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 8	2002	108	5					689	703		10.1016/S0092-8674(02)00657-8	http://dx.doi.org/10.1016/S0092-8674(02)00657-8			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	529TN	11893339	Bronze			2022-12-28	WOS:000174314800012
J	van Putten, MHPM; Levinson, A				van Putten, MHPM; Levinson, A			Detecting energy emissions from a rotating black hole	SCIENCE			English	Article							GAMMA-RAY BURSTS; MASS; INTERFEROMETER; ACCRETION; PULSARS	The rotational energy of a black hole surrounded by a torus is released through several channels. We have determined that a minor fraction of the energy is released in baryon-poor outflows from a differentially rotating open magnetic flux tube, and a major fraction of about eta/2 is released in gravitational radiation by the torus with angular velocity eta similar to 0.2 to 0.5 relative to that of the black hole. We associate the energy emitted in baryon-poor outflows with gamma-ray bursts. The remaining fraction is released in torus winds, thermal emissions, and (conceivably) megaelectron-volt neutrino emissions. The emitted gravitational radiation can be detected by gravitational wave experiments and provides a method for identifying Kerr black holes in the Universe.	MIT, Cambridge, MA 02139 USA; Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel	Massachusetts Institute of Technology (MIT); Tel Aviv University	van Putten, MHPM (corresponding author), MIT, Room 2-378, Cambridge, MA 02139 USA.	mvp@schauder.mit.edu	van Putten, Maurice H./F-5237-2011; van Putten, Maurice/R-3171-2019	Levinson, Amir/0000-0001-7572-4060				ABRAMOVICI A, 1992, SCIENCE, V256, P325, DOI 10.1126/science.256.5055.325; Bailyn CD, 1998, ASTROPHYS J, V499, P367, DOI 10.1086/305614; BLOOM JS, IN PRESS ASTROPHYS J; BRADASCHIA C, 1992, PHYS LETT A, V163, P15, DOI 10.1016/0375-9601(92)90152-C; CARTER B, 1968, PHYS REV, V174, P1559, DOI 10.1103/PhysRev.174.1559; COHEN JM, 1975, ASTROPHYS J, V201, P783, DOI 10.1086/153944; Frail DA, 2001, ASTROPHYS J, V562, pL55, DOI 10.1086/338119; GOLDREICH P, 1969, ASTROPHYS J, V157, P869, DOI 10.1086/150119; KERR RP, 1963, PHYS REV LETT, V11, P237, DOI 10.1103/PhysRevLett.11.237; KOUVELIOTOU C, 1993, ASTROPHYS J, V413, pL101, DOI 10.1086/186969; Lee HK, 2001, MON NOT R ASTRON SOC, V324, P781, DOI 10.1046/j.1365-8711.2001.04401.x; Levinson A, 2000, PHYS REV LETT, V85, P236, DOI 10.1103/PhysRevLett.85.236; MIRABEL IF, 1994, NATURE, V371, P46, DOI 10.1038/371046a0; Paczynski B., 1991, Acta Astronomica, V41, P257; Paczynski B, 1998, ASTROPHYS J, V494, pL45, DOI 10.1086/311148; PUNSLY B, 1990, ASTROPHYS J, V350, P518, DOI 10.1086/168408; RUDERMAN MA, 1975, ASTROPHYS J, V196, P51, DOI 10.1086/153393; TAKAHASHI M, 1990, ASTROPHYS J, V363, P206, DOI 10.1086/169331; UNRUH WG, 1974, PHYS REV D, V10, P3194, DOI 10.1103/PhysRevD.10.3194; van Putten MHPM, 2000, PHYS REV LETT, V84, P3752, DOI 10.1103/PhysRevLett.84.3752; van Putten MHPM, 1999, SCIENCE, V284, P115, DOI 10.1126/science.284.5411.115; van Putten MHPM, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.091101; van Putten MHPM, 2001, ASTROPHYS J, V562, pL51, DOI 10.1086/338120; van Putten MHPM, 2001, ASTROPHYS J, V552, pL31, DOI 10.1086/320253; van Putten MHPM, 2001, PHYS REP, V345, P1, DOI 10.1016/S0370-1573(01)00014-X; van Putten MHPM, 2001, ASTROPHYS J, V555, pL41, DOI 10.1086/321731; WALD RM, 1974, PHYS REV D, V10, P1680, DOI 10.1103/PhysRevD.10.1680; WOOSLEY SE, 1993, ASTROPHYS J, V405, P273, DOI 10.1086/172359	29	24	24	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2002	295	5561					1874	1877		10.1126/science.1068634	http://dx.doi.org/10.1126/science.1068634			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11859153				2022-12-28	WOS:000174299500032
J	Schwetz, BA				Schwetz, BA			Warning on Serzone	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commiss Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commiss Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	8	9	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2002	287	9					1103	1103		10.1001/jama.287.9.1103-b	http://dx.doi.org/10.1001/jama.287.9.1103-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527KV	11879090				2022-12-28	WOS:000174186000004
J	Loff, B				Loff, B			Detention of asylum seekers in Australia	LANCET			English	Editorial Material									Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3181, Australia	Monash University	Loff, B (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3181, Australia.		Loff, Bebe/G-9241-2014	Loff, Bebe/0000-0003-1963-6503				Mares P, 2001, BORDERLINE AUSTR TRE; Sultan A, 2001, MED J AUSTRALIA, V175, P593, DOI 10.5694/j.1326-5377.2001.tb143740.x; 2001, LANCET, V357, P1436; 2001, LANCET, V359, P683	4	12	12	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 2	2002	359	9308					792	793		10.1016/S0140-6736(02)07887-X	http://dx.doi.org/10.1016/S0140-6736(02)07887-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526DZ	11888610				2022-12-28	WOS:000174115200035
J	Davidson, EH; Rast, JP; Oliveri, P; Ransick, A; Calestani, C; Yuh, CH; Minokawa, T; Amore, G; Hinman, V; Arenas-Mena, C; Otim, O; Brown, CT; Livi, CB; Lee, PY; Revilla, R; Rust, AG; Pan, ZJ; Schilstra, MJ; Clarke, PJC; Arnone, MI; Rowen, L; Cameron, RA; McClay, DR; Hood, L; Bolouri, H				Davidson, EH; Rast, JP; Oliveri, P; Ransick, A; Calestani, C; Yuh, CH; Minokawa, T; Amore, G; Hinman, V; Arenas-Mena, C; Otim, O; Brown, CT; Livi, CB; Lee, PY; Revilla, R; Rust, AG; Pan, ZJ; Schilstra, MJ; Clarke, PJC; Arnone, MI; Rowen, L; Cameron, RA; McClay, DR; Hood, L; Bolouri, H			A genomic regulatory network for development	SCIENCE			English	Review							SEA-URCHIN EMBRYO; VEGETAL-PLATE; STRONGYLOCENTROTUS-PURPURATUS; BETA-CATENIN; CELL FATES; GENE; SPECIFICATION; MECHANISMS; PROTEIN; EMBRYOGENESIS	Development of the body plan is controlled by large networks of regulatory genes. A gene regulatory network that controls the specification of endoderm and mesoderm in the sea urchin embryo is summarized here. The network was derived from large-scale perturbation analyses, in combination with computational methodologies, genomic data, cis-regulatory analysis, and molecular embryology. The network contains over 40 genes at present, and each node can be directly verified at the DNA sequence level by cis-regulatory analysis. Its architecture reveals specific and general aspects of development, such as how given cells generate their ordained fates in the embryo and why the process moves inexorably forward in developmental time.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Hertfordshire, Sci & Technol Res Ctr, Hatfield AL10 9AB, Herts, England; Inst Syst Biol, Seattle, WA 98105 USA; Duke Univ, Dept Zool, Durham, NC 27708 USA; Staz Zool Anton Dohrn, I-80121 Naples, Italy	California Institute of Technology; University of Hertfordshire; Institute for Systems Biology (ISB); Duke University; Stazione Zoologica Anton Dohrn di Napoli	Davidson, EH (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	davidson@caltech.edu	Yuh, Chiou-Hwa/E-3972-2010; Otim, Ochan/AAN-7301-2020; Yuh, Chiou-Hwa/AAL-3531-2020; Yuh, Chiou-Hwa/AAL-2938-2020	Otim, Ochan/0000-0001-7272-4356; Livi, Carolina/0000-0001-8389-2830; Minokawa, Takuya/0000-0001-5145-7076; Revilla-i-Domingo, Roger/0000-0001-7943-5776; ARNONE, Maria Immacolata/0000-0002-9012-7624; Cameron, R. Andrew/0000-0003-3947-6041; Calestani, Cristina/0000-0001-8122-9349; Schilstra, Maria/0000-0001-5931-9049; Brown, C. Titus/0000-0001-6001-2677; Yuh, Chiou-Hwa/0000-0002-2356-1551; Oliveri, Paola/0000-0002-3477-8529; Rust, Alistair/0000-0001-7287-192X	NCRR NIH HHS [RR-06591, RR-15044] Funding Source: Medline; NICHD NIH HHS [HD-37105] Funding Source: Medline; NIGMS NIH HHS [GM-61005] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD037105] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR015044, R01RR006591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061005] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKASAKI K, COMMUNICATION; Angerer LM, 2000, DEV BIOL, V218, P1, DOI 10.1006/dbio.1999.9553; Arnone MI, 1997, DEVELOPMENT, V124, P1851; BOLOURI H, IN PRESS DEV BIOL; BRITTEN RJ, 1971, Q REV BIOL, V46, P111, DOI 10.1086/406830; BROWN CT, IN PRESS DEV BIOL; CALESTANI C, UNPUB; CAMERON R, UNPUB; Cameron RA, 1997, DEV BIOL, V187, P236, DOI 10.1006/dbio.1997.8615; Cameron RA, 2000, P NATL ACAD SCI USA, V97, P9514, DOI 10.1073/pnas.160261897; Chuang CK, 1996, DEV GENET, V19, P231, DOI 10.1002/(SICI)1520-6408(1996)19:3<231::AID-DVG6>3.0.CO;2-A; Davidson E. H., 2001, DEV EVOLUTION; Davidson EH, 1998, DEVELOPMENT, V125, P3269; DAVIDSON EH, 1991, DEVELOPMENT, V113, P1; DAVIDSON EH, IN PRESS DEV BIOL; FLYTZANIS CN, 1987, P NATL ACAD SCI USA, V84, P151, DOI 10.1073/pnas.84.1.151; Gonzalez P, 1999, MOL BIOL EVOL, V16, P938, DOI 10.1093/oxfordjournals.molbev.a026183; Gross JM, 2001, DEV BIOL, V239, P132, DOI 10.1006/dbio.2001.0426; HINMAN V, UNPUB; Horstadius S, 1939, BIOL REV CAMB PHILOS, V14, P132, DOI 10.1111/j.1469-185X.1939.tb00929.x; Howard EW, 2001, DEVELOPMENT, V128, P365; Jacobsen TL, 1998, DEVELOPMENT, V125, P4531; Kenny AP, 1999, DEVELOPMENT, V126, P5473; Kirchhamer CV, 1996, DEVELOPMENT, V122, P333; Kurokawa D, 1999, MECH DEVELOP, V80, P41, DOI 10.1016/S0925-4773(98)00192-0; Lee P.-F., UNPUB; Li XT, 1997, DEV BIOL, V187, P253, DOI 10.1006/dbio.1997.8610; Li XT, 1999, DEV BIOL, V212, P425, DOI 10.1006/dbio.1999.9360; LIVI C, UNPUB; Logan CY, 1999, DEVELOPMENT, V126, P345; Logan CY, 1997, DEVELOPMENT, V124, P2213; Luke NH, 1997, DEV GROWTH DIFFER, V39, P285; MCMAHON AP, 1985, DEV BIOL, V108, P420, DOI 10.1016/0012-1606(85)90045-4; NOCENTEMCGRATH C, 1989, DEV BIOL, V136, P264, DOI 10.1016/0012-1606(89)90147-4; OLIVERI P, UNPUB; OLIVERI P, IN PRESS DEV BIOL; PAUL CRC, 1984, BIOL REV, V59, P443, DOI 10.1111/j.1469-185X.1984.tb00411.x; Poustka AJ, 1999, GENOMICS, V59, P122, DOI 10.1006/geno.1999.5852; RANSICK A, 1993, MECH DEVELOP, V42, P117, DOI 10.1016/0925-4773(93)90001-E; Ransick A, 1998, DEV BIOL, V195, P38, DOI 10.1006/dbio.1997.8814; RANSICK A, 1995, DEVELOPMENT, V121, P3215; RANSICK A, 1993, SCIENCE, V259, P1134, DOI 10.1126/science.8438164; RANSICK A, UNPUB; RANSICK A, IN PRESS DEV BIOL; Rast JP, 2000, DEV BIOL, V228, P270, DOI 10.1006/dbio.2000.9941; RAST JP, UNPUB; Ruffins SW, 1996, DEVELOPMENT, V122, P253; RUFFINS SW, 1993, DEV BIOL, V160, P285, DOI 10.1006/dbio.1993.1306; Sherwood DR, 1997, DEVELOPMENT, V124, P3363; Sherwood DR, 1999, DEVELOPMENT, V126, P1703; Sherwood DR, 2001, DEVELOPMENT, V128, P2221; SOLTYSIKESPANOLA M, 1994, DEV BIOL, V165, P73, DOI 10.1006/dbio.1994.1235; SUCOV HM, 1988, GENE DEV, V2, P1238, DOI 10.1101/gad.2.10.1238; Sweet HC, 1999, DEVELOPMENT, V126, P5255; SWEET HC, IN PRESS DEVELOPMENT; Wang WY, 1996, MECH DEVELOP, V60, P185, DOI 10.1016/S0925-4773(96)00614-4; WIKRAMANAYAKE A, UNPUB; Yeh E, 2001, CURR BIOL, V11, P1675, DOI 10.1016/S0960-9822(01)00527-9; Yeh E, 2000, EMBO J, V19, P4827, DOI 10.1093/emboj/19.17.4827; Yuh CH, 1998, SCIENCE, V279, P1896, DOI 10.1126/science.279.5358.1896; Yuh CH, 2001, DEVELOPMENT, V128, P617; YUH CH, IN PRESS DEV BIOL; Zhu XD, 2001, DEVELOPMENT, V128, P2615	63	1081	1115	3	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2002	295	5560					1669	1678		10.1126/science.1069883	http://dx.doi.org/10.1126/science.1069883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872831				2022-12-28	WOS:000174212900035
J	Verlinsky, Y; Rechitsky, S; Verlinsky, O; Masciangelo, C; Lederer, K; Kuliev, A				Verlinsky, Y; Rechitsky, S; Verlinsky, O; Masciangelo, C; Lederer, K; Kuliev, A			Preimplantation diagnosis for early-onset Alzheimer disease caused by V717L mutation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRECURSOR PROTEIN GENE	Context Indications for preimplantation genetic diagnosis (PGD) have recently been expanded to include disorders with genetic predisposition to allow only embryos free of predisposing genes to be preselected for transfer back to patients, with no potential for pregnancy termination. Objective To perform PGD for early-onset Alzheimer disease (AD), determined by nearly completely penetrant autosomal dominant mutation in the amyloid precursor protein (APP) gene. Design Analysis undertaken in 1999-2000 of DNA for the V717L mutation (valine to leucine substitution at codon 717) in the APP gene in the first and second polar bodies, obtained by sequential sampling of oocytes following in vitro fertilization, to preselect and transfer back to the patient only the embryos that resulted from mutation-free oocytes. Setting An in vitro fertilization center in Chicago, III. Patients A 30-year-old AD-asymptomatic woman with a V717L mutation that was identified by predictive testing of a family with a history of early-onset AD. Main Outcome Measures Results of mutation analysis; pregnancy outcome. Results Four of 15 embryos tested for maternal mutation in 2 PGD cycles, originating from V717L mutation-free oocytes, were preselected for embryo transfer, yielding a clinical pregnancy and birth of a healthy child free of predisposing gene mutation according to chorionic villus sampling and testing of the neonate's blood. Conclusion This is the first known PGD procedure for inherited early-onset AD resulting in a clinical pregnancy and birth of a child free of inherited predisposition to early-onset AD.	Illinois Masonic Med Ctr, Inst Reprod Genet, Chicago, IL 60657 USA; IVF Illinois, Chicago, IL USA		Verlinsky, Y (corresponding author), 2825 N Halsted St, Chicago, IL 60657 USA.		Kuliev, Anver/P-5666-2018	Kuliev, Anver/0000-0002-2486-9339				Cram David, 2001, Reprod Biomed Online, V3, P3; Damewood MD, 2001, JAMA-J AM MED ASSOC, V285, P3143, DOI 10.1001/jama.285.24.3143; Edwards R G, 2000, Reprod Biomed Online, V1, P31; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; *INT WORK GROUP PR, 2001, REPROD BIOMED ONLINE, V3, P49; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Murrell JR, 2000, ARCH NEUROL-CHICAGO, V57, P885, DOI 10.1001/archneur.57.6.885; Rechitsky S, 1999, J ASSIST REPROD GEN, V16, P192, DOI 10.1023/A:1020312823155; RECHITSKY S, 2000, FETAL CELLS MATERNAL, P8; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Simpson Joe Leigh, 2001, Reprod Biomed Online, V3, P2; TUPLER R, 1993, HUM MOL GENET, V2, P620, DOI 10.1093/hmg/2.5.620; Verlinsky Y, 2001, JAMA-J AM MED ASSOC, V285, P3130, DOI 10.1001/jama.285.24.3130; VERLINSKY Y, 2000, ATLAS PREIMPLANTATIO; Verlinsky Yury, 2001, Reprod Biomed Online, V2, P102	15	60	65	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2002	287	8					1018	1021		10.1001/jama.287.8.1018	http://dx.doi.org/10.1001/jama.287.8.1018			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525CX	11866650				2022-12-28	WOS:000174052100030
J	Gibbons, GW; Shellard, EPS				Gibbons, GW; Shellard, EPS			Tales of singularities	SCIENCE			English	Editorial Material									Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England	University of Cambridge	Gibbons, GW (corresponding author), Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England.		Gibbons, Gary/AAD-5637-2022	Gibbons, Gary/0000-0001-7425-9478				Gibbons G, 2000, SCIENCE, V287, P49, DOI 10.1126/science.287.5450.49	1	7	7	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2002	295	5559					1476	1477		10.1126/science.1070253	http://dx.doi.org/10.1126/science.1070253			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11859182				2022-12-28	WOS:000173981300038
J	Whitchurch, CB; Tolker-Nielsen, T; Ragas, PC; Mattick, JS				Whitchurch, CB; Tolker-Nielsen, T; Ragas, PC; Mattick, JS			Extracellular DNA required for bacterial biofilm formation	SCIENCE			English	Article							PSEUDOMONAS-AERUGINOSA		Univ Queensland, Inst Mol Biosci, ARC Special Res Ctr Funct & Appl Genom, Brisbane, Qld 4072, Australia; Tech Univ Denmark, Bioctr DTU, Mol Microbial Ecol Grp, DK-2800 Lyngby, Denmark	University of Queensland; Technical University of Denmark	Mattick, JS (corresponding author), Univ Queensland, Inst Mol Biosci, ARC Special Res Ctr Funct & Appl Genom, Brisbane, Qld 4072, Australia.		Mattick, John/ABH-6130-2020; Mattick, John S/I-7789-2012; Whitchurch, Cynthia B/A-5954-2008	Mattick, John/0000-0002-7680-7527; Mattick, John S/0000-0002-7680-7527; Whitchurch, Cynthia B/0000-0003-2296-3791; Tolker-Nielsen, Tim/0000-0002-9751-474X				Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; KADURUGAMUWA JL, 1995, J BACTERIOL, V177, P3998, DOI 10.1128/jb.177.14.3998-4008.1995; Lipford GB, 1998, TRENDS MICROBIOL, V6, P496, DOI 10.1016/S0966-842X(98)01408-5; MUTO Y, 1986, MICROBIOL IMMUNOL, V30, P621, DOI 10.1111/j.1348-0421.1986.tb02989.x; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1; Tolker-Nielsen T, 2000, J BACTERIOL, V182, P6482, DOI 10.1128/JB.182.22.6482-6489.2000	8	1429	1536	10	376	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2002	295	5559					1487	1487		10.1126/science.295.5559.1487	http://dx.doi.org/10.1126/science.295.5559.1487			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11859186				2022-12-28	WOS:000173981300042
J	Clarke, AB; Voight, B; Neri, A; Macedonio, G				Clarke, AB; Voight, B; Neri, A; Macedonio, G			Transient dynamics of vulcanian explosions and column collapse	NATURE			English	Article							SOUFRIERE HILLS VOLCANO; PYROCLASTIC FLOWS; NUMERICAL-MODELS; WEST-INDIES; ERUPTIONS; MAGMA; MONTSERRAT; SIMULATION	Several analytical and numerical eruption models have provided insight into volcanic eruption behaviour(1-5), but most address plinian-type eruptions where vent conditions are quasi-steady. Only a few studies have explored the physics of short-duration vulcanian explosions(6-9) with unsteady vent conditions and blast events(10,11). Here we present a technique that links unsteady vent flux of vulcanian explosions to the resulting dispersal of volcanic ejecta, using a numerical, axisymmetric model with multiple particle sizes. We use observational data from well documented explosions in 1997 at the Soufriere Hills volcano in Montserrat, West Indies, to constrain pre-eruptive subsurface initial conditions and to compare with our simulation results. The resulting simulations duplicate many features of the observed explosions, showing transitional behaviour where mass is divided between a buoyant plume and hazardous radial pyroclastic currents fed by a collapsing fountain(12). We find that leakage of volcanic gas from the conduit through surrounding rocks over a short period (of the order of 10 hours) or retarded exsolution can dictate the style of explosion. Our simulations also reveal the internal plume dynamics and particle-size segregation mechanisms that may occur in such eruptions.	Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; Ist Geosci & Georisorse, Consiglio Nazl Ric, Dept Earth Sci, Pisa, Italy; Ist Nazl Geofis & Vulcanol, Osservatorio Vesuviano, Naples, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Consiglio Nazionale delle Ricerche (CNR); Istituto di Geoscienze e Georisorse (IGG-CNR); Istituto Nazionale Geofisica e Vulcanologia (INGV)	Clarke, AB (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.		Macedonio, Giovanni/G-3855-2011; Neri, Augusto/A-1623-2009	Macedonio, Giovanni/0000-0001-6604-1479; Neri, Augusto/0000-0002-3536-3624; Clarke, Amanda/0000-0002-1637-0474				AMSDEN AA, 1974, LA5680 LOS AL NAT LA; Barclay J, 1998, GEOPHYS RES LETT, V25, P3437, DOI 10.1029/98GL00856; DEVINE JD, 1998, GSA TODAY, V8, P2; DOBRAN F, 1993, J GEOPHYS RES-SOL EA, V98, P4231, DOI 10.1029/92JB02409; DRUITT TH, 1998, 04 MONTS VOLC OBS; FAGENTS SA, 1993, GEOPHYS J INT, V113, P359, DOI 10.1111/j.1365-246X.1993.tb00892.x; FORMENTI Y, 2000, IAVCEI GEN ASS 2000, P232; Gidaspow D., 1994, MULTIPLE FLOW FLUIDI, DOI [10.1177/1748895811401979, DOI 10.1177/1748895811401979]; HOBLITT RP, 1986, 1335 US GEOL SURV; JAUPART C, 1991, EARTH PLANET SC LETT, V102, P413, DOI 10.1016/0012-821X(91)90032-D; KIEFFER SW, 1981, US GEOL SURV PROF PA, V1250, P379; Melnik O, 1999, NATURE, V402, P37, DOI 10.1038/46950; Murphy MD, 2000, J PETROL, V41, P21, DOI 10.1093/petrology/41.1.21; Neri A, 1996, J GEOPHYS RES-SOL EA, V101, P8153, DOI 10.1029/95JB03451; NERI A, 2001, 20012 I NAZ GEOF VUL; NERI A, 1998, MULTIPHASE FLOW MODE; NERI A, IN PRESS J VOLCANOL; Oberhuber JM, 1998, J VOLCANOL GEOTH RES, V87, P29, DOI 10.1016/S0377-0273(98)00099-7; RIVARD WC, 1997, LANUREG6623 LOS AL N; SELF S, 1979, NATURE, V277, P440, DOI 10.1038/277440a0; Sparks RSJ, 1997, EARTH PLANET SC LETT, V150, P177, DOI 10.1016/S0012-821X(97)00109-X; SPARKS RSJ, 1978, J GEOPHYS RES, V83, P1727, DOI 10.1029/JB083iB04p01727; Taylor GA, 1958, AUSTR BUR MINERAL RE, V38, P1; TURCOTTE DL, 1990, GEOPHYS J INT, V103, P211, DOI 10.1111/j.1365-246X.1990.tb01763.x; VALENTINE GA, 1989, J GEOPHYS RES-SOLID, V94, P1867, DOI 10.1029/JB094iB02p01867; Voight B, 1999, SCIENCE, V283, P1138, DOI 10.1126/science.283.5405.1138; WILSON L, 1980, GEOPHYS J ROY ASTR S, V63, P117, DOI 10.1111/j.1365-246X.1980.tb02613.x; WOHLETZ KH, 1984, J GEOPHYS RES, V89, P8269, DOI 10.1029/JB089iB10p08269; Wolf T., 1878, NEUES JB MINERAL GEO, P113; WOODS AW, 1995, NUCL ENG DES, V155, P345, DOI 10.1016/0029-5493(94)00881-X	30	97	97	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 21	2002	415	6874					897	901		10.1038/415897a	http://dx.doi.org/10.1038/415897a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859366				2022-12-28	WOS:000173941000042
J	Fox, BA; Bzik, DJ				Fox, BA; Bzik, DJ			De novo pyrimidine biosynthesis is required for virulence of Toxoplasma gondii	NATURE			English	Article							CARBAMOYL-PHOSPHATE SYNTHETASE; PLASMODIUM-FALCIPARUM; PROTOZOAN PARASITE; GENE; TRANSFORMATION; RESISTANCE; CLONING	Toxoplasma gondii is a ubiquitous protozoan parasite that is responsible for severe congenital birth defects and fatal toxoplasmic encephalitis in immunocompromized people(1). Fundamental aspects of obligate intracellular replication and pathogenesis are only now beginning to emerge for protozoan parasites. T. gondii has a fragmented pathway for salvaging pyrimidine nucleobases derived from the parasite or host cell, and this limited pyrimidine salvage capacity is funnelled exclusively through uracil phosphoribosyltransferase(2,3). Disrupting the function of this enzyme does not affect the growth of T. gondii tachyzoites(4), which suggests that the de novo pyrimidine biosynthesis pathway may be necessary for growth. We have examined the virulence of T. gondii mutants that lack carbamoyl phosphate synthetase II (uracil auxotrophs) to determine whether de novo pyrimidine biosynthesis is required in vivo. Here we show that T. gondii uracil auxotrophs are completely avirulent not only in immune-competent BALB/c mice but also in mice that lack interferon-gamma. A single injection of the uracil auxotroph into BALB/c mice induces long-term protective immunity to toxoplasmosis. Our findings indicate the significance of the de novo pyrimidine biosynthesis pathway for the virulence of parasitic protozoa, and suggest routes for developing vaccines and chemotherapy.	Dartmouth Coll Sch Med, Dept Microbiol & Immunol, Lebanon, NH 03756 USA	Dartmouth College	Bzik, DJ (corresponding author), Dartmouth Coll Sch Med, Dept Microbiol & Immunol, Lebanon, NH 03756 USA.	David.J.Bzik@Dartmouth.edu			NIAID NIH HHS [R01 AI041930] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041930] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASAI T, 1983, MOL BIOCHEM PARASIT, V7, P89, DOI 10.1016/0166-6851(83)90037-3; BZIK DJ, 1987, P NATL ACAD SCI USA, V84, P8360, DOI 10.1073/pnas.84.23.8360; Chansiri K, 1995, MOL BIOCHEM PARASIT, V74, P239, DOI 10.1016/0166-6851(95)02499-9; Charest H, 2000, J IMMUNOL, V165, P2084, DOI 10.4049/jimmunol.165.4.2084; DONALD RGK, 1995, P NATL ACAD SCI USA, V92, P5749, DOI 10.1073/pnas.92.12.5749; DONALD RGK, 1993, P NATL ACAD SCI USA, V90, P11703, DOI 10.1073/pnas.90.24.11703; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; FLORES MVC, 1994, MOL BIOCHEM PARASIT, V68, P315, DOI 10.1016/0166-6851(94)90176-7; Fox BA, 2001, MOL BIOCHEM PARASIT, V116, P85, DOI 10.1016/S0166-6851(01)00302-4; ILTZSCH MH, 1993, J EUKARYOT MICROBIOL, V40, P24, DOI 10.1111/j.1550-7408.1993.tb04877.x; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; MAHAN MJ, 1993, SCIENCE, V259, P686, DOI 10.1126/science.8430319; MAHMOUD AAF, 1976, NATURE, V263, P56, DOI 10.1038/263056a0; PFEFFERKORN ER, 1976, EXP PARASITOL, V36, P365, DOI 10.1016/0014-4894(76)90040-0; PFEFFERKORN ER, 1978, EXP PARASITOL, V44, P26, DOI 10.1016/0014-4894(78)90077-2; Schardl J, 1996, J PLAST FILM SHEET, V12, P157, DOI 10.1177/875608799601200208; SIBLEY LD, 1994, P NATL ACAD SCI USA, V91, P5508, DOI 10.1073/pnas.91.12.5508; SOLDATI D, 1993, SCIENCE, V260, P349, DOI 10.1126/science.8469986; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869	19	168	189	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2002	415	6874					926	929		10.1038/415926a	http://dx.doi.org/10.1038/415926a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859373	Bronze			2022-12-28	WOS:000173941000049
J	Gmachl, C; Sivco, DL; Colombelli, R; Capasso, F; Cho, AY				Gmachl, C; Sivco, DL; Colombelli, R; Capasso, F; Cho, AY			Ultra-broadband semiconductor laser	NATURE			English	Article							QUANTUM CASCADE LASER; WAVELENGTH	The fundamental mechanism behind laser action leads in general only to narrowband, single-wavelength emission. Several approaches for achieving spectrally broadband laser action have been put forward, such as enhancing the optical feedback in the wings of the gain spectrum(1,2), multi-peaked gain spectra(3,4), and the most favoured technique at present, ultrashort pulse excitation(5,6). Each of these approaches has drawbacks, such as a complex external laser cavity configuration, a non-flat optical gain envelope function, or an inability to operate in continuous mode, respectively. Here we present a monolithic, mid-infrared 'super-continuum' semiconductor laser that has none of these drawbacks. We adopt a quantum cascade(7,8) configuration, where a number of dissimilar intersubband optical transitions are made to cooperate in order to provide broadband optical gain from 5 to 8 mum wavelength. Laser action with a Fabry-Perot spectrum covering all wavelengths from 6 to 8 mum simultaneously is demonstrated with this approach. Lasers that emit light over such an extremely wide wavelength range are of interest for applications as varied as terabit optical data communications(9) or ultra-precision metrology(10) and spectroscopy(11).	Lucent Technol, Bell Labs, Murray Hill, NJ 07974 USA	Alcatel-Lucent; Lucent Technologies; AT&T	Gmachl, C (corresponding author), Lucent Technol, Bell Labs, 600 Mt Ave, Murray Hill, NJ 07974 USA.			Colombelli, Raffaele/0000-0002-1540-9920				Campman KL, 1996, APPL PHYS LETT, V69, P2554, DOI 10.1063/1.117737; Capasso F, 2000, IEEE J SEL TOP QUANT, V6, P931, DOI 10.1109/2944.902142; CAPASSO F, 1987, SCIENCE, V235, P172, DOI 10.1126/science.235.4785.172; Chernikov SV, 1997, OPT LETT, V22, P298, DOI 10.1364/OL.22.000298; Cho AY, 1994, MOL BEAM EPITAXY; Collings BC, 2000, OPT PHOTONICS NEWS, V11, P31, DOI 10.1364/OPN.11.3.000031; FAIST J, 1994, SCIENCE, V264, P553, DOI 10.1126/science.264.5158.553; Faist J, 1996, APPL PHYS LETT, V68, P3680, DOI 10.1063/1.115741; FUKE A, 1987, AIP C P, V160, P229; Gmachl C, 2001, REP PROG PHYS, V64, P1533, DOI 10.1088/0034-4885/64/11/204; Gmachl C, 2001, APPL PHYS LETT, V79, P572, DOI 10.1063/1.1383806; HALL DC, 1989, APPL PHYS LETT, V55, P752, DOI 10.1063/1.101796; Jones DJ, 2000, SCIENCE, V288, P635, DOI 10.1126/science.288.5466.635; MITTELSTEIN M, 1989, APPL PHYS LETT, V54, P1092, DOI 10.1063/1.100767; Muravjov AV, 1999, J APPL PHYS, V86, P3512, DOI 10.1063/1.371250; Ranka JK, 2000, OPT LETT, V25, P25, DOI 10.1364/OL.25.000025; Schiff H. I, 1994, AIR MONITORING SPECT, P239; SIRTORI C, 1995, APPL PHYS LETT, V66, P3242, DOI 10.1063/1.113391; SPIELMANN C, 1994, IEEE J QUANTUM ELECT, V30, P1100, DOI 10.1109/3.291379	19	240	256	3	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 21	2002	415	6874					883	887		10.1038/415883a	http://dx.doi.org/10.1038/415883a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859362				2022-12-28	WOS:000173941000038
J	Mina, B; Dym, JP; Kuepper, F; Tso, R; Arrastia, C; Kaplounova, I; Faraj, H; Kwapniewski, A; Krol, CM; Grosser, M; Glick, J; Fochios, S; Remolina, A; Vasovic, L; Moses, J; Robin, T; DeVita, M; Tapper, ML				Mina, B; Dym, JP; Kuepper, F; Tso, R; Arrastia, C; Kaplounova, I; Faraj, H; Kwapniewski, A; Krol, CM; Grosser, M; Glick, J; Fochios, S; Remolina, A; Vasovic, L; Moses, J; Robin, T; DeVita, M; Tapper, ML			Fatal inhalational anthrax with unknown source of exposure in a 61-year-old woman in New York city	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								A 61-year-old woman who was a New York City hospital employee developed fatal inhalational anthrax, but with an unknown source of anthrax exposure. The patient presented with shortness of breath, malaise, and cough that had developed 3 days prior to admission. Within hours of presentation, she developed respiratory failure and septic shock and required mechanical ventilation and vasopressor therapy. Spiral contrast-enhanced computed tomography of the chest demonstrated large bilateral pleural effusions and hemorrhagic mediastinitis. Blood cultures, as well as DNA amplification by polymerase chain reaction of the blood, bronchial washings, and pleural fluid specimens, were positive for Bacillus anthracis. The clinical course was complicated by liver failure, renal failure, severe metabolic acidosis, disseminated intravascular coagulopathy, and cardiac tamponade, and the patient died on the fourth hospital day. The cause of death was inhalational anthrax. Despite epidemiologic investigation, including environmental samples from the patient's residence and workplace, no mechanism for anthrax exposure has been identified.	Lenox Hill Hosp, Dept Med, Sect Crit Care Med, New York, NY 10021 USA; Lenox Hill Hosp, Dept Radiol, New York, NY 10021 USA; Lenox Hill Hosp, Sect Emergency Med, New York, NY 10021 USA; Lenox Hill Hosp, Cardiol Sect, New York, NY 10021 USA; Lenox Hill Hosp, Dept Pathol, New York, NY 10021 USA; Lenox Hill Hosp, Sect Intervent Cardiol, New York, NY 10021 USA; Lenox Hill Hosp, Microbiol Lab, New York, NY 10021 USA; Lenox Hill Hosp, Nephrol Sect, New York, NY 10021 USA; Lenox Hill Hosp, Infect Dis Sect, New York, NY 10021 USA; Humboldt Univ, Charite, D-1086 Berlin, Germany	Northwell Health; Northwell Health; Northwell Health; Northwell Health; Northwell Health; Northwell Health; Northwell Health; Northwell Health; Northwell Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Mina, B (corresponding author), Lenox Hill Hosp, Dept Med, Sect Crit Care Med, 100 E 77th St, New York, NY 10021 USA.	bmina@lenoxhill.net		Vasovic, Ljiljana/0000-0001-7759-4546; Mina, Bushra/0000-0001-8796-9591				Borio L, 2001, JAMA-J AM MED ASSOC, V286, P2554, DOI 10.1001/jama.286.20.2554; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P1008; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P941; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; Mayer TA, 2001, JAMA-J AM MED ASSOC, V286, P2549, DOI 10.1001/jama.286.20.2549; Pile JC, 1998, ARCH INTERN MED, V158, P429, DOI 10.1001/archinte.158.5.429; Shafazand S, 1999, CHEST, V116, P1369, DOI 10.1378/chest.116.5.1369; Swartz MN, 2001, NEW ENGL J MED, V345, P1621, DOI 10.1056/NEJMra012892	11	69	71	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2002	287	7					858	862		10.1001/jama.287.7.858	http://dx.doi.org/10.1001/jama.287.7.858			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	522XP	11851577				2022-12-28	WOS:000173922500024
J	Irwig, L; Bossuyt, P; Glasziou, P; Gatsonis, C; Lijmer, J				Irwig, L; Bossuyt, P; Glasziou, P; Gatsonis, C; Lijmer, J			Evidence base of clinical diagnosis - Designing studies to ensure that estimates of test accuracy are transferable	BRITISH MEDICAL JOURNAL			English	Article							FACTORS AFFECTING SENSITIVITY; SPECIFICITY		Univ Sydney, Dept Publ Hlth & Community Med, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia; Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1100 DE Amsterdam, Netherlands; Univ Queensland, Sch Med, Sch Populat Hlth, Herston, Qld 4006, Australia; Brown Univ, Ctr Stat Sci, Providence, RI USA	University of Sydney; University of Amsterdam; Academic Medical Center Amsterdam; University of Queensland; Brown University	Irwig, L (corresponding author), Univ Sydney, Dept Publ Hlth & Community Med, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia.		Glasziou, Paul/A-7832-2008; Bossuyt, Patrick M./B-4557-2016; Bossuyt, Patrick M/AAR-1183-2021	Glasziou, Paul/0000-0001-7564-073X; Bossuyt, Patrick M./0000-0003-4427-0128; Bossuyt, Patrick M/0000-0003-4427-0128				BEAM C, 1997, ARCH INTERN MED, V156, P209; BEGG CB, 1987, STAT MED, V6, P411, DOI 10.1002/sim.4780060402; Biggerstaff BJ, 2000, STAT MED, V19, P649, DOI 10.1002/(SICI)1097-0258(20000315)19:5&lt;649::AID-SIM371&gt;3.0.CO;2-H; Chock C, 1997, J CLIN EPIDEMIOL, V50, P1211, DOI 10.1016/S0895-4356(97)00122-4; DETRANO R, 1988, AM J MED, V84, P699, DOI 10.1016/0002-9343(88)90107-6; DORSI CJ, 1995, NEW ENGL J MED, V332, P1172; FURUKAWA TGD, 1999, LANCET, V353, P10; GATSONIS C, 1990, RADIOLOGY, V175, P571, DOI 10.1148/radiology.175.2.2183290; HLATKY MA, 1984, AM J MED, V77, P64, DOI 10.1016/0002-9343(84)90437-6; IRWIG L, 1994, ANN INTERN MED, V120, P667, DOI 10.7326/0003-4819-120-8-199404150-00008; LACHS MS, 1992, ANN INTERN MED, V117, P135, DOI 10.7326/0003-4819-117-2-135; MARSHALL RJ, 1989, BIOMETRICS, V45, P1213, DOI 10.2307/2531772; Molarius A, 1999, J CLIN EPIDEMIOL, V52, P1213, DOI 10.1016/S0895-4356(99)00114-6; Moons KGM, 1997, EPIDEMIOLOGY, V8, P12, DOI 10.1097/00001648-199701000-00002; Pena BMG, 1999, JAMA-J AM MED ASSOC, V282, P1041, DOI 10.1001/jama.282.11.1041; Richardson W S, 1995, ACP J Club, V123, pA12; ROZANSKI A, 1983, NEW ENGL J MED, V309, P518, DOI 10.1056/NEJM198309013090902; Rutter C M, 1995, Acad Radiol, V2 Suppl 1, pS48; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; STARMANS R, 1994, MED DECIS MAKING, V14, P208, DOI 10.1177/0272989X9401400302; Zandbergen EGJ, 1998, LANCET, V352, P1808, DOI 10.1016/S0140-6736(98)04076-8	21	165	169	2	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 16	2002	324	7338					669	671		10.1136/bmj.324.7338.669	http://dx.doi.org/10.1136/bmj.324.7338.669			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532QW	11895830	Green Submitted, Green Published			2022-12-28	WOS:000174487400033
J	Kitagawa, N; Ichihara, S				Kitagawa, N; Ichihara, S			Hearing visual motion in depth	NATURE			English	Article							CORTEX; ADAPTATION; PSYCHOPHYSICS	Auditory spatial perception is strongly affected by visual cues. For example, if auditory and visual stimuli are presented synchronously but from different positions, the auditory event is mislocated towards the locus of the visual stimulus-the ventriloquism effect(1,2). This 'visual capture' also occurs in motion perception in which a static auditory stimulus appears to move with the visual moving object(3,4). We investigated how the human perceptual system coordinates complementary inputs from auditory and visual senses. Here we show that an auditory aftereffect occurs from adaptation to visual motion in depth. After a few minutes of viewing a square moving in depth, a steady sound was perceived as changing loudness in the opposite direction. Adaptation to a combination of auditory and visual stimuli changing in a compatible direction increased the aftereffect and the effect of visual adaptation almost disappeared when the directions were opposite. On the other hand, listening to a sound changing in intensity did not affect the visual changing-size aftereffect. The results provide psychophysical evidence that, for processing of motion in depth, the auditory system responds to both auditory changing intensity and visual motion in depth.	Tokyo Metropolitan Univ, Dept Psychol, Hachioji, Tokyo 1920397, Japan	Tokyo Metropolitan University	Kitagawa, N (corresponding author), Tokyo Metropolitan Univ, Dept Psychol, 1-1 Minami Osawa, Hachioji, Tokyo 1920397, Japan.							BERTELSON P, 1981, PERCEPT PSYCHOPHYS, V29, P578, DOI 10.3758/BF03207374; Blauert J., 1997, SPATIAL HEARING PSYC; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; CORNSWEET TN, 1962, AM J PSYCHOL, V75, P485, DOI 10.2307/1419876; CUMMING BG, 1994, VISUAL DETECTION MOT, P333; Dong CJ, 2000, PERCEPT PSYCHOPHYS, V62, P1099, DOI 10.3758/BF03212091; Driver J, 2000, CURR BIOL, V10, pR731, DOI 10.1016/S0960-9822(00)00740-5; Ehrenstein WH, 1996, PERCEPT MOTOR SKILL, V82, P23, DOI 10.2466/pms.1996.82.1.23; GRANTHAM DW, 1989, PERCEPT PSYCHOPHYS, V45, P129, DOI 10.3758/BF03208047; JACK CE, 1973, PERCEPT MOTOR SKILL, V37, P967, DOI 10.2466/pms.1973.37.3.967; Kayahara T., 2001, Acoustical Science and Technology, V22, P49, DOI 10.1250/ast.22.49; Kitajima N, 1999, PERCEPT MOTOR SKILL, V89, P1139, DOI 10.2466/PMS.89.7.1139-1158; Lewis JW, 2000, CEREB CORTEX, V10, P873, DOI 10.1093/cercor/10.9.873; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; MATEEFF S, 1985, PERCEPTION, V14, P721, DOI 10.1068/p140721; Mather G., 1998, MOTION AFTEREFFECT M; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; REGAN D, 1978, VISION RES, V18, P209, DOI 10.1016/0042-6989(78)90188-8; Reinhardt-Rutland AH, 1998, PERCEPTION, V27, P473, DOI 10.1068/p270473; REINHARDTRUTLAND A, 1982, PERCEPT PSYCHOPHYS, V31, P63, DOI 10.3758/BF03206201; SHU ZJ, 1993, NATURE, V364, P721, DOI 10.1038/364721a0; WADE NJ, 1994, PERCEPTION, V23, P1111, DOI 10.1068/p231111; WELCH RB, 1986, HDB PERCEPTION HUMAN, V1, pCH25	25	146	152	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2002	416	6877					172	174		10.1038/416172a	http://dx.doi.org/10.1038/416172a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894093				2022-12-28	WOS:000174348100036
J	Andreoni, M; Sarmati, L; Nicastri, E; El Sawaf, G; Uccella, I; Bugarini, R; Parisi, SG; Rezza, G				Andreoni, M; Sarmati, L; Nicastri, E; El Sawaf, G; Uccella, I; Bugarini, R; Parisi, SG; Rezza, G			Primary human herpesvirus 8 infection in immunocompetent children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							KAPOSIS-SARCOMA; DNA-SEQUENCES; TRANSMISSION; ANTIBODIES; RISK	Context Human herpesvirus 8 (HHV-8) infection causes Kaposi sarcoma and lymphoproliferative disorders in immunosuppresed adults. Its manifestations in immunocompetent hosts are unknown. Objectives To determine whether HHV-8 primary infection is symptomatic in immunocompetent children and to identify the epidemiological and virological correlates of HHV-8 infection. Design and Setting Prospective cohort study conducted in the pediatric emergency department of a hospital in Alexandria, Egypt, between December 1, 1999, and April 30, 2000. Patients Eighty-six children aged 1 to 4 years who were evaluated fora febrile syndrome of undetermined origin. Main Outcome Measures Serological assay and polymerase chain reaction of blood and saliva samples for HHV-8, Information on potential risk factors for HHV-8 infection was also collected. Results Thirty-six children (41.9%) were seropositive; HHV-8 DNA sequences were detected in 14 (38.9%) of these 36 children (detected in saliva in 11 of 14). Significant associations were found between HHV-8 infection and close contact with at least 2 other children in the community (36 of 63 vs 6 of 23 for <2 children; adjusted odds ratio [OR], 3.50; 95% confidence interval [CI], 1.11-12.22) and admission to the emergency department in December or January (28 of 47 vs 14 of 39 for February-April; adjusted OR, 3.15; 95% Cl, 1.23-8.58). Six children had suspected primary HHV-8 infection; all but 1 had a febrile cutaneous craniocaudal maculopapular rash, which was more common among these children (5 of 6 vs 10 of 75; P<.001). For 3 of these 6 children, a second blood sample was obtained after the convalescence phase, and all 3 seroconverted for HHV-8. Conclusions Primary infection with HHV-8 may be associated with a febrile maculopapular skin rash among immunocompetent children. The finding of HHV-8 DNA sequences in saliva supports the hypothesis that transmission through saliva is the main mode of transmission in the pediatric age group.	Univ Roma Tor Vergata, Dept Publ Hlth, Rome, Italy; IRCCS Lazzaro Spallanzani, Ist Nazl Malattie Infett, Rome, Italy; Ist Super Sanita, Epidemiol & Biostat Lab, AIDS & STD Unit, I-00161 Rome, Italy; Univ Alexandria, Med Res Inst, Alexandria, Egypt	University of Rome Tor Vergata; IRCCS Lazzaro Spallanzani; Istituto Superiore di Sanita (ISS); Egyptian Knowledge Bank (EKB); Alexandria University	Andreoni, M (corresponding author), Univ Roma Tor Vergata, Dept Publ Hlth & Cellular Biol, Via Montpellier 1, I-00133 Rome, Italy.	andreoni@uniroma2.it	Parisi, Saverio G/C-6088-2009; Andreoni, Masimo/AAL-2214-2020; parisi, saverio/D-3115-2012; nicastri, emanuele/K-7780-2016; rezza, giovanni/D-4393-2016	nicastri, emanuele/0000-0002-5606-8712; rezza, giovanni/0000-0003-0268-6790; Andreoni, Massimo/0000-0002-3205-9758; sarmati, loredana/0000-0003-1452-0333				Andreoni M, 1999, J NATL CANCER I, V91, P465, DOI 10.1093/jnci/91.5.465; World Medical Association, 2013, JAMA, V310, P2191, DOI 10.1001/jama.2013.281053; ASANO Y, 1989, J PEDIATR-US, V114, P535, DOI 10.1016/S0022-3476(89)80689-4; Blauvelt A, 1997, J INFECT DIS, V176, P771, DOI 10.1086/517298; Calabro ML, 2001, J NATL CANCER I, V93, P154, DOI 10.1093/jnci/93.2.154; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Gao SJ, 1996, NAT MED, V2, P925, DOI 10.1038/nm0896-925; Goudsmit J, 2000, P NATL ACAD SCI USA, V97, P4838, DOI 10.1073/pnas.97.9.4838; Kedes DH, 1996, NAT MED, V2, P918, DOI 10.1038/nm0896-918; Lock MJ, 1997, J VIROL METHODS, V64, P19, DOI 10.1016/S0166-0934(96)02139-8; Luppi M, 2000, BLOOD, V96, P2355; Luppi M, 2000, NEW ENGL J MED, V343, P1378, DOI 10.1056/NEJM200011093431905; Martin JN, 2000, AM J EPIDEMIOL, V151, P225, DOI 10.1093/oxfordjournals.aje.a010196; Mayama S, 1998, INT J CANCER, V77, P817, DOI 10.1002/(SICI)1097-0215(19980911)77:6&lt;817::AID-IJC2&gt;3.0.CO;2-X; Oksenhendler E, 1998, NEW ENGL J MED, V338, P1585, DOI 10.1056/NEJM199805283382204; Pauk J, 2000, NEW ENGL J MED, V343, P1369, DOI 10.1056/NEJM200011093431904; PRUKSANANONDA P, 1992, NEW ENGL J MED, V326, P1445, DOI 10.1056/NEJM199205283262201; Regamey N, 1998, NEW ENGL J MED, V339, P1358, DOI 10.1056/NEJM199811053391903; Rezza G, 1999, J NATL CANCER I, V91, P1468, DOI 10.1093/jnci/91.17.1468; Schatz O, 2001, J MED VIROL, V65, P123, DOI 10.1002/jmv.2011; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276	22	81	85	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2002	287	10					1295	1300		10.1001/jama.287.10.1295	http://dx.doi.org/10.1001/jama.287.10.1295			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529YU	11886321	Bronze			2022-12-28	WOS:000174329500028
J	Vasan, RS; Beiser, A; Seshadri, S; Larson, MG; Kannel, WB; D'Agostino, RB; Levy, D				Vasan, RS; Beiser, A; Seshadri, S; Larson, MG; Kannel, WB; D'Agostino, RB; Levy, D			Residual lifetime risk for developing hypertension in middle-aged women and men - The Framingham Heart Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BLOOD-PRESSURE; ALZHEIMERS-DISEASE; UNITED-STATES; TRENDS; MORTALITY; PREVALENCE; POPULATION	Context The long-term risk for developing hypertension is best described by the lifetime risk statistic. The lifetime risk for hypertension and trends in this risk over time are unknown. Objectives To estimate the residual lifetime risk for hypertension in older US adults and to evaluate temporal trends in this risk. Design, Setting, and Participants Community-based prospective cohort study of 1298 participants from the Framingham Heart Study who were aged 55 to 65 years and free of hypertension at baseline 1976-1998). Main Outcome Measures Residual lifetime risk (lifetime cumulative incidence not adjusted for competing causes of mortality) for hypertension, defined as blood pressure of 140/90 mm Hg or greater or use of anti hypertensive medications. Results The residual lifetime risks for developing hypertension and stage 1 high blood pressure or higher (greater than or equal to140/90 mm Hg regardless of treatment) were 90% in both 55- and 65-year-old participants. The lifetime probability of receiving anti hypertensive medication was 60%. The risk for hypertension remained unchanged for women, but it was approximately 60% higher for men in the contemporary 1976-1998 period compared with an earlier 1952-1975 period. In contrast, the residual lifetime risk for stage 2 high blood pressure or higher greater than or equal to160/100 mm Hg regardless of treatment) was considerably lower in both sexes in the recent period (35%-57% in 1952-1975 vs 35%-44% in 1976-1998), likely due to a marked increase in treatment of individuals with substantially elevated blood pressure. Conclusion The residual lifetime risk for hypertension for middle-aged and elderly individuals is 90%, indicating a huge public health burden. Although the decline in lifetime risk for stage 2 high blood pressure or higher represents a major achievement, efforts should be directed at the primary prevention of hypertension.	NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; Boston Univ, Sch Med, Cardiol Sect, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Boston, MA USA; Boston Univ, Dept Math, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Clin Epidemiol, Boston, MA 02215 USA; NHLBI, Bethesda, MD 20892 USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; Boston University; Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Vasan, RS (corresponding author), NHLBI, Framingham Heart Study, 5 Thurber St, Framingham, MA 01702 USA.	vasan@fram.nhlbi.nih.gov	Ramachandran, Vasan/Y-2527-2019; Levy, Daniel/ABB-2752-2021; Levy, Daniel/ABF-6873-2021	Ramachandran, Vasan/0000-0001-7357-5970; Levy, Daniel/0000-0003-1843-8724; Beiser, Alexa/0000-0001-8551-7778; Seshadri, Sudha/0000-0001-6135-2622; Larson, Martin/0000-0002-9631-1254	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC038038] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NHLBI NIH HHS [K24 HL 04334-01A1, N01-HC-38038] Funding Source: Medline; NINDS NIH HHS [NS17950, R01 NS017950] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON RN, 1999, NATL CTR HLTH STAT S, V47, P12; [Anonymous], 1997, ARCH INTERN MED, V157, P2413; Barker WH, 1998, HYPERTENSION, V31, P552, DOI 10.1161/01.HYP.31.1.552; Beiser A, 2000, STAT MED, V19, P1495, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1495::AID-SIM441>3.0.CO;2-E; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Chalmers J, 1999, J HYPERTENS, V17, P151; Cox D. R., 1984, ANAL SURVIVAL DATA; CUMMINGS SR, 1989, ARCH INTERN MED, V149, P2445, DOI 10.1001/archinte.149.11.2445; DANNENBERG AL, 1988, AM J PUBLIC HEALTH, V78, P676, DOI 10.2105/AJPH.78.6.676; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Fortin J M, 2001, BMC Med Inform Decis Mak, V1, P2, DOI 10.1186/1472-6947-1-2; GARRAWAY WM, 1987, JAMA-J AM MED ASSOC, V258, P214, DOI 10.1001/jama.258.2.214; GLYNN RJ, 1993, AM J EPIDEMIOL, V138, P365, DOI 10.1093/oxfordjournals.aje.a116869; GLYNN RJ, 1995, ARCH INTERN MED, V155, P1855; Hyman DJ, 2000, ARCH INTERN MED, V160, P2281, DOI 10.1001/archinte.160.15.2281; KINSELLA K, 2001, US GUREAU CENSUS SER, P1; Lloyd-Jones DM, 2000, HYPERTENSION, V36, P594, DOI 10.1161/01.HYP.36.4.594; Lloyd-Jones DM, 1999, LANCET, V353, P89, DOI 10.1016/S0140-6736(98)10279-9; MCGOVERN PG, 1992, JAMA-J AM MED ASSOC, V268, P753; Meissner I, 1999, HYPERTENSION, V34, P466, DOI 10.1161/01.HYP.34.3.466; Miura K, 2001, ARCH INTERN MED, V161, P1501, DOI 10.1001/archinte.161.12.1501; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Mosterd A, 1999, NEW ENGL J MED, V340, P1221, DOI 10.1056/NEJM199904223401601; Phillips KA, 1999, NEW ENGL J MED, V340, P141, DOI 10.1056/NEJM199901143400211; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; SAS Institute, 1996, SAS STAT SOFTW CHANG; Sasieni PD, 1999, AM J EPIDEMIOL, V149, P869; Seshadri S, 1997, NEUROLOGY, V49, P1498, DOI 10.1212/WNL.49.6.1498; STAMLER J, 1993, ARCH INTERN MED, V153, P598, DOI 10.1001/archinte.153.5.598; Stamler J, 1998, JAMA-J AM MED ASSOC, V279, P878, DOI 10.1001/jama.279.11.878; Sytkowski PA, 1996, CIRCULATION, V93, P697, DOI 10.1161/01.CIR.93.4.697; van den Hoogen PCW, 2000, NEW ENGL J MED, V342, P1, DOI 10.1056/NEJM200001063420101; WHELTON PK, 1993, ARCH INTERN MED, V153, P186, DOI 10.1001/archinte.153.2.186; Wun LM, 1998, LIFETIME DATA ANAL, V4, P169, DOI 10.1023/A:1009685507602	34	892	969	0	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2002	287	8					1003	1010		10.1001/jama.287.8.1003	http://dx.doi.org/10.1001/jama.287.8.1003			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525CX	11866648				2022-12-28	WOS:000174052100028
J	Eisenmesser, EZ; Bosco, DA; Akke, M; Kern, D				Eisenmesser, EZ; Bosco, DA; Akke, M; Kern, D			Enzyme dynamics during catalysis	SCIENCE			English	Article							HUMAN CYCLOPHILIN-A; PROTEIN DYNAMICS; BACKBONE DYNAMICS; CRYSTAL-STRUCTURE; NMR RELAXATION; TRANS; ISOMERIZATION; ISOMERASE; FLEXIBILITY; DOMAIN	Internal protein dynamics are intimately connected to enzymatic catalysis. However, enzyme motions linked to substrate turnover remain largely unknown. We have studied dynamics of an enzyme during catalysis at atomic resolution using nuclear magnetic resonance relaxation methods. During catalytic action of the enzyme cyclophilin A, we detect conformational fluctuations of the active site that occur on a time scale of hundreds of microseconds. The rates of conformational dynamics of the enzyme strongly correlate with the microscopic rates of substrate turnover. The present results, together with available structural data, allow a prediction of the reaction trajectory.	Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; Lund Univ, Dept Biophys Chem, SE-22100 Lund, Sweden	Brandeis University; Lund University	Kern, D (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA.			Akke, Mikael/0000-0002-2395-825X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062117] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62117] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bruice TC, 2000, BIOCHEMISTRY-US, V39, P6267, DOI 10.1021/bi0003689; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FERSHT A, 1999, STRUCTURE MECH PROTE, P44; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; Fischer MWF, 1998, PROG NUCL MAG RES SP, V33, P207, DOI 10.1016/S0079-6565(98)00023-5; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Gothel SF, 1996, BIOCHEMISTRY-US, V35, P3636, DOI 10.1021/bi9520803; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Ishima R, 1999, STRUCTURE, V7, P1047, DOI 10.1016/S0969-2126(99)80172-5; Ishima R, 2000, NAT STRUCT BIOL, V7, P740, DOI 10.1038/78963; Jardetzky O, 1996, PROG BIOPHYS MOL BIO, V65, P171, DOI 10.1016/S0079-6107(96)00010-7; Kay LE, 1998, NAT STRUCT BIOL, V5, P513, DOI 10.1038/755; KERN D, 1995, BIOCHEMISTRY-US, V34, P13594, DOI 10.1021/bi00041a039; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LUZ Z, 1963, J CHEM PHYS, V39, P366, DOI 10.1063/1.1734254; MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152; NICHOLSON LK, 1995, NAT STRUCT BIOL, V2, P274, DOI 10.1038/nsb0495-274; Osborne MJ, 2001, BIOCHEMISTRY-US, V40, P9846, DOI 10.1021/bi010621k; Ottiger M, 1997, J MOL BIOL, V272, P64, DOI 10.1006/jmbi.1997.1220; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Palmer AG, 1997, CURR OPIN STRUC BIOL, V7, P732, DOI 10.1016/S0959-440X(97)80085-1; PLOTTO M, 1992, J BIOMOL NMR, V2, P661; Rovira P, 2000, CURR MED CHEM, V7, P673, DOI 10.2174/0929867003374778; Rozovsky S, 2001, J MOL BIOL, V310, P271, DOI 10.1006/jmbi.2001.4673; Schiene C, 2000, CURR OPIN STRUC BIOL, V10, P40, DOI 10.1016/S0959-440X(99)00046-9; Stevens SY, 2001, NAT STRUCT BIOL, V8, P947, DOI 10.1038/nsb1101-947; Tjandra N, 1996, J AM CHEM SOC, V118, P6986, DOI 10.1021/ja960510m; Wang LC, 2001, P NATL ACAD SCI USA, V98, P7684, DOI 10.1073/pnas.121069998; WILLIAMS JC, 1995, BIOCHEMISTRY-US, V34, P8309, DOI 10.1021/bi00026a012; Zhao YD, 1996, BIOCHEMISTRY-US, V35, P7356, DOI 10.1021/bi9602775; Zhao YD, 1997, STRUCTURE, V5, P139, DOI 10.1016/S0969-2126(97)00172-X; Zhao YD, 1996, BIOCHEMISTRY-US, V35, P7362, DOI 10.1021/bi960278x; ZYDOWSKY LD, 1992, PROTEIN SCI, V1, P1092, DOI 10.1002/pro.5560010903	33	579	589	6	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2002	295	5559					1520	1523		10.1126/science.1066176	http://dx.doi.org/10.1126/science.1066176			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11859194	Green Submitted			2022-12-28	WOS:000173981300052
J	Lawrence, PA				Lawrence, PA			Rank injustice - The misallocation of credit is endemic in science.	NATURE			English	Editorial Material									MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Lawrence, PA (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	pal@mrc-lmb.cam.ac.uk		Lawrence, Peter/0000-0002-9554-8268				CREWDSON J, 1989, CHICAGO HERALD  1119; Crewdson J., 2002, SCI FICTIONS SCI MYS; *ETAN, 2000, SCI POL EUR UN PROM, P156; Fassler PE, 1996, ROUX ARCH DEV BIOL, V205, P323, DOI 10.1007/BF00377212; Freeman R, 2001, SCIENCE, V294, P2293, DOI 10.1126/science.1067477; Garfield E, 1999, CAN MED ASSOC J, V161, P979; MARX JL, 1979, SCIENCE, V206, P434, DOI 10.1126/science.41320; Schatz Albert, 1965, PAK DENT REV, V15, P125; WAINWRIGHT M, 1991, HIST PHIL LIFE SCI, V13, P97	9	62	63	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2002	415	6874					835	836		10.1038/415835a	http://dx.doi.org/10.1038/415835a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859339				2022-12-28	WOS:000173941000017
J	Ronshaugen, M; McGinnis, N; McGinnis, W				Ronshaugen, M; McGinnis, N; McGinnis, W			Hox protein mutation and macroevolution of the insect body plan	NATURE			English	Article							CASEIN KINASE-II; GENE-EXPRESSION; EVOLUTION; DROSOPHILA; ULTRABITHORAX; PHYLOGENY; PHOSPHORYLATION; ARTHROPODS; ORIGIN; CLADE	A fascinating question in biology is how molecular changes in developmental pathways lead to macroevolutionary changes in morphology. Mutations in homeotic (Hox) genes have long been suggested as potential causes of morphological evolution(1,2), and there is abundant evidence that some changes in Hox expression patterns correlate with transitions in animal axial pattern(3). A major morphological transition in metazoans occurred about 400 million years ago, when six-legged insects diverged from crustacean-like arthropod ancestors with multiple limbs(4-7). In Drosophila melanogaster and other insects, the Ultrabithorax (Ubx) and abdominal A (AbdA, also abd-A) Hox proteins are expressed largely in the abdominal segments, where they can suppress thoracic leg development during embryogenesis(3). In a branchiopod crustacean, Ubx/AbdA proteins are expressed in both thorax and abdomen, including the limb primordia, but do not repress limbs(8-11). Previous studies led us to propose that gain and loss of transcriptional activation and repression functions in Hox proteins was a plausible mechanism to diversify morphology during animal evolution(12). Here we show that naturally selected alteration of the Ubx protein is linked to the evolutionary transition to hexapod limb pattern.	Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	McGinnis, W (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.			Ronshaugen, Matthew/0000-0001-5326-5924				Abzhanov A, 2000, DEVELOPMENT, V127, P2239; Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Averof M, 1997, NATURE, V388, P682, DOI 10.1038/41786; AVEROF M, 1995, NATURE, V376, P420, DOI 10.1038/376420a0; BOORE JL, 1995, NATURE, V376, P163, DOI 10.1038/376163a0; Carroll S.B., 2001, DNA DIVERSITY; CHAN SK, 1993, GENE DEV, V7, P796, DOI 10.1101/gad.7.5.796; Fienberg AA, 1999, J EXP ZOOL, V285, P76, DOI 10.1002/(SICI)1097-010X(19990415)285:1<76::AID-JEZ9>3.0.CO;2-K; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; FRIEDRICH M, 1995, NATURE, V376, P165, DOI 10.1038/376165a0; GALANT R, 2002, NATURE          0202; Goldschmidt R., 1940, MAT BASIS EVOLUTION; GONZALEZREYES A, 1990, CELL, V61, P515, DOI 10.1016/0092-8674(90)90533-K; Grenier JK, 2000, P NATL ACAD SCI USA, V97, P704, DOI 10.1073/pnas.97.2.704; Grenier JK, 1997, CURR BIOL, V7, P547, DOI 10.1016/S0960-9822(06)00253-3; Jaffe L, 1997, GENE DEV, V11, P1327, DOI 10.1101/gad.11.10.1327; KELSH R, 1994, DEV GENET, V15, P19, DOI 10.1002/dvg.1020150104; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li C, 1999, MOL CELL, V3, P77, DOI 10.1016/S1097-2765(00)80176-8; Li XL, 1999, P NATL ACAD SCI USA, V96, P6802, DOI 10.1073/pnas.96.12.6802; MANN RS, 1990, CELL, V60, P597, DOI 10.1016/0092-8674(90)90663-Y; PANGANIBAN G, 1995, SCIENCE, V270, P1363, DOI 10.1126/science.270.5240.1363; Regier JC, 1997, MOL BIOL EVOL, V14, P902, DOI 10.1093/oxfordjournals.molbev.a025833; VACHON G, 1992, CELL, V71, P437, DOI 10.1016/0092-8674(92)90513-C	24	281	290	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 21	2002	415	6874					914	917		10.1038/nature716	http://dx.doi.org/10.1038/nature716			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859370				2022-12-28	WOS:000173941000046
J	Treasure, T				Treasure, T			Commentary: The surgeon is only one factor	BRITISH MEDICAL JOURNAL			English	Editorial Material									Guys Hosp, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust	Treasure, T (corresponding author), Guys Hosp, London SE1 9RT, England.							Braunholtz DA, 2001, J CLIN EPIDEMIOL, V54, P217, DOI 10.1016/S0895-4356(00)00305-X; HAMPTON JR, 1984, BRIT MED J, V289, P1166, DOI 10.1136/bmj.289.6453.1166; Rusch VW, 2001, J THORAC CARDIOV SUR, V121, P472, DOI 10.1067/mtc.2001.112465; Spence D, 2001, LANCET, V357, P1722, DOI 10.1016/S0140-6736(00)04929-1; 2000, LANCET, V356, P1205	5	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2002	324	7334					421	421						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524HC	11855388				2022-12-28	WOS:000174006300028
J	Brown, CA; Belfield, CR; Field, SJ				Brown, CA; Belfield, CR; Field, SJ			Cost effectiveness of continuing professional development health care: a critical review of the evidence	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PHYSICIAN PERFORMANCE; GENERAL-PRACTITIONERS; MEDICAL-EDUCATION; BENEFIT ANALYSES; STRATEGIES; PROGRAM		Univ Birmingham, Sch Educ, Ctr Res Med & Dent Educ, Birmingham B15 2TT, W Midlands, England; Columbia Univ, Teachers Coll, Natl Ctr Study Privatizat Educ, New York, NY 10027 USA; W Midlands Deanery, Birmingham, W Midlands, England	University of Birmingham; Columbia University; Columbia University Teachers College	Brown, CA (corresponding author), Univ Birmingham, Sch Educ, Ctr Res Med & Dent Educ, Birmingham B15 2TT, W Midlands, England.	C.A.Brown@bham.ac.uk	Taylor, Celia/E-3494-2010	Brown, Celia/0000-0002-7526-0793				Barber JA, 1998, BRIT MED J, V317, P1195, DOI 10.1136/bmj.317.7167.1195; Becker G.S, 1993, HUMAN CAPITAL; BEECH R, 1998, COSTS CONSEQUENCES P; BELFIELD CR, 2001, COST EFFECTIVE CONTI; CASEBEER L, 1997, J CONTIN EDUC HEALTH, V17, P224; CLUNE W, 1999, METHODOLOGICAL STREN; Davis D, 1998, INT J PSYCHIAT MED, V28, P21, DOI 10.2190/UA3R-JX9W-MHR5-RC81; DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700; *DEP HLTH, 1998, OUR HLTH NAT CONTR H; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Drummond MF, 2015, METHODS EC EVALUATIO; Gomel MK, 1998, SOC SCI MED, V47, P203, DOI 10.1016/S0277-9536(98)00063-X; GRAY A, 1999, EVIDENCE BASED PRACT, P101; KANER EFS, 1999, BR J GEN PRACT, V49, P353; Levin H.M., 2000, COST EFFECTIVENESS A, VVol. 4; LEVIN HM, 2001, EVALUATION FINDINGS, P55; Modell M, 1998, BMJ-BRIT MED J, V317, P788, DOI 10.1136/bmj.317.7161.788; MORRISON J, 1999, IMPROVING QUALITY RE; Morriss R, 1998, FAM PRACT, V15, P119, DOI 10.1093/fampra/15.2.119; Peck C, 2000, BRIT MED J, V320, P432, DOI 10.1136/bmj.320.7232.432; PRASHKER MJ, 1991, ANN INTERN MED, V115, P715, DOI 10.7326/0003-4819-115-9-715; RUTZ W, 1992, ACTA PSYCHIAT SCAND, V85, P457, DOI 10.1111/j.1600-0447.1992.tb03212.x; STEELE MA, 1989, DICP ANN PHARMAC, V23, P497, DOI 10.1177/106002808902300612; Stevens SA, 1997, AM J PUBLIC HEALTH, V87, P1177, DOI 10.2105/AJPH.87.7.1177; UDVARHELYI IS, 1992, ANN INTERN MED, V116, P238, DOI 10.7326/0003-4819-116-3-238; Zarnke KB, 1997, J CLIN EPIDEMIOL, V50, P813, DOI 10.1016/S0895-4356(97)00064-4	26	82	82	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2002	324	7338					652	655		10.1136/bmj.324.7338.652	http://dx.doi.org/10.1136/bmj.324.7338.652			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532QW	11895825	Green Published, Bronze			2022-12-28	WOS:000174487400028
J	Nelson, G; Chandrashekar, J; Hoon, MA; Feng, LX; Zhao, G; Ryba, NJP; Zuker, CS				Nelson, G; Chandrashekar, J; Hoon, MA; Feng, LX; Zhao, G; Ryba, NJP; Zuker, CS			An amino-acid taste receptor	NATURE			English	Article							GLUTAMATE RECEPTORS; MICE; G-ALPHA(16); RESPONSES; SACCHARIN; FAMILY	The sense of taste provides animals with valuable information about the nature and quality of food. Mammals can recognize and respond to a diverse repertoire of chemical entities, including sugars, salts, acids and a wide range of toxic substances(1). Several amino acids taste sweet or delicious (umami) to humans, and are attractive to rodents and other animals(2). This is noteworthy because L-amino acids function as the building blocks of proteins, as biosynthetic precursors of many biologically relevant small molecules, and as metabolic fuel. Thus, having a taste pathway dedicated to their detection probably had significant evolutionary implications. Here we identify and characterize a mammalian amino-acid taste receptor. This receptor, T1R1+3, is a heteromer of the taste-specific T1R1 and T1R3 G-protein-coupled receptors. We demonstrate that T1R1 and T1R3 combine to function as a broadly tuned L-amino-acid sensor responding to most of the 20 standard amino acids, but not to their D-enantiomers or other compounds. We also show that sequence differences in T1R receptors within and between species (human and mouse) can significantly influence the selectivity and specificity of taste responses.	Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Zuker, CS (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	charles@flyeye.ucsd.edu		Ryba, Nicholas/0000-0002-2060-8393; Chandrashekar, jayaram/0000-0001-6412-0114	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000561] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Bachmanov AA, 2001, CHEM SENSES, V26, P905, DOI 10.1093/chemse/26.7.905; Bachmanov AA, 2001, CHEM SENSES, V26, P925, DOI 10.1093/chemse/26.7.925; Bachmanov AA, 2000, J NUTR, V130, p935S, DOI 10.1093/jn/130.4.935S; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; Dahl M, 1997, BRAIN RES, V756, P22, DOI 10.1016/S0006-8993(97)00131-5; FULLER JL, 1974, J HERED, V65, P33, DOI 10.1093/oxfordjournals.jhered.a108452; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Ikeda Kikunae, 1909, J TOKYO CHEM SOC JAP, V30, P820, DOI DOI 10.1093/CHEMSE/27.9.847; IWASAKI K, 1985, PHYSIOL BEHAV, V34, P531, DOI 10.1016/0031-9384(85)90045-9; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kitagawa M, 2001, BIOCHEM BIOPH RES CO, V283, P236, DOI 10.1006/bbrc.2001.4760; Kurihara K, 1998, ANN NY ACAD SCI, V855, P393, DOI 10.1111/j.1749-6632.1998.tb10597.x; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; LUSH IE, 1989, GENET RES, V53, P95, DOI 10.1017/S0016672300027968; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; Mody SM, 2000, MOL PHARMACOL, V57, P13; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Sainz E, 2001, J NEUROCHEM, V77, P896, DOI 10.1046/j.1471-4159.2001.00292.x; Speca DJ, 1999, NEURON, V23, P487, DOI 10.1016/S0896-6273(00)80802-8; TSIEN RY, 1985, CELL CALCIUM, V6, P145, DOI 10.1016/0143-4160(85)90041-7; YOSHII K, 1986, BRAIN RES, V367, P45, DOI 10.1016/0006-8993(86)91577-5	27	1030	1095	7	263	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2002	416	6877					199	202		10.1038/nature726	http://dx.doi.org/10.1038/nature726			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894099				2022-12-28	WOS:000174348100043
J	Murakami, M; Hirose, K; Yurimoto, H; Nakashima, S; Takafuji, N				Murakami, M; Hirose, K; Yurimoto, H; Nakashima, S; Takafuji, N			Water in Earth's lower mantle	SCIENCE			English	Article							NOMINALLY ANHYDROUS MINERALS; GAMMA-PHASE; PEROVSKITE; HYDROGEN; PRESSURE; IRON; CORE	Secondary ion mass spectrometry measurements show that Earth's representative lower mantle minerals synthesized in a natural peridotitic composition can dissolve considerable amounts of hydrogen. Both MgSiO3-rich perovskite and magnesiowustite contain about 0.2 weight percent (wt%) H2O, and CaSiO3-rich perovskite contains about 0.4 wt% H2O. The OH absorption bands in Mg-perovskite and magnesiowustite were also confirmed with the use of infrared microspectroscopic measurements. Earth's lower mantle may store about five times more H2O than the oceans.	Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan; Tokyo Inst Technol, Interact Res Ctr Sci, Meguro Ku, Tokyo 1528551, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology	Murakami, M (corresponding author), Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan.		Hirose, Kei/C-2165-2009; Nakashima, Satoru/ABA-2157-2021; Yurimoto, Hisayoshi/S-9938-2018; Murakami, Motohiko/G-2806-2010	Hirose, Kei/0000-0003-4366-7721; Yurimoto, Hisayoshi/0000-0003-0702-0533; Murakami, Motohiko/0000-0002-2165-2994				AINES RD, 1984, J GEOPHYS RES, V89, P4059, DOI 10.1029/JB089iB06p04059; BELL DR, 1992, SCIENCE, V255, P1391, DOI 10.1126/science.255.5050.1391; Bolfan-Casanova N, 2000, EARTH PLANET SC LETT, V182, P209, DOI 10.1016/S0012-821X(00)00244-2; Brodholt JP, 2000, NATURE, V407, P620, DOI 10.1038/35036565; Frost DJ, 2001, PHYS CHEM MINER, V28, P455, DOI 10.1007/s002690100181; Hirose K, 2001, EARTH PLANET SC LETT, V184, P567, DOI 10.1016/S0012-821X(00)00354-X; Inoue T, 1998, EARTH PLANET SC LETT, V160, P107, DOI 10.1016/S0012-821X(98)00077-6; INOUE T, 1995, GEOPHYS RES LETT, V22, P117, DOI 10.1029/94GL02965; Iwamori H, 1998, EARTH PLANET SC LETT, V160, P65, DOI 10.1016/S0012-821X(98)00080-6; KARATO SI, 1986, J GEOPHYS RES-SOLID, V91, P8151, DOI 10.1029/JB091iB08p08151; KAWAMOTO T, 1996, EARTH PLANET SC LETT, V142, P58; Kesson SE, 1998, NATURE, V393, P252, DOI 10.1038/30466; Kohlstedt DL, 1996, CONTRIB MINERAL PETR, V123, P345, DOI 10.1007/s004100050161; Libowitzky E, 1997, AM MINERAL, V82, P1111; McCammon C, 1997, NATURE, V387, P694, DOI 10.1038/42685; MEADE C, 1994, SCIENCE, V264, P1558, DOI 10.1126/science.264.5165.1558; Miyagi I., 1995, B VOLCANOL SOC JPN, V40, P349; NAKASHIMA S, 1995, TECTONOPHYSICS, V245, P263, DOI 10.1016/0040-1951(94)00239-6; Navrotsky A, 1999, SCIENCE, V284, P1788, DOI 10.1126/science.284.5421.1788; Okuchi T, 1997, SCIENCE, V278, P1781, DOI 10.1126/science.278.5344.1781; RINGWOOD AE, 1977, GEOCHEM J, V11, P111, DOI 10.2343/geochemj.11.111; Shieh SR, 1998, EARTH PLANET SC LETT, V159, P13, DOI 10.1016/S0012-821X(98)00062-4; Wang WY, 2000, EARTH PLANET SC LETT, V181, P291, DOI 10.1016/S0012-821X(00)00208-9; Williams Q, 2001, ANNU REV EARTH PL SC, V29, P365, DOI 10.1146/annurev.earth.29.1.365; Wood BJ, 2000, EARTH PLANET SC LETT, V174, P341, DOI 10.1016/S0012-821X(99)00273-3; YURIMOTO H, 1989, GEOCHIM COSMOCHIM AC, V53, P751, DOI 10.1016/0016-7037(89)90018-5	26	146	163	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1885	1887		10.1126/science.1065998	http://dx.doi.org/10.1126/science.1065998			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884752				2022-12-28	WOS:000174299500036
J	Macklis, RM				Macklis, RM			Scientist, technologist, proto-feminist, superstar - Marie Curie (1867-1934)	SCIENCE			English	Biographical-Item							DISCOVERY; RADIUM		Cleveland Clin Fdn, Dept Radiat Oncol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Macklis, RM (corresponding author), Cleveland Clin Fdn, Dept Radiat Oncol, 9500 Euclid Ave, Cleveland, OH 44195 USA.							Coppes-Zantinga AR, 1998, AM J ROENTGENOL, V171, P1453, DOI 10.2214/ajr.171.6.9843270; CURIE M, PUBLICATION LIST; DELREGATO JA, 1976, INT J RADIAT ONCOL, V1, P345, DOI 10.1016/0360-3016(76)90065-1; HELLMAN S, 1992, BIOL MED, V36, P39; LANGEVINJOLIOT H, 1998, RADIAT RES, V150, P53; LENZ M, 1973, Cancer, V32, P519, DOI 10.1002/1097-0142(197309)32:3<519::AID-CNCR2820320301>3.0.CO;2-G; MACKLIS RM, 1990, JAMA-J AM MED ASSOC, V264, P614, DOI 10.1001/jama.264.5.614; Mazeron JJ, 1998, RADIOTHER ONCOL, V49, P205, DOI 10.1016/S0167-8140(98)00143-1; Mould RF, 1998, BRIT J RADIOL, V71, P1229, DOI 10.1259/bjr.71.852.10318996; QUINN S, 1955, M CURIE LIFE	10	5	5	3	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 1	2002	295	5560					1647	1648		10.1126/science.1069943	http://dx.doi.org/10.1126/science.1069943			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872821	Bronze			2022-12-28	WOS:000174212900023
J	Savage, DG; Antman, KH				Savage, DG; Antman, KH			Drug therapy: Imatinib mesylate - A new oral targeted therapy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CHRONIC MYELOGENOUS LEUKEMIA; TYROSINE KINASE INHIBITOR; CHRONIC MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; BONE-MARROW-TRANSPLANTATION; GASTROINTESTINAL STROMAL TUMORS; BCR-ABL; INTERFERON-ALPHA; C-KIT; PHILADELPHIA-CHROMOSOME		Columbia Univ Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA	Columbia University	Savage, DG (corresponding author), Columbia Univ Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, 630 W 168th St, New York, NY 10032 USA.			/0000-0002-1093-8356				ALLAN NC, 1995, LANCET, V345, P1392, DOI 10.1016/S0140-6736(95)92596-1; AMBACORTIPASSER.C, 2000, JNCI-J NATL CANCER I, V92, P1341; Apperley JF, 2001, BLOOD, V98, p726A; Arber DA, 1998, HUM PATHOL, V29, P498, DOI 10.1016/S0046-8177(98)90066-1; Arico M, 2000, NEW ENGL J MED, V342, P998, DOI 10.1056/NEJM200004063421402; Barnhill RL, 1996, BRIT J DERMATOL, V135, P898, DOI 10.1046/j.1365-2133.1996.d01-1092.x; BARTRAM CR, 1983, NATURE, V306, P277, DOI 10.1038/306277a0; BEDI A, 1994, BLOOD, V83, P2038; BEELEN DW, 1995, BLOOD, V85, P2981, DOI 10.1182/blood.V85.10.2981.bloodjournal85102981; Beran M, 1998, CLIN CANCER RES, V4, P1661; Bhatia R, 1998, BLOOD, V91, P3414, DOI 10.1182/blood.V91.9.3414.3414_3414_3422; Blanke CD., 2001, P AN M AM SOC CLIN, V20, p1a; BOLIN RW, 1982, CANCER-AM CANCER SOC, V50, P1683, DOI 10.1002/1097-0142(19821101)50:9<1683::AID-CNCR2820500904>3.0.CO;2-X; Brouard MC, 2001, DERMATOLOGY, V203, P57, DOI 10.1159/000051705; Buchdunger E, 1996, CANCER RES, V56, P100; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; BUCHDUNGER E, 1995, P NATL ACAD SCI USA, V92, P2558, DOI 10.1073/pnas.92.7.2558; Burton C, 2002, NEW ENGL J MED, V346, P713; Carpino N, 1997, CELL, V88, P197, DOI 10.1016/S0092-8674(00)81840-1; Carroll M, 1997, BLOOD, V90, P4947, DOI 10.1182/blood.V90.12.4947.4947_4947_4952; Clift RA, 1997, BAILLIERE CLIN HAEM, V10, P319, DOI 10.1016/S0950-3536(97)80010-8; CLIFT RA, 1982, LANCET, V2, P621; COHEN PS, 1994, BLOOD, V84, P3465; COPELAN EA, 1995, BLOOD, V85, P1151, DOI 10.1182/blood.V85.5.1151.bloodjournal8551151; CORTEZ D, 1995, MOL CELL BIOL, V15, P5531; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; DALEY GQ, 1991, P NATL ACAD SCI USA, V88, P11335, DOI 10.1073/pnas.88.24.11335; Deininger MWN, 1997, BLOOD, V90, P3691, DOI 10.1182/blood.V90.9.3691; Deininger MWN, 2000, CANCER RES, V60, P2049; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Delannoy A, 1997, J NATL CANCER I, V89, P1616; DOWDING C, 1991, BLOOD, V78, P499; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Druker BJ, 2000, J CLIN INVEST, V105, P3, DOI 10.1172/JCI9083; Druker BJ, 2001, NEW ENGL J MED, V345, P232; Emory TS, 1999, AM J SURG PATHOL, V23, P82, DOI 10.1097/00000478-199901000-00009; Faderl S, 1999, NEW ENGL J MED, V341, P164, DOI 10.1056/NEJM199907153410306; Fang GF, 2000, BLOOD, V96, P2246, DOI 10.1182/blood.V96.6.2246.h8002246_2246_2253; Gambacorti-Passerini C, 2001, BRIT J HAEMATOL, V112, P972, DOI 10.1046/j.1365-2141.2001.02653.x; GOLDMAN JM, 1993, BLOOD, V82, P2235; Goldman JM, 2000, LANCET, V355, P1031, DOI 10.1016/S0140-6736(00)02029-8; GOLDMAN JM, 1982, LANCET, V2, P623; Goldman JM, 2001, NEW ENGL J MED, V344, P1084, DOI 10.1056/NEJM200104053441409; Goldman JM, 2001, BLOOD, V98, P2039, DOI 10.1182/blood.V98.7.2039; GORDON MY, 1987, NATURE, V328, P342, DOI 10.1038/328342a0; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Gratwohl A, 1998, LANCET, V352, P1087, DOI 10.1016/S0140-6736(98)03030-X; Greco A, 2001, INT J CANCER, V92, P354, DOI 10.1002/ijc.1190; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; Guilhot F, 1997, NEW ENGL J MED, V337, P223, DOI 10.1056/NEJM199707243370402; Hansen JA, 1998, NEW ENGL J MED, V338, P962, DOI 10.1056/NEJM199804023381405; HEHLMANN R, 1993, BLOOD, V82, P398, DOI 10.1182/blood.V82.2.398.bloodjournal822398; Hehlmann R, 1999, BLOOD, V94, P3668, DOI 10.1182/blood.V94.11.3668.423a31_3668_3677; Heinrich MC, 2000, BLOOD, V96, P925, DOI 10.1182/blood.V96.3.925.015k50_925_932; HEISTERKAMP N, 1983, NATURE, V306, P239, DOI 10.1038/306239a0; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Holyoake TL, 2001, BRIT J HAEMATOL, V113, P11, DOI 10.1046/j.1365-2141.2001.02558.x; Horowitz MM, 1996, BONE MARROW TRANSPL, V17, pS5; Jahagirdar BN, 2001, EXP HEMATOL, V29, P543, DOI 10.1016/S0301-472X(01)00633-6; JANOSSY G, 1979, CANCER, V43, P426, DOI 10.1002/1097-0142(197902)43:2<426::AID-CNCR2820430204>3.0.CO;2-H; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; KANTARJIAN HM, 1991, CANCER-AM CANCER SOC, V68, P1201, DOI 10.1002/1097-0142(19910915)68:6<1201::AID-CNCR2820680604>3.0.CO;2-1; KANTARJIAN HM, 1995, ANN INTERN MED, V122, P254, DOI 10.7326/0003-4819-122-4-199502150-00003; Kantarjian HM, 2001, BLOOD, V98, p137A; Kilic T, 2000, CANCER RES, V60, P5143; KLOKE O, 1993, BRIT J HAEMATOL, V83, P399, DOI 10.1111/j.1365-2141.1993.tb04663.x; Kolibaba KS, 1997, BIOCHIM BIOPHYS ACTA, V1333, P217; Krystal GW, 2000, CLIN CANCER RES, V6, P3319; LANEUVILLE P, 1992, BLOOD, V80, P1788; le Coutre P, 2000, BLOOD, V95, P1758, DOI 10.1182/blood.V95.5.1758.005a41_1758_1766; le Coutre P, 1999, J NATL CANCER I, V91, P163, DOI 10.1093/jnci/91.2.163; Lee SJ, 2000, BRIT J HAEMATOL, V111, P993, DOI 10.1046/j.1365-2141.2000.02216.x; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; Mahon FX, 2000, BLOOD, V96, P1070, DOI 10.1182/blood.V96.3.1070.015k17_1070_1079; MANDANAS RA, 1993, BLOOD, V82, P1838; Miettinen M, 1999, HUM PATHOL, V30, P1213, DOI 10.1016/S0046-8177(99)90040-0; Miettinen M, 1999, AM J SURG PATHOL, V23, P1109, DOI 10.1097/00000478-199909000-00015; Morton AJ, 1998, BLOOD, V92, P394, DOI 10.1182/blood.V92.2.394.414k42_394_401; NOWELL PC, 1960, SCIENCE, V132, P1497; OHNISHI K, 1995, BLOOD, V86, P906; OKUDA K, 1994, EXP HEMATOL, V22, P1111; OZER H, 1993, BLOOD, V82, P2975; PENDERGAST AM, 1993, CELL, V75, P175, DOI 10.1016/S0092-8674(05)80094-7; Pietras K, 2001, CANCER RES, V61, P2929; PUIL L, 1994, EMBO J, V13, P764, DOI 10.1002/j.1460-2075.1994.tb06319.x; Raitano A. B., 1997, BIOCHIM BIOPHYS ACTA, V1333, P201, DOI 10.1016/S0304-419X(97)00023-1; Reichert A, 2001, BLOOD, V97, P1399, DOI 10.1182/blood.V97.5.1399; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Sacchi S, 1999, CANCER-AM CANCER SOC, V86, P2632, DOI 10.1002/(SICI)1097-0142(19991215)86:12<2632::AID-CNCR7>3.0.CO;2-A; Savage DG, 1997, BRIT J HAEMATOL, V96, P111, DOI 10.1046/j.1365-2141.1997.d01-1982.x; SAVAGE DG, 1999, HIGH DOSE THERAPY PH, P705; Sawyers CL, 1999, CANCER J SCI AM, V5, P63; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Sawyers CL, 2001, BLOOD, V98, p845A; Sawyers CL, 2001, SEMIN HEMATOL, V38, P15, DOI 10.1053/shem.2001.27078; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; STRIFE A, 1988, CANCER RES, V48, P1035; STRIFE A, 1988, CANCER RES, V48, P3298; Szydlo R, 1997, J CLIN ONCOL, V15, P1767, DOI 10.1200/JCO.1997.15.5.1767; TALPAZ M, 1986, NEW ENGL J MED, V314, P1065, DOI 10.1056/NEJM198604243141701; Talpaz M, 2001, BLOOD, V98, p845A; Talpaz M, 2001, SEMIN HEMATOL, V38, P22, DOI 10.1053/shem.2001.27080; TALPAZ M, 1983, BLOOD, V62, P689; Thiesing JT, 2000, BLOOD, V96, P3195, DOI 10.1182/blood.V96.9.3195.h8003195_3195_3199; Tonary AM, 2000, INT J CANCER, V89, P242, DOI 10.1002/1097-0215(20000520)89:3<242::AID-IJC6>3.0.CO;2-6; TURA S, 1994, NEW ENGL J MED, V330, P820; UEHARA H, 2001, P AM ASSOC CANC RES, V41, P407; van Oosterom AT, 2001, LANCET, V358, P1421, DOI 10.1016/S0140-6736(01)06535-7; vanRhee F, 1997, BONE MARROW TRANSPL, V20, P553, DOI 10.1038/sj.bmt.1700933; Vigneri P, 2001, NAT MED, V7, P228, DOI 10.1038/84683; VONCKEN JW, 1995, BLOOD, V86, P4603, DOI 10.1182/blood.V86.12.4603.bloodjournal86124603; WALTERS RS, 1987, CANCER, V60, P1708, DOI 10.1002/1097-0142(19871015)60:8<1708::AID-CNCR2820600803>3.0.CO;2-1; Wang WL, 2000, ONCOGENE, V19, P3521, DOI 10.1038/sj.onc.1203698; Weisberg E, 2000, BLOOD, V95, P3498, DOI 10.1182/blood.V95.11.3498.011k27_3498_3505; WESTBROOK CA, 1992, BLOOD, V80, P2983; YAISH P, 1988, SCIENCE, V242, P933, DOI 10.1126/science.3263702; Yamanashi Y, 1997, CELL, V88, P205, DOI 10.1016/S0092-8674(00)81841-3	120	616	654	3	61	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2002	346	9					683	693		10.1056/NEJMra013339	http://dx.doi.org/10.1056/NEJMra013339			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525HJ	11870247				2022-12-28	WOS:000174062800008
J	Bowler, I; Jackson, N				Bowler, I; Jackson, N			Experiences and career intentions of general practice registrars in Thames deaneries: postal survey	BRITISH MEDICAL JOURNAL			English	Article									London Dept Postgrad Med & Dent Educ, London WC1N 1DZ, England		Bowler, I (corresponding author), 22 Marriott Rd, London N4 3QL, England.							*NHS EX, 2000, GEN PERS MED STAT EN; *ROYAL COLL GEN PR, 1997, PRIM CAR WORKF DESCR; *SECR STAT HLTH, 2000, NHS PLAN PLAN INV PL	3	15	15	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 23	2002	324	7335					464	465		10.1136/bmj.324.7335.464	http://dx.doi.org/10.1136/bmj.324.7335.464			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526NJ	11859050	Green Published, Bronze			2022-12-28	WOS:000174136300020
J	Hayward, MA; Cussen, EJ; Claridge, JB; Bieringer, M; Rosseinsky, MJ; Kiely, CJ; Blundell, SJ; Marshall, IM; Pratt, FL				Hayward, MA; Cussen, EJ; Claridge, JB; Bieringer, M; Rosseinsky, MJ; Kiely, CJ; Blundell, SJ; Marshall, IM; Pratt, FL			The hydride anion in an extended transition metal oxide array: LaSrCoO3H0.7	SCIENCE			English	Article							ANTIFERROMAGNETS; SPILLOVER; CATALYSIS; SR2CUO3	We present the synthesis and structural characterization of a transition metal oxide hydride, LaSrCoO3H0.7, which adopts an unprecedented structure in which oxide chains are bridged by hydride anions to form a two-dimensional extended network. The metal centers are strongly coupled by their bonding with both oxide and hydride ligands to produce magnetic ordering at temperatures up to at least 350 kelvin. The synthetic route is sufficiently general to allow the prediction of a new class of transition metal-containing electronic and magnetic materials.	Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England; Univ Liverpool, Dept Engn, Div Sci Mat, Liverpool L69 3BX, Merseyside, England; Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; Rutherford Appleton Lab, ISIS Muon Facil, Didcot OX11 0QX, Oxon, England	University of Liverpool; University of Liverpool; University of Oxford; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Rosseinsky, MJ (corresponding author), Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England.		Claridge, John B/I-7395-2012; Kiely, Christopher/B-1959-2008; cussen, edmund/P-8666-2016; Hayward, Michael/B-8005-2008	Claridge, John B/0000-0003-4849-6714; Hayward, Michael/0000-0002-6248-2063; Kiely, Christopher/0000-0001-5412-0970; Cussen, Edmund/0000-0002-2899-6888; Pratt, Francis/0000-0002-5919-3885				Bacon GE, 1975, NEUTRON DIFFRACTION; Blundell SJ, 1999, CONTEMP PHYS, V40, P175, DOI 10.1080/001075199181521; Chuang YD, 2001, SCIENCE, V292, P1509, DOI 10.1126/science.1059255; CONNER WC, 1995, CHEM REV, V95, P759, DOI 10.1021/cr00035a014; GOODENOUGH JB, 1998, CHEM MATER, V10, P14; Hayward MA, 1999, J AM CHEM SOC, V121, P8843, DOI 10.1021/ja991573i; Hayward MA, 2000, CHEM MATER, V12, P2182, DOI 10.1021/cm9906811; KEREN A, 1993, PHYS REV B, V48, P12926, DOI 10.1103/PhysRevB.48.12926; Kojima KM, 1997, PHYS REV LETT, V78, P1787, DOI 10.1103/PhysRevLett.78.1787; LIN ZY, 1994, COORDIN CHEM REV, V135, P845, DOI 10.1016/0010-8545(94)80084-7; LOUREIRO SM, 2000, CHEM MATER, V12, P5; TEICHNER SJ, 1990, APPL CATAL, V62, P1, DOI 10.1016/S0166-9834(00)82232-0	12	206	209	6	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1882	1884		10.1126/science.1068321	http://dx.doi.org/10.1126/science.1068321			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884751	Green Submitted			2022-12-28	WOS:000174299500035
J	Li, JH; Sato, T; Kageyama, A				Li, JH; Sato, T; Kageyama, A			Repeated and sudden reversals of the dipole field generated by a spherical dynamo action	SCIENCE			English	Article							MAGNETOHYDRODYNAMIC DYNAMO; GEOMAGNETIC REVERSALS; COMPUTER-SIMULATION	Using long-duration, three-dimensional magnetohydrodynamic simulation, we found that the magnetic dipole field generated by a dynamo action in a rotating spherical shell repeatedly reverses its polarity at irregular intervals (that is, punctuated reversal). Although the total convection energy and magnetic energy alternate between a high-energy state and a low-energy state, the dipole polarity can reverse only at high-energy states where the north-south symmetry of the convection pattern is broken and the columnar vortex structure becomes vulnerable. Another attractive finding is that the quadrupole mode grows, exceeding the dipole mode before the reversal; this may help to explain how Earth's magnetic field reverses.	Grad Univ Adv Studies, Dept Fus Sci, Toki 5095292, Japan; Natl Inst Fus Sci, Theory & Comp Simulat Ctr, Toki 5095292, Japan; Inst Appl Phys & Computat Math, Beijing 100088, Peoples R China	Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Fusion Science (NIFS) - Japan; Chinese Academy of Sciences; Institute of Applied Physics & Computational Mathematics - China	Sato, T (corresponding author), Grad Univ Adv Studies, Dept Fus Sci, Toki 5095292, Japan.		Kageyama, Akira/H-4537-2013	Kageyama, Akira/0000-0003-0433-668X				[Anonymous], 1996, MAGNETIC FIELD EARTH; Coe RS, 2000, PHILOS T R SOC A, V358, P1141, DOI 10.1098/rsta.2000.0578; COX A, 1968, J GEOPHYS RES, V73, P3247, DOI 10.1029/JB073i010p03247; Glatzmaier GA, 1999, NATURE, V401, P885, DOI 10.1038/44776; GLATZMAIER GA, 1995, NATURE, V377, P203, DOI 10.1038/377203a0; Jacobs JA, 1994, REVERSALS EARTHS MAG; Kageyama A, 1999, PHYS REV LETT, V82, P5409, DOI 10.1103/PhysRevLett.82.5409; Kageyama A, 1997, PHYS REV E, V55, P4617, DOI 10.1103/PhysRevE.55.4617; KAGEYAMA A, 1995, PHYS PLASMAS, V2, P1421, DOI 10.1063/1.871485; Moffatt H. K., 1978, MAGNETIC FIELD GENER; Roberts PH, 2000, REV MOD PHYS, V72, P1081, DOI 10.1103/RevModPhys.72.1081; ROBERTS PH, 1992, ANNU REV FLUID MECH, V24, P459, DOI 10.1146/annurev.fluid.24.1.459; Sarson GR, 2000, PHILOS T R SOC A, V358, P921, DOI 10.1098/rsta.2000.0567; Sarson GR, 1999, PHYS EARTH PLANET IN, V111, P3, DOI 10.1016/S0031-9201(98)00142-3	14	30	31	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1887	1890		10.1126/science.1066959	http://dx.doi.org/10.1126/science.1066959			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884753	Green Submitted			2022-12-28	WOS:000174299500037
J	Da Costa, D; Brady, WJ; Edhouse, J				Da Costa, D; Brady, WJ; Edhouse, J			ABC of clinical electrocardiography - Bradycardias and atrioventricular conduction block	BRITISH MEDICAL JOURNAL			English	Article									No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England	Northern General Hospital	Da Costa, D (corresponding author), No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England.								0	31	31	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 2	2002	324	7336					535	538		10.1136/bmj.324.7336.535	http://dx.doi.org/10.1136/bmj.324.7336.535			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	528DT	11872557	Green Published			2022-12-28	WOS:000174229700024
J	Haj, FG; Verveer, PJ; Squire, A; Neel, BG; Bastiaens, PIH				Haj, FG; Verveer, PJ; Squire, A; Neel, BG; Bastiaens, PIH			Imaging sites of receptor dephosphorylation by PTP1B on the surface of the endoplasmic reticulum	SCIENCE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; CLATHRIN-MEDIATED ENDOCYTOSIS; INSULIN SENSITIVITY; SPATIAL-RESOLUTION; SUBSTRATE; SPECIFICITY; MICROSCOPY; LIGASE; CELL; MICE	When bound by extracellular ligands, receptor tyrosine kinases (RTKs) on the cell surface transmit critical signals to the cell interior. Although signal termination is less well understood, protein tyrosine phosphatase-1B (PTP1B) is implicated in the dephosphorytation and inactivation of several RTKs. However, PTP1B resides on the cytoplasmic surface of the endoplasmic reticulum (ER), so how and when it accesses RTKs has been unclear. Using fluorescence resonance energy transfer (FRET) methods, we monitored interactions between the epidermal- and platelet-derived growth factor receptors and PTP1B. PTP1B-catatyzed dephosphorylation required endocytosis of the receptors and occurred at specific sites on the surface of the ER. Most of the RTKs activated at the cell surface showed interaction with PTP1B after internalization, establishing that RTK activation and inactivation are spatially and temporally partitioned within cells.	Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Canc Biol Program, Boston, MA 02115 USA; European Mol Biol Lab, D-69117 Heidelberg, Germany	Harvard University; Beth Israel Deaconess Medical Center; European Molecular Biology Laboratory (EMBL)	Neel, BG (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Canc Biol Program, Boston, MA 02115 USA.				NATIONAL CANCER INSTITUTE [R01CA049152] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA49152] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bastiaens PIH, 1999, TRENDS CELL BIOL, V9, P48, DOI 10.1016/S0962-8924(98)01410-X; Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; BLISKA JB, 1992, J EXP MED, V176, P1625, DOI 10.1084/jem.176.6.1625; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Finkel T, 2000, FEBS LETT, V476, P52, DOI 10.1016/S0014-5793(00)01669-0; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; GADELLA TWJ, 1993, BIOPHYS CHEM, V48, P221, DOI 10.1016/0301-4622(93)85012-7; Garton AJ, 1996, MOL CELL BIOL, V16, P6408; GOLD T, 1982, ENERG EXPLOR EXPLOIT, V1, P1; HAJ FG, UNPUB; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; LAKOWICZ JR, 1991, REV SCI INSTRUM, V62, P1727, DOI 10.1063/1.1142413; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sever S, 2000, J CELL BIOL, V150, P1137, DOI 10.1083/jcb.150.5.1137; Squire A, 1999, J MICROSC-OXFORD, V193, P36, DOI 10.1046/j.1365-2818.1999.00427.x; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Verveer PJ, 2000, SCIENCE, V290, P1567, DOI 10.1126/science.290.5496.1567; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; WOODFORDTHOMAS TA, 1992, J CELL BIOL, V117, P401, DOI 10.1083/jcb.117.2.401; Wouters FS, 1999, CURR BIOL, V9, P1127, DOI 10.1016/S0960-9822(99)80484-9; ZHANG ZY, 1994, BIOCHEMISTRY-US, V33, P2285, DOI 10.1021/bi00174a040	26	342	354	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 1	2002	295	5560					1708	1711		10.1126/science.1067566	http://dx.doi.org/10.1126/science.1067566			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872838				2022-12-28	WOS:000174212900045
J	del Hoyo, GM; Martin, P; Vargas, HH; Ruiz, S; Arias, CF; Ardavin, C				del Hoyo, GM; Martin, P; Vargas, HH; Ruiz, S; Arias, CF; Ardavin, C			Characterization of a common precursor population for dendritic cells	NATURE			English	Article							MURINE BONE-MARROW; MYELOID PROGENITOR; LYMPH-NODES; MATURATION; INTERFERON; LINEAGES; MOUSE	Dendritic cells (DCs) are essential for the establishment of immune responses against pathogens and tumour cells, and thus have great potential as tools for vaccination and cancer immunotherapy trials. Experimental evidence has led to a dual DC differentiation model, which involves the existence of both myeloid- and lymphoid-derived DCs1. But this concept has been challenged by recent reports demonstrating that both CD8(-) and CD8(+) DCs, considered in mice as archetypes of myeloid and lymphoid DCs respectively, can be generated from either lymphoid(2-4) or myeloid progenitors(3,4). The issue of DC physiological derivation therefore remains an open question. Here we report the characterization of a DC-committed precursor population, which has the capacity to generate all the DC subpopulations present in mouse lymphoid organs-including CD8(-) and CD8(+) DCs, as well as the B220(+) DC subset-but which is devoid of myeloid or lymphoid differentiation potential. These data support an alternative model of DC development, in which there is an independent, common DC differentiation pathway.	Univ Complutense, Fac Biol, Dept Cell Biol, E-28040 Madrid, Spain	Complutense University of Madrid	Ardavin, C (corresponding author), Univ Complutense, Fac Biol, Dept Cell Biol, E-28040 Madrid, Spain.		Martin, Pilar/F-8193-2014; Martinez del Hoyo, Gloria/K-4750-2015; Fernandez-Arias, Cristina/D-1618-2018	Martin, Pilar/0000-0002-2392-1764; Martinez del Hoyo, Gloria/0000-0003-2588-2575; Hernandez-Vargas, Hector/0000-0001-6045-2103				Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Anjuere F, 2000, J LEUKOCYTE BIOL, V67, P206, DOI 10.1002/jlb.67.2.206; Anjuere F, 1999, BLOOD, V93, P590, DOI 10.1182/blood.V93.2.590.402k11_590_598; ARDAVIN C, 1993, NATURE, V362, P761, DOI 10.1038/362761a0; Ardavin C, 1999, J IMMUNOL, V162, P2538; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; del Hoyo GM, 2002, BLOOD, V99, P999, DOI 10.1182/blood.V99.3.999; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lyman SD, 1998, BLOOD, V91, P1101, DOI 10.1182/blood.V91.4.1101; Manz MG, 2001, BLOOD, V97, P3333, DOI 10.1182/blood.V97.11.3333; Martin P, 2000, BLOOD, V96, P2511, DOI 10.1182/blood.V96.7.2511.h8002511_2511_2519; MARTIN P, UNPUB BLOOD; Mebius RE, 2001, J IMMUNOL, V166, P6593, DOI 10.4049/jimmunol.166.11.6593; Mojica MP, 2001, J IMMUNOL, V166, P3042, DOI 10.4049/jimmunol.166.5.3042; Rolink A, 1996, J EXP MED, V183, P187, DOI 10.1084/jem.183.1.187; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Singh H, 1996, CURR OPIN IMMUNOL, V8, P160, DOI 10.1016/S0952-7915(96)80053-7; Sozzani S, 1998, J IMMUNOL, V161, P1083; Traver D, 2000, SCIENCE, V290, P2152, DOI 10.1126/science.290.5499.2152; Tudor KSRS, 2000, IMMUNITY, V12, P335, DOI 10.1016/S1074-7613(00)80186-7	21	173	179	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2002	415	6875					1043	1047		10.1038/4151043a	http://dx.doi.org/10.1038/4151043a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875574				2022-12-28	WOS:000174075000050
J	Bowling, JCR; Groves, R				Bowling, JCR; Groves, R			An unexpected tattoo	LANCET			English	Editorial Material									Middlesex Hosp, Dept Dermatol, London W1N 8AA, England; UCL Hosp, Dept Dermatol, London W1N 8AA, England	University of London; University College London; University College London Hospitals NHS Foundation Trust	Bowling, JCR (corresponding author), Middlesex Hosp, Dept Dermatol, Mortimer St, London W1N 8AA, England.								0	10	10	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 23	2002	359	9307					649	649		10.1016/S0140-6736(02)07809-1	http://dx.doi.org/10.1016/S0140-6736(02)07809-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526AZ	11879859				2022-12-28	WOS:000174107400007
J	Wang, JX; Knottnerus, AM; Schuit, G; Norman, RJ; Chan, A; Dekker, GA				Wang, JX; Knottnerus, AM; Schuit, G; Norman, RJ; Chan, A; Dekker, GA			Surgically obtained sperm, and risk of gestational hypertension and pre-eclampsia	LANCET			English	Article							PREECLAMPSIA; PREGNANCY	The cause of pre-eclampsia is unknown, although a partner-specific immune maladaptation might be Involved. We compared rates of pre-eclampsia and gestational hypertension in women whose genital tracts had and had not been exposed to their partner's sperm cells. Our aim was to ascertain whether or not protective partner-specific immune-tolerance is conveyed by sperm cells, rather than seminal fluid. Our findings Indicate that, compared with women exposed to their partner's sperm cells and seminal fluid-ie, those treated with in-vitro fertilisation (IVF) or intracytoplasmic sperm Injection (ICSI) with ejaculated sperm-the risk of hypertension was doubled and the risk of pre-eclampsia tripled In those never exposed to their partner's sperm-ie, those treated with ICSI done with surgically obtained sperm.	Univ Adelaide, Queen Elizabeth Hosp, Dept Obstet & Gynaecol, Reprod Med Unit, Woodville, SA 5011, Australia; Univ Adelaide, N Western Adelaide Hlth Serv, Dept Obstet & Gynaecol, Woodville, SA, Australia; Dept Human Serv, Pregnancy Outcome Unit, Adelaide, SA, Australia	University of Adelaide; University of Adelaide	Wang, JX (corresponding author), Univ Adelaide, Queen Elizabeth Hosp, Dept Obstet & Gynaecol, Reprod Med Unit, Woodville, SA 5011, Australia.		Knottnerus, Andre/F-4866-2013; Norman, Robert J/A-1155-2007	Norman, Robert J/0000-0002-3118-3896				Dekker G A, 1998, Obstet Gynecol Surv, V53, P377, DOI 10.1097/00006254-199806000-00023; Koelman CA, 2000, J REPROD IMMUNOL, V46, P155, DOI 10.1016/S0165-0378(99)00062-5; ROBILLARD PY, 1994, LANCET, V344, P973, DOI 10.1016/S0140-6736(94)91638-1; Salha O, 1999, HUM REPROD, V14, P2268, DOI 10.1093/humrep/14.9.2268; Smith GN, 1997, AM J OBSTET GYNECOL, V177, P455, DOI 10.1016/S0002-9378(97)70215-1	5	115	122	1	13	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 23	2002	359	9307					673	674		10.1016/S0140-6736(02)07804-2	http://dx.doi.org/10.1016/S0140-6736(02)07804-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526AZ	11879865				2022-12-28	WOS:000174107400013
J	Sawamura, H; Shima, K; Tanji, J				Sawamura, H; Shima, K; Tanji, J			Numerical representation for action in the parietal cortex of the monkey	NATURE			English	Article							NEURONAL-ACTIVITY; MACAQUE MONKEYS; AREA-5; ARM; ORGANIZATION; MOVEMENTS; NUMBERS; MOTOR	The anterior part of the parietal association area in the cerebral cortex of primates has been implicated in the integration of somatosensory signals(1,2), which generate neural images of body parts and apposed objects and provide signals for sensorial guidance of movements(3-6). Here we show that this area is active in primates performing numerically based behavioural tasks. We required monkeys to select and perform movement A five times, switch to movement B for five repetitions, and return to movement A, in a cyclical fashion. Cellular activity in the superior parietal lobule reflected the number of self-movement executions. For the most part, the number-selective activity was also specific for the type of movement. This type of numerical representation of self-action was seen less often in the inferior parietal lobule, and rarely in the primary somatosensory cortex. Such activity in the superior parietal lobule is useful for processing numerical information, which is necessary to provide a foundation for the forthcoming motor selection.	Tohoku Univ, Sch Med, Dept Physiol, Sendai, Miyagi 980, Japan; Core Res Evolut Sci & Technol Program, Kawaguchi 3320012, Japan	Tohoku University; Japan Science & Technology Agency (JST)	Tanji, J (corresponding author), Tohoku Univ, Sch Med, Dept Physiol, Sendai, Miyagi 980, Japan.							Balint R, 1909, MON PSYCHIATR NEUROL, V25, P51; Boysen S. T., 1993, DEV NUMERICAL COMPET; Brannon EM, 1998, SCIENCE, V282, P746, DOI 10.1126/science.282.5389.746; BURBAUD P, 1991, J NEUROPHYSIOL, V66, P429, DOI 10.1152/jn.1991.66.2.429; Chochon F, 1999, J COGNITIVE NEUROSCI, V11, P617, DOI 10.1162/089892999563689; CRAMMOND DJ, 1989, EXP BRAIN RES, V76, P458; Darian-Smith, 1984, HDB PHYSL 2 1, V3, P789; DEHAENE S, 1993, J COGNITIVE NEUROSCI, V5, P390, DOI 10.1162/jocn.1993.5.4.390; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; Hauser MD, 1996, P NATL ACAD SCI USA, V93, P1514, DOI 10.1073/pnas.93.4.1514; Iriki A, 1996, NEUROREPORT, V7, P2325; JONES EG, 1978, J COMP NEUROL, V181, P291, DOI 10.1002/cne.901810206; Lewis JW, 1999, SOMATOSENS MOT RES, V16, P382; MATSUZAWA T, 1985, NATURE, V315, P57, DOI 10.1038/315057a0; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Orlov T, 2000, NATURE, V404, P77, DOI 10.1038/35003571; PONS TP, 1985, J COMP NEUROL, V241, P445, DOI 10.1002/cne.902410405; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; SAKATA H, 1973, BRAIN RES, V64, P85, DOI 10.1016/0006-8993(73)90172-8; SEAL J, 1982, BRAIN RES, V250, P229, DOI 10.1016/0006-8993(82)90417-6; Shima K, 2000, J NEUROPHYSIOL, V84, P2148, DOI 10.1152/jn.2000.84.4.2148; WASHBURN DA, 1991, PSYCHOL SCI, V2, P190, DOI 10.1111/j.1467-9280.1991.tb00130.x	23	196	208	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 21	2002	415	6874					918	922		10.1038/415918a	http://dx.doi.org/10.1038/415918a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859371				2022-12-28	WOS:000173941000047
J	Borgstein, J; Grootendorst, C				Borgstein, J; Grootendorst, C			Half a brain	LANCET			English	Editorial Material									Univ Rotterdam Hosp, NL-3015 GJ Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Borgstein, J (corresponding author), Univ Rotterdam Hosp, NL-3015 GJ Rotterdam, Netherlands.								0	18	18	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 9	2002	359	9305					473	473		10.1016/S0140-6736(02)07676-6	http://dx.doi.org/10.1016/S0140-6736(02)07676-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520ML	11853792				2022-12-28	WOS:000173785600009
J	Duke, T; Poka, H; Dale, F; Michael, A; Mgone, J; Wal, T				Duke, T; Poka, H; Dale, F; Michael, A; Mgone, J; Wal, T			Chloramphenicol versus benzylpenicillin and gentamicin for the treatment of severe pneumonia in children in Papua New Guinea: a randomised trial	LANCET			English	Article							PENICILLIN; MENINGITIS; ETIOLOGY; PNEUMOCOCCI; MORTALITY; HIV	Background Pneumonia is the most frequent cause of child mortality in less-developed countries, We aimed to establish whether the combination of benzylpenicillin and gentamicin or chloramphenicol would be better as first-line treatment in children with severe pneumonia in Papua New Guinea. Methods We did an open randomised trial in which we enrolled children aged 1 month to 5 years of age who fulfilled the WHO criteria for very severe pneumonia and who presented to hospitals in two provinces. Children were randomly assigned to receive chloramphenicol (25 mg/kg 6 hourly) or benzylpenicillin (50 mg/kg 6 hourly) plus gentamicin (7.5 mg/kg daily) by intramuscular injection. The primary outcome measure was a good or an adverse outcome. Findings 1116 children were enrolled; 559 children were treated with chloramphenicol and 557 with benzylpenicillin and gentamicin. At presentation the median haemoglobin oxygen saturation was 71% (IQR 57-77) for those allocated chloramphenicol and 69% (55-77) for those allocated penicillin and gentamicin. 147 (26%) children treated with chloramphenicol and 123 (22%) treated with penicillin and gentamicin had adverse outcomes (p=0.11). 36 children treated with chloramphenicol and 29 treated with penicillin and gentamicin died. More children treated with chloramphenicol than penicillin and gentamicin represented with severe pneumonia within 1 month of hospital discharge (p=0.03). Interpretation For children with severe pneumonia in less-developed countries the probability of a good outcome is similar if treated with chloramphenicol or with the combination of benzylpenicillin and gentamicin.	Goroka Base Hosp, Dept Paediat, Goroka, Papua N Guinea; Kundiawa Hosp, Chimbu Prov, Papua N Guinea; Papua New Guinea Inst Med Res, Chimbu Prov, Papua N Guinea	PNG Institute Of Medical Research	Duke, T (corresponding author), Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Ctr Int Child Hlth, Flemington Rd, Parkville, Vic 3052, Australia.							ADEGBOLA RA, 1995, PEDIATR INFECT DIS J, V14, P920; BAHL R, 1995, ANN TROP PAEDIATR, V15, P173, DOI 10.1080/02724936.1995.11747768; Banejeh SM, 1997, ANN TROP PAEDIATR, V17, P321; *DEP HLTH PAP NEW, 1993, STAND TRETAM COMM IL; Duke T, 1999, LANCET, V354, P1291, DOI 10.1016/S0140-6736(99)00335-9; Duke T, 1999, LANCET, V353, P2210, DOI 10.1016/S0140-6736(99)02389-2; Duke T, 2001, INT J TUBERC LUNG D, V5, P511; FAGBULE DO, 1993, TROP GEOGR MED, V45, P294; Garenne Michel, 1992, World Health Statistics Quarterly, V45, P180; Graham SM, 2000, LANCET, V355, P369, DOI 10.1016/S0140-6736(98)11074-7; GRATTEN M, 1983, PAPUA NEW GUINEA MED, V26, P222; GRATTEN M, 1991, PAPUA NEW GUINEA MED, V34, P185; GRATTEN M, 1980, LANCET, V2, P192; Ikeogu MO, 1997, ARCH DIS CHILD, V76, P124, DOI 10.1136/adc.76.2.124; Lehmann D, 1997, PEDIATR INFECT DIS J, V16, P297, DOI 10.1097/00006454-199703000-00009; Lehmann D, 1999, ANN TROP PAEDIATR, V19, P21, DOI 10.1080/02724939992608; Lehmann D, 1999, PEDIATR INFECT DIS J, V18, pS62, DOI 10.1097/00006454-199910001-00011; Mulholland K, 1999, LANCET, V354, P590, DOI 10.1016/S0140-6736(98)10238-6; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; ODEMPSEY TJD, 1994, PEDIATR INFECT DIS J, V13, P122, DOI 10.1097/00006454-199402000-00009; Puthavathana Pilaipan, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P657; Rohdenburg GL, 1915, J AMER MED ASSOC, V64, P1227; Sehgal V, 1997, Indian Pediatr, V34, P213; Shann F, 1998, PEDIATR INFECT DIS J, V17, P1141, DOI 10.1097/00006454-199812000-00008; SHANN F, 1984, LANCET, V2, P537; SHANN F, 1986, BRIT MED J, V292, P314, DOI 10.1136/bmj.292.6516.314; SHANN F, 1985, LANCET, V2, P684; SHANN F, 1986, PEDIATR INFECT DIS J, V5, P247, DOI 10.1097/00006454-198603000-00017; SHANN F, 2000, COCHRANE DATABASE SY, V2; Smyth A, 1997, ARCH DIS CHILD, V77, P227, DOI 10.1136/adc.77.3.227; *WHO, 2000, MAN CHILD SER INF SE, P29	31	50	53	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 9	2002	359	9305					474	480		10.1016/S0140-6736(02)07677-8	http://dx.doi.org/10.1016/S0140-6736(02)07677-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520ML	11853793				2022-12-28	WOS:000173785600010
J	Kelly, J; Hunt, BJ				Kelly, J; Hunt, BJ			Role of D-dimers in diagnosis of venous thromboembolism	LANCET			English	Editorial Material							SUSPECTED PULMONARY-EMBOLISM; SIMPLE CLINICAL-MODEL; DEEP-VEIN THROMBOSIS; OUTPATIENTS; MANAGEMENT; VALIDITY		St Thomas Hosp, Guys & St Thomas Trust, Dept Haematol, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust	Hunt, BJ (corresponding author), St Thomas Hosp, Guys & St Thomas Trust, Dept Haematol, London SE1 7EH, England.							Anderson DR, 2001, BLOOD, V98, p447A; Bernardi E, 1998, BRIT MED J, V317, P1037; de Groot MR, 1999, THROMB HAEMOSTASIS, V82, P1588; HULL R, 1981, CIRCULATION, V64, P622, DOI 10.1161/01.CIR.64.3.622; HULL RD, 1990, CHEST, V97, P23, DOI 10.1378/chest.97.1.23; Kearon C, 2001, ANN INTERN MED, V135, P108, DOI 10.7326/0003-4819-135-2-200107170-00011; Kraaijenhagen RA, 1998, BAILLIERE CLIN HAEM, V11, P541, DOI 10.1016/S0950-3536(98)80083-8; KRAAIJENHAGEN RA, 1997, THROMB HAEMOST S JUN, P159; Perrier A, 1997, AM J RESP CRIT CARE, V156, P492, DOI 10.1164/ajrccm.156.2.9702032; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; Schutgens REG, 2001, BLOOD, V98, p448A; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753; Wells PS, 1998, J INTERN MED, V243, P15; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416	15	34	36	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 9	2002	359	9305					456	458		10.1016/S0140-6736(02)07669-9	http://dx.doi.org/10.1016/S0140-6736(02)07669-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520ML	11853785				2022-12-28	WOS:000173785600002
J	Wrigley, H; George, S; Smith, H; Snooks, H; Glasper, A; Thomas, E				Wrigley, H; George, S; Smith, H; Snooks, H; Glasper, A; Thomas, E			Trends in demand for emergency ambulance services in Wiltshire over nine years: observational study	BRITISH MEDICAL JOURNAL			English	Article									Univ Southampton, Sch Med, Community Clin Sci Div, Hlth Care Res Unit, Southampton SO16 6YD, Hants, England; Univ Southampton, Sch Med, Community Clin Sci Div, Acad Dept Primary Med Care, Southampton SO9 5NH, Hants, England; Univ Southampton, Sch Nursing, Southampton SO9 5NH, Hants, England; Univ Wales, Swansea SA2 8PP, W Glam, Wales; Portsmouth Hlth Care NHS Trust, Portsmouth PO3 6DP, Hants, England	University of Southampton; University of Southampton; University of Southampton; Portsmouth Hospitals NHS Trust	George, S (corresponding author), Univ Southampton, Sch Med, Community Clin Sci Div, Hlth Care Res Unit, Southampton SO16 6YD, Hants, England.		Snooks, Helen A/N-2165-2014; Smith, Helen E/M-2449-2016; Jordan, Hannah/AAN-8605-2020	Snooks, Helen A/0000-0003-0173-8843; Smith, Helen E/0000-0003-1883-6124; Jordan, Hannah/0000-0003-0036-8465				HALLAM L, 1994, BRIT MED J, V308, P249, DOI 10.1136/bmj.308.6923.249; Snooks H, 1998, J ACCID EMERG MED, V15, P212; Tuljapurkar S, 2000, NATURE, V405, P789, DOI 10.1038/35015561; *WILTSH AMB SERV N, 1995, SUMM ACT PAT MIL 199; Wrigley H., 1999, PREHOSPITAL IMMEDIAT, V3, P94	5	35	35	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 16	2002	324	7338					646	+		10.1136/bmj.324.7338.646	http://dx.doi.org/10.1136/bmj.324.7338.646			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532QW	11895823	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000174487400023
J	Chu, S				Chu, S			Cold atoms and quantum control	NATURE			English	Article							SPONTANEOUS EMISSION; RADIATION-PRESSURE; PHOTON RECOIL; LASER; SPECTROSCOPY; INTERFEROMETRY; SUPERFLUID; RESONANCE; INSULATOR; SOLITONS		Stanford Univ, Dept Phys, Stanford, CA 94305 USA	Stanford University	Chu, S (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.							ASPECT A, 1988, PHYS REV LETT, V61, P826, DOI 10.1103/PhysRevLett.61.826; BAKLANOV YV, 1976, APPL PHYS, V9, P171, DOI 10.1007/BF00903955; BEAUSOLEIL RG, 1986, PHYS REV A, V33, P1661, DOI 10.1103/PhysRevA.33.1661; Berman P., 1994, CAVITY QUANTUM ELECT; BORDE C, 1977, CR ACAD SCI B PHYS, V284, P101; BORDE CJ, 1989, PHYS LETT A, V140, P10, DOI 10.1016/0375-9601(89)90537-9; Burger S, 1999, PHYS REV LETT, V83, P5198, DOI 10.1103/PhysRevLett.83.5198; Chin C, 2000, PHYS REV LETT, V85, P2717, DOI 10.1103/PhysRevLett.85.2717; Chu S, 1998, REV MOD PHYS, V70, P685, DOI 10.1103/RevModPhys.70.685; DeMarco B, 1999, SCIENCE, V285, P1703, DOI 10.1126/science.285.5434.1703; Deng L, 1999, NATURE, V398, P218, DOI 10.1038/18395; Denschlag J, 2000, SCIENCE, V287, P97, DOI 10.1126/science.287.5450.97; DIEDRICH F, 1989, PHYS REV LETT, V62, P403, DOI 10.1103/PhysRevLett.62.403; Dirac PAM., 1930, PRINCIPLES QUANTUM M; DONLEY E, 2001, OPT PHOTON NEWS  OCT, P34; FESHBACH H, 1962, ANN PHYS-NEW YORK, V19, P287, DOI 10.1016/0003-4916(62)90221-X; FISHER MPA, 1989, PHYS REV B, V40, P546, DOI 10.1063/1.38820; Gangl M, 2000, J MOD OPTIC, V47, P2741, DOI 10.1080/095003400750039672; GORDON JP, 1980, PHYS REV A, V21, P1606, DOI 10.1103/PhysRevA.21.1606; GOY P, 1983, PHYS REV LETT, V50, P1903, DOI 10.1103/PhysRevLett.50.1903; Gustavson TL, 1997, PHYS REV LETT, V78, P2046, DOI 10.1103/PhysRevLett.78.2046; HANSCH TW, 1975, OPT COMMUN, V13, P68, DOI 10.1016/0030-4018(75)90159-5; Heitler W, 1954, QUANTUM THEORY RAD; HELMCKE J, 1988, APPL PHYS B, V28, P83; Helmerson K, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.170402; HENSLEY JM, 2000, P INT C AT PHYS ICAP, P43; HESS HF, 1986, PHYS REV B, V34, P3476, DOI 10.1103/PhysRevB.34.3476; HOLLAND MJ, 1993, PHYS REV LETT, V71, P1355, DOI 10.1103/PhysRevLett.71.1355; HULET RG, 1985, PHYS REV LETT, V55, P2137, DOI 10.1103/PhysRevLett.55.2137; Inouye S, 1998, NATURE, V392, P151, DOI 10.1038/32354; Jaksch D, 1999, PHYS REV LETT, V82, P1975, DOI 10.1103/PhysRevLett.82.1975; KASEVICH M, 1991, PHYS REV LETT, V67, P181, DOI 10.1103/PhysRevLett.67.181; KASEVICH M, 1992, PHYS REV LETT, V69, P1741, DOI 10.1103/PhysRevLett.69.1741; KASEVICH MA, 1989, PHYS REV LETT, V63, P612, DOI 10.1103/PhysRevLett.63.612; KASTLER A, 1991, NOBEL LECT PHYSICS 1, P180; Kerman AJ, 2000, PHYS REV LETT, V84, P439, DOI 10.1103/PhysRevLett.84.439; KETTERLE W, 1993, PHYS REV LETT, V70, P2253, DOI 10.1103/PhysRevLett.70.2253; KLEPPNER D, 1981, PHYS REV LETT, V47, P233, DOI 10.1103/PhysRevLett.47.233; LAURENT P, 1999, LASER SPECTROSCOPY, V14, P41; Leo PJ, 2000, PHYS REV LETT, V85, P2721, DOI 10.1103/PhysRevLett.85.2721; LETOKHOV VS, 1981, PHYS REP, V73, P1, DOI 10.1016/0370-1573(81)90116-2; MASUHARA N, 1988, PHYS REV LETT, V61, P935, DOI 10.1103/PhysRevLett.61.935; MOSSBERG TW, 1991, PHYS REV LETT, V67, P1723, DOI 10.1103/PhysRevLett.67.1723; Orzel C, 2001, SCIENCE, V291, P2386, DOI 10.1126/science.1058149; Osnaghi S, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.037902; Peters A, 2001, METROLOGIA, V38, P25, DOI 10.1088/0026-1394/38/1/4; PURCELL EM, 1946, PHYS REV, V69, P681; Rabi II, 1938, PHYS REV, V53, P318, DOI 10.1103/PhysRev.53.318; RAMSEY NF, 1949, PHYS REV, V76, P996, DOI 10.1103/PhysRev.76.996; SADDEN MJ, 1998, PHYS REV LETT, V81, P971; SALOMON C, 1983, LASER SPECTROSCOPY, V6, P159; Sorensen A, 1999, PHYS REV LETT, V83, P2274, DOI 10.1103/PhysRevLett.83.2274; Stwalley WC, 1999, J MOL SPECTROSC, V195, P194, DOI 10.1006/jmsp.1999.7838; TIESINGA E, 1993, PHYS REV A, V47, P4114, DOI 10.1103/PhysRevA.47.4114; Vuletic V, 2000, PHYS REV LETT, V84, P3787, DOI 10.1103/PhysRevLett.84.3787; Vuletic V, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.033405; WINELAND D, 1975, B AM PHYS SOC, V20, P637; WINELAND DJ, 1978, PHYS REV LETT, V40, P1639, DOI 10.1103/PhysRevLett.40.1639; WINELAND DJ, 1979, PHYS REV A, V20, P1521, DOI 10.1103/PhysRevA.20.1521; YOUNG BC, 1999, LASER SPECTROSCOPY, V14, P61	63	138	147	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2002	416	6877					206	210		10.1038/416206a	http://dx.doi.org/10.1038/416206a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894103				2022-12-28	WOS:000174348100046
J	Kunst, H; Groot, D; Latthe, PM; Latthe, M; Khan, KS				Kunst, H; Groot, D; Latthe, PM; Latthe, M; Khan, KS			Accuracy of information on apparently credible websites: survey of five common health topics	BRITISH MEDICAL JOURNAL			English	Article									Birmingham Womens Hlth Care NHS Trust, Birmingham B15 2TG, W Midlands, England; Tower Hill Med Ctr, Educ Resource Ctr, Birmingham B42 1LJ, W Midlands, England; St Marys Hosp, Dept Resp Med, London W2 1NY, England; Maastricht Univ, NL-6200 MD Maastricht, Netherlands	Imperial College London; Maastricht University	Khan, KS (corresponding author), Birmingham Womens Hlth Care NHS Trust, Birmingham B15 2TG, W Midlands, England.		Khan, Khalid S/AAT-8824-2020	Khan, Khalid S/0000-0001-5084-7312; Latthe, Pallavi/0000-0003-0529-0409				Griffiths KM, 2000, BMJ-BRIT MED J, V321, P1511, DOI 10.1136/bmj.321.7275.1511; *HLTH INF TECHN I, 2002, CRIT ASS QUAL HLTH I; Kim P, 1999, BMJ-BRIT MED J, V318, P647, DOI 10.1136/bmj.318.7184.647; Roberts JM, 2001, INT J MED INFORM, V62, P181, DOI 10.1016/S1386-5056(01)00162-9; Silberg WM, 1997, JAMA-J AM MED ASSOC, V277, P1244, DOI 10.1001/jama.277.15.1244	5	164	167	0	10	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 9	2002	324	7337					581	582		10.1136/bmj.324.7337.581	http://dx.doi.org/10.1136/bmj.324.7337.581			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	530XJ	11884323	Green Published, Bronze			2022-12-28	WOS:000174384000022
J	Meric, F; Bernstam, EV; Mirza, NQ; Hunt, KK; Ames, FC; Ross, MI; Kuerer, HM; Pollock, RE; Musen, MA; Singletary, SE				Meric, F; Bernstam, EV; Mirza, NQ; Hunt, KK; Ames, FC; Ross, MI; Kuerer, HM; Pollock, RE; Musen, MA; Singletary, SE			Breast cancer on the world wide web: cross sectional survey of quality of information and popularity of websites	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEDICAL INFORMATION; HEALTH INFORMATION; INTERNET	Objectives To determine the characteristics of popular breast cancer related websites and whether more popular sites are of higher quality. Design The search engine Google was used to generate a list of websites about breast cancer. Google ranks search results by measures of link popularity-the number of links to a site from other sites. The top 200 sites returned in response to the query "breast cancer" were divided into "more popular" and "less popular" subgroups by three different measures of link popularity: Google rank and number of links reported independently by Google and by AltaVista (another search engine). Main outcome measures Type and quality of content Results More popular sites according to Google rank were more likely than less popular ones to contain information on ongoing clinical trials (27% v 12%, P=0.01), results of trials (12% v 3%, P=0.02), and opportunities for psychosocial adjustment (48% v 23%, P < 0.01). These characteristics were also associated with higher number of links as reported by Google and AltaVista. More popular sites by number of linking sites were also more likely to provide updates on other breast cancer research, information on legislation and advocacy, and a message board service. Measures of quality such as display of authorship, attribution or references, currency of information, and disclosure did not differ between groups. Conclusions Popularity of websites is associated with type rather than quality of content Sites that include content correlated with popularity may best meet the public's desire for information about breast cancer.	Univ Texas, MD Anderson Canc Ctr, Dept Surg Oncol, Sect Breast Surg, Houston, TX 77030 USA; Stanford Univ, Sch Med, Dept Internal Med, Stanford, CA 94305 USA; Univ Texas, Hlth Sci Ctr, Sch Hlth Informat Sci, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; Stanford University; University of Texas System; University of Texas Health Science Center Houston	Meric, F (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Surg Oncol, Sect Breast Surg, 1515 Holcombe Blvd,Box 444, Houston, TX 77030 USA.	fmeric@mail.mdanderson.org		Musen, Mark/0000-0003-3325-793X	NLM NIH HHS [LM06594] Funding Source: Medline; NATIONAL LIBRARY OF MEDICINE [R01LM006594] Funding Source: NIH RePORTER	NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		BATEMAN M, 1998, P AN M AM SOC CLIN, V17, pA419; Berland GK, 2001, JAMA-J AM MED ASSOC, V285, P2612, DOI 10.1001/jama.285.20.2612; Bichakjian CK, 2002, J CLIN ONCOL, V20, P134, DOI 10.1200/JCO.20.1.134; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Eysenbach G, 1998, BRIT MED J, V317, P1496, DOI 10.1136/bmj.317.7171.1496; HELFT PR, 2000, P AN M AM SOC CLIN, V19, pA633; *HLTH NET FDN, 2001, HON COD COND HONC ME; Hoffman-Goetz L, 2000, CAN J PUBLIC HEALTH, V91, P281, DOI 10.1007/BF03404290; Jadad AR, 1998, JAMA-J AM MED ASSOC, V279, P611, DOI 10.1001/jama.279.8.611; KERBER R, 1998, WALL STREET J   0702, V232, pB4; LACROIX EM, 2001, HLTH TOPICS MOST HIT; METZ JM, 2001, P AN M AM SOC CLIN, V20, pA395; O'Connor JB, 2000, JAMA-J AM MED ASSOC, V284, P1962, DOI 10.1001/jama.284.15.1962; Price SL, 1999, J AM MED INFORM ASSN, P911; RUMSEY E, 2002, PEER REV POPULARITY; Sandvik H, 1999, BRIT MED J, V319, P29, DOI 10.1136/bmj.319.7201.29; Shon J, 1999, J AM MED INFORM ASSN, P945; Silberg WM, 1997, JAMA-J AM MED ASSOC, V277, P1244, DOI 10.1001/jama.277.15.1244; Yakren S., 2001, P AN M AM SOC CLIN, V20, p398a; 2002, HLTH NET SURVEY EVOL; 2001, SEARCH ENGINES TAKE	21	201	207	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2002	324	7337					577	581		10.1136/bmj.324.7337.577	http://dx.doi.org/10.1136/bmj.324.7337.577			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	530XJ	11884322	Bronze, Green Published			2022-12-28	WOS:000174384000021
J	Swartz, MN				Swartz, MN			Perspective: Attacking the pneumococcus - A hundred years' war.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	7	8	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2002	346	10					722	722		10.1056/NEJM200203073461002	http://dx.doi.org/10.1056/NEJM200203073461002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527UA	11882726				2022-12-28	WOS:000174205000001
J	Tward, AD; Patterson, HA				Tward, AD; Patterson, HA			From grave robbing to gifting: Cadaver supply in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Tward, AD (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.							DALLEY AF, 1993, CLIN ANAT, V6, P247, DOI DOI 10.1002/CA.980060409; Davidson M., 1995, NEW PHYS, V44, P30; HAGGARD HW, 1929, DEVILS DRUGS DOCTORS; Jones D. Gareth, 2000, SPEAKING DEAD CADAVE; Lassek, 1958, HUMAN DISSECTION ITS; RICHARDSON R, 1987, DEATH DISSECTION DES; Shultz, 1992, BODY SNATCHING ROBBI	7	18	19	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2002	287	9					1183	1183		10.1001/jama.287.9.1183	http://dx.doi.org/10.1001/jama.287.9.1183			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527KV	11879122	hybrid			2022-12-28	WOS:000174186000039
J	Dey, P; Bundred, N; Gibbs, A; Hopwood, P; Baildam, A; Boggis, C; James, M; Knox, F; Leidecker, V; Woodman, C				Dey, P; Bundred, N; Gibbs, A; Hopwood, P; Baildam, A; Boggis, C; James, M; Knox, F; Leidecker, V; Woodman, C			Costs and benefits of a one stop clinic compared with a dedicated breast clinic: randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							DIAGNOSIS; CANCER	Objective To determine the cost to the NHS and the impact on anxiety of a one stop clinic for assessing women with suspected breast cancer. Study design Randomised controlled trial. Participants Women aged 35 or over referred with a breast lump. Study setting Teaching hospital, north west England. Interventions Women were randomly allocated to attend a one stop clinic or a dedicated breast clinic. Outcome measures Reduction in mean anxiety from baseline at 24 hours after the first visit and at 3 weeks and 3 months after diagnosis; mean cost per patient. Results 670 women were randomised. Compared with women who attended the dedicated clinic, patients attending the one stop clinic were less anxious 24 hours after the visit (adjusted mean change in state anxiety - 5.7 (95% confidence interval - 8.4 to - 3.0)) but not at 3 weeks or 3 months after diagnosis. The additional cost to the NI IS of a one stop attendance was 02 per woman; this was largely explained by greater cytopathological and radiological staff costs. Conclusion One stop clinics may not be justified in terms of a reduction in short term anxiety.	Univ Manchester, Ctr Canc Epidemiol, Manchester M20 4QL, Lancs, England; S Manchester Univ Hosp Trust, Withington Hosp, Manchester M20 2LR, Lancs, England; Univ Keele, Ctr Hlth Policy & Planning, Keele ST5 5BG, Staffs, England; Christie Hosp NHS Trust, CRC, Psychol Med Grp, Manchester M20 4BX, Lancs, England	University of Manchester; Keele University; Christie NHS Foundation Trust; Christie Hospital	Dey, P (corresponding author), Univ Manchester, Ctr Canc Epidemiol, Manchester M20 4QL, Lancs, England.							Altman DG, 1995, EUR J CANCER, V31A, P1934, DOI 10.1016/0959-8049(95)00470-X; *CANC GUID SUBGR C, 1996, IMPR OUTC BREAST CAN; Department of Health, 2000, NHS CANC PLAN; Eltahir A, 1999, J ROY COLL SURG EDIN, V44, P226; GUI GPH, 1995, ANN ROY COLL SURG, V77, P24; Harcourt D, 1998, BREAST, V7, P314, DOI 10.1016/S0960-9776(98)90073-X; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Lowe JB, 1999, CANCER, V85, P1114, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1114::AID-CNCR15>3.0.CO;2-Y; Lucock MP, 1997, BRIT MED J, V315, P572; Mansel R, 1998, EUR J SURG ONCOL, V24, P464, DOI 10.1016/S0748-7983(98)93104-3; McPherson K, 1999, EUR J CANCER, V35, P1598, DOI 10.1016/S0959-8049(99)00196-3; Pocock SJ., 2013, CLIN TRIALS PRACTICA; Poole K, 1997, J ADV NURS, V25, P273, DOI 10.1046/j.1365-2648.1997.1997025273.x; Senn S, 2000, STAT MED, V19, P861, DOI 10.1002/(SICI)1097-0258(20000330)19:6<861::AID-SIM407>3.0.CO;2-F; Speilberger C.D., 1983, STATE TRAIT ANXIETY; Teh W, 1998, EUR J CANCER, V34, P449, DOI 10.1016/S0959-8049(97)10066-1; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	17	57	58	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 2	2002	324	7336					507	+		10.1136/bmj.324.7336.507	http://dx.doi.org/10.1136/bmj.324.7336.507			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	528DT	11872547	Green Published, Bronze			2022-12-28	WOS:000174229700015
J	Gillet, Y; Issartel, B; Vanhems, P; Fournet, JC; Lina, G; Bes, M; Vandenesch, F; Piemont, Y; Brousse, N; Floret, D; Etienne, J				Gillet, Y; Issartel, B; Vanhems, P; Fournet, JC; Lina, G; Bes, M; Vandenesch, F; Piemont, Y; Brousse, N; Floret, D; Etienne, J			Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients	LANCET			English	Article							GAMMA-HEMOLYSIN; IDENTIFICATION; LEUCOCIDINS; INVOLVEMENT; INFECTIONS; MEMBRANE; SPECTRUM	Background Between 1986 and 1998, eight cases of community-acquired pneumonia due to Staphylococcus aureus strains carrying the gene for the Panton-Valentine leukocidin (PVL) were recorded in France, six of which were fatal. We aimed to assess the clinical features of these eight cases, and those of other cases identified prospectively, and to compare them with the characteristics of patients with pneumonia caused by PVL-negative strains. Methods We compared eight retrospective and eight prospective cases of PVL-positive S aureus pneumonia with 36 cases of PVL-negative S aureus pneumonia. For all patients, we recorded age, length of hospital stay, risk factors for infection, signs and symptoms, laboratory findings, antibiotic treatment, and serial radiological findings. Findings Median age was 14.8 years (IQR 5.4-24.0) for the PVL-positive patients and 70.1 years (59.2-81.4) for the others (p=0.001). Influenza-like illness had occurred during the 2 days before admission in 12 of the 16 PVL-positive patients, but in only three of 33 PVL-negative patients (p<0.0001). PVL-positive infections were more often marked by: temperature greater than 39 degrees C (p=0.01), heart rate above 140 beats per min (p=0.02), haemoptysis (p=0.005), onset of pleural effusion during hospital stay (p=0.004), and leucopenia (p=0.001). The survival rate 48 h after admission was 63% for the PVL-positive patients and 94% for PVL-negative individuals (p=0.007). Histopathological examination of lungs at necropsy from three cases of necrotising pneumonia associated with PVL-positive S aureus showed extensive necrotic ulcerations of the tracheal and bronchial mucosa and massive haemorrhagic necrosis of interalveolar septa. Interpretation PVL-producing S aureus strains cause rapidly progressive, haemorrhagic, necrotising pneumonia, mainly in otherwise healthy children and young adults. The pneumonia is often preceded by influenza-like symptoms and has a high lethality rate.	Fac Med Laennec, Natl Reference Ctr Staphylococcal Toxaemia, EA 1655, F-69372 Lyon 08, France; Hop Edouard Herriot, INSERM, U271, Hyg & Epidemiol Unit, Lyon, France; Hop Edouard Herriot, Div Paediat Intens Care, Lyon, France; Univ Paris 05, Hop Necker Enfants Malad, Dept Pathol, EA 219, Paris, France; Univ Strasbourg, Inst Bacteriol, Strasbourg, France	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Etienne, J (corresponding author), Fac Med Laennec, Natl Reference Ctr Staphylococcal Toxaemia, EA 1655, Rue Guillaume Paradin, F-69372 Lyon 08, France.	jetienne@univ-lyon1.fr	Vandenesch, Francois/C-7209-2014; Lina, Gerard J/L-9352-2014; gillet, yves/C-6307-2012; ETIENNE, Jerome/C-5471-2014	Vandenesch, Francois/0000-0001-9412-7106; gillet, yves/0000-0003-1791-1639; ETIENNE, Jerome/0000-0002-3348-3315; ISSARTEL, Bertrand/0000-0002-2559-8534; Lina, Gerard/0000-0002-9236-7998				Buwalda M, 1995, NETH J MED, V47, P291, DOI 10.1016/0300-2977(95)00042-9; Chandler FW, 1994, PULMONARY PATHOLOGY, P255; Chickering HT, 1919, J AMER MED ASSOC, V72, P617, DOI 10.1001/jama.1919.02610090001001; Ferreras M, 1998, BBA-BIOMEMBRANES, V1414, P108, DOI 10.1016/S0005-2736(98)00160-6; FINCKBARBANCON V, 1993, BIOCHIM BIOPHYS ACTA, V1182, P275, DOI 10.1016/0925-4439(93)90069-D; FINE MJ, 1993, AM J MED, V94, P153, DOI 10.1016/0002-9343(93)90177-Q; Gauduchon V, 2001, INFECT IMMUN, V69, P2390, DOI 10.1128/IAI.69.4.2390-2395.2001; GOERING RV, 1992, J CLIN MICROBIOL, V30, P577, DOI 10.1128/JCM.30.3.577-580.1992; Gravet A, 1998, FEBS LETT, V436, P202, DOI 10.1016/S0014-5793(98)01130-2; Hunt C, 1999, JAMA-J AM MED ASSOC, V282, P1123; Jarraud S, 1999, J CLIN MICROBIOL, V37, P2446, DOI 10.1128/JCM.37.8.2446-2449.1999; Kaneko J, 1998, GENE, V215, P57, DOI 10.1016/S0378-1119(98)00278-9; KAYE MG, 1990, CHEST, V97, P788, DOI 10.1378/chest.97.4.788; KONIG B, 1995, J INFECT DIS, V171, P607, DOI 10.1093/infdis/171.3.607; Le Thomas I, 2001, J CLIN MICROBIOL, V39, P728, DOI 10.1128/JCM.39.2.728-729.2001; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Melish ME, 1998, TXB PEDIAT INFECT DI, P1039; Mongodin E, 2000, J HISTOCHEM CYTOCHEM, V48, P523, DOI 10.1177/002215540004800410; MURAKAMI K, 1991, J CLIN MICROBIOL, V29, P2240, DOI 10.1128/JCM.29.10.2240-2244.1991; MUSHER DM, 1994, MEDICINE, V73, P186, DOI 10.1097/00005792-199407000-00002; Narita S, 2001, GENE, V268, P195, DOI 10.1016/S0378-1119(01)00390-0; OLCAY L, 1995, ARCH PEDIAT ADOL MED, V149, P925, DOI 10.1001/archpedi.1995.02170210099019; Pedelacq JD, 2000, INT J MED MICROBIOL, V290, P395; Petros S, 1998, INTENS CARE MED, V24, P189, DOI 10.1007/s001340050544; PLOTKOWSKI MC, 1986, AM REV RESPIR DIS, V134, P1040, DOI 10.1164/arrd.1986.134.5.1040; PREVOST G, 1995, J MED MICROBIOL, V42, P237, DOI 10.1099/00222615-42-4-237; PREVOST G, 1995, INFECT IMMUN, V63, P4121; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; SCHWARZMANN SW, 1971, ARCH INTERN MED, V127, P1037, DOI 10.1001/archinte.127.6.1037; Staali L, 1998, J MEMBRANE BIOL, V162, P209, DOI 10.1007/s002329900358; SUPERSAC G, 1993, INFECT IMMUN, V61, P580, DOI 10.1128/IAI.61.2.580-587.1993; Touchie C, 1997, STAPHYLOCOCCI HUMAN, P475; WARD PD, 1980, INFECT IMMUN, V28, P393; WATANAKUNAKORN C, 1987, SCAND J INFECT DIS, V19, P623, DOI 10.3109/00365548709117196; Zou D, 2000, BIOSCI BIOTECH BIOCH, V64, P2631, DOI 10.1271/bbb.64.2631	35	1116	1182	0	55	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 2	2002	359	9308					753	759		10.1016/S0140-6736(02)07877-7	http://dx.doi.org/10.1016/S0140-6736(02)07877-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526DZ	11888586				2022-12-28	WOS:000174115200010
J	Kitano, H				Kitano, H			Systems biology: A brief overview	SCIENCE			English	Review							ROBUSTNESS; MODEL	To understand biology at the system level, we must examine the structure and dynamics of cellular and organismal function, rather than the characteristics of isolated parts of a cell or organism. Properties of systems, such as robustness, emerge as central issues, and understanding these properties may have an impact on the future of medicine. However, many breakthroughs in experimental devices, advanced software, and analytical methods are required before the achievements of systems biology can live up to their much-touted potential.	Sony Comp Sci Labs Inc, Shinagawa Ku, Tokyo 1410022, Japan; JST, ERATO, Kitano Symbiot Syst Project, Shibuya Ku, Tokyo 1500001, Japan; Syst Biol Inst, Shibuya Ku, Tokyo 1500001, Japan	Sony Corporation; Japan Science & Technology Agency (JST)	Kitano, H (corresponding author), Sony Comp Sci Labs Inc, Shinagawa Ku, 3-14-13 Higashi Gotanda, Tokyo 1410022, Japan.	katano@csl.sony.co.jp	Han, Liqi/K-6127-2013	Kitano, Hiroaki/0000-0002-3589-1953				Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Anderson RC, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e60; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Borisuk MT, 1998, J THEOR BIOL, V195, P69, DOI 10.1006/jtbi.1998.0781; Burns MA, 1998, SCIENCE, V282, P484, DOI 10.1126/science.282.5388.484; Chen KC, 2000, MOL BIOL CELL, V11, P369, DOI 10.1091/mbc.11.1.369; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; DASSAW V, 2000, NATURE, V406, P188; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gibbs JB, 2000, SCIENCE, V287, P1969, DOI 10.1126/science.287.5460.1969; Gilles PN, 1999, NAT BIOTECHNOL, V17, P365, DOI 10.1038/7921; Ideker T. E., 2000, PAC S BIOC, V5, P302; Imoto Seiya, 2002, Pac Symp Biocomput, P175; Kitano H, 2001, FDN SYSTEMS BIOL; Noble D, 2002, SCIENCE, V295, P1678, DOI 10.1126/science.1069881; Onami Shuichi, 2001, P59; Sander C, 2000, SCIENCE, V287, P1977, DOI 10.1126/science.287.5460.1977; Simpson PC, 1998, P NATL ACAD SCI USA, V95, P2256, DOI 10.1073/pnas.95.5.2256; Weiner N., 1948, CYBERNETICS CONTROL; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649; Yoo C, 2002, Pac Symp Biocomput, P498	25	2610	2758	13	533	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2002	295	5560					1662	1664		10.1126/science.1069492	http://dx.doi.org/10.1126/science.1069492			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872829	Green Submitted			2022-12-28	WOS:000174212900033
J	Enquist, BJ; Niklas, KJ				Enquist, BJ; Niklas, KJ			Global allocation rules for patterns of biomass partitioning in seed plants	SCIENCE			English	Article							SYSTEM; HISTORY; GROWTH	A general allometric model has been derived to predict intraspecific and interspecific scaling relationships among seed plant leaf, stem, and root biomass. Analysis of a large compendium of standing organ biomass sampled across a broad sampling of taxa inhabiting diverse ecological habitats supports the relations predicted by the model and defines the boundary conditions for above- and below-ground biomass partitioning. These canonical biomass relations are insensitive to phyletic affiliation (conifers versus angiosperms) and variation in averaged local environmental conditions. The model thus identifies and defines the limits that have guided the diversification of seed plant biomass allocation strategies.	Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; Conservat Int, Ctr Appl Biodivers Sci, Washington, DC 20036 USA; Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA	University of Arizona; Conservation International; Cornell University	Enquist, BJ (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA.	benquist@u.arizona.edu	Enquist, Brian J/B-6436-2008; Niklas, Karl/AAV-4760-2021	Enquist, Brian J/0000-0002-6124-7096; 				Bazzaz FA., 1997, PLANT RESOURCE ALLOC; Bazzaz Fakhri A., 1997, P1, DOI 10.1016/B978-012083490-7/50002-5; BROWN S, 1997, FOOD AGR ORG UN PAP, V134, P5; CALLAWAY RM, 1994, ECOLOGY, V75, P1474, DOI 10.2307/1937470; CANNELL MGR, 1994, ADV ECOL RES, V25, P59, DOI 10.1016/S0065-2504(08)60213-5; Cannell MGR, 1982, WORLD FOREST BIOMASS; Caspersen JP, 2000, SCIENCE, V290, P1148, DOI 10.1126/science.290.5494.1148; Charnov EL, 1997, NATURE, V387, P393, DOI 10.1038/387393a0; DETWILER RP, 1988, SCIENCE, V239, P42, DOI 10.1126/science.239.4835.42; Enquist BJ, 2001, NATURE, V410, P655, DOI 10.1038/35070500; Enquist BJ, 1998, NATURE, V395, P163, DOI 10.1038/25977; Enquist BJ, 1999, NATURE, V401, P907, DOI 10.1038/44819; IWASA Y, 1984, THEOR POPUL BIOL, V25, P78, DOI 10.1016/0040-5809(84)90007-8; Levis S, 2000, J CLIMATE, V13, P1313, DOI [10.1175/1520-0442(2000)013<1313:LSVFOA>2.0.CO;2, 10.1175/1520-0442(2000)013&lt;1313:LSVFOA&gt;2.0.CO;2]; MONK C, 1966, B TORREY BOT CLUB, V93, P402, DOI 10.2307/2483412; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; Niklas K.., 1994, PLANT ALLOMETRY; Niklas KJ, 2001, P NATL ACAD SCI USA, V98, P2922, DOI 10.1073/pnas.041590298; Pearsall WH, 1927, ANN BOT-LONDON, V41, P549, DOI 10.1093/oxfordjournals.aob.a090091; Smith B.W., 1983, NC299 US DEP AGR FOR, DOI DOI 10.2737/NC-RN-299; TAYLOR CR, 1981, RESP PHYSIOL, V44, P1, DOI 10.1016/0034-5687(81)90073-6; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; WARDLAW IF, 1990, NEW PHYTOL, V116, P341, DOI 10.1111/j.1469-8137.1990.tb00524.x; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251	24	510	637	20	297	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2002	295	5559					1517	1520		10.1126/science.1066360	http://dx.doi.org/10.1126/science.1066360			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11859193				2022-12-28	WOS:000173981300051
J	Florig, HK				Florig, HK			Public health - Is safe mail worth the price?	SCIENCE			English	Article									Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Florig, HK (corresponding author), Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA.	florig@cmu.edu						DAY TG, 2001, COMMUNICATION    NOV; Reichmanis Elsa, 1993, IRRADIATION POLYM MA; SULLIVAN DJ, 1987, ANN EMERG MED, V16, P662, DOI 10.1016/S0196-0644(87)80066-5; TENGS TO, 1995, RISK ANAL, V15, P369, DOI 10.1111/j.1539-6924.1995.tb00330.x; 2002, US POST REASSURES FE	6	8	8	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2002	295	5559					1467	1468		10.1126/science.1068835	http://dx.doi.org/10.1126/science.1068835			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11859178				2022-12-28	WOS:000173981300032
J	Elson, CO				Elson, CO			Genes, microbes, and T cells - New therapeutic targets in Crohn's disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Alabama, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Elson, CO (corresponding author), Univ Alabama, Birmingham, AL 35294 USA.							Beutler B, 2001, IMMUNITY, V15, P5, DOI 10.1016/S1074-7613(01)00176-5; ELSON CO, 1999, MUCOSAL IMMUNOLOGY, P1007; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jobin C, 2000, INFLAMM BOWEL DIS, V6, P206, DOI 10.1097/00054725-200008000-00007; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200	6	75	77	1	4	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2002	346	8					614	616		10.1056/NEJM200202213460812	http://dx.doi.org/10.1056/NEJM200202213460812			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	522ZK	11856802				2022-12-28	WOS:000173926700011
J	Markowitz, AJ; Rabow, MW				Markowitz, AJ; Rabow, MW			Caring for bereaved patients - "All the doctors just suddenly go"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article														Markowitz, Amy/0000-0001-9314-2814				Prigerson HG, 2001, JAMA-J AM MED ASSOC, V286, P1369, DOI 10.1001/jama.286.11.1369	1	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2002	287	7					882	882		10.1001/jama.287.7.882	http://dx.doi.org/10.1001/jama.287.7.882			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	522XP	11851581				2022-12-28	WOS:000173922500028
J	Tanaka, TU; Rachidi, N; Janke, C; Pereira, G; Galova, M; Schiebel, E; Stark, MJR; Nasmyth, K				Tanaka, TU; Rachidi, N; Janke, C; Pereira, G; Galova, M; Schiebel, E; Stark, MJR; Nasmyth, K			Evidence that the Ipl1-Sli15 (Aurora knase-INCENP) complex by altering promotes chromosome bi-orientation kinetochore-spindle pole connections	CELL			English	Article							CENTROMERE PROTEIN INCENP; HISTONE H3 PHOSPHORYLATION; INNER CENTROMERE; BUDDING YEAST; CHROMATID COHESION; KINASE; SEGREGATION; PHOSPHATASE; MITOSIS; CLEAVAGE	How sister kinetochores attach to microtubules from opposite spindle poles during mitosis (bi-orientation) remains poorly understood. In yeast, the ortholog of the Aurora B-INCENP protein kinase complex (Ipl1-Sli15) may have a role in this crucial process, because it is necessary to prevent attachment of sister kinetochores to microtubules from the same spindle pole. We investigated IPL1 function in cells that cannot replicate their chromosomes but nevertheless duplicate their spindle pole bodies (SPBs). Kinetochores detach from old SPBs and reattach to old and new SPBs with equal frequency in IPL1+ cells, but remain attached to old SPBs in ipl1 mutants. This raises the possibility that Ipl1-Sli15 facilitates bi-orientation by promoting turnover of kinetochore-SPB connections until traction of sister kinetochores toward opposite spindle poles creates tension in the surrounding chromatin.	Univ Dundee, Sch Life Sci, Dundee DD1 5EH, Scotland; Res Inst Mol Pathol, A-1030 Vienna, Austria; Beatson Inst Canc Res, CRC, Beatson Labs, Glasgow G61 1BD, Lanark, Scotland	University of Dundee; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Beatson Institute	Tanaka, TU (corresponding author), Univ Dundee, Sch Life Sci, MSI WTB Complex, Dundee DD1 5EH, Scotland.	t.tanaka@dundee.ac.uk	Tanaka, Tomoyuki U/A-4775-2008; Janke, Carsten/A-7279-2011; Stark, Michael J. R./B-2815-2014; Pereira, Gislene/D-4024-2014	Janke, Carsten/0000-0001-7053-2000; Stark, Michael J. R./0000-0001-9086-191X; Rachidi, Najma/0000-0002-1247-7768; Tanaka, Tomoyuki/0000-0002-9886-5947; Nasmyth, Kim/0000-0001-7030-4403				Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Adams RR, 2001, J CELL BIOL, V153, P865, DOI 10.1083/jcb.153.4.865; Adams RR, 2001, TRENDS CELL BIOL, V11, P49, DOI 10.1016/S0962-8924(00)01880-8; Amon A, 1999, CURR OPIN GENET DEV, V9, P69, DOI 10.1016/S0959-437X(99)80010-0; ARAKI H, 1992, J MOL BIOL, V225, P25, DOI 10.1016/0022-2836(92)91023-I; Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Bloecher A, 1999, GENE DEV, V13, P517, DOI 10.1101/gad.13.5.517; CHAN CSM, 1993, GENETICS, V135, P677; COOKE CA, 1987, J CELL BIOL, V105, P2053, DOI 10.1083/jcb.105.5.2053; FRANCISCO L, 1994, MOL CELL BIOL, V14, P4731, DOI 10.1128/MCB.14.7.4731; Friedman KL, 1996, GENE DEV, V10, P1595, DOI 10.1101/gad.10.13.1595; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Kaitna S, 2000, CURR BIOL, V10, P1172, DOI 10.1016/S0960-9822(00)00721-1; Kim JH, 1999, J CELL BIOL, V145, P1381, DOI 10.1083/jcb.145.7.1381; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Mackay AM, 1998, J CELL BIOL, V140, P991, DOI 10.1083/jcb.140.5.991; MCCARROLL RM, 1988, CELL, V54, P505, DOI 10.1016/0092-8674(88)90072-4; Murnion ME, 2001, J BIOL CHEM, V276, P26656, DOI 10.1074/jbc.M102288200; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; NICKLAS RB, 1994, J CELL BIOL, V126, P1241, DOI 10.1083/jcb.126.5.1241; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; OSTERGREN G, 1951, HEREDITAS, V37, P85; Pearson CG, 2001, J CELL BIOL, V152, P1255, DOI 10.1083/jcb.152.6.1255; Pereira G, 2001, EMBO J, V20, P6359, DOI 10.1093/emboj/20.22.6359; PLATTI S, 1995, EMBO J, V14, P3788; Rieder CL, 1999, J CELL SCI, V112, P2607; Rudner AD, 1996, CURR OPIN CELL BIOL, V8, P773, DOI 10.1016/S0955-0674(96)80077-9; Sassoon I, 1999, GENE DEV, V13, P545, DOI 10.1101/gad.13.5.545; Segal M, 2001, TRENDS CELL BIOL, V11, P160, DOI 10.1016/S0962-8924(01)01954-7; Sonoda E, 2001, DEV CELL, V1, P759, DOI 10.1016/S1534-5807(01)00088-0; Stern BM, 2001, CURR BIOL, V11, P1462, DOI 10.1016/S0960-9822(01)00451-1; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Winey M, 2001, NAT CELL BIOL, V3, pE23, DOI 10.1038/35050663; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669	45	564	604	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2002	108	3					317	329		10.1016/S0092-8674(02)00633-5	http://dx.doi.org/10.1016/S0092-8674(02)00633-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	520VB	11853667	Bronze			2022-12-28	WOS:000173801600005
J	Mazzone, A; Dal Canton, A				Mazzone, A; Dal Canton, A			Images in clinical medicine: Hypercarotenemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Pavia, Policlin San Matteo, I-27100 Pavia, Italy	IRCCS Fondazione San Matteo; University of Pavia	Mazzone, A (corresponding author), Univ Pavia, Policlin San Matteo, I-27100 Pavia, Italy.		dal canton, antonio/G-4388-2013						0	10	10	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2002	346	11					821	821		10.1056/NEJMicm950425	http://dx.doi.org/10.1056/NEJMicm950425			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529YM	11893793				2022-12-28	WOS:000174328900005
J	Rauhut, OWM; Martin, T; Ortiz-Jaureguizar, E; Puerta, P				Rauhut, OWM; Martin, T; Ortiz-Jaureguizar, E; Puerta, P			A jurassic mammal from South America	NATURE			English	Article							AUSTRALIA	The Jurassic period is an important stage in early mammalian evolution, as it saw the first diversification of this group, leading to the stem lineages of monotremes and modern therian mammals(1). However, the fossil record of Jurassic mammals is extremely poor, particularly in the southern continents. Jurassic mammals from Gondwanaland are so far only known from Tanzania(2,3) and Madagascar(4), and from trackway evidence from Argentina(5). Here we report a Jurassic mammal represented by a dentary, which is the first, to our knowledge, from South America. The tiny fossil from the Middle to Late Jurassic of Patagonia is a representative of the recently termed Australosphenida, a group of mammals from Gondwanaland that evolved tribosphenic molars convergently to the Northern Hemisphere Tribosphenida, and probably gave rise to the monotremes(1). Together with other mammalian evidence from the Southern Hemisphere(2-4,6-8), the discovery of this new mammal indicates that the Australosphenida had diversified and were widespread in Gondwanaland well before the end of the Jurassic, and that mammalian faunas from the Southern Hemisphere already showed a marked distinction from their northern counterparts by the Middle to Late Jurassic.	Free Univ Berlin, Inst Geol Wissensch, Fachrichtung Palaontol, D-12249 Berlin, Germany; Museo Paleontol Egidio Feruglio, RA-9100 Trelew, Argentina	Free University of Berlin	Martin, T (corresponding author), Free Univ Berlin, Inst Geol Wissensch, Fachrichtung Palaontol, Malteserstr 74-100, D-12249 Berlin, Germany.	tmartin@zedat.fu-berlin.de	Rauhut, Oliver/AAG-1029-2020; Ortiz-Jaureguizar, Edgardo/F-8193-2010	Ortiz-Jaureguizar, Edgardo/0000-0002-4333-1606; Rauhut, Oliver/0000-0003-3958-603X				ARCHER M, 1985, NATURE, V318, P363, DOI 10.1038/318363a0; Bonaparte J.F., 1994, Berliner Geowissenschaftliche Abhandlungen Reihe E Palaeobiologie, V13, P31; Bonaparte Jose F., 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P73; Casamicjuela R. M., 1961, Physis, V22, P225; CLEMENS W A, 1971, Bulletin of the British Museum (Natural History) Geology, V20, P89; Flynn JJ, 1999, NATURE, V401, P57, DOI 10.1038/43420; Hahn G, 1969, PALAEONTOGRAPHICA A, V133, P1; Heinrich Wolf-Dieter, 1999, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V2, P159; Heinrich Wolf-Dieter, 1998, Journal of Mammalian Evolution, V5, P269, DOI 10.1023/A:1020548010203; KERMACK KA, 1973, ZOOL J LINN SOC-LOND, V53, P87, DOI 10.1111/j.1096-3642.1973.tb00786.x; Kielan-Jaworowska Z, 1998, LETHAIA, V31, P267; KIELANJAWOROWSKA Z, 1989, ZOOL SCR, V18, P347, DOI 10.1111/j.1463-6409.1989.tb00460.x; Krause DW, 1997, NATURE, V390, P504, DOI 10.1038/37343; Luo ZX, 2002, ACTA PALAEONTOL POL, V47, P1; Luo ZX, 2001, NATURE, V409, P53, DOI 10.1038/35051023; LUO ZX, 1994, IN THE SHADOW OF THE DINOSAURS, P98; Martin T, 2000, GUIMAROTA JURASSIC E; MARTIN T, ABH SENCKENBERG NATU, V550, P1; McKenna MC, 1997, CLASSIFICATION MAMMA; MUSACCHIO EA, 1986, BIOESTRATIGRAFIA SIS, V1, P355; Pascual R., 1992, P1; PASCUAL R, 1992, NATURE, V356, P704, DOI 10.1038/356704a0; Pascual R, 1999, J VERTEBR PALEONTOL, V19, P373, DOI 10.1080/02724634.1999.10011148; Pascual Rosendo, 2000, Geodiversitas, V22, P395; Rich TH, 1997, SCIENCE, V278, P1438, DOI 10.1126/science.278.5342.1438; RICH TH, 2001, REC QUEEN VICT MUS, V101, P1; Rich Thomas H., 1999, Records of the Queen Victoria Museum, V106, P1; SIMPSON G. G., 1928, CATALOGUE MESOZOIC M; Tasch P., 1970, 50 U KANS PAL CONTR, V50, P1; Wible John R., 1995, American Museum Novitates, V3149, P1	30	96	110	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2002	416	6877					165	168		10.1038/416165a	http://dx.doi.org/10.1038/416165a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894091				2022-12-28	WOS:000174348100034
J	Bland, JM; Altman, DG				Bland, JM; Altman, DG			Statistics notes - Validating scales and indexes	BRITISH MEDICAL JOURNAL			English	Article									St George Hosp, Sch Med, Dept Publ Hlth Sci, London SW17 0RE, England; Inst Hlth Sci, Ctr Stat Med, Canc Res UK Med Stat Grp, Oxford OX3 7LF, England	St Georges University London; Cancer Research UK; University of Oxford	Bland, JM (corresponding author), St George Hosp, Sch Med, Dept Publ Hlth Sci, London SW17 0RE, England.							Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Gagliardi A, 2002, BMJ-BRIT MED J, V324, P569, DOI 10.1136/bmj.324.7337.569; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Muldoon MF, 1998, BMJ-BRIT MED J, V316, P542, DOI 10.1136/bmj.316.7130.542; Streiner D, 1996, HLTH MEASUREMENT SCA	5	142	155	0	13	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 9	2002	324	7337					606	607		10.1136/bmj.324.7337.606	http://dx.doi.org/10.1136/bmj.324.7337.606			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	530XJ	11884331	Bronze, Green Published			2022-12-28	WOS:000174384000032
J	Muller, M				Muller, M			Science, medicine, and the future - Microdialysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							IN-SITU MICRODIALYSIS; INSULIN; TISSUE		Univ Vienna, Sch Med, Vienna Gen Hosp,Allgemeines Krankenhaus AKH, Dept Clin Pharmacol, A-1090 Vienna, Austria	University of Vienna	Muller, M (corresponding author), Univ Vienna, Sch Med, Vienna Gen Hosp,Allgemeines Krankenhaus AKH, Dept Clin Pharmacol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	markus.mueller@univie.ac.at						BENVENISTE H, 1990, PROG NEUROBIOL, V35, P195, DOI 10.1016/0301-0082(90)90027-E; BOLINDER J, 1993, LANCET, V342, P1080, DOI 10.1016/0140-6736(93)92063-Y; BULLOCK R, 1995, STROKE, V26, P2187, DOI 10.1161/01.STR.26.11.2187; CHURCH MK, 1995, CLIN EXP ALLERGY, V25, P1027; Cline GW, 1999, NEW ENGL J MED, V341, P240, DOI 10.1056/NEJM199907223410404; Cross SE, 1997, LANCET, V350, P636, DOI 10.1016/S0140-6736(05)63324-7; DURING MJ, 1993, LANCET, V341, P1607; EBLAD P, 1996, J CEREB BLOOD FLOW M, V16, P637; ELMQUIST WF, 2000, ADV DRUG DELIVERY RE, V45; Fried I, 2001, NAT NEUROSCI, V4, P201, DOI 10.1038/84041; Herkner H, 2002, AM J RESP CRIT CARE, V165, P273, DOI 10.1164/ajrccm.165.2.2106082; Hillered L, 1999, SCAND J CLIN LAB INV, V59, P9, DOI 10.1080/00365519950185904; JAIN RK, 1994, SCI AM, V271, P58, DOI 10.1038/scientificamerican0794-58; JANSSON PAE, 1993, DIABETES, V42, P1469, DOI 10.2337/diabetes.42.10.1469; Joukhadar C, 2001, EUR J CLIN PHARMACOL, V57, P211, DOI 10.1007/s002280100301; Joukhadar C, 2001, CRIT CARE MED, V29, P385, DOI 10.1097/00003246-200102000-00030; Jungheim K, 2001, DIABETES CARE, V24, P1696, DOI 10.2337/diacare.24.9.1696; JUSTICE JB, 1993, J NEUROSCI METH, V48, P263, DOI 10.1016/0165-0270(93)90097-B; Kennergren C, 1999, CARDIOLOGY, V92, P162, DOI 10.1159/000006966; Lafontan M, 1996, TRENDS PHARMACOL SCI, V17, P309, DOI 10.1016/S0165-6147(96)40002-5; LONNROTH P, 1990, J INTERN MED, V227, P295; LONNROTH P, 1991, J INTERN MED, V230, P363; LONNROTH P, 1987, AM J PHYSIOL, V253, pE228, DOI 10.1152/ajpendo.1987.253.2.E228; MacLean DA, 1998, CIRCULATION, V98, P1990, DOI 10.1161/01.CIR.98.19.1990; Muller M, 1997, CANCER RES, V57, P2598; Muller M, 2000, ADV DRUG DELIVER REV, V45, P255, DOI 10.1016/S0169-409X(00)00113-7; Naredi S, 2001, ACTA ANAESTH SCAND, V45, P402, DOI 10.1034/j.1399-6576.2001.045004402.x; Rojdmark J, 1998, SCAND J PLAST RECONS, V32, P27; Tenhunen JJ, 1999, ANESTHESIOLOGY, V91, P1807, DOI 10.1097/00000542-199912000-00035; UNGERSTEDT U, 1991, J INTERN MED, V230, P365, DOI 10.1111/j.1365-2796.1991.tb00459.x	30	168	181	2	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2002	324	7337					588	591		10.1136/bmj.324.7337.588	http://dx.doi.org/10.1136/bmj.324.7337.588			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	530XJ	11884326	Green Published			2022-12-28	WOS:000174384000025
J	Richardson, D; Sawers, G				Richardson, D; Sawers, G			PMF through the redox loop	SCIENCE			English	Editorial Material							CYTOCHROME-C-OXIDASE; FORMATE DEHYDROGENASE; CRYSTAL-STRUCTURE; PROTEIN; NITRATE; SITES		Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; John Innes Ctr Plant Sci Res, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England	University of East Anglia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Richardson, D (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	d.richardson@uea.ac.uk; gary.sawers@bbsrc.ac.uk	Richardson, David J/E-2275-2011					BERKS BC, 1995, MOL MICROBIOL, V15, P319, DOI 10.1111/j.1365-2958.1995.tb02246.x; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Blasco F, 2001, CELL MOL LIFE SCI, V58, P179, DOI 10.1007/PL00000846; Boyington JC, 1997, SCIENCE, V275, P1305, DOI 10.1126/science.275.5304.1305; Fisher N, 2000, J MOL BIOL, V296, P1153, DOI 10.1006/jmbi.2000.3509; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; JONES RW, 1980, FEMS MICROBIOL LETT, V8, P167, DOI 10.1111/j.1574-6968.1980.tb05072.x; Jormakka M, 2002, SCIENCE, V295, P1863, DOI 10.1126/science.1068186; Khangulov SV, 1998, BIOCHEMISTRY-US, V37, P3518, DOI 10.1021/bi972177k; Lancaster CRD, 1999, NATURE, V402, P377, DOI 10.1038/46483; MITCHELL P, 1979, SCIENCE, V206, P1148, DOI 10.1126/science.388618; Moir JWB, 2001, CELL MOL LIFE SCI, V58, P215, DOI 10.1007/PL00000849; Ordal EJ, 1939, J BACTERIOL, V38, P199, DOI 10.1128/JB.38.2.199-220.1939; Richardson DJ, 2000, MICROBIOL-SGM, V146, P551, DOI 10.1099/00221287-146-3-551; SAWERS G, 1994, ANTON LEEUW INT J G, V66, P57, DOI 10.1007/BF00871633; SUPPMANN B, 1994, MOL MICROBIOL, V11, P965, DOI 10.1111/j.1365-2958.1994.tb00375.x; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60	19	55	56	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2002	295	5561					1842	1843		10.1126/science.1070366	http://dx.doi.org/10.1126/science.1070366			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884738				2022-12-28	WOS:000174299500021
J	Le Maho, Y				Le Maho, Y			Ecophysiology: Nature and function	NATURE			English	Editorial Material									CNRS, Ctr Ecol & Physiol Energet, F-67087 Strasbourg 2, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Le Maho, Y (corresponding author), CNRS, Ctr Ecol & Physiol Energet, 23 Rue Becquerel, F-67087 Strasbourg 2, France.							Feder ME, 2000, ANNU REV ECOL SYST, V31, P315, DOI 10.1146/annurev.ecolsys.31.1.315; Harvey J, 2001, NATURE, V413, P463, DOI 10.1038/35097209; Michener WK, 2001, BIOSCIENCE, V51, P1018, DOI 10.1641/0006-3568(2001)051[1018:DAUB]2.0.CO;2; Schmidt-Nielsen K., 1972, ANIMALS WORK; Wikelski Martin, 2001, Trends in Ecology and Evolution, V16, P479, DOI 10.1016/S0169-5347(01)02279-0	5	15	15	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2002	416	6876					21	21		10.1038/416021a	http://dx.doi.org/10.1038/416021a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882871	Bronze			2022-12-28	WOS:000174211600019
J	Norell, M; Ji, Q; Gao, KQ; Yuan, CX; Zhao, YB; Wang, LX				Norell, M; Ji, Q; Gao, KQ; Yuan, CX; Zhao, YB; Wang, LX			Palaeontology - 'Modern' feathers on a non-avian dinosaur	NATURE			English	Article							THEROPOD DINOSAUR; ORIGIN; CHINA		Amer Museum Nat Hist, New York, NY 10024 USA; Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China; Liaoning Prov Bur Land & Resources, Shenyang 110032, Peoples R China	American Museum of Natural History (AMNH); Chinese Academy of Geological Sciences	Norell, M (corresponding author), Amer Museum Nat Hist, Cent Pk W & 79th St, New York, NY 10024 USA.	norell@amnh.org						Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Feduccia A., 1999, ORIGIN EVOLUTION BIR, V2; Ji Q, 2001, NATURE, V410, P1084, DOI 10.1038/35074079; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Jin F, 1996, VERTEBRATA PALASIATI, V34, P102; Jones TD, 2000, NATURE, V406, P716, DOI 10.1038/35021041; Norell MA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P49; Norell Mark A., 1997, American Museum Novitates, V3215, P1; Ostrom J.H., 1990, P269; Prum RO, 1999, J EXP ZOOL, V285, P291; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; Xu X, 2001, NATURE, V410, P200, DOI 10.1038/35065589	13	78	90	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2002	416	6876					36	37		10.1038/416036a	http://dx.doi.org/10.1038/416036a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882883				2022-12-28	WOS:000174211600029
J	Pittock, SJ				Pittock, SJ			Unilateral osteoarthritis - "The working hand''.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA	Mayo Clinic	Pittock, SJ (corresponding author), Mayo Clin & Mayo Fdn, 200 1st St SW, Rochester, MN 55905 USA.								0	4	4	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2002	346	10					E3	E3		10.1056/ENEJMicm010036	http://dx.doi.org/10.1056/ENEJMicm010036			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527UA	11883473				2022-12-28	WOS:000174205000007
J	Schwetz, BA				Schwetz, BA			Treatment for psoriatic arthritis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commiss Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commiss Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	8	9	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2002	287	9					1103	1103		10.1001/jama.287.9.1103-b	http://dx.doi.org/10.1001/jama.287.9.1103-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527KV	11879090				2022-12-28	WOS:000174186000007
J	Kovalchuk, Y; Hanse, E; Kafitz, KW; Konnerth, A				Kovalchuk, Y; Hanse, E; Kafitz, KW; Konnerth, A			Postsynaptic induction of BDNF-mediated long-term potentiation	SCIENCE			English	Article							NEUROTROPHIC FACTOR BDNF; SYNAPTIC TRANSMISSION; RAT HIPPOCAMPUS; LASTING POTENTIATION; TRKB RECEPTORS; DENTATE GYRUS; KNOCKOUT MICE; CA1 REGION; ADULT-RAT; PLASTICITY	Brain-derived neurotrophic factor (BDNF) and other neurotrophins are critically involved in long-term potentiation (LTP). Previous reports point to a presynaptic site of neurotrophin action. By imaging dentate granule cells in mouse hippocampal slices, we identified BDNF-evoked Ca2+ transients in dendrites and spines, but not at presynaptic sites. Pairing a weak burst of synaptic stimulation with a brief dendritic BDNF application caused an immediate and robust induction of LTP. LTP induction required activation of postsynaptic Ca2+ channels and N-methyl-D-aspartate receptors and was prevented by the blockage of postsynaptic Call transients. Thus, our results suggest that BDNF-mediated LTP is induced postsynaptically. Our finding that dendritic spines are the exclusive synaptic sites for rapid BDNF-evoked Ca2+ signaling supports this conclusion.	Univ Munich, Inst Physiol, D-80336 Munich, Germany	University of Munich	Konnerth, A (corresponding author), Univ Munich, Inst Physiol, D-80336 Munich, Germany.		Hanse, Eric/B-4935-2009					ANDERSEN P, 1966, ACTA PHYSIOL SCAND, V66, P448, DOI 10.1111/j.1748-1716.1966.tb03223.x; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Chen GQ, 1999, J NEUROSCI, V19, P7983; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Frerking M, 1998, J NEUROPHYSIOL, V80, P3383, DOI 10.1152/jn.1998.80.6.3383; Gottschalk W, 1998, J NEUROSCI, V18, P6830; GUSTAFSSON B, 1988, TRENDS NEUROSCI, V11, P156, DOI 10.1016/0166-2236(88)90142-7; HANSE E, 1992, J NEUROSCI, V12, P3226, DOI 10.1523/JNEUROSCI.12-08-03226.1992; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Kang HJ, 2000, NEUROSCI LETT, V282, P141, DOI 10.1016/S0304-3940(00)00893-4; KELLER BU, 1991, J PHYSIOL-LONDON, V435, P275, DOI 10.1113/jphysiol.1991.sp018510; Kohara K, 2001, SCIENCE, V291, P2419, DOI 10.1126/science.1057415; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Korte M, 1996, P NATL ACAD SCI USA, V93, P12547, DOI 10.1073/pnas.93.22.12547; Kossel AH, 2001, P NATL ACAD SCI USA, V98, P14702, DOI 10.1073/pnas.251326998; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; Messaoudi E, 1998, J NEUROPHYSIOL, V79, P496, DOI 10.1152/jn.1998.79.1.496; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; REGEHR WG, 1991, J NEUROSCI METH, V37, P111, DOI 10.1016/0165-0270(91)90121-F; Scharfman HE, 1997, J NEUROPHYSIOL, V78, P1082, DOI 10.1152/jn.1997.78.2.1082; Schinder AF, 2000, TRENDS NEUROSCI, V23, P639, DOI 10.1016/S0166-2236(00)01672-6; Schinder AF, 2000, NEURON, V25, P151, DOI 10.1016/S0896-6273(00)80879-X; Schuman EM, 1999, CURR OPIN NEUROBIOL, V9, P105, DOI 10.1016/S0959-4388(99)80013-0; Sherwood NT, 1999, J NEUROSCI, V19, P7025, DOI 10.1523/JNEUROSCI.19-16-07025.1999; Tanaka T, 1997, J NEUROSCI, V17, P2959; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; WU LG, 1994, J NEUROSCI, V14, P645; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000	37	360	378	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 1	2002	295	5560					1729	1734		10.1126/science.1067766	http://dx.doi.org/10.1126/science.1067766			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872844				2022-12-28	WOS:000174212900051
J	Kurth, WS; Gurnett, DA; Hospodarsky, GB; Farrell, WM; Roux, A; Dougherty, MK; Joy, SP; Kivelson, MG; Walker, RJ; Crary, FJ; Alexander, CJ				Kurth, WS; Gurnett, DA; Hospodarsky, GB; Farrell, WM; Roux, A; Dougherty, MK; Joy, SP; Kivelson, MG; Walker, RJ; Crary, FJ; Alexander, CJ			The dusk flank of Jupiter's magnetosphere	NATURE			English	Article							PLASMA-WAVE OBSERVATIONS; SOLAR-WIND; MAGNETOPAUSE; MAGNETOTAIL; VOYAGER-1	Limited single-spacecraft observations of Jupiter's magnetopause have been used to infer that the boundary moves inward or outward in response to variations in the dynamic pressure of the solar wind(1-8). At Earth, multiple-spacecraft observations have been implemented to understand the physics of how this motion occurs, because they can provide a snapshot of a transient event in progress. Here we present a set of nearly simultaneous two-point measurements of the jovian magnetopause at a time when the jovian magnetopause was in a state of transition from a relatively larger to a relatively smaller size in response to an increase in solar-wind pressure. The response of Jupiter's magnetopause is very similar to that of the Earth, confirming that the understanding built on studies of the Earth's magnetosphere is valid. The data also reveal evidence for a well-developed boundary layer just inside the magnetopause.	Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Univ Versailles, CETP, F-78140 Velizy Villacoublay, France; Univ London Imperial Coll Sci & Technol, Blackett Lab, London SW7 2BZ, England; Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90024 USA; Univ Michigan, Space Phys Res Lab, Ann Arbor, MI 48109 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	University of Iowa; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; UDICE-French Research Universities; Universite Paris Saclay; Imperial College London; University of California System; University of California Los Angeles; University of Michigan System; University of Michigan; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Kurth, WS (corresponding author), Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA.		Farrell, William/I-4865-2013; Hospodarsky, George B/A-7996-2015; Kivelson, Margaret G/I-9019-2012; Kurth, William/AAA-7334-2019	Hospodarsky, George B/0000-0001-9200-9878; Kivelson, Margaret G/0000-0003-3859-8581; Kurth, William/0000-0002-5471-6202				Acuna M. H., 1983, PHYSICS JOVIAN MAGNE, P1, DOI [10. 1017/cbo9780511564574. 003, DOI 10.1017/CBO9780511564574.003]; BRIDGE HS, 1979, SCIENCE, V206, P972, DOI 10.1126/science.206.4421.972; BRIDGE HS, 1979, SCIENCE, V204, P987, DOI 10.1126/science.204.4396.987; ELPHIC RC, 1988, ADV SPACE RES, V8, P223; FAIRFIELD DH, 1971, J GEOPHYS RES, V76, P6700, DOI 10.1029/JA076i028p06700; GRODENT D, UNPUB ICARUS; GURNETT DA, 1981, J GEOPHYS RES-SPACE, V86, P8833, DOI 10.1029/JA086iA10p08833; GURNETT DA, 1992, SPACE SCI REV, V60, P341, DOI 10.1007/BF00216861; GURNETT DA, 1980, GEOPHYS RES LETT, V7, P53, DOI 10.1029/GL007i001p00053; GURNETT DA, IN PRESS SPACE SCI R; JOY SP, IN PRESS J GEOPHYS R; KIVELSON MG, 1991, J GEOPHYS RES-SPACE, V96, P1661, DOI 10.1029/90JA01805; KIVELSON MG, 1990, AGU MONOGRAPH, V58, P619; KURTH WS, 1979, J GEOPHYS RES-SPACE, V84, P3413, DOI 10.1029/JA084iA07p03413; LEPPING RP, 1981, GEOPHYS RES LETT, V8, P99, DOI 10.1029/GL008i001p00099; LEPPING RP, 1983, J GEOPHYS RES-SPACE, V88, P8801, DOI 10.1029/JA088iA11p08801; NESS NF, 1979, SCIENCE, V206, P966, DOI 10.1126/science.206.4421.966; NESS NF, 1979, SCIENCE, V204, P982, DOI 10.1126/science.204.4396.982; Ogino T, 1998, J GEOPHYS RES-SPACE, V103, P225, DOI 10.1029/97JA02247; SCARF FL, 1979, SCIENCE, V204, P991, DOI 10.1126/science.204.4396.991; SIBECK DG, 1991, J GEOPHYS RES-SPACE, V96, P5489, DOI 10.1029/90JA02464; SLAVIN JA, 1985, J GEOPHYS RES-SPACE, V90, P6275, DOI 10.1029/JA090iA07p06275; SMITH EJ, 1978, J GEOPHYS RES-SPACE, V83, P4733, DOI 10.1029/JA083iA10p04733; SOUTHWOOD DJ, 1990, J GEOPHYS RES-SPACE, V95, P2301, DOI 10.1029/JA095iA03p02301; Walker RJ, 2001, PLANET SPACE SCI, V49, P237, DOI 10.1016/S0032-0633(00)00145-8; YOUNG DT, IN PRESS SPACE SCI R	26	38	38	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2002	415	6875					991	994		10.1038/415991a	http://dx.doi.org/10.1038/415991a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875558	Bronze, Green Published			2022-12-28	WOS:000174075000034
J	Gans, H				Gans, H			A word of advice	LANCET			English	Editorial Material											Gans, H (corresponding author), 522 Colorado Ave, Stuart, FL 34994 USA.							NIEWIAROWSKI S., 1958, REV HEMATOL, V13, P320	1	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 23	2002	359	9307					695	695		10.1016/S0140-6736(02)07845-5	http://dx.doi.org/10.1016/S0140-6736(02)07845-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526AZ	11879883				2022-12-28	WOS:000174107400030
J	McEvilly, RJ; de Diaz, MO; Schonemann, MD; Hooshmand, F; Rosenfeld, MG				McEvilly, RJ; de Diaz, MO; Schonemann, MD; Hooshmand, F; Rosenfeld, MG			Transcriptional regulation of cortical neuron migration by POU domain factors	SCIENCE			English	Article							EXPRESSION; FOREBRAIN; BRAIN; PATTERNS; REELIN; ORIGIN; GENES; BRN-2	The identification of pathways mediated by the kinase Cdk5 and the ligand reelin has provided a conceptual framework for exploring the molecular mechanisms underlying proper lamination of the developing mammalian cerebral cortex. In this report, we identify a component of the regulation of Cdk5-mediated cortical lamination by genetic analysis of the roles of the class III POU domain transcription factors, Brn-1 and Brn-2, expressed during the development of the forebrain and coexpressed in most layer II-V cortical neurons. Brn-1 and Brn-2 appear to critically control the initiation of radial migration, redundantly regulating the cell-autonomous expression of the p35 and p39 regulatory subunits of Cdk5 in migrating cortical neurons, with Brn-1((-)/-)/Brn-2((-)/-) mice exhibiting cortical inversion.	Univ Calif San Diego, Howard Hughes Med Inst, Dept Med, La Jolla, CA 92037 USA; Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	McEvilly, RJ (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Dept Med, 9500 Gilman Dr, La Jolla, CA 92037 USA.	rmcevilly@ucsd.edu; mrosenfeld@ucsd.edu						Acampora D, 1999, CEREB CORTEX, V9, P533, DOI 10.1093/cercor/9.6.533; Alcantara S, 1998, J NEUROSCI, V18, P7779; Allen T, 1999, CELL MOL BIOL, V45, P687; ALVAREZBOLADO G, 1995, J COMP NEUROL, V355, P237, DOI 10.1002/cne.903550207; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Cooper JA, 1999, CELL, V97, P671, DOI 10.1016/S0092-8674(00)80778-3; FUJII H, 1993, NEURON, V11, P1197, DOI 10.1016/0896-6273(93)90231-F; Herz J, 2001, NEURON, V29, P571, DOI 10.1016/S0896-6273(01)00234-3; Ko J, 2001, J NEUROSCI, V21, P6758; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; LI P, 1993, GENE DEV, V7, P2483, DOI 10.1101/gad.7.12b.2483; MCEVILLY RJ, UNPUB; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Rice DS, 1998, DEVELOPMENT, V125, P3719; Schonemann MD, 1995, GENE DEV, V9, P3122, DOI 10.1101/gad.9.24.3122; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Smith DS, 2001, CELL GROWTH DIFFER, V12, P277; Takahashi T, 1999, J NEUROSCI, V19, P10357; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0; Zhou C, 1999, NEURON, V24, P847, DOI 10.1016/S0896-6273(00)81032-6	21	201	202	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2002	295	5559					1528	1532		10.1126/science.1067132	http://dx.doi.org/10.1126/science.1067132			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11859196				2022-12-28	WOS:000173981300055
J	Grantham-McGregor, S				Grantham-McGregor, S			Linear growth retardation and cognition	LANCET			English	Editorial Material							EARLY-CHILDHOOD		Inst Child Hlth, Ctr Int Child Hlth, London WC1N 1EH, England	University of London; University College London	Grantham-McGregor, S (corresponding author), Inst Child Hlth, Ctr Int Child Hlth, 30 Guilford St, London WC1N 1EH, England.	S.McGregor@ich.ucl.ac.uk						Grantham-McGregor Sally M., 1999, Food and Nutrition Bulletin, V20, P76; GRANTHAMMCGREGOR SM, 1991, LANCET, V338, P1, DOI 10.1016/0140-6736(91)90001-6; Hamill P. V. V., 1977, DHEW Publication; Martorell R, 1992, HUMAN GROWTH BASIC C, P143; Mendez MA, 1999, J NUTR, V129, P1555, DOI 10.1093/jn/129.8.1555; NEUMANN C, 1991, PEDIATRICS, V88, P934; RICHARDSON SA, 1979, BEHAV EFFECTS ENERGY, P172; SIGMAN M, 1991, J CHILD PSYCHOL PSYC, V32, P307, DOI 10.1111/j.1469-7610.1991.tb00309.x; *UNICEF, 2001, STAT WORLDS CHILDR 2; Walker SP, 2001, NESTLE NUTR WORKS SE, V47, P241; Walker SP, 2000, J PEDIATR-US, V137, P36, DOI 10.1067/mpd.2000.106227; Wechsler DW., 1999, INTELLIGENCE SCALE C	12	46	47	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2002	359	9306					542	542		10.1016/S0140-6736(02)07719-X	http://dx.doi.org/10.1016/S0140-6736(02)07719-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523FP	11867104				2022-12-28	WOS:000173943600003
J	Li, J; Bursten, BE; Liang, BY; Andrews, L				Li, J; Bursten, BE; Liang, BY; Andrews, L			Noble gas-actinide compounds: Complexation of the CUO molecule by Ar, Kr, and Xe atoms in noble gas matrices	SCIENCE			English	Article							METAL-CARBONYL-COMPLEXES; MICROWAVE-SPECTRA; INFRARED-SPECTRA; ARGON; XENON; CONSTANTS; NEON; NG; MO	The CUO molecule, formed from the reaction of laser-ablated U atoms with CO in a noble gas, exhibits very different stretching frequencies in a solid argon matrix [804.3 and 852.5 wave numbers (cm(-1))] than in a solid neon matrix (872.2 and 1047.3 cm(-1)). Related experiments in a matrix consisting of 1% argon in neon suggest that the argon atoms are interacting directly with the CUO molecule. Relativistic density functional calculations predict that CUO can bind directly to one argon atom (U-Ar = 3.16 angstroms; binding energy = 3.2 kilocalories per mole), accompanied by a change in the ground state from a singlet to a triplet. Our experimental and theoretical results also suggest that multiple argon atoms can bind to a single CUO molecule.	Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA; Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA	University System of Ohio; Ohio State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Virginia	Bursten, BE (corresponding author), Ohio State Univ, Dept Chem, 120 W 18th Ave, Columbus, OH 43210 USA.	bursten.1@osu.edu; lsa@unix.mail.virginia.edu	Li, Jun/E-5334-2011; Bursten, Bruce/AAC-6212-2021	Li, Jun/0000-0002-8456-3980; 				Andrews L, 2000, ANGEW CHEM INT EDIT, V39, P4565; BARTLETT N, 1962, P CHEM SOC LONDON, P218; Christe KO, 2001, ANGEW CHEM INT EDIT, V40, P1419, DOI 10.1002/1521-3773(20010417)40:8<1419::AID-ANIE1419>3.0.CO;2-J; DENNING RG, 1992, STRUCT BOND, V79, P215; Ehlers AW, 1997, ORGANOMETALLICS, V16, P4896, DOI 10.1021/om9704962; Evans CJ, 2000, J AM CHEM SOC, V122, P6100, DOI 10.1021/ja000874l; Evans CJ, 2000, J CHEM PHYS, V112, P1321, DOI 10.1063/1.480684; Evans CJ, 2000, J CHEM PHYS, V112, P9363, DOI 10.1063/1.481557; FRENKING G, 1990, STRUCT BOND, V73, P17; Grills DC, 2001, ADV INORG CHEM, V52, P113, DOI 10.1016/S0898-8838(05)52002-6; Hu WP, 2001, J AM CHEM SOC, V123, P2340, DOI 10.1021/ja0033842; Hyman HH, 1963, NOBLE GAS COMPOUNDS; JACOX ME, 1994, CHEM PHYS, V189, P149, DOI 10.1016/0301-0104(94)00143-X; Khriachtchev L, 2000, NATURE, V406, P874, DOI 10.1038/35022551; Lorenz M, 2000, J PHYS CHEM A, V104, P3770, DOI 10.1021/jp993891+; Lundell J, 2000, J PHYS CHEM A, V104, P7944, DOI 10.1021/jp000786n; Pyykko P, 2000, SCIENCE, V290, P64, DOI 10.1126/science.290.5489.64; Runeberg N, 2001, J CHEM PHYS, V114, P836, DOI 10.1063/1.1331105; Seidel S, 2000, SCIENCE, V290, P117, DOI 10.1126/science.290.5489.117; Sun XZ, 1996, J AM CHEM SOC, V118, P10525, DOI 10.1021/ja960485k; TAGUE TJ, 1993, J PHYS CHEM-US, V97, P10920, DOI 10.1021/j100144a004; THOMPSON CA, 1994, J AM CHEM SOC, V116, P423, DOI 10.1021/ja00080a069; VELDKAMP A, 1994, CHEM PHYS LETT, V226, P11, DOI 10.1016/0009-2614(94)00697-0; WELLS JR, 1992, J AM CHEM SOC, V114, P2783, DOI 10.1021/ja00034a003; Zhou MF, 1999, J AM CHEM SOC, V121, P9712, DOI 10.1021/ja9921322; Zhou MF, 1999, J CHEM PHYS, V111, P11044, DOI 10.1063/1.480463	26	214	217	3	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2002	295	5563					2242	2245		10.1126/science.1069342	http://dx.doi.org/10.1126/science.1069342			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534AD	11872801				2022-12-28	WOS:000174561700037
J	Cote, HCF; Brumme, ZL; Craib, KJP; Alexander, CS; Wynhoven, B; Ting, LL; Wong, H; Harris, M; Harrigan, PR; O'Shaughnessy, MV; Montaner, JSG				Cote, HCF; Brumme, ZL; Craib, KJP; Alexander, CS; Wynhoven, B; Ting, LL; Wong, H; Harris, M; Harrigan, PR; O'Shaughnessy, MV; Montaner, JSG			Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; LACTIC-ACIDOSIS; AIDS PATIENTS; ANTIRETROVIRAL THERAPY; SKELETAL-MUSCLE; ANALOG; HYPERLACTATEMIA; APOPTOSIS; FAILURE; ABNORMALITIES	Background: Nucleoside analogues can induce toxic effects on mitochondria by inhibiting the human DNA polymerase gamma. The toxic effects can range from increased serum lactate levels to potentially fatal lactic acidosis. We studied changes in mitochondrial DNA relative to nuclear DNA in the peripheral-blood cells of patients with symptomatic, nucleoside-induced hyperlactatemia. Methods: Total DNA was extracted from blood cells. A nuclear gene and a mitochondrial gene were quantified by real-time polymerase chain reaction. Three groups were studied: 24 controls not infected with the human immunodeficiency virus (HIV), 47 HIV-infected asymptomatic patients who had never been treated with antiretroviral drugs, and 8 HIV-infected patients who were receiving antiretroviral drugs and had symptomatic hyperlactatemia. The patients in the last group were studied longitudinally before, during, and after antiretroviral therapy. Results: Symptomatic hyperlactatemia was associated with marked reductions in the ratios of mitochondrial to nuclear DNA, which, during therapy, averaged 68 percent lower than those of non-HIV-infected controls and 43 percent lower than those of HIV-infected asymptomatic patients never treated with antiretroviral drugs. After the discontinuation of antiretroviral therapy, there was a statistically significant increase in the ratio of mitochondrial to nuclear DNA (P=0.02). In the patients followed longitudinally, the decline in mitochondrial DNA preceded the increase in venous lactate levels. Conclusions: Mitochondrial DNA levels are significantly decreased in patients with symptomatic, nucleoside-related hyperlactatemia, an effect that resolves on the discontinuation of therapy. (N Engl J Med 2002;346:811-20.) Copyright (C) 2002 Massachusetts Medical Society.	Univ British Columbia, St Pauls Hosp, Providence Hlth Care, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; Univ British Columbia, St Pauls Hosp, Providence Hlth Care, Canadian HIV Trials Network, Vancouver, BC V6Z 1Y6, Canada	B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; St. Paul's Hospital; University of British Columbia; University of Saskatchewan	Montaner, JSG (corresponding author), Univ British Columbia, St Pauls Hosp, Providence Hlth Care, British Columbia Ctr Excellence HIV AIDS, 667-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	jmontaner@hivnet.ubc.ca	Cote, Helene/K-7896-2012; Franzeck, Fabian C/B-5055-2011; Montaner, Julio/K-7621-2012	Brumme, Zabrina/0000-0002-8157-1037; Wong, Hubert/0000-0001-8840-4509				ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5; Benbrik E, 1997, J NEUROL SCI, V149, P19, DOI 10.1016/S0022-510X(97)05376-8; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brinkman K, 1999, LANCET, V354, P1112, DOI 10.1016/S0140-6736(99)06102-4; Brinkman K, 2001, AIDS, V15, P795, DOI 10.1097/00002030-200104130-00016; Brinkman K, 1998, AIDS, V12, P1735, DOI 10.1097/00002030-199814000-00004; Carr A, 2000, LANCET, V356, P1423, DOI 10.1016/S0140-6736(00)02854-3; Carr A, 2001, LANCET, V357, P1412, DOI 10.1016/S0140-6736(00)04579-7; CHEN CH, 1991, MOL PHARMACOL, V39, P625; Dalakas MC, 2001, LAB INVEST, V81, P1537, DOI 10.1038/labinvest.3780367; DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602; Delgado J, 2001, CLIN INFECT DIS, V33, P2072, DOI 10.1086/323980; Ferri KF, 2000, ANN NY ACAD SCI, V926, P149; FORTGANG IS, 1995, AM J GASTROENTEROL, V90, P1433; Gerard Y, 2000, AIDS, V14, P2723; HARRIS M, 2000, ANTIVIR THER S, V5, P31; John M, 2001, AIDS, V15, P717, DOI 10.1097/00002030-200104130-00007; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kakuda TN, 1999, AIDS, V13, P2311, DOI 10.1097/00002030-199911120-00019; Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3; Lafeuillade A, 2001, LANCET, V357, P280, DOI 10.1016/S0140-6736(00)03618-7; LEWIS W, 1992, J CLIN INVEST, V89, P1354, DOI 10.1172/JCI115722; LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417; Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200; Lonergan JT, 2000, CLIN INFECT DIS, V31, P162, DOI 10.1086/313912; Mallal SA, 2000, AIDS, V14, P1309, DOI 10.1097/00002030-200007070-00002; MARTIN JL, 1994, ANTIMICROB AGENTS CH, V38, P2743, DOI 10.1128/AAC.38.12.2743; MCKENZIE R, 1995, NEW ENGL J MED, V333, P1099, DOI 10.1056/NEJM199510263331702; MEDINA DJ, 1994, ANTIMICROB AGENTS CH, V38, P1824, DOI 10.1128/AAC.38.8.1824; Megarbane B, 1999, PRESSE MED, V28, P2257; Moraes CT, 1999, MOL BIOL CELL, V10, P3345, DOI 10.1091/mbc.10.10.3345; Moretti S, 2000, CLIN EXP IMMUNOL, V122, P364, DOI 10.1046/j.1365-2249.2000.01375.x; Pan-Zhou XR, 2000, ANTIMICROB AGENTS CH, V44, P496, DOI 10.1128/AAC.44.3.496-503.2000; Plymale DR, 1999, AIDS, V13, P1827, DOI 10.1097/00002030-199910010-00004; Roggero R, 2001, J VIROL, V75, P7637, DOI 10.1128/JVI.75.16.7637-7650.2001; Shikuma CM, 2001, AIDS, V15, P1801, DOI 10.1097/00002030-200109280-00009; SINNWELL TM, 1995, J CLIN INVEST, V96, P126, DOI 10.1172/JCI118012; ter Hofstede HJM, 2000, INT J STD AIDS, V11, P611; Zaera MG, 2001, AIDS, V15, P1643, DOI 10.1097/00002030-200109070-00006	39	455	473	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2002	346	11					811	820		10.1056/NEJMoa012035	http://dx.doi.org/10.1056/NEJMoa012035			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529YM	11893792	Bronze			2022-12-28	WOS:000174328900004
J	Petrelli, A; Gilestro, GF; Lanzardo, S; Comoglio, PM; Migone, N; Giordano, S				Petrelli, A; Gilestro, GF; Lanzardo, S; Comoglio, PM; Migone, N; Giordano, S			The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met	NATURE			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; TYROSINE KINASE RECEPTOR; ADAPTER PROTEIN; FAMILY; CBL; PHOSPHORYLATION; TRANSFORMATION; CIN85; SITE; GAB1	Ligand-dependent downregulation of tyrosine kinase receptors is a critical step for modulating their activity. Upon ligand binding, hepatocyte growth factor (HGF) receptor (Met) is polyubiquitinated(1) and degraded(2); however, the mechanisms underlying HGF receptor endocytosis are not yet known. Here we demonstrate that a complex involving endophilins, CIN85 and Cbl controls this process. Endophilins(3) are regulatory components of clathrin-coated vesicle formation. Through their acyltransferase activity they are thought to modify the membrane phospholipids and induce negative curvature and invagination of the plasma membrane during the early steps of endocytosis(4). Furthermore, by means of their Src-homology 3 domains, endophilins are able to bind CIN85, a recently identified protein that interacts with the Cbl proto-oncogene(5). Cbl, in turn, binds and ubiquitinates activated HGF receptor, and by recruiting the endophilin-CIN85 complex, it regulates receptor internalization. Inhibition of complex formation is sufficient to block HGF receptor internalization and to enhance HGF-induced signal transduction and biological responses. These data provide further evidence of a relationship between receptor-mediated signalling and endocytosis, and disclose a novel functional role for Cbl in HGF receptor signalling.	Univ Turin, Sch Med, Inst Canc Res & Treatment, Div Mol Oncol, I-10060 Turin, Italy; Univ Turin, Dept Genet Biol & Biochem, I-10126 Turin, Italy; CNR, CIOS, I-10126 Turin, Italy	University of Turin; University of Turin; Consiglio Nazionale delle Ricerche (CNR)	Giordano, S (corresponding author), Univ Turin, Sch Med, Inst Canc Res & Treatment, Div Mol Oncol, I-10060 Turin, Italy.		Giordano, Silvia/J-9858-2018; Gilestro, Giorgio/A-8721-2010	Giordano, Silvia/0000-0003-1854-1086; Gilestro, Giorgio/0000-0001-7512-8541; Comoglio, Paolo/0000-0002-7056-5328				Brodin L, 2000, CURR OPIN NEUROBIOL, V10, P312, DOI 10.1016/S0959-4388(00)00097-0; Cestra G, 1999, J BIOL CHEM, V274, P32001, DOI 10.1074/jbc.274.45.32001; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Fixman ED, 1997, J BIOL CHEM, V272, P20167, DOI 10.1074/jbc.272.32.20167; Garcia-Guzman M, 2000, ONCOGENE, V19, P4058, DOI 10.1038/sj.onc.1203750; Giachino C, 1997, GENOMICS, V41, P427, DOI 10.1006/geno.1997.4645; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; Hammond DE, 2001, ONCOGENE, V20, P2761, DOI 10.1038/sj.onc.1204475; Hill E, 2001, J CELL BIOL, V152, P309, DOI 10.1083/jcb.152.2.309; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Huttner WB, 2000, CURR OPIN NEUROBIOL, V10, P543, DOI 10.1016/S0959-4388(00)00126-4; Jeffers M, 1997, MOL CELL BIOL, V17, P799, DOI 10.1128/MCB.17.2.799; Kirsch KH, 1999, P NATL ACAD SCI USA, V96, P6211, DOI 10.1073/pnas.96.11.6211; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Prat M, 1998, J CELL SCI, V111, P237; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Take H, 2000, BIOCHEM BIOPH RES CO, V268, P321, DOI 10.1006/bbrc.2000.2147; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Watanabe S, 2000, BIOCHEM BIOPH RES CO, V278, P167, DOI 10.1006/bbrc.2000.3760; Waterman H, 2001, FEBS LETT, V490, P142, DOI 10.1016/S0014-5793(01)02117-2; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0	25	354	372	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2002	416	6877					187	190		10.1038/416187a	http://dx.doi.org/10.1038/416187a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894096				2022-12-28	WOS:000174348100040
J	Piatelli-Palmarini, M				Piatelli-Palmarini, M			Grammar - The barest essentials	NATURE			English	Article									Univ Arizona, Dept Linguist, Tucson, AZ 85721 USA	University of Arizona	Piatelli-Palmarini, M (corresponding author), Univ Arizona, Dept Linguist, Tucson, AZ 85721 USA.							CHOMSKY Noam, 1986, KNOWLEDGE LANGUAGE I; Pullum GK, 2001, NATURE, V413, P367, DOI 10.1038/35096656; WASOW T, 1991, FDN COGNITIVE SCI, P161	3	4	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2002	416	6877					129	129		10.1038/416129a	http://dx.doi.org/10.1038/416129a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894075	Bronze			2022-12-28	WOS:000174348100019
J	Yokouchi, Y; Ikeda, M; Inuzuka, Y; Yukawa, T				Yokouchi, Y; Ikeda, M; Inuzuka, Y; Yukawa, T			Strong emission of methyl chloride from tropical plants	NATURE			English	Article							DIMETHYL SULFIDE; ATMOSPHERE; BROMIDE; PACIFIC; BIOMASS; BUDGETS; OCEAN	Methyl chloride is the largest natural source of ozone-depleting chlorine compounds, and accounts for about 15 per cent of the present atmospheric chlorine content(1). This contribution was likely to have been relatively greater in pre-industrial times 2, when additional anthropogenic sources-such as chlorofluoro-carbons-were absent. Although it has been shown that there are large emissions of methyl chloride from coastal lands in the tropics 3,4, there remains a substantial shortfall in the overall methyl chloride budget. Here we present observations of large emissions of methyl chloride from some common tropical plants (certain types of ferns and Dipterocarpaceae), ranging from 0.1 to 3.7 mug per gram of dry leaf per hour. On the basis of these preliminary measurements, the methyl chloride flux from Dipterocarpaceae in southeast Asia alone is estimated at 0.91 Tg yr(-1), which could explain a large portion of missing methyl chloride sources. With continuing tropical deforestation, natural sources of chlorine compounds may accordingly decrease in the future. Conversely, the abundance of massive ferns in the Carboniferous period(5) may have created an atmosphere rich in methyl chloride.	Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; Meisei Univ, Tokyo 1918506, Japan; Museum Nat Sci, Tsukuba Bot Garden, Tsukuba, Ibaraki 3050005, Japan	National Institute for Environmental Studies - Japan; Meisei University	Yokouchi, Y (corresponding author), Natl Inst Environm Studies, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	yokouchi@nies.go.jp	陽子, 横内/E-8041-2010					Aiba S, 1999, PLANT ECOL, V140, P139, DOI 10.1023/A:1009710618040; BERG LR, 1997, INTRO BOT; Butler JH, 1999, NATURE, V399, P749, DOI 10.1038/21586; Butler JH, 2000, NATURE, V403, P260, DOI 10.1038/35002232; FAO, 1997, STAT WORLDS FOR 1997; Khalil MAK, 1999, ATMOS ENVIRON, V33, P1305, DOI 10.1016/S1352-2310(98)00234-9; Li HJ, 2001, GEOCHEM J, V35, P137, DOI 10.2343/geochemj.35.137; Li HJ, 1999, ATMOS ENVIRON, V33, P1881, DOI 10.1016/S1352-2310(98)00303-3; Lobert JM, 1999, J GEOPHYS RES-ATMOS, V104, P8373, DOI 10.1029/1998JD100077; Manokaran N., 1998, CONSERVATION MANAGEM, P41; Moore RM, 1996, J GEOPHYS RES-OCEANS, V101, P28529, DOI 10.1029/96JC02915; Redeker KR, 2000, SCIENCE, V290, P966, DOI 10.1126/science.290.5493.966; Rhew RC, 2000, NATURE, V403, P292, DOI 10.1038/35002043; Takhtajan AL., 1986, FLORISTIC REGIONS WO; Watling R, 1998, MYCOL RES, V102, P769, DOI 10.1017/S0953756298006157; Watts SF, 2000, ATMOS ENVIRON, V34, P761, DOI 10.1016/S1352-2310(99)00342-8; YAMAKURA T, 1986, VEGETATIO, V68, P71; Yokouchi Y, 2000, NATURE, V403, P295, DOI 10.1038/35002049; Yokouchi Y, 1999, J GEOPHYS RES-ATMOS, V104, P8067, DOI 10.1029/1998JD100013	19	106	108	6	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2002	416	6877					163	165		10.1038/416163a	http://dx.doi.org/10.1038/416163a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894090				2022-12-28	WOS:000174348100033
J	Mehta, RH; Montoye, CK; Gallogly, M; Baker, P; Blount, A; Faul, J; Roychoudhury, C; Borzak, S; Fox, S; Franklin, M; Freundl, M; Kline-Rogers, E; LaLonde, T; Orza, M; Parrish, R; Satwicz, M; Smith, MJ; Sobotka, P; Winston, S; Riba, AA; Eagle, KA				Mehta, RH; Montoye, CK; Gallogly, M; Baker, P; Blount, A; Faul, J; Roychoudhury, C; Borzak, S; Fox, S; Franklin, M; Freundl, M; Kline-Rogers, E; LaLonde, T; Orza, M; Parrish, R; Satwicz, M; Smith, MJ; Sobotka, P; Winston, S; Riba, AA; Eagle, KA		GAP Steering Comm Amer Coll Cardio	Improving quality of care for acute myocardial infarction - The guidelines applied in practice (GAP) initiative	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COOPERATIVE CARDIOVASCULAR PROJECT; MEDICARE PATIENTS; THROMBOLYTIC THERAPY; UNITED-STATES; MANAGEMENT; MORTALITY; IMPACT	Context Quality of care of patients with acute myocardial infarction (AMI) has received intense attention. However, it is unknown if a structured initiative for improving care of patients with AMI can be effectively implemented at a wide variety of hospitals. Objective To measure the effects of a quality improvement project on adherence to evidence-based therapies for patients with AMI. Design and Setting The Guidelines Applied in Practice (GAP) quality improvement project, which consisted of baseline measurement, implementation of improvement strategies, and remeasurement, in 10 acute-care hospitals in southeast Michigan. Patients A random sample of Medicare and non-Medicare patients at baseline (July 1998-June 1999; n =735) and following intervention (September 1-December 15, 2000; n=914) admitted at the 10 study c enters for treatment of confirmed AMI. A random sample of Medicare patients at baseline (January-December 1998; n=513) and at remeasurement (March-August 2001; n = 388) admitted to 11 hospitals that volunteered, but were not selected, served as a control group. Intervention The GAP project consisted of a kickoff presentation; creation of customized, guideline-oriented tools designed to facilitate adherence to key quality indicators; identification and assignment of local physician and nurse opinion leaders; grand rounds site visits; and premeasurement and postmeasurement of quality indicators. Main Outcome Measures Differences in adherence to quality indicators (use of aspirin, beta-blockers, and angiotensin-converting enzyme [ACE] inhibitors at discharge; time to reperfusion; smoking cessation and diet counseling; and cholesterol assessment and treatment) in ideal patients, compared between baseline and postintervention samples and among Medicare patients in GAP hospitals and the control group. Results Increases in adherence to key treatments were seen in the administration of aspirin (81% vs 87%; P=.02) and beta-blockers (65% vs 74%; P=.04) on admission and use of aspirin (84% vs 92%; P=.002) and smoking cessation counseling (53% vs 65%; P=.02) at discharge. For most of the other indicators, nonsignificant but favorable trends toward improvement in adherence to treatment goals were observed. Compared with the control group, Medicare patients in GAP hospitals showed a significant increase in the use of aspirin at discharge (5% vs 10%; P<001). Use of aspirin on admission, ACE inhibitors at discharge, and documentation of smoking cessation also showed a trend for greater improvement among GAP hospitals compared with control hospitals, although none of these were statistically significant. Evidence of tool use noted during chart review was associated with a very high level of adherence to most quality indicators. Conclusions Implementation of guideline-based tools for AMI may facilitate quality improvement among a variety of institutions, patients, and caregivers. This initial project provides a foundation for future initiatives aimed at quality improvement.	Univ Michigan, Dept Internal Med, Div Cardiol, Ann Arbor, MI 48109 USA; Amer Coll Cardiol, Bethesda, MD USA; Michigan Peer Review Org, Plymouth, MI USA; Henry Ford Hlth Syst, Dept Internal Med, Div Cardiol, Detroit, MI USA; St John Hosp & Med Ctr, Dept Internal Med, Div Cardiol, Detroit, MI USA; St John Hlth Syst, Warren, MI USA; Greater Detroit Area Hlth Council, Detroit, MI USA; St Joseph Mercy Hlth Syst, Dept Internal Med, Div Cardiol, Ann Arbor, MI USA; Detroit Med Ctr, Dept Internal Med, Div Cardiol, Detroit, MI USA; Dept Internal Med, Div Cardiol, Dearborn, MI USA	University of Michigan System; University of Michigan; Henry Ford Health System; Henry Ford Hospital; St. John Hospital & Medical Center; Saint Joseph Mercy Health System (SJMHS); Detroit Medical Center	Eagle, KA (corresponding author), Univ Michigan Hosp, Div Cardiol, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.			Faul, Jessica/0000-0002-6969-6478				Alexander KP, 1998, J AM COLL CARDIOL, V32, P2023, DOI 10.1016/S0735-1097(98)00466-5; Allison JJ, 1996, J GEN INTERN MED, V11, P736, DOI 10.1007/BF02598987; Allison JJ, 2000, JAMA-J AM MED ASSOC, V284, P1256, DOI 10.1001/jama.284.10.1256; AYANIAN JZ, 1994, NEW ENGL J MED, V331, P1136, DOI 10.1056/NEJM199410273311707; Casale PN, 1998, J AM COLL CARDIOL, V32, P885, DOI 10.1016/S0735-1097(98)00325-8; ELLERBECK EF, 1995, JAMA-J AM MED ASSOC, V273, P1509, DOI 10.1001/jama.273.19.1509; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; Gurwitz JH, 1996, ANN INTERN MED, V124, P283, DOI 10.7326/0003-4819-124-3-199602010-00001; GURWITZ JH, 1992, AM J MED, V93, P605, DOI 10.1016/0002-9343(92)90192-E; HISS RG, 1978, P 17 ANN C RES MED E, P283; Jencks SF, 2000, JAMA-J AM MED ASSOC, V284, P1670, DOI 10.1001/jama.284.13.1670; Krumholz HM, 1998, JAMA-J AM MED ASSOC, V280, P623, DOI 10.1001/jama.280.7.623; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; McLaughlin TJ, 1996, ARCH INTERN MED, V156, P799, DOI 10.1001/archinte.156.7.799; Mehta RH, 2000, ARCH INTERN MED, V160, P1301, DOI 10.1001/archinte.160.9.1301; Mehta RH, 2000, ARCH INTERN MED, V160, P3057, DOI 10.1001/archinte.160.20.3057; MEHTA RH, 2001, PREV MED MANAG CARE, V2, P15; O'Connor GT, 1999, JAMA-J AM MED ASSOC, V281, P627, DOI 10.1001/jama.281.7.627; PILOTE L, 1995, NEW ENGL J MED, V333, P565, DOI 10.1056/NEJM199508313330907; ROGERS WJ, 1994, CIRCULATION, V90, P2103, DOI 10.1161/01.CIR.90.4.2103; Ryan TJ, 1999, J AM COLL CARDIOL, V34, P890, DOI 10.1016/S0735-1097(99)00351-4; Soumerai SB, 1998, JAMA-J AM MED ASSOC, V279, P1358, DOI 10.1001/jama.279.17.1358; Soumeral SB, 1997, JAMA-J AM MED ASSOC, V277, P115, DOI 10.1001/jama.277.2.115; THOMSON MA, 2001, LOCAL OPINION LEADER; Vaccarino V, 1998, ARCH INTERN MED, V158, P2054, DOI 10.1001/archinte.158.18.2054; WEINGARTEN S, 1993, AM J CARDIOL, V342, P1317; Yarzebski J, 1996, AM HEART J, V131, P43, DOI 10.1016/S0002-8703(96)90049-6	27	352	361	0	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2002	287	10					1269	1276		10.1001/jama.287.10.1269	http://dx.doi.org/10.1001/jama.287.10.1269			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529YU	11886318				2022-12-28	WOS:000174329500025
J	Poeppelmeier, K				Poeppelmeier, K			A mixed oxide-hydride perovskite	SCIENCE			English	Editorial Material							CA2MNO3.5; PHASE		Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Northwestern University	Poeppelmeier, K (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.							Hayward MA, 2002, SCIENCE, V295, P1882, DOI 10.1126/science.1068321; Hayward MA, 2000, CHEM MATER, V12, P2182, DOI 10.1021/cm9906811; Huang BQ, 1998, J SOLID STATE CHEM, V141, P570, DOI 10.1006/jssc.1998.8022; Huang BQ, 1998, INORG CHEM, V37, P1892, DOI 10.1021/ic971339y; LEONOWICZ ME, 1985, J SOLID STATE CHEM, V59, P71, DOI 10.1016/0022-4596(85)90352-4; LIEDL GL, 1986, SCI AM, V255, P127; MALAMAN B, 1984, J SOLID STATE CHEM, V53, P44, DOI 10.1016/0022-4596(84)90226-3; POEPPELMEIER KR, 1982, J SOLID STATE CHEM, V44, P89, DOI 10.1016/0022-4596(82)90404-2; Poulsen FW, 2001, SOLID STATE IONICS, V145, P387, DOI 10.1016/S0167-2738(01)00935-3; Salvador PA, 1998, CHEMISTRY OF ADVANCED MATERIALS, P449; Shriver D. F., 1999, INORG CHEM, P253; Steinsvik S, 2001, SOLID STATE IONICS, V143, P103, DOI 10.1016/S0167-2738(01)00838-4	12	14	15	2	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1849	1849		10.1126/science.1070030	http://dx.doi.org/10.1126/science.1070030			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884742				2022-12-28	WOS:000174299500025
J	Postle, K				Postle, K			Structure - Close before opening	SCIENCE			English	Editorial Material							ESCHERICHIA-COLI; OUTER-MEMBRANE; TONB; TRANSPORT; RECEPTOR; VITAMIN-B12; MUTANTS		Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Washington State University	Postle, K (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.			Postle, Kathleen/0000-0001-9451-777X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042146] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM042146] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barnard TJ, 2001, MOL MICROBIOL, V41, P527, DOI 10.1046/j.1365-2958.2001.02473.x; BASSFORD PJ, 1976, J BACTERIOL, V128, P242, DOI 10.1128/JB.128.1.242-247.1976; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Ferguson AD, 2002, SCIENCE, V295, P1715, DOI 10.1126/science.1067313; FROST GE, 1975, J BACTERIOL, V124, P704, DOI 10.1128/JB.124.2.704-712.1975; GUTERMAN SK, 1973, J BACTERIOL, V114, P1225, DOI 10.1128/JB.114.3.1225-1230.1973; HANCOCK REW, 1976, J BACTERIOL, V125, P409, DOI 10.1128/JB.125.2.409-415.1976; HELLER KJ, 1988, GENE, V64, P147, DOI 10.1016/0378-1119(88)90488-X; Jiang XQ, 1997, SCIENCE, V276, P1261, DOI 10.1126/science.276.5316.1261; Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6; Merianos HJ, 2000, NAT STRUCT BIOL, V7, P205; Moeck GS, 1996, MOL MICROBIOL, V22, P459, DOI 10.1046/j.1365-2958.1996.00112.x; REYNOLDS PR, 1980, J BIOL CHEM, V255, P4313; Usher KC, 2001, P NATL ACAD SCI USA, V98, P10676, DOI 10.1073/pnas.181353398; WILLIAMS PH, 1979, INFECT IMMUN, V26, P925, DOI 10.1128/IAI.26.3.925-932.1979	15	10	11	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 1	2002	295	5560					1658	1659						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872826				2022-12-28	WOS:000174212900030
J	Jayaraman, KS				Jayaraman, KS			Cutbacks cost jobs at agricultural institute	NATURE			English	News Item																			0	0	0	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2002	415	6875					949	949		10.1038/415949b	http://dx.doi.org/10.1038/415949b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875534	Bronze			2022-12-28	WOS:000174075000012
J	Lacroix-Desmazes, S; Bayry, J; Misra, N; Horn, MP; Villard, S; Pashov, A; Stieltjes, N; d'Oiron, R; Saint-Remy, J; Hoebeke, J; Kazatchkine, MD; Kaveri, SV				Lacroix-Desmazes, S; Bayry, J; Misra, N; Horn, MP; Villard, S; Pashov, A; Stieltjes, N; d'Oiron, R; Saint-Remy, J; Hoebeke, J; Kazatchkine, MD; Kaveri, SV			The prevalence of proteolytic antibodies against factor VIII in hemophilia A.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; VON-WILLEBRAND-FACTOR; LIGHT-CHAIN; PROCOAGULANT ACTIVITY; MONOCLONAL-ANTIBODY; CATALYTIC ACTIVITY; C2 DOMAIN; FACTOR-IX; INHIBITOR; BINDING	Background: Factor VIII inhibitors are IgG alloantibodies that arise during replacement therapy in 25 to 50 percent of patients with severe hemophilia A. The hydrolysis of factor VIII by anti-factor VIII antibodies has been proposed as a mechanism of inactivation of factor VIII. Methods: We purified IgG from patients with severe hemophilia A. The proteolytic activity of the antibodies was assessed by incubating the IgG with biotinylated human factor VIII and analyzing patterns of factor VIII cleavage by sodium dodecyl sulfate-polyacrylamide-gel electrophoresis and immunoblotting. The controls were normal human IgG and IgG purified from plasma of patients with hemophilia who did not have inhibitory antibodies. Results: Significant proteolytic activity was detected in IgG from 13 of 24 inhibitor-positive patients. No hydrolytic activity was detected in control antibodies of IgG from patients without inhibitors. The rate of hydrolysis of factor VIII by purified IgG correlated positively with the factor VIII-neutralizing activity of IgG in plasma (r(sup 2)=0.67, P=0.029). Principal-component analysis of migration profiles of digestion fragments demonstrated the heterogeneity of the catalytic potential of factor VIII inhibitors among patients. Conclusions: Proteolysis is a mechanism by which IgG antibodies against factor VIII can inactivate factor VIII. (N Engl J Med 2002;346:662-7.) Copyright (C) 2002 Massachusetts Medical Society.	Hop Broussais, INSERM, U430, F-75014 Paris, France; Univ Paris 06, Hop Broussais, Paris, France; Fac Pharm Montpellier, CNRS, Unite Mixte Rech 5094, Montpellier, France; Hop Cochin & Bicetre, Ctr Hemophiles, F-75674 Paris, France; Katholieke Univ Leuven, Ctr Mol & Vasc Biol, Louvain, Belgium; Inst Biol Mol & Cellulaire, CNRS, Unite Propre Rech 9021, F-67084 Strasbourg, France; Inst Biol Mol & Cellulaire, CNRS, Unite Propre Rech 9002, F-67084 Strasbourg, France; Inst Immunohaematol, Mumbai, India	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; KU Leuven; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Indian Council of Medical Research (ICMR); ICMR - National Institute of Immunohaemotology (NIIH)	Lacroix-Desmazes, S (corresponding author), Hop Broussais, INSERM, U430, 96 Rue Didot, F-75014 Paris, France.		Pashov, Anastas/AAE-7997-2019; Bayry, Jagadeesh/A-6589-2011	Bayry, Jagadeesh/0000-0003-0498-9808; Pashov, Anastas/0000-0002-6033-3566; Lacroix-Desmazes, Sebastien/0000-0001-5625-8447; d'Oiron, Roseline/0000-0002-4843-7805				ARAI M, 1989, J CLIN INVEST, V83, P1978, DOI 10.1172/JCI114107; DEBIASI R, 1994, THROMB HAEMOSTASIS, V71, P544; EHRENFORTH S, 1992, LANCET, V339, P594, DOI 10.1016/0140-6736(92)90874-3; FOSTER PA, 1988, J CLIN INVEST, V82, P123, DOI 10.1172/JCI113559; GILLES JGG, 1993, BLOOD, V82, P2452; GOLOLOBOV GV, 1995, P NATL ACAD SCI USA, V92, P254, DOI 10.1073/pnas.92.1.254; KASPER CK, 1975, THROMB DIATH HAEMOST, V34, P612; Lacroix-Desmazes S, 1999, NAT MED, V5, P1044, DOI 10.1038/12483; LI L, 1995, J IMMUNOL, V154, P3328; LUBAHN BC, 1989, BLOOD, V73, P497; Moreau A, 2000, BLOOD, V95, P3435, DOI 10.1182/blood.V95.11.3435.011k32_3435_3441; PAUL S, 1991, J BIOL CHEM, V266, P16128; PAUL S, 1989, SCIENCE, V244, P1158, DOI 10.1126/science.2727702; Ray WD, 1992, J R STAT SOC A, DOI [10.2307/2982904, DOI 10.2307/2982904]; SAENKO EL, 1994, J BIOL CHEM, V269, P11601; Saenko EL, 1996, J BIOL CHEM, V271, P27424, DOI 10.1074/jbc.271.44.27424; Schwaab R, 1995, THROMB HAEMOSTASIS, V74, P1402; SHIMA M, 1993, THROMB HAEMOSTASIS, V69, P240; SHUSTER AM, 1992, SCIENCE, V256, P665, DOI 10.1126/science.1585181; Stahl D, 2000, J IMMUNOL METHODS, V240, P1, DOI 10.1016/S0022-1759(00)00185-X; Thiagarajan P, 2000, BIOCHEMISTRY-US, V39, P6459, DOI 10.1021/bi992588w; Zhong DG, 1998, BLOOD, V92, P136, DOI 10.1182/blood.V92.1.136.413k35_136_142	22	87	92	0	7	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2002	346	9					662	667		10.1056/NEJMoa011979	http://dx.doi.org/10.1056/NEJMoa011979			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525HJ	11870243				2022-12-28	WOS:000174062800004
J	Harris, HE; Ramsay, ME; Andrews, N; Eldridge, KP				Harris, HE; Ramsay, ME; Andrews, N; Eldridge, KP		HCV Natl Register Steering Grp	Clinical course of hepatitis C virus during the first decade of infection: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NATURAL-HISTORY; LIVER-CANCER; TRANSFUSION; MORTALITY; TRANSMISSION; PROGRESSION; OUTCOMES; DISEASE; ALCOHOL; IMPACT	Objective To determine the clinical Course of hepatitis C virus in the first decade of infection ill it group of patients who acquired their infections on a known date. Design Cohort study. Setting Clinical centres throughout the United Kingdom, Participants 924 transfusion recipients infected with die hepatitis C virus (HCV) traced during die HCV lookback programme and 475 transfusion recipients who tested negative for antibodies to HCV (controls). Main outcome measures Clinical evidence of liver disease and survival after 10 years of infection. Results All cause mortality was not significant-IN. different between patients and controls (Cox's hazards ratio 1.41, 95% confidence interval 0.95 to 2.08). Patients were more likely to be certified with a death related to liver disease than were controls (12.84 1.73 to 95.44). but although the risk of death directly from liver disease was higher in patients than controls this difference was not significant (5.78, 0.72 to 46.70). Forty per cent of the patients who died directly, From lifer disease were known to have consumed excess alcohol. Clinical follow up of 826 patients showed that liver function was abnormal in 307 (37.2%) and 115 (13.9%) reported physical signs or symptoms of liver disease. Factors associated with developing liver disease were testing positive for HCV ribonucleic acid (odds ratio 6.44. 2.67 to 15.48), having acquired infection when older (at age greater than or equal to 40 Nears; 1.80, 1.14 to 2.85), and years since transfusion (odds ratio 1.096 per year, 1.00 to 1.20). For patients with severe disease, sex was also significant (odds ratio For women 0.38,0.17 to 0.88). Of die 362 patients who had undergone liver biopsy, 328 (91%) had abnormal histological results and 35 (10%) of these were Cirrhotic. Conclusions Hepatitis C virus infection did not have it great impact oil all cause mortality in the first decade of infection. Infected patients were at increased risk of dying directly from liver disease, particularly if they consumed excess alcohol, but this difference was not statistically significant.	Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England	Public Health England	Harris, HE (corresponding author), Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England.	bharris@phls.nhs.uk	; Ramsay, Mary Elizabeth/S-8281-2016	Harris, Helen/0000-0002-0575-9513; Ramsay, Mary Elizabeth/0000-0002-7156-7640				[Anonymous], 1999, Wkly Epidemiol Rec, V74, P425; Darby SC, 1997, LANCET, V350, P1425, DOI 10.1016/S0140-6736(97)05413-5; Darke S, 1998, DRUG ALCOHOL DEPEN, V51, P253, DOI 10.1016/S0376-8716(98)00028-3; *DEP HLTH, 1995, CMO951 PL DEP HLTH; Deuffic S, 1999, HEPATOLOGY, V29, P1596, DOI 10.1002/hep.510290528; Di Bisceglie AM, 2000, HEPATOLOGY, V31, P1014, DOI 10.1053/he.2000.5762; DITTMANN S, 1991, J HEPATOL, V13, P323, DOI 10.1016/0168-8278(91)90076-N; *ENGL NAT BLOOD SE, IN PRESS TRANSFUSION; Ghodse H, 1998, INT J EPIDEMIOL, V27, P473, DOI 10.1093/ije/27.3.473; GORDON SC, 1993, HEPATOLOGY, V18, P1338, DOI 10.1002/hep.1840180609; Harris HE, 2000, J VIRAL HEPATITIS, V7, P420, DOI 10.1046/j.1365-2893.2000.00255.x; Hope VD, 2001, AM J PUBLIC HEALTH, V91, P38, DOI 10.2105/AJPH.91.1.38; Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602; Lopez-Morante A, 1998, EUR J GASTROEN HEPAT, V10, P15, DOI 10.1097/00042737-199801000-00004; Mohsen AH, 2001, GUT, V48, P707, DOI 10.1136/gut.48.5.707; PERCY C, 1990, PUBLIC HEALTH REP, V105, P361; Pessione F, 1998, HEPATOLOGY, V27, P1717, DOI 10.1002/hep.510270635; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0; Ramsay M E, 1998, Commun Dis Public Health, V1, P89; SEEFF LB, 1992, NEW ENGL J MED, V327, P1906, DOI 10.1056/NEJM199212313272703; Seeff LB, 1998, HEPATOLOGY, V28, P1710, DOI 10.1002/hep.510280636; Seeff LB, 2000, ANN INTERN MED, V132, P105, DOI 10.7326/0003-4819-132-2-200001180-00003; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P2592, DOI 10.1001/jama.284.20.2592; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; TONG MJ, 1995, NEW ENGL J MED, V332, P1463, DOI 10.1056/NEJM199506013322202; Wiley TE, 1998, HEPATOLOGY, V28, P805, DOI 10.1002/hep.510280330	27	65	68	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2002	324	7335					450	453		10.1136/bmj.324.7335.450	http://dx.doi.org/10.1136/bmj.324.7335.450			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526NJ	11859045	Bronze, Green Published			2022-12-28	WOS:000174136300015
J	Curfman, GD				Curfman, GD			Perspective - Hypothermia to protect the brain	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	35	41	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2002	346	8					546	546		10.1056/NEJM200202213460802	http://dx.doi.org/10.1056/NEJM200202213460802			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	522ZK	11856792				2022-12-28	WOS:000173926700001
J	Hay, SI; Cox, J; Rogers, DJ; Randolph, SE; Stern, DI; Shanks, GD; Myers, MF; Snow, RW				Hay, SI; Cox, J; Rogers, DJ; Randolph, SE; Stern, DI; Shanks, GD; Myers, MF; Snow, RW			Climate change and the resurgence of malaria in the East African highlands	NATURE			English	Article							AUTOREGRESSIVE TIME-SERIES; UNIT-ROOT; EL-NINO; VARIABILITY; UGANDA	The public health and economic consequences of Plasmodium falciparum malaria are once again regarded as priorities for global development. There has been much speculation on whether anthropogenic climate change is exacerbating the malaria problem, especially in areas of high altitude where P. falciparum transmission is limited by low temperature(1-4). The International Panel on Climate Change has concluded that there is likely to be a net extension in the distribution of malaria and an increase in incidence within this range(5). We investigated long-term meteorological trends in four high-altitude sites in East Africa, where increases in malaria have been reported in the past two decades. Here we show that temperature, rainfall, vapour pressure and the number of months suitable for P. falciparum transmission have not changed significantly during the past century or during the period of reported malaria resurgence. A high degree of temporal and spatial variation in the climate of East Africa suggests further that claimed associations between local malaria resurgences and regional changes in climate are overly simplistic.	Univ Oxford, Dept Zool, TALA Res Grp, Oxford OX1 3PS, England; Kenya Med Res Inst Wellcome Trust Collaborat Prog, Nairobi, Kenya; Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Univ Oxford, Dept Zool, Oxford Tick Res Grp, Oxford OX1 3PS, England; Australian Natl Univ, Ctr Resource & Environm Studies, Canberra, ACT 0200, Australia; USA, Med Res Unit Kenya, Nairobi, Kenya; Decis Syst Technol Inc, Rockville, MD 20850 USA; Univ Oxford, John Radcliffe Hosp, Ctr Trop Med, Oxford OX3 9DU, England	University of Oxford; Kenya Medical Research Institute; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; Australian National University; University of Oxford	Hay, SI (corresponding author), Univ Oxford, Dept Zool, TALA Res Grp, S Parks Rd, Oxford OX1 3PS, England.		Stern, David I/B-4700-2009; Snow, Robert William/AFR-1436-2022; Shanks, George Dennis/F-4056-2014; Randolph, Sarah/AAR-9346-2021; Hay, Simon Iain/F-8967-2015	Stern, David I/0000-0001-6595-4268; Snow, Robert William/0000-0003-3725-6088; Shanks, George Dennis/0000-0001-5763-8660; Hay, Simon Iain/0000-0002-0611-7272	Wellcome Trust [079080, 056642] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bodker R, 2000, GLOBAL CHANGE HUMAN, V1, P134, DOI DOI 10.1023/A:1010077105257; Box GeorgeE.P., 1970, J AM STAT ASSOC, V1st; DICKEY DA, 1981, ECONOMETRICA, V49, P1057, DOI 10.2307/1912517; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; DIXON S, 1950, E AFR MED J, V27, P10; Epstein PR, 1998, B AM METEOROL SOC, V79, P409, DOI 10.1175/1520-0477(1998)079<0409:BAPSOC>2.0.CO;2; Garnham P. C. C., 1948, Journal of the National Malaria Society, V7, P275; Granger C.W., 1974, J ECONOMETRICS, V2, P111, DOI [10.1016/0304-4076(74)90034-7, DOI 10.1016/0304-4076(74)90034-7]; Hay SI, 2000, P NATL ACAD SCI USA, V97, P9335, DOI 10.1073/pnas.97.16.9335; Houghton J. T., 2001, CLIMATE CHANGE 2001; Kilian AHD, 1999, T ROY SOC TROP MED H, V93, P22, DOI 10.1016/S0035-9203(99)90165-7; King'uyu SM, 2000, J CLIMATE, V13, P2876, DOI 10.1175/1520-0442(2000)013&lt;2876:RTOMAM&gt;2.0.CO;2; Lindblade KA, 1999, T ROY SOC TROP MED H, V93, P480, DOI 10.1016/S0035-9203(99)90344-9; LOEVINSOHN ME, 1994, LANCET, V343, P714, DOI 10.1016/S0140-6736(94)91586-5; MARIMBU J, 1993, B SOC PATHOL EXOT, V86, P399; Martens P, 1999, AM SCI, V87, P534, DOI 10.1511/1999.42.839; MATOLA YG, 1987, J TROP MED HYG, V90, P127; McCarthy J.J., 2001, CLIMATE CHANGE 2001; McMichael A.J., 1996, CLIMATE CHANGE HUMAN; Mouchet J, 1998, J AM MOSQUITO CONTR, V14, P121; Mouchet J, 1997, B SOC PATHOL EXOT, V90, P162; *NAT RES COUNC, 2001, WEATH CLIM EC INF DI; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; New M, 2000, J CLIMATE, V13, P2217, DOI 10.1175/1520-0442(2000)013<2217:RTCSTC>2.0.CO;2; Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853; Shanks GD, 2000, T ROY SOC TROP MED H, V94, P253, DOI 10.1016/S0035-9203(00)90310-9; Stern DI, 2000, CLIMATIC CHANGE, V47, P411, DOI 10.1023/A:1005672231474	27	328	337	1	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 21	2002	415	6874					905	909		10.1038/415905a	http://dx.doi.org/10.1038/415905a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859368	Green Accepted			2022-12-28	WOS:000173941000044
J	Erhardt, A; Aker, S; Saleh, A; Hennersdorf, M; Gross-Weege, W				Erhardt, A; Aker, S; Saleh, A; Hennersdorf, M; Gross-Weege, W			A seropneumothorax?	LANCET			English	Editorial Material							BOCHDALEK HERNIA; ADULT		Univ Dusseldorf, Dept Internal Med, D-40225 Dusseldorf, Germany; Univ Dusseldorf, Inst Diagnost Radiol, D-40225 Dusseldorf, Germany; Univ Dusseldorf, Dept Surg, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Erhardt, A (corresponding author), Univ Dusseldorf, Dept Internal Med, D-40225 Dusseldorf, Germany.							Bujanda L, 2001, J CLIN GASTROENTEROL, V32, P155, DOI 10.1097/00004836-200102000-00013; MULLINS ME, 2001, AJR, V177, P63; SHIN MS, 1987, CHEST, V92, P1098, DOI 10.1378/chest.92.6.1098; THOMAS S, 1991, JPN J SURG, V21, P114, DOI 10.1007/BF02470876	4	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 16	2002	359	9306					578	578		10.1016/S0140-6736(02)07747-4	http://dx.doi.org/10.1016/S0140-6736(02)07747-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523FP	11867113				2022-12-28	WOS:000173943600012
J	Zhang, L; Doudna, JA				Zhang, L; Doudna, JA			Structural insights into group II intron catalysis and branch-site selection	SCIENCE			English	Article							CRYSTAL-STRUCTURE; RIBOZYME DOMAIN; ACTIVE-SITE; RNA; SPLICEOSOME; CORE; SUPPORTS; BINDING; MODEL; SNRNA	Group II self-splicing introns catalyze autoexcision from precursor RNA transcripts by a mechanism strikingly similar to that of the spliceosome, an RNA-protein assembly responsible for splicing together the protein-coding parts of most eukaryotic pre-mRNAs. Splicing in both cases initiates via nucleophilic attack at the 5' splice site by the 2' OH of a conserved intron adenosine residue, creating a branched (lariat) intermediate. Here, we describe the crystal structure at 3.0 Angstrom resolution of a 70-nucleotide RNA containing the catalytically essential domains 5 and 6 of the yeast ai5gamma group II self-splicing intron, revealing an unexpected two-nucleotide bulged structure around the branch-point adenosine in domain 6.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Doudna, JA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.							Abramovitz DL, 1996, SCIENCE, V271, P1410, DOI 10.1126/science.271.5254.1410; Baugh C, 2000, J MOL BIOL, V301, P117, DOI 10.1006/jmbi.2000.3951; Berglund JA, 2001, RNA, V7, P682, DOI 10.1017/S1355838201002187; Boudvillain M, 2000, NATURE, V406, P315, DOI 10.1038/35018589; Boudvillain M, 1998, EMBO J, V17, P7091, DOI 10.1093/emboj/17.23.7091; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Cate JH, 1997, NAT STRUCT BIOL, V4, P553, DOI 10.1038/nsb0797-553; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; CHANFREAU G, 1994, SCIENCE, V266, P1383, DOI 10.1126/science.7973729; CHIN K, 1995, RNA, V1, P391; Chu VT, 2001, EMBO J, V20, P6866, DOI 10.1093/emboj/20.23.6866; Chu VT, 1998, RNA, V4, P1186, DOI 10.1017/S1355838298980724; Collins CA, 2000, NAT STRUCT BIOL, V7, P850; COSTA M, 1995, EMBO J, V14, P1276, DOI 10.1002/j.1460-2075.1995.tb07111.x; Costa M, 1998, RNA, V4, P1055, DOI 10.1017/S1355838298980670; Daniels DL, 1996, J MOL BIOL, V256, P31, DOI 10.1006/jmbi.1996.0066; Ferre-D'Amare AR, 1998, J MOL BIOL, V279, P621, DOI 10.1006/jmbi.1998.1789; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; Gordon PM, 2001, NAT STRUCT BIOL, V8, P893, DOI 10.1038/nsb1001-893; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Konforti BB, 1998, MOL CELL, V1, P433, DOI 10.1016/S1097-2765(00)80043-X; MICHEL F, 1995, ANNU REV BIOCHEM, V64, P435, DOI 10.1146/annurev.bi.64.070195.002251; PARKER R, 1987, CELL, V49, P229, DOI 10.1016/0092-8674(87)90564-2; PEEBLES CL, 1995, P NATL ACAD SCI USA, V92, P4422, DOI 10.1073/pnas.92.10.4422; PEEBLES CL, 1986, CELL, V44, P213, DOI 10.1016/0092-8674(86)90755-5; Podar M, 1999, RNA, V5, P318, DOI 10.1017/S1355838299981724; PYLE AM, 1994, BIOCHEMISTRY-US, V33, P2716, DOI 10.1021/bi00175a047; PYLE AM, 1993, SCIENCE, V261, P709, DOI 10.1126/science.7688142; Qin PZ, 1998, CURR OPIN STRUC BIOL, V8, P301, DOI 10.1016/S0959-440X(98)80062-6; QUERY CC, 1994, GENE DEV, V8, P587, DOI 10.1101/gad.8.5.587; Sigel R. K. O., COMMUNICATION; Sigel RKO, 2000, NAT STRUCT BIOL, V7, P1111; Sontheimer EJ, 1999, GENE DEV, V13, P1729, DOI 10.1101/gad.13.13.1729; WU J, 1989, GENE DEV, V3, P1553, DOI 10.1101/gad.3.10.1553; Yean SL, 2000, NATURE, V408, P881, DOI 10.1038/35048617; Zhang L., UNPUB; ZHUANG Y, 1989, GENE DEV, V3, P1545, DOI 10.1101/gad.3.10.1545	37	94	97	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2002	295	5562					2084	2088		10.1126/science.1069268	http://dx.doi.org/10.1126/science.1069268			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532AY	11859154				2022-12-28	WOS:000174450500052
J	Mekler, V; Kortkhonjia, E; Mukhopadhyay, J; Knight, J; Revyakin, A; Kapanidis, AN; Niu, W; Ebright, YW; Levy, R; Ebright, RH				Mekler, V; Kortkhonjia, E; Mukhopadhyay, J; Knight, J; Revyakin, A; Kapanidis, AN; Niu, W; Ebright, YW; Levy, R; Ebright, RH			Structural organization of bacterial RNA polymerase holoenzyme and the RNA polymerase-promoter open complex	CELL			English	Article							RESONANCE ENERGY-TRANSFER; SIGMA(70) BINDING-SITE; ESCHERICHIA-COLI; MUTATIONAL ANALYSIS; ELONGATION COMPLEX; CRYSTAL-STRUCTURE; LARGE SUBUNITS; BETA-SUBUNIT; AMINO-ACIDS; TRANSCRIPTION	We have used systematic fluorescence resonance energy transfer and distance-constrained docking to define the three-dimensional structures of bacterial RNA polymerase holoenzyme and the bacterial RNA polymerase-promoter open complex in solution. The structures provide a framework for understanding sigma(70)-(RNA polymerase core), sigma(70)-DNA, and sigma(70)-RNA interactions. The positions of sigma(70) regions 1.2, 2, 3, and 4 are similar in holoenzyme and open complex. In contrast, the position of sigma(70) region 1.1 differs dramatically in holoenzyme and open complex. In holoenzyme, region 1.1 is located within the active-center cleft, apparently serving as a "molecular mimic" of DNA, but, in open complex, region 1.1 is located outside the active center cleft. The approach described here should be applicable to the analysis of other nanometer-scale complexes.	Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Chem, Piscataway, NJ 08854 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Ebright, RH (corresponding author), Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, POB 759, Piscataway, NJ 08854 USA.	ebright@mbcl.rutges.edu	Ebright, Richard/O-3321-2019	Ebright, Richard/0000-0001-8915-7140	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM064375, R01GM041376] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM41376, GM64375] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIYAR SE, 1994, BIOCHEMISTRY-US, V33, P11501, DOI 10.1021/bi00204a012; Arthur TM, 2000, J BIOL CHEM, V275, P23113, DOI 10.1074/jbc.M002040200; Arthur TM, 1998, J BIOL CHEM, V273, P31381, DOI 10.1074/jbc.273.47.31381; Ayers B, 1999, BIOPOLYMERS, V51, P343, DOI 10.1002/(SICI)1097-0282(1999)51:5<343::AID-BIP4>3.0.CO;2-W; Baikalov I, 1996, BIOCHEMISTRY-US, V35, P11053, DOI 10.1021/bi960919o; Bown JA, 1999, J BIOL CHEM, V274, P2263, DOI 10.1074/jbc.274.4.2263; BURGESS RR, 1975, BIOCHEMISTRY-US, V14, P4634, DOI 10.1021/bi00692a011; Burley SK, 1998, CELL, V94, P551, DOI 10.1016/S0092-8674(00)81596-2; Callaci S, 1998, J BIOL CHEM, V273, P32995, DOI 10.1074/jbc.273.49.32995; Callaci S, 1998, BIOCHEMISTRY-US, V37, P3312, DOI 10.1021/bi972041m; CANTOR CR, 1980, BIOPHYSICAL CHEM, V2; CECH CL, 1980, BIOCHEMISTRY-US, V19, P2440, DOI 10.1021/bi00552a023; CHEN RF, 1965, SCIENCE, V147, P729, DOI 10.1126/science.147.3659.729; Chong SR, 1996, J BIOL CHEM, V271, P22159, DOI 10.1074/jbc.271.36.22159; Chong SR, 1997, GENE, V192, P271, DOI 10.1016/S0378-1119(97)00105-4; Christie GE, 1996, J BACTERIOL, V178, P6991, DOI 10.1128/jb.178.23.6991-6993.1996; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; DANIELS D, 1990, P NATL ACAD SCI USA, V87, P8075, DOI 10.1073/pnas.87.20.8075; Daube SS, 1999, P NATL ACAD SCI USA, V96, P8390, DOI 10.1073/pnas.96.15.8390; DeHaseth PL, 1998, J BACTERIOL, V180, P3019, DOI 10.1128/JB.180.12.3019-3025.1998; Ebright RH, 2000, J MOL BIOL, V304, P687, DOI 10.1006/jmbi.2000.4309; Estrem ST, 1999, GENE DEV, V13, P2134, DOI 10.1101/gad.13.16.2134; Fenton MS, 2000, EMBO J, V19, P1130, DOI 10.1093/emboj/19.5.1130; FISHER R, 1953, PROC R SOC LON SER-A, V217, P295, DOI 10.1098/rspa.1953.0064; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Ghosh A, 1998, J PHYS CHEM B, V102, P10983, DOI 10.1021/jp982533o; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Gruber TM, 2001, MOL CELL, V8, P21, DOI 10.1016/S1097-2765(01)00292-1; Huang XJ, 1997, NUCLEIC ACIDS RES, V25, P2603, DOI 10.1093/nar/25.13.2603; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JUANG YL, 1994, J MOL BIOL, V239, P1, DOI 10.1006/jmbi.1994.1346; Kapanidis AN, 2001, J MOL BIOL, V312, P453, DOI 10.1006/jmbi.2001.4976; Kashlev M, 1996, METHOD ENZYMOL, V274, P326; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Kuznedelov K, 2002, SCIENCE, V295, P855, DOI 10.1126/science.1066303; LAKOWICZ J, 1999, PRINCIPLES FLUORESCE, V27; LESLEY SA, 1989, BIOCHEMISTRY-US, V28, P7728, DOI 10.1021/bi00445a031; LEVITT M, 1976, J MOL BIOL, V104, P59, DOI 10.1016/0022-2836(76)90004-8; Lilley DMJ, 2000, CURR OPIN CHEM BIOL, V4, P507, DOI 10.1016/S1367-5931(00)00124-1; Liu DJ, 1998, CELL, V94, P573, DOI 10.1016/S0092-8674(00)81599-8; Lonetto MA, 1998, J MOL BIOL, V284, P1353, DOI 10.1006/jmbi.1998.2268; Malhotra A, 1996, CELL, V87, P127, DOI 10.1016/S0092-8674(00)81329-X; Marr MT, 1997, SCIENCE, V276, P1258, DOI 10.1126/science.276.5316.1258; Marr MT, 2001, P NATL ACAD SCI USA, V98, P8972, DOI 10.1073/pnas.161253298; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Minakhin L, 2001, P NATL ACAD SCI USA, V98, P892, DOI 10.1073/pnas.98.3.892; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Mukhopadhyay J, 2001, CELL, V106, P453, DOI 10.1016/S0092-8674(01)00464-0; Murakami K, 1997, P NATL ACAD SCI USA, V94, P11274, DOI 10.1073/pnas.94.21.11274; Naryshkin N, 2000, METH MOL B, V148, P337; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; NIU W, 1999, THESIS RUTGERS U NEW; Owens JT, 1998, BIOCHEMISTRY-US, V37, P7670, DOI 10.1021/bi980188n; Owens JT, 1998, P NATL ACAD SCI USA, V95, P6021, DOI 10.1073/pnas.95.11.6021; Record Jr MT, 1996, ESCHERICHIA COLI SAL, P792; Selvin PR, 2000, NAT STRUCT BIOL, V7, P730, DOI 10.1038/78948; SEVERINOV K, 1995, P NATL ACAD SCI USA, V92, P4591, DOI 10.1073/pnas.92.10.4591; Severinov K, 1996, J BIOL CHEM, V271, P27969, DOI 10.1074/jbc.271.44.27969; Severinov K, 1997, J BIOL CHEM, V272, P24137, DOI 10.1074/jbc.272.39.24137; Sharp MM, 1999, GENE DEV, V13, P3015, DOI 10.1101/gad.13.22.3015; SUH WC, 1992, BIOCHEMISTRY-US, V31, P7815, DOI 10.1021/bi00149a011; TANG H, 1994, GENE DEV, V8, P3058, DOI 10.1101/gad.8.24.3058; TANG H, 1995, P NATL ACAD SCI USA, V92, P4902, DOI 10.1073/pnas.92.11.4902; Traviglia SL, 1999, BIOCHEMISTRY-US, V38, P4259, DOI 10.1021/bi983016z; Vuthoori S, 2001, J MOL BIOL, V309, P561, DOI 10.1006/jmbi.2001.4690; Waldspurger J.-L., 1990, ISRAEL MATH C P, V2, P267; Wilson C, 1997, J MOL BIOL, V267, P60, DOI 10.1006/jmbi.1997.0875; WU PG, 1992, BIOCHEMISTRY-US, V31, P7939, DOI 10.1021/bi00149a027; Young BA, 2001, CELL, V105, P935, DOI 10.1016/S0092-8674(01)00398-1; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	72	229	236	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 8	2002	108	5					599	614		10.1016/S0092-8674(02)00667-0	http://dx.doi.org/10.1016/S0092-8674(02)00667-0			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	529TN	11893332	Bronze			2022-12-28	WOS:000174314800005
J	Solowij, N; Stephens, RS; Roffman, RA; Babor, T; Kadden, R; Miller, M; Christiansen, K; McRee, B; Vendetti, J				Solowij, N; Stephens, RS; Roffman, RA; Babor, T; Kadden, R; Miller, M; Christiansen, K; McRee, B; Vendetti, J		Marijuana Treatment Project Res	Cognitive functioning of long-term heavy cannabis users seeking treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SELECTIVE ATTENTION; MARIJUANA USE; MEMORY; IMPAIRMENTS; ABSTINENCE; CEREBELLAR; EDUCATION; ADDICTION; SMOKING; INJURY	Context Cognitive impairments are associated with long-term cannabis use, but the parameters of use that contribute to impairments and the nature and endurance of cognitive dysfunction remain uncertain. Objective To examine the effects of duration of cannabis use on specific areas of cognitive functioning among users seeking treatment for cannabis dependence. Design, Setting, and Participants Multisite retrospective cross-sectional neuropsychological study conducted in the United States (Seattle, Wash; Farmington, Conn; and Miami, Fla) between 1997 and 2000 among 102 near-daily cannabis users (51 long-term users: mean, 23.9 years of use; 51 shorter-term users: mean, 10.2 years of use) compared with 33 nonuser controls. Main Outcome Measures Measures from 9 standard neuropsychological tests that assessed attention, memory, and executive functioning, and were administered prior to entry to a treatment program and following a median 17-hour abstinence. Results Long-term cannabis users performed significantly less well than shorter-term users and controls on tests of memory and attention. On the Rey Auditory Verbal Learning Test, long-term users recalled significantly fewer words than either shorter-term users (P=.001) or controls (P=.005); there was no difference between shorter-term users and controls. Long-term users showed impaired learning (P=.007), retention (P=.003), and retrieval (P=.002) compared with controls. Both user groups performed poorly on a time estimation task (P<.001 vs controls). Performance measures often correlated significantly with the duration of cannabis use, being worse with increasing years of use, but were unrelated to withdrawal symptoms and persisted after controlling for recent cannabis use and other drug use. Conclusions These results confirm that long-term heavy cannabis users show impairments in memory and attention that endure beyond the period of intoxication and worsen with increasing years of regular cannabis use.	Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia; Univ Wollongong, Dept Psychol, Wollongong, NSW 2500, Australia; Virginia Polytech Inst & State Univ, Dept Psychol, Blacksburg, VA 24061 USA; Univ Washington, Sch Social Work, Innovat Programs Res Grp, Seattle, WA 98195 USA; Univ Connecticut, Ctr Hlth, Dept Psychiat, Farmington, CT 06032 USA; Univ Connecticut, Ctr Hlth, Dept Community Med, Farmington, CT USA; Village S Inc, Miami, FL USA	University of New South Wales Sydney; University of Wollongong; Virginia Polytechnic Institute & State University; University of Washington; University of Washington Seattle; University of Connecticut; University of Connecticut	Solowij, N (corresponding author), Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia.		Young, Alexander/A-1523-2009	Young, Alexander/0000-0002-9367-9213; Solowij, Nadia/0000-0002-5222-5637; Babor, Thomas/0000-0002-2580-0835	CSAT SAMHSA HHS [UR4 TI11273, UR4TI11274, UR4TI11310, UR4 TI11270] Funding Source: Medline	CSAT SAMHSA HHS		Baddeley AD, 1992, SPEED CAPACITY LANGU; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BELL R, 1989, J TOXICOL-CLIN TOXIC, V27, P109, DOI 10.3109/15563658909038574; Blair J. R., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI DOI 10.1080/13854048908403285; Block RI, 2000, NEUROREPORT, V11, P749, DOI 10.1097/00001756-200003200-00019; BLOCK RI, 2000, ABSTR SOC NEUROSCI, V26, P2080; BLOCK RI, IN PRESS PHARM BIOCH; Bohme GA, 2000, NEUROSCIENCE, V95, P5; Bohnen N, 1992, Clin Neuropsychol, V6, P178, DOI 10.1080/13854049208401854; Brittain J.L., 1991, CLIN NEUROPSYCHOL, V5, P163, DOI DOI 10.1080/13854049108403300; DACKIS CA, 1982, AM J PSYCHIAT, V139, P1196; ELLIS GM, 1985, CLIN PHARMACOL THER, V38, P572, DOI 10.1038/clpt.1985.226; Elwan O, 1997, J NEUROL SCI, V148, P79, DOI 10.1016/S0022-510X(96)05336-1; First M. D., 1996, USERS GUIDE STRUCTUR; Fletcher JM, 1996, ARCH GEN PSYCHIAT, V53, P1051; Fraser AD, 1999, J ANAL TOXICOL, V23, P531, DOI 10.1093/jat/23.6.531; Fried PA, 1998, NEUROTOXICOL TERATOL, V20, P293, DOI 10.1016/S0892-0362(97)00091-3; Geffen Gina, 1990, Clin Neuropsychol, V4, P45, DOI 10.1080/13854049008401496; Golden C.J., 1978, STROOP COLOR WORD TE; Hall W, 2000, ADDICTION, V95, P485, DOI 10.1046/j.1360-0443.2000.9544851.x; Hampson RE, 1999, LIFE SCI, V65, P715, DOI 10.1016/S0024-3205(99)00294-5; Hampson RE, 2000, J NEUROSCI, V20, P8932; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Hermann BP, 1996, CORTEX, V32, P323, DOI 10.1016/S0010-9452(96)80054-2; Jastak S., 1984, WIDE RANGE ACHIEVEME; KAREKEN DA, 1995, ARCH CLIN NEUROPSYCH, V10, P147, DOI 10.1016/0887-6177(94)E0012-E; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Levy R, 2000, EXP BRAIN RES, V133, P23, DOI 10.1007/s002210000397; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Loeber RT, 1999, HUM PSYCHOPHARM CLIN, V14, P291, DOI 10.1002/(SICI)1099-1077(199907)14:5<291::AID-HUP100>3.0.CO;2-H; Lyketsos CG, 1999, AM J EPIDEMIOL, V149, P794; *MAR TREATM PROJ R, IN PRESS ARCH GEN PS; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; Miller W. R., 1996, PROJECT MATCH MONOGR, V5; Pope HG, 1997, PSYCHOTHER PSYCHOSOM, V66, P179; POPE HG, 1995, DRUG ALCOHOL DEPEN, V38, P25, DOI 10.1016/0376-8716(95)01097-I; Pope HG, 1996, JAMA-J AM MED ASSOC, V275, P521, DOI 10.1001/jama.275.7.521; *PSYCH ASS RES INC, 1989, WISC CARD SORT TEST; Reibaud M, 1999, EUR J PHARMACOL, V379, pR1, DOI 10.1016/S0014-2999(99)00496-3; Rey A, 1964, LEXAMEN CLINIQUE PSY; Roman DD, 1991, CLIN NEUROPSYCHOL, V5, P33, DOI DOI 10.1080/13854049108401840; Schacter DL, 1998, SCIENCE, V280, P59, DOI 10.1126/science.280.5360.59; Schmahmann J. D., 1997, CEREBELLUM COGNITION; Sobell L. C, 1992, MEASURING ALCOHOL CO; SOLOWIJ N, 1995, BIOL PSYCHIAT, V37, P731, DOI 10.1016/0006-3223(94)00178-6; SOLOWIJ N, 1991, PHARMACOL BIOCHEM BE, V40, P683, DOI 10.1016/0091-3057(91)90382-C; SOLOWIJ N, 1995, LIFE SCI, V56, P2119, DOI 10.1016/0024-3205(95)00197-E; Solowij N., 1998, CANNABIS COGNITIVE F; SOLOWIJ N, 1997, 1997 S CANN BURL VT, P84; Spreen O, 1998, COMPENDIUM NEUROPSYC; Stuss D, 1987, CLIN NEUROPSYCHOL, V1, P139, DOI [10.1080/13854048708520046, DOI 10.1080/13854048708520046]; Stuss D.T., 1988, CLIN NEUROPSYCHOL, V2, P246, DOI [10.1080/13854048808520107, DOI 10.1080/13854048808520107]; *SUBST AB MENT HLT, 1998, NAT HOUS SURV DRUG H, V6; Voelker R, 1997, JAMA-J AM MED ASSOC, V278, P802, DOI 10.1001/jama.278.10.802; Watson SJ, 2000, ARCH GEN PSYCHIAT, V57, P547, DOI 10.1001/archpsyc.57.6.547	56	547	562	1	97	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2002	287	9					1123	1131		10.1001/jama.287.9.1123	http://dx.doi.org/10.1001/jama.287.9.1123			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	527KV	11879109	Bronze			2022-12-28	WOS:000174186000027
J	Schulz, KF; Grimes, DA				Schulz, KF; Grimes, DA			Sample size slippages in randomised trials: exclusions and the lost and wayward	LANCET			English	Article							REQUIRING PROLONGED OBSERVATION; CLINICAL-TRIALS; ALLOCATION; TREAT; INTENTION; PATIENT; DESIGN	Proper randomisation means little if Investigators cannot include all randomised participants in the primary analysis. Participants might ignore follow-up, leave town, or take aspartame when instructed to take aspirin. Exclusions before randomisation do not bias the treatment comparison, but they can hurt generalisability. Eligibility criteria for a trial should be clear, specific, and applied before randomisation. Readers should assess whether any of the criteria make the trial sample atypical or unrepresentative of the people in which they are interested. In principle, assessment of exclusions after randomisation is simple: none are allowed. For the primary analysis, all participants enrolled should be included and analysed as part of the original group assigned (an intent-to-treat analysis). In reality, however, losses frequently occur. Investigators should, therefore, commit adequate resources to develop and implement procedures to maximise retention of participants. Moreover, researchers should provide clear, explicit information on the progress of all randomised participants through the trial by use of, for instance, a trial profile. Investigators can also do secondary analyses on, for instance, per-protocol or as-treated participants. Such analyses should be described as secondary and non-randomised comparisons. Mishandling of exclusions causes serious methodological difficulties. Unfortunately, some explanations for mishandling exclusions intuitively appeal to readers, disguising the seriousness of the issues. Creative mismanagement of exclusions can undermine trial validity.	Family Hlth Int, Res Triangle Pk, NC 27709 USA		Schulz, KF (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.	KSchulz@fhi.org	Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285				Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Anturane Reinfarction Trial Research Group, 1978, NEW ENGL J MED, V298 , P289; DERSIMONIAN R, 1982, NEW ENGL J MED, V306, P1332, DOI 10.1056/NEJM198206033062204; FRIEDMAN LM, 1996, FUNDAMENTALS CLIN TR; Grimes DA, 2002, LANCET, V359, P57, DOI 10.1016/S0140-6736(02)07283-5; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Lachin JM, 2000, CONTROL CLIN TRIALS, V21, P167, DOI 10.1016/S0197-2456(00)00046-5; LEE YJ, 1991, STAT MED, V10, P1595, DOI 10.1002/sim.4780101011; LEWIS JA, 1993, BRIT J CANCER, V68, P647, DOI 10.1038/bjc.1993.402; MEIER P, 1981, NEW ENGL J MED, V304, P730; MEINERT CL, 1984, CONTROL CLIN TRIALS, V5, P328, DOI 10.1016/S0197-2456(84)80013-6; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; RODDY RE, IN PRESS JAMA; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; Sackett D. L., 1997, EVIDENCE BASED MED P; SACKETT DL, 1983, CLIN TRIALS, P65; Schulz KF, 2002, LANCET, V359, P614, DOI 10.1016/S0140-6736(02)07750-4; Schulz KF, 1996, BRIT MED J, V312, P742; Schulz KF, 2002, LANCET, V359, P515, DOI 10.1016/S0140-6736(02)07683-3; SHERRY S, 1980, NEW ENGL J MED, V302, P250; TEMPLE R, 1980, NEW ENGL J MED, V303, P1488, DOI 10.1056/NEJM198012183032534	23	382	385	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 2	2002	359	9308					781	785		10.1016/S0140-6736(02)07882-0	http://dx.doi.org/10.1016/S0140-6736(02)07882-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526DZ	11888606				2022-12-28	WOS:000174115200030
J	Klein-Seetharaman, J; Oikawa, M; Grimshaw, SB; Wirmer, J; Duchardt, E; Ueda, T; Imoto, T; Smith, LJ; Dobson, CM; Schwalbe, H				Klein-Seetharaman, J; Oikawa, M; Grimshaw, SB; Wirmer, J; Duchardt, E; Ueda, T; Imoto, T; Smith, LJ; Dobson, CM; Schwalbe, H			Long-range interactions within a nonnative protein	SCIENCE			English	Article							FREE-ENERGY FUNCTIONALS; ACID-BINDING PROTEIN; RESIDUAL STRUCTURE; EXPLORING STRUCTURES; DENATURED PROTEIN; FOLDING FUNNELS; CHEMICAL-SHIFTS; PHOTO-CIDNP; MAIN-CHAIN; NMR	Protein folding and unfolding are coupled to a range of biological phenomena, from the regulation of cellular activity to the onset of neurodegenerative diseases. Defining the nature of the conformations sampled in nonnative proteins is crucial for understanding the origins of such phenomena. We have used a combination of nuclear magnetic resonance (NMR) spectroscopy and site-directed mutagenesis to study unfolded states of the protein lysozyme. Extensive clusters of hydrophobic structure exist within the wild-type protein even under strongly denaturing conditions. These clusters involve distinct regions of the sequence but are all disrupted by a single point mutation that replaced residue Trp(62) with Gly located at the interface of the two major structural domains in the native state. Thus, nativelike structure in the denatured protein is stabilized by the involvement of Trp(62) in nonnative and long-range interactions.	MIT, Dept Chem, Francis Bitter Magnet Lab, Cambridge, MA 02139 USA; Kyushu Univ, Grad Sch Pharmaceut Sci, Fukuoka 8128582, Japan; Univ Oxford, Oxford Ctr Mol Sci, New Chem Lab, Oxford OX1 3QH, England	Massachusetts Institute of Technology (MIT); Kyushu University; University of Oxford	Klein-Seetharaman, J (corresponding author), Goethe Univ Frankfurt, Ctr Biol Magnet Resonance, Inst Organ Chem, Marie Curie Str 11, D-60439 Frankfurt, Germany.	schwalbe@nmr.uni-frankfurt.de	Schwalbe, Harald/AAB-3143-2020; Schwalbe, Harald J/F-9023-2010	Schwalbe, Harald/0000-0001-5693-7909; Schwalbe, Harald J/0000-0001-5693-7909				BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; Blanco FJ, 1998, J MOL BIOL, V284, P1153, DOI 10.1006/jmbi.1998.2229; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; BUCK M, 1995, BIOCHEMISTRY-US, V34, P4041, DOI 10.1021/bi00012a023; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; Dyson HJ, 1998, NAT STRUCT BIOL, V5, P499, DOI 10.1038/739; Fiebig KM, 1996, J PHYS CHEM-US, V100, P2661, DOI 10.1021/jp952747v; Hodsdon ME, 2001, BIOCHEMISTRY-US, V40, P732, DOI 10.1021/bi001518i; Hore PJ, 1997, J AM CHEM SOC, V119, P5049, DOI 10.1021/ja9644135; Lyon CE, 1999, J AM CHEM SOC, V121, P6505, DOI 10.1021/ja9907663; MERUTKA G, 1995, J BIOMOL NMR, V5, P14, DOI 10.1007/BF00227466; MIRANKER A, 1993, SCIENCE, V262, P896, DOI 10.1126/science.8235611; Mok YK, 1999, J MOL BIOL, V289, P619, DOI 10.1006/jmbi.1999.2769; NERI D, 1992, SCIENCE, V257, P1559, DOI 10.1126/science.1523410; Radford SE, 1999, CELL, V97, P291, DOI 10.1016/S0092-8674(00)80739-4; RADFORD SE, 1992, NATURE, V358, P302, DOI 10.1038/358302a0; ROMERO P, 1998, PAC S BIOCOMPUT, V3; ROPSON IJ, 1992, P NATL ACAD SCI USA, V89, P7222, DOI 10.1073/pnas.89.15.7222; Rothwarf DM, 1996, BIOCHEMISTRY-US, V35, P13797, DOI 10.1021/bi9608119; SaabRincon G, 1996, BIOCHEMISTRY-US, V35, P1988, DOI 10.1021/bi951726o; Schwalbe H, 1997, BIOCHEMISTRY-US, V36, P8977, DOI 10.1021/bi970049q; Schwalbe H, 2001, PROTEIN SCI, V10, P677, DOI 10.1110/ps.43301; Shoemaker BA, 1999, J MOL BIOL, V287, P675, DOI 10.1006/jmbi.1999.2613; Shoemaker BA, 1999, J MOL BIOL, V287, P657, DOI 10.1006/jmbi.1999.2612; SHORTLE D, 1993, STRUCTURE, V1, P121, DOI 10.1016/0969-2126(93)90027-E; Shortle D, 2001, SCIENCE, V293, P487, DOI 10.1126/science.1060438; Shortle DR, 1996, CURR OPIN STRUC BIOL, V6, P24, DOI 10.1016/S0959-440X(96)80091-1; Smith LJ, 1996, J MOL BIOL, V255, P494, DOI 10.1006/jmbi.1996.0041; Sober H. A., 1970, HDB BIOCH SELECTED D; UEDA T, 1990, J BIOCHEM-TOKYO, V108, P886, DOI 10.1093/oxfordjournals.jbchem.a123297; UEDA T, 1994, J MOL BIOL, V235, P1312, DOI 10.1006/jmbi.1994.1084; Ueda T, 1996, BIOCHEM BIOPH RES CO, V228, P203, DOI 10.1006/bbrc.1996.1640; van Gunsteren WF, 2001, ANGEW CHEM INT EDIT, V40, P351, DOI 10.1002/1521-3773(20010119)40:2<351::AID-ANIE351>3.0.CO;2-6; Vaney MC, 1996, ACTA CRYSTALLOGR D, V52, P505, DOI 10.1107/S090744499501674X; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wong KB, 1996, J MOL BIOL, V259, P805, DOI 10.1006/jmbi.1996.0359; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110	38	544	548	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2002	295	5560					1719	1722		10.1126/science.1067680	http://dx.doi.org/10.1126/science.1067680			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872841				2022-12-28	WOS:000174212900048
J	Shapiro, B; Sibthorpe, D; Rambaut, A; Austin, J; Wragg, GM; Bininda-Emonds, ORP; Lee, PLM; Cooper, A				Shapiro, B; Sibthorpe, D; Rambaut, A; Austin, J; Wragg, GM; Bininda-Emonds, ORP; Lee, PLM; Cooper, A			Flight of the dodo	SCIENCE			English	Article									Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Univ Oxford, Henry Wellcome Ancient Biomol Ctr, Oxford OX1 3PS, England; Nat Hist Museum, Dept Zool, London SW7 5BD, England	University of Oxford; University of Oxford; Natural History Museum London	Cooper, A (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.		Austin, Jeremy J/F-8729-2010; Lee, Patricia/N-4157-2013; Rambaut, Andrew/B-2481-2009; Bininda-Emonds, Olaf/P-6718-2019; Bininda-Emonds, Olaf R.P:/C-5405-2008; Cooper, Alan/E-8171-2012	Austin, Jeremy J/0000-0003-4244-2942; Lee, Patricia/0000-0002-8489-9206; Rambaut, Andrew/0000-0003-4337-3707; Bininda-Emonds, Olaf R.P:/0000-0003-4432-224X; Cooper, Alan/0000-0002-7738-7851				Cooper A, 2000, SCIENCE, V289, P1139; Gibbs D., 2001, BRIT BIRDS, V94, P336; Janoo Anwar, 1996, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V18, P57; MCDOUGAL.I, 1969, GEOL SOC AM BULL, V80, P1419, DOI 10.1130/0016-7606(1969)80[1419:IDAGPS]2.0.CO;2	4	123	133	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 1	2002	295	5560					1683	1683		10.1126/science.295.5560.1683	http://dx.doi.org/10.1126/science.295.5560.1683			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872833				2022-12-28	WOS:000174212900037
J	Zaccolo, M; Pozzan, T				Zaccolo, M; Pozzan, T			Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; CYCLIC-AMP; HEART; COMPARTMENTATION; PROSTAGLANDIN-E1; ISOPROTERENOL; ACTIVATION; BETA	The second messenger cyclic adenosine monophosphate (cAMP) is the most important modulator of sympathetic control over cardiac contractility. In cardiac myocytes and many other cell types, however, cAMP transduces the signal generated upon stimulation of various receptors and activates different cellular functions, raising the issue of how specificity can be achieved. In the general field of signal transduction, the view is emerging that specificity is guaranteed by tight localization of signaling events. Here, we show that in neonatal rat cardiac myocytes, P-adrenergic stimulation generates multiple microdomains with increased concentration of cAMP in correspondence with the region of the transverse tubule/junctional sarcoplasmic reticulum membrane. The restricted pools of cAMP show a range of action as small as approximately 1 micrometer, and free diffusion of the second messenger is limited by the activity of phosphodiesterases. Furthermore, we demonstrate that such gradients of cAMP specifically activate a subset of protein kinase A molecules anchored in proximity to the T tubule.	Univ Padua, Dept Biomed Sci, I-35129 Padua, Italy; Univ Padua, Venetian Inst Mol Med, I-35129 Padua, Italy	University of Padua; University of Padua; Veneto Institute Molecular Medicine	Zaccolo, M (corresponding author), Univ Padua, Dept Biomed Sci, Via Orus 2, I-35129 Padua, Italy.		Zaccolo, Manuela/AAP-6706-2020; Zaccolo, Manuela/B-3802-2011	Zaccolo, Manuela/0000-0002-0934-3662; 	Telethon [TCP00089] Funding Source: Medline	Telethon(Fondazione Telethon)		BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; BRUNTON LL, 1981, ADV CYCL NUCL RES<D>, V14, P391; BUXTON ILO, 1983, J BIOL CHEM, V258, P233; CARR DW, 1992, J BIOL CHEM, V267, P13376; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; DOSTAL DE, 1992, AM J PHYSIOL, V263, pC838, DOI 10.1152/ajpcell.1992.263.4.C838; Gao TY, 1997, J BIOL CHEM, V272, P19401, DOI 10.1074/jbc.272.31.19401; HAYES JS, 1982, BIOCHIM BIOPHYS ACTA, V714, P136, DOI 10.1016/0304-4165(82)90135-0; HAYES JS, 1980, J BIOL CHEM, V255, P5113; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Jurevicius J, 1996, P NATL ACAD SCI USA, V93, P295, DOI 10.1073/pnas.93.1.295; Laflamme MA, 1999, AM J PHYSIOL-HEART C, V277, pH1841, DOI 10.1152/ajpheart.1999.277.5.H1841; LI Y, 1995, J BIOL CHEM, V270, P1935, DOI 10.1074/jbc.270.4.1935; Schillace RV, 1999, J CLIN INVEST, V103, P761, DOI 10.1172/JCI6491; Steinberg SF, 2001, ANNU REV PHARMACOL, V41, P751, DOI 10.1146/annurev.pharmtox.41.1.751; Yang JC, 1998, J CELL BIOL, V142, P511, DOI 10.1083/jcb.142.2.511; Zaccolo M, 2000, NAT CELL BIOL, V2, P25, DOI 10.1038/71345; ZACCOLO M, UNPUB	19	651	681	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 1	2002	295	5560					1711	1715		10.1126/science.1069982	http://dx.doi.org/10.1126/science.1069982			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872839				2022-12-28	WOS:000174212900046
J	van Praag, H; Schinder, AF; Christie, BR; Toni, N; Palmer, TD; Gage, FH				van Praag, H; Schinder, AF; Christie, BR; Toni, N; Palmer, TD; Gage, FH			Functional neurogenesis in the adult hippocampus	NATURE			English	Article							LONG-TERM POTENTIATION; DENTATE GYRUS; STEM-CELLS; IN-VITRO; RAT; NEURONS; MICE; PROLIFERATION; VIRUS	There is extensive evidence indicating that new neurons are generated in the dentate gyrus of the adult mammalian hippocampus, a region of the brain that is important for learning and memory(1-5). However, it is not known whether these new neurons become functional, as the methods used to study adult neurogenesis are limited to fixed tissue. We use here a retroviral vector expressing green fluorescent protein that only labels dividing cells, and that can be visualized in live hippocampal slices. We report that newly generated cells in the adult mouse hippocampus have neuronal morphology and can display passive membrane properties, action potentials and functional synaptic inputs similar to those found in mature dentate granule cells. Our findings demonstrate that newly generated cells mature into functional neurons in the adult mammalian brain.	Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Salk Institute	van Praag, H (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	vanpraag@salk.edu	van Praag, Henriette/F-3939-2015; Christie, Brian Ross/AAF-3766-2019; Toni, Nicolas/M-2057-2014; Palmer, Theo/GSI-6635-2022	van Praag, Henriette/0000-0002-5727-434X; Christie, Brian Ross/0000-0002-6830-0160; Toni, Nicolas/0000-0001-5585-268X; Palmer, Theo/0000-0002-6266-1862; Schinder, Alejandro/0000-0003-4863-8348	NIMH NIH HHS [R01 MH090258] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; BARNEA A, 1994, P NATL ACAD SCI USA, V91, P11217, DOI 10.1073/pnas.91.23.11217; Biebl M, 2000, NEUROSCI LETT, V291, P17, DOI 10.1016/S0304-3940(00)01368-9; COLEMAN LA, 1992, J NEUROSCI METH, V44, P167, DOI 10.1016/0165-0270(92)90009-3; COLEMAN PA, 1989, J NEUROPHYSIOL, V61, P218, DOI 10.1152/jn.1989.61.1.218; CRAIN B, 1973, BRAIN RES, V63, P195, DOI 10.1016/0006-8993(73)90088-7; EDWARDS FA, 1995, PHYSIOL REV, V75, P759, DOI 10.1152/physrev.1995.75.4.759; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; GOULD E, 1992, J NEUROSCI, V12, P3642; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; LEWIS PF, 1994, J VIROL, V68, P510, DOI 10.1128/JVI.68.1.510-516.1994; Liu JL, 1998, J NEUROSCI, V18, P7768; Lubke J, 1998, J NEUROPHYSIOL, V79, P1518, DOI 10.1152/jn.1998.79.3.1518; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Markakis EA, 1999, J COMP NEUROL, V406, P449; Palmer TD, 1999, J NEUROSCI, V19, P8487; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Parent JM, 1997, J NEUROSCI, V17, P3727; Roy NS, 2000, NAT MED, V6, P271; Sah DWY, 1997, J NEUROBIOL, V32, P95, DOI 10.1002/(SICI)1097-4695(199701)32:1<95::AID-NEU9>3.0.CO;2-9; STALEY KJ, 1992, J NEUROPHYSIOL, V67, P1346, DOI 10.1152/jn.1992.67.5.1346; Suzuki F, 1997, EXP NEUROL, V145, P203, DOI 10.1006/exnr.1997.6469; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Vicario-Abejon C, 2000, EUR J NEUROSCI, V12, P677, DOI 10.1046/j.1460-9568.2000.00953.x; XU L, 1989, VIROLOGY, V171, P331, DOI 10.1016/0042-6822(89)90600-4	30	2203	2265	2	217	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2002	415	6875					1030	1034		10.1038/4151030a	http://dx.doi.org/10.1038/4151030a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875571	Green Accepted			2022-12-28	WOS:000174075000047
J	Olsen, SF; Secher, NJ				Olsen, SF; Secher, NJ			Low consumption of seafood in early pregnancy as a risk factor for preterm delivery: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							N-3 FATTY-ACIDS; BIRTH-WEIGHT; GESTATIONAL-AGE; FISH-OIL; FETAL GROWTH; MARINE FAT; INCREASE; SUPPLEMENTATION; DETERMINANT; DIETS	Objective To determine the relation between intake of seafood in pregnancy and risk of preterm delivery and low birth weight. Design Prospective cohort study. Setting Aarhus, Denmark. Participants 8729 pregnant,omen. Main outcome measures Preterm delivery and low birth weight. Results The occurrence of preterm delivery differed significantly across four groups of seafood intake, falling progressively from 7.1% in the group never consuming fish to 1.9% in the group consuming fish as a hot meal and an open sandwich with fish at least once a week. Adjusted odds for preterm delivery were increased by a Factor of 3.6 (95% confidence interval 1.2 to 11.2) in the zero consumption group compared with the highest consumption group, Analyses based on quantified intakes indicated that the working range of the dose-response relation is mainly from zero intake up to a daily intake of 15 g fish or 0.15 g n-3 fatty acids. Estimates of risk For low birth weight were similar to those for preterm delivery. Conclusions Low consumption of fish was a strong risk factor for preterm delivery and low birth weight. In women with zero or low intake of fish, small amounts of n-3 fatty acids-provided as fish or fish oil-may confer protection against preterm delivery and low birth weight.	Statens Serum Inst, Danish Epidemiol Sci Ctr, Matern Nutr Grp, DK-2300 Copenhagen S, Denmark; Skejby Univ Hosp, Dept Obstet & Gynaecol, Epidemiol Res Unit, DK-8200 Aarhus N, Denmark	Aarhus University; Statens Serum Institut; Aarhus University	Olsen, SF (corresponding author), Statens Serum Inst, Danish Epidemiol Sci Ctr, Matern Nutr Grp, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	sfo@ssi.dk		Olsen, Sjurdur/0000-0003-3017-7096				Andersen LT, 1996, SCAND J NUTR, V40, pS129; [Anonymous], 1946, J OBSTET GYN BRIT EM, V53, P498; Baguma-Nibasheka M, 1999, BIOL REPROD, V60, P698, DOI 10.1095/biolreprod60.3.698; DAGNELIE PC, 1988, EUR J CLIN NUTR, V42, P1007; DAR E, 1992, ENVIRON RES, V59, P189, DOI 10.1016/S0013-9351(05)80239-7; Kesmodel U, 1997, ACTA OBSTET GYN SCAN, V76, P38, DOI 10.3109/00016349709047782; Kesmodel U, 2000, EPIDEMIOLOGY, V11, P512, DOI 10.1097/00001648-200009000-00005; *LEBN, 1996, LEBN; Levnedsmiddelstyrelsen, 1996, LEVN; Olsen S F, 1987, Prog Clin Biol Res, V242, P51; OLSEN SF, 1994, AM J EPIDEMIOL, V139, P856; OLSEN SF, 1985, J EPIDEMIOL COMMUN H, V39, P27, DOI 10.1136/jech.39.1.27; OLSEN SF, 1995, BRIT J NUTR, V73, P387, DOI 10.1079/BJN19950041; Olsen SF, 2000, BRIT J OBSTET GYNAEC, V107, P382, DOI 10.1111/j.1471-0528.2000.tb13235.x; OLSEN SF, 1992, LANCET, V339, P1003, DOI 10.1016/0140-6736(92)90533-9; OLSEN SF, 1993, EPIDEMIOL REV, V15, P399, DOI 10.1093/oxfordjournals.epirev.a036127; OLSEN SF, 1990, INT J EPIDEMIOL, V19, P971, DOI 10.1093/ije/19.4.971; OLSEN SF, 1986, LANCET, V2, P367; OLSEN SF, 1994, J CLIN EPIDEMIOL, V47, P565, DOI 10.1016/0895-4356(94)90303-4; OLSEN SF, 1993, J EPIDEMIOL COMMUN H, V47, P436, DOI 10.1136/jech.47.6.436; OLSEN SF, 1990, PROSTAG LEUKOTR ESS, V40, P255, DOI 10.1016/0952-3278(90)90046-N; OLSEN SF, 1987, AGENTS ACTIONS, V22, P373, DOI 10.1007/BF02009084; OLSEN SF, 1990, BRIT J NUTR, V64, P599, DOI 10.1079/BJN19900063; OLSEN SF, 1991, AM J OBSTET GYNECOL, V164, P1203, DOI 10.1016/0002-9378(91)90683-I; *PEOPL LEAG HLTH, 1942, BMJ-BRIT MED J, V2, P77; *PEOPL LEAG HLTH, 1946, J OBSTET GYN BR COMM, V53, P198; People's League of Health, 1942, LANCET, V2, P10; SECHER NJ, 1986, BRIT J OBSTET GYNAEC, V93, P128, DOI 10.1111/j.1471-0528.1986.tb07877.x	28	224	231	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2002	324	7335					447	450		10.1136/bmj.324.7335.447	http://dx.doi.org/10.1136/bmj.324.7335.447			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526NJ	11859044	Bronze, Green Published			2022-12-28	WOS:000174136300014
J	Roberts, I; Kwan, I; Evans, P; Haig, S				Roberts, I; Kwan, I; Evans, P; Haig, S			Does animal experimentation inform human healthcare? Observations from a systematic review of international animal experiments on fluid resuscitation	BRITISH MEDICAL JOURNAL			English	Review							UNCONTROLLED HEMORRHAGIC-SHOCK; VOLUME HYPERTONIC SALINE; SODIUM-CHLORIDE; RATS; TRIALS; SURVIVAL; INFUSION; MODEL		London Sch Hyg & Trop Med, Publ Hlth Intervent Res Unit, Cochrane Injuries Grp, London WC1B 3DP, England; Univ Hosp Leicester NHS Trust, Leicester Royal Infirm, Dept Accid & Emergency, Leicester LE1 5WW, Leics, England	University of London; London School of Hygiene & Tropical Medicine; University Hospitals of Leicester NHS Trust; University of Leicester	Roberts, I (corresponding author), London Sch Hyg & Trop Med, Publ Hlth Intervent Res Unit, Cochrane Injuries Grp, London WC1B 3DP, England.			Evans, Phillip Adrian/0000-0002-0814-5162				BILYNSKYJ MCV, 1992, CIRC SHOCK, V36, P68; CAPONE A, 1995, RESUSCITATION, V29, P143, DOI 10.1016/0300-9572(95)00829-I; CAPONE AC, 1995, J AM COLL SURGEONS, V180, P49; Chalmers I., 2001, SYSTEMATIC REV HLTH, P429, DOI DOI 10.1002/9780470693926.CH24; Croce P., 1999, VIVISECTION SCI INVE; Dries DJ, 1996, SHOCK, V6, P311, DOI 10.1097/00024382-199611000-00001; Greene SP, 1998, SURGERY, V124, P568, DOI 10.1016/S0039-6060(98)70104-7; GROSS D, 1989, J TRAUMA, V29, P79, DOI 10.1097/00005373-198901000-00016; Horton R, 1999, LANCET, V354, P1138, DOI 10.1016/S0140-6736(99)00328-1; Kim SH, 1997, J TRAUMA, V42, P213, DOI 10.1097/00005373-199702000-00006; KRAUSZ MM, 1992, ARCH SURG-CHICAGO, V127, P93; KRAUSZ MM, 1991, CIRC SHOCK, V35, P9; KRAUSZ MM, 1992, J TRAUMA, V33, P6, DOI 10.1097/00005373-199207000-00002; KRAUSZ MM, 1992, SURG GYNECOL OBSTET, V174, P363; PETO R, 1995, J CLIN EPIDEMIOL, V48, P23, DOI 10.1016/0895-4356(94)00150-O; RABINOVICI R, 1989, SURG GYNECOL OBSTET, V169, P137; Roberts I, 2001, LANCET, V357, P385, DOI 10.1016/S0140-6736(00)03653-9; Russell WMS., 1959, MED J AUSTRALIA; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; SINDLINGER JF, 1993, SURG GYNECOL OBSTET, V177, P545; Smith R, 2001, BMJ-BRIT MED J, V322, P248, DOI 10.1136/bmj.322.7281.248; Soucy DM, 1999, J TRAUMA, V46, P209, DOI 10.1097/00005373-199902000-00001; SOUCY DM, 1995, ANN SURG, V222, P89; Talmor D, 1999, ANESTH ANALG, V89, P950, DOI 10.1097/00000539-199910000-00024; 2001, GUIDANCE OPERATION A	25	92	106	0	17	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 23	2002	324	7335					474	476		10.1136/bmj.324.7335.474	http://dx.doi.org/10.1136/bmj.324.7335.474			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526NJ	11859053	Green Accepted, Green Published			2022-12-28	WOS:000174136300023
J	Bernard, SA; Gray, TW; Buist, MD; Jones, BM; Silvester, W; Gutteridge, G; Smith, K				Bernard, SA; Gray, TW; Buist, MD; Jones, BM; Silvester, W; Gutteridge, G; Smith, K			Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MILD RESUSCITATIVE HYPOTHERMIA; MODERATE HYPOTHERMIA; BRAIN; ISCHEMIA; TRIAL; DOGS; REPERFUSION; FEASIBILITY; RECOVERY; INJURY	Background: Cardiac arrest outside the hospital is common and has a poor outcome. Studies in laboratory animals suggest that hypothermia induced shortly after the restoration of spontaneous circulation may improve neurologic outcome, but there have been no conclusive studies in humans. In a randomized, controlled trial, we compared the effects of moderate hypothermia and normothermia in patients who remained unconscious after resuscitation from out-of-hospital cardiac arrest. Methods: The study subjects were 77 patients who were randomly assigned to treatment with hypothermia (with the core body temperature reduced to 33degreesC within 2 hours after the return of spontaneous circulation and maintained at that temperature for 12 hours) or normothermia. The primary outcome measure was survival to hospital discharge with sufficiently good neurologic function to be discharged to home or to a rehabilitation facility. Results: The demographic characteristics of the patients were similar in the hypothermia and normothermia groups. Twenty-one of the 43 patients treated with hypothermia (49 percent) survived and had a good outcome -- that is, they were discharged home or to a rehabilitation facility -- as compared with 9 of the 34 treated with normothermia (26 percent, P=0.046). After adjustment for base-line differences in age and time from collapse to the return of spontaneous circulation, the odds ratio for a good outcome with hypothermia as compared with normothermia was 5.25 (95 percent confidence interval, 1.47 to 18.76; P=0.011). Hypothermia was associated with a lower cardiac index, higher systemic vascular resistance, and hyperglycemia. There was no difference in the frequency of adverse events. Conclusions: Our preliminary observations suggest that treatment with moderate hypothermia appears to improve outcomes in patients with coma after resuscitation from out-of-hospital cardiac arrest. Copyright (C) 2002 Massachusetts Medical Society.	Dandenong Hosp, Intens Care Unit, Dandenong, Vic 3175, Australia; Knox Hosp, Intens Care Unit, Melbourne, Vic, Australia; Monash Med Ctr, Dept Emergency Med, Clayton, Vic 3168, Australia; Austin & Repatriat Med Ctr, Dept Intens Care, Heidelberg, Vic, Australia; Monash Univ, Dept Epidemiol & Prevent Med, St Kilda, Australia	Monash University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Monash University	Bernard, SA (corresponding author), Dandenong Hosp, Intens Care Unit, David St, Dandenong, Vic 3175, Australia.		; Hachimi-Idrissi, Said/I-6422-2018	Kochanek, Patrick/0000-0002-2627-913X; Fischer, Matthias/0000-0003-4728-8497; Hachimi-Idrissi, Said/0000-0002-8455-1410; Smith, Karen/0000-0002-9057-0685				ABRAMSON NS, 1991, NEW ENGL J MED, V324, P1225; ABRAMSON NS, 1986, NEW ENGL J MED, V314, P397; ARCHER FL, 1993, MED J AUSTRALIA, V159, P616; BENSON D W, 1959, Anesth Analg, V38, P423; Bernard S, 1996, ANAESTH INTENS CARE, V24, P382, DOI 10.1177/0310057X9602400315; Bernard S., 1998, EMERG MED AUSTRALAS, V10, P25; Bernard SA, 1997, ANN EMERG MED, V30, P146, DOI 10.1016/S0196-0644(97)70133-1; Bernard SA, 1999, CRIT CARE, V3, P167, DOI 10.1186/cc371; BOHN DJ, 1986, CRIT CARE MED, V14, P529, DOI 10.1097/00003246-198606000-00002; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; CLEMMER TP, 1992, CRIT CARE MED, V20, P1395, DOI 10.1097/00003246-199210000-00006; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Colbourne F, 1999, J CEREBR BLOOD F MET, V19, P742, DOI 10.1097/00004647-199907000-00003; CURRY DL, 1970, ENDOCRINOLOGY, V87, P750, DOI 10.1210/endo-87-4-750; EDGREN E, 1994, LANCET, V343, P1055, DOI 10.1016/S0140-6736(94)90179-1; EISENBERG MS, 1990, ANN EMERG MED, V19, P179, DOI 10.1016/S0196-0644(05)81805-0; Gentilello LM, 1997, ANN SURG, V226, P439, DOI 10.1097/00000658-199710000-00005; Hicks SD, 2000, J CEREBR BLOOD F MET, V20, P520, DOI 10.1097/00004647-200003000-00011; Hsu JWY, 1996, ANN EMERG MED, V28, P597, DOI 10.1016/S0196-0644(96)70080-X; ILLIEVICH UM, 1994, ANESTH ANALG, V78, P905; JASTREMSKI M, 1989, JAMA-J AM MED ASSOC, V262, P3427, DOI 10.1001/jama.262.24.3427; Kammersgaard LP, 2000, STROKE, V31, P2251, DOI 10.1161/01.STR.31.9.2251; KUBOYAMA K, 1993, CRIT CARE MED, V21, P1348, DOI 10.1097/00003246-199309000-00019; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MORIMOTO Y, 1993, CRIT CARE MED, V21, P104, DOI 10.1097/00003246-199301000-00020; MYERBURG RJ, 1997, HEART DIS TXB CARDIO, V1, P742; OKU K, 1994, RESUSCITATION, V27, P141, DOI 10.1016/0300-9572(94)90007-8; ROINE RO, 1990, JAMA-J AM MED ASSOC, V264, P3171; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; STERZ F, 1991, CRIT CARE MED, V19, P379, DOI 10.1097/00003246-199103000-00017; WEINRAUCH V, 1992, STROKE, V23, P1454, DOI 10.1161/01.STR.23.10.1454; White BC, 1996, ANN EMERG MED, V27, P588, DOI 10.1016/S0196-0644(96)70161-0; WILLIAMS GR, 1958, ANN SURG, V148, P462, DOI 10.1097/00000658-195809000-00014; Yanagawa Y, 1998, RESUSCITATION, V39, P61, DOI 10.1016/S0300-9572(98)00118-X; Zeiner A, 2000, STROKE, V31, P86, DOI 10.1161/01.STR.31.1.86; 1999, STATA STAT SOFTWARE	36	3766	3969	3	140	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2002	346	8					557	563		10.1056/NEJMoa003289	http://dx.doi.org/10.1056/NEJMoa003289			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	522ZK	11856794				2022-12-28	WOS:000173926700003
J	Schmidt, PJ				Schmidt, PJ			Blood and disaster - Supply and demand	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material											Schmidt, PJ (corresponding author), 913 Mooring Cir, Tampa, FL 33602 USA.							BELCHER L, 1995, 48 ANN M AM ASS BLOO; BUSCH MP, 1991, TRANSFUSION, V31, P719, DOI 10.1046/j.1537-2995.1991.31892023497.x; *CTR BIOL EV RES, 2001, FDA POL STAT URG COL; *CTR BIOL EV RES, 2001, REV FDA POL STAT URG; Dariotis J, 2001, TRANSFUSION, V41, P1181, DOI 10.1046/j.1537-2995.2001.41101181.x; Gaul GM, 2001, WASH POST, pA34; Greenberg DS, 2001, LANCET, V358, P1789, DOI 10.1016/S0140-6736(01)06854-4; Healy B, 2001, TRANSFUSION, V41, P1185, DOI 10.1046/j.1537-2995.2001.41101185.x; JONES RL, 2001, MIAMI HERALD    1008; Klein HG, 2001, TRANSFUSION, V41, P1179, DOI 10.1046/j.1537-2995.2001.41101179.x; SCHMIDT PJ, 1996, NEDERL MILIT GENEESK, V49, P204; Schmidt PJ, 1985, SUPPORTIVE THERAPY H, P371; 2001, ABC NEWSLETTER  0914, P1; 2002, MMWR MORB MORTAL WKL, V51, P1; 2001, ABC NEWSLETTER  1214, P3	15	64	67	0	13	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2002	346	8					617	620		10.1056/NEJM200202213460813	http://dx.doi.org/10.1056/NEJM200202213460813			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	522ZK	11856803				2022-12-28	WOS:000173926700012
J	Costigan, M; Woolf, CJ				Costigan, M; Woolf, CJ			No DREAM, no pain: Closing the spinal gate	CELL			English	Review							PRODYNORPHIN GENE	Pain transmission in the spinal cord is regulated by a balance of facilitatory and inhibitory influences operating on the neural circuits of the somatosensory system. The transcriptional repressor DREAM acts constitutively to suppress prodynorphin expression in spinal cord neurons. Knocking out DREAM results in sufficient dynorphin expression to produce a strong reduction in generalized pain behavior, highlighting the role that intracellular molecules play in modulating pain gating in the spinal cord.	Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp E, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University	Woolf, CJ (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, Charlestown, MA 02129 USA.		Woolf, Clifford/A-9784-2010					Carrion AM, 1998, MOL CELL BIOL, V18, P6921, DOI 10.1128/MCB.18.12.6921; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Cheng HYM, 2002, CELL, V108, P31, DOI 10.1016/S0092-8674(01)00629-8; COLE RL, 1995, NEURON, V14, P813, DOI 10.1016/0896-6273(95)90225-2; Fields H., 1999, TXB PAIN; Ji RR, 2002, J NEUROSCI, V22, P478, DOI 10.1523/JNEUROSCI.22-02-00478.2002; Laughlin TM, 2001, J PHARMACOL EXP THER, V299, P6; Ledo F, 2000, MOL CELL BIOL, V20, P9120, DOI 10.1128/MCB.20.24.9120-9126.2000; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; NARANJO JR, 1991, NEURON, V6, P607, DOI 10.1016/0896-6273(91)90063-6; Naranjo JR, 1997, EUR J NEUROSCI, V9, P2778, DOI 10.1111/j.1460-9568.1997.tb01707.x; Pasternak GW, 2001, NEUROSCIENTIST, V7, P220, DOI 10.1177/107385840100700307; Sanz C, 2001, EMBO J, V20, P2286, DOI 10.1093/emboj/20.9.2286; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765	14	64	72	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 8	2002	108	3					297	300		10.1016/S0092-8674(02)00640-2	http://dx.doi.org/10.1016/S0092-8674(02)00640-2			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	520VB	11853663	Bronze			2022-12-28	WOS:000173801600001
J	Wang, L; Seeley, ES; Wickner, W; Merz, AJ				Wang, L; Seeley, ES; Wickner, W; Merz, AJ			Vacuole fusion at a ring of vertex docking sites leaves membrane fragments within the organelle	CELL			English	Article							SEC17P ALPHA-SNAP; SACCHAROMYCES-CEREVISIAE; HOMOTYPIC FUSION; T-SNARE; MULTIVESICULAR BODY; YEAST VACUOLES; GTPASE YPT7P; IN-VITRO; COMPLEX; PROTEIN	Three membrane microdomains can be identified on docked vacuoles: "outside" membrane, not in contact with other vacuoles, "boundary" membrane that contacts adjacent vacuoles, and "vertices," where boundary and outside membrane meet. In living cells and in vitro, vacuole fusion occurs at vertices rather than from a central pore expanding radially. Vertex fusion leaves boundary membrane within the fused organelle and is an unexpected pathway for the formation of intralumenal membranes. Proteins that regulate docking and fusion (Vac8p, the GTPase Ypt7p, its HOPS/Vps-C effector complex, the t-SNARE Vam3p, and protein phosphatase 1) accumulate at these vertices during docking. Their vertex enrichment requires cis-SNARE complex disassembly and is thus part of the normal fusion pathway.	Dartmouth Coll Sch Med, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Wang, L (corresponding author), Dartmouth Coll Sch Med, Dept Biochem, 7200 Vail Bldg, Hanover, NH 03755 USA.							Bone N, 1998, CURR BIOL, V8, P135, DOI 10.1016/S0960-9822(98)00060-8; Burgoyne RD, 1998, CELL CALCIUM, V24, P367, DOI 10.1016/S0143-4160(98)90060-4; CHERNOMORDIK LV, 1991, BIOPHYS J, V60, P1026, DOI 10.1016/S0006-3495(91)82140-3; CONRADT B, 1994, J CELL BIOL, V126, P99, DOI 10.1083/jcb.126.1.99; CONRADT B, 1992, J CELL BIOL, V119, P1469, DOI 10.1083/jcb.119.6.1469; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; Denzer K, 2000, J CELL SCI, V113, P3365; DUBLOVA I, 2001, NAT STRUCT BIOL, V8, P258; Eitzen G, 2000, EMBO J, V19, P6713, DOI 10.1093/emboj/19.24.6713; Guo W, 2001, NAT CELL BIOL, V3, P353, DOI 10.1038/35070029; HAAS A, 1994, J CELL BIOL, V126, P87, DOI 10.1083/jcb.126.1.87; HAAS A, 1995, EMBO J, V14, P5258, DOI 10.1002/j.1460-2075.1995.tb00210.x; Haas A, 1996, EMBO J, V15, P3296, DOI 10.1002/j.1460-2075.1996.tb00694.x; Haas Albert, 1995, Methods in Cell Science, V17, P283, DOI 10.1007/BF00986234; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HIRSCH JG, 1968, J CELL BIOL, V38, P629, DOI 10.1083/jcb.38.3.629; Kahana JA, 1998, GREEN FLUORESCENT PROTEIN: PROPERTIES, APPLICATIONS, AND PROTOCOLS, P139; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mayer A, 1997, J CELL BIOL, V136, P307, DOI 10.1083/jcb.136.2.307; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; MILLER F, 1964, J CELL BIOL, V23, P519, DOI 10.1083/jcb.23.3.519; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; OLBRICHT K, 1984, EXP CELL RES, V151, P14, DOI 10.1016/0014-4827(84)90351-3; Pan XZ, 1998, J CELL SCI, V111, P2137; Peters C, 1999, SCIENCE, V285, P1084, DOI 10.1126/science.285.5430.1084; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Price A, 2000, J CELL BIOL, V148, P1231, DOI 10.1083/jcb.148.6.1231; Price A, 2000, J CELL BIOL, V148, P1223, DOI 10.1083/jcb.148.6.1223; Roberts RL, 1999, J CELL SCI, V112, P3667; Sato TK, 2000, MOL CELL, V6, P661, DOI 10.1016/S1097-2765(00)00064-2; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Sokal R.R., 1994, BIOMETRY PRINCIPLES; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; Ungermann C, 1999, P NATL ACAD SCI USA, V96, P11194, DOI 10.1073/pnas.96.20.11194; Ungermann C, 1999, J CELL BIOL, V145, P1435, DOI 10.1083/jcb.145.7.1435; Ungermann C, 1998, EMBO J, V17, P3269, DOI 10.1093/emboj/17.12.3269; Ungermann C, 1998, J CELL BIOL, V140, P61, DOI 10.1083/jcb.140.1.61; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Ungermann C, 2000, P NATL ACAD SCI USA, V97, P8889, DOI 10.1073/pnas.160269997; Veit M, 2001, EMBO J, V20, P3145, DOI 10.1093/emboj/20.12.3145; Wang L, 2000, J BIOL CHEM, V275, P22862, DOI 10.1074/jbc.M001447200; Wang YX, 2001, J BIOL CHEM, V276, P35133, DOI 10.1074/jbc.M103937200; Wickner W, 2000, ANNU REV BIOCHEM, V69, P247, DOI 10.1146/annurev.biochem.69.1.247; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551; Xu ZY, 1998, CELL, V93, P1125, DOI 10.1016/S0092-8674(00)81457-9; YAMAMOTO A, 1995, MOL BIOL CELL, V6, P525, DOI 10.1091/mbc.6.5.525	50	176	179	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 8	2002	108	3					357	369		10.1016/S0092-8674(02)00632-3	http://dx.doi.org/10.1016/S0092-8674(02)00632-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	520VB	11853670	Bronze			2022-12-28	WOS:000173801600008
J	Choe, KM; Werner, T; Stoven, S; Hultmark, D; Anderson, KV				Choe, KM; Werner, T; Stoven, S; Hultmark, D; Anderson, KV			Requirement for a peptidoglycan recognition protein (PGRP) in relish activation and antibacterial immune responses in Drosophila	SCIENCE			English	Article							GENE; ANTIFUNGAL; DEFENSE	Components of microbial cell walls are potent activators of innate immune responses in animals. For example, the mammalian TLR4 signaling pathway is activated by bacterial lipopolysaccharide and is required for resistance to infection by Gram-negative bacteria. Other components of microbial surfaces, such as peptidoglycan, are also potent activators of innate immune responses, but less is known about how those components activate host defense. Here we show that a peptidoglycan recognition protein, PGRP-LC, is absolutely required for the induction of antibacterial peptide genes in response to infection in Drosophila and acts by controlling activation of the NF-kappaB family transcription factor Relish.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Mol & Cell Biol Program, New York, NY 10021 USA; Umea Univ, Umea Ctr Mol Pathogenesis, SE-90187 Umea, Sweden	Memorial Sloan Kettering Cancer Center; Cornell University; Umea University	Anderson, KV (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Biol, 1275 York Ave, New York, NY 10021 USA.		Hultmark, Dan/C-5058-2013	Hultmark, Dan/0000-0002-6506-5855; Anderson, Kathryn/0000-0003-1657-2161				BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen B, 1998, GENETICS, V149, P157; CHOE KH, UNPUB; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; Elrod-Erickson M, 2000, CURR BIOL, V10, P781, DOI 10.1016/S0960-9822(00)00569-8; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; HATTON LS, 1999, ELSEVIER TRENDS J TE; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Khush RS, 2001, TRENDS IMMUNOL, V22, P260, DOI 10.1016/S1471-4906(01)01887-7; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Lu YR, 2001, GENE DEV, V15, P104, DOI 10.1101/gad.856901; Meng XJ, 1999, GENE DEV, V13, P792, DOI 10.1101/gad.13.7.792; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Spradling A. C, 1986, DROSOPHILA PRACTICAL; Stoven S, 2000, EMBO REP, V1, P347, DOI 10.1093/embo-reports/kvd072; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Wu LP, 1998, NATURE, V392, P93, DOI 10.1038/32195; Wu LP, 2001, GENETICS, V159, P189; Yoshida H, 1996, J BIOL CHEM, V271, P13854, DOI 10.1074/jbc.271.23.13854	29	466	499	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 12	2002	296	5566					359	362		10.1126/science.1070216	http://dx.doi.org/10.1126/science.1070216			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541TJ	11872802				2022-12-28	WOS:000175000300062
J	Kew, O; Morris-Glasgow, V; Landaverde, M; Burns, C; Shaw, J; Garib, Z; Andre, J; Blackman, E; Freeman, CJ; Jorba, J; Sutter, R; Tambini, G; Venczel, L; Pedreira, C; Laender, F; Shimizu, H; Yoneyama, T; Miyamura, T; van der Avoort, H; Oberste, MS; Kilpatrick, D; Cochi, S; Pallansch, M; de Quadros, C				Kew, O; Morris-Glasgow, V; Landaverde, M; Burns, C; Shaw, J; Garib, Z; Andre, J; Blackman, E; Freeman, CJ; Jorba, J; Sutter, R; Tambini, G; Venczel, L; Pedreira, C; Laender, F; Shimizu, H; Yoneyama, T; Miyamura, T; van der Avoort, H; Oberste, MS; Kilpatrick, D; Cochi, S; Pallansch, M; de Quadros, C			Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus	SCIENCE			English	Article							WILD POLIOVIRUS; PARALYTIC POLIOMYELITIS; MOLECULAR EVOLUTION; EPIDEMIOLOGY; ERADICATION; REGION; DETERMINANTS; TRANSMISSION; ATTENUATION; AMERICA	An outbreak of paralytic poliomyelitis occurred in the Dominican Republic (13 confirmed cases) and Haiti (8 confirmed cases, including 2 fatal cases) during 2000-2001. All but one of the patients were either unvaccinated or incompletely vaccinated children, and cases occurred in communities with very Low (7 to 40%) rates of coverage with oral poliovirus vaccine (OPV). The outbreak was associated with the circulation of a derivative of the type 1 OPV strain, probably originating from a single OPV dose given in 1998-1999. The vaccine-derived poliovirus associated with the outbreak had biological properties indistinguishable from those of wild poliovirus.	Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Pan Amer Hlth Org, Caribbean Epidemiol Ctr Lab, Port of Spain, Trinidad Tobago; PAHO, Div Vaccines & Immunizat, Washington, DC 20037 USA; Minist Hlth, Santo Domingo, Dominican Rep; Minist Publ Hlth, Port au Prince, Haiti; Ctr Dis Control & Prevent, Vaccine Preventable Dis Eradicat Div, Natl Immunizat Program, Atlanta, GA 30333 USA; PAHO, Santo Domingo, Dominican Rep; PAHO, Port au Prince, Haiti; Natl Inst Infect Dis, Dept Virol 2, Shinjuku Ku, Tokyo 162, Japan; Natl Inst Publ Hlth & Environm, Polio Lab, RIVM, NL-3720 BA Bilthoven, Netherlands	Centers for Disease Control & Prevention - USA; Pan American Health Organization; Pan American Health Organization; Centers for Disease Control & Prevention - USA; National Institute of Infectious Diseases (NIID); Netherlands National Institute for Public Health & the Environment	Kew, O (corresponding author), Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, 1600 Clifton Rd, Atlanta, GA 30333 USA.	okew@cdc.gov	Shimizu, Hiroyuki/AAU-9621-2020	Shimizu, Hiroyuki/0000-0002-2987-2377				ANDRUS JK, 1995, B WORLD HEALTH ORGAN, V73, P33; BOUCHARD MJ, 1995, J VIROL, V69, P4972, DOI 10.1128/JVI.69.8.4972-4978.1995; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P874; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P41; DE L, 1995, J CLIN MICROBIOL, V33, P562, DOI 10.1128/JCM.33.3.562-571.1995; deQuadros CA, 1997, J INFECT DIS, V175, pS37, DOI 10.1093/infdis/175.Supplement_1.S37; Drebot MA, 1997, APPL ENVIRON MICROB, V63, P519, DOI 10.1128/AEM.63.2.519-523.1997; Gromeier M, 1999, J VIROL, V73, P958, DOI 10.1128/JVI.73.2.958-964.1999; KAWAMURA N, 1989, J VIROL, V63, P1302, DOI 10.1128/JVI.63.3.1302-1309.1989; Kew OM, 1995, SEMIN VIROL, V6, P401, DOI 10.1016/S1044-5773(05)80017-4; Liu HM, 2000, J VIROL, V74, P11153, DOI 10.1128/JVI.74.23.11153-11161.2000; MINOR PD, 1988, J GEN VIROL, V69, P1091, DOI 10.1099/0022-1317-69-5-1091; MINOR PD, 1990, CURR TOP MICROBIOL, V161, P121; MUZYCHENKO AR, 1991, VIRUS RES, V21, P111, DOI 10.1016/0168-1702(91)90002-D; NATHANSON N, 1979, AM J EPIDEMIOL, V110, P672, DOI 10.1093/oxfordjournals.aje.a112848; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; *PAN AM HLTH ORG, 1996, EPI NEWSL, V18, P4; Patriarca PA, 1997, J INFECT DIS, V175, pS165, DOI 10.1093/infdis/175.Supplement_1.S165; Robbins FC, 1997, J INFECT DIS, V175, pS281, DOI 10.1093/infdis/175.Supplement_1.S281; Shulman LM, 2000, J CLIN MICROBIOL, V38, P945, DOI 10.1128/JCM.38.3.945-952.2000; STREBEL PM, 1992, CLIN INFECT DIS, V14, P568, DOI 10.1093/clinids/14.2.568; VANDERAVOORT HGAM, 1995, J CLIN MICROBIOL, V33, P2562, DOI 10.1128/JCM.33.10.2562-2566.1995; Wood DJ, 2000, B WORLD HEALTH ORGAN, V78, P347; World Health Organ, 2001, WKLY EPIDEMIOL REC, V76, P126	24	418	455	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2002	296	5566					356	359		10.1126/science.1068284	http://dx.doi.org/10.1126/science.1068284			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541TJ	11896235	Green Submitted			2022-12-28	WOS:000175000300061
J	Chapman, ALN; Watkin, R; Ellis, CJ				Chapman, ALN; Watkin, R; Ellis, CJ			Lesson of the week - Abdominal pain in acute infectious mononucleosis	BRITISH MEDICAL JOURNAL			English	Review							RUPTURE; SPLEEN		Birmingham Heartlands Hosp, Dept Infect & Trop Med, Birmingham B9 5SS, W Midlands, England	Heart of England NHS Foundation Trust; University of Birmingham	Chapman, ALN (corresponding author), Birmingham Heartlands Hosp, Dept Infect & Trop Med, Birmingham B9 5SS, W Midlands, England.							Blaivas M, 1998, ANN EMERG MED, V32, P627, DOI 10.1016/S0196-0644(98)70046-0; FARLEY DR, 1992, MAYO CLIN PROC, V67, P846, DOI 10.1016/S0025-6196(12)60822-2; HOAGLAND RJ, 1957, ANN INTERN MED, V46, P1181; KONVOLINKA C W, 1989, Journal of Emergency Medicine, V7, P471, DOI 10.1016/0736-4679(89)90148-0; LEE PWR, 1976, POSTGRAD MED J, V52, P725, DOI 10.1136/pgmj.52.613.725; LOWENFELS AB, 1966, NEW ENGL J MED, V274, P1019, DOI 10.1056/NEJM196605052741810; PATEL JM, 1982, JAMA-J AM MED ASSOC, V247, P3243; PETERS RM, 1986, AM J MED, V80, P123, DOI 10.1016/0002-9343(86)90061-6; RUTKOW IM, 1978, ARCH SURG-CHICAGO, V113, P718; SMITH JN, 1956, ANN INTERN MED, V44, P861, DOI 10.7326/0003-4819-44-5-861	10	10	10	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 16	2002	324	7338					660	661		10.1136/bmj.324.7338.660	http://dx.doi.org/10.1136/bmj.324.7338.660			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532QW	11895827	Green Published			2022-12-28	WOS:000174487400030
J	Whincup, PH; Gilg, JA; Papacosta, O; Seymour, C; Miller, GJ; Alberti, KGMM; Cook, DG				Whincup, PH; Gilg, JA; Papacosta, O; Seymour, C; Miller, GJ; Alberti, KGMM; Cook, DG			Early evidence of ethnic differences in cardiovascular risk: cross sectional comparison of British South Asian and white children	BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; INSULIN-RESISTANCE SYNDROME; GLUCOSE-TOLERANCE; LONDON; PREVALENCE; PLASMA; BIRTH; BANGLADESHIS; PREVENTION; CHILDHOOD	Objectives To examine whether British South Asian children differ in insulin resistance, adiposity, and cardiovascular risk profile from white children. Design Cross sectional study. Setting Primary schools in 10 British towns. Participants British children aged 8 to 11 years (227 South Asian and 3415 white); 73 South Asian and 1287 were children aged 10 and 11 years provided blood samples (half fasting, half after glucose load). Main outcome measures Insulin concentrations, anthropometric measures, established cardiovascular risk factors. Results Mean ponderal index was lower in South Asian children than in white children (mean difference - 0.43 kg/m(3), 95% confidence interval - 0.13 kg/m(3) to - 0.73 kg/m(3)). Mean waist circumferences and waist:hip ratios were similar. Mean insulin concentrations were higher in South Asian children (percentage difference was 53%, 14% to 106%, after fasting and 54%, 19% to 99%, after glucose load), though glucose concentrations were similar. Mean heart rate and triglyceride and fibrinogen concentrations were higher among South Asian children; serum total, low density lipoprotein, and high density lipoprotein cholesterol concentrations were similar in the two groups. Differences in insulin concentrations remained after adjustment for adiposity and other potential confounders. However, the relations between adiposity and insulin concentrations (particularly fasting insulin) were much stronger among South Asian children than among white children. Conclusions The tendency to insulin resistance observed in British South Asian adults is apparent in children, in whom it may reflect an increased sensitivity to adiposity. Action to prevent non-insulin dependent diabetes in South Asian adults may need to begin during childhood.	St Georges Hosp, Sch Med, Dept Publ Hlth Sci, London SW17 0RE, England; Univ London, Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London NW3 2PF, England; Univ London St Georges Hosp, Sch Med, Div Cardiol Sci Metab Med, London, England; Wolfson Inst, MRC, Epidemiol & Med Care Unit, London EC1M 6BQ, England; Univ Newcastle Upon Tyne, Human Diabet & Metab Res Ctr, Dept Diabet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	St Georges University London; University of London; University College London; St Georges University London; University of London; Queen Mary University London; Newcastle University - UK	Whincup, PH (corresponding author), St Georges Hosp, Sch Med, Dept Publ Hlth Sci, London SW17 0RE, England.			Whincup, Peter/0000-0002-5589-4107; Cook, Derek/0000-0002-9723-5759; Papacosta, Olia/0000-0001-8781-6747	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDERSEN L, 1993, CLIN CHEM, V39, P578; Balarajan R, 1996, HLTH TRENDS, V28, P45; Barker DJP, 1998, MOTHERS BABIES HLTH; Berenson GS, 1999, LANCET, V354, P1223; BHATNAGAR D, 1995, LANCET, V345, P405; Bhopal R, 1999, BRIT MED J, V319, P215, DOI 10.1136/bmj.319.7204.215; Cappuccio FP, 1997, HEART, V78, P555, DOI 10.1136/hrt.78.6.555; Chinn S, 2001, BRIT MED J, V322, P24, DOI 10.1136/bmj.322.7277.24; CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; Cook DG, 2000, ATHEROSCLEROSIS, V149, P139, DOI 10.1016/S0021-9150(99)00312-3; Cook DG, 2001, AM J EPIDEMIOL, V153, P799, DOI 10.1093/aje/153.8.799; CRUICKSHANK JK, 1991, LANCET, V338, P842, DOI 10.1016/0140-6736(91)91501-K; Fagot-Campagna A, 2000, J PEDIATR-US, V136, P664, DOI 10.1067/mpd.2000.105141; FOROUHI NG, 2000, THESIS LONDON U LOND; HAFFNER SM, 1992, DIABETES, V41, P715, DOI 10.2337/diabetes.41.6.715; KNIGHT TM, 1992, BRIT HEART J, V67, P343; Markovitz JH, 1998, EUR HEART J, V19, P720, DOI 10.1053/euhj.1997.0800; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MCKEIGUE PM, 1988, BRIT HEART J, V60, P390; MCKEIGUE PM, 1992, BRIT HEART J, V67, P341, DOI 10.1136/hrt.67.5.341; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; MCKEIGUE PM, 1985, LANCET, V2, P1086; MILLER GJ, 1994, THROMB HAEMOSTASIS, V71, P38; MILLER GJ, 1988, ATHEROSCLEROSIS, V70, P63, DOI 10.1016/0021-9150(88)90100-1; Phillips DIW, 1997, DIABETIC MED, V14, P673, DOI 10.1002/(SICI)1096-9136(199708)14:8<673::AID-DIA458>3.0.CO;2-9; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; SHAUKAT N, 1995, FIBRINOLYSIS, V9, P55, DOI 10.1016/S0268-9499(08)80046-X; SIMMONS D, 1991, Q J MED, V81, P1021, DOI 10.1093/qjmed/81.3.1021; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; WALKER ARP, 1972, S AFR MED J, V46, P1916; Whincup PH, 1997, DIABETOLOGIA, V40, P319, DOI 10.1007/s001250050681; Whincup PH, 1996, BMJ-BRIT MED J, V313, P79, DOI 10.1136/bmj.313.7049.79; Whitty CJM, 1999, ATHEROSCLEROSIS, V142, P279, DOI 10.1016/S0021-9150(98)00239-1; Wild S, 1997, BRIT MED J, V314, P705, DOI 10.1136/bmj.314.7082.705; WILLIAMS B, 1995, LANCET, V345, P401, DOI 10.1016/S0140-6736(95)90394-1	35	272	273	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 16	2002	324	7338					635	638B		10.1136/bmj.324.7338.635	http://dx.doi.org/10.1136/bmj.324.7338.635			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532QW	11895820	Bronze, Green Published			2022-12-28	WOS:000174487400020
J	Krumholz, HM; Rathore, SS; Chen, J; Wang, YF; Radford, MJ				Krumholz, HM; Rathore, SS; Chen, J; Wang, YF; Radford, MJ			Evaluation of a consumer-oriented internet health care report card - The risk of quality ratings based on mortality data	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; MEDICARE PATIENTS; HOSPITALS; DEATH	Context Healthcare "report cards" have attracted significant consumer interest, particularly publicly available Internet health care quality rating systems. However, the ability of these ratings to discriminate between hospitals is not known. Objective To determine whether hospital ratings for acute myocardial infarction (AN) mortality from a prominent Internet hospital rating system accurately discriminate between hospitals' performance based on process of care and outcomes. Design, Setting, and Patients Data from the Cooperative Cardiovascular Project, a retrospective systematic medical record review of 141914 Medicare fee-for-service beneficiaries 65 years or older hospitalized with AM[ at 3363 US acute care hospitals during a 4- to 8-month period between January 1994 and February 1996 were compared with ratings obtained from HealthGrades.com (1-star worse outcomes than predicted, 5-star: better outcomes than predicted) based on 1994-1997 Medicare data. Main Outcome Measures Quality indicators of AN care, including use of acute reperfusion therapy, aspirin, beta-blockers, angiotensin-converting enzyme inhibitors; 30-day mortality. Results Patients treated at higher-rated hospitals were significantly more likely to receive aspirin (admission: 75.4% 5-star vs 66.4% 1-star, P for trend =.001; discharge: 79.7% 5-star vs 68.0% 1-star, P=.001) and beta-blockers (admission: 54.8% 5-star vs 35.7% 1-star, P=.001; discharge: 63.3% 5-star vs 52.1% 1-star, P=.001), but not angiotensin-converting enzyme inhibitors (59.6% 5-star vs 57.4% 1-star, P=.40). Acute reperfusion therapy rates were highest for patients treated at 2-star hospitals (60.6%) and lowest for 5-star hospitals (53.6% 5-star, P=.008). Risk-standardized 30-day mortality rates were lower for patients treated at higher-rated than lower-rated hospitals (21.9% 1-star vs 15.9% 5-star, P=.001). However, there was marked heterogeneity within rating groups and substantial overlap of individual hospitals across rating strata for mortality and process of care; only 3.1% of comparisons between 1-star and 5-star hospitals had statistically lower risk-standardized 30-day mortality rates in 5-star hospitals. Similar findings were observed in comparisons of 30-day mortality rates between individual hospitals in all other rating groups and when comparisons were restricted to hospitals with a minimum of 30 cases during the study period. Conclusion Hospital ratings published by a prominent Internet health care quality rating system identified groups of hospitals that, in the aggregate, differed in their quality of care and outcomes. However, the ratings poorly discriminated between any 2 individual hospitals' process of care or mortality rates during the study period. Limitations in discrimination may undermine the value of health care quality ratings for patients or payers and may lead to misperceptions of hospitals' performance.	Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06510 USA; Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; Qualidigm, Middletown, CT USA	Yale University; Yale University; Yale University	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, 333 Cedar St,POB 208025, New Haven, CT 06520 USA.		, Harlan/AAI-2875-2020	Radford, Martha/0000-0001-7503-9557				APPLEBY J, 2000, US TODAY        1011, pB1; *ATL INF SERV INC, 1998, HLTH CAR REP CARDS 1; Braun BI, 1999, EVAL HEALTH PROF, V22, P283, DOI 10.1177/016327879902200301; BUTLER R, 2002, YAHOO INTERNET L JUL; DALEY J, 1988, JAMA-J AM MED ASSOC, V260, P3617, DOI 10.1001/jama.260.24.3617; DRANOVE D, 2002, 8697 NBER; FLEMING C, 1992, MED CARE, V30, P377, DOI 10.1097/00005650-199205000-00001; GREEN J, 1991, JAMA-J AM MED ASSOC, V265, P1849; GREEN J, 1990, JAMA-J AM MED ASSOC, V263, P241, DOI 10.1001/jama.263.2.241; GREEN J, 1995, NEW ENGL J MED, V332, P1229, DOI 10.1056/NEJM199505043321812; IEZZONI LI, 1988, ANN INTERN MED, V109, P745, DOI 10.7326/0003-4819-109-9-745; IEZZONI LI, 1994, ADJUSTMENT MEASURING; Jencks SF, 2000, JAMA-J AM MED ASSOC, V284, P1670, DOI 10.1001/jama.284.13.1670; JENCKS SF, 1988, JAMA-J AM MED ASSOC, V262, P2240; Krumholz HM, 1999, CIRCULATION, V99, P2986, DOI 10.1161/01.CIR.99.23.2986; LOHR KN, 1988, INQUIRY-J HEALTH CAR, V25, P37; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; Mehta RH, 1999, AM HEART J, V138, P688, DOI 10.1016/S0002-8703(99)70184-5; Mennemeyer ST, 1997, INQUIRY-J HEALTH CAR, V34, P117; MILLER MG, 1994, JAMA-J AM MED ASSOC, V271, P1493, DOI 10.1001/jama.271.19.1493; Morrissey J, 1999, Mod Healthc, V29, P24; *NAT COMM QUAL ASS, 2000, NCQAS HLTH PLAN REP; PEAR R, 2001, NY TIMES        0928, pA19; PRAGER LO, 1999, AM MED NEWS     0906; Ryan TJ, 1996, J AM COLL CARDIOL, V28, P1328; SAY CB, 2001, LOS ANGELES TIM 0702, pS2; SCHIFRIN M, 2002, USE CARE FORBES BEST; Thiemann DR, 2000, JAMA-J AM MED ASSOC, V284, P2994, DOI 10.1001/jama.284.23.2994; Thomas JW, 1999, MED CARE, V37, P83, DOI 10.1097/00005650-199901000-00012; VLADECK BC, 1988, HEALTH AFFAIR, V7, P122, DOI 10.1377/hlthaff.7.1.122; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; WILSON P, 1996, 2 OFF STAT HLTH PLAN; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; 1986, NY TIMES        0317, pA18; 2001, HEALTHCARE QUALITY E; 2003, AM BEST HOSP 2001 HO	36	83	85	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2002	287	10					1277	1287		10.1001/jama.287.10.1277	http://dx.doi.org/10.1001/jama.287.10.1277			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529YU	11886319				2022-12-28	WOS:000174329500026
J	Terry, N				Terry, N			Education and debate - Regulating health information: a US perspective	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUALITY; INTERNET; MAIL		St Louis Univ, Sch Law, Ctr Hlth Law Studies, St Louis, MO 63108 USA	Saint Louis University	Terry, N (corresponding author), St Louis Univ, Sch Law, Ctr Hlth Law Studies, 3700 Lindell Blvd, St Louis, MO 63108 USA.	terry@slu.edu						Berland GK, 2001, JAMA-J AM MED ASSOC, V285, P2612, DOI 10.1001/jama.285.20.2612; *CONS INT, 2001, PRIV INT COMP STUD C, P5; *CTR DRUG EV RES, 1999, GUID IND CONS DIR BR; *CTR DRUG EV RES, 2002, WARN LETT NOT VIOL L; Delamothe T, 2000, BRIT MED J, V321, P843, DOI 10.1136/bmj.321.7265.843; Eysenbach G, 1998, JAMA-J AM MED ASSOC, V280, P1333, DOI 10.1001/jama.280.15.1333; Eysenbach G, 2001, J MED INTERNET RES, V3, DOI 10.2196/jmir.3.4.e34; *FED TRAD COMM, 2002, OP CUR WAG NEW BATTL; Jadad AR, 1998, JAMA-J AM MED ASSOC, V279, P611, DOI 10.1001/jama.279.8.611; Kane B, 1998, J AM MED INFORM ASSN, V5, P104, DOI 10.1136/jamia.1998.0050104; *NAT ASS BOARDS PH, 2002, VIPPS; *OFF FED PRIV COMM, 2001, GUID PRIV PRIV HLTH; Terry NP, 2000, J MED INTERNET RES, V2, DOI 10.2196/jmir.2.3.e18; Terry NP, 1999, AM J LAW MED, V25, P327; Terry NP, 2001, AM J LAW MED, V27, P361; TERRY NP, 2001, AM MED NEWS     0604; U. S. Dept. of Health and Human Services, 2000, FED REGISTER, V65, P82462; *URAC AM ACCR HLTH, 2002, HLTH WEB SIT ACCR; *WHO, 2002, WHO PROP WOULD RAIS; 2002, MEDEM ONLINE MED LIA; 2001, LA TIMES        1107	21	12	13	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2002	324	7337					602	605		10.1136/bmj.324.7337.602	http://dx.doi.org/10.1136/bmj.324.7337.602			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	530XJ	11884330	Green Published			2022-12-28	WOS:000174384000030
J	Scheschkewitz, D; Amii, H; Gornitzka, H; Schoeller, WW; Bourissou, D; Bertrand, G				Scheschkewitz, D; Amii, H; Gornitzka, H; Schoeller, WW; Bourissou, D; Bertrand, G			Singlet diradicals: from transition states to crystalline compounds	SCIENCE			English	Article							SPECTROSCOPY; BIRADICALS	Singlet diradicals are usually not energy minima. As observed by femtosecond spectroscopy, they readily couple to form sigma bonds. Substituent effects allow lifetimes to increase into the microsecond range. Taking advantage of the properties of hetero-elements, a diradical has been prepared that is indefinitely stable at room temperature. The availability of diradicals that can be handled under standard laboratory conditions wilt lead to further insight into their chemical and physical properties, raising the likelihood of practical applications, especially in the field of molecular materials such as electrical conductors and ferromagnets.	Univ Calif Riverside, Dept Chem, Joint Res Chem Lab, CNRS,UMR 2282, Riverside, CA 92521 USA; Univ Toulouse 3, Lab Heterochim Fondamentale & Appl, UMR 5069, F-31062 Toulouse 04, France; Univ Bielefeld, Fak Chem, D-33615 Bielefeld, Germany	University of California System; University of California Riverside; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Bielefeld	Bertrand, G (corresponding author), Univ Calif Riverside, Dept Chem, Joint Res Chem Lab, CNRS,UMR 2282, Riverside, CA 92521 USA.		Scheschkewitz, David/A-5050-2008; Bourissou, Didier/F-7761-2014; Schoeller, Wolfgang W/A-5755-2011	Scheschkewitz, David/0000-0001-5600-8034; 				Abe M, 2000, J AM CHEM SOC, V122, P2019, DOI 10.1021/ja992507j; Adam W, 1998, J AM CHEM SOC, V120, P593, DOI 10.1021/ja972977i; BADER RWF, 1994, ATOMS MOL; BECKE AD, 1990, J CHEM PHYS, V92, P5397, DOI 10.1063/1.458517; BERSON JA, 1994, SCIENCE, V266, P1338, DOI 10.1126/science.266.5189.1338; Berson JA, 1997, ACCOUNTS CHEM RES, V30, P238, DOI 10.1021/ar9700015; Borden WT, 1998, ENCY COMPUTATIONAL C, P708; Frisch M.J., 2016, GAUSSIAN 16 REVISION; Harcourt RD, 1998, J PHYS CHEM A, V102, P1850, DOI 10.1021/jp9733835; JAIN R, 1988, J AM CHEM SOC, V110, P1356, DOI 10.1021/ja00213a006; Kato T, 2000, SCIENCE, V289, P754, DOI 10.1126/science.289.5480.754; Michl J, 1996, J AM CHEM SOC, V118, P3568, DOI 10.1021/ja9538391; NGUYEN KA, 1994, J AM CHEM SOC, V116, P9241, DOI 10.1021/ja00099a047; NIECKE E, 1995, ANGEW CHEM INT EDIT, V34, P555, DOI 10.1002/anie.199505551; OLMSTEAD MM, 1986, J AM CHEM SOC, V108, P4235, DOI 10.1021/ja00274a071; PEDERSEN S, 1994, SCIENCE, V266, P1359, DOI 10.1126/science.266.5189.1359; PILZ M, 1991, Z NATURFORSCH B, V46, P1085; PILZ M, 1990, ANGEW CHEM INT EDIT, V29, P1030, DOI 10.1002/anie.199010301; RAJCA A, 1994, CHEM REV, V94, P871, DOI 10.1021/cr00028a002; Staroverov VN, 2001, J MOL STRUC-THEOCHEM, V573, P81, DOI 10.1016/S0166-1280(01)00536-X; Zewail AH, 2000, ANGEW CHEM INT EDIT, V39, P2587	22	270	269	4	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1880	1881		10.1126/science.1068167	http://dx.doi.org/10.1126/science.1068167			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884750				2022-12-28	WOS:000174299500034
J	McKee, CF; Tan, JC				McKee, CF; Tan, JC			Massive star formation in 100,000 years from turbulent and pressurized molecular clouds	NATURE			English	Article							EVOLUTION; ORION; PROTOSTARS; ACCRETION; COLLAPSE; CLUSTER; CORES; GAS	Massive stars (with mass m(*) > 8 solar masses M.) are fundamental to the evolution of galaxies, because they produce heavy elements, inject energy into the interstellar medium, and possibly regulate the star formation rate. The individual star formation time, t(*f), determines the accretion rate of the star; the value of the former quantity is currently uncertain by many orders of magnitude(1-6) , leading to other astrophysical questions. For example, the variation of t(*f) with stellar mass dictates whether massive stars can form simultaneously with low-mass stars in clusters. Here we show that t(*f) is determined by the conditions in the star's natal cloud, and is typically similar to10(5) yr. The corresponding mass accretion rate depends on the pressure within the cloud-which we relate to the gas surface density-and on both the instantaneous and final stellar masses. Characteristic accretion rates are sufficient to overcome radiation pressure from similar to100M. protostars, while simultaneously driving intense bipolar gas outflows. The weak dependence of t(*f) on the final mass of the star allows high- and low-mass star formation to occur nearly simultaneously in clusters.	Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; Princeton Univ Observ, Princeton, NJ 08544 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Princeton University	McKee, CF (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	cmckee@mckee.berkeley.edu						Behrend R, 2001, ASTRON ASTROPHYS, V373, P190, DOI 10.1051/0004-6361:20010585; Bernasconi PA, 1996, ASTRON ASTROPHYS, V307, P829; BERTOLDI F, 1992, ASTROPHYS J, V395, P140, DOI 10.1086/171638; Bonnell IA, 2001, MON NOT R ASTRON SOC, V323, P785, DOI 10.1046/j.1365-8711.2001.04270.x; Crutcher RM, 1999, ASTROPHYS J, V520, P706, DOI 10.1086/307483; Hillenbrand LA, 1998, ASTROPHYS J, V492, P540, DOI 10.1086/305076; Hunter TR, 1998, ASTROPHYS J, V493, pL97, DOI 10.1086/311142; Jijina J, 1996, ASTROPHYS J, V462, P874, DOI 10.1086/177201; Kaufman MJ, 1998, ASTROPHYS J, V497, P276, DOI 10.1086/305444; LARSON RB, 1981, MON NOT R ASTRON SOC, V194, P809, DOI 10.1093/mnras/194.4.809; Matzner CD, 2000, ASTROPHYS J, V545, P364, DOI 10.1086/317785; McLaughlin DE, 1996, ASTROPHYS J, V469, P194, DOI 10.1086/177771; McLaughlin DE, 1997, ASTROPHYS J, V476, P750, DOI 10.1086/303657; Molinari S, 1998, ASTROPHYS J, V505, pL39, DOI 10.1086/311591; Nakano T, 2000, ASTROPHYS J, V534, P976, DOI 10.1086/308765; NAKANO T, 1995, ASTROPHYS J, V450, P183, DOI 10.1086/176130; Osorio M, 1999, ASTROPHYS J, V525, P808, DOI 10.1086/307929; Palla F, 1999, ASTROPHYS J, V525, P772, DOI 10.1086/307928; PALLA F, 1991, ASTROPHYS J, V375, P288, DOI 10.1086/170188; PALLA F, 1992, ASTROPHYS J, V392, P667, DOI 10.1086/171468; Plume R, 1997, ASTROPHYS J, V476, P730, DOI 10.1086/303654; Richer J. S., 2000, Protostars and planets 4, P867; SCHALLER G, 1992, ASTRON ASTROPHYS SUP, V96, P269; SHU FH, 1977, ASTROPHYS J, V214, P488, DOI 10.1086/155274; Stahler S. W., 2000, Protostars and planets 4, P327; STAHLER SW, 1980, ASTROPHYS J, V241, P637, DOI 10.1086/158377; van der Tak FFS, 2000, ASTROPHYS J, V537, P283, DOI 10.1086/309011; VAZQUEZSEMADENI E, 2000, PROTOSTARS PLANETS, V4, P3; WOLFIRE MG, 1987, ASTROPHYS J, V319, P850, DOI 10.1086/165503; Wyrowski F, 1999, ASTROPHYS J, V514, pL43, DOI 10.1086/311934	30	276	278	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 7	2002	416	6876					59	61		10.1038/416059a	http://dx.doi.org/10.1038/416059a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882889	Green Submitted			2022-12-28	WOS:000174211600035
J	Gregory, SR; Cole, TR				Gregory, SR; Cole, TR			The changing role of dissection in medical education	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Univ Texas, Med Branch, Galveston, TX 77550 USA	University of Texas System; University of Texas Medical Branch Galveston	Gregory, SR (corresponding author), Univ Texas, Med Branch, Galveston, TX 77550 USA.							Dyer GSM, 2000, ACAD MED, V75, P969, DOI 10.1097/00001888-200010000-00008; HILL RB, 1988, AUTOPSY MED PRACTICE, P191; Jonsen A.R., 1998, BIRTH BIOETHICS; LIND LR, 1975, PREVESALIAN ANATOMY; LUDMERER KM, 1985, LEARNING HEAL; MALL F, 1904, MICHIGAN ALUMNUS, P395; MARKS SC, 1980, J MED EDUC, V55, P48; Morman ET, 1989, EFFICIENCY SCI MANAG; Nnodim J O, 1996, Clin Anat, V9, P258, DOI 10.1002/(SICI)1098-2353(1996)9:4<258::AID-CA8>3.0.CO;2-A; O'Malley C. D., 1964, A VESALIUS BRUSSELS; PELLEGRINO ED, 1979, HUMANISM PHYSICIAN; Persaud TV, 1984, EARLY HIST HUMAN ANA; ROTHMAN D, 1991, STRANGERS BEDSIDE; SHRYOCK RH, 1974, DEV MODERN MED INTER, P35; Singer, 1957, SHORT HIST ANATOMY G	15	57	59	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2002	287	9					1180	1181		10.1001/jama.287.9.1180	http://dx.doi.org/10.1001/jama.287.9.1180			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527KV	11879120	hybrid			2022-12-28	WOS:000174186000037
J	Wong, TY; Klein, R; Sharrett, AR; Duncan, BB; Couper, DJ; Tielsch, JM; Klein, BEK; Hubbard, LD				Wong, TY; Klein, R; Sharrett, AR; Duncan, BB; Couper, DJ; Tielsch, JM; Klein, BEK; Hubbard, LD			Retinal arteriolar narrowing and risk of coronary heart disease in men and women - The atherosclerosis risk in communities study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MYOCARDIAL-INFARCTION; ANGINA-PECTORIS; ARTERY DISEASE; CHEST PAIN; ANGIOGRAMS; MORTALITY; SEX	Context Microvascular processes have been hypothesized to play a greater role in the development of coronary heart disease (CHD) in women than in men; however, prospective clinical data are limited. Objective To examine the association between retinal arteriolar narrowing, a marker of microvascular damage from hypertension and inflammation, and incident CHD in healthy middle-aged women and men. Design, Setting, and Participants The Atherosclerosis Risk in Communities Study, an ongoing prospective, population-based cohort study in 4 US communities initiated in 1987-1989. Retinal photographs were taken in 9648 women and men aged 51 to 72 years without CHD at the third examination (1993-1995). To quantify retinal arteriolar narrowing, the photographs were digitized, individual arteriolar and venular diameters were measured, and a summary arteriole-to-venule ratio (AVR) was calculated. Main Outcome Measure Risk of CHD associated with retinal arteriolar narrowing. Results During an average 3.5 years of follow-up, 84 women and 187 men experienced incident CHD events. In women, after controlling for mean arterial blood pressure averaged over the previous 6 years, diabetes, cigarette smoking, plasma lipid levels, and other risk factors, each SD decrease in the AVR was associated with an increased risk of any incident CHD (relative risk [RR], 1.37; 95% confidence interval [CI], 1.08-1.72) and of acute myocardial infarction (RR, 1.50; 95% CI, 1.10-2.04). In contrast, AVR was unrelated to any incident CHD in men (RR, 1,00; 95% CI, 0.84-1.18) or to acute myocardial infarction (RR, 1.08; 95% CI, 0.85-1.38). Conclusion Retinal arteriolar narrowing is related to risk of CHD in women but not in men, supporting a more prominent microvascular role in the development of CHD in women than in men. Future work is needed to confirm these findings.	Natl Univ Singapore, Dept Ophthalmol, Singapore 119260, Singapore; Univ Wisconsin, Dept Ophthalmol, Madison, WI USA; NHLBI, Bethesda, MD 20892 USA; Univ Fed Rio Grande Sul, Sch Med, Dept Social Med, Porto Alegre, RS, Brazil; Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; Johns Hopkins Univ, Dept Int Hlth, Baltimore, MD USA	National University of Singapore; University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Universidade Federal do Rio Grande do Sul; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University	Wong, TY (corresponding author), Natl Univ Singapore, Dept Ophthalmol, 10 Kent Ridge Crescent, Singapore 119260, Singapore.		Duncan, Bruce B/L-4140-2016; Wong, Tien Yin/AAC-9724-2020	Duncan, Bruce B/0000-0002-7491-2630; Wong, Tien Yin/0000-0002-8448-1264; Klein, Ronald/0000-0002-4428-6237; Tielsch, James/0000-0002-1151-060X; Couper, David/0000-0002-4313-9235	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055015, N01HC035126, N01HC035125, N01HC055021, N01HC055016, N01HC055019, N01HC055020, N01HC055018, N01HC055022] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, N01-HC-35125, N01-HC-35126, N01-HC-55015, N01-HC-55016] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABBOTT RD, 1988, JAMA-J AM MED ASSOC, V260, P3456, DOI 10.1001/jama.260.23.3456; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; BARRETTCONNOR EL, 1991, JAMA-J AM MED ASSOC, V265, P627, DOI 10.1001/jama.265.5.627; BRUSH JE, 1988, NEW ENGL J MED, V319, P1302, DOI 10.1056/NEJM198811173192002; Buchthal SD, 2000, NEW ENGL J MED, V342, P829, DOI 10.1056/NEJM200003233421201; Burchfiel CM, 1997, ARTERIOSCL THROM VAS, V17, P760, DOI 10.1161/01.ATV.17.4.760; Cannon RO, 2000, NEW ENGL J MED, V342, P885, DOI 10.1056/NEJM200003233421209; CANNON RO, 1992, CIRCULATION, V85, P883, DOI 10.1161/01.CIR.85.3.883; CANNON RO, 1985, AM J CARDIOL, V55, P50; Chilian WM, 1997, CIRCULATION, V95, P522; EGASHIRA K, 1993, NEW ENGL J MED, V328, P1659, DOI 10.1056/NEJM199306103282302; EYSMANN SB, 1992, JAMA-J AM MED ASSOC, V268, P1903, DOI 10.1001/jama.268.14.1903; GILLUM RF, 1991, AM HEART J, V122, P262, DOI 10.1016/0002-8703(91)90796-K; GREENLAND P, 1991, CIRCULATION, V83, P484, DOI 10.1161/01.CIR.83.2.484; Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291; Hochman JS, 1999, NEW ENGL J MED, V341, P226, DOI 10.1056/NEJM199907223410402; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; KARLSON BW, 1994, AM HEART J, V128, P477, DOI 10.1016/0002-8703(94)90620-3; Klein R, 2000, ARTERIOSCL THROM VAS, V20, P1644, DOI 10.1161/01.ATV.20.6.1644; Lekakis JP, 1998, J AM COLL CARDIOL, V31, P541, DOI 10.1016/S0735-1097(97)00542-1; LIKOFF W, 1967, NEW ENGL J MED, V276, P1063, DOI 10.1056/NEJM196705112761904; Liu PP, 1999, AM J CARDIOL, V84, p23L; MARCUS ML, 1990, CIRCULATION, V82, P1, DOI 10.1161/01.CIR.82.1.1; Mehilli J, 2000, JAMA-J AM MED ASSOC, V284, P1799, DOI 10.1001/jama.284.14.1799; MOSSERI M, 1986, CIRCULATION, V74, P964, DOI 10.1161/01.CIR.74.5.964; *NAT HEART LUNG BL, 1988, ATH RISK COMM STUD O; Prineas R., 1982, MINNESOTA CODE MANUA; SAX FL, 1987, NEW ENGL J MED, V317, P1366, DOI 10.1056/NEJM198711263172202; Sharrett AR, 1999, AM J EPIDEMIOL, V150, P263; TANAKA M, 1987, CIRCULATION, V75, P1130, DOI 10.1161/01.CIR.75.6.1130; TSO MOM, 1982, OPHTHALMOLOGY, V89, P1132; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; Wexler LF, 1999, NEW ENGL J MED, V341, P275, DOI 10.1056/NEJM199907223410409; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wong TY, 2001, SURV OPHTHALMOL, V46, P59, DOI 10.1016/S0039-6257(01)00234-X; Wu KC, 1998, CIRCULATION, V97, P765, DOI 10.1161/01.CIR.97.8.765	37	591	611	2	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2002	287	9					1153	1159		10.1001/jama.287.9.1153	http://dx.doi.org/10.1001/jama.287.9.1153			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527KV	11879113	Bronze			2022-12-28	WOS:000174186000031
J	French, A; Masters, E				French, A; Masters, E			Warts from minor trauma	LANCET			English	Editorial Material									Reg Primary Care Inc, Cape Girardeau, MO 63703 USA		Masters, E (corresponding author), Reg Primary Care Inc, Cape Girardeau, MO 63703 USA.							ARCHER CB, 1984, CLIN EXP DERMATOL, V9, P312, DOI 10.1111/j.1365-2230.1984.tb00805.x; Hentges PP, 2001, CUTIS, V67, P299; MILLER DM, 1995, J AM ACAD DERMATOL, V33, P834, DOI 10.1016/0190-9622(95)91844-2; PARKER F, 1985, J AM ACAD DERMATOL, V13, P1, DOI 10.1016/S0190-9622(85)70139-9; Robson KJ, 1998, MED CLIN N AM, V82, P1359, DOI 10.1016/S0025-7125(05)70419-3	5	3	3	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 2	2002	359	9308					760	760		10.1016/S0140-6736(02)07879-0	http://dx.doi.org/10.1016/S0140-6736(02)07879-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526DZ	11888588				2022-12-28	WOS:000174115200012
J	Baldwin, RL				Baldwin, RL			Protein folding - Making a network of hydrophobic clusters	SCIENCE			English	Editorial Material							RESIDUAL STRUCTURE; KINETICS; LYSOZYME		Stanford Univ, Sch Med, Beckman Ctr, Dept Biochem, Stanford, CA 94305 USA	Stanford University	Baldwin, RL (corresponding author), Stanford Univ, Sch Med, Beckman Ctr, Dept Biochem, Stanford, CA 94305 USA.							Akiyama S, 2002, P NATL ACAD SCI USA, V99, P1329, DOI 10.1073/pnas.012458999; Colon W, 1996, BIOCHEMISTRY-US, V35, P5538, DOI 10.1021/bi960052u; DILL KA, 1993, P NATL ACAD SCI USA, V90, P1942, DOI 10.1073/pnas.90.5.1942; Eliezer D, 1998, NAT STRUCT BIOL, V5, P148; Hodsdon ME, 2001, BIOCHEMISTRY-US, V40, P732, DOI 10.1021/bi001518i; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680; NERI D, 1992, SCIENCE, V257, P1559, DOI 10.1126/science.1523410; RADFORD SE, 1992, NATURE, V358, P302, DOI 10.1038/358302a0; Rothwarf DM, 1996, BIOCHEMISTRY-US, V35, P13797, DOI 10.1021/bi9608119; SaabRincon G, 1996, BIOCHEMISTRY-US, V35, P1988, DOI 10.1021/bi951726o; Shortle D, 2002, PROTEIN SCI, V11, P18, DOI 10.1110/ps.ps.31002; Shortle D, 2001, SCIENCE, V293, P487, DOI 10.1126/science.1060438; Srinivasan R, 1999, P NATL ACAD SCI USA, V96, P14258, DOI 10.1073/pnas.96.25.14258; Ueda T, 1996, BIOCHEM BIOPH RES CO, V228, P203, DOI 10.1006/bbrc.1996.1640; Zdanowski K, 1999, J MOL BIOL, V287, P433, DOI 10.1006/jmbi.1999.2622	16	79	81	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 1	2002	295	5560					1657	1658		10.1126/science.1069893	http://dx.doi.org/10.1126/science.1069893			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872825				2022-12-28	WOS:000174212900029
J	Bolton, SJ; Janssen, M; Thorne, R; Levin, S; Klein, M; Gulkis, S; Bastian, T; Sault, R; Elachi, C; Hofstadter, M; Bunker, A; Dulk, G; Gudim, E; Hamilton, G; Johnson, WTK; Leblanc, Y; Liepack, O; McLeod, R; Roller, J; Roth, L; West, R				Bolton, SJ; Janssen, M; Thorne, R; Levin, S; Klein, M; Gulkis, S; Bastian, T; Sault, R; Elachi, C; Hofstadter, M; Bunker, A; Dulk, G; Gudim, E; Hamilton, G; Johnson, WTK; Leblanc, Y; Liepack, O; McLeod, R; Roller, J; Roth, L; West, R			Ultra-relativistic electrons in Jupiter's radiation belts	NATURE			English	Article							SYNCHROTRON-RADIATION; CHARGED-PARTICLES; MAGNETOSPHERE; ENERGIZATION; DIFFUSION; SIMULATION	Ground-based observations have shown that Jupiter is a two-component source of microwave radio emission(1): thermal atmospheric emission and synchrotron emission(2) from energetic electrons spiralling in Jupiter's magnetic field. Later in situ measurements(3,4) confirmed the existence of Jupiter's high-energy electron-radiation belts, with evidence for electrons at energies up to 20 MeV. Although most radiation belt models predict electrons at higher energies(5,6), adiabatic diffusion theory can account only for energies up to around 20 MeV. Unambiguous evidence for more energetic electrons is lacking. Here we report observations of 13.8 GHz synchrotron emission that confirm the presence of electrons with energies up to 50 MeV; the data were collected during the Cassini fly-by of Jupiter. These energetic electrons may be repeatedly accelerated through an interaction with plasma waves, which can transfer energy into the electrons. Preliminary comparison of our data with model results suggests that electrons with energies of less than 20 MeV are more numerous than previously believed.	CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Calif Los Angeles, Dept Atmospher Sci, Los Angeles, CA 90024 USA; Natl Radio Astron Observ, Charlottesville, VA 24944 USA; Australia Telescope Natl Facil, Epping, NSW 1710, Australia; Observ Paris, Dept Space Res, F-92195 Meudon, France; Lewis Ctr Educ Res, Apple Valley, CA 92307 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California Los Angeles; National Radio Astronomy Observatory (NRAO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris	Bolton, SJ (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.		Bolton, Scott/M-4392-2019; Hofstadter, Mark/AAO-8401-2021	Hofstadter, Mark/0000-0002-3208-3918; Levin, Steven/0000-0003-2242-5459; bolton, scott/0000-0002-9115-0789				Berge G.L., 1976, JUPITER, P621; Bird MK, 1996, ICARUS, V121, P450, DOI 10.1006/icar.1996.0100; Bolton SJ, 2001, GEOPHYS RES LETT, V28, P907, DOI 10.1029/2000GL012071; BOLTON SJ, 1989, J GEOPHYS RES, V94, P121, DOI 10.1029/JA094iA01p00121; BOLTON SJ, 1995, GEOPHYS RES LETT, V22, P13; BURKE FB, 1955, J GEOPHYS RES, V60, P213; Carlson CW, 1998, GEOPHYS RES LETT, V25, P2017, DOI 10.1029/98GL00851; CORONITI FV, 1975, MAGNETOSPHERES EARTH, P391; DEPATER I, 1990, J GEOPHYS RES-SPACE, V95, P39, DOI 10.1029/JA095iA01p00039; DIVINE N, 1983, J GEOPHYS RES-SPACE, V88, P6889, DOI 10.1029/JA088iA09p06889; ELACHI C, IN PRESS SPACE SCI R; Fischer HM, 1996, SCIENCE, V272, P856, DOI 10.1126/science.272.5263.856; FUJIMOTO M, 1990, J GEOPHYS RES-SPACE, V95, P3841, DOI 10.1029/JA095iA04p03841; Galopeau PHM, 1997, PLANET SPACE SCI, V45, P1197, DOI 10.1016/S0032-0633(97)00032-9; GOERTZ CK, 1978, J GEOPHYS RES-SPACE, V83, P3145, DOI 10.1029/JA083iA07p03145; Klein M. J., 1996, PLANETARY RADIO EMIS, P217; Klein M. J., 1989, NASA SP, V494, P151; Levin SM, 2001, GEOPHYS RES LETT, V28, P903, DOI 10.1029/2000GL012087; LI XL, 1993, GEOPHYS RES LETT, V20, P2423, DOI 10.1029/93GL02701; Miyoshi Y, 1999, GEOPHYS RES LETT, V26, P9, DOI 10.1029/1998GL900244; NISHIDA A, 1976, J GEOPHYS RES-SPACE, V81, P1771, DOI 10.1029/JA081i010p01771; SENTMAN DD, 1975, GEOPHYS RES LETT, V2, P465, DOI 10.1029/GL002i010p00465; Summers D, 1998, J GEOPHYS RES-SPACE, V103, P20487, DOI 10.1029/98JA01740; Summers D, 2001, J GEOPHYS RES-SPACE, V106, P10853, DOI 10.1029/2000JA000309; VANALLEN JA, 1975, SCIENCE, V188, P459, DOI 10.1126/science.188.4187.459	25	101	102	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2002	415	6875					987	991		10.1038/415987a	http://dx.doi.org/10.1038/415987a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875557	Bronze			2022-12-28	WOS:000174075000033
J	Braddock, DT; Louis, JM; Baber, JL; Levens, D; Clore, GM				Braddock, DT; Louis, JM; Baber, JL; Levens, D; Clore, GM			Structure and dynamics of KH domains from FBP bound to single-stranded DNA	NATURE			English	Article							RESIDUAL DIPOLAR COUPLINGS; FAR UPSTREAM ELEMENT; C-MYC; STRUCTURE REFINEMENT; INTERDOMAIN MOTION; RNA-BINDING; RELAXATION; COMPLEXES; PROTEINS; TFIIH	Gene regulation can be tightly controlled by recognition of DNA deformations that are induced by stress generated during transcription(1-3). The KH domains of the FUSE-binding protein (FBP), a regulator of c-myc expression(1,4), bind in vivo and in vitro to the single-stranded far-upstream element (FUSE), 1,500 base pairs upstream from the c-myc promoter(4-6). FBP bound to FUSE acts through TFIIH at the promoter(4). Here we report the solution structure of a complex between the KH3 and KH4 domains of FBP and a 29-base single-stranded DNA from FUSE. The KH domains recognize two sites, 9-10 bases in length, separated by 5 bases, with KH4 bound to the 5' site and KH3 to the 3' site. The central portion of each site comprises a tetrad of sequence 5'd-ATTC for KH4 and 5'd-TTTT for KH3. Dynamics measurements show that the two KH domains bind as articulated modules to single-stranded DNA, providing a flexible framework with which to recognize transient, moving targets.	NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Clore, GM (corresponding author), NIDDKD, Chem Phys Lab, NIH, Bldg 2, Bethesda, MD 20892 USA.	clore@speck.niddk.nih.gov	Clore, G. Marius/A-3511-2008; Levens, David/C-9216-2009; Clore, G Marius/L-2546-2018	Clore, G. Marius/0000-0003-3809-1027; Levens, David/0000-0002-7616-922X; Clore, G Marius/0000-0003-3809-1027; Louis, John M/0000-0002-0052-1899	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029023, Z01DK029023] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AVIGAN MI, 1990, J BIOL CHEM, V265, P18538; Baber JL, 2001, J AM CHEM SOC, V123, P3953, DOI 10.1021/ja0041876; Baber JL, 1999, J MOL BIOL, V289, P949, DOI 10.1006/jmbi.1999.2818; Braddock DT, 2001, J AM CHEM SOC, V123, P8634, DOI 10.1021/ja016234f; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; CANTOR CR, 1980, BIOPHYSICAL CHEM 2, P564; CANTOR CR, 1980, BIOPHYSICAL CHEM 3, P1008; Clore GM, 1998, J MAGN RESON, V131, P159, DOI 10.1006/jmre.1997.1345; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Clore GM, 1998, J AM CHEM SOC, V120, P10571, DOI 10.1021/ja982592f; Clore GM, 1998, P NATL ACAD SCI USA, V95, P5891, DOI 10.1073/pnas.95.11.5891; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DUNCAN R, 1994, GENE DEV, V8, P465, DOI 10.1101/gad.8.4.465; GORENSTEIN DG, 1994, CHEM REV, V94, P1315, DOI 10.1021/cr00029a007; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; He LS, 2000, EMBO J, V19, P1034, DOI 10.1093/emboj/19.5.1034; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Liu JH, 2000, MOL CELL, V5, P331, DOI 10.1016/S1097-2765(00)80428-1; Liu JH, 2001, CELL, V104, P353, DOI 10.1016/S0092-8674(01)00223-9; Michelotti EF, 1997, NATURE, V388, P895, DOI 10.1038/42282; Michelotti GA, 1996, MOL CELL BIOL, V16, P2656, DOI 10.1128/mcb.16.6.2656; Musco G, 1996, CELL, V85, P237, DOI 10.1016/S0092-8674(00)81100-9; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Rothman-Denes LB, 1998, COLD SPRING HARB SYM, V63, P63, DOI 10.1101/sqb.1998.63.63; Saenger W., 1984, PRINCIPLES NUCL ACID; Schwieters CD, 2001, J MAGN RESON, V152, P288, DOI 10.1006/jmre.2001.2413; Schwieters CD, 2001, J MAGN RESON, V149, P239, DOI 10.1006/jmre.2001.2300	31	143	148	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2002	415	6875					1051	1056		10.1038/4151051a	http://dx.doi.org/10.1038/4151051a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875576	Green Published			2022-12-28	WOS:000174075000052
J	Cervelli, P; Segall, P; Johnson, K; Lisowski, M; Miklius, A				Cervelli, P; Segall, P; Johnson, K; Lisowski, M; Miklius, A			Sudden aseismic fault slip on the south flank of Kilauea volcano	NATURE			English	Article							GLOBAL POSITIONING SYSTEM; RAPID DEFORMATION; MAUNA-LOA; HAWAII; EARTHQUAKE; BENEATH	One of the greatest hazards associated with oceanic volcanoes is not volcanic in nature, but lies with the potential for catastrophic flank failure(1,2). Such flank failure can result in devastating tsunamis and threaten not only the immediate vicinity, but coastal cities along the entire rim of an ocean basin(3). Kilauea volcano on the island of Hawaii, USA, is a potential source of such flank failures(3,4) and has therefore been monitored by a network of continuously recording geodetic instruments, including global positioning system (GPS) receivers, tilt meters and strain meters. Here we report that, in early November 2000, this network recorded transient southeastward displacements, which we interpret as an episode of aseismic fault slip. The duration of the event was about 36 hours, it had an equivalent moment magnitude of 5.7 and a maximum slip velocity of about 6 cm per day. Inversion of the GPS data reveals a shallow-dipping thrust fault at a depth of 4.5 km that we interpret as the down-dip extension of the Hilina Pali-Holei Pali normal fault system. This demonstrates that continuously recording geodetic networks can detect accelerating slip, potentially leading to warnings of volcanic flank collapse.	Stanford Univ, Dept Geophys, Stanford, CA 94305 USA; US Geol Survey, Hawaiian Volcano Observ, Hawaii Natl Pk, HI 96718 USA; US Geol Survey, Cascades Volcano Observ, Vancouver, WA 98661 USA	Stanford University; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Cervelli, P (corresponding author), Stanford Univ, Dept Geophys, Mitchell Bldg, Stanford, CA 94305 USA.	cervelli@sumo.wr.usgs.gov		Cervelli, Peter/0000-0001-6765-1009				AKI K, 1970, QUANTITATIVE SEISMOL; CANNON EC, IN PRESS B SEISMOL S; Cervelli P, 2001, J GEOPHYS RES-SOL EA, V106, P11217, DOI 10.1029/2000JB900399; DAVID C, 1994, PURE APPL GEOPHYS, V143, P425, DOI 10.1007/BF00874337; DELANEY PT, 1993, J GEOPHYS RES-SOL EA, V98, P17801, DOI 10.1029/93JB01819; DIETERICH JH, 1988, J GEOPHYS RES-SOLID, V93, P4258, DOI 10.1029/JB093iB05p04258; Dragert H, 2001, SCIENCE, V292, P1525, DOI 10.1126/science.1060152; Du YJ, 1997, GEOPHYS RES LETT, V24, P2347, DOI 10.1029/97GL02341; DVORAK JJ, 1994, B SEISMOL SOC AM, V84, P133; Efron B., 1994, MONOGRAPHS STAT APPL; Elosegui P, 1996, J GEOPHYS RES-SOL EA, V101, P11249, DOI 10.1029/96JB00327; HOFMANNWELLENHO.B, 1994, GPS THEORY PRACTICE; Ingebritsen S. E., 1993, Geothermics, V22, P255, DOI 10.1016/0375-6505(93)90003-6; Larson KM, 2001, J GEOPHYS RES-SOL EA, V106, P19453, DOI 10.1029/2001JB000305; LICHTEN SM, 1987, J GEOPHYS RES-SOLID, V92, P12751, DOI 10.1029/JB092iB12p12751; Linde AT, 1996, NATURE, V383, P65, DOI 10.1038/383065a0; LIPMAN PW, 1988, J GEOPHYS RES-SOLID, V93, P4279, DOI 10.1029/JB093iB05p04279; McGuire WJ, 1996, GEOL SOC SP, P1, DOI 10.1144/GSL.SP.1996.110.01.01; MOORE JG, 1989, J GEOPHYS RES-SOLID, V94, P17465, DOI 10.1029/JB094iB12p17465; Morgan JK, 2000, GEOLOGY, V28, P667, DOI 10.1130/0091-7613(2000)28<667:OASAAK>2.0.CO;2; Nakamura K., 1980, B VOLCANOL SOC JAPAN, V25, P255; Okubo PG, 1997, GEOLOGY, V25, P867, DOI 10.1130/0091-7613(1997)025<0867:ITCMSB>2.3.CO;2; OWEN S, 1995, SCIENCE, V267, P1328, DOI 10.1126/science.267.5202.1328; Owen S, 2000, J GEOPHYS RES-SOL EA, V105, P18983, DOI 10.1029/2000JB900109; Stein RS, 1999, NATURE, V402, P605, DOI 10.1038/45144; Swanson D.A., 1976, US GEOL SURV PROF PA, V963, P1; THURBER CH, 1988, J GEOPHYS RES-SOLID, V93, P4271, DOI 10.1029/JB093iB05p04271; Ward SN, 2001, J GEOPHYS RES-SOL EA, V106, P11201, DOI 10.1029/2000JB900450; WARD SN, 1985, TECTONOPHYSICS, V120, P83, DOI 10.1016/0040-1951(85)90088-5	29	115	116	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2002	415	6875					1014	1018		10.1038/4151014a	http://dx.doi.org/10.1038/4151014a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875566				2022-12-28	WOS:000174075000042
J	Galant, R; Carroll, SB				Galant, R; Carroll, SB			Evolution of a transcriptional repression domain in an insect Hox protein	NATURE			English	Article							FUNCTIONAL EQUIVALENCE; GENE-EXPRESSION; HOMEOTIC GENES; DNA-BINDING; EXTRADENTICLE; ULTRABITHORAX	Homeotic (Hox) genes code for principal transcriptional regulators of animal body regionalization(1). The duplication and divergence of Hox genes, changes in their regulation, and changes in the regulation of Hox target genes have all been implicated in the evolution of animal diversity(2-4). It is not known whether Hox proteins have also acquired new activities during the evolution of specific lineages. Amino-acid sequences outside the DNA-binding homeodomains of Hox orthologues diverge significantly. These sequence differences may be neutral with respect to protein function, or they could be involved in the functional divergence of Hox proteins and the evolutionary diversification of animals. Here, we identify a transcriptional repression domain in the carboxy-terminal region of the Drosophila Ultrabithorax (Ubx) protein. This domain is highly conserved among Ubx orthologues in other insects, but is absent from Ubx in other arthropods and onychophorans. The evolution of this domain may have facilitated the greater morphological diversification of posterior thoracic and anterior abdominal segments characteristic of modern insects.	Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Carroll, SB (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, 1525 Linden Dr, Madison, WI 53706 USA.	sbcarrol@facstgaff.wisc.edu						Alonso CR, 2001, CURR BIOL, V11, P1473, DOI 10.1016/S0960-9822(01)00425-0; BACHILLER D, 1994, EMBO J, V13, P1930, DOI 10.1002/j.1460-2075.1994.tb06462.x; Bennett RL, 1999, DEV GENES EVOL, V209, P608, DOI 10.1007/s004270050295; BRAND AH, 1993, DEVELOPMENT, V118, P401; Carroll S. B., 2001, DNA DIVERSITY MOL GE; CARROLL SB, 1995, NATURE, V376, P479, DOI 10.1038/376479a0; CASTELLIGAIR J, 1994, DEVELOPMENT, V120, P1983; CHANG CP, 1995, GENE DEV, V9, P663, DOI 10.1101/gad.9.6.663; DALTON S, 1992, CELL, V68, P597, DOI 10.1016/0092-8674(92)90194-H; Dearden P, 1999, CURR BIOL, V9, pR591, DOI 10.1016/S0960-9822(99)80381-9; Gellon G, 1998, BIOESSAYS, V20, P116, DOI 10.1002/(SICI)1521-1878(199802)20:2<116::AID-BIES4>3.3.CO;2-N; Gibson G, 2000, CURR BIOL, V10, pR452, DOI 10.1016/S0960-9822(00)00531-5; Greer JM, 2000, NATURE, V403, P661, DOI 10.1038/35001077; Grenier JK, 2000, P NATL ACAD SCI USA, V97, P704, DOI 10.1073/pnas.97.2.704; HannaRose W, 1996, TRENDS GENET, V12, P229, DOI 10.1016/0168-9525(96)10022-6; Janody F, 2001, DEVELOPMENT, V128, P2281; JOHNSON FB, 1995, P NATL ACAD SCI USA, V92, P739, DOI 10.1073/pnas.92.3.739; KELSH R, 1994, DEV GENET, V15, P19, DOI 10.1002/dvg.1020150104; Lohr U, 2001, CURR BIOL, V11, P1403, DOI 10.1016/S0960-9822(01)00443-2; MANAK JR, 1994, DEVELOPMENT, V120, P3605; MCGINNIS N, 1990, CELL, V63, P969, DOI 10.1016/0092-8674(90)90500-E; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; RAUSKOLB C, 1994, EMBO J, V13, P3561, DOI 10.1002/j.1460-2075.1994.tb06663.x; RONSHAUGEN M, 2002, NATURE          0202; VACHON G, 1992, CELL, V71, P437, DOI 10.1016/0092-8674(92)90513-C; VANDIJK MA, 1994, CELL, V78, P617, DOI 10.1016/0092-8674(94)90526-6; White RAH, 2000, MECH DEVELOP, V91, P217, DOI 10.1016/S0925-4773(99)00306-8; Yeung K, 1997, MOL CELL BIOL, V17, P36, DOI 10.1128/MCB.17.1.36; Zakany J, 1996, DEV BIOL, V176, P325, DOI 10.1006/dbio.1996.0137; ZHAO JJ, 1993, GENE DEV, V7, P343, DOI 10.1101/gad.7.3.343	30	251	262	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2002	415	6874					910	913		10.1038/nature717	http://dx.doi.org/10.1038/nature717			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859369				2022-12-28	WOS:000173941000045
J	Pascual, M; Theruvath, T; Kawai, T; Tolkoff-Rubin, N; Cosimi, AB				Pascual, M; Theruvath, T; Kawai, T; Tolkoff-Rubin, N; Cosimi, AB			Medical progress - Strategies to improve long-term outcomes after renal transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							DELAYED GRAFT FUNCTION; DONOR BONE-MARROW; CHRONIC ALLOGRAFT NEPHROPATHY; TRIAL COMPARING TACROLIMUS; ACUTE HUMORAL REJECTION; MYCOPHENOLATE-MOFETIL; STEROID WITHDRAWAL; RANDOMIZED-TRIAL; DOUBLE-BLIND; CYCLOSPORINE		Massachusetts Gen Hosp, Renal Unit, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Transplantat Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Pascual, M (corresponding author), Massachusetts Gen Hosp, Renal Unit, Dept Med, Box MZ 70, Boston, MA 02114 USA.	mpascual@partners.org		Pascual, Manuel A./0000-0001-7747-1693	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037692, R21AI037692] Funding Source: NIH RePORTER; NHLBI NIH HHS [P0I-HL 18646] Funding Source: Medline; NIAID NIH HHS [R01 AI037692, R21 AI037692, R21 AI037692-06, R01 AI037692-09] Funding Source: Medline; PHS HHS [R01 A 137692-05] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abe M, 1997, TRANSPLANTATION, V63, P1616, DOI 10.1097/00007890-199706150-00014; Ahsan N, 1999, TRANSPLANTATION, V68, P1865; ALMOND PS, 1993, TRANSPLANTATION, V55, P752, DOI 10.1097/00007890-199304000-00013; Amuchastegui SC, 1998, J AM SOC NEPHROL, V9, P1948; Arnadottir M, 1997, TRANSPLANTATION, V63, P339, DOI 10.1097/00007890-199702150-00002; Arnadottir M, 1996, TRANSPLANTATION, V61, P509, DOI 10.1097/00007890-199602150-00034; AZUMA H, 1995, TRANSPLANTATION, V59, P460; BARBER WH, 1991, TRANSPLANTATION, V51, P70, DOI 10.1097/00007890-199101000-00011; Behrend M, 1999, TRANSPLANTATION, V68, P391; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; Calne R, 1999, TRANSPLANTATION, V68, P1613, DOI 10.1097/00007890-199911270-00032; Cantarovich D, 2000, TRANSPLANTATION, V69, P1505, DOI 10.1097/00007890-200004150-00051; Cho S, 1999, AM J KIDNEY DIS, V34, P296; Ciancio G, 2001, TRANSPLANTATION, V71, P827, DOI 10.1097/00007890-200104150-00002; Colvin RB, 1996, KIDNEY INT, V50, P1069, DOI 10.1038/ki.1996.410; Corry RJ, 1999, ANN SURG, V230, P372, DOI 10.1097/00000658-199909000-00010; COSIMI AB, 1981, NEW ENGL J MED, V305, P308, DOI 10.1056/NEJM198108063050603; Crespo M, 2001, TRANSPLANTATION, V71, P652, DOI 10.1097/00007890-200103150-00013; Danovitch G, 1996, TRANSPLANTATION, V61, P722; DAVENPORT A, 1994, NEPHROL DIAL TRANSPL, V9, P1315; del Castillo D., 1999, Journal of the American Society of Nephrology, V10, p726A; Denton MD, 1999, LANCET, V353, P1083, DOI 10.1016/S0140-6736(98)07493-5; Dunn B, 1999, SURGERY, V125, P155; Fishman JA, 1998, NEW ENGL J MED, V338, P1741, DOI 10.1056/NEJM199806113382407; Gaber AO, 1998, TRANSPLANTATION, V66, P29, DOI 10.1097/00007890-199807150-00005; Gauthier P, 2000, J AM SOC NEPHROL, V11, P1933, DOI 10.1681/ASN.V11101933; Gjertson DW, 2000, KIDNEY INT, V58, P491, DOI 10.1046/j.1523-1755.2000.00195.x; Gregoor PJHS, 2000, TRANSPLANTATION, V70, P143; Grinyo JM, 1997, TRANSPLANTATION, V63, P1688, DOI 10.1097/00007890-199706150-00026; Groth CG, 1999, TRANSPLANTATION, V67, P1036, DOI 10.1097/00007890-199904150-00017; Halloran P, 1997, TRANSPLANTATION, V63, P39, DOI 10.1097/00007890-199701150-00008; Halloran PF, 2000, LANCET, V356, P179, DOI 10.1016/S0140-6736(00)02473-9; Halloran PF, 1999, J AM SOC NEPHROL, V10, P167; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; HELDERMAN JH, 1994, J AM SOC NEPHROL, V4, pS2; HELG C, 1994, TRANSPLANTATION, V58, P1420; HOLLANDER AAMJ, 1995, LANCET, V345, P610, DOI 10.1016/S0140-6736(95)90520-0; Hong JC, 2001, TRANSPLANTATION, V71, P1320, DOI 10.1097/00007890-200105150-00025; HRICIK DE, 1994, TRANSPLANTATION, V57, P979, DOI 10.1097/00007890-199404150-00001; Humar A, 2000, TRANSPLANTATION, V69, P1942, DOI 10.1097/00007890-200005150-00033; ILDSTAD ST, 1984, NATURE, V307, P168, DOI 10.1038/307168a0; JEANNET M, 1970, NEW ENGL J MED, V282, P111, DOI 10.1056/NEJM197001152820301; Jordan ML, 1997, TRANSPLANTATION, V63, P223, DOI 10.1097/00007890-199701270-00008; Kahan BD, 2000, LANCET, V356, P194, DOI 10.1016/S0140-6736(00)02480-6; Kasiske BL, 2000, J AM SOC NEPHROL, V11, P1910, DOI 10.1681/ASN.V11101910; Kasiske BL, 2000, J AM SOC NEPHROL, V11, P1735, DOI 10.1681/ASN.V1191735; Kawai T, 1999, TRANSPLANTATION, V68, P1767, DOI 10.1097/00007890-199912150-00022; Kawai T, 1999, CURR OPIN IMMUNOL, V11, P516, DOI 10.1016/S0952-7915(99)00009-6; KELLY PA, 1999, GRAFT, V2, P189; KEW CE, 2000, GRAFT, V3, P172; Kirk AD, 1997, P NATL ACAD SCI USA, V94, P8789, DOI 10.1073/pnas.94.16.8789; Knechtle SJ, 1999, TRANSPLANT P, V31, p27S, DOI 10.1016/S0041-1345(99)00100-1; Kobashigawa JA, 1997, TRANSPLANTATION, V63, P331, DOI 10.1097/00007890-199702150-00001; Kreis H, 2000, TRANSPLANTATION, V69, P1252, DOI 10.1097/00007890-200004150-00009; Li BG, 2001, NEW ENGL J MED, V344, P947, DOI 10.1056/NEJM200103293441301; MASSY ZA, 1995, KIDNEY INT, V48, pS85; Mathew TH, 1998, TRANSPLANTATION, V65, P1450, DOI 10.1097/00007890-199806150-00007; Matthew TH, 1998, TRANSPLANTATION, V66, P817; Mauiyyedi S, 2001, J AM SOC NEPHROL, V12, P574, DOI 10.1681/ASN.V123574; Mayer AD, 1997, TRANSPLANTATION, V64, P436, DOI 10.1097/00007890-199708150-00012; McAlister VC, 2000, LANCET, V355, P376, DOI 10.1016/S0140-6736(99)03882-9; McCune TR, 1998, TRANSPLANTATION, V65, P87, DOI 10.1097/00007890-199801150-00017; Miller J, 2000, TRANSPLANTATION, V69, P875; Monaco AP, 1999, AM J KIDNEY DIS, V33, P150, DOI 10.1016/S0272-6386(99)70273-8; Morris PJ, 1999, TRANSPLANTATION, P285; MORRIS RE, 1991, TRANSPL P, V23, P521; Nashan B, 1997, LANCET, V350, P1193, DOI 10.1016/S0140-6736(97)09278-7; Ojo AO, 2000, KIDNEY INT, V57, P307, DOI 10.1046/j.1523-1755.2000.00816.x; Ojo AO, 2000, TRANSPLANTATION, V69, P2405, DOI 10.1097/00007890-200006150-00033; Opelz G, 1998, KIDNEY INT, V53, P217, DOI 10.1046/j.1523-1755.1998.00744.x; Pascual M, 1998, TRANSPLANTATION, V66, P1460, DOI 10.1097/00007890-199812150-00008; Pascual M, 1999, TRANSPLANTATION, V67, P495; Pascual M, 1998, IMMUNOL TODAY, V19, P514, DOI 10.1016/S0167-5699(98)01324-3; PAUL LC, 1999, GRAFT, V2, P146; Pirsch JD, 1997, TRANSPLANTATION, V63, P977, DOI 10.1097/00007890-199704150-00013; Prommool S, 2000, J AM SOC NEPHROL, V11, P565, DOI 10.1681/ASN.V113565; Ratcliffe PJ, 1996, LANCET, V348, P643, DOI 10.1016/S0140-6736(96)02510-X; Remuzzi G, 1998, J AM SOC NEPHROL, V9, P1321; SAYEGH MH, 1991, ANN INTERN MED, V114, P954, DOI 10.7326/0003-4819-114-11-954; Sayegh MH, 1999, KIDNEY INT, V56, P1967, DOI 10.1046/j.1523-1755.1999.00751.x; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; SHAPIRO R, 2000, GRAFT, V3, P64; Shoskes DA, 1998, TRANSPLANTATION, V66, P1697, DOI 10.1097/00007890-199812270-00022; Shoskes DA, 1996, J UROLOGY, V155, P1831, DOI 10.1016/S0022-5347(01)66023-3; Solez K, 1998, TRANSPLANTATION, V66, P1736, DOI 10.1097/00007890-199812270-00029; Southard JH, 1999, TRANSPLANTATION, P271; Spitzer TR, 1999, TRANSPLANTATION, V68, P480, DOI 10.1097/00007890-199908270-00006; SUTHANTHIRAN M, 1994, NEW ENGL J MED, V331, P365, DOI 10.1056/NEJM199408113310606; Suthanthiran M, 1996, AM J KIDNEY DIS, V28, P159, DOI 10.1016/S0272-6386(96)90297-8; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; THOMAS JM, 1994, TRANSPLANTATION, V57, P101, DOI 10.1097/00007890-199401000-00018; Tran HTB, 2000, J AM SOC NEPHROL, V11, P1903, DOI 10.1681/ASN.V11101903; TROPPMANN C, 1995, TRANSPLANTATION, V59, P962, DOI 10.1097/00007890-199504150-00007; Vincenti F, 1998, NEW ENGL J MED, V338, P161, DOI 10.1056/NEJM199801153380304; VINCENTI F, 1999, GRAFT, V2, P56; Weir MR, 1997, TRANSPLANTATION, V64, P1706, DOI 10.1097/00007890-199712270-00013; Wekerle T, 1999, TRANSPLANTATION, V68, P459, DOI 10.1097/00007890-199908270-00001; Wenke K, 1997, CIRCULATION, V96, P1398, DOI 10.1161/01.CIR.96.5.1398; West M, 1996, TRANSPLANTATION, V62, P1029, DOI 10.1097/00007890-199610150-00025; Wheeler DC, 2000, TRANSPLANTATION, V70, pSS41; Wissing KM, 2000, TRANSPLANTATION, V70, P464, DOI 10.1097/00007890-200008150-00012	101	657	710	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2002	346	8					580	590		10.1056/NEJMra011295	http://dx.doi.org/10.1056/NEJMra011295			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	522ZK	11856798				2022-12-28	WOS:000173926700007
J	Rosenbaum, S				Rosenbaum, S			Medicaid	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		BEACH WW, 1996, COST STATES NOT FUND; *C BUDG OFF, 2001, BUDG EC OUTL 2002 20; *C RES SERV, 1990, MED SOURC BOOK BACKG; *CTR HLTH CAR STRA, 2001, FAC MED COMPL CAR PE; Davis K, 1978, HLTH WAR POVERTY 10; DUBAY L, 1999, EXPANSIONS PUBLIC HL; Feder J, 2001, HEALTH AFFAIR, V20, P27, DOI 10.1377/hlthaff.20.1.27; HEFFLER S, 1999, HLTH AFF MILLWOOD, V209, P193; *HJ KAIS FAM FDN, 2001, DAIL HLTH POL REP WA; *HLTH CAR FIN ADM, 2001, HLTH INS FLEX ACC DE; HOFFMAN C, 2000, UNINSURED AM CHART B; HOLAHAN J, 2001, RESTRUCTURING MEDICA; *KAIS COMM MED UN, 2001, MED MAND OPT EL BEN; *KAIS COMM MED UN, 2001, MED PRIM; *KAIS COMM MED UN, 2001, MED PROGR GLANC; Lewin ME, 2000, AM HLTH CARE SAFETY; *MILB MEM FUND NAT, 2001, REF STAT GROUP 1998; *NAT GOV ASS, 2001, POL POS STAT HR 16 M; PERKINS J, 2000, ST LOUIS U LAW REV, V45, P117; Rosenbaum S, 1998, HEALTH AFFAIR, V17, P75, DOI 10.1377/hlthaff.17.1.75; ROSENBAUM S, 1999, ACCESS HLTH CARE PRO, P179; ROSENBLATT R, 1997, LAW AM HLTH CARE SYS; ROSENBLATT RE, 2001, LAW AM HLTH CARE SYS; ROWLAND D, 2001, HLTH INSURANCE UNEMP; RUSSAKOFF D, 2001, WASHINGTON POST 1126, pA2; SCHNEIDER A, 1999, MEDICAID ELIGIBILITY; SCHNEIDER A, 1998, MED ELIGIBILITY FAMI; *US CENS BUR, 2001, 2001 POV EST; *US HR, 1998, GREEN BOOK; WELCH WP, 1995, HEALTH AFFAIR, V14, P212, DOI 10.1377/hlthaff.14.2.212; WESTMORELAND T, 1999, MEDICAID HIV AIDS PO; WESTMORELAND T, 2001, COMMUNICATION   0104	32	62	62	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2002	346	8					635	640		10.1056/NEJM200202213460825	http://dx.doi.org/10.1056/NEJM200202213460825			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	522ZK	11856811				2022-12-28	WOS:000173926700034
J	Peters, NS; Schilling, RJ; Kanagaratnam, P; Markides, V				Peters, NS; Schilling, RJ; Kanagaratnam, P; Markides, V			Atrial fibrillation: strategies to control, combat, and cure	LANCET			English	Review							ENERGY INTRACARDIAC CARDIOVERSION; HEART-RATE CONTROL; QUALITY-OF-LIFE; SINUS RHYTHM; VENTRICULAR RATE; DOUBLE-BLIND; ELECTROPHYSIOLOGICAL CHARACTERISTICS; RADIOFREQUENCY ABLATION; NATURAL-HISTORY; FOLLOW-UP	Atrial fibrillation is the commonest clinical arrhythmia, is increasing in incidence and prevalence, and is associated with substantial morbidity and mortality. The arrhythmia may be paroxysmal (self-limiting), persistent (amenable to cardioversion), or permanent. Especially in its paroxysmal form, atrial fibrillation may be initiated by rapidly firing foci, generally located in the proximal pulmonary veins. Sustained atrial fibrillation is maintained by an atrial tissue substrate capable of accommodating many meandering wavelets. With continuing arrhythmia, the electrophysiological properties of the atria change and further facilitate continuing fibrillation. Treatment is aimed at prevention of thromboembolic complications, restoration and maintenance of sinus rhythm, and control of ventricular rate during atrial fibrillation. With greater understanding of the arrhythmia mechanisms, it is becoming possible to offer targeted curative treatments to more and more patients.	St Marys Hosp, Waller Cardiac Dept, London W2 1NY, England; Imperial Coll Sch Med, London, England	Imperial College London; Imperial College London	Peters, NS (corresponding author), St Marys Hosp, Waller Cardiac Dept, S Wharf Rd, London W2 1NY, England.	n.peters@ic.ac.uk						AHUJA RC, 1989, INT J CARDIOL, V25, P325, DOI 10.1016/0167-5273(89)90223-4; ALBERS GW, 2001, STROKE, V119, pS194; Aliot E, 1996, AM J CARDIOL, V77, pA66; ALLESSIE M, 1982, ATRIAL FIBRILLATION, P44; ALLESSIE MA, 1977, CIRC RES, V41, P9, DOI 10.1161/01.RES.41.1.9; ANDERSON DC, 1992, ANN INTERN MED, V116, P1, DOI 10.7326/0003-4819-116-1-1; Anderson DC, 1998, JAMA-J AM MED ASSOC, V279, P1273; ANDERSON JL, 1989, CIRCULATION, V80, P1557, DOI 10.1161/01.CIR.80.6.1557; [Anonymous], 2001, CIRCULATION, V104, P2118; [Anonymous], 1997, Arch Intern Med, V157, P1237; ANTMAN EM, 1988, J AM COLL CARDIOL, V12, P1005, DOI 10.1016/0735-1097(88)90468-8; Bellandi F, 1996, G Ital Cardiol, V26, P379; Bennett DH, 2000, HEART, V84, P193, DOI 10.1136/heart.84.2.193; Blackshear JL, 1996, LANCET, V348, P633; Blackshear JL, 1996, AM J CARDIOL, V78, P1246, DOI 10.1016/S0002-9149(96)00604-2; Boriani G, 1999, J AM COLL CARDIOL, V33, P333, DOI 10.1016/S0735-1097(98)00577-4; Bosch RF, 1999, CARDIOVASC RES, V44, P121, DOI 10.1016/S0008-6363(99)00178-9; BOTKER HE, 1991, BRIT HEART J, V65, P337; Botto GL, 1998, CLIN CARDIOL, V21, P837, DOI 10.1002/clc.4960211110; BRAND FN, 1985, JAMA-J AM MED ASSOC, V254, P3449, DOI 10.1001/jama.254.24.3449; Brignole M, 1998, CIRCULATION, V98, P953, DOI 10.1161/01.CIR.98.10.953; Brugada R, 1997, NEW ENGL J MED, V336, P905, DOI 10.1056/NEJM199703273361302; Brugada R, 1999, J INTERV CARD ELECTR, V3, P7, DOI 10.1023/A:1009859119791; CANAVAN TE, 1988, ANN THORAC SURG, V46, P223, DOI 10.1016/S0003-4975(10)65903-6; Chen SA, 1999, CIRCULATION, V100, P1879, DOI 10.1161/01.CIR.100.18.1879; Chimienti M, 1995, EUR HEART J, V16, P1943, DOI 10.1093/oxfordjournals.eurheartj.a060852; CHUN SH, 1995, AM J CARDIOL, V76, P47, DOI 10.1016/S0002-9149(99)80799-1; CONNOLLY SJ, 1989, AM J CARDIOL, V63, P817, DOI 10.1016/0002-9149(89)90049-0; Cox J L, 2000, Semin Thorac Cardiovasc Surg, V12, P15; COX JL, 1991, J THORAC CARDIOV SUR, V101, P406, DOI 10.1016/s0022-5223(19)36723-6; COX JL, 1993, ANN THORAC SURG, V56, P814, DOI 10.1016/0003-4975(93)90338-I; Crijns HJGM, 1996, CARDIOVASC DRUG THER, V10, P145, DOI 10.1007/BF00823592; Daoud EG, 1996, AM J CARDIOL, V78, P1433, DOI 10.1016/S0002-9149(97)89297-1; DAVIDSON E, 1989, ARCH INTERN MED, V149, P457, DOI 10.1001/archinte.149.2.457; Deedwania PC, 1998, CIRCULATION, V98, P2574, DOI 10.1161/01.CIR.98.23.2574; Defaye P, 1999, ARCH MAL COEUR VAISS, V92, P719; Delfaut P, 1998, J AM COLL CARDIOL, V32, P1900, DOI 10.1016/S0735-1097(98)00489-6; Dries DL, 1998, J AM COLL CARDIOL, V32, P695, DOI 10.1016/S0735-1097(98)00297-6; ELLENBOGEN KA, 1991, J AM COLL CARDIOL, V18, P891, DOI 10.1016/0735-1097(91)90743-S; Ezekowitz M, 1998, ARCH INTERN MED, V158, P1316; FALK RH, 1987, ANN INTERN MED, V106, P503, DOI 10.7326/0003-4819-106-4-503; FALK RH, 1997, ATRIAL FIBRILLATION; Fan K, 2000, CIRCULATION, V102, P755, DOI 10.1161/01.CIR.102.7.755; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; FLEGEL KM, 1987, LANCET, V1, P526; Friedman PA, 1998, MAYO CLIN PROC, V73, P848, DOI 10.4065/73.9.848; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Garrigue S, 1998, PACE, V21, P1751, DOI 10.1111/j.1540-8159.1998.tb00275.x; Godtfredsen J, 1975, THESIS U COPENHAGEN; GOLD RL, 1986, AM J CARDIOL, V57, P124, DOI 10.1016/0002-9149(86)90964-1; GOLDMAN S, 1975, AM J CARDIOL, V35, P651, DOI 10.1016/0002-9149(75)90051-X; GOSSELINK ATM, 1994, BRIT HEART J, V72, P161; GUARNIERI T, 1991, PACE, V14, P1007, DOI 10.1111/j.1540-8159.1991.tb04150.x; Guize L., 1999, European Heart Journal, V20, P467; Haissaguerre M, 2000, J CARDIOVASC ELECTR, V11, P2, DOI 10.1111/j.1540-8167.2000.tb00727.x; Haissaguerre M, 2000, CIRCULATION, V101, P1409, DOI 10.1161/01.CIR.101.12.1409; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Haissaguerre M, 2000, CIRCULATION, V102, P2463, DOI 10.1161/01.CIR.102.20.2463; HAMER ME, 1994, AM J CARDIOL, V74, P826, DOI 10.1016/0002-9149(94)90448-0; Harada A, 1996, ANN THORAC SURG, V61, P104, DOI 10.1016/0003-4975(95)00824-1; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Hobbs WJC, 2000, CIRCULATION, V101, P1145, DOI 10.1161/01.CIR.101.10.1145; Hocini M., 1999, European Heart Journal, V20, P347; Hofmann R, 2000, HEART, V84, P635, DOI 10.1136/heart.84.6.635; Holm M, 1997, EUR HEART J, V18, P290; HOROWITZ LN, 1985, J AM COLL CARDIOL, V6, P1402, DOI 10.1016/S0735-1097(85)80232-1; Hwang C, 1999, J CARDIOVASC ELECTR, V10, P636, DOI 10.1111/j.1540-8167.1999.tb00240.x; Jessurun ER, 2000, CIRCULATION, V101, P1559, DOI 10.1161/01.CIR.101.13.1559; Joglar JA, 2000, AM J CARDIOL, V86, P348, DOI 10.1016/S0002-9149(00)00932-2; Jordaens L, 1997, EUR HEART J, V18, P643; KANNEL WB, 1982, NEW ENGL J MED, V306, P1018, DOI 10.1056/NEJM198204293061703; Kannel WB, 1998, AM J CARDIOL, V82, p2N, DOI 10.1016/S0002-9149(98)00583-9; Karki K, 1997, EUR HEART J, V18, P649; Kerin NZ, 1996, ARCH INTERN MED, V156, P49, DOI 10.1001/archinte.156.1.49; Klein AL, 2001, NEW ENGL J MED, V344, P1411, DOI 10.1056/NEJM200105103441901; Kober L, 2000, LANCET, V356, P2052, DOI 10.1016/S0140-6736(00)03402-4; Koh KK, 1995, INT J CARDIOL, V52, P167, DOI 10.1016/0167-5273(95)02480-K; KONINGS KTS, 1994, CIRCULATION, V89, P1665, DOI 10.1161/01.CIR.89.4.1665; KOPECKY SL, 1987, NEW ENGL J MED, V317, P669, DOI 10.1056/NEJM198709103171104; KOUDSTAAL PJ, 1993, LANCET, V342, P1255; KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9; Kuhlkamp V, 2000, J AM COLL CARDIOL, V36, P139, DOI 10.1016/S0735-1097(00)00693-8; Lau CP, 1997, PACE, V20, P2442, DOI 10.1111/j.1540-8159.1997.tb06084.x; Lau CP, 1999, J AM COLL CARDIOL, V33, P1217, DOI 10.1016/S0735-1097(98)00691-3; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; Lee SH, 1996, J INTERN MED, V239, P253, DOI 10.1046/j.1365-2796.1996.451805000.x; Levy S, 1998, EUR HEART J, V19, P1294, DOI 10.1053/euhj.1998.1050; Levy T, 1999, AM J CARDIOL, V84, P426, DOI 10.1016/S0002-9149(99)00327-6; Levy T, 2001, HEART, V85, P48, DOI 10.1136/heart.85.1.48; Lewis T, 1921, HEART-J STUD CIRC, V8, P361; Li-Saw-Hee FL, 2000, STROKE, V31, P828, DOI 10.1161/01.STR.31.4.828; Lip GYH, 1998, INT J CARDIOL, V65, P187, DOI 10.1016/S0167-5273(98)00125-9; Lonnerholm S, 2000, CIRCULATION, V101, P2607, DOI 10.1161/01.CIR.101.22.2607; LUNDSTROM T, 1990, J AM COLL CARDIOL, V16, P86, DOI 10.1016/0735-1097(90)90461-W; Martinez-Marcos FJ, 2000, AM J CARDIOL, V86, P950, DOI 10.1016/S0002-9149(00)01128-0; Mines GR, 1914, T R SOC CAN, V8, P43; MISIER ARR, 1992, J AM COLL CARDIOL, V19, P1531; MOE GK, 1962, ARCH INT PHARMACOD T, V140, P183; MURGATROYD FD, 1994, PACE, V17, P1966, DOI 10.1111/j.1540-8159.1994.tb03782.x; Naccarelli GV, 1996, AM J CARDIOL, V77, pA53, DOI 10.1016/S0002-9149(97)89118-7; Narayan SM, 1997, LANCET, V350, P943, DOI 10.1016/S0140-6736(97)06359-9; Natale A, 1998, AM J CARDIOL, V82, P989, DOI 10.1016/S0002-9149(98)00522-0; ONUNDARSON PT, 1987, EUR HEART J, V8, P521; Oral H, 1999, NEW ENGL J MED, V340, P1849, DOI 10.1056/NEJM199906173402401; Ozcan C, 2001, NEW ENGL J MED, V344, P1043, DOI 10.1056/NEJM200104053441403; PAGE RL, 1994, CIRCULATION, V89, P224, DOI 10.1161/01.CIR.89.1.224; Pandozi C, 1998, CIRCULATION, V98, P2860, DOI 10.1161/01.CIR.98.25.2860; Pappone C, 2000, CIRCULATION, V102, P2619; Pedersen OD, 1999, EUR HEART J, V20, P748, DOI 10.1053/euhj.1998.1352; PETERSEN P, 1986, STROKE, V17, P622, DOI 10.1161/01.STR.17.4.622; Plewan A., 1999, European Heart Journal, V20, P223; Prakash A, 1997, J AM COLL CARDIOL, V29, P1007, DOI 10.1016/S0735-1097(97)00043-0; Proclemer A, 1999, AM J CARDIOL, V83, P1437, DOI 10.1016/S0002-9149(99)00121-6; Prystowsky EN, 1996, CIRCULATION, V93, P1262, DOI 10.1161/01.CIR.93.6.1262; Psaty BM, 1997, CIRCULATION, V96, P2455; RAWLES JM, 1990, BRIT HEART J, V63, P225; Rodriguez LM, 1999, CIRCULATION, V100, P113, DOI 10.1161/01.CIR.100.2.113; Rohr S, 1998, CIRC RES, V83, P781, DOI 10.1161/01.RES.83.8.781; Roy D, 2000, NEW ENGL J MED, V342, P913, DOI 10.1056/NEJM200003303421302; Saksena S, 1996, J AM COLL CARDIOL, V28, P687, DOI 10.1016/0735-1097(96)00232-X; Santini M, 1998, PACE, V21, P2641, DOI 10.1111/j.1540-8159.1998.tb00041.x; Scardi S, 1999, AM HEART J, V137, P686, DOI 10.1016/S0002-8703(99)70224-3; Schilling RJ, 2000, EUR HEART J, V21, P550, DOI 10.1053/euhj.1999.1851; Schmit C, 1996, J AM COLL CARDIOL, V28, P994, DOI 10.1016/S0735-1097(96)00274-4; Schreck DM, 1997, ANN EMERG MED, V29, P135, DOI 10.1016/S0196-0644(97)70319-6; Segal JB, 2000, J FAM PRACTICE, V49, P47; Sie HT, 2001, J THORAC CARDIOV SUR, V122, P249, DOI 10.1067/mtc.2001.114633; Singer DE, 1998, AM J CARDIOL, V81, p35C, DOI 10.1016/S0002-9149(98)00185-4; Singh S, 2000, CIRCULATION, V102, P2385, DOI 10.1161/01.CIR.102.19.2385; Steeds RP, 1999, HEART, V82, P170, DOI 10.1136/hrt.82.2.170; SUTTORP MJ, 1989, AM J CARDIOL, V63, P693, DOI 10.1016/0002-9149(89)90253-1; TAKAHASHI N, 1981, JPN HEART J, V22, P143; Tieleman RG, 1998, J AM COLL CARDIOL, V31, P167, DOI 10.1016/S0735-1097(97)00455-5; Timmermans C, 1998, J AM COLL CARDIOL, V31, p331A, DOI 10.1016/S0735-1097(97)85156-X; Tsai CF, 2000, CIRCULATION, V102, P67, DOI 10.1161/01.CIR.102.1.67; Tse HF, 1999, J CARDIOVASC ELECTR, V10, P1200, DOI 10.1111/j.1540-8167.1999.tb00296.x; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Wolff L, 1943, NEW ENGL J MED, V229, P396, DOI 10.1056/NEJM194309022291002	138	107	117	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2002	359	9306					593	603		10.1016/S0140-6736(02)07748-6	http://dx.doi.org/10.1016/S0140-6736(02)07748-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523FP	11867130				2022-12-28	WOS:000173943600028
J	Stapleton, H; Kirkham, M; Thomas, G				Stapleton, H; Kirkham, M; Thomas, G			Qualitative study of evidence based leaflets in maternity care	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SHARED DECISION-MAKING; CHOICE; WOMEN	Objective To examine the use of evidence based leaflets on informed choice in maternity services. Design Non-participant observation of 886 antenatal consultations. 383 in depth interviews with women using maternity services and health professionals providing antenatal care. Setting Women's homes; antenatal and ultrasound clinics in 13 maternity units in Wales. Participants Childbearing women and health professionals who provide antenatal care. Intervention Provision of 10 pairs of Informed Choice leaflets for service users and staff and a training session in their use. Main outcome measures Participants' views and commonly observed responses during consultations and interviews. Results Health professionals were positive about the leaflets and their potential to assist women in making informed choices, but competing demands within the clinical environment undermined their effective use. Time pressures limited discussion, and choice was often not available in practice. A widespread belief that technological intervention would be viewed positively in the event of litigation reinforced notions of "right" and "wrong" choices rather than "informed" choices. Hierarchical power structures resulted in obstetricians defining the norms of clinical practice and hence which choices were possible. Women's trust in health professionals ensured their compliance with professionally defined choices, and only rarely were they observed asking questions or making alternative requests. Midwives rarely discussed the contents of the leaflets or distinguished them from other literature related to pregnancy. The visibility and potential of the leaflets as evidence based decision aids was thus greatly reduced. Conclusions The way in which the leaflets were disseminated affected promotion of informed choice in maternity care. The culture into which the leaflets were introduced supported existing normative patterns of care and this ensured informed compliance rather than informed choice.	Univ Sheffield, Sch Nursing & Midwifery, Womens Informed Childbearing & Hlth Res Grp, Sheffield, S Yorkshire, England; W Wales Gen Hosp, Carmarthenshire NHS Trust, Carmarthen, Dyfed, Wales	University of Sheffield	Stapleton, H (corresponding author), Univ Sheffield, Sch Nursing & Midwifery, Womens Informed Childbearing & Hlth Res Grp, Sheffield, S Yorkshire, England.	h.stapleton@sheffield.ac.uk	Sandall, Jane/D-4146-2009	Sandall, Jane/0000-0003-2000-743X				Barbour R S, 1999, J Health Serv Res Policy, V4, P39; Bekker H., 1999, HLTH TECHNOL ASSESS, V3, P1, DOI DOI 10.3310/HTA3010; Charles C, 1998, SOCIOL HEALTH ILL, V20, P71, DOI 10.1111/1467-9566.00081; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Davies C., 1995, GENDER PROFESSIONAL; Davies HTO, 2000, QUAL HEALTH CARE, V9, P111, DOI 10.1136/qhc.9.2.111; Department of Health, 1993, CHANGING CHILDBIRTH; DINGWALL R, 1997, CONTEXT METHOD QUALI; Edwards N. P., 2000, MIDWIFE MOTHER RELAT; Elwyn G, 1999, BRIT MED J, V319, P753, DOI 10.1136/bmj.319.7212.753; Entwistle VA, 1998, INT J TECHNOL ASSESS, V14, P212, DOI 10.1017/S0266462300012204; FITZGERALD L, 1999, ORG BEHAV HLTH CARE; GAHAN C, 1999, DOING QUALITATIVE RE; Glaser B.G., 1965, AWARENESS DYING; Holmes-Rovner Margaret, 2000, Health Expect, V3, P182, DOI 10.1046/j.1369-6513.2000.00093.x; Jones S, 1998, BRIT MED J, V316, P272, DOI 10.1136/bmj.316.7127.272; KIRKHAM M, 2001, INFORMED CHOICE MATE; Levy V, 1999, J ADV NURS, V29, P104, DOI 10.1046/j.1365-2648.1999.00867.x; MACHIN D, 1998, BR J MIDWIFERY, V6, P304; MARTEAU TM, 1989, BRIT J SOC PSYCHOL, V28, P89, DOI 10.1111/j.2044-8309.1989.tb00849.x; McCrea BH, 1998, MIDWIFERY, V14, P174, DOI 10.1016/S0266-6138(98)90032-8; Murphy-Lawless Jo, 1998, READING BIRTH DEATH; O'Cathain A, 2002, BRIT MED J, V324, P643, DOI 10.1136/bmj.324.7338.643; PAIRMAN S, 2000, MIDWIFE MOTHER RELAT; Press N, 1997, SOC SCI MED, V45, P979, DOI 10.1016/S0277-9536(97)00011-7; Proctor S, 1998, BIRTH-ISS PERINAT C, V25, P85, DOI 10.1046/j.1523-536x.1998.00085.x; ROSSER J, 1996, J CLIN EFFECTIVENESS, V1, P143; Roter Debra, 2000, Health Expect, V3, P17, DOI 10.1046/j.1369-6513.2000.00073.x; *ROYAL SOC MED NHS, 1999, EFFECT HLTH CARE B, V5, P1; Strauss A., 1990, BASICS QUALITATIVE R; Wolff N, 2001, J Health Serv Res Policy, V6, P123, DOI 10.1258/1355819011927224	31	109	111	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2002	324	7338					639	+		10.1136/bmj.324.7338.639	http://dx.doi.org/10.1136/bmj.324.7338.639			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	532QW	11895821	Bronze, Green Published			2022-12-28	WOS:000174487400021
J	Hoppe, HG; Gocke, K; Koppe, R; Begler, C				Hoppe, HG; Gocke, K; Koppe, R; Begler, C			Bacterial growth and primary production along a north-south transect of the Atlantic Ocean	NATURE			English	Article							EUPHOTIC ZONE; RESPIRATION; ECOSYSTEMS; BACTERIOPLANKTON; PHOTOSYNTHESIS; TEMPERATURE; BALANCE; BIOMASS; WATERS; FRESH	The oceanic carbon cycle is mainly determined by the combined activities of bacteria and phytoplankton(1,2), but the interdependence of climate, the carbon cycle and the microbes is not well understood. To elucidate this interdependence, we performed high-frequency sampling of sea water along a north-south transect of the Atlantic Ocean. Here we report that the interaction of bacteria and phytoplankton is closely related to the meridional profile of water temperature, a variable directly dependent on climate. Water temperature was positively correlated with the ratio of bacterial production to primary production, and, more strongly, with the ratio of bacterial carbon demand to primary production. In warm latitudes (25degrees N to 30degrees S), we observed alternating patches of predominantly heterotrophic and autotrophic community metabolism. The calculated regression lines (for data north and south of the Equator) between temperature and the ratio of bacterial production to primary production give a maximum value for this ratio of 40% in the oligotrophic equatorial regions. Taking into account a bacterial growth efficiency(3,4) of 30%, the resulting area of net heterotrophy (where the bacterial carbon demand for growth plus respiration exceeds phytoplankton carbon fixation(4-6)) expands from 8degrees N (27 degreesC) to 20degrees S (23 degreesC). This suggests an output of CO2 from parts of the ocean to the atmosphere(6,7).	Inst Marine Sci, Sect Marine Ecol, D-24105 Kiel, Germany; Inst Marine Sci, Sect Ocean Circulat & Climate, D-24105 Kiel, Germany		Hoppe, HG (corresponding author), Inst Marine Sci, Sect Marine Ecol, Dusternbroker Weg 20, D-24105 Kiel, Germany.	hhoppe@ifm.uni-kiel.de						AMON RMW, 1994, NATURE, V369, P549, DOI 10.1038/369549a0; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; AZAM F, 1994, P INDIAN AS-EARTH, V103, P341; BIRD DF, 1984, CAN J FISH AQUAT SCI, V41, P1015, DOI 10.1139/f84-118; COLE JJ, 1988, MAR ECOL PROG SER, V43, P1, DOI 10.3354/meps043001; delGiorgio PA, 1997, NATURE, V385, P148, DOI 10.1038/385148a0; Duarte CM, 1998, SCIENCE, V281, P234, DOI 10.1126/science.281.5374.234; Duarte MC, 2001, LIMNOL OCEANOGR, V46, P425, DOI 10.4319/lo.2001.46.2.0425; Ducklow HW, 1999, FEMS MICROBIOL ECOL, V30, P1, DOI 10.1111/j.1574-6941.1999.tb00630.x; Fasham MJR, 1999, LIMNOL OCEANOGR, V44, P80, DOI 10.4319/lo.1999.44.1.0080; FUHRMAN JA, 1982, MAR BIOL, V66, P109, DOI 10.1007/BF00397184; Geider RJ, 1997, NATURE, V388, P132, DOI 10.1038/40536; Hoppe H. G., 1993, CURRENT METHODS AQUA, P423; Karrasch B, 1996, J MAR RES, V54, P99, DOI 10.1357/0022240963213420; KIRCHMAN DL, 1995, DEEP-SEA RES PT II, V42, P603, DOI 10.1016/0967-0645(95)00021-H; Kuipers B, 2000, MAR ECOL PROG SER, V201, P13, DOI 10.3354/meps201013; Lochte K, 1997, DEEP-SEA RES PT II, V44, P321, DOI 10.1016/S0967-0645(96)00081-1; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; Raymond PA, 2001, NATURE, V409, P497, DOI 10.1038/35054034; Rivkin RB, 2001, SCIENCE, V291, P2398, DOI 10.1126/science.291.5512.2398; Rivkin RB, 1996, AQUAT MICROB ECOL, V10, P243, DOI 10.3354/ame010243; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; SIMON M, 1992, MAR ECOL PROG SER, V86, P103, DOI 10.3354/meps086103; SOROKIN YI, 1971, MAR BIOL, V11, P101; WILLIAMS PJ, 1999, SCIENCE, V284, P1735, DOI DOI 10.1126/SCIENCE.284.5421.1735B; Williams PJL, 1998, NATURE, V394, P55; Zubkov MV, 2001, DEEP-SEA RES PT II, V48, P987, DOI 10.1016/S0967-0645(00)00105-3	29	126	130	4	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2002	416	6877					168	171		10.1038/416168a	http://dx.doi.org/10.1038/416168a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894092				2022-12-28	WOS:000174348100035
J	Sinha, R; Fisch, G; Teague, B; Tamborlane, WV; Banyas, B; Allen, K; Savoye, M; Rieger, V; Taksali, S; Barbetta, G; Sherwin, RS; Caprio, S				Sinha, R; Fisch, G; Teague, B; Tamborlane, WV; Banyas, B; Allen, K; Savoye, M; Rieger, V; Taksali, S; Barbetta, G; Sherwin, RS; Caprio, S			Prevalence of impaired glucose tolerance among children and adolescents with marked obesity	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TYPE-2 DIABETES-MELLITUS; BETA-CELL DYSFUNCTION; INSULIN-RESISTANCE; IMMUNOREACTIVE PROINSULIN; RISK-FACTORS; NIDDM; SECRETION; PATHOGENESIS; INTOLERANCE; PREVENTION	Background: Childhood obesity, epidemic in the United States, has been accompanied by an increase in the prevalence of type 2 diabetes among children and adolescents. We determined the prevalence of impaired glucose tolerance in a multiethnic cohort of 167 obese children and adolescents. Methods: All subjects underwent a two-hour oral glucose-tolerance test (1.75 mg of glucose per kilogram of body weight), and glucose, insulin, and C-peptide levels were measured. Fasting levels of proinsulin were obtained, and the ratio of proinsulin to insulin was calculated. Insulin resistance was estimated by homeostatic model assessment, and beta-cell function was estimated by calculating the ratio between the changes in the insulin level and the glucose level during the first 30 minutes after the ingestion of glucose. Results: Impaired glucose tolerance was detected in 25 percent of the 55 obese children (4 to 10 years of age) and 21 percent of the 112 obese adolescents (11 to 18 years of age); silent type 2 diabetes was identified in 4 percent of the obese adolescents. Insulin and C-peptide levels were markedly elevated after the glucose-tolerance test in subjects with impaired glucose tolerance but not in adolescents with diabetes, who had a reduced ratio of the 30-minute change in the insulin level to the 30-minute change in the glucose level. After the body-mass index had been controlled for, insulin resistance was greater in the affected cohort and was the best predictor of impaired glucose tolerance. Conclusions: Impaired glucose tolerance is highly prevalent among children and adolescents with severe obesity, irrespective of ethnic group. Impaired oral glucose tolerance was associated with insulin resistance while beta-cell function was still relatively preserved. Overt type 2 diabetes was linked to beta-cell failure. (N Engl J Med 2002;346:802-10.) Copyright (C) 2002 Massachusetts Medical Society.	Yale Univ, Sch Med, Dept Pediat, 333 Cedar St,POB 208064, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Childrens Gen Clin Res Ctr, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Div Biostat, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University	Caprio, S (corresponding author), Yale Univ, Sch Med, Dept Pediat, 333 Cedar St,POB 208064, New Haven, CT 06520 USA.	sonia.caprio@yale.edu	Robles-Sardin, Alma E/M-7714-2015	Robles-Sardin, Alma E/0000-0003-2044-7793	NCRR NIH HHS [M01 RR 06022, M01 RR 00125] Funding Source: Medline; NICHD NIH HHS [R01 HD-28016, R01 HD 40787, K24HD01464] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040787, R01HD028016] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD001464] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR006022, M01RR000125] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Arslanian SA, 2001, J CLIN ENDOCR METAB, V86, P66, DOI 10.1210/jc.86.1.66; Bonora E, 1998, DIABETES, V47, P1643, DOI 10.2337/diabetes.47.10.1643; Dabelea D, 1999, ENDOCRIN METAB CLIN, V28, P709, DOI 10.1016/S0889-8529(05)70098-0; DeFronzo RA, 1997, DIABETES REV, V5, P177; Edelstein SL, 1997, DIABETES, V46, P701, DOI 10.2337/diabetes.46.4.701; EFENDIC S, 1984, ENDOCR REV, V5, P395, DOI 10.1210/edrv-5-3-395; FAGOTCOMPAGNA A, 2001, DIABETES CARE S5, V24, pS134; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gerich JE, 1998, ENDOCR REV, V19, P491, DOI 10.1210/er.19.4.491; HAFFNER SM, 1990, JAMA-J AM MED ASSOC, V263, P2893, DOI 10.1001/jama.263.21.2893; Haffner SM, 1996, DIABETOLOGIA, V39, P1201, DOI 10.1007/BF02658507; HAFFNER SM, 1995, DIABETES, V44, P1386, DOI 10.2337/diabetes.44.12.1386; Haffner SM, 1997, DIABETOLOGIA, V40, P830, DOI 10.1007/s001250050756; HAMMER LD, 1991, AM J DIS CHILD, V145, P259, DOI 10.1001/archpedi.1991.02160030027015; KADOWAKI T, 1984, DIABETOLOGIA, V26, P44, DOI 10.1007/BF00252262; KAHN SE, 1995, DIABETES, V44, P173, DOI 10.2337/diabetes.44.2.173; KOSAKA K, 1977, DIABETES, V26, P944, DOI 10.2337/diab.26.10.944; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MYKKANEN L, 1995, DIABETOLOGIA, V38, P1176, DOI 10.1007/BF00422366; PHILLIPS DIW, 1994, DIABETIC MED, V11, P286, DOI 10.1111/j.1464-5491.1994.tb00273.x; Polonsky KS, 1996, NEW ENGL J MED, V334, P777, DOI 10.1056/NEJM199603213341207; PORTE D, 1989, DIABETES, V38, P1333, DOI 10.2337/diabetes.38.11.1333; Porte D, 2001, DIABETES, V50, pS160, DOI 10.2337/diabetes.50.2007.S160; REAVEN GM, 1973, J CLIN ENDOCR METAB, V76, P44; Rosenbloom AL, 1999, DIABETES CARE, V22, P345, DOI 10.2337/diacare.22.2.345; SAAD MF, 1988, NEW ENGL J MED, V319, P1500, DOI 10.1056/NEJM198812083192302; STOKES ME, 1995, CATEGORICAL DATA ANA, P163; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; TUOMILEHTO J, 1992, DIABETES METAB REV, V8, P339, DOI 10.1002/dmr.5610080403; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; WARD WK, 1987, DIABETOLOGIA, V30, P698, DOI 10.1007/BF00296991	31	1159	1199	1	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2002	346	11					802	810		10.1056/NEJMoa012578	http://dx.doi.org/10.1056/NEJMoa012578			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529YM	11893791				2022-12-28	WOS:000174328900003
J	Suster, ML; Bate, M				Suster, ML; Bate, M			Embryonic assembly of a central pattern generator without sensory input	NATURE			English	Article							XENOPUS-LAEVIS EMBRYOS; DROSOPHILA; EXPRESSION; BEHAVIOR; LOCOMOTION; MOVE	Locomotion depends on the integration of sensory information with the activity of central circuitry, which generates patterned discharges in motor nerves to appropriate muscles(1,2). Isolated central networks generate fictive locomotor rhythms (recorded in the absence of movement), indicating that the fundamental pattern of motor output depends on the intrinsic connectivity and electrical properties of these central circuits(3,4). Sensory inputs are required to modify the pattern of motor activity in response to the actual circumstances of real movement. A central issue for our understanding of how locomotor circuits are specified and assembled is the extent to which sensory inputs are required as such systems develop(5). Here we describe the effects of eliminating sensory function and structure on the development of the peristaltic motor pattern of Drosophila embryos and larvae. We infer that the circuitry for peristaltic crawling develops in the complete absence of sensory input; however, the integration of this circuitry into actual patterns of locomotion requires additional information from the sensory system. In the absence of sensory inputs, the polarity of movement is deranged, and backward peristaltic waves predominate at the expense of forward peristalsis.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Suster, ML (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.							Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; BERRIGAN D, 1995, J INSECT PHYSIOL, V41, P329, DOI 10.1016/0022-1910(94)00113-U; BOOTHBY KM, 1992, J COMP PHYSIOL A, V170, P171; BRAND AH, 1993, DEVELOPMENT, V118, P401; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; GRILLNER S, 1985, SCIENCE, V228, P143, DOI 10.1126/science.3975635; HAMBURGER V, 1967, J EXP ZOOL, V166, P171, DOI 10.1002/jez.1401660203; HAVERKAMP LJ, 1986, J NEUROSCI, V6, P1332; HILDAGO A, 1995, DEVELOPMENT, V121, P3703; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Jan Yuh Nung, 1993, P1207; Kaliss N, 1939, GENETICS, V24, P244; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Marder E, 2000, CURR OPIN NEUROBIOL, V10, P691, DOI 10.1016/S0959-4388(00)00157-4; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Pearson KG, 1995, CURR OPIN NEUROBIOL, V5, P786, DOI 10.1016/0959-4388(95)80107-3; Reynolds SA, 1998, J COMP NEUROL, V402, P168, DOI 10.1002/(SICI)1096-9861(19981214)402:2&lt;168::AID-CNE3&gt;3.0.CO;2-W; Richards KS, 2000, J NEUROBIOL, V44, P31, DOI 10.1002/1097-4695(200007)44:1<31::AID-NEU4>3.0.CO;2-F; Sanes DH., 2000, DEV NERVOUS SYSTEM; SCHNEIDERMAN AM, 1986, NATURE, V323, P801, DOI 10.1038/323801a0; Siekhaus DE, 1999, J NEUROSCI, V19, P6942, DOI 10.1523/JNEUROSCI.19-16-06942.1999; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; VANMIER P, 1989, NEUROSCIENCE, V32, P113, DOI 10.1016/0306-4522(89)90111-5; Wang JW, 1997, J NEUROGENET, V11, P231, DOI 10.3109/01677069709115098	30	122	124	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2002	416	6877					174	178		10.1038/416174a	http://dx.doi.org/10.1038/416174a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894094				2022-12-28	WOS:000174348100037
J	Skellett, S; Tibby, SM; Durward, A; Murdoch, IA				Skellett, S; Tibby, SM; Durward, A; Murdoch, IA			Lesson of the week - Immobilisation of the cervical spine in children	BRITISH MEDICAL JOURNAL			English	Review							TRAUMA; INJURY		Guys Hosp, Dept Paediat Intens Care, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust	Skellett, S (corresponding author), Guys Hosp, Dept Paediat Intens Care, London SE1 9RT, England.		Skellett, Sophie/AAF-5538-2020					*ADV LIF SUPP GROU, 1999, PREH PAED LIF SUPP; *ADV LIF SUPP GROU, 1995, ADV PAED LIF SUPP PR, P132; BACHULIS BL, 1987, AM J SURG, V153, P473, DOI 10.1016/0002-9610(87)90796-3; CHAMEIDES L, 1994, PEDIAT ADV LIFE SUPP, P8; Eleraky MA, 2000, J NEUROSURG, V92, P12, DOI 10.3171/spi.2000.92.1.0012; HARRIS JH, 1986, ORTHOP CLIN N AM, V17, P75; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; HUERTA C, 1987, ANN EMERG MED, V16, P1121, DOI 10.1016/S0196-0644(87)80468-7; Kokoska ER, 2001, J PEDIATR SURG, V36, P100, DOI 10.1053/jpsu.2001.20022; Lloyd DA, 1997, BRIT MED J, V315, P1308; PANG D, 1989, J TRAUMA, V29, P654, DOI 10.1097/00005373-198905000-00021; Patel JC, 2001, J PEDIATR SURG, V36, P373, DOI 10.1053/jpsu.2001.20720	12	6	8	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 9	2002	324	7337					591	593		10.1136/bmj.324.7337.591	http://dx.doi.org/10.1136/bmj.324.7337.591			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	530XJ	11884327	Green Published			2022-12-28	WOS:000174384000026
J	Smith, ZM; Delgutte, B; Oxenham, AJ				Smith, ZM; Delgutte, B; Oxenham, AJ			Chimaeric sounds reveal dichotomies in auditory perception	NATURE			English	Article							INTERAURAL TIME DIFFERENCES; SPEECH RECOGNITION; LOW-FREQUENCY; MECHANISMS; CORTEX; CAT	By Fourier's theorem(1), signals can be decomposed into a sum of sinusoids of different frequencies. This is especially relevant for hearing, because the inner ear performs a form of mechanical Fourier transform by mapping frequencies along the length of the cochlear partition. An alternative signal decomposition, originated by Hilbert(2), is to factor a signal into the product of a slowly varying envelope and a rapidly varying fine time structure. Neurons in the auditory brainstem(3-6) sensitive to these features have been found in mammalian physiological studies. To investigate the relative perceptual importance of envelope and fine structure, we synthesized stimuli that we call 'auditory chimaeras', which have the envelope of one sound and the fine structure of another. Here we show that the envelope is most important for speech reception, and the fine structure is most important for pitch perception and sound localization. When the two features are in conflict, the sound of speech is heard at a location determined by the fine structure, but the words are identified according to the envelope. This finding reveals a possible acoustic basis for the hypothesized 'what' and 'where' pathways in the auditory cortex(7-10).	Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA; MIT, Elect Res Lab, Cambridge, MA 02139 USA; MIT, Harvard Mit Div Hlth Sci & Technol, Speech & Hearing Biosci & Technol Program, Cambridge, MA 02139 USA	Harvard University; Massachusetts Eye & Ear Infirmary; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT)	Delgutte, B (corresponding author), Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA.		Smith, Zachary/B-2879-2009	Smith, Zachary/0000-0002-0819-4562; Oxenham, Andrew/0000-0002-9365-1157; Delgutte, Bertrand/0000-0003-1349-9608	NIDCD NIH HHS [R01 DC002258, R01 DC005216-02, R01 DC005216, R01 DC002258-07] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005216, R01DC002258] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BERNSTEIN LR, 1985, J ACOUST SOC AM, V77, P1868, DOI 10.1121/1.391938; Delgutte B, 2001, AUDITORY CHIMERA DEM; DEPALLE P, 1994, P ICMC, P357; DODGE C, 1997, COMPUTER MUSIC SYNTH; Fourier J, 1829, MEM ACAD R SCI, V8, P581; Ghitza O, 2001, J ACOUST SOC AM, V110, P1628, DOI 10.1121/1.1396325; GREENWOOD DD, 1990, J ACOUST SOC AM, V87, P2592, DOI 10.1121/1.399052; HARTMANN WM, 1991, MUSIC PERCEPT, V9, P155; HENNING GB, 1981, HEARING RES, V4, P184; Hilbert D., 1912, GRUNDZUGE ALLGEMEINE; JORIS PX, 1995, J NEUROPHYSIOL, V73, P1043, DOI 10.1152/jn.1995.73.3.1043; LANGNER G, 1988, J NEUROPHYSIOL, V60, P1799, DOI 10.1152/jn.1988.60.6.1799; LICKLIDER JCR, 1946, J ACOUST SOC AM, V18, P429, DOI 10.1121/1.1916383; Litvak L, 2001, J ACOUST SOC AM, V110, P368, DOI 10.1121/1.1375140; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Recanzone GH, 2000, P NATL ACAD SCI USA, V97, P11829, DOI 10.1073/pnas.97.22.11829; RHODE WS, 1983, J COMP NEUROL, V213, P448, DOI 10.1002/cne.902130408; Rubinstein JT, 1999, HEARING RES, V127, P108, DOI 10.1016/S0378-5955(98)00185-3; Saberi K, 1999, NATURE, V398, P760, DOI 10.1038/19652; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; TROULLINOS G, 1990, DIGIT SIGNAL PROCESS, P221; Ville J., 1948, CABLES TRANSM, V2A, P61; WIGHTMAN FL, 1992, J ACOUST SOC AM, V91, P1648, DOI 10.1121/1.402445; WILSON BS, 1991, NATURE, V352, P236, DOI 10.1038/352236a0; Yin T. C., 1990, J NEUROPHYSIOL, V65, P465	28	591	644	4	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2002	416	6876					87	90		10.1038/416087a	http://dx.doi.org/10.1038/416087a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882898	Green Accepted			2022-12-28	WOS:000174211600044
J	Corcoran, M				Corcoran, M			An unhappy coincidence between multiple sclerosis and trauma?	LANCET			English	Editorial Material									Legal Hlth Consulting, Bristol BS6 7UN, Avon, England		Corcoran, M (corresponding author), Legal Hlth Consulting, Bristol BS6 7UN, Avon, England.								0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 2	2002	359	9308					726	726		10.1016/S0140-6736(02)07902-3	http://dx.doi.org/10.1016/S0140-6736(02)07902-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526DZ	11888581				2022-12-28	WOS:000174115200005
J	Iseki, M; Matsunaga, S; Murakami, A; Ohno, K; Shiga, K; Yoshida, K; Sugai, M; Takahashi, T; Hori, T; Watanabe, M				Iseki, M; Matsunaga, S; Murakami, A; Ohno, K; Shiga, K; Yoshida, K; Sugai, M; Takahashi, T; Hori, T; Watanabe, M			A blue-light-activated adenylyl cyclase mediates photoavoidance in Euglena gracilis	NATURE			English	Article							COMPLETE GENOME SEQUENCE; DOUBLE-STRANDED-RNA; STEP-DOWN; PHOTORECEPTOR; PROTEIN; GENE; TRANSDUCTION; PIGMENTS; ENCODES; CELLS	Blue light regulates processes such as the development of plants and fungi and the behaviour of microbes(1,2). Two types of blue-light receptor flavoprotein have been identified: cryptochromes, which have partial similarity to photolyases(3,4), and phototropins, which are photoregulated protein kinases(5,6). The former have also been found in animals with evidence of essential roles in circadian rhythms(7,8). Euglena gracilis, a unicellular flagellate, abruptly changes its swimming direction after a sudden increase or decrease in incident blue light intensity, that is, step-up or step-down photophobic responses, resulting in photoavoidance or photoaccumulation, respectively(9). Although these photobehaviours of Euglena have been studied for a century(10), the photoreceptor molecules mediating them have remained unknown(9). Here we report the discovery and biochemical characterization of a new type of blue-light receptor flavoprotein, photoactivated adenylyl cyclase, in the photoreceptor organelle of Euglena gracilis, with molecular genetic evidence that it mediates the step-up photophobic response.	Natl Inst Basic Biol, Okazaki 4448585, Japan; Biooriented Technol Res Advancement Inst, Minato Ku, Tokyo 1050001, Japan; Nagoya Univ, Ctr Gene Res, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 3058572, Japan; Kobe Univ, Res Ctr Inland Seas, Awaji, Hyogo 6562401, Japan; Kumamoto Univ, Sch Med, Dept Physiol, Kumamoto 8608556, Japan; Toyama Univ, Fac Sci, Dept Biol, Toyama 9308555, Japan; Toho Univ, Sch Pharmaceut Sci, Chiba 2748510, Japan; Grad Univ Adv Studies, Sch Adv Sci, Dept Photosci, Kanagawa 2400193, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Nagoya University; University of Tsukuba; Kobe University; Kumamoto University; University of Toyama; Toho University; Graduate University for Advanced Studies - Japan	Watanabe, M (corresponding author), Natl Inst Basic Biol, Okazaki 4448585, Japan.	machakou@nibb.ac.jp		Ohno, Kaoru/0000-0001-7648-3940				AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; BARGHIGIANI C, 1979, PHOTOCHEM PHOTOBIOL, V29, P1015, DOI 10.1111/j.1751-1097.1979.tb07806.x; BENEDETTI PA, 1977, PHOTOCHEM PHOTOBIOL, V26, P315, DOI 10.1111/j.1751-1097.1977.tb07492.x; BESSEY OA, 1949, J BIOL CHEM, V180, P755; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Briggs WR, 2001, PLANT CELL, V13, P993, DOI 10.1105/tpc.13.5.993; BRODHUN B, 1990, PHOTOCHEM PHOTOBIOL, V52, P865, DOI 10.1111/j.1751-1097.1990.tb08695.x; Buder J, 1919, JB WISS BOTAN, V58, P105; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; DANCHIN A, 1993, ADV SEC MESS PHOSPH, V27, P109; Darszon A, 1999, PHYSIOL REV, V79, P481, DOI 10.1152/physrev.1999.79.2.481; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Gomelsky M, 1998, J BIOL CHEM, V273, P35319, DOI 10.1074/jbc.273.52.35319; HASEGAWA E, 1987, CELL MOTIL CYTOSKEL, V8, P302, DOI 10.1002/cm.970080403; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; Hurley JH, 1999, J BIOL CHEM, V274, P7599, DOI 10.1074/jbc.274.12.7599; Kaneko T, 1996, DNA Res, V3, P109; Kasahara M, 1997, PLANT CELL PHYSIOL, V38, P828, DOI 10.1093/oxfordjournals.pcp.a029241; KATAYAMA M, 1995, J BACTERIOL, V177, P3873, DOI 10.1128/jb.177.13.3873-3878.1995; Lebert M, 2001, COMPREHENSIVE SERIES, P297; Matsunaga S, 1998, PROTOPLASMA, V201, P45, DOI 10.1007/BF01280710; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Senger Horst, 1994, P301; TESSIER LH, 1991, EMBO J, V10, P2621, DOI 10.1002/j.1460-2075.1991.tb07804.x; Torre V, 1995, J NEUROSCI, V15, P7757; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; WATANABE M, 1982, PHOTOCHEM PHOTOBIOL, V36, P491, DOI 10.1111/j.1751-1097.1982.tb04407.x; WATANABE M, 1995, HDB ORGANIC PHOTOCHE, P1276	30	360	380	1	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2002	415	6875					1047	1051		10.1038/4151047a	http://dx.doi.org/10.1038/4151047a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875575				2022-12-28	WOS:000174075000051
J	Rasmussen, LEL; Riddle, HS; Krishnamurthy, V				Rasmussen, LEL; Riddle, HS; Krishnamurthy, V			Mellifluous matures to malodorous in musth	NATURE			English	Article									Oregon Hlth & Sci Univ, OGI Sch Sci & Engn, Dept Biochem & Mol Biol, Beaverton, OR 97006 USA; Riddles Elephant & Wildlife Sanctuary, Greenbrier, AR 72058 USA; Indian Inst Sci, Asian Elephant Res & Conservat Ctr, Bangalore 560012, Karnataka, India	Oregon Health & Science University; Indian Institute of Science (IISC) - Bangalore	Rasmussen, LEL (corresponding author), Oregon Hlth & Sci Univ, OGI Sch Sci & Engn, Dept Biochem & Mol Biol, Beaverton, OR 97006 USA.							ARTHUR CL, 1990, ANAL CHEM, V62, P2145, DOI 10.1021/ac00218a019; Chandrasekharan K., 1992, ASIAN ELEPHANT ECOLO, P71; EDGERTON F, 1931, ELEPHANT LORE HINDUS; FRANCKE W, 1995, J CHEM ECOL, V21, P1043, DOI 10.1007/BF02033807; Free J. B., 1987, PHEROMONES SOCIAL BE; JAINUDEEN M R, 1972, Mammalia, V36, P247, DOI 10.1515/mamm.1972.36.2.247; KRISHNAN M, 1972, J BOMBAY NAT HIST SO, V69, P298; McKay G.M., 1973, Smithsonian Contributions to Zoology, VNo. 125, P1; PERRIN TE, 1996, J CHEM ECOL, V21, P207; PHILLIPS TW, 1989, J CHEM ECOL, V15, P1513, DOI 10.1007/BF01012380; Rasmussen LEL, 1998, ECOSCIENCE, V5, P410, DOI 10.1080/11956860.1998.11682469; Rasmussen LEL, 1999, PHYSIOL BEHAV, V67, P539, DOI 10.1016/S0031-9384(99)00114-6; Sukumar R., 1989, ASIAN ELEPHANT ECOLO	13	58	59	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2002	415	6875					975	976		10.1038/415975a	http://dx.doi.org/10.1038/415975a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875552				2022-12-28	WOS:000174075000028
J	Loomis, D; Marshall, SW; Wolf, SH; Runyan, CW; Butts, JD				Loomis, D; Marshall, SW; Wolf, SH; Runyan, CW; Butts, JD			Effectiveness of safety measures recommended for prevention of workplace homicide	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HIGH-RISK; VIOLENCE; INJURIES; WORK; OCCUPATIONS; INDUSTRIES	Context Homicide is the second leading cause of death on the job for US workers. Government agencies recommend that employers prevent violence against workers by adopting interventions originally designed to prevent robbery, but the effectiveness of these interventions is unknown. Objective To investigate the effectiveness of existing administrative and environmental interventions recommended for preventing workplace homicide. Design, Setting, and Participants Population-based case-control study of North Carolina workplaces where a worker had been killed between January 1, 1994, and March 31,1998, identified through a statewide medical examiner system (cases; n=105) and an industry-matched random sample of workplaces at risk during the same period, selected from business telephone listings (controls; n=210). Main Outcome Measure Risk of death of a worker due to homicide. Results Among environmental interventions, strong and consistent reductions in the risk of a worker being killed on the job were associated with bright exterior lighting (odds ratio [OR], 0.5; 95% confidence interval [CI], 0.3-1.0). Among administrative interventions, the largest beneficial effect was for staffing practices that prevented workers from being alone at night (OR, 0,4; 95% Cl, 0.2-0.9). Keeping doors closed during working hours was also associated consistently with substantially reduced risk (OR, 0.4; 95% Cl, 0.1-1.1) but was not statistically significant. Combinations of 5 or more administrative measures were associated with significantly lower levels of risk (OR, 0.1; 95% Cl, 0.0-0.5). Conclusions We found evidence suggesting that eliminating solo work at night could reduce the risk of homicide for workers. Keeping doors closed and using bright exterior lighting or combinations of administrative interventions also appear to be beneficial, but there was no evidence of effectiveness for a number of other recommended measures.	Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC USA; Univ N Carolina, Dept Hlth Behav & Hlth Educ, Chapel Hill, NC USA; Univ N Carolina, Dept Pathol, Off Chief Med Examiner, Chapel Hill, NC USA; N Carolina Dept Hlth & Human Serv, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Loomis, D (corresponding author), Univ N Carolina, Dept Epidemiol, CB-7435, Chapel Hill, NC 27599 USA.		Loomis, Dana/AAE-3988-2019	Loomis, Dana/0000-0003-3297-5200; Marshall, Stephen/0000-0002-2664-9233	ODCDC CDC HHS [R49/CCR402444] Funding Source: Medline	ODCDC CDC HHS		BELL CA, 1991, AM J PUBLIC HEALTH, V81, P729, DOI 10.2105/AJPH.81.6.729; *BUR LAB STAT, 1999, NAT CENS FAT OCC INJ; Casteel C, 2000, AM J PREV MED, V18, P99, DOI 10.1016/S0749-3797(00)00146-X; CASTILLO DN, 1994, J OCCUP ENVIRON MED, V36, P125, DOI 10.1097/00043764-199402000-00006; COOK PJ, 1987, J CRIM LAW CRIM, V78, P357, DOI 10.2307/1143453; *DAT US SERV DIV, 1992, CENS POP HOUS 1990 P; DAVIS H, 1987, AM J PUBLIC HEALTH, V77, P1290, DOI 10.2105/AJPH.77.10.1290; DAVIS H, 1987, AM J PUBLIC HEALTH, V77, P1524, DOI 10.2105/AJPH.77.12.1524; Erickson RJ, 1996, OCCUP MED, V11, P269; Erickson Rosemary, 1998, CONVENIENCE STORE SE; KRAUS JF, 1995, ANNU REV PUBL HEALTH, V16, P355; KRAUS JF, 1987, AM J PUBLIC HEALTH, V77, P1285, DOI 10.2105/AJPH.77.10.1285; Loomis D, 2001, AM J EPIDEMIOL, V154, P410, DOI 10.1093/aje/154.5.410; *NAT I OCC SAF HLT, 1995, NIOSH AL PREV HOM WO; *NAT I OCC SAF HLT, 1996, VIOL WORKPL RISK FAC; *NC STAT BUR INV, 1998, CRIM N CAR 1997; Nelson NA, 1996, AM J IND MED, V30, P438; *OCC SAF HLTH ADM, 1999, WORKPL VIOL; Occupational Safety and Health Administration, 1998, REC WORKPL VIOL PREV; Office of Management and Budget, 1987, STAND IND CLASS MAN; Runyan CW, 2000, AM J PREV MED, V18, P116, DOI 10.1016/S0749-3797(00)00147-1; Toscano G, 1996, OCCUP MED, V11, P227	22	44	46	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2002	287	8					1011	1017		10.1001/jama.287.8.1011	http://dx.doi.org/10.1001/jama.287.8.1011			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	525CX	11866649				2022-12-28	WOS:000174052100029
J	Wood, V; Gwilliam, R; Rajandream, MA; Lyne, M; Lyne, R; Stewart, A; Sgouros, J; Peat, N; Hayles, J; Baker, S; Basham, D; Bowman, S; Brooks, K; Brown, D; Brown, S; Chillingworth, T; Churcher, C; Collins, M; Connor, R; Cronin, A; Davis, P; Feltwell, T; Fraser, A; Gentles, S; Goble, A; Hamlin, N; Harris, D; Hidalgo, J; Hodgson, G; Holroyd, S; Hornsby, T; Howarth, S; Huckle, EJ; Hunt, S; Jagels, K; James, K; Jones, L; Jones, M; Leather, S; McDonald, S; McLean, J; Mooney, P; Moule, S; Mungall, K; Murphy, L; Niblett, D; Odell, C; Oliver, K; O'Neil, S; Pearson, D; Quail, MA; Rabbinowitsch, E; Rutherford, K; Rutter, S; Saunders, D; Seeger, K; Sharp, S; Skelton, J; Simmonds, M; Squares, R; Squares, S; Stevens, K; Taylor, K; Taylor, RG; Tivey, A; Walsh, S; Warren, T; Whitehead, S; Woodward, J; Volckaert, G; Aert, R; Robben, J; Grymonprez, B; Weltjens, I; Vanstreels, E; Rieger, M; Schafer, M; Muller-Auer, S; Gabel, C; Fuchs, M; Fritzc, C; Holzer, E; Moestl, D; Hilbert, H; Borzym, K; Langer, I; Beck, A; Lehrach, H; Reinhardt, R; Pohl, TM; Eger, P; Zimmermann, W; Wedler, H; Wambutt, R; Purnelle, B; Goffeau, A; Cadieu, E; Dreano, S; Gloux, S; Lelaure, V; Mottier, S; Galibert, F; Aves, SJ; Xiang, Z; Hunt, C; Moore, K; Hurst, SM; Lucas, M; Rochet, M; Gaillardin, C; Tallada, VA; Garzon, A; Thode, G; Daga, RR; Cruzado, L; Jimenez, J; Sanchez, M; del Rey, F; Benito, J; Dominguez, A; Revuelta, JL; Moreno, S; Armstrong, J; Forsburg, SL; Cerrutti, L; Lowe, T; McCombie, WR; Paulsen, I; Potashkin, J; Shpakovski, GV; Ussery, D; Barrell, BG; Nurse, P				Wood, V; Gwilliam, R; Rajandream, MA; Lyne, M; Lyne, R; Stewart, A; Sgouros, J; Peat, N; Hayles, J; Baker, S; Basham, D; Bowman, S; Brooks, K; Brown, D; Brown, S; Chillingworth, T; Churcher, C; Collins, M; Connor, R; Cronin, A; Davis, P; Feltwell, T; Fraser, A; Gentles, S; Goble, A; Hamlin, N; Harris, D; Hidalgo, J; Hodgson, G; Holroyd, S; Hornsby, T; Howarth, S; Huckle, EJ; Hunt, S; Jagels, K; James, K; Jones, L; Jones, M; Leather, S; McDonald, S; McLean, J; Mooney, P; Moule, S; Mungall, K; Murphy, L; Niblett, D; Odell, C; Oliver, K; O'Neil, S; Pearson, D; Quail, MA; Rabbinowitsch, E; Rutherford, K; Rutter, S; Saunders, D; Seeger, K; Sharp, S; Skelton, J; Simmonds, M; Squares, R; Squares, S; Stevens, K; Taylor, K; Taylor, RG; Tivey, A; Walsh, S; Warren, T; Whitehead, S; Woodward, J; Volckaert, G; Aert, R; Robben, J; Grymonprez, B; Weltjens, I; Vanstreels, E; Rieger, M; Schafer, M; Muller-Auer, S; Gabel, C; Fuchs, M; Fritzc, C; Holzer, E; Moestl, D; Hilbert, H; Borzym, K; Langer, I; Beck, A; Lehrach, H; Reinhardt, R; Pohl, TM; Eger, P; Zimmermann, W; Wedler, H; Wambutt, R; Purnelle, B; Goffeau, A; Cadieu, E; Dreano, S; Gloux, S; Lelaure, V; Mottier, S; Galibert, F; Aves, SJ; Xiang, Z; Hunt, C; Moore, K; Hurst, SM; Lucas, M; Rochet, M; Gaillardin, C; Tallada, VA; Garzon, A; Thode, G; Daga, RR; Cruzado, L; Jimenez, J; Sanchez, M; del Rey, F; Benito, J; Dominguez, A; Revuelta, JL; Moreno, S; Armstrong, J; Forsburg, SL; Cerrutti, L; Lowe, T; McCombie, WR; Paulsen, I; Potashkin, J; Shpakovski, GV; Ussery, D; Barrell, BG; Nurse, P			The genome sequence of Schizosaccharomyces pombe	NATURE			English	Article							TRANSFER-RNA GENES; FISSION YEAST; NUCLEOTIDE-SEQUENCE; FUNCTIONAL-ANALYSIS; MOLECULAR EVIDENCE; DNA; ORGANIZATION; CENTROMERE; DATABASE; REPEAT	We have sequenced and annotated the genome of fission yeast (Schizosaccharomyces pombe), which contains the smallest number of protein-coding genes yet recorded for a eukaryote: 4,824. The centromeres are between 35 and 110 kilobases (kb) and contain related repeats including a highly conserved 1.8-kb element. Regions upstream of genes are longer than in budding yeast (Saccharomyces cerevisiae), possibly reflecting more-extended control regions. Some 43% of the genes contain introns, of which there are 4,730. Fifty genes have significant similarity with human disease genes; half of these are cancer related. We identify highly conserved genes important for eukaryotic cell organization including those required for the cytoskeleton, compartmentation, cell-cycle control, proteolysis, protein phosphorylation and RNA splicing. These genes may have originated with the appearance of eukaryotic life. Few similarly conserved genes that are important for multicellular organization were identified, suggesting that the transition from prokaryotes to eukaryotes required more new genes than did the transition from unicellular to multicellular organization.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Canc Res UK London Res Inst, Computat Genome Anal Lab, London WC2A 3PX, England; Canc Res UK London Res Inst, Cell Cycle Lab, London WC2A 3PX, England; Katholieke Univ Leuven, Fac Agr & Appl Biol Sci, Lab Gene Technol, B-3001 Louvain, Belgium; Genotype GmbH, Mol Biol & Biotech Res, D-69259 Wilhelmsfeld, Germany; QIAGEN GmbH, D-40724 Hilden, Germany; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; GATC Biotech AG, D-78467 Constance, Germany; AGOWA GmbH, D-12489 Berlin, Germany; Catholic Univ Louvain, Unite Biochim Physiol, B-1348 Louvain, Belgium; Fac Med, UMR CNRS Genet & Dev 6061, F-35043 Rennes, France; Univ Exeter, Sch Biol Sci, Washington Singer Labs, Exeter EX4 4QG, Devon, England; Inst Natl Agron Paris Grignon, INRA, CNRS, URA1925,UMR216, F-78850 Thiverval Grignon, France; Univ Malaga, Fac Ciencias, Dept Genet, E-29071 Malaga, Spain; Univ Pablo de Olavide, Lab Andaluz Biol, Seville, Spain; Univ Salamanca, Edificio Dept, CSIC, Dept Microbiol & Genet,Inst Microbiol & Bioquim, Salamanca 37007, Spain; Univ Sussex, Brighton BN1 9QG, E Sussex, England; Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; TIGR, Rockville, MD 20850 USA; Finch Univ Hlth Sci Chicago Med Sch, N Chicago, IL 60064 USA; Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; Tech Univ Denmark, Bioctr DTU, Ctr Biol Sequence Anal, DK-2800 Kgs Lyngby, Denmark	Wellcome Trust Sanger Institute; Cancer Research UK; The Genome Analysis Centre (TGAC); Cancer Research UK; KU Leuven; QIAGEN GmbH; Max Planck Society; Universite Catholique Louvain; University of Exeter; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Universidad de Malaga; Universidad Pablo de Olavide; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; University of Sussex; Salk Institute; Stanford University; Cold Spring Harbor Laboratory; J. Craig Venter Institute; Chicago Medical School; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Technical University of Denmark	Rajandream, MA (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	mar@sanger.ac.uk	Moreno, Sergio/K-3671-2014; MARTINEZ, J JIMENEZ/I-7959-2017; Garzon, Andres/F-7009-2016; Daga, Rafael/P-8340-2014; Shpakovski, George V. Вячеславович/AAU-7443-2020; Paulsen, Ian T/K-3832-2012; Lowe, Todd Michael/ABJ-5261-2022; Quail, michael/ABE-6131-2020; Ussery, David/J-2026-2019; Rutherford, Kim/Y-7995-2018; Revuelta, Jose Luis/ABG-1502-2020; Wood, Valerie/Y-7759-2018; Tallada, Victor/F-5454-2016; Revuelta, Jose L/C-2324-2012; Vanstreels, Els/I-2366-2018; Lyne, Rachel/AAE-2189-2020; del Rey, Francisco/L-7132-2014; jimenez, juan/AAB-5357-2019	Moreno, Sergio/0000-0002-8039-1413; MARTINEZ, J JIMENEZ/0000-0002-3851-7393; Garzon, Andres/0000-0003-4299-7198; Daga, Rafael/0000-0001-5726-761X; Shpakovski, George V. Вячеславович/0000-0003-2851-7020; Paulsen, Ian T/0000-0001-9015-9418; Ussery, David/0000-0003-3632-5512; Rutherford, Kim/0000-0001-6277-726X; Revuelta, Jose Luis/0000-0001-7838-5308; Wood, Valerie/0000-0001-6330-7526; Tallada, Victor/0000-0001-9526-5957; Revuelta, Jose L/0000-0001-7838-5308; Vanstreels, Els/0000-0002-7814-8035; Lyne, Rachel/0000-0001-8050-402X; del Rey, Francisco/0000-0002-6517-7400; jimenez, juan/0000-0002-3851-7393; Sgouros, John G./0000-0002-9141-5257; Aves, Stephen/0000-0002-5600-900X; McCombie, W. Richard/0000-0003-1899-0682; Baker, Stephen/0000-0003-1308-5755; Murphy, Lee/0000-0001-6467-7449; Hunt, Sarah/0000-0002-8350-1235; Davis, Paul/0000-0001-5545-0824; Reinhardt, Richard/0000-0001-9376-2132; Forsburg, Susan L/0000-0002-4895-8598				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; [Anonymous], 1997, NATURE, V387, pS; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Ashburner M, 1999, GENETICS, V153, P179; Bairoch A, 1999, NUCLEIC ACIDS RES, V27, P49, DOI 10.1093/nar/27.1.49; BARNITZ JT, 1982, FEBS LETT, V143, P129, DOI 10.1016/0014-5793(82)80288-3; Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; BAUM M, 1994, MOL BIOL CELL, V5, P747, DOI 10.1091/mbc.5.7.747; Birney E, 1996, NUCLEIC ACIDS RES, V24, P2730, DOI 10.1093/nar/24.14.2730; Blandin G, 2000, FEBS LETT, V487, P31, DOI 10.1016/S0014-5793(00)02275-4; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CARR AM, 1989, MOL GEN GENET, V218, P41, DOI 10.1007/BF00330563; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Chervitz SA, 1998, SCIENCE, V282, P2022, DOI 10.1126/science.282.5396.2022; CHIKASHIGE Y, 1989, CELL, V57, P739, DOI 10.1016/0092-8674(89)90789-7; CLARKE L, 1990, MOL CELL BIOL, V10, P1863, DOI 10.1128/MCB.10.5.1863; Costanzo MC, 2000, NUCLEIC ACIDS RES, V28, P73, DOI 10.1093/nar/28.1.73; Davis L, 2001, P NATL ACAD SCI USA, V98, P8395, DOI 10.1073/pnas.121005598; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; EGEL R, 1993, CURR GENET, V24, P179, DOI 10.1007/BF00324684; Erickson HP, 1998, TRENDS CELL BIOL, V8, P133, DOI 10.1016/S0962-8924(98)01237-9; FANTES P, 2000, YEAST NUCL; FINK GR, 1987, CELL, V49, P5, DOI 10.1016/0092-8674(87)90746-X; FISHEL B, 1988, MOL CELL BIOL, V8, P754, DOI 10.1128/MCB.8.2.754; Fisher DL, 1996, EMBO J, V15, P850, DOI 10.1002/j.1460-2075.1996.tb00420.x; FUNK M, 1989, MOL GEN GENET, V219, P153, DOI 10.1007/BF00261171; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Gomez M, 1999, EMBO J, V18, P5683, DOI 10.1093/emboj/18.20.5683; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Gu ZL, 2000, GENE, V259, P81, DOI 10.1016/S0378-1119(00)00434-0; Harris DE, 2001, METH MOL B, V175, P217; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; HIETER P, 1985, CELL, V42, P913, DOI 10.1016/0092-8674(85)90287-9; HOHEISEL JD, 1993, CELL, V73, P109, DOI 10.1016/0092-8674(93)90164-L; Humphrey T, 2000, MUTAT RES-FUND MOL M, V451, P211, DOI 10.1016/S0027-5107(00)00051-8; Hunt C, 2001, YEAST, V18, P355, DOI 10.1002/1097-0061(20010315)18:4<355::AID-YEA676>3.0.CO;2-P; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Hyman AA, 1995, ANNU REV CELL DEV BI, V11, P471, DOI 10.1146/annurev.cb.11.110195.002351; Itoh T, 1999, DNA Res, V6, P299, DOI 10.1093/dnares/6.5.299; KABSCH W, 1995, FASEB J, V9, P167, DOI 10.1096/fasebj.9.2.7781919; Kaneko T, 2000, DNA RES, V7, P381, DOI 10.1093/dnares/7.6.381; Kim JM, 1998, GENOME RES, V8, P464, DOI 10.1101/gr.8.5.464; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LANG BF, 1987, EUR J BIOCHEM, V169, P527, DOI 10.1111/j.1432-1033.1987.tb13641.x; LEUPOLD U., 1950, Comptes rendus des Travaux du Laboratoire Carlsberg, V24, P381; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Lopez JB, 1999, INT J BIOL MARKER, V14, P172, DOI 10.1177/172460089901400309; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lundin LG, 1999, SEMIN CELL DEV BIOL, V10, P523, DOI 10.1006/scdb.1999.0333; MANIATIS T, 1987, NATURE, V325, P673, DOI 10.1038/325673a0; MAO J, 1982, NUCLEIC ACIDS RES, V10, P487, DOI 10.1093/nar/10.2.487; Mewes HW, 2000, NUCLEIC ACIDS RES, V28, P37, DOI 10.1093/nar/28.1.37; MITCHISON JM, 1957, EXP CELL RES, V13, P244, DOI 10.1016/0014-4827(57)90005-8; MIZUSAKI J, 1993, SENSOR ACTUAT B-CHEM, V13, P121, DOI 10.1016/0925-4005(93)85340-G; MORIMYO M, 1998, BIODEFENCE MECH ENV, P115; MURAKAMI S, 1991, CHROMOSOMA, V101, P214, DOI 10.1007/BF00365153; NAGAWA F, 1985, P NATL ACAD SCI USA, V82, P8557, DOI 10.1073/pnas.82.24.8557; NAKASEKO Y, 1986, EMBO J, V5, P1011, DOI 10.1002/j.1460-2075.1986.tb04316.x; Partridge JF, 2000, GENE DEV, V14, P783; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Robertson HM, 2000, GENOME RES, V10, P192, DOI 10.1101/gr.10.2.192; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; RUSSELL PR, 1985, GENE, V40, P125, DOI 10.1016/0378-1119(85)90031-9; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SCHAAK J, 1982, NUCLEIC ACIDS RES, V10, P2851, DOI 10.1093/nar/10.9.2851; Sipiczki M, 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-2-reviews1011, DOI 10.1186/GB-2000-1-2-REVIEWS1011]; SMITH CL, 1987, NUCLEIC ACIDS RES, V15, P4481, DOI 10.1093/nar/15.11.4481; SONNHAMMER ELL, 1994, COMPUT APPL BIOSCI, V10, P301; Stoesser G, 1999, NUCLEIC ACIDS RES, V27, P18, DOI 10.1093/nar/27.1.18; TAKAHASHI K, 1991, J MOL BIOL, V218, P13, DOI 10.1016/0022-2836(91)90867-6; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wood V, 2001, COMP FUNCT GENOM, V2, P143, DOI 10.1002/cfg.86	78	1183	6417	1	192	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 21	2002	415	6874					871	880		10.1038/nature724	http://dx.doi.org/10.1038/nature724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859360	Green Published, Bronze			2022-12-28	WOS:000173941000036
J	Yin, QZ; Jacobsen, SB; Yamashita, K				Yin, QZ; Jacobsen, SB; Yamashita, K			Diverse supernova sources of pre-solar material inferred from molybdenum isotopes in meteorites	NATURE			English	Article							PRESOLAR GRAINS; SILICON-CARBIDE; ABUNDANCES; SYSTEM; CHONDRITES; SURVIVAL; ELEMENTS; STARS; DISKS	Variations in the isotopic composition of some components in primitive meteorites demonstrate that the pre-solar material was not completely homogenized, nor was it processed at sufficiently high temperatures to erase the signatures of the diverse stellar sources(1). This is in accord with the observation that accretion disks of young stellar objects are at relatively low temperatures(2). Carbonaceous chondrites are considered to represent the 'average' Solar System composition; the rare pre-solar grains in the matrixes of carbonaceous chondrites(3) have been used to identify some sources of the pre-solar material. Here we report that the molybdenum isotopic composition of bulk carbonaceous chondrites is distinctly different from the accepted average solar value. We show that the Mo data require the presence of material produced in at least two different r-processes, and that the contribution from the p-process material is decoupled from the r-process, all occurring in supernova explosions. This is consistent with the emerging picture of diverse sources inferred from short-lived isotopes in the early Solar System(4) and elemental analyses of metal-poor stars(5,6).	Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 01238 USA	Harvard University	Jacobsen, SB (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 01238 USA.	jacobsen@neodymium.harvard.edu	Yin, Qing-Zhu/B-8198-2009; YAMASHITA, Katsuyuki/B-1887-2011; Jacobsen, Stein/B-1759-2013; Jacobsen, Stein/ABA-1063-2021	Yin, Qing-Zhu/0000-0002-4445-5096; Jacobsen, Stein/0000-0003-2164-0720				Alexander CMO, 2001, SCIENCE, V293, P64; ALEXANDER CMOD, 1995, GEOCHIM COSMOCHIM AC, V59, P3247, DOI 10.1016/0016-7037(95)00208-H; ANDERS E, 1993, METEORITICS, V28, P490, DOI 10.1111/j.1945-5100.1993.tb00274.x; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; Arlandini C, 1999, ASTROPHYS J, V525, P886, DOI 10.1086/307938; BECKWITH SVW, 1990, ASTRON J, V99, P924, DOI 10.1086/115385; Cameron AGW, 2001, ASTROPHYS J, V562, P456, DOI 10.1086/323869; Cassen P, 1997, AIP CONF PROC, P697, DOI 10.1063/1.53324; DAUPHAS N, IN PRESS ASTROPHYS J; Huss GR, 1997, AIP CONF PROC, P721, DOI 10.1063/1.53338; KASHIV Y, 2001, LUNAR PLANET SCI, V32, pA2192; MCCULLOCH MT, 1978, GEOPHYS RES LETT, V5, P599, DOI 10.1029/GL005i007p00599; Meyer BS, 2000, ASTROPHYS J, V540, pL49, DOI 10.1086/312865; Nicolussi GK, 1998, GEOCHIM COSMOCHIM AC, V62, P1093, DOI 10.1016/S0016-7037(98)00038-6; NIEDERER FR, 1985, GEOCHIM COSMOCHIM AC, V49, P835, DOI 10.1016/0016-7037(85)90176-0; Nittler LR, 1998, NATURE, V393, P222, DOI 10.1038/30377; PELLIN MJ, 1999, LUNAR PLANET SCI, V30, pA1969; Qian YZ, 2001, ASTROPHYS J, V552, pL55, DOI 10.1086/320266; ROTARU M, 1992, NATURE, V358, P465, DOI 10.1038/358465a0; Sneden C, 2000, ASTROPHYS J, V533, pL139, DOI 10.1086/312631; Wallerstein G, 1997, REV MOD PHYS, V69, P995, DOI 10.1103/RevModPhys.69.995; YIN QZ, 1998, LUNAR PLANET SCI, V29, pA1802; YIN QZ, 2001, LUNAR PLANET SCI, V32, pA2128; YIN QZ, 1999, 9 ANN VM GOLDSCHM C, pA7637; YIN QZ, 2000, LUNAR PLANET SCI, V31, pA1920; Zinner E, 1997, AIP CONF PROC, P3, DOI 10.1063/1.53326	27	97	101	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 21	2002	415	6874					881	883		10.1038/415881a	http://dx.doi.org/10.1038/415881a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859361				2022-12-28	WOS:000173941000037
J	Schwartz, RS				Schwartz, RS			A new element in the mechanism of asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article																		Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544	3	16	20	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2002	346	11					857	858		10.1056/NEJM200203143461114	http://dx.doi.org/10.1056/NEJM200203143461114			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529YM	11893801				2022-12-28	WOS:000174328900013
J	Udem, T; Holzwarth, R; Hansch, TW				Udem, T; Holzwarth, R; Hansch, TW			Optical frequency metrology	NATURE			English	Review							1S-2S TRANSITION FREQUENCY; PHASE-CONTROL; LIGHT; GENERATION; HYDROGEN; SPECTROSCOPY; MICROWAVE; DIVISION; FIBERS; SINGLE		Max Planck Inst Quantum Opt, D-85748 Garching, Germany	Max Planck Society	Udem, T (corresponding author), Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany.	thomas.udem@mpq.mpg.de						Apolonski A, 2000, PHYS REV LETT, V85, P740, DOI 10.1103/PhysRevLett.85.740; Becker T, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.051802; Bernard JE, 1999, PHYS REV LETT, V82, P3228, DOI 10.1103/PhysRevLett.82.3228; Birks TA, 1997, OPT LETT, V22, P961, DOI 10.1364/OL.22.000961; Birks TA, 2000, OPT LETT, V25, P1415, DOI 10.1364/OL.25.001415; BLOEMBERGEN N, 1977, NONLINEAR SPECTROSCO; CHEBOTAYEV VP, 1990, APPL PHYS B-PHOTO, V50, P1, DOI 10.1007/BF00330084; Diddams SA, 2000, PHYS REV LETT, V84, P5102, DOI 10.1103/PhysRevLett.84.5102; Diddams SA, 2002, OPT LETT, V27, P58, DOI 10.1364/OL.27.000058; Diddams SA, 2001, SCIENCE, V293, P825, DOI 10.1126/science.1061171; Dirac P. A. M., 1937, NATURE, V139, P323, DOI [10.1038/139323a0, DOI 10.1038/139323A0]; Drescher M, 2001, SCIENCE, V291, P1923, DOI 10.1126/science.1058561; DUBE P, 2002, P 6 S FREQ STAND MET, P489; ECKSTEIN JN, 1978, PHYS REV LETT, V40, P847, DOI 10.1103/PhysRevLett.40.847; Ell R, 2001, OPT LETT, V26, P373, DOI 10.1364/OL.26.000373; EVENSON KM, 1973, APPL PHYS LETT, V22, P192, DOI 10.1063/1.1654607; FERGUSON AI, 1979, APPL PHYS, V18, P257, DOI 10.1007/BF00885511; Hansch T. W., 1989, HYDROGEN ATOM, P93; HANSCH TW, 1994, FRONTIERS LASER SPEC; HENSLEY JM, 2001, THESIS STANFORD U; Holzwarth R, 2000, PHYS REV LETT, V85, P2264, DOI 10.1103/PhysRevLett.85.2264; Holzwarth R, 2001, APPL PHYS B-LASERS O, V73, P269, DOI 10.1007/s003400100633; Jones DJ, 2000, SCIENCE, V288, P635, DOI 10.1126/science.288.5466.635; KANE DM, 1986, APPL PHYS B-PHOTO, V39, P171, DOI 10.1007/BF00697415; Karshenboim SG, 2000, CAN J PHYS, V78, P639, DOI 10.1139/cjp-78-7-639; LEA SN, 2002, P 6 S FREQ STAND MET, P144; MADEJ AA, 2001, FREQUENCY MEASUREMEN, V79, P153; NEVSKY A, 2001, OPT COMMUN, V263, P192; Niering M, 2000, PHYS REV LETT, V84, P5496, DOI 10.1103/PhysRevLett.84.5496; Paulus GG, 2001, NATURE, V414, P182, DOI 10.1038/35102520; POKASOV PV, 2002, P 6 S FREQ STAND MET, P510; Ranka JK, 2000, OPT LETT, V25, P25, DOI 10.1364/OL.25.000025; Reichert J, 2000, PHYS REV LETT, V84, P3232, DOI 10.1103/PhysRevLett.84.3232; Reichert J, 1999, OPT COMMUN, V172, P59, DOI 10.1016/S0030-4018(99)00491-5; RIEHLE F, 2001, FREQUENCY MEASUREMEN, P95; Salomon C, 2001, AIP CONF PROC, V551, P23, DOI 10.1063/1.1354337; Schnatz H, 1996, PHYS REV LETT, V76, P18, DOI 10.1103/PhysRevLett.76.18; Schwob C, 1999, PHYS REV LETT, V82, P4960, DOI 10.1103/PhysRevLett.82.4960; Schwob C, 2001, PHYS REV LETT, V86, P4193, DOI 10.1103/PhysRevLett.86.4193; Stenger J, 2001, OPT LETT, V26, P1589, DOI 10.1364/OL.26.001589; Stenger J, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.021802; Telle HR, 1999, APPL PHYS B-LASERS O, V69, P327, DOI 10.1007/s003400050813; TELLE HR, 1990, OPT LETT, V15, P532, DOI 10.1364/OL.15.000532; TELLE HR, 1996, FREQUENCY CONTROL SE, P137; Udem T., 1999, Proceedings of the 1999 Joint Meeting of the European Frequency and Time Forum and the IEEE International Frequency Control Symposium (Cat. No.99CH36313), P620, DOI 10.1109/FREQ.1999.841383; Udem T, 1999, OPT LETT, V24, P881, DOI 10.1364/OL.24.000881; Udem T, 2001, PHYS REV LETT, V86, P4996, DOI 10.1103/PhysRevLett.86.4996; Udem T, 1997, PHYS REV LETT, V79, P2646, DOI 10.1103/PhysRevLett.79.2646; Udem T, 1999, PHYS REV LETT, V82, P3568, DOI 10.1103/PhysRevLett.82.3568; UDEM T, 1997, THESIS LUDWIGMAXIMIL; VESSOT RFC, 1980, PHYS REV LETT, V45, P2081, DOI 10.1103/PhysRevLett.45.2081; von Zanthier J, 2000, OPT LETT, V25, P1729, DOI 10.1364/OL.25.001729; Wadsworth WJ, 2000, ELECTRON LETT, V36, P53, DOI 10.1049/el:20000134; Webb JK, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.091301; WICHT A, IN PRESS P 6 S FREQ; WINELAND DJ, 1989, HYDROGEN ATOM, P123; Xu L, 1996, OPT LETT, V21, P2008, DOI 10.1364/OL.21.002008; Ye J, 2000, PHYS REV LETT, V85, P3797, DOI 10.1103/PhysRevLett.85.3797	58	2174	2253	42	687	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2002	416	6877					233	237		10.1038/416233a	http://dx.doi.org/10.1038/416233a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894107				2022-12-28	WOS:000174348100050
J	Kuhn, RJ; Zhang, W; Rossmann, MG; Pletnev, SV; Corver, J; Lenches, E; Jones, CT; Mukhopadhyay, S; Chipman, PR; Strauss, EG; Baker, TS; Strauss, JH				Kuhn, RJ; Zhang, W; Rossmann, MG; Pletnev, SV; Corver, J; Lenches, E; Jones, CT; Mukhopadhyay, S; Chipman, PR; Strauss, EG; Baker, TS; Strauss, JH			Structure of dengue virus: Implications for flavivirus organization, maturation, and fusion	CELL			English	Article							BORNE ENCEPHALITIS-VIRUS; ENVELOPE PROTEIN-E; RECOMBINANT SUBVIRAL PARTICLES; SEMLIKI-FOREST-VIRUS; MEMBRANE-FUSION; 3-DIMENSIONAL STRUCTURE; ANGSTROM RESOLUTION; MODEL SYSTEM; GLYCOPROTEIN; REPLICATION	The first structure of a flavivirus has been determined by using a combination of cryoelectron microscopy and fitting of the known structure of glycoprotein E into the electron density map. The virus core, within a lipid bilayer, has a less-ordered structure than the external, icosahedral scaffold of 90 glycoprotein E dimers. The three E monomers per icosahedral asymmetric unit do not have quasiequivalent symmetric environments. Difference maps indicate the location of the small membrane protein M relative to the overlaying scaffold of E dimers. The structure suggests that flaviviruses, and by analogy also alphaviruses, employ a fusion mechanism in which the distal beta barrels of domain II of the glycoprotein E are inserted into the cellular membrane.	Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; California Institute of Technology	Kuhn, RJ (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.		Kuhn, Richard/AAR-2722-2021	Kuhn, Richard/0000-0003-4148-1026; , Timothy/0000-0001-6543-8968; Chipman, Paul/0000-0003-3652-4087; Corver, Jeroen/0000-0002-9262-5475	NIAID NIH HHS [AI10793, AI45976, P01 AI045976, AI20612, R01 AI020612] Funding Source: Medline; NIGMS NIH HHS [GM08296, T32 GM008296] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI010793, R01AI020612, R01AI010793, R22AI020612, P01AI045976] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008296] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLISON SL, 1995, J VIROL, V69, P695, DOI 10.1128/JVI.69.2.695-700.1995; Allison SL, 1999, J VIROL, V73, P5605, DOI 10.1128/JVI.73.7.5605-5612.1999; Allison SL, 2001, J VIROL, V75, P4268, DOI 10.1128/JVI.75.9.4268-4275.2001; ALLISON SL, 1995, J VIROL, V69, P5816, DOI 10.1128/JVI.69.9.5816-5820.1995; Baker TS, 1999, MICROBIOL MOL BIOL R, V63, P862, DOI 10.1128/MMBR.63.4.862-922.1999; Burke DS, 2001, FIELDS VIROLOGY, P1043, DOI 10.1093/emboj/cdg270; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; CHEN ZG, 1989, SCIENCE, V245, P154, DOI 10.1126/science.2749253; CHENG RH, 1995, CELL, V80, P621; Corver J, 2000, VIROLOGY, V269, P37, DOI 10.1006/viro.1999.0172; Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4; Forsell K, 2000, EMBO J, V19, P5081, DOI 10.1093/emboj/19.19.5081; HAHN YS, 1988, VIROLOGY, V162, P167, DOI 10.1016/0042-6822(88)90406-0; HEINZ FX, 1994, VIROLOGY, V198, P109, DOI 10.1006/viro.1994.1013; Heinz FX, 2000, ADV VIRUS RES, V55, P231, DOI 10.1016/S0065-3527(00)55005-2; HEINZ FX, 1991, J VIROL, V65, P5579, DOI 10.1128/JVI.65.10.5579-5583.1991; Kielian M, 1996, J CELL BIOL, V134, P863, DOI 10.1083/jcb.134.4.863; KIELIAN M, 1995, ADV VIRUS RES, V45, P113, DOI 10.1016/S0065-3527(08)60059-7; LARSON SB, 1993, J MOL BIOL, V231, P375, DOI 10.1006/jmbi.1993.1289; Lee S, 1996, STRUCTURE, V4, P531, DOI 10.1016/S0969-2126(96)00059-7; LENARD J, 1980, TOGAVIRUSES, P335; Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8; LINDENBACH BD, 2001, FIELDS VIROLOGY, P991; MANDL CW, 1989, J VIROL, V63, P564, DOI 10.1128/JVI.63.2.564-571.1989; Mandl CW, 2001, J VIROL, V75, P5627, DOI 10.1128/JVI.75.12.5627-5637.2001; PAREDES AM, 1993, P NATL ACAD SCI USA, V90, P9095, DOI 10.1073/pnas.90.19.9095; Pletnev SV, 2001, CELL, V105, P127, DOI 10.1016/S0092-8674(01)00302-6; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Roehrig JT, 1998, VIROLOGY, V246, P317, DOI 10.1006/viro.1998.9200; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; Rossmann MG, 2000, ACTA CRYSTALLOGR D, V56, P1341, DOI 10.1107/S0907444900009562; Schulz GE, 2000, CURR OPIN STRUC BIOL, V10, P443, DOI 10.1016/S0959-440X(00)00120-2; Skehel JJ, 1998, CELL, V95, P871, DOI 10.1016/S0092-8674(00)81710-9; Skoging U, 1996, STRUCTURE, V4, P519, DOI 10.1016/S0969-2126(96)00058-5; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Strauss JH, 2001, CELL, V105, P5, DOI 10.1016/S0092-8674(01)00291-4; Subramaniam S, 2000, NATURE, V406, P653, DOI 10.1038/35020614; Vashishtha M, 1998, J CELL BIOL, V140, P91, DOI 10.1083/jcb.140.1.91; *WHO, 1998, 117 WHO	42	1125	1187	3	164	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 8	2002	108	5					717	725		10.1016/S0092-8674(02)00660-8	http://dx.doi.org/10.1016/S0092-8674(02)00660-8			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	529TN	11893341	Green Accepted, Bronze			2022-12-28	WOS:000174314800014
J	Teruel, MN; Meyer, T				Teruel, MN; Meyer, T			Parallel single-cell monitoring of receptor-triggered membrane translocation of a calcium-sensing protein module	SCIENCE			English	Article							KINASE-C-ALPHA; DOMAIN; DESENSITIZATION; ENTRY; SITES	Time courses of translocation of fluorescently conjugated proteins to the plasma membrane were simultaneously measured in thousands of individual rat basophilic leukemia cells. We found that the C2 domain-a calcium-sensing, lipid-binding protein module that is an essential regulator of protein kinase C and numerous other proteins-targeted proteins to the plasma membrane transiently if calcium was released from internal stores, and persistently in response to entry of extracellular calcium across the plasma membrane. The C2 domain translocation time courses of stimulated cells clustered into only two primary modes. Hence, the reversible recruitment of families of signaling proteins from one cellular compartment to another is a rapid bifurcation mechanism for inducing discrete states of cellular signaling net works.	Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA	Stanford University	Meyer, T (corresponding author), Stanford Univ, Sch Med, Dept Mol Pharmacol, 269 Campus Dr, Stanford, CA 94305 USA.			Teruel, Mary/0000-0002-2854-3598; Meyer, Tobias/0000-0003-4339-3804	NCI NIH HHS [CA83229] Funding Source: Medline; NHGRI NIH HHS [HG00057] Funding Source: Medline; NIGMS NIH HHS [GM062144] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R33CA083229, R21CA083229] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R43HG000057, R44HG000057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062144] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALI H, 1994, J BIOL CHEM, V269, P24557; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Boue-Grabot E, 2000, J BIOL CHEM, V275, P10190, DOI 10.1074/jbc.275.14.10190; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Codazzi F, 2001, CURR BIOL, V11, P1089, DOI 10.1016/S0960-9822(01)00326-8; Corbalan-Garcia S, 1999, BIOCHEM J, V337, P513, DOI 10.1042/0264-6021:3370513; Dessen A, 1999, CELL, V97, P349, DOI 10.1016/S0092-8674(00)80744-8; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; GOUY H, 1990, EUR J IMMUNOL, V20, P2269, DOI 10.1002/eji.1830201016; HARDMAN JG, 1996, GOODMAN GILMANS PHAR, P38; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; TERUEL M, UNPUB; Teruel MN, 1997, BIOPHYS J, V73, P1785, DOI 10.1016/S0006-3495(97)78209-2; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329	22	73	81	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1910	1912		10.1126/science.1065028	http://dx.doi.org/10.1126/science.1065028			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884760				2022-12-28	WOS:000174299500045
J	Yang, CH; Axelrod, JD; Simon, MA				Yang, CH; Axelrod, JD; Simon, MA			Regulation of Frizzled by fat-like cadherins during planar polarity signaling in the Drosophila compound eye	CELL			English	Article							4-JOINTED GENE; CELL POLARITY; ENCODES; WINGLESS; MEMBER; SUPERFAMILY; LOCUS; NOTCH; AXIS; MORPHOGENESIS	Planar polarity is evident in the coordinated orientation of ommatidia in the Drosophila eye. This process requires that the R3 photoreceptor precursor of each ommatidium have a higher level of Frizzled signaling than its neighboring R4 precursor. We show that two cadherin superfamily members, Fat and Dachsous, and the transmembrane/secreted protein Four-jointed play important roles in this process. Our data support a model in which the bias of Frizzled signaling between the R3/R4 precursors results from higher Fat function in the precursor cell closer to the equator, which becomes R3, We also provide evidence that positional information regulating Fat action is provided by graded expression of Dachsous across the eye and the action of Four-jointed, which is expressed in an opposing expression gradient and appears to modulate Dachsous function.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University; Stanford University	Simon, MA (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.				NEI NIH HHS [R01EY9845] Funding Source: Medline; NIGMS NIH HHS [R01GM59823-01] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059823] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adler PN, 1997, CURR BIOL, V7, P940, DOI 10.1016/S0960-9822(06)00413-1; Adler PN, 1998, DEVELOPMENT, V125, P959; Adler PN, 2001, CURR OPIN CELL BIOL, V13, P635, DOI 10.1016/S0955-0674(00)00263-5; ADLER PN, 1990, GENETICS, V126, P401; ADLER PN, 1987, DEV GENET, V8, P99, DOI 10.1002/dvg.1020080206; Alagramam KN, 2001, NAT GENET, V27, P99, DOI 10.1038/83837; Axelrod JD, 2001, GENE DEV, V15, P1182; Bhanot P, 1999, DEVELOPMENT, V126, P4175; Brodsky MH, 1996, DEV BIOL, V173, P428, DOI 10.1006/dbio.1996.0038; BRYANT PJ, 1988, DEV BIOL, V129, P541, DOI 10.1016/0012-1606(88)90399-5; Buckles GR, 2001, DEVELOPMENT, V128, P3533; Chae J, 1999, DEVELOPMENT, V126, P5421; CLARK HF, 1995, GENE DEV, V9, P1530, DOI 10.1101/gad.9.12.1530; Cooper MTD, 1999, NATURE, V397, P526, DOI 10.1038/17395; Eaton S, 1997, CURR OPIN CELL BIOL, V9, P860, DOI 10.1016/S0955-0674(97)80089-0; Fanto M, 1999, NATURE, V397, P523, DOI 10.1038/17389; Irvine KD, 1997, CURR OPIN CELL BIOL, V9, P867, DOI 10.1016/S0955-0674(97)80090-7; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; LAWRENCE PA, 1966, J EXP BIOL, V44, P607; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; Mohr O, 1923, STUDIA MENDELIANA AD, P266; Pai LM, 1997, DEVELOPMENT, V124, P2255; PEIFER M, 1990, CELL, V63, P1167, DOI 10.1016/0092-8674(90)90413-9; Raphael Y, 2001, HEARING RES, V151, P237, DOI 10.1016/S0378-5955(00)00233-1; Shimada Y, 2001, CURR BIOL, V11, P859, DOI 10.1016/S0960-9822(01)00233-0; Shulman JM, 1998, TRENDS GENET, V14, P452, DOI 10.1016/S0168-9525(98)01584-4; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Strutt H, 1999, CURR OPIN GENET DEV, V9, P442, DOI 10.1016/S0959-437X(99)80067-7; STUMPF HF, 1966, NATURE, V212, P430, DOI 10.1038/212430a0; TOMLINSON A, 1987, DEV BIOL, V123, P264, DOI 10.1016/0012-1606(87)90448-9; Tomlinson A, 1999, DEVELOPMENT, V126, P5725; TREISMAN JE, 1995, DEVELOPMENT, V121, P3519; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; VILLANO JL, 1995, DEVELOPMENT, V121, P2767; VINSON CR, 1989, NATURE, V338, P263, DOI 10.1038/338263a0; Wehrli M, 1998, DEVELOPMENT, V125, P1421; Wolff Tanya, 1993, P1277; XU T, 1993, DEVELOPMENT, V117, P1223; Zeidler MP, 1999, CURR BIOL, V9, P1363, DOI 10.1016/S0960-9822(00)80081-0; Zeidler MP, 2000, DEV BIOL, V228, P181, DOI 10.1006/dbio.2000.9940; ZHENG L, 1995, DEVELOPMENT, V121, P3045	41	297	305	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 8	2002	108	5					675	688		10.1016/S0092-8674(02)00658-X	http://dx.doi.org/10.1016/S0092-8674(02)00658-X			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	529TN	11893338	Bronze			2022-12-28	WOS:000174314800011
J	Schieve, LA; Meikle, SF; Ferre, C; Peterson, HB; Jeng, G; Wilcox, LS				Schieve, LA; Meikle, SF; Ferre, C; Peterson, HB; Jeng, G; Wilcox, LS			Low and very low birth weight in infants conceived with use of assisted reproductive technology.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IN-VITRO FERTILIZATION; SINGLETON PREGNANCIES; INVITRO FERTILIZATION; EMBRYO TRANSFER; RISK; DELIVERIES; IVF	Background: The increased risk of low birth weight associated with the use of assisted reproductive technology has been attributed largely to the higher rate of multiple gestations associated with such technology. It is uncertain, however, whether singleton infants conceived with the use of assisted reproductive technology may also have a higher risk of low birth weight than those who are conceived spontaneously. Methods: We used population-based data to compare the rates of low birth weight (lessthan/equal 2500 g) and very low birth weight (<1500 g) among infants conceived with assisted reproductive technology with the rates in the general population. Results: We studied 42,463 infants who were born in 1996 and 1997 and conceived with assisted reproductive technology and used as a comparison group 3,389,098 infants born in the United States in 1997. Among singleton infants born at 37 weeks of gestation or later, those conceived with assisted reproductive technology had a risk of low birth weight that was 2.6 times that in the general population (95 percent confidence interval, 2.4 to 2.7). The use of assisted reproductive technology was associated with an increased rate of multiple gestations; however, its use was not associated with a further increase in the risk of low birth weight in multiple births. Among twins, the ratio of the rate of low birth weight after the use of assisted reproductive technology to the rate in the general population was 1.0 (95 percent confidence interval, 1.0 to 1.1). Infants conceived with assisted reproductive technology accounted for 0.6 percent of all infants born to mothers who were 20 years of age or older in 1997, but for 3.5 percent of low-birth-weight and 4.3 percent of very-low-birth-weight infants. Conclusions: The use of assisted reproductive technology accounts for a disproportionate number of low-birth-weight and very-low-birth-weight infants in the United States, in part because of absolute increases in multiple gestations and in part because of higher rates of low birth weight among singleton infants conceived with this technology.	CDCP, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Schieve, LA (corresponding author), CDCP, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Mailstop K-34,4770 Buford Hwy NE, Atlanta, GA 30341 USA.							ALBERMAN E, 1994, EPIDEMIOLOGY CHILDHO, P49; [Anonymous], 2000, MMWR MORB MORTAL WKL, V49, P535; BERAL V, 1990, BMJ-BRIT MED J, V300, P1229; Bergh T, 1999, LANCET, V354, P1579, DOI 10.1016/S0140-6736(99)04345-7; *CDCP, 2000, 1998 ASS REPR TECHN; Daniel Y, 2000, FERTIL STERIL, V74, P683, DOI 10.1016/S0015-0282(00)01491-6; Dhont M, 1999, AM J OBSTET GYNECOL, V181, P688, DOI 10.1016/S0002-9378(99)70514-4; FRIEDLER S, 1992, HUM REPROD, V7, P1159, DOI 10.1093/oxfordjournals.humrep.a137813; GISSLER M, 1995, HUM REPROD, V10, P1856, DOI 10.1093/oxfordjournals.humrep.a136191; Guyer B, 1999, PEDIATRICS, V104, P1229, DOI 10.1542/peds.104.6.1229; Henriksen TB, 1997, OBSTET GYNECOL, V89, P594; Hills, 1993, STAT MODELS EPIDEMIO; JAUNIAUX E, 1990, OBSTET GYNECOL, V76, P61; JOHNSON MR, 1995, EUR J OBSTET GYN R B, V59, P193, DOI 10.1016/0028-2243(95)02040-Y; JOHNSON MR, 1993, HUM REPROD, V8, P323, DOI 10.1093/oxfordjournals.humrep.a138044; LOGEROTLEBRUN H, 1995, FERTIL STERIL, V64, P746; Maman E, 1998, FERTIL STERIL, V70, P240, DOI 10.1016/S0015-0282(98)00160-5; Martin JA, 1999, NATL VITAL STAT REPO, V47; McElrath TF, 1997, OBSTET GYNECOL, V90, P600, DOI 10.1016/S0029-7844(97)00362-1; *NAT CTR HLTH STAT, 1997, NAT PUBL US TAP; OLIVENNES F, 1993, HUM REPROD, V8, P1297, DOI 10.1093/oxfordjournals.humrep.a138245; Sundstrom I, 1997, ACTA OBSTET GYN SCAN, V76, P238, DOI 10.1111/j.1600-0412.1997.tb07852.x; TANBO T, 1995, OBSTET GYNECOL, V86, P188, DOI 10.1016/0029-7844(95)00159-O; VERLAENEN H, 1995, OBSTET GYNECOL, V86, P906, DOI 10.1016/0029-7844(95)00322-I; Westergaard HB, 1999, HUM REPROD, V14, P1896, DOI 10.1093/humrep/14.7.1896; WILLIAMS MA, 1991, FERTIL STERIL, V56, P668	26	722	765	0	49	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2002	346	10					731	737		10.1056/NEJMoa010806	http://dx.doi.org/10.1056/NEJMoa010806			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527UA	11882728	Bronze			2022-12-28	WOS:000174205000003
J	Winston, FK; Kallan, MJ; Elliott, MR; Menon, RA; Durbin, DR				Winston, FK; Kallan, MJ; Elliott, MR; Menon, RA; Durbin, DR			Risk of injury to child passengers in compact extended-cab pickup trucks	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context An increasing number of compact pickup trucks can accommodate restrained rear occupants. Rear seats in these pickup trucks are exempt from regulatory safety testing though their relative safety has not been determined. Objectives To evaluate the risk of injury to children in compact extended-cab pickup trucks compared with children in other vehicles and to determine if any unique hazards exist. Design Cross-sectional study of children aged 15 years or younger in crashes of insured vehicles, with data collected via insurance claim records and a telephone survey. Setting and Participants Probability sample of 7192 multirow vehicles involved in crashes, with 11335 child occupants, in 3 large US regions from December 1, 1998, to November 30, 2000. Main Outcome Measure Relative risk of injury, defined as concussions and more serious brain injuries, spinal cord injuries, internal organ injuries, extremity fractures, and facial lacerations, estimated by odds ratios (ORs) adjusting for age, restraint use, point of impact, vehicle weight, and crash severity. Results Injuries were reported for 1356 children, representing 1.6% of the population. Children in compact extended-cab pickup trucks were at greater risk of injury than children in other vehicles (adjusted OR, 2.96; 95% confidence interval [CI], 1.68-5.21). Children in the rear seats of compact pickup trucks were at substantially greater risk of injury than rear-seated children in other vehicles (adjusted OR, 4.75; 95% CI, 2.39-9.43). Children seated in the front seat of compact extended-cab pickup trucks were at greater risk of injury than children in the front seats of other vehicles, but this risk was not statistically significant (adjusted OR, 1.70; 95% CI, 0.78-3.69). Conclusions Children in compact extended-cab pickup trucks are not as safe as children in other vehicles, primarily due to the increased relative risk of injury in the back seat. For families with another choice of vehicle, clinicians should advise parents against transporting children in compact pickup trucks. The current exemption for regulatory testing for occupant protection in the rear seats of compact pickup trucks should be reconsidered.	Childrens Hosp Philadelphia, TraumaLink Interdisciplinary Pediat Trauma Res Ct, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Div Gen Pediat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Div Emergency Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Winston, FK (corresponding author), Childrens Hosp Philadelphia, TraumaLink Interdisciplinary Pediat Trauma Res Ct, 34th St & Civ Ctr Blvd,3535 TraumaLink,10th Floor, Philadelphia, PA 19104 USA.		Durbin, Dennis/AAD-7829-2022					AGRAN PF, 1990, JAMA-J AM MED ASSOC, V264, P712, DOI 10.1001/jama.264.6.712; *AM AC PED, 2001, INF CHILD RESTR; ANDERSON C, 2000, 44 ANN P ASS ADV AUT; Anderson CL, 2000, ACCIDENT ANAL PREV, V32, P533, DOI 10.1016/S0001-4575(99)00075-5; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; Braver E R, 1998, Inj Prev, V4, P181; Bull MJ, 2000, PEDIATRICS, V106, P857; *BUR CENS, 1999, PUBL BUR CENS; Durbin DR, 1999, ARCH PEDIAT ADOL MED, V153, P404; Durbin DR, 2001, ACCIDENT ANAL PREV, V33, P407, DOI 10.1016/S0001-4575(00)00054-3; EDWARDS J, 1997, SOC AUT ENG GOV IND; *INS I HIGHW SAF H, 1999, VINDICATOR 2000; KORN EL, 1995, AM STAT, V49, P291, DOI 10.2307/2684203; *NAT HIGHW TRAFF S, 2001, CHILD SAF SEAT US CH; *NAT INS CRIM BUR, 2000, 2000 PASS VEH ID MAN; WILLIAMS AF, 1977, ACCIDENT ANAL PREV, V9, P69, DOI 10.1016/0001-4575(77)90007-0; Winston FK, 2000, PEDIATRICS, V105, P1179, DOI 10.1542/peds.105.6.1179; Wittenberg E, 1999, PEDIATRICS, V104, P1247, DOI 10.1542/peds.104.6.1247	18	11	11	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2002	287	9					1147	1152		10.1001/jama.287.9.1147	http://dx.doi.org/10.1001/jama.287.9.1147			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	527KV	11879112	Bronze			2022-12-28	WOS:000174186000030
J	Telenti, A; Aubert, V; Spertini, F				Telenti, A; Aubert, V; Spertini, F			Individualising HIV treatment - pharmacogenetics and immunogenetics	LANCET			English	Editorial Material									CHU Vaudois, Univ Hosp, Div Infect Dis, CH-1011 Lausanne, Switzerland; CHU Vaudois, Univ Hosp, Div Immunol & Allergy, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Telenti, A (corresponding author), CHU Vaudois, Univ Hosp, Div Infect Dis, CH-1011 Lausanne, Switzerland.		Telenti, Amalio/AAY-1674-2021					Carrington M, 2001, IMMUNOL LETT, V79, P131, DOI 10.1016/S0165-2478(01)00275-9; Elmets CA, 1998, P NATL ACAD SCI USA, V95, P14915, DOI 10.1073/pnas.95.25.14915; Fellay J, 2001, LANCET, V358, P1322, DOI 10.1016/S0140-6736(01)06413-3; Fellay J, 2002, LANCET, V359, P30, DOI 10.1016/S0140-6736(02)07276-8; HETHERINGTON S, 2000, 9 C RETR OPP INF SEA; Liang JS, 2001, NAT MED, V7, P1327, DOI 10.1038/nm1201-1327; Miserez AR, 2001, AIDS, V15, P2045, DOI 10.1097/00002030-200110190-00020; Ozkaya-Bayazit E, 2001, J AM ACAD DERMATOL, V45, P712, DOI 10.1067/mjd.2001.117854; Pellicano R, 1997, J AM ACAD DERMATOL, V36, P782, DOI 10.1016/S0190-9622(97)80347-7; Phillips KA, 2001, JAMA-J AM MED ASSOC, V286, P2270, DOI 10.1001/jama.286.18.2270; Pichler WJ, 2001, TOXICOLOGY, V158, P31, DOI 10.1016/S0300-483X(00)00399-1; Quiralte J, 1999, J ALLERGY CLIN IMMUN, V103, P685, DOI 10.1016/S0091-6749(99)70243-5; Schaeffeler E, 2001, LANCET, V358, P383, DOI 10.1016/S0140-6736(01)05579-9; von Greyerz S, 1999, J IMMUNOL, V162, P595; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761	15	23	24	2	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 2	2002	359	9308					722	723		10.1016/S0140-6736(02)07899-6	http://dx.doi.org/10.1016/S0140-6736(02)07899-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526DZ	11888578				2022-12-28	WOS:000174115200002
J	Vajk, OP; Mang, PK; Greven, M; Gehring, PM; Lynn, JW				Vajk, OP; Mang, PK; Greven, M; Gehring, PM; Lynn, JW			Quantum impurities in the two-dimensional spin one-half Heisenberg antiferromagnet	SCIENCE			English	Article							SQUARE-LATTICE; PERCOLATION-THRESHOLD; PHASE-TRANSITIONS; LOW-TEMPERATURES; SINGLE-CRYSTALS; LA2CUO4; STATE; ORDER; HOLES	The study of randomness in low-dimensional quantum antiferromagnets is at the forefront of research in the field of strongly correlated electron systems, yet there have been relatively few experimental model systems. Complementary neutron scattering and numerical experiments demonstrate that the spin-diluted Heisenberg antiferromagnet La2Cu1-z(Zn,Mg)(z)O-4 is an excellent model material for square-lattice site percolation in the extreme quantum limit of spin one-half. Measurements of the ordered moment and spin correlations provide important quantitative information for tests of theories for this complex quantum-impurity problem.	Stanford Univ, Dept Appl Phys, Stanford, CA 94309 USA; Stanford Univ, Dept Phys, Stanford, CA 94309 USA; Stanford Synchrotron Radiat Lab, Stanford, CA 94305 USA; Natl Inst Stand & Technol, NIST Ctr Neutron Res, Gaithersburg, MD 20899 USA	Stanford University; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; National Institute of Standards & Technology (NIST) - USA	Greven, M (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94309 USA.	greven@stanford.edu	Lynn, Jeffrey/AAI-2588-2021; Lynn, Jeffrey/R-4030-2019; Gehring, Peter/AAY-9557-2020	Lynn, Jeffrey/0000-0003-3626-4932; Gehring, Peter/0000-0002-9236-2046				AHARONY A, 1988, PHYS REV LETT, V60, P1330, DOI 10.1103/PhysRevLett.60.1330; AZMA M, 1997, PHYS REV B, V55, P8658; Beard BB, 1998, PHYS REV LETT, V80, P1742, DOI 10.1103/PhysRevLett.80.1742; Birgeneau RJ, 1999, PHYS REV B, V59, P13788, DOI 10.1103/PhysRevB.59.13788; BIRGENEAU RJ, 1984, J STAT PHYS, V34, P817, DOI 10.1007/BF01009443; Castro Neto AH, 1996, PHYS REV LETT, V76, P2165, DOI 10.1103/PhysRevLett.76.2165; CHAKRAVARTY S, 1989, PHYS REV B, V39, P2344, DOI 10.1103/PhysRevB.39.2344; Chen YC, 2000, PHYS REV B, V61, pR3772, DOI 10.1103/PhysRevB.61.R3772; Coldea R, 2001, PHYS REV LETT, V86, P5377, DOI 10.1103/PhysRevLett.86.5377; CONIGLIO A, 1981, PHYS REV LETT, V46, P250, DOI 10.1103/PhysRevLett.46.250; CORTI M, 1995, PHYS REV B, V52, P4226, DOI 10.1103/PhysRevB.52.4226; GREVEN M, 1995, Z PHYS B CON MAT, V96, P465, DOI 10.1007/BF01313844; Greven M, 1998, PHYS REV LETT, V81, P1945, DOI 10.1103/PhysRevLett.81.1945; HARRIS AB, 1977, PHYS REV B, V16, P542, DOI 10.1103/PhysRevB.16.542; HASENFRATZ P, 1991, PHYS LETT B, V268, P231, DOI 10.1016/0370-2693(91)90809-5; Hucker M, 1999, PHYS REV B, V59, pR725, DOI 10.1103/PhysRevB.59.R725; Kato K, 2000, PHYS REV LETT, V84, P4204, DOI 10.1103/PhysRevLett.84.4204; KEIMER B, 1992, PHYS REV B, V46, P14034, DOI 10.1103/PhysRevB.46.14034; Kim YJ, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.024435; MANOUSAKIS E, 1992, PHYS REV B, V45, P7570, DOI 10.1103/PhysRevB.45.7570; MATSUDA T, 1998, PHYS REV LETT, V80, P4566; MIYASHITA S, 1992, COMPUTATIONAL APPROA, P97; Newman MEJ, 2000, PHYS REV LETT, V85, P4104, DOI 10.1103/PhysRevLett.85.4104; Sachdev S, 1999, SCIENCE, V286, P2479, DOI 10.1126/science.286.5449.2479; STANLEY HE, 1976, J PHYS C SOLID STATE, V9, pL553, DOI 10.1088/0022-3719/9/20/001; STAUFFER D, 1994, INTRO PERCOLATION TH; UCHINOKURA K, 1995, PHYSICA B, V205, P234, DOI 10.1016/0921-4526(94)00906-C; WAN CC, 1991, J APPL PHYS, V69, P5191, DOI 10.1063/1.348123; YAMADA K, 1987, SOLID STATE COMMUN, V64, P753, DOI 10.1016/0038-1098(87)90693-4; Yasuda C, 1999, J PHYS SOC JPN, V68, P2773, DOI 10.1143/JPSJ.68.2773	30	125	125	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2002	295	5560					1691	1695		10.1126/science.1067110	http://dx.doi.org/10.1126/science.1067110			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872834	Green Submitted			2022-12-28	WOS:000174212900040
J	Parker, RA; Hartman, EE				Parker, RA; Hartman, EE			A 45-year-old woman with obsessive-compulsive disorder, 1 year later	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article																		Parker RA, 2001, JAMA-J AM MED ASSOC, V285, P2121, DOI 10.1001/jama.285.16.2121	1	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2002	287	8					1037	1037		10.1001/jama.287.8.1037	http://dx.doi.org/10.1001/jama.287.8.1037			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525CX	11866653				2022-12-28	WOS:000174052100033
J	Scott, LT; Boorum, MM; McMahon, BJ; Hagen, S; Mack, J; Blank, J; Wegner, H; de Meijere, A				Scott, LT; Boorum, MM; McMahon, BJ; Hagen, S; Mack, J; Blank, J; Wegner, H; de Meijere, A			A rational chemical synthesis of C-60	SCIENCE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; FULLERENE FORMATION; CORANNULENE; CARBON; C60H6	Notable quantities of C-60, the smallest stable fullerene, have been synthesized in 12 steps from commercially available starting materials by rational chemical methods. A molecular polycyclic aromatic precursor bearing chlorine substituents at key positions forms C-60 when subjected to flash vacuum pyrolysis at 1100degreesC. No other fullerenes are formed as by-products. The methods we have developed for the target-specific synthesis of fullerenes, applied here to a synthesis of C-60, should make possible the directed laboratory preparation of other fullerenes as well, including those not accessible by graphite vaporization.	Boston Coll, Merkert Chem Ctr, Dept Chem, Chestnut Hill, MA 02467 USA; Univ Gottingen, Inst Organ Chem, D-37077 Gottingen, Germany	Boston College; University of Gottingen	Scott, LT (corresponding author), Boston Coll, Merkert Chem Ctr, Dept Chem, Chestnut Hill, MA 02467 USA.		Wegner, Hermann/P-3826-2019; Scott, Lawrence T./G-5020-2018	Scott, Lawrence T./0000-0003-3496-8506				Ansems RBM, 2000, J AM CHEM SOC, V122, P2719, DOI 10.1021/ja993028n; Boorum MM, 2001, SCIENCE, V294, P828, DOI 10.1126/science.1064250; BOORUM MM, 2001, THESIS BOSTON COLL C; Brooks MA, 1999, J AM CHEM SOC, V121, P5444, DOI 10.1021/ja984472d; Clayton MD, 1997, TETRAHEDRON LETT, V38, P741, DOI 10.1016/S0040-4039(96)02450-1; Goroff NS, 1996, ACCOUNTS CHEM RES, V29, P77, DOI 10.1021/ar950162d; Hagen S, 1997, ANGEW CHEM INT EDIT, V36, P406, DOI 10.1002/anie.199704061; Komatsu K, 2000, CHEM COMMUN, P1583, DOI 10.1039/b003719m; KRATSCHMER W, 1990, NATURE, V347, P354, DOI 10.1038/347354a0; MCELVANY SW, 1993, SCIENCE, V259, P1594, DOI 10.1126/science.259.5101.1594; MCMAHON BJ, 1997, THESIS BOSTON COLL C; Necula A, 2000, J ANAL APPL PYROL, V54, P65, DOI 10.1016/S0165-2370(99)00085-6; RUBIN Y, 1991, J AM CHEM SOC, V113, P495, DOI 10.1021/ja00002a017; Rubin Y, 1998, ANGEW CHEM INT EDIT, V37, P1226, DOI 10.1002/(SICI)1521-3773(19980518)37:9<1226::AID-ANIE1226>3.0.CO;2-H; Scott LT, 1999, PURE APPL CHEM, V71, P209, DOI 10.1351/pac199971020209; Scott LT, 1997, J AM CHEM SOC, V119, P10963, DOI 10.1021/ja972019g; Scott LT, 1996, J AM CHEM SOC, V118, P8743, DOI 10.1021/ja9621511; SCOTT LT, 1991, J AM CHEM SOC, V113, P7082, DOI 10.1021/ja00018a082; Scott LT, 1996, PURE APPL CHEM, V68, P291, DOI 10.1351/pac199668020291; Tobe Y, 1998, J AM CHEM SOC, V120, P4544, DOI 10.1021/ja9803308; Tobe Y, 2001, TETRAHEDRON, V57, P3629, DOI 10.1016/S0040-4020(01)00250-2; Wu MF, 1996, TETRAHEDRON LETT, V37, P7409, DOI 10.1016/0040-4039(96)01613-9	22	350	355	2	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2002	295	5559					1500	1503		10.1126/science.1068427	http://dx.doi.org/10.1126/science.1068427			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	523WV	11859187				2022-12-28	WOS:000173981300045
J	Moldoveanu, T; Hosfield, CM; Lim, D; Elce, JS; Jia, ZC; Davies, PL				Moldoveanu, T; Hosfield, CM; Lim, D; Elce, JS; Jia, ZC; Davies, PL			A Ca2+ switch aligns the active site of calpain	CELL			English	Article							MUSCLE-SPECIFIC CALPAIN; SMALL-SUBUNIT GENE; CRYSTAL-STRUCTURE; CA2+-BINDING DOMAIN; CALCIUM; PROTEASE; RESOLUTION; ACTIVATION; BINDING; CALPASTATIN	Ca2+ signaling by calpains leads to controlled proteolysis during processes ranging from cytoskeleton remodeling in mammals to sex determination in nematodes. Deregulated Ca2+ levels result in aberrant proteolysis by calpains, which contributes to tissue damage in heart and brain ischemias as well as neurodegeneration in Alzheimer's disease. Here we show that activation of the protease core of mu calpain requires cooperative binding of two Ca2+ atoms at two non-EF-hand sites revealed in the 2.1 Angstrom crystal structure. Conservation of the Ca2+ binding residues defines an ancestral general mechanism of activation for most calpain isoforms, including some that lack EF-hand domains. The protease region is not affected by the endogenous inhibitor, calpastatin, and may contribute to calpain-mediated pathologies when the core is released by autoproteolysis.	Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; Queens Univ, Prot Engn Network Ctr Excellence, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Queens University - Canada	Davies, PL (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	daviesp@post.queensu.ca	Moldoveanu, Tudor/N-8173-2018	Moldoveanu, Tudor/0000-0003-0791-318X				Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; Benetti R, 2001, EMBO J, V20, P2702, DOI 10.1093/emboj/20.11.2702; BERTI PJ, 1995, J MOL BIOL, V246, P273, DOI 10.1006/jmbi.1994.0083; Blanchard H, 1997, NAT STRUCT BIOL, V4, P532, DOI 10.1038/nsb0797-532; Branca D, 1999, EUR J BIOCHEM, V265, P839, DOI 10.1046/j.1432-1327.1999.00817.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carafoli E, 1998, BIOCHEM BIOPH RES CO, V247, P193, DOI 10.1006/bbrc.1998.8378; Carragher NO, 2002, MOL CELL BIOL, V22, P257, DOI 10.1128/MCB.22.1.257-269.2002; *CCPA, 1994, ACTA CRYSTALLOGR D, V50, P760; Cohen GH, 1997, J APPL CRYSTALLOGR, V30, P1160, DOI 10.1107/S0021889897006729; Cox EA, 1998, MICROSC RES TECHNIQ, V43, P412, DOI 10.1002/(SICI)1097-0029(19981201)43:5<412::AID-JEMT7>3.0.CO;2-F; CRAWFORD C, 1993, BIOCHEM J, V296, P135, DOI 10.1042/bj2960135; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Dutt P, 2000, BIOCHEM J, V348, P37, DOI 10.1042/0264-6021:3480037; ELCE JS, 1995, PROTEIN ENG, V8, P843, DOI 10.1093/protein/8.8.843; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Hosfield CM, 1999, EMBO J, V18, P6880, DOI 10.1093/emboj/18.24.6880; Hosfield CM, 2001, J BIOL CHEM, V276, P7404, DOI 10.1074/jbc.M007352200; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KAMPHUIS IG, 1984, J MOL BIOL, V179, P233, DOI 10.1016/0022-2836(84)90467-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee KS, 1997, ANN NY ACAD SCI, V825, P95, DOI 10.1111/j.1749-6632.1997.tb48419.x; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; Lin GD, 1997, NAT STRUCT BIOL, V4, P539, DOI 10.1038/nsb0797-539; MAKI M, 1991, BIOMED BIOCHIM ACTA, V50, P509; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Nakagawa K, 2001, J BIOCHEM-TOKYO, V130, P605, DOI 10.1093/oxfordjournals.jbchem.a003025; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NISHIMURA T, 1991, J BIOL CHEM, V266, P11842; Nixon RA, 2000, ANN NY ACAD SCI, V924, P117; OHNO S, 1984, NATURE, V312, P566, DOI 10.1038/312566a0; Ono Y, 1998, J BIOL CHEM, V273, P17073, DOI 10.1074/jbc.273.27.17073; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pal GP, 2001, J BIOL CHEM, V276, P47233, DOI 10.1074/jbc.M105149200; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Santella L, 1998, CELL CALCIUM, V23, P123, DOI 10.1016/S0143-4160(98)90110-5; Sorimachi H, 2001, J BIOCHEM-TOKYO, V129, P653, DOI 10.1093/oxfordjournals.jbchem.a002903; Sorimachi H, 1997, BIOCHEM J, V328, P721, DOI 10.1042/bj3280721; Strobl S, 2000, P NATL ACAD SCI USA, V97, P588, DOI 10.1073/pnas.97.2.588; Strynadka NCJ, 1997, J MOL BIOL, V273, P238, DOI 10.1006/jmbi.1997.1257; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tompa P, 1996, J BIOL CHEM, V271, P33161, DOI 10.1074/jbc.271.52.33161; Tompa P, 2001, BIOCHEM BIOPH RES CO, V280, P1333, DOI 10.1006/bbrc.2001.4279; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; WANG KKW, 1994, TRENDS PHARMACOL SCI, V15, P412, DOI 10.1016/0165-6147(94)90090-6; YOSHIZAWA T, 1995, BIOCHEM BIOPH RES CO, V208, P376, DOI 10.1006/bbrc.1995.1348; Zimmerman UJP, 2000, IUBMB LIFE, V50, P63	55	253	259	2	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 8	2002	108	5					649	660		10.1016/S0092-8674(02)00659-1	http://dx.doi.org/10.1016/S0092-8674(02)00659-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	529TN	11893336	Bronze			2022-12-28	WOS:000174314800009
J	Anderson, DM; Archer, D				Anderson, DM; Archer, D			Glacial-interglacial stability of ocean pH inferred from foraminifer dissolution rates	NATURE			English	Article							DEEP-SEA; CALCIUM-CARBONATE; ATMOSPHERIC CO2; PRESERVATION; WATER; CIRCULATION; SOLUBILITY; PRESSURE	The pH of the ocean is controlled by the chemistry of calcium carbonate. This system in turn plays a large role in regulating the CO2 concentration of the atmosphere on timescales of thousands of years and longer. Reconstructions of ocean pH and carbonate-ion concentration are therefore needed to understand the ocean's role in the global carbon cycle. During the Last Glacial Maximum (LGM), the pH of the whole ocean is thought to have been significantly more basic(1), as inferred from the isotopic composition of boron incorporated into calcium carbonate shells, which would partially explain the lower atmospheric CO2 concentration at that time. Here we reconstruct carbonate-ion concentration-and hence pH-of the glacial oceans, using the extent of calcium carbonate dissolution observed in foraminifer faunal assemblages as compiled in the extensive global CLIMAP data set(2). We observe decreased carbonate-ion concentrations in the glacial Atlantic Ocean, by roughly 20 mumol kg(-1), while little change occurred in the Indian and Pacific oceans relative to today. In the Pacific Ocean, a small (5 mumol kg(-1)) increase occurred below 3,000 m. This rearrangement of ocean pH may be due to changing ocean circulation from glacial to present times, but overall we see no evidence for a shift in the whole-ocean pH as previously inferred from boron isotopes(1).	NOAA, Paleoclimatol Program, Boulder, CO 80303 USA; Univ Colorado, Boulder, CO 80303 USA; Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; University of Chicago	Anderson, DM (corresponding author), NOAA, Paleoclimatol Program, 325 Broadway, Boulder, CO 80303 USA.		anderson, david/E-6416-2011; Archer, David/K-7371-2012	Archer, David/0000-0002-4523-7912				ALTABET MA, 1995, NATURE, V373, P506, DOI 10.1038/373506a0; Archer D, 2000, REV GEOPHYS, V38, P159, DOI 10.1029/1999RG000066; ARCHER D, 1994, NATURE, V367, P260, DOI 10.1038/367260a0; Archer DE, 1996, GLOBAL BIOGEOCHEM CY, V10, P159, DOI 10.1029/95GB03016; *CLIMAP PROJ MEMB, 1981, GEOLOGICAL SOC AM MA; Crowley T. J., 1985, CARBON CYCLE ATMOSPH, V32, P271; CURRY WB, 1985, CARBON CYCLE ATMOSPH, P285; Duplessy JC, 1988, PALEOCEANOGRAPHY, V3, P343, DOI 10.1029/PA003i003p00343; EMERSON S, 1981, J MAR RES, V39, P139; Farrell JW, 1989, PALEOCEANOGRAPHY, V4, P447, DOI 10.1029/PA004i004p00447; GANESHRAM RS, 1995, NATURE, V376, P755, DOI 10.1038/376755a0; HOWARD WR, 1994, PALEOCEANOGRAPHY, V9, P453, DOI 10.1029/93PA03524; KENNETT JP, 1995, NATURE, V377, P510, DOI 10.1038/377510a0; MILLERO FJ, 1982, GEOCHIM COSMOCHIM AC, V46, P11, DOI 10.1016/0016-7037(82)90286-1; MIX AC, 1989, NATURE, V337, P541, DOI 10.1038/337541a0; MUCCI A, 1983, AM J SCI, V283, P780, DOI 10.2475/ajs.283.7.780; Oppo DW, 2000, PALEOCEANOGRAPHY, V15, P147, DOI 10.1029/1999PA000436; OVERPECK JT, 1985, QUATERNARY RES, V23, P87, DOI 10.1016/0033-5894(85)90074-2; PETERSON LC, 1985, CARBON CYCLE ATMOSPH, P251; PRELL WL, 1985, TR025 DEP EN; Ravelo AC, 1990, PALEOCEANOGRAPHY, V5, P409, DOI 10.1029/PA005i003p00409; SANYAL A, 1995, NATURE, V373, P234, DOI 10.1038/373234a0; Winguth A., 2000, INVERSE METHODS GLOB; Yu EF, 1996, NATURE, V379, P689, DOI 10.1038/379689a0	24	77	83	4	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2002	416	6876					70	73		10.1038/416070a	http://dx.doi.org/10.1038/416070a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882893				2022-12-28	WOS:000174211600039
J	Katz, KC; Walmsley, SL; McLeod, AG; Keystone, JS; Detsky, AS				Katz, KC; Walmsley, SL; McLeod, AG; Keystone, JS; Detsky, AS			Where are you from?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS		Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, Rm 427,600 Univ Ave, Toronto, ON M5G 1X5, Canada.			Walmsley, Sharon/0000-0002-3959-5692				Alvar J, 1997, CLIN MICROBIOL REV, V10, P298, DOI 10.1128/CMR.10.2.298; Barat LIM, 1996, CLIN INFECT DIS, V23, P320, DOI 10.1093/clinids/23.2.320	2	5	5	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2002	346	10					764	767		10.1056/NEJMcps3461002	http://dx.doi.org/10.1056/NEJMcps3461002			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527UA	11882733				2022-12-28	WOS:000174205000009
J	Morgante, L; Trimarchi, F; Benvenga, S				Morgante, L; Trimarchi, F; Benvenga, S			Fahr's disease	LANCET			English	Editorial Material									Univ Messina Policlin, Clin Neurol 1, I-98125 Messina, Italy; Univ Messina Policlin, Sez Endocrinol, I-98125 Messina, Italy; Univ Messina Policlin, Dipartimento Clin Sperimentale Med & Farmacol, I-98125 Messina, Italy	AOU Policlinico Gaetano Martino; AOU Policlinico Gaetano Martino; AOU Policlinico Gaetano Martino	Morgante, L (corresponding author), Univ Messina Policlin, Clin Neurol 1, I-98125 Messina, Italy.								0	20	20	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 2	2002	359	9308					759	759		10.1016/S0140-6736(02)07878-9	http://dx.doi.org/10.1016/S0140-6736(02)07878-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526DZ	11888587				2022-12-28	WOS:000174115200011
J	Gewin, V				Gewin, V			Poor nations seek new biodiversity deal	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2002	415	6875					949	949		10.1038/415949a	http://dx.doi.org/10.1038/415949a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875533	Bronze			2022-12-28	WOS:000174075000013
J	Hochedlinger, K; Jaenisch, R				Hochedlinger, K; Jaenisch, R			Monoclonal mice generated by nuclear transfer from mature B and T donor cells	NATURE			English	Article							EMBRYONIC STEM-CELLS; EXPRESSION; SELECTION; OOCYTES; CLONING; MOUSE	Cloning from somatic cells is inefficient, with most clones dying during gestation(1,2). Cloning from embryonic stem (ES) cells is much more effective, suggesting that the nucleus of an embryonic cell is easier to reprogram(3-7). It is thus possible that most surviving clones are, in fact, derived from the nuclei of rare somatic stem cells present in adult tissues rather than from the nuclei of differentiated cells as has been assumed(1,8,9). Here we report the generation of monoclonal mice by nuclear transfer from mature lymphocytes. In a modified two-step cloning procedure, we established ES cells from cloned blastocysts and injected them into tetraploid blastocysts to generate mice. In this approach, the embryo is derived from the ES cells and the extra-embryonic tissues from the tetraploid host(6). Animals cloned from a B-cell nucleus were viable and carried fully rearranged immunoglobulin alleles in all tissues. Similarly, a mouse cloned from a T-cell nucleus carried rearranged T-cell-receptor genes in all tissues. This is an unequivocal demonstration that a terminally differentiated cell can be reprogrammed to produce an adult cloned animal.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Univ Vienna, A-1010 Vienna, Austria	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Vienna	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.							BRIGGS ROBERT, 1957, J MORPH, V100, P269, DOI 10.1002/jmor.1051000204; Cascalho M, 1996, SCIENCE, V272, P1649, DOI 10.1126/science.272.5268.1649; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; DIBERARDINO MA, 1980, DIFFERENTIATION, V17, P17, DOI 10.1111/j.1432-0436.1980.tb01078.x; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Galli C, 1999, Cloning, V1, P161, DOI 10.1089/15204559950019924; GURDON JB, 1975, J EMBRYOL EXP MORPH, V34, P93; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Kawase E, 2000, GENESIS, V28, P156, DOI 10.1002/1526-968X(200011/12)28:3/4<156::AID-GENE100>3.3.CO;2-K; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; Kouskoff V, 2001, LIFE SCI, V69, P1105, DOI 10.1016/S0024-3205(01)01219-X; Liu L, 2001, NAT BIOTECHNOL, V19, P406, DOI 10.1038/88052; LIVAK F, 1995, IMMUNITY, V2, P617, DOI 10.1016/1074-7613(95)90006-3; McCreath KJ, 2000, NATURE, V405, P1066, DOI 10.1038/35016604; Munsie MJ, 2000, CURR BIOL, V10, P989, DOI 10.1016/S0960-9822(00)00648-5; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Novobrantseva TI, 1999, J EXP MED, V189, P75, DOI 10.1084/jem.189.1.75; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rideout WM, 2000, NAT GENET, V24, P109, DOI 10.1038/72753; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Solter D, 2000, NAT REV GENET, V1, P199, DOI 10.1038/35042066; WABL MR, 1975, SCIENCE, V190, P1310, DOI 10.1126/science.1198115; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wakayama T, 2001, MOL REPROD DEV, V58, P376, DOI 10.1002/1098-2795(20010401)58:4<376::AID-MRD4>3.0.CO;2-L; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wells DN, 1999, BIOL REPROD, V60, P996, DOI 10.1095/biolreprod60.4.996; Whitehurst CE, 1999, IMMUNITY, V10, P313, DOI 10.1016/S1074-7613(00)80031-X	30	392	464	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2002	415	6875					1035	1038		10.1038/nature718	http://dx.doi.org/10.1038/nature718			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875572				2022-12-28	WOS:000174075000048
J	Krimigis, SM; Mitchell, DG; Hamilton, DC; Dandouras, J; Armstrong, TP; Bolton, SJ; Cheng, AF; Gloeckler, G; Hsieh, KC; Keath, EP; Krupp, N; Lagg, A; Lanzerotti, LJ; Livi, S; Mauk, BH; McEntire, RW; Roelof, EC; Wilken, B; Williams, DJ				Krimigis, SM; Mitchell, DG; Hamilton, DC; Dandouras, J; Armstrong, TP; Bolton, SJ; Cheng, AF; Gloeckler, G; Hsieh, KC; Keath, EP; Krupp, N; Lagg, A; Lanzerotti, LJ; Livi, S; Mauk, BH; McEntire, RW; Roelof, EC; Wilken, B; Williams, DJ			A nebula of gases from Io surrounding Jupiter	NATURE			English	Article							MAGNETOSPHERE; VOYAGER-1; UPSTREAM; EMISSION; EVENTS	Several planetary missions have reported(1-4) the presence of substantial numbers of energetic ions and electrons surrounding Jupiter; relativistic electrons are observable up to several astronomical units (AU) from the planet. A population of energetic (>30 keV) neutral particles also has been reported(5), but the instrumentation was not able to determine the mass or charge state of the particles, which were subsequently labelled(6) energetic neutral atoms. Although images showing the presence of the trace element sodium were obtained(7), the source and identity of the neutral atoms-and their overall significance relative to the loss of charged particles from Jupiter's magnetosphere-were unknown. Here we report the discovery by the Cassini spacecraft of a fast (>10(3) km s(-1)) and hot magnetospheric neutral wind extending more than 0.5 AU from Jupiter, and the presence of energetic neutral atoms (both hot and cold) that have been accelerated by the electric field in the solar wind. We suggest that these atoms originate in volcanic gases from Io, undergo significant evolution through various electromagnetic interactions, escape Jupiter's magnetosphere and then populate the environment around the planet. Thus a 'nebula' is created that extends outwards over hundreds of jovian radii.	Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; Univ Maryland, Dept Phys, College Pk, MD 20742 USA; CNES, F-31028 Toulouse 4, France; Fundamental Technol, Lawrence, KS 66046 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Arizona, Dept Phys, Tucson, AZ 85721 USA; Max Planck Inst Aeron, D-37191 Katlenburg Lindau, Germany; Bell Labs, Murray Hill, NJ 07974 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University System of Maryland; University of Maryland College Park; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Arizona; Max Planck Society; AT&T	Krimigis, SM (corresponding author), Johns Hopkins Univ, Appl Phys Lab, 11100 Johns Hopkins Rd, Laurel, MD 20723 USA.	tom.krimigis@jhuapl.edu	Mitchell, Donald G/H-4601-2016; Krimigis, Stamatios/G-4591-2019; Korpi-Lagg, Andreas/W-8166-2019; Bolton, Scott/M-4392-2019; Mauk, Barry H/E-8420-2017; Dandouras, Iannis/V-2709-2017; Roelof, Edmond/G-6654-2019	Mitchell, Donald G/0000-0003-1960-2119; Krimigis, Stamatios/0000-0003-2781-2386; Korpi-Lagg, Andreas/0000-0003-1459-7074; Mauk, Barry H/0000-0001-9789-3797; Dandouras, Iannis/0000-0002-7121-1118; Roelof, Edmond/0000-0002-2270-0652; Hamilton, Douglas/0000-0001-6103-8019; bolton, scott/0000-0002-9115-0789				BARBOSA DD, 1986, ASTROPHYS J, V310, P927, DOI 10.1086/164744; GLOECKLER G, 2001, S-P B ASTROPHYS, P287; Haggerty D, 1999, J GEOPHYS RES-SPACE, V104, P4629, DOI 10.1029/1998JA900148; KIRSCH E, 1981, GEOPHYS RES LETT, V8, P169, DOI 10.1029/GL008i002p00169; KRIMIGIS SM, 1985, J GEOPHYS RES-SPACE, V90, P3947, DOI 10.1029/JA090iA05p03947; KRIMIGIS SM, 1981, J GEOPHYS RES-SPACE, V86, P8227, DOI 10.1029/JA086iA10p08227; KRIMIGIS SM, IN PRESS SPACE SCI R; LUHMANN JG, 1994, J GEOPHYS RES-SPACE, V99, P13285, DOI 10.1029/94JA00488; Mauk BH, 1998, ADV SPACE RES, V21, P1483, DOI 10.1016/S0273-1177(98)00021-0; MENDILLO M, 1992, SCIENCE, V257, P1510, DOI 10.1126/science.257.5076.1510; Mitchell DG, 1996, P SOC PHOTO-OPT INS, V2803, P154, DOI 10.1117/12.253415; ROELOF EC, 1985, J GEOPHYS RES-SPACE, V90, P991, DOI 10.1029/JA090iA11p10991; TEEGARDEN BJ, 1974, J GEOPHYS RES, V79, P3615, DOI 10.1029/JA079i025p03615; ZWICKL RD, 1981, J GEOPHYS RES-SPACE, V86, P8125, DOI 10.1029/JA086iA10p08125	14	33	33	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2002	415	6875					994	996		10.1038/415994a	http://dx.doi.org/10.1038/415994a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875559	Bronze			2022-12-28	WOS:000174075000035
J	Towner, D; Loewy, RS				Towner, D; Loewy, RS			Ethics of preimplantation diagnosis for a woman destined to develop early-onset Alzheimer disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Calif Davis, Bioeth Program, Sacramento, CA 95817 USA; Univ Calif Davis, Dept Obstet & Gynecol, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Loewy, RS (corresponding author), Univ Calif Davis, Bioeth Program, 4150 V St,PSSB 2400, Sacramento, CA 95817 USA.	roberta.loewy@ucdmc.ucdavis.edu		Towner, Dena/0000-0002-1767-4197				Amer Soc Reprod Med, 1999, FERTIL STERIL, V72, P595; [Anonymous], 1960, THEORY MORAL LIFE; Bayertz K., 1994, CONCEPT MORAL CONSEN; CHURCHILL LR, 1982, HASTINGS CENT REP, V12, P9, DOI 10.2307/3560614; Comm Obstet Practice, 2001, INT J GYNECOL OBSTET, V73, P279; COOPER SL, 1998, CHOOSING ASSISTED RE; Ethics Comm Amer Soc Reprod Med, 2001, FERTIL STERIL, V75, P861; Fasouliotis SJ, 2000, EUR J OBSTET GYN R B, V90, P171, DOI 10.1016/S0301-2115(00)00271-2; Hart 5HLA, 1955, PHILOS REV, V64, P177, DOI [DOI 10.2307/2182586, 10.2307/2182586]; LOEWY EH, 1987, SOC SCI MED, V25, P783, DOI 10.1016/0277-9536(87)90036-0; Murrell JR, 2000, ARCH NEUROL-CHICAGO, V57, P885, DOI 10.1001/archneur.57.6.885; Rachels J, 1993, ELEMENTS MORAL PHILO; ROBERTS MA, 1998, CHILD VESUS CHILDMAK; Ross W. D., 2002, RIGHT GOOD, P16; SCHENKER JG, 1992, J ASSIST REPROD GEN, V9, P411, DOI 10.1007/BF01204043; Verlinsky Y, 2002, JAMA-J AM MED ASSOC, V287, P1018, DOI 10.1001/jama.287.8.1018	16	20	20	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2002	287	8					1038	1040		10.1001/jama.287.8.1038	http://dx.doi.org/10.1001/jama.287.8.1038			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	525CX	11866654				2022-12-28	WOS:000174052100034
J	Meek, S; Morris, F				Meek, S; Morris, F			ABC of clinical electrocardiography - Introduction. II - Basic terminology	BRITISH MEDICAL JOURNAL			English	Article									Royal United Hosp, Bath BA1 3NG, Avon, England; No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England	Northern General Hospital	Meek, S (corresponding author), Royal United Hosp, Bath BA1 3NG, Avon, England.								0	18	18	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 23	2002	324	7335					470	473		10.1136/bmj.324.7335.470	http://dx.doi.org/10.1136/bmj.324.7335.470			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526NJ	11859052	Green Published			2022-12-28	WOS:000174136300022
J	Lee, KH; Holdorf, AD; Dustin, ML; Chan, AC; Allen, PM; Shaw, AS				Lee, KH; Holdorf, AD; Dustin, ML; Chan, AC; Allen, PM; Shaw, AS			T cell receptor signaling precedes immunological synapse formation	SCIENCE			English	Article							ANTIGEN RECEPTOR; ACTIVATION; STIMULATION; ZAP-70; COMMITMENT; COMPLEXES; MOLECULE; ZETA; CD28; TCR	The area of contact between a T cell and an antigen-presenting cell (APC) is known as the immunological synapse. Although its exact function is unknown, one model suggests that it allows for T cell receptor (TCR) clustering and for sustained signaling in T cells for many hours. Here we demonstrate that TCR-mediated tyrosine kinase signaling in naive T cells occurred primarily at the periphery of the synapse and was largely abated before mature immunological synapses had formed. These data suggest that many hours of TCR signaling are not required for T cell activation. These observations challenge current ideas about the role of immunological synapses in T cell activation.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Skirbal Inst Biomol Med, Program Mol Pathogenesis, New York, NY 10016 USA; Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA	Washington University (WUSTL); Roche Holding; Genentech	Shaw, AS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid,Box 8118, St Louis, MO 63110 USA.		Dustin, Michael/AAM-4611-2020	Holdorf, Amy/0000-0001-5699-4081; Dustin, Michael/0000-0003-4983-6389; Lee, Kyeong-Hee/0000-0002-9455-4201				Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; CENCIARELLI C, 1992, SCIENCE, V257, P795, DOI 10.1126/science.1323144; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; Davis SJ, 2001, CURR BIOL, V11, pR289, DOI 10.1016/S0960-9822(01)00165-8; Delon J, 2000, CURR BIOL, V10, pR923, DOI 10.1016/S0960-9822(00)00870-8; GAUEN LKT, 1994, MOL CELL BIOL, V14, P3729, DOI 10.1128/MCB.14.6.3729; GOLDSMITH MA, 1988, SCIENCE, V240, P1029, DOI 10.1126/science.3259335; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; HOLDORF AD, IN PRESS NATURE IMMU; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Itoh Y, 1999, J IMMUNOL, V162, P2073; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Lee K. T., UNPUB; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; LINSLEY PS, 1992, J EXP MED, V176, P1595, DOI 10.1084/jem.176.6.1595; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Parish CR, 1999, IMMUNOL CELL BIOL, V77, P499, DOI 10.1046/j.1440-1711.1999.00877.x; PONT S, 1986, J IMMUNOL, V136, P3750; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; Valitutti S, 1997, IMMUNOL TODAY, V18, P299, DOI 10.1016/S0167-5699(97)01075-X; Valitutti S, 1997, J EXP MED, V185, P1859, DOI 10.1084/jem.185.10.1859; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; WEISS A, 1987, J IMMUNOL, V138, P2169; Williams BL, 1999, EMBO J, V18, P1832, DOI 10.1093/emboj/18.7.1832	28	548	576	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2002	295	5559					1539	1542		10.1126/science.1067710	http://dx.doi.org/10.1126/science.1067710			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11859198				2022-12-28	WOS:000173981300058
J	Bouillet, P; Purton, JF; Godfrey, DI; Zhang, LC; Coultas, L; Puthalakath, H; Pellegrini, M; Cory, S; Adams, JM; Strasser, A				Bouillet, P; Purton, JF; Godfrey, DI; Zhang, LC; Coultas, L; Puthalakath, H; Pellegrini, M; Cory, S; Adams, JM; Strasser, A			BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes	NATURE			English	Article							T-CELL-RECEPTOR; INHIBITS MULTIPLE FORMS; NEGATIVE SELECTION; TRANSGENIC MICE; CLONAL DELETION; EXPRESSION; LYMPHOCYTES; ACTIVATION; SURVIVAL; DEATH	During lymphocyte development, the assembly of genes coding for antigen receptors occurs by the combinatorial linking of gene segments. The stochastic nature of this process gives rise to lymphocytes that can recognize self-antigens, thereby having the potential to induce autoimmune disease. Such autoreactive lymphocytes can be silenced by developmental arrest or unresponsiveness (anergy)(1), or can be deleted from the repertoire by cell death(1). In the thymus, developing T lymphocytes (thymocytes) bearing a T-cell receptor (TCR)-CD3 complex that engages self-antigens are induced to undergo programmed cell death (apoptosis)(2-4), but the mechanisms ensuring this 'negative selection' are unclear. We now report that thymocytes lacking the pro-apoptotic Bcl-2 family member Bim(5,6) (also known as Bcl2l11) are refractory to apoptosis induced by TCR-CD3 stimulation. Moreover, in transgenic mice expressing autoreactive TCRs that provoke widespread deletion, Bim deficiency severely impaired thymocyte killing. TCR ligation upregulated Bim expression and promoted interaction of Bim with Bcl-X-L, inhibiting its survival function. These findings identify Bim as an essential initiator of apoptosis in thymocyte-negative selection.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Monash Univ, Sch Med, Dept Pathol & Immunol, Prahran, Vic 3181, Australia	Walter & Eliza Hall Institute; Monash University	Strasser, A (corresponding author), Walter & Eliza Hall Inst Med Res, PO Royal Melbourne Hosp, Melbourne, Vic 3050, Australia.		Adams, Jerry M/E-1199-2013; Puthalakath, Hamsa/B-8541-2011; Pellegrini, Marc/F-7670-2014; Bouillet, Philippe/E-1241-2013; Strasser, Andreas/C-7581-2013; Cory, Suzanne/E-1642-2013	Bouillet, Philippe/0000-0002-9012-6058; Strasser, Andreas/0000-0002-5020-4891; Cory, Suzanne/0000-0002-6818-3451; Adams, Jerry/0000-0002-4360-8628; Godfrey, Dale/0000-0002-3009-5472; Pellegrini, Marc/0000-0003-3627-3126				Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bouillet P, 2001, DEV CELL, V1, P645, DOI 10.1016/S1534-5807(01)00083-1; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; CALNAN BJ, 1995, IMMUNITY, V3, P273; Clayton LK, 1997, EMBO J, V16, P2282, DOI 10.1093/emboj/16.9.2282; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; GRILLOT DAM, 1995, J EXP MED, V182, P1973, DOI 10.1084/jem.182.6.1973; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; JENKINSON EJ, 1990, EUR J IMMUNOL, V20, P2517, DOI 10.1002/eji.1830201125; MA A, 1995, P NATL ACAD SCI USA, V92, P4763, DOI 10.1073/pnas.92.11.4763; Martin S, 1997, EUR J IMMUNOL, V27, P2726, DOI 10.1002/eji.1830271037; NAKAYAMA T, 1992, SCIENCE, V257, P96, DOI 10.1126/science.1621102; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Smith KGC, 1996, EMBO J, V15, P5167, DOI 10.1002/j.1460-2075.1996.tb00901.x; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; STRASSER A, 1994, P NATL ACAD SCI USA, V91, P1376, DOI 10.1073/pnas.91.4.1376; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; SWAT W, 1991, NATURE, V351, P150, DOI 10.1038/351150a0; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; Walsh CM, 1998, IMMUNITY, V8, P439, DOI 10.1016/S1074-7613(00)80549-X; Zhou T, 1996, J EXP MED, V183, P1879, DOI 10.1084/jem.183.4.1879; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	30	619	630	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 21	2002	415	6874					922	926		10.1038/415922a	http://dx.doi.org/10.1038/415922a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859372				2022-12-28	WOS:000173941000048
J	Farrell, MH; Foody, JM; Krumholz, HM				Farrell, MH; Foody, JM; Krumholz, HM			beta-blockers in heart failure - Clinical applications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ACUTE MYOCARDIAL-INFARCTION; COOPERATIVE CARDIOVASCULAR PROJECT; LEFT-VENTRICULAR FUNCTION; ELDERLY PATIENTS; CARVEDILOL; MORTALITY; METOPROLOL; MANAGEMENT; BLOCKADE; PERFORMANCE	beta-Blockers reduce morbidity and mortality in heart failure patients with left ventricular systolic dysfunction and stable fluid status. The successful adoption of beta-blocker guidelines for these patients requires an understanding of the value of this therapy and effective systems to maintain safety and ensure high quality of care. This article distills scientific evidence and consensus guidelines into a series of cases and practical answers about patient selection, discussions with patients, management and monitoring, and systems improvements to optimize quality of care, safety, and benefit for all patients with heart failure.	Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Internal Med, Sect Gen Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06510 USA; Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	Yale University; Yale University; Yale University; Yale University	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, 333 Cedar St,POB 208025, New Haven, CT 06520 USA.		, Harlan/AAI-2875-2020	Farrell, Michael/0000-0002-2842-0205				Adams KF, 1999, J CARD FAIL, V5, P357; Albert NM, 2001, CLEV CLIN J MED, V68, P53, DOI 10.3949/ccjm.68.1.53; Balas EA, 2000, ARCH INTERN MED, V160, P301, DOI 10.1001/archinte.160.3.301; Berwick DM, 1998, ANN INTERN MED, V128, P651, DOI 10.7326/0003-4819-128-8-199804150-00009; Bristow MR, 1996, CIRCULATION, V94, P2807, DOI 10.1161/01.CIR.94.11.2807; BRISTOW MR, 1996, CIRCULATION, V94, P644; Brophy JM, 2001, ANN INTERN MED, V134, P550, DOI 10.7326/0003-4819-134-7-200104030-00008; CHADDA K, 1986, CIRCULATION, V73, P503, DOI 10.1161/01.CIR.73.3.503; Chen J, 1999, J AM COLL CARDIOL, V34, P1388, DOI 10.1016/S0735-1097(99)00383-6; Chen J, 2001, J AM COLL CARDIOL, V37, P1950, DOI 10.1016/S0735-1097(01)01225-6; Colucci WS, 1996, CIRCULATION, V94, P2800, DOI 10.1161/01.CIR.94.11.2800; CURB JD, 1983, JAMA-J AM MED ASSOC, V250, P2814; Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8; DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700; Eichhorn E, 2001, NEW ENGL J MED, V344, P1659; EPSTEIN SE, 1965, J CLIN INVEST, V44, P1745, DOI 10.1172/JCI105282; Foody JM, 2002, JAMA-J AM MED ASSOC, V287, P883, DOI 10.1001/jama.287.7.883; Gottlieb SS, 1998, NEW ENGL J MED, V339, P489, DOI 10.1056/NEJM199808203390801; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; HALL SA, 1995, J AM COLL CARDIOL, V25, P1154, DOI 10.1016/0735-1097(94)00543-Y; Hennekens CH, 1996, NEW ENGL J MED, V335, P1660, DOI 10.1056/NEJM199611283352207; Hjalmarson A, 2000, JAMA-J AM MED ASSOC, V283, P1295, DOI 10.1001/jama.283.10.1295; Hjalmarson A, 1999, LANCET, V353, P2001; HUNT SA, 2002, ACC AHA GUIDELINES E; JOHNSTON ME, 1994, ANN INTERN MED, V120, P135, DOI 10.7326/0003-4819-120-2-199401150-00007; Krum H, 2000, HEART, V84, P615, DOI 10.1136/heart.84.6.615; Krumholz HM, 1998, JAMA-J AM MED ASSOC, V280, P623, DOI 10.1001/jama.280.7.623; Lechat P, 1999, LANCET, V353, P9; *MED EC CO, 2001, 2001 DRUG TOP RED BO; *MED EC CO, 2001, PHYS DESK REF 2001; Metra M, 2000, CIRCULATION, V102, P546; Michalsen A, 1998, HEART, V80, P437, DOI 10.1136/hrt.80.5.437; NAYLER WG, 1969, CARDIOVASC RES, V3, P30, DOI 10.1093/cvr/3.1.30; OBRIEN MA, 2000, COCHRANE DATABASE SY; OBRIEN T, 2001, COCHRANE DATABASE SY; Owen A, 2000, EUR J HEART FAIL, V2, P287, DOI 10.1016/S1388-9842(00)00092-1; OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423; Packer M, 1999, CIRCULATION, V100, P2312, DOI 10.1161/01.CIR.100.23.2312; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Packer M, 1999, AM J CARDIOL, V83, p1A; Philbin EF, 1999, J GEN INTERN MED, V14, P130, DOI 10.1046/j.1525-1497.1999.00291.x; POOLEWILSON PH, 1999, CARDIOVASC DRUG THER, V13, P24; Remme WJ, 2001, EUR HEART J, V22, P1527, DOI 10.1053/euhj.2001.2783; Rich MW, 1999, J CARD FAIL, V5, P64, DOI 10.1016/S1071-9164(99)90026-X; Sanderson JE, 1999, J AM COLL CARDIOL, V34, P1522, DOI 10.1016/S0735-1097(99)00367-8; Simon T, 2001, CIRCULATION, V103, P375; Vantrimpont P, 1997, J AM COLL CARDIOL, V29, P229, DOI 10.1016/S0735-1097(96)00489-5; VINSON JM, 1990, J AM GERIATR SOC, V38, P1290, DOI 10.1111/j.1532-5415.1990.tb03450.x; Wedel H, 2001, AM HEART J, V142, P502, DOI 10.1067/mhj.2001.117600; Yancy CW, 2001, NEW ENGL J MED, V344, P1358, DOI 10.1056/NEJM200105033441803; YUE TL, 1992, J PHARMACOL EXP THER, V263, P92	52	32	33	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2002	287	7					890	897		10.1001/jama.287.7.890	http://dx.doi.org/10.1001/jama.287.7.890			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	522XP	11851583	Bronze			2022-12-28	WOS:000173922500030
J	Foody, JM; Farrell, MH; Krumholz, HM				Foody, JM; Farrell, MH; Krumholz, HM			beta-blocker therapy in heart failure - Scientific review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							MYOCARDIAL CATECHOLAMINE BALANCE; LEFT-VENTRICULAR DYSFUNCTION; SYMPATHETIC-NERVOUS-SYSTEM; PLASMA NOREPINEPHRINE; ADRENERGIC-BLOCKADE; DILATED CARDIOMYOPATHY; CORONARY HEMODYNAMICS; NORMOTENSIVE PATIENTS; HYDROXYLASE ACTIVITY; METOPROLOL CR/XL	Context Care of patients with heart failure has been revolutionized throughout the past decade. A paradigm shift in the strategy for treating heart failure caused by systolic dysfunction is in progress. Despite the initial perception about beta-blockers' safety, they are now the most extensively studied class of agents in the treatment of heart failure and have emerged as an important intervention to improve the clinical outcomes of heart failure patients. Objective To provide scientific rationale for the use of beta-blockers for patients with heart failure. Data Sources All English-language articles of large, randomized controlled clinical trials assessing the mortality benefits of beta-blockers in patients with heart failure were identified to provide the scientific rationale for the use of beta-blockers in heart failure. Basic science studies were reviewed to provide an overview of the potential physiologic role of beta-blockers in heart failure. Finally, clinical guidelines for the treatment of patients with heart failure were assessed to determine current recommendations for the use of these agents. Study Selection and Data Extraction Randomized controlled clinical trials of beta-blockers that included more than 300 subjects and assessed mortality as a primary end point. Data Synthesis Of the 4 beta-blockers tested in large randomized controlled clinical trials of patients with heart failure, 3 are available in the United States, bisoprolol, carvedilol, and metoprolol; 2 of these, carvedilol and metoprolol, have Food and Drug Administration indications for the treatment of heart failure. Compared with placebo treatment, beta-blocker use is associated with a consistent 30% reduction in mortality and a 40% reduction in hospitalizations in patients with class II and III heart failure. Conclusions Tested in more than 10000 patients, beta-blockers reduce morbidity and mortality in class 11 through IV heart failure. Along with angiotensin-converting enzyme inhibitors, digoxin, and diuretics, beta-blockers have strengthened the armamentarium to improve clinical outcomes of heart failure patients. The science supporting beta-blockers must be translated into practice safely and rationally if the agents are to achieve their full potential.	Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Internal Med, Sect Gen Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06510 USA; Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	Yale University; Yale University; Yale University; Yale University	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, 333 Cedar St,POB 208025, New Haven, CT 06520 USA.		, Harlan/AAI-2875-2020	Farrell, Michael/0000-0002-2842-0205				Adams KF, 1999, J CARD FAIL, V5, P357; *AG HLTH CAR POL R, 1994, CLIN PRACT GUIDED QU, V11, P1; Anthonio RL, 1999, AM J CARDIOL, V83, P1286, DOI 10.1016/S0002-9149(99)00077-6; Avezum A, 1998, CAN J CARDIOL, V14, P1045; BAKER DW, 1994, JAMA-J AM MED ASSOC, V272, P1361, DOI 10.1001/jama.272.17.1361; Barone FC, 1998, J HYPERTENS, V16, P871, DOI 10.1097/00004872-199816060-00019; Basu S, 1997, CIRCULATION, V96, P183; Braunwald E, 1970, UCLA Forum Med Sci, V10, P289; BRAUNWALD E, 1965, P ROY SOC MED, V58, P1063, DOI 10.1177/003591576505801221; Bristow MR, 1996, CIRCULATION, V94, P2807, DOI 10.1161/01.CIR.94.11.2807; Bristow MR, 1997, AM J CARDIOL, V80, pL26, DOI 10.1016/S0002-9149(97)00846-1; BRISTOW MR, 1994, CIRCULATION, V89, P1632, DOI 10.1161/01.CIR.89.4.1632; Bristow MR, 2000, J CARD FAIL, V6, P8; Bristow MR, 1998, CLIN CARDIOL, V21, P3; BRISTOW MR, 1996, CIRCULATION, V94, P644; BROOKS NH, 1994, AM FAM PHYSICIAN, V50, P531; Brophy JM, 2001, ANN INTERN MED, V134, P550, DOI 10.7326/0003-4819-134-7-200104030-00008; Carson P, 1996, J AM COLL CARDIOL, V27, P642, DOI 10.1016/0735-1097(95)00503-X; CHIDSEY CA, 1966, PHARMACOL REV, V18, P685; CHIDSEY CA, 1966, CIRCULATION, V33, P43, DOI 10.1161/01.CIR.33.1.43; Cohn J N, 1997, J Card Fail, V3, P173, DOI 10.1016/S1071-9164(97)90013-0; COHN JN, 1995, CLIN CARDIOL, V18, P4; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; COHN JN, 1988, AM J CARDIOL, V62, pA25, DOI 10.1016/S0002-9149(88)80081-X; COHN JN, 1988, J AM COLL CARDIOL, V12, P554, DOI 10.1016/0735-1097(88)90435-4; COHN JN, 1993, CIRCULATION, V87, P1; Colucci WS, 1996, CIRCULATION, V94, P2800, DOI 10.1161/01.CIR.94.11.2800; CURRIE PJ, 1984, J AM COLL CARDIOL, V3, P203, DOI 10.1016/S0735-1097(84)80449-0; Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8; Dernellis JM, 1998, CLIN CARDIOL, V21, P28, DOI 10.1002/clc.4960210106; DiBona GF, 1999, CIRCULATION, V100, P82, DOI 10.1161/01.CIR.100.1.82; Doughty RN, 1997, ANNU REV MED, V48, P103; Doughty RN, 1997, EUR HEART J, V18, P560; Eichhorn E, 2001, NEW ENGL J MED, V344, P1659; EICHHORN EJ, 1992, AM J MED, V92, P527, DOI 10.1016/0002-9343(92)90750-6; Eichhorn Eric J., 1994, Cardiology Clinics, V12, P133; EPSTEIN SE, 1965, J CLIN INVEST, V44, P1745, DOI 10.1172/JCI105282; FELDMAN AM, 1990, CARDIOLOGY, V77, P1, DOI 10.1159/000174645; FELDMAN RL, 1988, CLIN CARDIOL, V11, P383, DOI 10.1002/clc.4960110605; FELDMAN RL, 1988, CARDIOVASC DRUG THER, V2, P355, DOI 10.1007/BF00054643; Ferrari R, 1998, EUR HEART J, V19, pF45; FRANCIS GS, 1982, AM J CARDIOL, V49, P1152, DOI 10.1016/0002-9149(82)90039-X; FRANCIS GS, 1990, CIRCULATION, V82, P1724, DOI 10.1161/01.CIR.82.5.1724; FRANCIS GS, 1986, ANNU REV MED, V37, P235, DOI 10.1146/annurev.me.37.020186.001315; FRANCIS GS, 1993, CIRCULATION, V87, P40; Frankenberger O, 1999, Curr Cardiol Rep, V1, P274, DOI 10.1007/s11886-999-0050-8; Gilbert EM, 1996, CIRCULATION, V94, P2817, DOI 10.1161/01.CIR.94.11.2817; Goldstein S, 1999, CLIN CARDIOL, V22, pV30; Hasegawa K, 2001, J CELL PHYSIOL, V186, P11, DOI 10.1002/1097-4652(200101)186:1<11::AID-JCP1013>3.0.CO;2-5; Hash TW, 1997, J CLIN PHARMACOL, V37, P7, DOI 10.1177/009127009703700103; Heidenreich PA, 1997, J AM COLL CARDIOL, V30, P27, DOI 10.1016/S0735-1097(97)00104-6; Hjalmarson A, 2000, JAMA-J AM MED ASSOC, V283, P1295, DOI 10.1001/jama.283.10.1295; Hjalmarson A, 1997, AM J CARDIOL, V80, pJ54; Hunt SA, 2001, J AM COLL CARDIOL, V38, P2101, DOI 10.1016/S0735-1097(01)01683-7; IKRAM H, 1981, LANCET, V2, P490; Jaffe R, 1997, ADV EXP MED BIOL, V430, P257; KAPPAGODA CT, 1974, J PHYSIOL-LONDON, V242, pP79; KATZ AM, 1992, AM J CARDIOL, V70, pC126; KATZ AM, 1990, AM J CARDIOL, V66, P468, DOI 10.1016/0002-9149(90)90707-8; KRAMER RS, 1968, CIRCULATION, V38, P629, DOI 10.1161/01.CIR.38.4.629; Lechat P, 1999, LANCET, V353, P9; LECHAT P, 1994, CIRCULATION, V90, P1765, DOI 10.1161/01.CIR.90.4.1765; Lechat P, 1998, CIRCULATION, V98, P1184, DOI 10.1161/01.CIR.98.12.1184; Lechat P, 2001, CIRCULATION, V103, P1428, DOI 10.1161/01.CIR.103.10.1428; LEVINE TB, 1982, AM J CARDIOL, V49, P1659, DOI 10.1016/0002-9149(82)90243-0; LEVY JV, 1967, ARCH INT PHYS BIOCH, V75, P381, DOI 10.3109/13813456709089585; Mann DL, 1998, PROG CARDIOVASC DIS, V41, P1, DOI 10.1016/S0033-0620(98)80025-X; MANN DL, 1989, CLIN CARDIOL, V12, P485, DOI 10.1002/clc.4960120904; Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999; MCDONALD KM, 1992, J AM COLL CARDIOL, V19, P460, DOI 10.1016/0735-1097(92)90506-I; MEIJLER FL, 1989, J AM COLL CARDIOL, V13, P769, DOI 10.1016/0735-1097(89)90625-6; METRA M, 1994, J AM COLL CARDIOL, V24, P1678, DOI 10.1016/0735-1097(94)90174-0; MINAMI M, 1983, CIRCULATION, V67, P1324, DOI 10.1161/01.CIR.67.6.1324; NAYLER WG, 1969, CARDIOVASC RES, V3, P30, DOI 10.1093/cvr/3.1.30; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; PACKER M, 1995, EUR HEART J, V16, P4, DOI 10.1093/eurheartj/16.suppl_F.4; Patten RD, 1998, CURR OPIN CARDIOL, V13, P162; PIERPONT GL, 1987, AM J CARDIOL, V60, P316, DOI 10.1016/0002-9149(87)90234-7; POOL PE, 1968, AM J CARDIOL, V22, P7, DOI 10.1016/0002-9149(68)90241-5; POOL PE, 1967, CIRC RES, V20, P349, DOI 10.1161/01.RES.20.3.349; Raju T N, 2000, Lancet, V355, P1022, DOI 10.1016/S0140-6736(05)74775-9; RECTOR TS, 1987, AM HEART J, V114, P148, DOI 10.1016/0002-8703(87)90318-8; Remme WJ, 2001, EUR HEART J, V22, P1527, DOI 10.1053/euhj.2001.2783; Rundqvist B, 1997, CIRCULATION, V95, P169, DOI 10.1161/01.CIR.95.1.169; SPANN JF, 1965, CIRC RES, V17, P312, DOI 10.1161/01.RES.17.4.312; SWEDBERG K, 1984, AM J CARDIOL, V54, P783, DOI 10.1016/S0002-9149(84)80208-8; VIQUERAT CE, 1985, AM J MED, V78, P455, DOI 10.1016/0002-9343(85)90338-9; VIQUERAT CE, 1985, J AM COLL CARDIOL, V5, P326, DOI 10.1016/S0735-1097(85)80054-1; WAAGSTEIN F, 1975, BRIT HEART J, V37, P1022; WAAGSTEIN F, 1993, LANCET, V342, P1441, DOI 10.1016/0140-6736(93)92930-R; WAAGSTEIN F, 1981, AM HEART J, V102, P548, DOI 10.1016/0002-8703(81)90743-2; WAAGSTEIN F, 1976, ACTA MED SCAND, P201; WAAGSTEIN F, 1976, ACTA MED SCAND, P193; WAAGSTEIN F, 1974, BRIT HEART J, V36, P1109; Wiklund I, 1996, CARDIOVASC DRUG THER, V10, P361; WILLIAMS JF, 1995, CIRCULATION, V92, P2764	97	229	238	3	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2002	287	7					883	889		10.1001/jama.287.7.883	http://dx.doi.org/10.1001/jama.287.7.883			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	522XP	11851582	Bronze			2022-12-28	WOS:000173922500029
J	Whitley, RJ; Gnann, JW				Whitley, RJ; Gnann, JW			Viral encephalitis: familiar infections and emerging pathogens	LANCET			English	Review							HERPES-SIMPLEX ENCEPHALITIS; WEST NILE VIRUS; POLYMERASE-CHAIN-REACTION; ENTEROVIRUS 71 INFECTION; NIPAH-VIRUS; JAPANESE ENCEPHALITIS; B-VIRUS; CEREBROSPINAL-FLUID; NERVOUS-SYSTEM; UNITED-STATES	Significant advances have been made in our understanding of the natural history and pathogenesis of viral encephalitides. The development of PCR has greatly increased our ability to diagnose viral infections of the central nervous system, particularly for herpes and enteroviral infections. Advancing knowledge has led to the recognition that some encephalitides can be reliably prevented by vaccination (eg, Japanese encephalitis and rabies). For other pathogens such as the arboviruses, the focus has been on prevention by vector control. Finally, effective therapy has been established for a very limited number of viral infections (eg, aciclovir for herpes simplex encephalitis). Other potentially useful treatments, such as pleconaril for enteroviral meningoencephalitis are under clinical evaluation. We review current understanding of viral encephalitides with particular reference to emerging viral infections and the availibility of existing treatment regimens.	Univ Alabama Birmingham, Dept Pediat Microbiol & Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Whitley, RJ (corresponding author), Univ Alabama Birmingham, Dept Pediat Microbiol & Med, 1600 7th Ave S,ACC 616, Birmingham, AL 35294 USA.	R.Whitley@peds.uab.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI024009, N01AI062554, N01AI015113, N01AI065306] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-032] Funding Source: Medline; NIAID NIH HHS [N01-AI-65306, P01 AI 24009, N01-AI-62554, N01-AI-15113] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARINGER JR, 1994, ANN NEUROL, V36, P823, DOI 10.1002/ana.410360605; BOERMAN RH, 1989, J VIROL METHODS, V25, P189, DOI 10.1016/0166-0934(89)90032-3; Briese T, 1999, LANCET, V354, P1261, DOI 10.1016/S0140-6736(99)04576-6; *CDCP, 1998, MMWR-MORBID MORTAL W, V47, P1073; *CDCP, 1999, MMWR MORB MORTA SRR1, V48, pS1; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P845; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P25; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P265; Cernescu C, 2000, J INFECT DIS, V181, P710, DOI 10.1086/315225; Childs James E., 1993, Morbidity and Mortality Weekly Report, V42, P1; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 1999, LANCET, V354, P1257, DOI 10.1016/S0140-6736(99)04299-3; Deresiewicz RL, 1997, NEW ENGL J MED, V336, P1867, DOI 10.1056/NEJM199706263362604; Domingues RB, 1998, J NEUROL SCI, V157, P148, DOI 10.1016/S0022-510X(98)00069-0; Enserink M, 2000, SCIENCE, V289, P518, DOI 10.1126/science.289.5479.518; FREIFELD AG, 1995, J INFECT DIS, V171, P1031, DOI 10.1093/infdis/171.4.1031; GERBER SI, 1995, VIROLOGY, V214, P29, DOI 10.1006/viro.1995.9957; Goh KJ, 2000, NEW ENGL J MED, V342, P1229, DOI 10.1056/NEJM200004273421701; GRIFFIN DE, 1990, ANTIVIR AGENTS VIR, P461; Hanlon CA, 1999, J AM VET MED ASSOC, V215, P1444; Hanna JN, 2000, MED J AUSTRALIA, V172, P597, DOI 10.5694/j.1326-5377.2000.tb124126.x; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; HOLMES GP, 1995, CLIN INFECT DIS, V20, P421, DOI 10.1093/clinids/20.2.421; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505; Ito Y, 2000, CLIN INFECT DIS, V30, P185, DOI 10.1086/313618; Jainkittivong A, 1998, ORAL SURG ORAL MED O, V85, P399, DOI 10.1016/S1079-2104(98)90064-6; JAMIESON GA, 1991, J MED VIROL, V33, P224, DOI 10.1002/jmv.1890330403; Jia XY, 1999, LANCET, V354, P1971, DOI 10.1016/S0140-6736(99)05384-2; Johnson R.T., 1998, VIRAL INFECT NERVOUS; JOHNSON RT, 1968, NEW ENGL J MED, V278, P23, DOI 10.1056/NEJM196801042780106; JOHNSON RT, 1987, J INFECT DIS, V155, P359, DOI 10.1093/infdis/155.3.359; Kalita J, 2000, J NEUROL SCI, V174, P3, DOI 10.1016/S0022-510X(99)00318-4; Krebs JW, 2000, J AM VET MED ASSOC, V217, P1799, DOI 10.2460/javma.2000.217.1799; LAKEMAN FD, 1995, J INFECT DIS, V171, P857, DOI 10.1093/infdis/171.4.857; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; LONGSON M, 1983, J INFECTION, V6, P15, DOI 10.1016/S0163-4453(83)94063-X; McGrath N, 1997, J NEUROL NEUROSUR PS, V63, P321, DOI 10.1136/jnnp.63.3.321; McJunkin JE, 1998, INFECT DIS CLIN N AM, V12, P83, DOI 10.1016/S0891-5520(05)70410-4; McJunkin JE, 2001, NEW ENGL J MED, V344, P801, DOI 10.1056/NEJM200103153441103; Moran GJ, 2000, JAMA-J AM MED ASSOC, V284, P1001, DOI 10.1001/jama.284.8.1001; Noah DL, 1998, ANN INTERN MED, V128, P922, DOI 10.7326/0003-4819-128-11-199806010-00012; Ostrowski SR, 1998, EMERG INFECT DIS, V4, P117, DOI 10.3201/eid0401.980117; Paton NI, 1999, LANCET, V354, P1253, DOI 10.1016/S0140-6736(99)04379-2; Pevear DC, 1999, ANTIMICROB AGENTS CH, V43, P2109, DOI 10.1128/AAC.43.9.2109; Plotkin SA, 2000, CLIN INFECT DIS, V30, P4, DOI 10.1086/313632; POWELL KF, 1990, LANCET, V335, P357, DOI 10.1016/0140-6736(90)90648-O; PUCHHAMMERSTOCKL E, 1990, J MED VIROL, V32, P77, DOI 10.1002/jmv.1890320202; Rappole JH, 2000, EMERG INFECT DIS, V6, P319, DOI 10.3201/eid0604.000401; ROWLEY AH, 1990, LANCET, V335, P440, DOI 10.1016/0140-6736(90)90667-T; Samaratunga H, 1998, NEUROPATH APPL NEURO, V24, P331, DOI 10.1046/j.1365-2990.1998.00129.x; Sarji SA, 2000, AM J ROENTGENOL, V175, P437, DOI 10.2214/ajr.175.2.1750437; SELVEY LA, 1995, MED J AUSTRALIA, V162, P642, DOI 10.5694/j.1326-5377.1995.tb126050.x; Siegel-Itzkovich J, 2000, BRIT MED J, V321, P724; Solomon T, 1998, J CLIN MICROBIOL, V36, P2030, DOI 10.1128/JCM.36.7.2030-2034.1998; Solomon T, 2000, J NEUROL NEUROSUR PS, V68, P405, DOI 10.1136/jnnp.68.4.405; Solomon T, 1998, LANCET, V351, P1094, DOI 10.1016/S0140-6736(97)07509-0; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; Tsai TF, 1998, J INFECT DIS, V177, P221, DOI 10.1086/517358; VAHLNE A, 1980, INFECT IMMUN, V28, P675; VAUGHN DW, 1992, EPIDEMIOL REV, V14, P197, DOI 10.1093/oxfordjournals.epirev.a036087; Wang SM, 1999, CLIN INFECT DIS, V29, P184, DOI 10.1086/520149; WHITLEY RJ, 1982, JAMA-J AM MED ASSOC, V247, P317, DOI 10.1001/jama.247.3.317; WHITLEY RJ, 1995, CLIN INFECT DIS, V20, P414, DOI 10.1093/clinids/20.2.414; WHITLEY RJ, 1989, JAMA-J AM MED ASSOC, V262, P234, DOI 10.1001/jama.262.2.234; WHITLEY RJ, 1986, NEW ENGL J MED, V314, P144, DOI 10.1056/NEJM198601163140303; WHITLEY RJ, 1990, NEW ENGL J MED, V323, P242, DOI 10.1056/NEJM199007263230406; WHITLEY RJ, 1996, INFECT CENTRAL NERVO, P73; 1997, WKLY EPIDEMIOL REC, V74, P381	69	282	315	2	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2002	359	9305					507	514		10.1016/S0140-6736(02)07681-X	http://dx.doi.org/10.1016/S0140-6736(02)07681-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520ML	11853816				2022-12-28	WOS:000173785600031
J	Sharp, PM				Sharp, PM			Origins of human virus diversity	CELL			English	Review							HEMAGGLUTININ GENE; EVOLUTION; HIV-1; HERPESVIRUSES; PHYLOGENY; SEQUENCE; AIDS	The diverse consequences of different viral infections on the human population reflect both the history of their origins and the nature of their ongoing evolution. Advances in the ease of finding and characterizing viral genome sequences are having a major impact on our understanding of the diversity of human viruses and of their relatives infecting other species.	Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2UH, England	University of Nottingham	Sharp, PM (corresponding author), Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2UH, England.		Sharp, Paul M/F-5783-2010; Sharp, Paul M/GPX-1497-2022; Sharp, Paul/Y-3787-2019	Sharp, Paul M/0000-0001-9771-543X; Sharp, Paul M/0000-0001-9771-543X; 	NIAID NIH HHS [R01 AI50529, N01 AI85338] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI085338, R01AI050529] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Basler CF, 2001, P NATL ACAD SCI USA, V98, P2746, DOI 10.1073/pnas.031575198; Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057; Cliff A, 2000, ISLAND EPIDEMICS; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; GENTRY GA, 1988, P NATL ACAD SCI USA, V85, P2658, DOI 10.1073/pnas.85.8.2658; Gibbs MJ, 2001, SCIENCE, V293, P1842, DOI 10.1126/science.1061662; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Hatwell JN, 2000, J GEN VIROL, V81, P1191, DOI 10.1099/0022-1317-81-5-1191; JENKINS GM, IN PRESS J MOL EVOL; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Lacoste V, 2001, GENOME RES, V11, P1511, DOI 10.1101/gr.158601; Liffick SL, 2001, VIRUS RES, V77, P81, DOI 10.1016/S0168-1702(01)00268-4; Mahony TJ, 1999, J GEN VIROL, V80, P433, DOI 10.1099/0022-1317-80-2-433; Malim MH, 2001, CELL, V104, P469, DOI 10.1016/S0092-8674(01)00234-3; McGeoch DJ, 2000, J VIROL, V74, P10401, DOI 10.1128/JVI.74.22.10401-10406.2000; McGeoch DJ, 2001, PHILOS T ROY SOC B, V356, P421, DOI 10.1098/rstb.2000.0775; MCGEOCH DJ, 1995, J MOL BIOL, V247, P443, DOI 10.1006/jmbi.1995.0152; Moore JP, 2001, J VIROL, V75, P5721, DOI 10.1128/JVI.75.13.5721-5729.2001; Peeters M, 2000, AIDS, V14, pS129; Rambaut A, 2001, NATURE, V410, P1047, DOI 10.1038/35074179; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Salemi M, 2001, FASEB J, V15, P276, DOI 10.1096/fj.00-0449fje; Santiago ML, 2002, SCIENCE, V295, P465, DOI 10.1126/science.295.5554.465; Sharp PM, 2000, BIOCHEM SOC T, V28, P275, DOI 10.1042/bst0280275; Sibold C, 1999, J VIROL, V73, P667, DOI 10.1128/JVI.73.1.667-675.1999; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108; Taubenberger JK, 2000, EMERG INFECT DIS, V6, P42, DOI 10.3201/eid0601.000107; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Webster RG, 2001, SCIENCE, V293, P1773; Woelk CH, 2001, J GEN VIROL, V82, P2463, DOI 10.1099/0022-1317-82-10-2463; World Health Organization, 1998, WKLY EPIDEMIOL REC, V73, P265; Zhu TF, 1998, NATURE, V391, P594, DOI 10.1038/35400	32	49	51	2	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 8	2002	108	3					305	312		10.1016/S0092-8674(02)00639-6	http://dx.doi.org/10.1016/S0092-8674(02)00639-6			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	520VB	11853665	Bronze			2022-12-28	WOS:000173801600003
J	Coulson, T; Lindstrom, J; Cotgreave, P				Coulson, T; Lindstrom, J; Cotgreave, P			Ecology - Seeking new recruits	SCIENCE			English	Editorial Material							POPULATION; EXTINCTION; DENSITY		Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Glasgow, Div Environm & Evolutionary Biol, Glasgow G12 8QQ, Lanark, Scotland; Save British Soc, London WC1H 9QU, England	University of Cambridge; University of Glasgow	Coulson, T (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.		Coulson, Tim/AAL-8148-2021; Lindstrom, Jan/A-8890-2008	Coulson, Tim/0000-0001-9371-9003; Lindstrom, Jan/0000-0001-5630-6680				Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; GRANT BR, 1993, P ROY SOC B-BIOL SCI, V251, P111, DOI 10.1098/rspb.1993.0016; Leirs H, 1997, NATURE, V389, P176, DOI 10.1038/38271; Lima M, 1999, AM NAT, V153, P476, DOI 10.1086/303191; MACE GM, 1991, CONSERV BIOL, V5, P148, DOI 10.1111/j.1523-1739.1991.tb00119.x; OWENSMITH N, 1990, J ANIM ECOL, V59, P893, DOI 10.2307/5021; Saether BE, 2000, P ROY SOC B-BIOL SCI, V267, P621, DOI 10.1098/rspb.2000.1047; Saether BE, 2002, SCIENCE, V295, P2070; Stearns S.C., 1992, pi	9	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2002	295	5562					2023	2024		10.1126/science.1070514	http://dx.doi.org/10.1126/science.1070514			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532AY	11896258				2022-12-28	WOS:000174450500028
J	Guo, ZT; Ruddiman, WF; Hao, QZ; Wu, HB; Qiao, YS; Zhu, RX; Peng, SZ; Wei, JJ; Yuan, BY; Liu, TS				Guo, ZT; Ruddiman, WF; Hao, QZ; Wu, HB; Qiao, YS; Zhu, RX; Peng, SZ; Wei, JJ; Yuan, BY; Liu, TS			Onset of Asian desertification by 22 Myr ago inferred from loess deposits in China	NATURE			English	Article							NORTHERN-HEMISPHERE; PLATEAU; UPLIFT; MAGNETOSTRATIGRAPHY; CLIMATE; ORIGIN	The initial desertification in the Asian interior is thought to be one of the most prominent climate changes in the Northern Hemisphere during the Cenozoic era(1-4). But the dating of this transition is uncertain, partly because desert sediments are usually scattered, discontinuous and difficult to date. Here we report nearly continuous aeolian deposits covering the interval from 22 to 6.2 million years ago, on the basis of palaeomagnetic measurements and fossil evidence. A total of 231 visually definable aeolian layers occur as brownish loesses interbedded with reddish soils. This new evidence indicates that large source areas of aeolian dust and energetic winter monsoon winds to transport the material must have existed in the interior of Asia by the early Miocene epoch, at least 14 million years earlier than previously thought(3,5). Regional tectonic changes and ongoing global cooling are probable causes of these changes in aridity and circulation in Asia.	Chinese Acad Sci, Inst Geol & Geophys, Beijing 100029, Peoples R China; Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA	Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; University of Virginia	Guo, ZT (corresponding author), Chinese Acad Sci, Inst Geol & Geophys, POB 9825, Beijing 100029, Peoples R China.		Zhu, Rixiang/F-2126-2018; Guo, Zhengtang/B-6854-2008; Hao, Qingzhen/E-4605-2010	Zhu, Rixiang/0000-0002-4985-925X; Guo, Zhengtang/0000-0003-2259-9715; Hao, Qingzhen/0000-0002-6281-5817				An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; BERGER A, 1992, SCIENCE, V255, P560, DOI 10.1126/science.255.5044.560; BRUIJN H, 1981, P KONINKLIJKE NEDE B, V84, P71; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; Chung SL, 1998, NATURE, V394, P769, DOI 10.1038/29511; Ding ZL, 1998, EARTH PLANET SC LETT, V161, P135, DOI 10.1016/S0012-821X(98)00145-9; Duchaufour P., 1983, PEDOLOGIE, V1; Guo ZT, 1998, GLOBAL PLANET CHANGE, V18, P113, DOI 10.1016/S0921-8181(98)00010-1; Guo ZT, 2001, PALAEOGEOGR PALAEOCL, V170, P11, DOI 10.1016/S0031-0182(01)00235-8; HARRISON TM, 1992, SCIENCE, V255, P1663, DOI 10.1126/science.255.5052.1663; JANSEN E, 1991, NATURE, V349, P600, DOI 10.1038/349600a0; KUKLA G, 1990, T ROY SOC EDIN-EARTH, V81, P263, DOI 10.1017/S0263593300020794; Liu T.S., 1985, LOESS ENV; MAHER BA, 1986, PHYS EARTH PLANET IN, V42, P76, DOI 10.1016/S0031-9201(86)80010-3; MANABE S, 1990, SCIENCE, V247, P192, DOI 10.1126/science.247.4939.192; Mein P., 1989, NATO ASI SER A, V180, P73; Miller KG, 1987, PALEOCEANOGRAPHY, V2, P1, DOI 10.1029/PA002i001p00001; PYE K, 1983, SEDIMENTOLOGY, V30, P49, DOI 10.1111/j.1365-3091.1983.tb00649.x; Qiu ZD., 1996, MIDDLE MIOCENE MICRO; Qiu Zhangxiang, 1999, P443; Ramsey M, 1997, J SOC HIST, V30, P788, DOI 10.1353/jsh/30.3.788; Rea DK, 1998, PALEOCEANOGRAPHY, V13, P215, DOI 10.1029/98PA00123; RUDDIMAN WF, 1989, J GEOPHYS RES-ATMOS, V94, P18409, DOI 10.1029/JD094iD15p18409; Sun DG, 1998, GEOPHYS J INT, V134, P207, DOI 10.1046/j.1365-246x.1998.00553.x; Sun DH, 1998, GEOPHYS RES LETT, V25, P85, DOI 10.1029/97GL03353; WANG HZ, 1985, ATLAS PALEOGEOGRAPHY, P121; WHALLEY WB, 1982, NATURE, V300, P433, DOI 10.1038/300433a0; Wolfe J.A., 1985, GEOPHYS MONOGR SER, V32, P357, DOI DOI 10.1029/GM032P0357; Zhang XY, 1997, J GEOPHYS RES-ATMOS, V102, P28041, DOI 10.1029/97JD02300; ZHENG S, 1994, RODENT LAGOMORPH FAM, P57	30	1282	1790	28	526	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2002	416	6877					159	163		10.1038/416159a	http://dx.doi.org/10.1038/416159a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894089				2022-12-28	WOS:000174348100032
J	Steinbrook, R				Steinbrook, R			Perspective - The prescription-drug problem	NEW ENGLAND JOURNAL OF MEDICINE			English	Article																			0	16	17	1	4	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2002	346	11					790	790		10.1056/NEJM200203143461102	http://dx.doi.org/10.1056/NEJM200203143461102			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529YM	11893789				2022-12-28	WOS:000174328900001
J	Fry, CJ; Peterson, CL				Fry, CJ; Peterson, CL			Unlocking the gates to gene expression	SCIENCE			English	Editorial Material							ORDERED RECRUITMENT; TRANSCRIPTION; PROMOTER		Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Fry, CJ (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.							Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Brown SA, 1996, GENE DEV, V10, P1479, DOI 10.1101/gad.10.12.1479; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; Krebs JE, 2000, CELL, V102, P587, DOI 10.1016/S0092-8674(00)00081-7; Krebs JE, 1999, GENE DEV, V13, P1412, DOI 10.1101/gad.13.11.1412; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356	8	71	72	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1847	1848		10.1126/science.1070260	http://dx.doi.org/10.1126/science.1070260			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884741				2022-12-28	WOS:000174299500024
J	Dennis, C				Dennis, C			Stem-cell reverse angers Australian biologists	NATURE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2002	416	6876					4	4		10.1038/416004b	http://dx.doi.org/10.1038/416004b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882855	Bronze			2022-12-28	WOS:000174211600005
J	Stewart, S; Charon, R				Stewart, S; Charon, R			Art, anatomy, learning, and living	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA	Columbia University	Stewart, S (corresponding author), Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA.							Berg Geri, 1983, VISUAL ARTS MED ED; Bertman S.L., 1989, CLIN ANAT, V2, P103; Langer Susanne, 1957, PROBLEMS ART, P15	3	9	11	2	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2002	287	9					1182	1182		10.1001/jama.287.9.1182	http://dx.doi.org/10.1001/jama.287.9.1182			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527KV	11879121	hybrid			2022-12-28	WOS:000174186000038
J	Roger, VL; Jacobsen, SJ; Weston, SA; Goraya, TY; Killian, J; Reeder, GS; Kottke, TE; Yawn, BP; Frye, RL				Roger, VL; Jacobsen, SJ; Weston, SA; Goraya, TY; Killian, J; Reeder, GS; Kottke, TE; Yawn, BP; Frye, RL			Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979 to 1994	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; SEX-DIFFERENCES; MEDICAL-CARE; MORTALITY; RATES; ATHEROSCLEROSIS; PERSPECTIVE; MORBIDITY; PROJECT; HISTORY	Background: Evidence indicates that deaths from coronary disease are decreasing less in elderly persons and women. Understanding the determinants of these trends is important for prevention. Objective: To test the hypothesis that trends in incidence and survival of hospitalized myocardial infarction differ according to sex and age. Design: Longitudinal observational study. Setting: Community-dwelling persons in Olmsted County, Minnesota. Patients: 5117 patients who had an estimated 1820 incident myocardial infarctions from 1979 to 1994. Measurements: Myocardial infarctions were validated by using epidemiologic criteria. Rates were directly adjusted to the age distribution of the 2000 U.S. population. Results: Of the 1820 incident infarctions, 44% occurred in women and 36% in persons 75 years of age or older. In 1979, the age-adjusted incidence of myocardial infarction was 205 per 100000 persons (95% Cl, 162 to 247 per 100000 persons). Between 1979 and 1994, the age-adjusted incidence of myocardial infarction decreased by 8% (Cl, -23% to 10%) in men but increased by 36% (Cl, 9% to 70%) in women. A 31% decrease in the incidence of infarction over time was observed in men 40 years of age compared with a 49% increase in women 80 years of age. Survival improved predominately in younger persons. Conclusions: over time, the incidence of hospitalized infarction decreased in men but increased in women and elderly persons. Survival benefits were clustered among younger persons. These results suggest that both incidence and survival contribute to the contrasting mortality trends by age and sex and that the burden of coronary disease has shifted toward elderly persons, a finding that has public health implications in an aging population.	Mayo Clin & Mayo Fdn, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA; Olmsted Med Grp, Rochester, MN 55903 USA	Mayo Clinic; Mayo Clinic; Olmsted Medical Center	Roger, VL (corresponding author), Mayo Clin & Mayo Fdn, Div Cardiovasc Dis & Internal Med, 200 1st St SW, Rochester, MN 55905 USA.		Roger, Veronique/AAV-5951-2020	Jacobsen, Steven/0000-0002-8174-8533	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030582] Funding Source: NIH RePORTER; NHLBI NIH HHS [AND RO1 HL 59205] Funding Source: Medline; NIAMS NIH HHS [AR30582] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bergstralh EJ., 1992, CALCULATING INCIDENC; Daly SC, 2000, J CLIN EPIDEMIOL, V53, P661, DOI 10.1016/S0895-4356(99)00223-1; FEINLEIB M, 1988, TRENDS CORONARY HEAR; GILLUM RF, 1984, AM HEART J, V108, P150, DOI 10.1016/0002-8703(84)90558-1; Goff DC, 1997, CIRCULATION, V95, P1433; Goldberg RJ, 1999, J AM COLL CARDIOL, V33, P1533, DOI 10.1016/S0735-1097(99)00040-6; Goldberg RJ, 1998, AM J CARDIOL, V82, P1311, DOI 10.1016/S0002-9149(98)00633-X; GOLDBERG RJ, 1993, CIRCULATION, V87, P1947, DOI 10.1161/01.CIR.87.6.1947; Gurwitz JH, 1997, JAMA-J AM MED ASSOC, V277, P1723, DOI 10.1001/jama.277.21.1723; Krumholz HM, 1997, JAMA-J AM MED ASSOC, V277, P1683, DOI 10.1001/jama.277.21.1683; Kurland LT, 1970, COMMUNITY EPIDEMIOLO, P47; McGovern PG, 1996, NEW ENGL J MED, V334, P884, DOI 10.1056/NEJM199604043341403; McGovern PG, 2001, CIRCULATION, V104, P19, DOI 10.1161/01.CIR.104.1.19; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; MELTON LJ, 1985, MAYO CLIN PROC, V60, P880, DOI 10.1016/S0025-6196(12)64794-6; Prineas R., 1982, MINNESOTA CODE MANUA; Roger VL, 1999, MAYO CLIN PROC, V74, P651, DOI 10.4065/74.7.651; Roger VL, 2001, AM J MED, V110, P267, DOI 10.1016/S0002-9343(00)00709-9; Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	22	195	200	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 5	2002	136	5					341	348		10.7326/0003-4819-136-5-200203050-00005	http://dx.doi.org/10.7326/0003-4819-136-5-200203050-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525VT	11874305				2022-12-28	WOS:000174095300001
J	Yamanouchi, K				Yamanouchi, K			Laser chemistry and physics - The next frontier	SCIENCE			English	Editorial Material							INTENSITY		Univ Tokyo, Sch Sci, Dept Chem, Tokyo 1130033, Japan	University of Tokyo	Yamanouchi, K (corresponding author), Univ Tokyo, Sch Sci, Dept Chem, Tokyo 1130033, Japan.		YAMANOUCHI, KAORU/G-5047-2014					BATANI DCJ, 2001, ATOMS SOLIDS PLASMAS; Ditmire T, 1997, PHYS REV LETT, V78, P3121, DOI 10.1103/PhysRevLett.78.3121; Hasegawa H, 2001, CHEM PHYS LETT, V349, P57, DOI 10.1016/S0009-2614(01)01087-9; Hishikawa A, 1999, PHYS REV LETT, V83, P1127, DOI 10.1103/PhysRevLett.83.1127; Hoshina K, 2002, CHEM PHYS LETT, V353, P27, DOI 10.1016/S0009-2614(01)01460-9; Hoshina K, 2002, CHEM PHYS LETT, V353, P33, DOI 10.1016/S0009-2614(01)01461-0; Levis RJ, 2001, SCIENCE, V292, P709, DOI 10.1126/science.1059133; Mourou GA, 1998, PHYS TODAY, V51, P22, DOI 10.1063/1.882131; TAJIMA T, 2000, HIGH FIELD SCI; [No title captured]	10	175	179	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 1	2002	295	5560					1659	1660		10.1126/science.1068449	http://dx.doi.org/10.1126/science.1068449			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872827				2022-12-28	WOS:000174212900031
J	Kantarjian, H; Sawyers, C; Hochhaus, A; Guilhot, F; Schiffer, C; Gambacorti-Passerini, C; Niederwieser, D; Resta, D; Capdeville, R; Zoellner, U; Talpaz, M; Druker, B				Kantarjian, H; Sawyers, C; Hochhaus, A; Guilhot, F; Schiffer, C; Gambacorti-Passerini, C; Niederwieser, D; Resta, D; Capdeville, R; Zoellner, U; Talpaz, M; Druker, B		Int STI571 CML Study Grp	Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	42nd Annual Meeting of the American-Society-of-Hematology	DEC 01-05, 2000	SAN FRANCISCO, CA	Amer Soc Hematol			CHRONIC MYELOID-LEUKEMIA; ABL TYROSINE KINASE; BONE-MARROW-TRANSPLANTATION; BCR-ABL; CHRONIC-PHASE; INHIBITOR; INTERFERON; HOMOHARRINGTONINE; CYTARABINE; CHROMOSOME	Background: Chronic myelogenous leukemia (CML) is caused by the BCR-ABL tyrosine kinase, the product of the Philadelphia chromosome. Imatinib mesylate, formerly STI571, is a selective inhibitor of this kinase. Methods: A total of 532 patients with late-chronic-phase CML in whom previous therapy with interferon alfa had failed were treated with 400 mg of oral imatinib daily. Patients were evaluated for cytogenetic and hematologic responses. Time to progression, survival, and toxic effects were also evaluated. Results: Imatinib induced major cytogenetic responses in 60 percent of the 454 patients with confirmed chronic-phase CML and complete hematologic responses in 95 percent. After a median follow-up of 18 months, CML had not progressed to the accelerated or blast phases in an estimated 89 percent of patients, and 95 percent of the patients were alive. Grade 3 or 4 nonhematologic toxic effects were infrequent, and hematologic toxic effects were manageable. Only 2 percent of patients discontinued treatment because of drug-related adverse events, and no treatment-related deaths occurred. Conclusions: Imatinib induced high rates of cytogenetic and hematologic responses in patients with chronic-phase CML in whom previous interferon therapy had failed. (N Engl J Med 2002;346:645-52.) Copyright (C) 2002 Massachusetts Medical Society.	Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; Univ Calif Los Angeles, Los Angeles, CA USA; Univ Klinikum Mannheim, Mannheim, Germany; Heidelberg Univ, D-6800 Mannheim, Germany; Ctr Hosp Univ Poitiers, Poitiers, France; Wayne State Univ, Detroit, MI USA; San Gerardo Hosp, Milan, Italy; Natl Canc Inst, I-20133 Milan, Italy; Univ Leipzig, Leipzig, Germany; Novartis Pharmaceut, E Hanover, NJ USA; Novartis Pharmaceut, Basel, Switzerland; Oregon Hlth & Sci Univ, Portland, OR 97201 USA	University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Los Angeles; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; CHU Poitiers; Universite de Poitiers; Wayne State University; San Gerardo Hospital; Fondazione IRCCS Istituto Nazionale Tumori Milan; Leipzig University; Novartis; Novartis; Oregon Health & Science University	Kantarjian, H (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Box 428,1515 Holcombe Blvd, Houston, TX 77030 USA.	hkantarj@mdanderson.org	Sawyers, Charles/G-5327-2016; Ottmann, Oliver/D-5007-2016	Hochhaus, Andreas/0000-0003-0626-0834; Ottmann, Oliver/0000-0001-9559-1330; Talpaz, Moshe/0000-0003-3361-3981; Druker, Brian/0000-0001-8331-8206; GAMBACORTI PASSERINI, CARLO/0000-0001-6058-515X; Guilhot, Francois/0000-0001-7222-487X				DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Deininger MWN, 1997, BLOOD, V90, P3691, DOI 10.1182/blood.V90.9.3691; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Druker BJ, 2000, J CLIN INVEST, V105, P3, DOI 10.1172/JCI9083; Druker BJ, 2001, NEW ENGL J MED, V345, P232; ELEFANTY AG, 1990, EMBO J, V9, P1069, DOI 10.1002/j.1460-2075.1990.tb08212.x; Faderl S, 1999, ANN INTERN MED, V131, P207, DOI 10.7326/0003-4819-131-3-199908030-00008; GambacortiPasserini C, 1997, BLOOD CELL MOL DIS, V23, P380, DOI 10.1006/bcmd.1997.0155; Goldman JM, 2001, BLOOD, V98, P2039, DOI 10.1182/blood.V98.7.2039; Guilhot F, 1997, NEW ENGL J MED, V337, P223, DOI 10.1056/NEJM199707243370402; HEISTERKAMP N, 1990, NATURE, V344, P251, DOI 10.1038/344251a0; Kantarjian HM, 2000, J CLIN ONCOL, V18, P3513, DOI 10.1200/JCO.2000.18.20.3513; KANTARJIAN HM, 1993, BLOOD, V82, P691; Kantarjian HM, 1999, J CLIN ONCOL, V17, P284, DOI 10.1200/JCO.1999.17.1.284; KELLIHER M, 1990, P NATL ACAD SCI USA, V87, P9072; KELLIHER MA, 1990, P NATL ACAD SCI USA, V87, P6649, DOI 10.1073/pnas.87.17.6649; le Coutre P, 1999, J NATL CANCER I, V91, P163, DOI 10.1093/jnci/91.2.163; NOWELL PC, 1960, SCIENCE, V132, P1497; OBRIEN S, 1995, BLOOD, V86, P3322, DOI 10.1182/blood.V86.9.3322.bloodjournal8693322; Rodriguez J, 1998, J CLIN ONCOL, V16, P3782, DOI 10.1200/JCO.1998.16.12.3782; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Savage DG, 1997, BRIT J HAEMATOL, V96, P111, DOI 10.1046/j.1365-2141.1997.d01-1982.x; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Silver RT, 1999, BLOOD, V94, P1517; SOKAL JE, 1988, SEMIN HEMATOL, V25, P49; SPECK B, 1984, LANCET, V1, P665	28	1580	1660	1	74	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2002	346	9					645	652		10.1056/NEJMoa011573	http://dx.doi.org/10.1056/NEJMoa011573			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	525HJ	11870241	Bronze			2022-12-28	WOS:000174062800002
J	Weinger, MB; Ancoli-Israel, S				Weinger, MB; Ancoli-Israel, S			Sleep deprivation and clinical performance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICAL HOUSE STAFF; COGNITIVE PERFORMANCE; WORKING HOURS; PATIENT-CARE; FATIGUE; NIGHT; MOOD; METAANALYSIS; VIGILANCE; IMPACT		Univ Calif San Diego, Dept Anesthesiol, San Diego Ctr Patient Safety, San Diego, CA 92103 USA; Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; Vet Affairs San Diego Healthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Weinger, MB (corresponding author), Vet Affairs Med Ctr, 125,3350 La Jolla Village Dr, La Jolla, CA 92161 USA.				AHRQ HHS [R01-HS11375, P20-HS11521] Funding Source: Medline; NCI NIH HHS [R01-CA85264] Funding Source: Medline; NIA NIH HHS [R01-AG08415] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [P20HS011521, R01HS011375] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA085264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008415] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 2000, PRINCIPLES PRACTICE; Dawson D, 1997, NATURE, V388, P235, DOI 10.1038/40775; Dinges DF, 1997, SLEEP, V20, P267; ENGLUND CE, 1985, BEHAV RES METH INS C, V17, P75, DOI 10.3758/BF03200899; FRIEDMAN RC, 1971, NEW ENGL J MED, V285, P201, DOI 10.1056/NEJM197107222850405; GABA DM, 1998, ENHANCING PATIENT SA, P302; GOTTLIEB DJ, 1991, ARCH INTERN MED, V151, P2065, DOI 10.1001/archinte.151.10.2065; Grantcharov TP, 2001, BRIT MED J, V323, P1222, DOI 10.1136/bmj.323.7323.1222; HOWARD SK, IN PRESS ACAD MED; KOSLOWSKY M, 1992, CHRONOBIOL INT, V9, P132, DOI 10.3109/07420529209064524; LAINE C, 1993, JAMA-J AM MED ASSOC, V269, P374, DOI 10.1001/jama.269.3.374; LEES DE, 1988, APSF NEWSLETTER, V3, P18; Leonard C, 1998, IRISH J MED SCI, V167, P22, DOI 10.1007/BF02937548; LEUNG L, 1992, J OCCUP ENVIRON MED, V34, P1153; Nelson C S, 1995, J Am Osteopath Assoc, V95, P600; OU JC, 2001, ANESTHESIOLOGY, V95, pA1196; Owens JA, 2001, SLEEP, V24, P493, DOI 10.1093/sleep/24.5.493; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; Richardson GS, 1996, SLEEP, V19, P718; SAMKOFF JS, 1991, ACAD MED, V66, P687, DOI 10.1097/00001888-199111000-00013; SMITHCOGGINS R, 1994, ANN EMERG MED, V24, P928, DOI 10.1016/S0196-0644(94)70209-8; SmithCoggins R, 1997, ACAD EMERG MED, V4, P951, DOI 10.1111/j.1553-2712.1997.tb03658.x; Taffinder NJ, 1998, LANCET, V352, P1191, DOI 10.1016/S0140-6736(98)00034-8; WEINGER MB, 1990, ANESTHESIOLOGY, V73, P995; WEINGER MB, 1998, ENHANCING PATIENT SA, P306; Wesnes KA, 1997, BRIT J SURG, V84, P493	26	248	257	0	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2002	287	8					955	957		10.1001/jama.287.8.955	http://dx.doi.org/10.1001/jama.287.8.955			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525CX	11866625				2022-12-28	WOS:000174052100001
J	Falke, JJ				Falke, JJ			A moving story	SCIENCE			English	Editorial Material							DYNAMICS; RECEPTOR; BINDING		Univ Colorado, Mol Biophys Program, Boulder, CO 80309 USA; Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Falke, JJ (corresponding author), Univ Colorado, Mol Biophys Program, Boulder, CO 80309 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040731] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM040731] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; Daggett V, 2000, CURR OPIN STRUC BIOL, V10, P160, DOI 10.1016/S0959-440X(00)00062-2; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; FABER HR, 1990, NATURE, V348, P263, DOI 10.1038/348263a0; FALKE JJ, 1987, SCIENCE, V237, P1596, DOI 10.1126/science.2820061; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Forman-Kay JD, 1999, NAT STRUCT BIOL, V6, P1086, DOI 10.1038/70008; Hoogstraten CG, 2000, BIOCHEMISTRY-US, V39, P9951, DOI 10.1021/bi0007627; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Huyghues-Despointes B M, 2001, Methods Mol Biol, V168, P69; JOSEPH D, 1990, SCIENCE, V249, P1425, DOI 10.1126/science.2402636; Kay LE, 1998, NAT STRUCT BIOL, V5, P513, DOI 10.1038/755; Moffat K, 2001, CHEM REV, V101, P1569, DOI 10.1021/cr990039q; Osborne MJ, 2001, BIOCHEMISTRY-US, V40, P9846, DOI 10.1021/bi010621k; Palmer AG, 2001, ANNU REV BIOPH BIOM, V30, P129, DOI 10.1146/annurev.biophys.30.1.129; Wand AJ, 2001, NAT STRUCT BIOL, V8, P926, DOI 10.1038/nsb1101-926; Wang CY, 2001, J MOL BIOL, V313, P873, DOI 10.1006/jmbi.2001.5083; Weiss S, 2000, NAT STRUCT BIOL, V7, P724, DOI 10.1038/78941; WUTHRICH K, 1978, TRENDS BIOCHEM SCI, V9, P152; Zhao YD, 1996, BIOCHEMISTRY-US, V35, P7356, DOI 10.1021/bi9602775; ZYDOWSKY LD, 1992, PROTEIN SCI, V1, P1092, DOI 10.1002/pro.5560010903	21	51	51	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2002	295	5559					1480	1481		10.1126/science.1069823	http://dx.doi.org/10.1126/science.1069823			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11859184	Green Accepted			2022-12-28	WOS:000173981300040
J	Purcell, GP; Wilson, P; Delamothe, T				Purcell, GP; Wilson, P; Delamothe, T			The quality of health information on the internet - As for any other medium it varies widely; revelation is not the answer	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Duke Univ, Med Ctr, Durham, NC 27710 USA; European Commiss, Directorate Gen Informat Soc Applicat Relating Hl, B-1049 Brussels, Belgium	Duke University	Purcell, GP (corresponding author), Duke Univ, Med Ctr, Durham, NC 27710 USA.	purcell@duke.edu; petra.wilson@cec.eu.int; tdelamothe@bmj.com						[Anonymous], 2001, BMJ-BRIT MED J, V323, P651; Eysenbach G, 2002, BMJ-BRIT MED J, V324, P573, DOI 10.1136/bmj.324.7337.573; Ferguson T, 2002, BMJ-BRIT MED J, V324, P555, DOI 10.1136/bmj.324.7337.555; FORSYTHE DE, 1992, USING ETHNOGRAPHY BU, P505; Gagliardi A, 2002, BMJ-BRIT MED J, V324, P569, DOI 10.1136/bmj.324.7337.569; Impicciatore P, 1997, BMJ-BRIT MED J, V314, P1875, DOI 10.1136/bmj.314.7098.1875; Meric F, 2002, BMJ-BRIT MED J, V324, P577, DOI 10.1136/bmj.324.7337.577; NIELSEN J, 1999, TOP 10 MISTAKES REV; NIELSEN J, 2002, TOP 10 MISTAKES WEB; *OXF CTR EV BAS ME, 2001, LEV EV GRAD REC 2001; Shepperd S, 2002, BRIT MED J, V324, P556, DOI 10.1136/bmj.324.7337.556; Standage Tom., 1999, VICTORIAN INTERNET; *WBC, 2002, WEB ACC IN WAD	13	146	151	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2002	324	7337					557	558		10.1136/bmj.324.7337.557	http://dx.doi.org/10.1136/bmj.324.7337.557			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	530XJ	11884303	Green Published			2022-12-28	WOS:000174384000003
J	Montell, C; Birnbaumer, L; Flockerzi, V				Montell, C; Birnbaumer, L; Flockerzi, V			The TRP channels, a remarkably functional family	CELL			English	Review								TRIP cation channels display an extraordinary assortment of selectivities and activation mechanisms, some of which represent previously unrecognized modes for regulating ion channels. Moreover, the biological roles of TRP channels appear to be equally diverse and range from roles in pain perception to male aggression.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; NIEHS, Res Triangle Pk, NC 27709 USA; Univ Saarland, Inst Pharmakol & Toxikol, D-66421 Homburg, Germany	Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Saarland University	Montell, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.		Montell, Craig/AAH-3357-2021	Montell, Craig/0000-0001-5637-1482				Boels K, 2001, J CELL SCI, V114, P3599; Boulay G, 1999, P NATL ACAD SCI USA, V96, P14955, DOI 10.1073/pnas.96.26.14955; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Jungnickel MK, 2001, NAT CELL BIOL, V3, P499, DOI 10.1038/35074570; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; MCKEMY DD, 2002, IN PRESS NATURE; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; Montell C., 2001, SCI STKE; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; PELER A, 2002, CELL, V108, P705; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Voets T, 2001, J BIOL CHEM, V276, P47767, DOI 10.1074/jbc.C100607200; Wissenbach U, 2001, J BIOL CHEM, V276, P19461, DOI 10.1074/jbc.M009895200; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8; Yue LX, 2001, NATURE, V410, P705, DOI 10.1038/35070596	20	657	690	1	46	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 8	2002	108	5					595	598		10.1016/S0092-8674(02)00670-0	http://dx.doi.org/10.1016/S0092-8674(02)00670-0			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	529TN	11893331	Bronze			2022-12-28	WOS:000174314800004
J	Burnham, G				Burnham, G			Maternal deaths among Afghan refugees	LANCET			English	Editorial Material									Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Int Emergency Disaster & Refugee Studies, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Burnham, G (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Int Emergency Disaster & Refugee Studies, Baltimore, MD 21205 USA.	gburnham@jhsph.edu						Assefa F, 2001, JAMA-J AM MED ASSOC, V286, P2723, DOI 10.1001/jama.286.21.2723; Hill K, 2001, B WORLD HEALTH ORGAN, V79, P182; MACRAE I, 1997, REBUILDING CIVIL SOC, P183; MUGGAH R, 2002, HUMANITARIANISM THRE; *POP REF BUR, 2001, 2001 WORLD POP DAT S; Rasekh Z, 1998, JAMA-J AM MED ASSOC, V280, P449, DOI 10.1001/jama.280.5.449; ROINIK B, 1995, INT J GYNECOL OBSTET, V48, P311; Spiegel PB, 2001, DISASTERS, V25, P172, DOI 10.1111/1467-7717.00169; UN High Commissioner for Refugees (UNHCR), 1991, GUID PROT REF WOM; *UN POP FUND, 2000, UPD 1998 99 MAT MORT; Van Damme W, 1998, LANCET, V351, P1609, DOI 10.1016/S0140-6736(97)10348-8; VanLerberghe W, 1997, TROP MED INT HEALTH, V2, P799, DOI 10.1046/j.1365-3156.1997.d01-382.x; 2001, LANCET, V358, P2009	13	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 23	2002	359	9307					639	640		10.1016/S0140-6736(02)07780-2	http://dx.doi.org/10.1016/S0140-6736(02)07780-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526AZ	11879855				2022-12-28	WOS:000174107400003
J	Graham, WJ				Graham, WJ			Now or never: the case for measuring maternal mortality	LANCET			English	Editorial Material							DEVELOPING-COUNTRIES		Aberdeen Matern Hosp, Dugald Baird Ctr Res Womens Hlth, Dept Obstet & Gynaecol, Aberdeen AB25 2ZL, Scotland	University of Aberdeen	Graham, WJ (corresponding author), Aberdeen Matern Hosp, Dugald Baird Ctr Res Womens Hlth, Dept Obstet & Gynaecol, Cornhill Rd, Aberdeen AB25 2ZL, Scotland.			Graham, Wendy/0000-0003-1473-5342				ABOUZAHR C, 1998, GLOBAL BURDEN DIS IN, V3; BENNETT FJ, 1990, HLTH CARE WOMEN CHIL, P364; Berhane Y, 2000, ACTA OBSTET GYN SCAN, V79, P968, DOI 10.1034/j.1600-0412.2000.079011968.x; BORGHI J, 2001, STUD HLTH SERV ORGAN, V17, P247; *COCHR PREGN CHILD, 2001, COCHR COLL; De Brouwere V, 1998, TROP MED INT HEALTH, V3, P771, DOI 10.1046/j.1365-3156.1998.00310.x; Department of Health, 1998, WHY MOTH DIE REP CON; FORTNEY JA, 1996, BASE ICEBERG PREVALC; Goodburn E, 2001, BRIT MED J, V322, P917, DOI 10.1136/bmj.322.7291.917; Goodburn EA, 2001, INT J GYNECOL OBSTET, V74, P105, DOI 10.1016/S0020-7292(01)00426-X; GRAHAM W, 1989, STUD FAMILY PLANN, V20, P125, DOI 10.2307/1966567; GRAHAM W, 1996, HLTH POLICY PLANN, P16; Graham W.J., 2001, SAFE MOTHERHOOD STRA, P97; GRAHAM WJ, 1992, SOC SCI MED, V35, P967, DOI 10.1016/0277-9536(92)90236-J; Hill K, 2001, B WORLD HEALTH ORGAN, V79, P182; MAHLER H, 1987, LANCET, V1, P668; Maine D, 2001, INT J GYNECOL OBSTET, V74, P99, DOI 10.1016/S0020-7292(01)00428-3; Maine D, 1991, SAFE MOTHERHOOD PROG; MCDONAGH M, 2001, STUD HLTH SERV ORGAN, V17, P371; Ronsmans C, 1997, LANCET, V350, P1810, DOI 10.1016/S0140-6736(97)08012-4; STARRS A, 1998, SAFE MOTHERHOOD ACTI; STEWART K, 1995, INT J GYNECOL OBSTET, V48, pS53; *U AB, 2001, IMMPACT DEV PHAS; *UNICEF, 1999, PROGR SAF MOTH; United Nations, 1999, KEY ACT FURTH IMPL P; WALKER GJA, 1990, INT J EPIDEMIOL, V19, P599, DOI 10.1093/ije/19.3.599; West KP, 1999, BMJ-BRIT MED J, V318, P570, DOI 10.1136/bmj.318.7183.570; *WHO, 1986, WHOFHE861; WHO/UNICEF, 1996, WHOFRHMSM9611 UNICEF; World Bank, 1999, LESS 10 YEARS EXP SA; ZAHR CA, 2001, STUD HLTH SERVICES O, V17, P387	31	62	62	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 23	2002	359	9307					701	704		10.1016/S0140-6736(02)07817-0	http://dx.doi.org/10.1016/S0140-6736(02)07817-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526AZ	11879885				2022-12-28	WOS:000174107400032
J	Vieth, R; Pinto, TR; Reen, BS; Wong, MM				Vieth, R; Pinto, TR; Reen, BS; Wong, MM			Vitamin D poisoning by table sugar	LANCET			English	Editorial Material									Univ Toronto, Mt Sinai Hosp, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X5, Canada; William Osler Hlth Ctr, Dept Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Vieth, R (corresponding author), Univ Toronto, Mt Sinai Hosp, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X5, Canada.							BLANK S, 1995, AM J PUBLIC HEALTH, V85, P656, DOI 10.2105/AJPH.85.5.656; DOWN PF, 1979, POSTGRAD MED J, V55, P897, DOI 10.1136/pgmj.55.650.897; Koutkia P, 2001, NEW ENGL J MED, V345, P66, DOI 10.1056/NEJM200107053450115; PETTIFOR JM, 1995, ANN INTERN MED, V122, P511, DOI 10.7326/0003-4819-122-7-199504010-00006; Vieth R, 2001, AM J CLIN NUTR, V73, P288	5	39	40	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 23	2002	359	9307					672	672		10.1016/S0140-6736(02)07814-5	http://dx.doi.org/10.1016/S0140-6736(02)07814-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526AZ	11879864				2022-12-28	WOS:000174107400012
J	Schulz, KF; Grimes, DA				Schulz, KF; Grimes, DA			Generation of allocation sequences in randomised trials: chance, not choice	LANCET			English	Article							CLINICAL-TRIALS; QUALITY	The randomised controlled trial sets the gold standard of clinical research. However, randomisation persists as perhaps the least-understood aspect of a trial. Moreover, anything short of proper randomisation courts selection and confounding biases. Researchers should spurn all systematic, non-random methods of allocation. Trial participants should be assigned to comparison groups based on a random process. Simple (unrestricted) randomisation, analogous to repeated fair coin-tossing, is the most basic of sequence generation approaches. Furthermore, no other approach, irrespective of its complexity and sophistication, surpasses simple randomisation for prevention of bias. Investigators should, therefore, use this method more often than they do, and readers should expect and accept disparities in group sizes. Several other complicated restricted randomisation procedures limit the likelihood of undesirable sample size imbalances in the intervention groups. The most frequently used restricted sequence generation procedure is blocked randomisation. If this method is used, investigators should randomly vary the block sizes and use larger block sizes, particularly in an unblinded trial. Other restricted procedures, such as urn randomisation, combine beneficial attributes of simple and restricted randomisation by preserving most of the unpredictability while achieving some balance. The effectiveness of stratified randomisation depends on use of a restricted randomisation approach to balance the allocation sequences for each stratum. Generation of a proper randomisation sequence takes little time and effort but affords big rewards in scientific accuracy and credibility. Investigators should devote appropriate resources to the generation of properly randomised trials and reporting their methods clearly.	Family Hlth Int, Res Triangle Pk, NC 27709 USA		Schulz, KF (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.	KSchulz@fhi.org						ALTMAN DG, 1991, BRIT MED J, V302, P1481, DOI 10.1136/bmj.302.6791.1481; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Altman DG, 1991, PRACTICAL STAT MED R; Armitage P, 1982, Stat Med, V1, P345, DOI 10.1002/sim.4780010412; Cox D., 1958, PLANNING EXPT; Doll R, 1998, BMJ-BRIT MED J, V317, P1217, DOI 10.1136/bmj.317.7167.1217; Fisher RA, 1935, DESIGN EXPT; FRIEDMAN LM, 1996, FUNDAMENTALS CLIN TR; GRIMES DA, 1991, OBSTET GYNECOL, V78, P703; GRIMES DA, 1994, OBSTET GYNECOL, V83, P637; HILL AB, 1952, NEW ENGL J MED, V247, P113, DOI 10.1056/NEJM195207242470401; LACHIN JM, 1988, CONTROL CLIN TRIALS, V9, P289, DOI 10.1016/0197-2456(88)90045-1; LACHIN JM, 1988, CONTROL CLIN TRIALS, V9, P365, DOI 10.1016/0197-2456(88)90049-9; LACHIN JM, 1988, CONTROL CLIN TRIALS, V9, P312, DOI 10.1016/0197-2456(88)90046-3; MACFARLANE A, 1978, BRIT MED J, V2, P1670, DOI 10.1136/bmj.2.6153.1670; MATTS JP, 1988, CONTROL CLIN TRIALS, V9, P327, DOI 10.1016/0197-2456(88)90047-5; Meinert CL., 1986, CLIN TRIALS DESIGN C; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; PETO R, 1987, STAT MED, V6, P233, DOI 10.1002/sim.4780060306; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; PIANTADOSI S, 1997, CLIN TRIALS METHODOL; Pocock SJ., 2013, CLIN TRIALS PRACTICA; SCHULZ KF, 1994, JAMA-J AM MED ASSOC, V272, P125, DOI 10.1001/jama.272.2.125; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V274, P1456; Schulz KF, 1998, CLIN OBSTET GYNECOL, V41, P245, DOI 10.1097/00003081-199806000-00005; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; SCHULZ KF, 1995, CAN MED ASSOC J, V153, P783; SCHULZ KF, 1995, ONLINE J CURR CLIN T; Treasure T, 1998, BRIT MED J, V317, P362; Tuberculosis Trials Committee iMRCS, 1948, BMJ, V2, P769; WEI LJ, 1988, CONTROL CLIN TRIALS, V9, P345, DOI 10.1016/0197-2456(88)90048-7	31	476	494	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2002	359	9305					515	519		10.1016/S0140-6736(02)07683-3	http://dx.doi.org/10.1016/S0140-6736(02)07683-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520ML	11853818				2022-12-28	WOS:000173785600033
J	Stocker, H; Andjelkovic, M; Oldham, S; Laffargue, M; Wymann, MP; Hemmings, BA; Hafen, E				Stocker, H; Andjelkovic, M; Oldham, S; Laffargue, M; Wymann, MP; Hemmings, BA; Hafen, E			Living with lethal PIP3 levels: Viability of flies lacking PTEN restored by a PH domain mutation in Akt/PKB	SCIENCE			English	Article							TUMOR-SUPPRESSOR PTEN; PROTEIN-KINASE-B; SIGNALING PATHWAY; CAENORHABDITIS-ELEGANS; CELL-SIZE; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; DROSOPHILA; ACTIVATION; PHOSPHATASE; HOMOLOG	The phosphoinositide phosphatase PTEN is mutated in many human cancers. Although the role of PTEN has been studied extensively, the relative contributions of its numerous potential downstream effectors to deregulated growth and tumorigenesis remain uncertain. We provide genetic evidence in Drosophila melanogaster for the paramount importance of the protein kinase Akt [also called protein kinase B (PKB)] in mediating the effects of increased phosphatidylinositol 3,4,5-trisphosphate (PIP3) concentrations that are caused by the loss of PTEN function. A mutation in the pleckstrin homology (PH) domain of Akt that reduces its affinity for PIP3 sufficed to rescue the lethality of flies devoid of PTEN activity. Thus, Akt appears to be the only critical target activated by increased PIP3 concentrations in Drosophila.	Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland; Friedrich Miescher Inst, CH-4058 Basel, Switzerland; Univ Fribourg, CH-1700 Fribourg, Switzerland	University of Zurich; Friedrich Miescher Institute for Biomedical Research; University of Fribourg	Hafen, E (corresponding author), Univ Zurich, Inst Zool, Winterthurerstr 190, CH-8057 Zurich, Switzerland.		Danyushevsky, Leonid V/C-5346-2013; Tyson, Gene W/C-6558-2013; Yaxley, Greg M/A-1167-2008; Kamenetsky, Vadim/K-2200-2019; Krivolutskaya, Nadezhda A./C-3554-2015; Wymann, Matthias P/C-3227-2008; Sobolev, Alexander/E-6367-2010; Thelen, Michael P/G-2032-2014; Chung, Sun-Lin/F-5559-2010; Stoecker, Horst/F-8382-2012; Laffargue, Muriel/AAE-7849-2021; Kerr, Andrew C/A-1206-2008; Kamenetsky, Vadim S/B-1019-2008	Danyushevsky, Leonid V/0000-0003-4050-6850; Tyson, Gene W/0000-0001-8559-9427; Yaxley, Greg M/0000-0003-0445-8812; Krivolutskaya, Nadezhda A./0000-0002-5709-7785; Wymann, Matthias P/0000-0003-3349-4281; Sobolev, Alexander/0000-0002-1997-2032; Thelen, Michael P/0000-0002-2479-5480; Chung, Sun-Lin/0000-0002-5362-4496; Stoecker, Horst/0000-0002-3282-3664; Kerr, Andrew C/0000-0001-5569-4730; Kamenetsky, Vadim S/0000-0002-2734-8790; Laffargue, Muriel/0000-0003-1833-639X				Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; ANDJELKOVIC M, 1995, J BIOL CHEM, V270, P4066, DOI 10.1074/jbc.270.8.4066; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; ANDJELKOVIC M, UNPUB; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Coffer PJ, 1998, BIOCHEM J, V335, P1; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Gil EB, 1999, P NATL ACAD SCI USA, V96, P2925, DOI 10.1073/pnas.96.6.2925; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Gu JG, 1999, J CELL BIOL, V146, P389, DOI 10.1083/jcb.146.2.389; Huang H, 1999, DEVELOPMENT, V126, P5365; Lawlor MA, 2001, J CELL SCI, V114, P2903; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; Li DM, 1997, CANCER RES, V57, P2124; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; Mihaylova VT, 1999, P NATL ACAD SCI USA, V96, P7427, DOI 10.1073/pnas.96.13.7427; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; OLDHAM S, UNPUB; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Rouault JP, 1999, CURR BIOL, V9, P329, DOI 10.1016/S0960-9822(99)80143-2; Scanga SE, 2000, ONCOGENE, V19, P3971, DOI 10.1038/sj.onc.1203739; Simpson L, 2001, EXP CELL RES, V264, P29, DOI 10.1006/excr.2000.5130; Spradling AC, 1999, GENETICS, V153, P135; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Staveley BE, 1998, CURR BIOL, V8, P599, DOI 10.1016/S0960-9822(98)70231-3; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; STOCKER H, UNPUB; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293	35	158	164	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2002	295	5562					2088	2091		10.1126/science. 1068094	http://dx.doi.org/10.1126/science. 1068094			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532AY	11872800	Green Submitted			2022-12-28	WOS:000174450500053
J	Maron, BJ				Maron, BJ			Hypertrophic cardiomyopathy - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							LEFT-VENTRICULAR HYPERTROPHY; SYSTOLIC ANTERIOR MOTION; BINDING-PROTEIN-C; MUSCLE CELL DISORGANIZATION; SUDDEN CARDIAC DEATH; TERM-FOLLOW-UP; IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; NONSURGICAL SEPTAL REDUCTION; BLOOD-PRESSURE RESPONSE; OUTFLOW TRACT GRADIENT	Context Throughout the past 40 years, a vast and sometimes contradictory literature has accumulated regarding hypertrophic cardiomyopathy (HCM), a genetic cardiac disease caused by a variety of mutations in genes encoding sarcomeric proteins and characterized by a broad and expanding clinical spectrum. Objectives To clarify and summarize the relevant clinical issues and to profile rapidly evolving concepts regarding HCM. DataSources Systematic analysis of the relevant HCM literature, accessed through MEDLINE (1966-2000), bibliographies, and interactions with investigators. Study Selection and Data Extraction Diverse information was assimilated into a rigorous and objective contemporary description of HCM, affording greatest weight to prospective, controlled, and evidence-based studies. Data Synthesis Hypertrophic cardiomyopathy is a relatively common genetic cardiac disease (1:500 in the general population) that is heterogeneous with respect to disease-causing mutations, presentation, prognosis, and treatment strategies. Visibility attached to HCM relates largely to its recognition as the most common cause of sudden death in the young (including competitive athletes). Clinical diagnosis is by 2-dimensional echocardiographic identification of otherwise unexplained left ventricular wall thickening in the presence of a nondilated cavity. Overall, HCM confers an annual mortality rate of about 1% and in most patients is compatible with little or no disability and normal life expectancy. Subsets with higher mortality or morbidity are linked to the complications of sudden death, progressive heart failure, and atrial fibrillation with embolic stroke. Treatment strategies depend on appropriate patient selection, including drug treatment for exertional dyspnea (beta-blockers, verapamil, disopyramide) and the septal myotomymyectomy operation, which is the standard of care for severe refractory symptoms associated with marked outflow obstruction; alcohol septal ablation and pacing are alternatives to surgery for selected patients. High-risk patients may be treated effectively for sudden death prevention with the implantable cardioverter-defibrillator. Conclusions Substantial understanding has evolved regarding the epidemiology and clinical course of HCM, as well as novel treatment strategies that may after its natural history. An appreciation that HCM, although an important cause of death and disability at all ages, does not invariably convey ominous prognosis and is compatible with normal longevity should dictate a large measure of reassurance for many patients.	Minneapolis Heart Inst Fdn, 920 E 28th St,Suite 60, Minneapolis, MN 55407 USA	Minneapolis Heart Institute Foundation	Maron, BJ (corresponding author), Minneapolis Heart Inst Fdn, 920 E 28th St,Suite 60, Minneapolis, MN 55407 USA.	hcm.maron@mhif.org						ANAN R, 1994, J CLIN INVEST, V93, P280, DOI 10.1172/JCI116957; Anan R, 1998, CIRCULATION, V98, P391, DOI 10.1161/01.CIR.98.5.391; Arad M, 2002, J CLIN INVEST, V109, P357, DOI 10.1172/JCI200214571; Basso C, 2000, HUM PATHOL, V31, P988, DOI 10.1053/hupa.2000.16659; BONOW RO, 1981, CIRCULATION, V64, P787, DOI 10.1161/01.CIR.64.4.787; BRAUNWALD E, 1964, CIRCULATION, V30, P3; Briguori C, 1999, AM J CARDIOL, V84, P309, DOI 10.1016/S0002-9149(99)00282-9; Bryce M, 2001, ANN INTERN MED, V134, P1130, DOI 10.7326/0003-4819-134-12-200106190-00014; CAMICI P, 1991, J AM COLL CARDIOL, V17, P879, DOI 10.1016/0735-1097(91)90869-B; Camm AJ, 2000, EUR HEART J, V21, P1998, DOI 10.1053/euhj.2000.2473; CANNAN CR, 1995, CIRCULATION, V92, P2488, DOI 10.1161/01.CIR.92.9.2488; CANNON RO, 1987, J AM COLL CARDIOL, V10, P53, DOI 10.1016/S0735-1097(87)80159-6; CANNON RO, 1985, CIRCULATION, V71, P234, DOI 10.1161/01.CIR.71.2.234; CANNON RO, 1989, CIRCULATION, V79, P766, DOI 10.1161/01.CIR.79.4.766; CECCHI F, 1995, J AM COLL CARDIOL, V26, P1529, DOI 10.1016/0735-1097(95)00353-3; CECCHI F, 1989, J AM COLL CARDIOL, V13, P1283, DOI 10.1016/0735-1097(89)90302-1; Cecchi F, 1998, HEART, V79, P331, DOI 10.1136/hrt.79.4.331; Charron P, 1997, CIRCULATION, V96, P214; Charron P, 1998, CIRCULATION, V97, P2230, DOI 10.1161/01.CIR.97.22.2230; CHIKAMORI T, 1992, J AM COLL CARDIOL, V19, P507, DOI 10.1016/S0735-1097(10)80262-1; CIRO E, 1983, CIRCULATION, V67, P1227, DOI 10.1161/01.CIR.67.6.1227; COHN LH, 1992, AM J CARDIOL, V70, P657, DOI 10.1016/0002-9149(92)90208-G; Corrado D, 1998, NEW ENGL J MED, V339, P364, DOI 10.1056/NEJM199808063390602; DILSIZIAN V, 1993, J AM COLL CARDIOL, V22, P796, DOI 10.1016/0735-1097(93)90193-5; Elliott PM, 1996, EUR HEART J, V17, P1056; Elliott PM, 1999, J AM COLL CARDIOL, V33, P1596, DOI 10.1016/S0735-1097(99)00056-X; Elliott PM, 2001, LANCET, V357, P420, DOI 10.1016/S0140-6736(00)04005-8; Elliott PM, 2000, J AM COLL CARDIOL, V36, P2212, DOI 10.1016/S0735-1097(00)01003-2; EPSTEIN SE, 1981, CIRCULATION, V64, P437, DOI 10.1161/01.CIR.64.3.437; Faber L, 2000, HEART, V83, P326, DOI 10.1136/heart.83.3.326; FACTOR SM, 1991, J AM COLL CARDIOL, V17, P1343, DOI 10.1016/S0735-1097(10)80145-7; FANANAPAZIR L, 1989, CIRCULATION, V80, P1259, DOI 10.1161/01.CIR.80.5.1259; FANANAPAZIR L, 1994, CIRCULATION, V90, P2731, DOI 10.1161/01.CIR.90.6.2731; FAY WP, 1990, J AM COLL CARDIOL, V16, P821, DOI 10.1016/S0735-1097(10)80328-6; FERRANS VJ, 1972, CIRCULATION, V45, P769, DOI 10.1161/01.CIR.45.4.769; FIDDLER GI, 1978, AM J CARDIOL, V42, P793, DOI 10.1016/0002-9149(78)90099-1; FOX PR, 1995, CIRCULATION, V92, P2645, DOI 10.1161/01.CIR.92.9.2645; FRANK S, 1968, CIRCULATION, V37, P759, DOI 10.1161/01.CIR.37.5.759; FRENNEAUX MP, 1992, J AM COLL CARDIOL, V19, P1521; Gadler F, 1999, EUR HEART J, V20, P1044, DOI 10.1053/euhj.1998.1331; GeisterferLowrance AAT, 1996, SCIENCE, V272, P731, DOI 10.1126/science.272.5262.731; Gietzen FH, 1999, EUR HEART J, V20, P1342, DOI 10.1053/euhj.1999.1520; GILLIGAN DM, 1991, J AM COLL CARDIOL, V18, P429, DOI 10.1016/0735-1097(91)90596-2; GILLIGAN DM, 1993, J AM COLL CARDIOL, V21, P1672, DOI 10.1016/0735-1097(93)90386-F; GISTRI R, 1994, AM J CARDIOL, V74, P363, DOI 10.1016/0002-9149(94)90404-9; Gollob MH, 2001, NEW ENGL J MED, V344, P1823, DOI 10.1056/NEJM200106143442403; GRIGG LE, 1992, J AM COLL CARDIOL, V20, P42, DOI 10.1016/0735-1097(92)90135-A; GROVERMCKAY M, 1989, J AM COLL CARDIOL, V13, P317, DOI 10.1016/0735-1097(89)90505-6; Hagege AA, 1998, EUR HEART J, V19, P490, DOI 10.1053/euhj.1997.0735; HANRATH P, 1981, EUR HEART J, V2, P177, DOI 10.1093/oxfordjournals.eurheartj.a061192; Hecht GM, 1993, J AM COLL CARDIOL, V22, P489, DOI 10.1016/0735-1097(93)90054-5; HERIC B, 1995, J THORAC CARDIOV SUR, V110, P195, DOI 10.1016/S0022-5223(05)80026-1; Kappenberger L, 1997, EUR HEART J, V18, P1249; Kizilbash AM, 1998, CIRCULATION, V97, P461; KLUES HG, 1993, CIRCULATION, V87, P1570, DOI 10.1161/01.CIR.87.5.1570; KLUES HG, 1992, J AM COLL CARDIOL, V19, P527, DOI 10.1016/S0735-1097(10)80266-9; KLUES HG, 1991, CIRCULATION, V84, P1188, DOI 10.1161/01.CIR.84.3.1188; KLUES HG, 1995, J AM COLL CARDIOL, V26, P1699, DOI 10.1016/0735-1097(95)00390-8; KLUES HG, 1992, CIRCULATION, V85, P1651, DOI 10.1161/01.CIR.85.5.1651; Knight C, 1997, CIRCULATION, V95, P2075, DOI 10.1161/01.CIR.95.8.2075; KOFFLARD MJ, 1993, AM J CARDIOL, V72, P939, DOI 10.1016/0002-9149(93)91111-T; KRAJCER Z, 1989, CIRCULATION, V80, P57; Krams R, 1998, CIRCULATION, V97, P230, DOI 10.1161/01.CIR.97.3.230; KRIKLER DM, 1980, BRIT HEART J, V43, P245; Lakkis NM, 1998, CIRCULATION, V98, P1750, DOI 10.1161/01.CIR.98.17.1750; Lazzeroni E, 1997, CIRCULATION, V96, P4268; LECHIN M, 1995, CIRCULATION, V92, P1808, DOI 10.1161/01.CIR.92.7.1808; LELE SS, 1995, CIRCULATION, V92, P2886, DOI 10.1161/01.CIR.92.10.2886; LEVER HM, 1989, CIRCULATION, V79, P580, DOI 10.1161/01.CIR.79.3.580; LEWIS JF, 1994, AM J CARDIOL, V73, P1105, DOI 10.1016/0002-9149(94)90291-7; LEWIS JF, 1989, J AM COLL CARDIOL, V13, P36, DOI 10.1016/0735-1097(89)90545-7; Lim DS, 2001, CIRCULATION, V103, P789, DOI 10.1161/01.CIR.103.6.789; Linde C, 1999, AM J CARDIOL, V83, P903, DOI 10.1016/S0002-9149(98)01065-0; LOUIE EK, 1986, J AM COLL CARDIOL, V8, P57, DOI 10.1016/S0735-1097(86)80092-4; LOUIE EK, 1994, PROG CARDIOVASC DIS, V36, P275, DOI 10.1016/S0033-0620(05)80036-2; LOUIE EK, 1987, ANN INTERN MED, V106, P663, DOI 10.7326/0003-4819-106-5-663; Maki S, 1998, AM J CARDIOL, V82, P774, DOI 10.1016/S0002-9149(98)00455-X; MARIAN AJ, 1993, LANCET, V342, P1085, DOI 10.1016/0140-6736(93)92064-Z; Marian AJ, 1999, J CLIN INVEST, V104, P1683, DOI 10.1172/JCI7956; Marian AJ, 2000, LANCET, V355, P58, DOI 10.1016/S0140-6736(99)06187-5; MARIAN AJ, 1995, CIRCULATION, V92, P1336, DOI 10.1161/01.CIR.92.5.1336; MARON BJ, 1983, CIRCULATION, V68, P282, DOI 10.1161/01.CIR.68.2.282; Maron BJ, 2000, CIRCULATION, V102, P858; MARON BJ, 1992, AM J CARDIOL, V70, P785, DOI 10.1016/0002-9149(92)90560-L; Maron BJ, 1998, CIRCULATION, V98, P1460, DOI 10.1161/01.CIR.98.14.1460; Maron BJ, 1999, JAMA-J AM MED ASSOC, V281, P650, DOI 10.1001/jama.281.7.650; MARON BJ, 1982, CIRCULATION, V65, P7, DOI 10.1161/01.CIR.65.1.7; MARON BJ, 1994, J AM COLL CARDIOL, V24, P880, DOI 10.1016/0735-1097(94)90844-3; MARON BJ, 1987, NEW ENGL J MED, V316, P844, DOI 10.1056/NEJM198704023161405; MARON BJ, 1995, CIRCULATION, V91, P1596, DOI 10.1161/01.CIR.91.5.1596; Maron BJ, 1998, CIRCULATION, V98, P2505, DOI 10.1161/01.CIR.98.23.2505; Maron BJ, 1999, CIRCULATION, V99, P2927, DOI 10.1161/01.CIR.99.22.2927; Maron BJ, 2000, LANCET, V355, P425, DOI 10.1016/S0140-6736(00)82005-X; Maron BJ, 2000, NEW ENGL J MED, V342, P365, DOI 10.1056/NEJM200002103420601; Maron BJ, 2002, J AM COLL CARDIOL, V39, P301, DOI 10.1016/S0735-1097(01)01727-2; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; MARON BJ, 1984, AM J CARDIOL, V53, P1087, DOI 10.1016/0002-9149(84)90643-X; Maron BJ, 1999, J AM COLL CARDIOL, V33, P1590, DOI 10.1016/S0735-1097(99)00039-X; MARON BJ, 1995, CIRCULATION, V92, P2748, DOI 10.1161/01.CIR.92.9.2748; Maron BJ, 2001, ANN NONINVAS ELECTRO, V6, P277, DOI 10.1111/j.1542-474X.2001.tb00118.x; MARON BJ, 1994, AM J CARDIOL, V73, P577, DOI 10.1016/0002-9149(94)90337-9; MARON BJ, 1993, AM J CARDIOL, V72, P970, DOI 10.1016/0002-9149(93)91117-Z; MARON BJ, 1981, AM J CARDIOL, V48, P252, DOI 10.1016/0002-9149(81)90604-4; MARON BJ, 1981, AM J CARDIOL, V48, P418, DOI 10.1016/0002-9149(81)90068-0; MARON BJ, 1979, AM J CARDIOL, V43, P1242, DOI 10.1016/0002-9149(79)90160-7; Maron BJ, 2001, J AM COLL CARDIOL, V38, P315, DOI 10.1016/S0735-1097(01)01386-9; MARON BJ, 1982, CIRCULATION, V65, P1388, DOI 10.1161/01.CIR.65.7.1388; Maron BJ, 1998, AM J CARDIOL, V81, P1339; Maron BJ, 1997, LANCET, V350, P127, DOI 10.1016/S0140-6736(97)01282-8; MARON BJ, 1979, CIRCULATION, V59, P689, DOI 10.1161/01.CIR.59.4.689; MARON BJ, 1986, NEW ENGL J MED, V315, P610, DOI 10.1056/NEJM198609043151003; MARON BJ, 1986, J AM COLL CARDIOL, V8, P545, DOI 10.1016/S0735-1097(86)80181-4; MARON BJ, 1979, AM J CARDIOL, V43, P1086, DOI 10.1016/0002-9149(79)90139-5; MARON BJ, 1987, J AM COLL CARDIOL, V10, P733, DOI 10.1016/S0735-1097(87)80264-4; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; MARON BJ, 1981, CIRCULATION, V63, P882, DOI 10.1161/01.CIR.63.4.882; Mazur W, 2001, CIRCULATION, V103, P1492; McCully RB, 1996, CIRCULATION, V94, P467, DOI 10.1161/01.CIR.94.3.467; MCINTOSH CL, 1988, CIRCULATION, V78, P487, DOI 10.1161/01.CIR.78.3.487; MCKENNA WJ, 1984, ARCH DIS CHILD, V59, P971, DOI 10.1136/adc.59.10.971; MCKENNA WJ, 1981, BRIT HEART J, V46, P168; MCKENNA WJ, 1985, BRIT HEART J, V53, P412; Moolman JC, 1997, J AM COLL CARDIOL, V29, P549, DOI 10.1016/S0735-1097(96)00530-X; MORROW AG, 1975, CIRCULATION, V52, P88, DOI 10.1161/01.CIR.52.1.88; MURGO JP, 1980, J CLIN INVEST, V66, P1369, DOI 10.1172/JCI109990; Nagueh SF, 2001, J AM COLL CARDIOL, V38, P1701, DOI 10.1016/S0735-1097(01)01614-X; Nagueh SF, 2001, CIRCULATION, V104, P128, DOI 10.1161/01.CIR.104.2.128; NICOD P, 1988, NEW ENGL J MED, V318, P1255, DOI 10.1056/NEJM198805123181907; NIENABER CA, 1993, CIRCULATION, V87, P1580, DOI 10.1161/01.CIR.87.5.1580; NIHOYANNOPOULOS P, 1992, J AM COLL CARDIOL, V19, P536, DOI 10.1016/S0735-1097(10)80268-2; Niimura H, 2002, CIRCULATION, V105, P446, DOI 10.1161/hc0402.102990; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; Nishimura RA, 1997, J AM COLL CARDIOL, V29, P435, DOI 10.1016/S0735-1097(96)00473-1; Obeid AI, 2001, CIRCULATION, V103, P1605; OGARA PT, 1987, CIRCULATION, V76, P1214, DOI 10.1161/01.CIR.76.6.1214; Olivotto I, 2001, CIRCULATION, V104, P2517, DOI 10.1161/hc4601.097997; Olivotto I, 1999, J AM COLL CARDIOL, V33, P2044, DOI 10.1016/S0735-1097(99)00094-7; Ommen SR, 1999, J AM COLL CARDIOL, V34, P191, DOI 10.1016/S0735-1097(99)00173-4; Ostman-Smith I, 1999, J AM COLL CARDIOL, V34, P1813, DOI 10.1016/S0735-1097(99)00421-0; PANZA JA, 1989, AM J CARDIOL, V63, P1258, DOI 10.1016/0002-9149(89)90187-2; PANZA JA, 1992, CIRCULATION, V85, P1398, DOI 10.1161/01.CIR.85.4.1398; PASTERNAC A, 1982, CIRCULATION, V65, P778, DOI 10.1161/01.CIR.65.4.778; PELLICCIA A, 1991, NEW ENGL J MED, V324, P295, DOI 10.1056/NEJM199101313240504; PETRONE RK, 1992, J AM COLL CARDIOL, V20, P55, DOI 10.1016/0735-1097(92)90137-C; POLLICK C, 1984, CIRCULATION, V69, P43, DOI 10.1161/01.CIR.69.1.43; POLLICK C, 1982, NEW ENGL J MED, V307, P997, DOI 10.1056/NEJM198210143071607; Qin JX, 2001, J AM COLL CARDIOL, V38, P1994; Robbins RC, 1996, J THORAC CARDIOV SUR, V111, P586, DOI 10.1016/S0022-5223(96)70310-0; ROBINSON K, 1990, J AM COLL CARDIOL, V15, P1279, DOI 10.1016/S0735-1097(10)80014-2; ROMEO F, 1990, EUR HEART J, V11, P233, DOI 10.1093/oxfordjournals.eurheartj.a059689; ROSENZWEIG A, 1991, NEW ENGL J MED, V325, P1753, DOI 10.1056/NEJM199112193252501; ROSING DR, 1981, AM J CARDIOL, V48, P545, DOI 10.1016/0002-9149(81)90086-2; ROSING DR, 1979, CIRCULATION, V60, P1208, DOI 10.1161/01.CIR.60.6.1208; Sadoul N, 1997, CIRCULATION, V96, P2987, DOI 10.1161/01.CIR.96.9.2987; SAUMAREZ RC, 1995, CIRCULATION, V91, P2762, DOI 10.1161/01.CIR.91.11.2762; SCHOENDUBE FA, 1995, CIRCULATION, V92, P122, DOI 10.1161/01.CIR.92.9.122; Schonbeck MH, 1998, ANN THORAC SURG, V65, P1207, DOI 10.1016/S0003-4975(98)00187-8; SCHULTE HD, 1993, J THORAC CARDIOV SUR, V106, P709, DOI 10.1016/S0022-5223(19)33715-8; SCHWAMMENTHAL E, 1992, J AM COLL CARDIOL, V20, P964, DOI 10.1016/0735-1097(92)90199-W; SCHWARTZ K, 1995, CIRCULATION, V91, P532, DOI 10.1161/01.CIR.91.2.532; SHAH PM, 1981, AM J CARDIOL, V48, P258, DOI 10.1016/0002-9149(81)90605-6; SHAH PM, 1974, CIRC RES, V35, P179; SHAPIRO LM, 1983, J AM COLL CARDIOL, V2, P437, DOI 10.1016/S0735-1097(83)80269-1; SHAPIRO LM, 1983, BRIT HEART J, V50, P530; Sharma S, 2000, AM J CARDIOL, V86, P162, DOI 10.1016/S0002-9149(00)00854-7; SHERRID M, 1988, AM J CARDIOL, V62, P1085, DOI 10.1016/0002-9149(88)90553-X; SHERRID MV, 1993, J AM COLL CARDIOL, V22, P816, DOI 10.1016/0735-1097(93)90196-8; Sherrid MV, 1998, CIRCULATION, V97, P41, DOI 10.1161/01.CIR.97.1.41; Shirani J, 2000, J AM COLL CARDIOL, V35, P36, DOI 10.1016/S0735-1097(99)00492-1; SHIRANI J, 1993, AM J CARDIOL, V72, P434, DOI 10.1016/0002-9149(93)91136-6; SILKA MJ, 1993, CIRCULATION, V87, P800, DOI 10.1161/01.CIR.87.3.800; Skinner JR, 1997, HEART, V77, P229, DOI 10.1136/hrt.77.3.229; Slade AKB, 1996, HEART, V75, P44, DOI 10.1136/hrt.75.1.44; SPICER RL, 1984, AM J CARDIOL, V53, P1614, DOI 10.1016/0002-9149(84)90589-7; SPIRITO P, 1994, CIRCULATION, V90, P2743, DOI 10.1161/01.CIR.90.6.2743; Spirito P, 1999, CIRCULATION, V99, P2132, DOI 10.1161/01.CIR.99.16.2132; Spirito P, 2000, NEW ENGL J MED, V342, P1778, DOI 10.1056/NEJM200006153422403; SPIRITO P, 1985, CIRCULATION, V72, P310, DOI 10.1161/01.CIR.72.2.310; SPIRITO P, 1989, NEW ENGL J MED, V320, P749, DOI 10.1056/NEJM198903233201201; SPIRITO P, 1989, J AM COLL CARDIOL, V13, P820, DOI 10.1016/0735-1097(89)90222-2; SPIRITO P, 1987, J AM COLL CARDIOL, V9, P1013, DOI 10.1016/S0735-1097(87)80301-7; SPIRITO P, 1990, J AM COLL CARDIOL, V15, P808, DOI 10.1016/0735-1097(90)90278-W; Spirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107; SPIRITO P, 1979, J AM COLL CARDIOL, V44, P401; STAFFORD WJ, 1986, J AM COLL CARDIOL, V7, P701, DOI 10.1016/S0735-1097(86)80484-3; STJOHNSUTTON MG, 1980, BRIT HEART J, V44, P433; SUZUKI Y, 1984, AM J CARDIOL, V53, P1095, DOI 10.1016/0002-9149(84)90644-1; TAKATA J, 1993, AM J CARDIOL, V72, P211, DOI 10.1016/0002-9149(93)90162-6; TANAKA M, 1987, CIRCULATION, V75, P1130, DOI 10.1161/01.CIR.75.6.1130; TANAKA M, 1986, BRIT HEART J, V55, P575; TEARE D, 1958, BRIT HEART J, V20, P1; TENBERG JM, 1994, CIRCULATION, V90, P1781, DOI 10.1161/01.CIR.90.4.1781; Theodoro DA, 1996, J THORAC CARDIOV SUR, V112, P1589, DOI 10.1016/S0022-5223(96)70018-1; Varnava AM, 2001, CIRCULATION, V104, P1380, DOI 10.1161/hc3701.095952; Varnava AM, 2001, AM J CARDIOL, V88, P275, DOI 10.1016/S0002-9149(01)01640-X; Watkins H, 2000, NEW ENGL J MED, V342, P422, DOI 10.1056/NEJM200002103420609; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603; WATKINS H, 1992, NEW ENGL J MED, V326, P1108, DOI 10.1056/NEJM199204233261703; WEBB JG, 1990, J AM COLL CARDIOL, V15, P83, DOI 10.1016/0735-1097(90)90180-W; Wigle ED, 2001, J AM COLL CARDIOL, V38, P1707, DOI 10.1016/S0735-1097(01)01594-7; WIGLE ED, 1995, CIRCULATION, V92, P1680, DOI 10.1161/01.CIR.92.7.1680; WIGLE ED, 1985, PROG CARDIOVASC DIS, V28, P1, DOI 10.1016/0033-0620(85)90024-6; WILLIAMS WG, 1987, CIRCULATION, V76, P104; YAMAGUCHI H, 1979, AM J CARDIOL, V44, P401, DOI 10.1016/0002-9149(79)90388-6; Yang QL, 1998, J CLIN INVEST, V102, P1292, DOI 10.1172/JCI3880; Yetman AT, 1998, NEW ENGL J MED, V339, P1201, DOI 10.1056/NEJM199810223391704; Yu EHC, 2000, J AM COLL CARDIOL, V36, P2219, DOI 10.1016/S0735-1097(00)01019-6	207	1558	1684	5	224	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2002	287	10					1308	1320		10.1001/jama.287.10.1308	http://dx.doi.org/10.1001/jama.287.10.1308			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529YU	11886323	Bronze			2022-12-28	WOS:000174329500030
J	Davidson, R; Cavalcanti, R; Brunton, JL; Bast, DJ; de Azavedo, JCS; Kibsey, P; Fleming, C; Low, DE				Davidson, R; Cavalcanti, R; Brunton, JL; Bast, DJ; de Azavedo, JCS; Kibsey, P; Fleming, C; Low, DE			Brief report: Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; STREPTOCOCCUS-PNEUMONIAE; FLUOROQUINOLONE RESISTANCE; PHARMACODYNAMICS; SUSCEPTIBILITY; CIPROFLOXACIN; MANAGEMENT; MECHANISMS; ADULTS		Mt Sinai Hosp, Dept Microbiol, Toronto, ON M5G 1X5, Canada; Toronto Med Labs, Toronto, ON, Canada; Mt Sinai Hosp, Toronto Med Labs, Toronto, ON M5G 1X5, Canada; Univ Hlth Network, Toronto, ON, Canada; Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada; Univ Toronto, Toronto, ON, Canada; Victoria Gen Hosp, Victoria, BC, Canada; Ontario Med Assoc, Lab Serv, Qual Management Program, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Queen Elizabeth II Health Sciences Centre; University of Toronto; University of Victoria	Low, DE (corresponding author), Mt Sinai Hosp, Dept Microbiol, 600 Univ Ave,Rm 1487, Toronto, ON M5G 1X5, Canada.	dlow@mtsinai.on.ca	Low, Donald/B-1726-2012	Cavalcanti, Rodrigo B/0000-0001-8980-159X				Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954; Bast DJ, 2000, ANTIMICROB AGENTS CH, V44, P3049, DOI 10.1128/AAC.44.11.3049-3054.2000; Chen DK, 1999, NEW ENGL J MED, V341, P233, DOI 10.1056/NEJM199907223410403; Chien SC, 1997, ANTIMICROB AGENTS CH, V41, P2256, DOI 10.1128/AAC.41.10.2256; File TM, 1997, ANTIMICROB AGENTS CH, V41, P1965, DOI 10.1128/AAC.41.9.1965; Frisch AW, 1942, J EXP MED, V76, P505, DOI 10.1084/jem.76.6.505; Heffelfinger JD, 2000, ARCH INTERN MED, V160, P1399, DOI 10.1001/archinte.160.10.1399; Ho PL, 1999, ANTIMICROB AGENTS CH, V43, P1310, DOI 10.1128/AAC.43.5.1310; Ho PL, 2001, CLIN INFECT DIS, V32, P701, DOI 10.1086/319222; Hooper DC, 2001, CLIN INFECT DIS, V32, pS9, DOI 10.1086/319370; Lister PD, 1999, ANTIMICROB AGENTS CH, V43, P1118, DOI 10.1128/AAC.43.5.1118; Mandell LA, 2000, CLIN INFECT DIS, V31, P422, DOI 10.1086/313965; MONSO E, 1995, AM J RESP CRIT CARE, V152, P1316, DOI 10.1164/ajrccm.152.4.7551388; MURRAY BE, 1990, J CLIN MICROBIOL, V28, P2059, DOI 10.1128/JCM.28.9.2059-2063.1990; MURRAY BE, 1991, J CLIN MICROBIOL, V29, P418; *NAT COMM CLIN LAB, 2001, M100S11 NCCLS; Niederman MS, 2001, AM J RESP CRIT CARE, V163, P1730, DOI 10.1164/ajrccm.163.7.at1010; Petitpretz P, 2001, CHEST, V119, P185, DOI 10.1378/chest.119.1.185; Preston SL, 1998, JAMA-J AM MED ASSOC, V279, P125, DOI 10.1001/jama.279.2.125; Richardson DC, 2001, ANTIMICROB AGENTS CH, V45, P1911, DOI 10.1128/AAC.45.6.1911-1914.2001; Sahm DF, 2000, ANTIMICROB AGENTS CH, V44, P2521, DOI 10.1128/AAC.44.9.2521-2524.2000; Van Rie A, 2001, J CLIN MICROBIOL, V39, P636, DOI 10.1128/JCM.39.2.636-641.2001; Weiss K, 2001, CLIN INFECT DIS, V33, P517, DOI 10.1086/322658	23	400	413	2	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2002	346	10					747	750		10.1056/NEJMoa012122	http://dx.doi.org/10.1056/NEJMoa012122			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527UA	11882730	Bronze			2022-12-28	WOS:000174205000005
J	Nielsen, PR; Nietlispach, D; Mott, HR; Callaghan, J; Bannister, A; Kouzarides, T; Murzin, AG; Murzina, NV; Laue, ED				Nielsen, PR; Nietlispach, D; Mott, HR; Callaghan, J; Bannister, A; Kouzarides, T; Murzin, AG; Murzina, NV; Laue, ED			Structure of the HP1 chromodomain bound to histone H3 methylated at lysine 9	NATURE			English	Article							NMR-SPECTROSCOPY; MACROMOLECULAR STRUCTURE; INTERMOLECULAR NOES; DOMAIN; PROGRAM	Specific modifications to histones are essential epigenetic markers(1)-heritable changes in gene expression that do not affect the DNA sequence. Methylation of lysine 9 in histone H3 is recognized by heterochromatin protein 1 (HP1), which directs the binding of other proteins to control chromatin structure and gene expression(2-4). Here we show that HP1 uses an induced-fit mechanism for recognition of this modification, as revealed by the structure of its chromodomain bound to a histone H3 peptide dimethylated at Nzeta of lysine 9. The binding pocket for the N-methyl groups is provided by three aromatic side chains, Tyr 21, Trp 42 and Phe 45, which reside in two regions that become ordered on binding of the peptide. The side chain of Lys 9 is almost fully extended and surrounded by residues that are conserved in many other chromodomains. The QTAR peptide sequence preceding Lys 9 makes most of the additional interactions with the chromodomain, with HP1 residues Val 23, Leu 40, Trp 42, Leu 58 and Cys 60 appearing to be a major determinant of specificity by binding the key buried Ala 7. These findings predict which other chromodomains will bind methylated proteins and suggest a motif that they recognize.	Univ Cambridge, Dept Biochem, Cambridge Ctr Mol Recognit, Cambridge CB2 1GA, England; Univ Cambridge, Wellcome Canc Res UK, Inst Canc & Dev Biol, Cambridge CB2 1QR, England; Univ Cambridge, Dept Pathol, Cambridge CB2 1QR, England; MRC, Ctr Prot Engn, Cambridge CB2 2QH, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge	Murzina, NV (corresponding author), Univ Cambridge, Dept Biochem, Cambridge Ctr Mol Recognit, 80 Tennis Court Rd, Cambridge CB2 1GA, England.		Mott, Helen/AAV-3873-2020	Mott, Helen/0000-0002-7890-7097; Kouzarides, Tony/0000-0002-8918-4162; Bannister, Andrew/0000-0002-6312-4436; Nietlispach, Daniel/0000-0003-4364-9291; Laue, Ernest/0000-0002-7476-4148				Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169; Ball LJ, 1997, EMBO J, V16, P2473, DOI 10.1093/emboj/16.9.2473; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cowieson NP, 2000, CURR BIOL, V10, P517, DOI 10.1016/S0960-9822(00)00467-X; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Horita DA, 2001, J MOL BIOL, V307, P861, DOI 10.1006/jmbi.2001.4515; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRAULIS PJ, 1994, BIOCHEMISTRY-US, V33, P3515, DOI 10.1021/bi00178a008; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; MEANS GE, 1968, BIOCHEMISTRY-US, V7, P2192, DOI 10.1021/bi00846a023; Melacini G, 2000, J AM CHEM SOC, V122, P9735, DOI 10.1021/ja0015996; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; PLATERO JS, 1995, EMBO J, V14, P3977, DOI 10.1002/j.1460-2075.1995.tb00069.x; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	27	479	492	4	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2002	416	6876					103	107		10.1038/nature722	http://dx.doi.org/10.1038/nature722			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882902				2022-12-28	WOS:000174211600048
J	Brundtland, GH				Brundtland, GH			Smallpox revisited	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									WHO, CH-1211 Geneva, Switzerland	World Health Organization	Brundtland, GH (corresponding author), WHO, CH-1211 Geneva, Switzerland.							2002, JAMA-J AM MED ASSOC, V287, P706	1	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2002	287	9					1104	1104		10.1001/jama.287.9.1104	http://dx.doi.org/10.1001/jama.287.9.1104			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527KV	11879094				2022-12-28	WOS:000174186000008
J	Roddy, RE; Zekeng, L; Ryan, KA; Tamoufe, U; Tweedy, KG				Roddy, RE; Zekeng, L; Ryan, KA; Tamoufe, U; Tweedy, KG			Effect of nonoxynol-9 gel on urogenital gonorrhea and chlamydial infection - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNODEFICIENCY VIRUS; NEISSERIA-GONORRHOEAE; IN-VITRO; TRANSMISSION; INACTIVATION; INVITRO; DISEASE; MODEL; HIV	Context Nonoxynol-9 has been suggested as a vaginal microbicide to protect against common sexually transmitted infections. Objective To compare nonoxynol-9 gel and condom use (gel group) vs condom use alone (condom group) for the prevention of male-to-female transmission of urogenital gonococcal and chlamydial infection. Design and Setting Randomized controlled trial conducted at 10 community clinics and 10 pharmacies in Yaounde, Cameroon, between October 1998 and September 2000, with 6 months of follow-up. Participants High-risk population of 1251 women (excluding sex workers) being treated for or who had symptoms of sexually transmitted infections. Three were excluded from the gel group (0.5%) and 7 from the condom group (1%) because of no follow-up data. Interventions Nonoxynol-9 gel (100 mg) and condoms or condoms only. Main Outcome Measure A positive test result for gonococcal or chlamydial infection by the ligase chain reaction assay; secondary outcome measure was a positive test result for human immunodeficiency virus (HIV). Results The rate ratio (RR) for new urogenital infections was 1.2 for the gel group vs condom group (95% confidence interval [CI], 0.9-1.6; P=.21). The gel group had 116 diagnosed gonococcal infections, chlamydial infections, or both fora rate of 43.6 per 100 person-years, and the condom group had 100 infections for a rate of 36.6 per 100 person-years. The RR for gonococcal infection in the gel group vs the condom group was 1.5 (95% CI, 1.0-2.3) and for chlamydial infection was 1.0 (95% CI, 0.7-1.4). There were 5 new cases of HIV infections in the gel group and 4 in the condom group. Three women in each group became pregnant during the study. Conclusion Nonoxynol-9 gel did not protect against urogenital gonococcal or chlamydial infection.	Family Hlth Int, Durham, NC USA; Minist Publ Hlth, Lab Sante Hyg Mobile, Yaounde, Cameroon; Care & Hlth Program, Yaounde, Cameroon		Roddy, RE (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.							BENES S, 1985, ANTIMICROB AGENTS CH, V27, P724, DOI 10.1128/AAC.27.5.724; BOLCH OH, 1973, AM J OBSTET GYNECOL, V115, P1145, DOI 10.1016/0002-9378(73)90566-8; BRUNHAM RC, 1990, MED CLIN N AM, V74, P1339, DOI 10.1016/S0025-7125(16)30484-9; DEMETS DL, 1994, STAT MED, V13, P1341, DOI 10.1002/sim.4780131308; Farr G, 1996, SEX TRANSM DIS, V23, P206, DOI 10.1097/00007435-199605000-00008; Gerbase AC, 1998, SEX TRANSM INFECT, V74, pS12; HICKS DR, 1985, LANCET, V2, P1422; HOOTON TM, 1991, J INFECT DIS, V164, P1216, DOI 10.1093/infdis/164.6.1216; KREISS J, 1992, JAMA-J AM MED ASSOC, V268, P477, DOI 10.1001/jama.268.4.477; LOUV WC, 1988, J INFECT DIS, V158, P518, DOI 10.1093/infdis/158.3.518; MALKOVSKY M, 1988, LANCET, V1, P645; MILLER CJ, 1992, FERTIL STERIL, V57, P1126; MOENCH TR, 1993, AIDS, V7, P797, DOI 10.1097/00002030-199306000-00006; NIRUTHISARD S, 1992, LANCET, V339, P1371, DOI 10.1016/0140-6736(92)91195-E; Richardson BA, 2001, SEX TRANSM DIS, V28, P394, DOI 10.1097/00007435-200107000-00006; Roddy RE, 1998, NEW ENGL J MED, V339, P504, DOI 10.1056/NEJM199808203390803; SINGH B, 1972, BRIT J VENER DIS, V48, P57	17	87	91	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2002	287	9					1117	1122		10.1001/jama.287.9.1117	http://dx.doi.org/10.1001/jama.287.9.1117			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527KV	11879108	Bronze			2022-12-28	WOS:000174186000026
J	Fildes, B; Langford, J				Fildes, B; Langford, J			Graduated licensing programmes and young-driver crashes	LANCET			English	Editorial Material									Monash Univ, Accid Res Ctr, Melbourne, Vic 3800, Australia	Monash University	Fildes, B (corresponding author), Monash Univ, Accid Res Ctr, Melbourne, Vic 3800, Australia.							BOASE P, 1998, 98 MIN TRANSP ONT SA; Evans L., 1991, TRAFFIC SAFETY DRIVE; FERGUSON SA, 2001, J CRASH PREVENTION I, V2, P221; Foss RD, 2001, JAMA-J AM MED ASSOC, V286, P1588, DOI 10.1001/jama.286.13.1588; FRITH WJ, 1992, NAT ROAD SAF SEM WEL, V2, P256; Gregersen NP, 2000, ACCIDENT ANAL PREV, V32, P25, DOI 10.1016/S0001-4575(99)00045-7; HAGGE RA, 1988, CALDMVRSS88116; HAWORTH NH, 1994, CR136 AUSTR TRANSP S; *I NS I HIGHW SAF, 1997, 32 INS I HIGHW SAF; KESKINEN E, 1999, IATSS RES, V23, P78; LANGFORD JL, 2001, TASM ROAD SAF COUNC; Langley JD, 1996, ACCIDENT ANAL PREV, V28, P139, DOI 10.1016/0001-4575(95)00040-2; National Highway Traffic Safety Administration, 1998, SAV TEEN LIV CAS GRA; REGAN MA, 2001, CD ROM PRODUCT ENHAN; TRIGGS T, 1996, CR164 AUSTR TRANSP S; Ulmer RG, 2000, ACCIDENT ANAL PREV, V32, P527, DOI 10.1016/S0001-4575(99)00074-3; 1999, KENT TRANSP CAB MARC; 2000, IMPACT GRADUATED DRI	18	4	4	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 2	2002	359	9308					725	726		10.1016/S0140-6736(02)07901-1	http://dx.doi.org/10.1016/S0140-6736(02)07901-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	526DZ	11888580				2022-12-28	WOS:000174115200004
J	Csete, ME; Doyle, JC				Csete, ME; Doyle, JC			Reverse engineering of biological complexity	SCIENCE			English	Review							BACTERIAL CHEMOTAXIS; FEEDBACK-CONTROL	Advanced technologies and biology have extremely different physical implementations, but they are far more alike in systems-level organization than is widely appreciated. Convergent evolution in both domains produces modular architectures that are composed of elaborate hierarchies of protocols and layers of feedback regulation, are driven by demand for robustness to uncertain environments, and use often imprecise components. This complexity may be largely hidden in idealized laboratory settings and in nor-mat operation, becoming conspicuous only when contributing to rare cascading failures. These puzzling and paradoxical features are neither accidental nor artificial, but derive from a deep and necessary interplay between complexity and robustness, modularity, feedback, and fragility. This review describes insights from engineering theory and practice that can shed some tight on biological complexity.	CALTECH, Pasadena, CA 91125 USA; Univ Michigan, Sch Med, Dept Anesthesiol & Cell & Dev Biol, Ann Arbor, MI 48109 USA	California Institute of Technology; University of Michigan System; University of Michigan	Doyle, JC (corresponding author), CALTECH, Pasadena, CA 91125 USA.	doyle@cds.caltech.edu						Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; BAUM D, 2000, EXTREME MINDSTORMS A; Bode H. W., 1945, NETWORK ANAL FEEDBAC; BROWN JH, 2000, SCALING BIL; Chiourel M, 2000, NATURE, V408, P900, DOI 10.1038/35050249; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; El-Samad H, 2002, J THEOR BIOL, V214, P17, DOI 10.1006/jtbi.2001.2422; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Kirschner M, 2000, CELL, V100, P79, DOI 10.1016/S0092-8674(00)81685-2; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Lauffenburger DA, 2000, P NATL ACAD SCI USA, V97, P5031, DOI 10.1073/pnas.97.10.5031; Levchenko A, 2002, BIOPHYS J, V82, P50, DOI 10.1016/S0006-3495(02)75373-3; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Noble D, 2002, SCIENCE, V295, P1678, DOI 10.1126/science.1069881; Rao CV, 2001, ANNU REV BIOMED ENG, V3, P391, DOI 10.1146/annurev.bioeng.3.1.391; Savageau MA, 1998, GENETICS, V149, P1665; SAVAGEAU MA, 1976, BIOCH SYSTEMS THEORY; Sontag E.D., 1998, MATH CONTROL THEORY; Tennekes H, 1997, SIMPLE SCI FLIGHT IN; Von Bertalanffy L., 1933, MODERN THEORIES DEV; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Whitfield J, 2001, NATURE, V413, P342, DOI 10.1038/35096683; Wiener N, 1948, CYBERNETICS; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649; Zhou K., 1996, ROBUST OPTIMAL CONTR; 1999, SCIENCE, V284	30	770	790	2	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2002	295	5560					1664	1669		10.1126/science.1069981	http://dx.doi.org/10.1126/science.1069981			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872830				2022-12-28	WOS:000174212900034
J	Loscertales, IG; Barrero, A; Guerrero, I; Cortijo, R; Marquez, M; Ganan-Calvo, AM				Loscertales, IG; Barrero, A; Guerrero, I; Cortijo, R; Marquez, M; Ganan-Calvo, AM			Micro/nano encapsutation via electrified coaxial liquid jets	SCIENCE			English	Article							ELECTROSPRAY-IONIZATION; SELECTIVE WITHDRAWAL; DRUG-DELIVERY; TAYLOR CONES; MICROENCAPSULATION; MICROPARTICLES; NANOPARTICLES; MICROSPHERE; GENERATION; PEPTIDES	We report a method to generate steady coaxial jets of immiscible liquids with diameters in the range of micrometer/nanometer size. This compound jet is generated by the action of electro-hydrodynamic (EHD) forces with a diameter that ranges from tens of nanometers to tens of micrometers. The eventual jet breakup results in an aerosol of monodisperse compound droplets with the outer liquid surrounding or encapsulating the inner one. Following this approach, we have produced monodisperse capsules with diameters varying between 10 and 0.15 micrometers, depending on the running parameters.	Univ Malaga, Escuela Tecn Super Ingn Ind, Malaga 29013, Spain; Univ Seville, Escuela Super Ingn, Seville 41092, Spain; Kraft Foods R&D, Nanotechnol Lab, Glenview, IL 60025 USA; Los Alamos Natl Lab, Chem Sci & Technol Div, Los Alamos, NM 87545 USA	Universidad de Malaga; University of Sevilla; Kraft Heinz; United States Department of Energy (DOE); Los Alamos National Laboratory	Loscertales, IG (corresponding author), Univ Malaga, Escuela Tecn Super Ingn Ind, Plaza El Ejido,S-N, Malaga 29013, Spain.	loscertales@uma.es; barrero@eurus2.us.es	Ganan-Calvo, Alfonso M./F-1169-2013	Ganan-Calvo, Alfonso M./0000-0002-7552-6184; Loscertales, Ignacio G./0000-0001-7634-8757				Aboubakar M, 1999, INT J PHARM, V183, P63, DOI 10.1016/S0378-5173(99)00045-9; Barrero A, 1998, PHYS REV E, V58, P7309, DOI 10.1103/PhysRevE.58.7309; Bartus RT, 1998, SCIENCE, V281, P1161, DOI 10.1126/science.281.5380.1161; BLAKE S, 1986, J VOLCANOL GEOTH RES, V27, P153, DOI 10.1016/0377-0273(86)90084-3; Burlak G, 2001, OPT COMMUN, V187, P91, DOI 10.1016/S0030-4018(00)01105-6; CIACH T, 2001, J AEROSOL SCI, V32, pS1001; CLOUPEAU M, 1994, J AEROSOL SCI, V25, P1021, DOI 10.1016/0021-8502(94)90199-6; Cohen I, 2001, SCIENCE, V292, P265, DOI 10.1126/science.1059175; DELAMORA JF, 1994, J FLUID MECH, V260, P155, DOI 10.1017/S0022112094003472; FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315; Gamero-Castano M, 2000, ANAL CHIM ACTA, V406, P67, DOI 10.1016/S0003-2670(99)00596-6; Ganan-Calvo AM, 1999, J AEROSOL SCI, V30, P117, DOI 10.1016/S0021-8502(98)00029-9; Ganan-Calvo AM, 1997, J AEROSOL SCI, V28, P249, DOI 10.1016/S0021-8502(96)00433-8; Ganan-Calvo AM, 1998, PHYS REV LETT, V80, P285, DOI 10.1103/PhysRevLett.80.285; GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245; Hardas N, 2000, LEBENSM-WISS TECHNOL, V33, P506, DOI 10.1006/fstl.2000.0696; Hildebrand GE, 2000, INT J PHARM, V196, P173, DOI 10.1016/S0378-5173(99)00415-9; Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0; Jung T, 2000, EUR J PHARM BIOPHARM, V50, P147, DOI 10.1016/S0939-6411(00)00084-9; Langer R, 1998, NATURE, V392, P5; Lee SJ, 2000, LEBENSM-WISS TECHNOL, V33, P80, DOI 10.1006/fstl.1999.0619; Lee YH, 2001, POLYMER, V42, P8277, DOI 10.1016/S0032-3861(01)00342-1; LISTER JR, 1989, J FLUID MECH, V198, P231, DOI 10.1017/S002211208900011X; LOSCERTALES IG, 1995, J CHEM PHYS, V103, P5041, DOI 10.1063/1.470591; LOSCERTALES IG, 1993, SYNTHESIS CHARACTERI, P115; LOSCERTALES IG, 2001, Patent No. 200100231; Mathiowitz E, 1997, NATURE, V386, P410, DOI 10.1038/386410a0; Mathiowitz E., 1999, ENCY CONTROLLED DRUG; Reithmeier H, 2001, INT J PHARM, V218, P133, DOI 10.1016/S0378-5173(01)00620-2; ROSELLLLOMPART J, 1994, J AEROSOL SCI, V25, P1093, DOI 10.1016/0021-8502(94)90204-6; RosellLlompart J, 1996, J AEROSOL SCI, V27, P695, DOI 10.1016/0021-8502(96)00016-X; WOLTERS GHJ, 1992, J APPL BIOMATER, V3, P281, DOI 10.1002/jab.770030407; YOSII H, 2001, INN FOOD SCI EM TECH, V2, P55	33	819	978	10	491	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 1	2002	295	5560					1695	1698		10.1126/science.1067595	http://dx.doi.org/10.1126/science.1067595			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872835				2022-12-28	WOS:000174212900041
J	Schonbachler, M; Rehkamper, M; Halliday, AN; Lee, DC; Bourot-Denise, M; Zanda, B; Hattendorf, B; Gunther, D				Schonbachler, M; Rehkamper, M; Halliday, AN; Lee, DC; Bourot-Denise, M; Zanda, B; Hattendorf, B; Gunther, D			Niobium-zirconium chronometry and early solar system development	SCIENCE			English	Article							P-PROCESS; ISOTOPIC COMPOSITION; NB; ZR; TERRESTRIAL; ABUNDANCES; ANOMALIES; NUCLEI	Niobium-92 (Nb-92) decays to zirconium-92 (Zr-92) with a half-life of 36 million years and can be used to place constraints on the site of p-process nucleosynthesis and the timing of early solar system processes. Recent results have suggested that the initial Nb-92/Nb-93 of the solar system was high (>10(-3)). We report Nb-Zr internal isochrons for the ordinary chondrite Estacado (H6) and a clast of the mesosiderite Vaca Muerta, both of which define an initial Nb-92/Nb-93 ratio of similar to10(-5). Therefore, the solar system appears to have started with a ratio of <3 x 10(-5), which implies that Earth's initial differentiation need not have been as protracted as recently suggested.	Swiss Fed Inst Technol, Inst Isotope Geol & Mineral Resources, CH-8092 Zurich, Switzerland; Swiss Fed Inst Technol, Inorgan Chem Lab, CH-8092 Zurich, Switzerland; Museum Natl Hist Nat, F-75005 Paris, France; Rutgers State Univ, Dept Geol Sci, Wright Lab, Piscataway, NJ 08854 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Museum National d'Histoire Naturelle (MNHN); Rutgers State University New Brunswick	Schonbachler, M (corresponding author), Swiss Fed Inst Technol, Inst Isotope Geol & Mineral Resources, CH-8092 Zurich, Switzerland.	maria@erdw.ethz.ch	IMPMC, ROCKS @/U-8478-2017; Lee, Der-Chuen/N-9225-2013; Schönbächler, Maria/AAL-3318-2020; Zanda, Brigitte M/D-6787-2015	Schönbächler, Maria/0000-0003-4304-214X; Zanda, Brigitte M/0000-0002-4210-7151; Hattendorf, Bodo/0000-0001-9991-2410; Lee, Der-Chuen/0000-0001-8855-9594				Amelin Y, 1999, NATURE, V399, P252, DOI 10.1038/20426; CAMERON AGW, 1962, ICARUS, V1, P13, DOI 10.1016/0019-1035(62)90005-2; CAMERON AGW, 1993, PROTOSTARS PLANETS, V3, P47; CLAYTON DD, 1977, ASTROPHYS J, V214, P300, DOI 10.1086/155252; FLOHS I, 1981, EOS, V62, P17; GOPEL C, 1994, EARTH PLANET SC LETT, V121, P153, DOI 10.1016/0012-821X(94)90038-8; Harper CL, 1996, ASTROPHYS J, V466, P437, DOI 10.1086/177523; Hattendorf B, 2001, ANAL CHEM, V73, P5494, DOI 10.1021/ac015549a; Hirata T, 2001, CHEM GEOL, V176, P323, DOI 10.1016/S0009-2541(00)00370-3; Hoffman RD, 1996, ASTROPHYS J, V460, P478, DOI 10.1086/176986; HOWARD WM, 1991, ASTROPHYS J, V373, pL5, DOI 10.1086/186038; HOWARD WM, 1993, NUCL COSMOS, V2, P575; IRELAND TR, 1992, EARTH PLANET SC LETT, V109, P1, DOI 10.1016/0012-821X(92)90069-8; IRELAND TR, 1991, LUNAR PLANET SCI, V22, P609; JACOBSEN SB, 2001, LUN PLANET SCI C, V32; JOCHUM KP, 1986, GEOCHIM COSMOCHIM AC, V50, P1173, DOI 10.1016/0016-7037(86)90400-X; LAMBERT DL, 1992, ASTRON ASTROPHYS REV, V3, P201, DOI 10.1007/BF00872527; Lee DC, 1997, NATURE, V388, P854, DOI 10.1038/42206; LEYA I, 2001, LUNAR PLANET SCI C, V32, P1521; Lugmair GW, 1998, GEOCHIM COSMOCHIM AC, V62, P2863, DOI 10.1016/S0016-7037(98)00189-6; MAKINO T, 1982, GEOCHIM COSMOCHIM AC, V46, P565; MINSTER JF, 1982, GEOCHIM COSMOCHIM AC, V46, P565, DOI 10.1016/0016-7037(82)90159-4; Munker C, 2000, SCIENCE, V289, P1538, DOI 10.1126/science.289.5484.1538; NETHAWAY DR, 1978, PHYS REV C, V17, P1409, DOI 10.1103/PhysRevC.17.1409; Nicolussi GK, 1998, ASTROPHYS J, V504, P492, DOI 10.1086/306072; Podosek FA, 1997, AIP CONF PROC, P617, DOI 10.1063/1.53321; PODOSEK FA, 1988, METEORITES EARLY SOL, P1093; RAYET M, 1995, ASTRON ASTROPHYS, V298, P517; Sahoo SK, 1997, CHEM GEOL, V141, P117, DOI 10.1016/S0009-2541(97)00024-7; Sanloup C, 2000, EARTH PLANET SC LETT, V184, P75, DOI 10.1016/S0012-821X(00)00306-X; SCHONBACHLER M, 2001, METEORIT PLANET SCI, V36, pA184; STEWART BW, 1994, GEOCHIM COSMOCHIM AC, V58, P3487, DOI 10.1016/0016-7037(94)90100-7; SWINDLE TD, 1993, PROTOSTARS PLANETS, V3, P867; Wade J, 2001, NATURE, V409, P75, DOI 10.1038/35051064; Wasserburg G.J., 1985, PROTOSTARS PLANETS, P703; WASSERBURG GJ, 1960, PHYS REV LETT, V4, P112, DOI 10.1103/PhysRevLett.4.112; WOOSLEY SE, 1978, ASTROPHYS J SUPPL S, V36, P285, DOI 10.1086/190501; Yin QZ, 2000, ASTROPHYS J, V536, pL49, DOI 10.1086/312718; YIN QZ, 2001, LUNAR PLANET SCI C, V32	39	67	67	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2002	295	5560					1705	1708		10.1126/science.1067400	http://dx.doi.org/10.1126/science.1067400			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872837				2022-12-28	WOS:000174212900044
J	Solomon, CG				Solomon, CG			Perspective: Bisphosphonates and osteoporosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	25	29	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2002	346	9					642	642		10.1056/NEJM200202283460902	http://dx.doi.org/10.1056/NEJM200202283460902			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525HJ	11870240				2022-12-28	WOS:000174062800001
J	El-ReFaey, H				El-ReFaey, H			Use of misoprostol in third stage of labour	LANCET			English	Letter							ADMINISTERED MISOPROSTOL		Chelsea & Westminster Hosp, Acad Dept Obstet & Gynaecol, London NW10 9NH, England	Imperial College London	El-ReFaey, H (corresponding author), Chelsea & Westminster Hosp, Acad Dept Obstet & Gynaecol, London NW10 9NH, England.							Chong YS, 2001, BRIT J OBSTET GYNAEC, V108, P41; El-Refaey H, 2000, BRIT J OBSTET GYNAEC, V107, P1104, DOI 10.1111/j.1471-0528.2000.tb11108.x; GIBBENS D, 1972, J OBSTET GYN BR COMM, V79, P644; Gulmezoglu AM, 2001, LANCET, V358, P689, DOI 10.1016/S0140-6736(01)05835-4; O'Brien P, 1998, OBSTET GYNECOL, V92, P212, DOI 10.1016/S0029-7844(98)00161-6	5	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 23	2002	359	9307					707	708		10.1016/S0140-6736(02)07787-5	http://dx.doi.org/10.1016/S0140-6736(02)07787-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526AZ	11879890				2022-12-28	WOS:000174107400037
J	Larson, BC; Yang, W; Ice, GE; Budai, JD; Tischler, JZ				Larson, BC; Yang, W; Ice, GE; Budai, JD; Tischler, JZ			Three-dimensional X-ray structural microscopy with submicrometre resolution	NATURE			English	Article							STRAIN; RECRYSTALLIZATION; SIMULATIONS; PLASTICITY; MECHANISM; TEXTURE	Advanced materials and processing techniques are based largely on the generation and control of non-homogeneous microstructures, such as precipitates and grain boundaries. X-ray tomography can provide three-dimensional density and chemical distributions of such structures with submicrometre resolution(1); structural methods exist that give submicrometre resolution in two dimensions(2-8); and techniques are available for obtaining grain-centroid positions and grain-average strains in three dimensions(7,9). But non-destructive point-to-point three-dimensional structural probes have not hitherto been available for investigations at the critical mesoscopic length scales (tenths to hundreds of micrometres). As a result, investigations of three-dimensional mesoscale phenomena-such as grain growth 10,11, deformation(12-16), crumpling(17-19) and strain-gradient effects(20) - rely increasingly on computation and modelling without direct experimental input. Here we describe a three-dimensional X-ray microscopy technique that uses polychromatic synchrotron X-ray microbeams to probe local crystal structure, orientation and strain tensors with submicrometre spatial resolution. We demonstrate the utility of this approach with micrometre-resolution three-dimensional measurements of grain orientations and sizes in polycrystalline aluminium, and with micrometre depth-resolved measurements of elastic strain tensors in cylindrically bent silicon. This technique is applicable to single-crystal, polycrystalline, composite and functionally graded materials.	Oak Ridge Natl Lab, Div Solid State, Oak Ridge, TN 37831 USA; Oak Ridge Natl Lab, Div Met & Ceram, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory	Larson, BC (corresponding author), Oak Ridge Natl Lab, Div Solid State, POB 2008, Oak Ridge, TN 37831 USA.	bcl@ornl.gov	Yang, Wenge/H-2740-2012; Budai, John/R-9276-2016; Yang, Wenge/ABD-6594-2020	Budai, John/0000-0002-7444-1306; 				BILDERBACK DH, 1994, SCIENCE, V263, P201, DOI 10.1126/science.8284671; Boudaoud A, 2000, NATURE, V407, P718, DOI 10.1038/35037535; Bulatov V, 1998, NATURE, V391, P669, DOI 10.1038/35577; Chaieb S, 1998, PHYS REV LETT, V80, P2354, DOI 10.1103/PhysRevLett.80.2354; Chung JS, 1999, J APPL PHYS, V86, P5249, DOI 10.1063/1.371507; Cleri F, 1997, PHYS REV LETT, V79, P1309, DOI 10.1103/PhysRevLett.79.1309; de la Rubia TD, 2000, NATURE, V406, P871, DOI 10.1038/35022544; Di Fonzo S, 2000, NATURE, V403, P638, DOI 10.1038/35001035; Doherty RD, 1997, MAT SCI ENG A-STRUCT, V238, P219, DOI 10.1016/S0921-5093(97)00424-3; Field DP, 1997, ULTRAMICROSCOPY, V67, P1, DOI 10.1016/S0304-3991(96)00104-0; Fleck NA, 1997, ADV APPL MECH, V33, P295, DOI 10.1016/s0065-2156(08)70388-0; Gao H, 1999, NATURWISSENSCHAFTEN, V86, P507, DOI 10.1007/s001140050665; Hirsch PB, 1996, ACTA MATER, V44, P2361, DOI 10.1016/1359-6454(95)00363-0; Holm EA, 1998, ACTA MATER, V46, P953, DOI 10.1016/S1359-6454(97)00307-8; Huang Y, 2000, J MATER RES, V15, P1786, DOI 10.1557/JMR.2000.0258; Humphreys Frederick John, 2012, RECRYSTALLIZATION RE; Ice GE, 2000, ADV ENG MATER, V2, P643, DOI 10.1002/1527-2648(200010)2:10<643::AID-ADEM643>3.0.CO;2-U; KHANTHA M, 1994, PHYS REV LETT, V73, P684, DOI 10.1103/PhysRevLett.73.684; KJELMSTEAD KD, 1997, FUNDAMENTALS STRUCTU; Landau LD, 1986, THEORY ELASTICITY, DOI 10.1016/C2009-0-25521-8; Lengeler B, 1999, APPL PHYS LETT, V74, P3924, DOI 10.1063/1.124225; LOBKOVSKY A, 1995, SCIENCE, V270, P1482, DOI 10.1126/science.270.5241.1482; MacDowell AA, 2001, NUCL INSTRUM METH A, V467, P936, DOI 10.1016/S0168-9002(01)00530-7; Margulies L, 2001, SCIENCE, V291, P2392, DOI 10.1126/science.1057956; Needleman A, 2000, ACTA MATER, V48, P105, DOI 10.1016/S1359-6454(99)00290-6; Radhakrishnan B, 1998, ACTA MATER, V46, P4415, DOI 10.1016/S1359-6454(98)00077-9; Tamura N, 1999, MATER RES SOC SYMP P, V563, P175, DOI 10.1557/PROC-563-175; Vashishta P, 1999, COMPUT SCI ENG, V1, P56, DOI 10.1109/5992.790588; Wang YX, 2001, REV SCI INSTRUM, V72, P2062, DOI 10.1063/1.1355270; Yun W, 1999, REV SCI INSTRUM, V70, P2238, DOI 10.1063/1.1149744	30	564	571	5	211	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2002	415	6874					887	890		10.1038/415887a	http://dx.doi.org/10.1038/415887a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859363				2022-12-28	WOS:000173941000039
J	Liu, YF; Xu, LG; Opalka, N; Kappler, J; Shu, HB; Zhang, GY				Liu, YF; Xu, LG; Opalka, N; Kappler, J; Shu, HB; Zhang, GY			Crystal structure of sTALL-1 reveals a virus-like assembly of TNF family ligands	CELL			English	Article							NECROSIS-FACTOR FAMILY; B-CELL MATURATION; AUTOIMMUNE-DISEASE; FACTOR-ALPHA; RECEPTOR; PROTEIN; BAFF; MEMBER; TACI; BCMA	TALL-1/BAFF/BLyS was recently identified as a member of the tumor necrosis factor (TNF) ligand family. The crystal structure of the functional soluble TALL-1 (sTALL-1) has been determined at 3.0 Angstrom. sTALL-1 forms a virus-like assembly with 200 Angstrom diameter in the crystals, containing 60 sTALL-1 monomers. The cluster formation is mediated by a "flap" region of the sTALL-1 monomer. The virus-like assembly was also detected in solution using gel filtration and electron microscopy. Deletion of the flap region disrupted the formation of the virus-like assembly. The mutant sTALL-1 still bound its receptor but could not activate NF-kappaB and did not stimulate B lymphocyte proliferation. Finally, we found the virus-like cluster of sTALL-1 exists in physiological condition. We propose that this virus-like assembly of sTALL-1 is the functional unit for TALL-1 in vivo.	Univ Colorado, Hlth Sci Ctr, Natl Jewish Med & Res Ctr, Integrated Dept Immunol, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Ctr Canc, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Sch Med, Howard Hughes Med Inst, Denver, CO 80206 USA; Rockefeller Univ, New York, NY 10021 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Rockefeller University	Zhang, GY (corresponding author), Univ Colorado, Hlth Sci Ctr, Natl Jewish Med & Res Ctr, Integrated Dept Immunol, 1400 Jackson St, Denver, CO 80206 USA.	zhangg@njc.org		Xu, Liangguo/0000-0003-1991-2889	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065341] Funding Source: NIH RePORTER; NIAID NIH HHS [AI49992] Funding Source: Medline; NIGMS NIH HHS [GM65341] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Bodmer JL, 2000, J BIOL CHEM, V275, P20632, DOI 10.1074/jbc.M909721199; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Cha SS, 1999, IMMUNITY, V11, P253, DOI 10.1016/S1074-7613(00)80100-4; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; CORTI A, 1992, BIOCHEM J, V284, P905, DOI 10.1042/bj2840905; ECK MJ, 1992, J BIOL CHEM, V267, P2119; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Fesik SW, 2000, CELL, V103, P273, DOI 10.1016/S0092-8674(00)00119-7; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; JONES EY, 1989, NATURE, V338, P225, DOI 10.1038/338225a0; JONES TA, 1984, J MOL BIOL, V177, P735, DOI 10.1016/0022-2836(84)90047-0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kanakaraj P, 2001, CYTOKINE, V13, P25, DOI 10.1006/cyto.2000.0793; KARPUSAS M, 1995, STRUCTURE, V3, P1031, DOI 10.1016/S0969-2126(01)00239-8; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mongkolsapaya J, 1999, NAT STRUCT BIOL, V6, P1048; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Mukhopadhyay A, 1999, J BIOL CHEM, V274, P15978, DOI 10.1074/jbc.274.23.15978; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Shu HB, 2000, P NATL ACAD SCI USA, V97, P9156, DOI 10.1073/pnas.160213497; Shu HB, 1999, J LEUKOCYTE BIOL, V65, P680, DOI 10.1002/jlb.65.5.680; Siegel RM, 2000, NAT IMMUNOL, V1, P469, DOI 10.1038/82712; TERWILLIGER TC, 1987, ACTA CRYSTALLOGR A, V43, P34; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; Xia XZ, 2000, J EXP MED, V192, P137, DOI 10.1084/jem.192.1.137; Xu SL, 2001, MOL CELL BIOL, V21, P4067, DOI 10.1128/MCB.21.12.4067-4074.2001; Yan MH, 2000, NAT IMMUNOL, V1, P37, DOI 10.1038/76889; Yan MH, 2001, CURR BIOL, V11, P1547, DOI 10.1016/S0960-9822(01)00481-X; Yu G, 2000, NAT IMMUNOL, V1, P252, DOI 10.1038/79802	45	161	196	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2002	108	3					383	394		10.1016/S0092-8674(02)00631-1	http://dx.doi.org/10.1016/S0092-8674(02)00631-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	520VB	11853672	Bronze			2022-12-28	WOS:000173801600010
J	Kobayashi, K; Inohara, N; Hernandez, LD; Galan, JE; Nunez, G; Janeway, CA; Medzhitov, R; Flavell, RA				Kobayashi, K; Inohara, N; Hernandez, LD; Galan, JE; Nunez, G; Janeway, CA; Medzhitov, R; Flavell, RA			RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems	NATURE			English	Article							NF-KAPPA-B; PROTEIN; KINASE; RECOGNITION; EXPRESSION; INHIBITOR; APOPTOSIS; PATHWAYS; DOMAIN; MICE	The immune system consists of two evolutionarily different but closely related responses, innate immunity and adaptive immunity. Each of these responses has characteristic receptors-Toll-like receptors (TLRs) for innate immunity and antigen-specific receptors for adaptive immunity. Here we show that the caspase recruitment domain (CARD)-containing serine/threonine kinase Rip2 (also known as RICK, CARDIAK, CCK and Ripk2)(1-4) transduces signals from receptors of both immune responses. Rip2 was recruited to TLR2 signalling complexes after ligand stimulation. Moreover, cytokine production in Rip2-deficient cells was reduced on stimulation of TLRs with lipopolysaccharide, peptidoglycan and double-stranded RNA, but not with bacterial DNA, indicating that Rip2 is downstream of TLR2/3/4 but not TLR9. Rip2-deficient cells were also hyporesponsive to signalling through interleukin (IL)-1 and IL-18 receptors, and deficient for signalling through Nod proteins-molecules also implicated in the innate immune response. Furthermore, Rip2-deficient T cells showed severely reduced NF-kappaB activation, IL-2 production and proliferation on T-cell-receptor (TCR) engagement, and impaired differentiation to T-helper subtype 1 (T(H)1) cells, indicating that Rip2 is required for optimal TCR signalling and T-cell differentiation. Rip2 is therefore a signal transducer and integrator of signals for both the innate and adaptive immune systems.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Ctr Microbial Pathogenesis, New Haven, CT 06536 USA	Yale University; Howard Hughes Medical Institute; Yale University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Yale University	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.		Nuñez, Gabriel/A-7160-2014	Kobayashi, Koichi/0000-0003-2930-0114				Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aronica MA, 1999, J IMMUNOL, V163, P5116; Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Demuth A, 1996, INFECT IMMUN, V64, P3475, DOI 10.1128/IAI.64.9.3475-3483.1996; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Growney JD, 2000, GENOME RES, V10, P1158, DOI 10.1101/gr.10.8.1158; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Inohara N, 1998, J BIOL CHEM, V273, P12296, DOI 10.1074/jbc.273.20.12296; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kobayashi K, 1999, P NATL ACAD SCI USA, V96, P1457, DOI 10.1073/pnas.96.4.1457; Leitenberg D, 1999, SEMIN IMMUNOL, V11, P283, DOI 10.1006/smim.1999.0184; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264	29	712	749	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2002	416	6877					194	199		10.1038/416194a	http://dx.doi.org/10.1038/416194a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894098	Green Published			2022-12-28	WOS:000174348100042
J	Wilson, T; Sheikh, A				Wilson, T; Sheikh, A			Enhancing public safety in primary care	BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTICE; NEED; MANAGEMENT; DIAGNOSIS; INCIDENTS; QUALITY; ERRORS; EVENTS		RCGP Qual Unit, London SW7 1PU, England; Univ London Imperial Coll Sci Technol & Med, Dept Primary Hlth Care & Gen Practice, London SW7 2AZ, England	Imperial College London	Wilson, T (corresponding author), RCGP Qual Unit, 14 Princes Gate, London SW7 1PU, England.		Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056				[Anonymous], 1999, CORPORATE CULTURE SU; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; Bhasale A, 1998, FAM PRACT, V15, P308, DOI 10.1093/fampra/15.4.308; Bhasale AL, 1998, MED J AUSTRALIA, V169, P73, DOI 10.5694/j.1326-5377.1998.tb140186.x; Britt H, 1997, FAM PRACT, V14, P101, DOI 10.1093/fampra/14.2.101; BUETOW S, 1996, BRIT MED J, V331, P1371; Campbell S, 2001, BRIT MED J, V322, P1580, DOI 10.1136/bmj.322.7302.1580; Charatan F, 2000, WESTERN J MED, V173, P81, DOI 10.1136/ewjm.173.2.81; Chassin MR, 1998, JAMA-J AM MED ASSOC, V280, P1000, DOI 10.1001/jama.280.11.1000; *DEP HLTH, 2001, BUILD SAF NHS; Department of Health, 2000, ORG MEM; DUGGAN C, 1996, PHARM J, V256, P65; FRASER RC, 1992, CLIN METHODS GEN PRA; Green S, 1996, PROBLEMS GEN PRACTIC; GREENFIELD S, 1992, JAMA-J AM MED ASSOC, V267, P1624, DOI 10.1001/jama.267.12.1624; HART JT, 1993, BRIT MED J, V306, P1337, DOI 10.1136/bmj.306.6888.1337-b; Heath I, 2000, BRIT MED J, V320, P326, DOI 10.1136/bmj.320.7231.326; Helmreich RL, 2000, BRIT MED J, V320, P781, DOI 10.1136/bmj.320.7237.781; Jones D R, 1978, J R Coll Gen Pract, V28, P543; KOHN LT, 1999, ERR HUMAN BUILDING S; LEAPE LL, 1998, REDUCING ADVERSE DRU; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; Marklund B, 1999, FAM PRACT, V16, P112, DOI 10.1093/fampra/16.2.112; MCCARTHY GM, 1991, J GEN INTERN MED, V6, P52, DOI 10.1007/BF02599393; Meisel S, 1998, Qual Manag Health Care, V6, P15; MOORE W, 2000, WHY DOCTORS MAKE MIS; NEVILLE RG, 1989, J ROY COLL GEN PRACT, V39, P110; O'Donnell CA, 2000, FAM PRACT, V17, P462, DOI 10.1093/fampra/17.6.462; Olesen F, 2000, BMJ-BRIT MED J, V320, P354, DOI 10.1136/bmj.320.7231.354; PENDELTON D, 1997, CONSULTATION; Pringle M, 1998, BMJ-BRIT MED J, V317, P1120; Pringle M, 1995, 70 ROYAL COLL GEN PR; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; REBILLOT K, 2002, ACCELERATING CHANGE; *ROYAL COLL GEN PR, 1995, FELL ASS, P50; *ROYAL COLL GEN PR, 1996, 10 ROYAL COL GEN PRA; Schein EH., 2010, ORG CULTURE LEADERSH; Sheikh A, 2001, BRIT J GEN PRACT, V51, P57; SHERWOOD P, 1908, BRIT MED J, V322, P276; Starfield B, 2001, BRIT J GEN PRACT, V51, P303; Starfield B, 1998, PRIMARY CARE BALANCI; Sweeney G, 2000, J CLIN GOVERNANCE, V8, P128; Veldhuis M, 1998, BRIT J GEN PRACT, V48, P1833; Vincent C, 2000, BRIT MED J, V320, P777, DOI 10.1136/bmj.320.7237.777; Vincent C, 2001, BRIT MED J, V322, P517, DOI 10.1136/bmj.322.7285.517; Weed LL, 1999, BRIT MED J, V319, P1279, DOI 10.1136/bmj.319.7220.1279; WILLCOX SM, 1994, JAMA-J AM MED ASSOC, V272, P292, DOI 10.1001/jama.272.4.292; Wilson T, 2002, BRIT MED J, V324, P170; Wilson T, 2001, BRIT MED J, V323, P583, DOI 10.1136/bmj.323.7313.583; WINOGRAD T, 1997, HUMAN CENTERED SYSTE; WOODS D, 2002, HUMAN ERROR HUMAN FA	51	57	60	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 9	2002	324	7337					584	587		10.1136/bmj.324.7337.584	http://dx.doi.org/10.1136/bmj.324.7337.584			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	530XJ	11884325	Green Published, Bronze			2022-12-28	WOS:000174384000024
J	Mel, BW				Mel, BW			What the synapse tells the neuron	SCIENCE			English	Editorial Material									Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; Univ So Calif, Grad Program Neurosci, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Mel, BW (corresponding author), Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA.							CAULLER LJ, 1994, J NEUROSCI, V14, P751; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Stuart G., 1999, DENDRITES; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; ZADOR AM, 1995, J NEUROSCI, V15, P1669, DOI 10.1523/JNEUROSCI.15-03-01669.1995; Zochowski M, 2000, BIOL BULL-US, V198, P1, DOI 10.2307/1542798	9	2	2	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1845	1846		10.1126/science.1070513	http://dx.doi.org/10.1126/science.1070513			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884739				2022-12-28	WOS:000174299500022
J	Ishikawa, T; Yamaoka, H; Harada, Y; Fujii, T; Nagasawa, T				Ishikawa, T; Yamaoka, H; Harada, Y; Fujii, T; Nagasawa, T			A general process for in situ formation of functional surface layers on ceramics	NATURE			English	Article							SIC FIBER; COATINGS; CRYSTALS; NITRIDE; CARBIDE; FILMS	Ceramics are often prepared with surface layers of different composition from the bulk(1,2), in order to impart a specific functionality to the surface or to act as a protective layer for the bulk material(3,4). Here we describe a general process by which functional surface layers with a nanometre-scale compositional gradient can be readily formed during the production of bulk ceramic components. The basis of our approach is to incorporate selected low-molecular-mass additives into either the precursor polymer from which the ceramic forms, or the binder polymer used to prepare bulk components from ceramic powders. Thermal treatment of the resulting bodies leads to controlled phase separation ('bleed out') of the additives, analogous to the normally undesirable outward loss of low-molecular-mass components from some plastics(5-9); subsequent calcination stabilizes the compositionally changed surface region, generating a functional surface layer. This approach is applicable to a wide range of materials and morphologies, and should find use in catalysts, composites and environmental barrier coatings.	Ube Ind Ltd, Ube Res Lab, Corp Res & Dev, Yamaguchi 7558633, Japan	Ube Industries Ltd.	Ishikawa, T (corresponding author), Ube Ind Ltd, Ube Res Lab, Corp Res & Dev, 1978-5 Kogushi, Yamaguchi 7558633, Japan.	24613u@ube-ind.co.jp						ABE Y, 1986, NIPPON SERAM KYO GAK, V94, P1243, DOI 10.2109/jcersj1950.94.1096_1243; BESMANN TM, 1991, SCIENCE, V253, P1104, DOI 10.1126/science.253.5024.1104; BHAT DG, 1991, J MATER SCI, V26, P4567, DOI 10.1007/BF00612391; Dariel MP, 2001, MATER CHEM PHYS, V67, P192, DOI 10.1016/S0254-0584(00)00438-7; FISCHBACH DB, 1990, COMPOS SCI TECHNOL, V37, P55, DOI 10.1016/0266-3538(90)90092-J; GLADDEN LF, 1992, J NON-CRYST SOLIDS, V139, P47, DOI 10.1016/S0022-3093(05)80804-X; GOGOTSI YG, 1994, NATURE, V367, P628, DOI 10.1038/367628a0; Ishikawa T, 1998, NATURE, V391, P773, DOI 10.1038/35820; KERK SL, 1989, J ELECTRON MATER, V18, P117, DOI 10.1007/BF02657396; LI JX, 1991, B CERAM SOC JAPAN, V99, P1207; MOYA JS, 1993, 3 EUR CER, V3, P289; NEEDLES HL, 1980, J APPL POLYM SCI, V25, P1737, DOI 10.1002/app.1980.070250820; Neubrand A, 1997, Z METALLKD, V88, P358; PEROVIC A, 1982, POLYM BULL, V6, P277, DOI 10.1007/BF00255398; PEROVIC A, 1985, J MATER SCI, V20, P1370, DOI 10.1007/BF01026334; PEROVIC A, 1984, J APPL POLYM SCI, V29, P4321, DOI 10.1002/app.1984.070291260; ROY R, 1987, SCIENCE, V238, P1664, DOI 10.1126/science.238.4834.1664; SHEN L, 1994, J AM CERAM SOC, V77, P1011, DOI 10.1111/j.1151-2916.1994.tb07260.x; Sidky PS, 1999, BRIT CORROS J, V34, P171, DOI 10.1179/000705999101500815; Singh RK, 1996, SCIENCE, V272, P396, DOI 10.1126/science.272.5260.396; Somiya S., 1989, HYDROTHERMAL REACTIO; Takeda M., 1995, 22 ANN C COMP ADV CE, V16, P37; VARAPRASAD DV, 1991, INDIAN J FIBRE TEXT, V16, P73; YAMAOKA H, 2001, Patent No. 2001167679	24	113	115	8	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 7	2002	416	6876					64	67		10.1038/416064a	http://dx.doi.org/10.1038/416064a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882891				2022-12-28	WOS:000174211600037
J	Williams, JW; Noel, PH; Cordes, JA; Ramirez, G; Pignone, M				Williams, JW; Noel, PH; Cordes, JA; Ramirez, G; Pignone, M			Is this patient clinically depressed?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DSM-III-R; RANDOMIZED CONTROLLED TRIAL; DIAGNOSING MENTAL-DISORDERS; CASE-FINDING INSTRUMENTS; PRIMARY-CARE; MAJOR DEPRESSION; MEDICAL OUTPATIENTS; COLLABORATIVE MANAGEMENT; TREATMENT GUIDELINES; LIKELIHOOD RATIOS	Context Depressive disorders are highly prevalent in the general population, but recognition and accurate diagnosis are made difficult by the lack of a simple confirmatory test. Objective To review the accuracy and precision of depression questionnaires and the clinical examination for diagnosing clinical depression. Data Sources We searched the English-language literature from 1970 through July 2000 using MEDLINE, a specialized registry of depression trials, and bibliographies of selected articles. Study Selection Case-finding studies were included if they used depression questionnaires with easy to average literacy requirements, evaluated at least 100 primary care patients, and compared questionnaire results with accepted diagnostic criteria for major depression. Eleven questionnaires, ranging in length from 1 to 30 questions, were assessed in 28 published studies. Reliability studies for the clinical examination required criterion-based diagnoses made by at least 2 clinicians who interviewed the patient or reviewed a taped examination. Fourteen studies evaluated interrater reliability. Data Extraction Pairs of authors independently reviewed articles. For case-finding studies, quality assessment addressed sample size and whether patients were selected consecutively or randomly, the criterion standard was administered and interpreted independently of and blind to the results of the case-finding instrument, and the proportion of persons receiving the criterion standard assessment was less than or more than 50% of those approached for criterion standard assessment. For reliability studies, quality assessment addressed whether key patient characteristics were described, the interviewers collected clinical history independently, and diagnoses were made blinded to other clinicians' evaluations. Data Synthesis In case-finding studies, average questionnaire administration times ranged from less than 1 minute to 5 minutes. The median likelihood ratio positive for major depression was 3.3 (range, 2.3-12.2) and the median likelihood ratio negative was 0.19 (range, 0.14-0.35). No significant differences between questionnaires were found. For mental health care professionals using a semistructured interview, agreement was substantial to almost perfect for major depression (kappa=0.64-0.93), Non-standardized interviews yielded somewhat lower agreement (kappa=0.55-0.74). A single study showed that primary care clinicians using a semistructured interview have high agreement with mental health care professionals (kappa=0.71). Conclusions Multiple, practical questionnaires with reasonable performance characteristics are available to help clinicians identify and diagnose patients with major depression. Diagnostic confirmation by mental health care professionals using a clinical interview or by primary care physicians using a semistructured interview can be made with high reliability.	S Texas Vet Hlth Care Syst, Audie Murphy Div, San Antonio, TX USA; Univ Texas, Hlth Sci Ctr, San Antonio Evidence Based Practice Ctr, San Antonio, TX USA; Univ Texas, Hlth Sci Ctr, Dept Psychiat, San Antonio, TX 78284 USA; Univ N Carolina, Dept Med, Chapel Hill, NC USA; RTI UNC Evidence Based Practice Ctr, Chapel Hill, NC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of North Carolina; University of North Carolina Chapel Hill; Research Triangle Institute	Williams, JW (corresponding author), Dept Vet Affairs Med Ctr, Ctr Hlth Serv Res Primary Care, HSR&D, 508 Fulton St,Bldg 6, Durham, NC 27705 USA.	jw.williams@duke.edu	Greiver, Michelle/N-8764-2015; Williams, John W/A-3696-2008; Williams, John/AAM-4572-2020	Greiver, Michelle/0000-0001-8957-0285; Williams, John W/0000-0002-5267-5558; Williams, John/0000-0002-5267-5558; Noel, Polly/0000-0002-1519-7489; Pignone, Michael/0000-0002-6657-7342				American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Arthur A, 1999, INT J GERIATR PSYCH, V14, P431, DOI 10.1002/(SICI)1099-1166(199906)14:6<431::AID-GPS937>3.3.CO;2-9; Ballenger JC, 1999, J CLIN PSYCHIAT, V60, P54; Bottomley A, 1998, Eur J Cancer Care (Engl), V7, P181; Broadhead W E, 1995, Arch Fam Med, V4, P211, DOI 10.1001/archfami.4.3.211; BUCHSBAUM DG, 1991, ANN INTERN MED, V115, P774, DOI 10.7326/0003-4819-115-10-774; BUCHWALD AM, 1993, J ABNORM PSYCHOL, V102, P197, DOI 10.1037/0021-843X.102.2.197; Carney PA, 1999, J FAM PRACTICE, V48, P958; Carney PA, 1999, J FAM PRACTICE, V48, P965; *COCHR CONTR TRIAL, 2000, COCHR LIB; DATH P, 1994, FAM PRACT, V11, P260, DOI 10.1093/fampra/11.3.260; DEYO RA, 1985, ARTHRITIS RHEUM, V28, P1066, DOI 10.1002/art.1780280916; Edelman D, 1997, J GEN INTERN MED, V12, P537, DOI 10.1046/j.1525-1497.1997.07108.x; ENDICOTT J, 1984, CANCER, V53, P2243; FECHNERBATES S, 1994, J CONSULT CLIN PSYCH, V62, P550, DOI 10.1037/0022-006X.62.3.550; Fifield J, 1998, ARTHRITIS RHEUM-US, V41, P1851; FUHRER R, 1986, ACTA PSYCHIAT SCAND, V73, P12, DOI 10.1111/j.1600-0447.1986.tb02658.x; GAVARD JA, 1993, DIABETES CARE, V16, P1167, DOI 10.2337/diacare.16.8.1167; Gerrity MS, 1999, J FAM PRACTICE, V48, P949; GOODWIN FK, 1971, SEMIN PSYCHIAT, V3, P435; GREENES RA, 1985, INVEST RADIOL, V20, P751, DOI 10.1097/00004424-198510000-00018; Gunning R., 1952, TECHNIQUE CLEAR WRIT; HASSELBLAD V, 1995, PSYCHOL BULL, V117, P167, DOI 10.1037/0033-2909.117.1.167; HENDRIE HC, 1995, AM J GERIAT PSYCHIAT, V3, P119, DOI 10.1097/00019442-199500320-00004; Hirschfeld RMA, 1997, NEW ENGL J MED, V337, P910, DOI 10.1056/NEJM199709253371307; Hough R, 1983, COMP PSYCHIAT SCREEN; Hunkeler EM, 2000, ARCH FAM MED, V9, P700, DOI 10.1001/archfami.9.8.700; HYLER SE, 1982, ARCH GEN PSYCHIAT, V39, P1275; IRWIG L, 1995, J CLIN EPIDEMIOL, V48, P119, DOI 10.1016/0895-4356(94)00099-C; Irwin M, 1999, ARCH INTERN MED, V159, P1701, DOI 10.1001/archinte.159.15.1701; KATHOL RG, 1990, AM J PSYCHIAT, V147, P1021; Katon W, 1997, J CLIN PSYCHIAT, V58, P20; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; Katzelnick DJ, 2000, ARCH FAM MED, V9, P345, DOI 10.1001/archfami.9.4.345; KELLER MB, 1995, AM J PSYCHIAT, V152, P843; KIRMAYER LJ, 1993, AM J PSYCHIAT, V150, P734; Klinkman MS, 1997, ARCH FAM MED, V6, P567, DOI 10.1001/archfami.6.6.567; Koenig HG, 1997, AM J PSYCHIAT, V154, P1376; KOENIG HG, 1995, J AM GERIATR SOC, V43, P472, DOI 10.1111/j.1532-5415.1995.tb06091.x; KOENIG HG, 1993, J AM GERIATR SOC, V41, P1169, DOI 10.1111/j.1532-5415.1993.tb07298.x; Kroenke K, 1997, AM J MED, V103, P339, DOI 10.1016/S0002-9343(97)00241-6; Kroenke K, 1994, Arch Fam Med, V3, P774; Leon AC, 1996, J GEN INTERN MED, V11, P426, DOI 10.1007/BF02600191; LEWIS DA, 1983, J AFFECT DISORDERS, V5, P319, DOI 10.1016/0165-0327(83)90022-8; LIEBERMAN PB, 1985, HOSP COMMUNITY PSYCH, V36, P291; Lipkin MJ, 1995, MED INTERVIEW CLIN C; Lyness JM, 1997, ARCH INTERN MED, V157, P449, DOI 10.1001/archinte.157.4.449; MAGRUDERHABIB K, 1990, MED CARE, V28, P239, DOI 10.1097/00005650-199003000-00004; MELLSOP GW, 1991, ACTA PSYCHIAT SCAND, V84, P332, DOI 10.1111/j.1600-0447.1991.tb03155.x; MULROW CD, 1995, ANN INTERN MED, V122, P913, DOI 10.7326/0003-4819-122-12-199506150-00004; MULROW CD, 2001, EVIDENCE BASED HYPER; MULROW CD, 1999, AHCPR PUBL; Murray C. J. L., 1996, GLOBAL BURDEN DIS; NEAL RM, 1994, AGE AGEING, V23, P461, DOI 10.1093/ageing/23.6.461; NETTELBLADT P, 1993, SOC PSYCH PSYCH EPID, V28, P130, DOI 10.1007/BF00801743; NORDEN C, 1970, AM J EPIDEMIOL, V91, P155, DOI 10.1093/oxfordjournals.aje.a121123; OKIMOTO JT, 1982, AM J PSYCHIAT, V139, P799; Parkerson G R Jr, 1997, Fam Med, V29, P177; PEREZSTABLE EJ, 1990, ARCH INTERN MED, V150, P1083, DOI 10.1001/archinte.150.5.1083; PIGNONE MP, IN PRESS ANN INTERN; Pincus HA, 1999, BRIT J PSYCHIAT, V174, P288, DOI 10.1192/bjp.174.4.288; POPE HG, 1988, AM J PSYCHIAT, V145, P487; RAFT D, 1977, DIS NERV SYST, V38, P999; RAPP SR, 1989, AM J PSYCHIAT, V146, P1197; RISKIND JH, 1987, ARCH GEN PSYCHIAT, V44, P817; Rost K, 2000, GEN HOSP PSYCHIAT, V22, P66, DOI 10.1016/S0163-8343(00)00059-1; ROTER DL, 1995, ARCH INTERN MED, V155, P1877, DOI 10.1001/archinte.155.17.1877; SACKETT DL, 1992, JAMA-J AM MED ASSOC, V267, P2638, DOI 10.1001/jama.267.19.2638; SALOKANGAS RKR, 1995, ACTA PSYCHIAT SCAND, V92, P10, DOI 10.1111/j.1600-0447.1995.tb09536.x; SCHLEIFER SJ, 1989, ARCH INTERN MED, V149, P1785, DOI 10.1001/archinte.149.8.1785; Schmitz N, 1999, SOC PSYCH PSYCH EPID, V34, P360, DOI 10.1007/s001270050156; SCHULBERG HC, 1985, ARCH GEN PSYCHIAT, V42, P1164; SEGAL DL, 1994, COMPR PSYCHIAT, V35, P316, DOI 10.1016/0010-440X(94)90025-6; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; SKRE I, 1991, ACTA PSYCHIAT SCAND, V84, P167, DOI 10.1111/j.1600-0447.1991.tb03123.x; SPITZER RL, 1979, AM J PSYCHIAT, V136, P815; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; SPITZER RL, 1991, STRUCTURED CLIN INTE; STANGE KC, 1994, J FAM PRACTICE, V38, P231; Steer RA, 1999, GEN HOSP PSYCHIAT, V21, P106, DOI 10.1016/S0163-8343(98)00070-X; STUKENBERG KW, 1990, PSYCHOL ASSESSMENT, V2, P134, DOI DOI 10.1037/1040-3590.2.2.134; Thompson C, 2000, LANCET, V355, P185, DOI 10.1016/S0140-6736(99)03171-2; *US DEP HHS, 1993, AHCPR PUBL; *US DEP HHS, 1988, INT CLASS DIS 9 REV; VANMARWIJK HWJ, 1995, BRIT J GEN PRACT, V45, P195; WARNER MD, 1995, PSYCHIATR SERV, V46, P1284; WEBB LJ, 1981, AM J PSYCHIAT, V138, P376; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Whooley MA, 2000, NEW ENGL J MED, V343, P1942, DOI 10.1056/NEJM200012283432607; WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630; Williams JW, 1999, AM J MED, V106, P36, DOI 10.1016/S0002-9343(98)00371-4; Worrall G, 1999, CAN MED ASSOC J, V161, P37; ZICH JM, 1990, INT J PSYCHIAT MED, V20, P259, DOI 10.2190/LYKR-7VHP-YJEM-MKM2; ZIMMERMAN M, 1995, J GEN INTERN MED, V10, P573, DOI 10.1007/BF02640368; ZIMMERMAN M, 1994, DIAGNOSING DSM 4 PSY	97	221	225	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2002	287	9					1160	1170		10.1001/jama.287.9.1160	http://dx.doi.org/10.1001/jama.287.9.1160			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	527KV	11879114				2022-12-28	WOS:000174186000032
J	Manabe, T				Manabe, T			Neurobiology - Does BDNF have pre- or postsynaptic targets?	SCIENCE			English	Editorial Material							LONG-TERM POTENTIATION; TRKB RECEPTORS; HIPPOCAMPUS		Kobe Univ, Fac Med, Dept Neurosci, Div Cell Biol & Neurophysiol, Kobe, Hyogo 6500017, Japan; Univ Tokyo, Inst Med Sci, Dept Basic Med Sci, Div Neuronal Network, Tokyo 1088639, Japan	Kobe University; University of Tokyo	Manabe, T (corresponding author), Kobe Univ, Fac Med, Dept Neurosci, Div Cell Biol & Neurophysiol, Kobe, Hyogo 6500017, Japan.							BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Kovalchuk Y, 2002, SCIENCE, V295, P1729, DOI 10.1126/science.1067766; LEHOF AM, 1993, NATURE, V363, P350; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004	9	21	25	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 1	2002	295	5560					1651	+		10.1126/science.1070163	http://dx.doi.org/10.1126/science.1070163			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872822				2022-12-28	WOS:000174212900026
J	Butler, S; Harrowell, P				Butler, S; Harrowell, P			Factors determining crystal-liquid coexistence under shear	NATURE			English	Article							COLLOIDAL CRYSTALS; PHASE-TRANSITIONS; FLOW; SIMULATIONS	The interaction between an imposed shear flow and an order- disorder transition underlies a broad range of phenomena. Under the influence of shear flow, a variety of soft matter(1-4) is observed to spontaneously form bands characterized by different local order-for example, thermotropic liquid crystals subjected to shear flow exhibit rich phase behaviour(5). The stability of order under the influence of shear flow is also fundamental to understanding frictional wear(6) and lubrication(7,8). Although there exists a well developed theoretical approach to the influence of shear flow on continuous transitions in fluid mixtures(9), little is known about the underlying principles governing non-equilibrium coexistence between phases of different symmetry. Here we show, using non-equilibrium molecular dynamics simulations of a system of spherical particles, that a stationary coexistence exists between a strained crystal and the shearing liquid, and that this coexistence cannot be accounted for by invoking a non-equilibrium analogue of the chemical potential. Instead of such thermodynamic arguments(10,11), we argue that a balancing of the crystal growth rate with the rate of surface erosion by the shearing melt can account for the observed coexistence.	Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia	University of Sydney	Harrowell, P (corresponding author), Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia.		Harrowell, Peter/N-6737-2017	Harrowell, Peter/0000-0002-8871-5013				ACKERSON BJ, 1984, PHYS REV A, V30, P906, DOI 10.1103/PhysRevA.30.906; Ajdari A, 1998, PHYS REV E, V58, P6294, DOI 10.1103/PhysRevE.58.6294; ALLEN MP, 1990, COMPUTER SIMULATIONS; Baranyai A, 1999, PHYS REV E, V60, P5522, DOI 10.1103/PhysRevE.60.5522; Berret JF, 1997, PHYS REV E, V55, P1668, DOI 10.1103/PhysRevE.55.1668; Bordarier P, 1998, PHYS REV E, V57, P1621, DOI 10.1103/PhysRevE.57.1621; BUTLER S, 1995, J CHEM PHYS, V103, P4653, DOI 10.1063/1.470653; CHEN LB, 1994, LANGMUIR, V10, P2817, DOI 10.1021/la00020a052; Eiser E, 2000, PHYS REV E, V61, P6759, DOI 10.1103/PhysRevE.61.6759; Fischer E, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011501; Goveas JL, 1999, EUROPHYS LETT, V48, P706, DOI 10.1209/epl/i1999-00542-5; Olmsted PD, 1999, PHYS REV E, V60, P4397, DOI 10.1103/PhysRevE.60.4397; Onuki A, 1997, J PHYS-CONDENS MAT, V9, P6119, DOI 10.1088/0953-8984/9/29/001; RAMASWAMY S, 1986, PHYS REV LETT, V56, P945, DOI 10.1103/PhysRevLett.56.945; SASADA T, 1981, WEAR, V74, P263, DOI 10.1016/0043-1648(81)90167-8; STEVENS MJ, 1993, PHYS REV E, V48, P3778, DOI 10.1103/PhysRevE.48.3778; Stevens MJ, 1997, J CHEM PHYS, V106, P7303, DOI 10.1063/1.473692; THOMPSON PA, 1990, SCIENCE, V250, P792, DOI 10.1126/science.250.4982.792; Tsuji T, 2000, PHYS REV E, V62, P8141, DOI 10.1103/PhysRevE.62.8141	19	51	51	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2002	415	6875					1008	1011		10.1038/4151008a	http://dx.doi.org/10.1038/4151008a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875564				2022-12-28	WOS:000174075000040
J	Slom, TJ; Cortese, MM; Gerber, SI; Jones, RC; Holtz, TH; Lopez, AS; Zambrano, CH; Sufit, RL; Sakolvaree, Y; Chaicumpa, W; Herwaldt, BL; Johnson, S				Slom, TJ; Cortese, MM; Gerber, SI; Jones, RC; Holtz, TH; Lopez, AS; Zambrano, CH; Sufit, RL; Sakolvaree, Y; Chaicumpa, W; Herwaldt, BL; Johnson, S			An outbreak of eosinophilic meningitis caused by Angiostrongylus cantonensis in travelers returning from the Caribbean.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							1ST RECORD; MENINGOENCEPHALITIS; CUBA; JAMAICA; SNAILS	Background: Outbreaks of eosinophilic meningitis caused by the roundworm Angiostrongylus cantonensis are rarely reported, even in regions of endemic infection such as Southeast Asia and the Pacific Basin. We report an outbreak of A. cantonensis meningitis among travelers returning from the Caribbean. Methods: We conducted a retrospective cohort study among 23 young adults who had traveled to Jamaica. We used a clinical definition of eosinophilic meningitis that included headache that began within 35 days after the trip plus at least one of the following: neck pain, nuchal rigidity, altered cutaneous sensations, photophobia, or visual disturbances. Results: Twelve travelers met the case definition for eosinophilic meningitis. The symptoms began a median of 11 days (range, 6 to 31) after their return to the United States. Eosinophilia was eventually documented in all nine patients who were hospitalized, although on initial evaluation, it was present in the peripheral blood of only four of the nine (44 percent) and in the cerebrospinal fluid of five (56 percent). Repeated lumbar punctures and corticosteroid therapy led to improvement in symptoms in two of three patients with severe headache, and intracranial pressure decreased during corticosteroid therapy in all three. Consumption of one meal (P=0.001) and of a Caesar salad at that meal (P=0.007) were strongly associated with eosinophilic meningitis. Antibodies against an A. cantonensis-specific 31-kD antigen were detected in convalescent-phase serum samples from 11 patients. Conclusions: Among travelers at risk, the presence of headache, elevated intracranial pressure, and pleocytosis, with or without eosinophilia, particularly in association with paresthesias or hyperesthesias, should alert clinicians to the possibility of A. cantonensis infection. (N Engl J Med 2002;346:668-75.) Copyright (C) 2002 Massachusetts Medical Society.	VA Chicago HCS, Med Serv, Lakeside Div, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Dept Infect Dis, Chicago, IL USA; Northwestern Univ, Sch Med, Dept Neurol, Chicago, IL 60611 USA; Ctr Dis Control & Prevent, Epidem Inteligence Serv, Epidemiol Program Off, Atlanta, GA USA; Ctr Dis Control & Prevent, Div Parasit Dis, Atlanta, GA USA; Chicago Dept Publ Hlth, Chicago, IL USA; Atlanta Res & Educ Fdn, Atlanta, GA USA; Mahidol Univ, Fac Trop Med, Bangkok, Thailand	Northwestern University; Northwestern University; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Chicago Department of Public Health; Mahidol University	Johnson, S (corresponding author), VA Chicago HCS, Med Serv, Lakeside Div, 333 E Huron, Chicago, IL 60611 USA.	stu-johnson@northwestern.edu		Johnson, Stuart/0000-0001-9548-229X				AGUIAR PH, 1981, AM J TROP MED HYG, V30, P963, DOI 10.4269/ajtmh.1981.30.963; ANDERSEN E, 1986, AM J TROP MED HYG, V35, P319, DOI 10.4269/ajtmh.1986.35.319; ASH L R, 1976, Revista de Biologia Tropical, V24, P163; Barrow KO, 1996, W INDIAN MED J, V45, P70; BOWDEN DK, 1981, AM J TROP MED HYG, V30, P1141, DOI 10.4269/ajtmh.1981.30.1141; Brown FM, 1996, LANCET, V348, P964, DOI 10.1016/S0140-6736(05)65382-2; CAMPBELL BG, 1988, AM J TROP MED HYG, V38, P568, DOI 10.4269/ajtmh.1988.38.568; Chotmongkol V, 2000, CLIN INFECT DIS, V31, P660, DOI 10.1086/314036; EAMSOBHANA P, 1996, MOL BIOL IMMUNOLOGY, P159; GARDINER CH, 1990, AM J TROP MED HYG, V42, P70, DOI 10.4269/ajtmh.1990.42.70; HEATON DC, 1980, AUST NZ J MED, V10, P255, DOI 10.1111/j.1445-5994.1980.tb03725.x; Hwang K P, 1991, Southeast Asian J Trop Med Public Health, V22 Suppl, P194; KLIKS MM, 1992, SOC SCI MED, V34, P199, DOI 10.1016/0277-9536(92)90097-A; KLIKS MM, 1982, AM J TROP MED HYG, V31, P1114, DOI 10.4269/ajtmh.1982.31.1114; KO RC, 1984, T ROY SOC TROP MED H, V78, P354, DOI 10.1016/0035-9203(84)90119-6; LINDO JF, IN PRESS EMERG INFEC; Martinez-Delgado JF, 2000, REV NEUROLOGIA, V31, P417, DOI 10.33588/rn.3105.2000146; NEW D, 1995, NEW ENGL J MED, V332, P1105, DOI 10.1056/NEJM199504203321619; NOSKIN GA, 1992, NEUROLOGY, V42, P1423, DOI 10.1212/WNL.42.7.1423; NOZAIS JP, 1980, B SOC PATHOL EXOT, V73, P179; Nuamtanong Supaporn, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P291; Ogawa K, 1998, Rinsho Shinkeigaku, V38, P22; Pascual Gispert J E, 1981, Rev Cubana Med Trop, V33, P92; PASCUAL JE, 1981, AM J TROP MED HYG, V30, P960, DOI 10.4269/ajtmh.1981.30.960; PETITHORY J, 1977, B SOC PATHOL EXOT, V70, P151; PROCIV P, 1987, MED J AUSTRALIA, V147, P294; Prociv P, 2000, INT J PARASITOL, V30, P1295, DOI 10.1016/S0020-7519(00)00133-8; PUNYAGUPTA S, 1975, AM J TROP MED HYG, V24, P921, DOI 10.4269/ajtmh.1975.24.921; RACHFORD FW, 1975, J PARASITOL, V61, P1117, DOI 10.2307/3279394; RENAPURKAR DM, 1982, J HELMINTHOL, V56, P345, DOI 10.1017/S0022149X00034751; ROSEN L, 1967, AM J EPIDEMIOL, V85, P17, DOI 10.1093/oxfordjournals.aje.a120673; Steffen R, 1999, JAMA-J AM MED ASSOC, V281, P811, DOI 10.1001/jama.281.9.811; Tsai HC, 2001, AM J MED, V111, P109, DOI 10.1016/S0002-9343(01)00766-5; UCHIKAWA R, 1984, J HELMINTHOL, V58, P231, DOI 10.1017/S0022149X00027024; VARGAS M, 1992, TROP MED PARASITOL, V43, P253; WALLACE GD, 1967, AM J EPIDEMIOL, V85, P395, DOI 10.1093/oxfordjournals.aje.a120701; Wilson Marianna, 1995, P1159; YII CY, 1975, AM J TROP MED HYG, V24, P447, DOI 10.4269/ajtmh.1975.24.447	38	184	200	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2002	346	9					668	675		10.1056/NEJMoa012462	http://dx.doi.org/10.1056/NEJMoa012462			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525HJ	11870244				2022-12-28	WOS:000174062800005
J	Ahmad, K				Ahmad, K			Pakistan's province limits private practice in public hospitals	LANCET			English	News Item													Ahmad, Khabir/G-3903-2012; Ahmad, Khabir/I-6882-2019	Ahmad, Khabir/0000-0002-1569-0628; Ahmad, Khabir/0000-0002-1569-0628					0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 23	2002	359	9307					685	685		10.1016/S0140-6736(02)07842-X	http://dx.doi.org/10.1016/S0140-6736(02)07842-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526AZ	11879880				2022-12-28	WOS:000174107400027
J	Hughes, RAC				Hughes, RAC			Regular review - Peripheral neuropathy	BRITISH MEDICAL JOURNAL			English	Review									Guys Kings & St Thomas Sch Med, Dept Neuroimmunol, London SE1 1UL, England	University of London; King's College London	Hughes, RAC (corresponding author), Guys Kings & St Thomas Sch Med, Dept Neuroimmunol, Guys Campus, London SE1 1UL, England.							Boulton AJM, 1998, DIABETIC MED, V15, P508, DOI 10.1002/(SICI)1096-9136(199806)15:6<508::AID-DIA613>3.0.CO;2-L; Davies L, 1996, BRAIN, V119, P1441, DOI 10.1093/brain/119.5.1441; DYCK PJ, 1987, BRAIN, V110, P843, DOI 10.1093/brain/110.4.843; Dyck PJB, 1999, NEUROLOGY, V53, P2113, DOI 10.1212/WNL.53.9.2113; Gabriel CM, 2000, J NEUROL NEUROSUR PS, V69, P442, DOI 10.1136/jnnp.69.4.442; HUGHES RAC, 2001, COCHRANE DATABASE SY, DOI UNSP CD20014; Martyn C, 1997, J NEUROL NEUROSUR PS, V62, P310, DOI 10.1136/jnnp.62.4.310; Nobile-Orazio E, 2001, J NEUROIMMUNOL, V115, P4, DOI 10.1016/S0165-5728(01)00266-1; NOTERMANS NC, 1994, J NEUROL NEUROSUR PS, V57, P1525, DOI 10.1136/jnnp.57.12.1525; Reilly MM, 2000, CURR OPIN NEUROL, V13, P561, DOI 10.1097/00019052-200010000-00009; Rosenberg NR, 2001, J NEUROL NEUROSUR PS, V71, P205, DOI 10.1136/jnnp.71.2.205; Russell JW, 2001, MUSCLE NERVE, V24, P1109, DOI 10.1002/mus.1122; Saperstein DS, 2001, MUSCLE NERVE, V24, P311, DOI 10.1002/1097-4598(200103)24:3<311::AID-MUS1001>3.3.CO;2-1; Schenone A, 1999, CURR OPIN NEUROL, V12, P603, DOI 10.1097/00019052-199910000-00015; Sindrup SH, 1999, PAIN, V83, P389, DOI 10.1016/S0304-3959(99)00154-2; VANKONINGSVELD R, 2000, J PERIPHER NERV SYST, V6, P186; Yan WX, 2001, ANN NEUROL, V50, P286, DOI 10.1002/ana.1129	17	149	162	1	14	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 23	2002	324	7335					466	469		10.1136/bmj.324.7335.466	http://dx.doi.org/10.1136/bmj.324.7335.466			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526NJ	11859051	Green Published			2022-12-28	WOS:000174136300021
J	Sharma, A; Scott, JH; Cody, GD; Fogel, ML; Hazen, RM; Hemley, RJ; Huntress, WT				Sharma, A; Scott, JH; Cody, GD; Fogel, ML; Hazen, RM; Hemley, RJ; Huntress, WT			Microbial activity at gigapascal pressures	SCIENCE			English	Article							DIAMOND-ANVIL CELL; ESCHERICHIA-COLI; LAKE VOSTOK; ICE; LIFE; METABOLISM; GROWTH	We observed physiological and metabolic activity of Shewanella oneidensis strain MR1 and Escherichia coli strain MG1655 at pressures of 68 to 1680 megapascals (MPa) in diamond anvil cells. We measured biological formate oxidation at high pressures(68 to 1060 MPa). At pressures of 1200 to 1600 MPa, living bacteria resided in fluid inclusions in ice-VI crystals and continued to be viable upon subsequent release to ambient pressures (0.1 MPa). Evidence of microbial viability and activity at these extreme pressures expands by an order of magnitude the range of conditions representing the habitable zone in the solar system.	Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA	Carnegie Institution for Science	Sharma, A (corresponding author), Carnegie Inst Sci, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA.	sharma@gl.ciw.edu; j.scott@gl.ciw.edu	Fogel, Marilyn L/M-2395-2015	Fogel, Marilyn L/0000-0002-1176-3818				Abe F, 1999, TRENDS MICROBIOL, V7, P447, DOI 10.1016/S0966-842X(99)01608-X; Abe F, 2001, TRENDS BIOTECHNOL, V19, P102, DOI 10.1016/S0167-7799(00)01539-0; BARTLETT DH, 1992, SCI PROG, V76, P479; BASSETT WA, 1993, REV SCI INSTRUM, V64, P2340, DOI 10.1063/1.1143931; BROCK TD, 1967, SCIENCE, V158, P1012, DOI 10.1126/science.158.3804.1012; CARPENTER JF, 1992, P NATL ACAD SCI USA, V89, P8953, DOI 10.1073/pnas.89.19.8953; Carr MH, 1998, NATURE, V391, P363, DOI 10.1038/34857; Chyba CF, 2001, P NATL ACAD SCI USA, V98, P801, DOI 10.1073/pnas.98.3.801; DEMING JW, 1993, GEOCHIM COSMOCHIM AC, V57, P3219, DOI 10.1016/0016-7037(93)90535-5; ENOCH HG, 1975, J BIOL CHEM, V250, P6693; FERRY JG, 1990, FEMS MICROBIOL LETT, V87, P377, DOI 10.1111/j.1574-6968.1990.tb04940.x; Haselton HT, 1995, AM MINERAL, V80, P1302; Hauben KJA, 1997, APPL ENVIRON MICROB, V63, P945, DOI 10.1128/AEM.63.3.945-950.1997; JONES KM, 1969, DATA BIOCH RES, P436; Karl DM, 1999, SCIENCE, V286, P2144, DOI 10.1126/science.286.5447.2144; LIBEREK K, 1992, P NATL ACAD SCI USA, V89, P3516, DOI 10.1073/pnas.89.8.3516; Price PB, 2000, P NATL ACAD SCI USA, V97, P1247, DOI 10.1073/pnas.97.3.1247; Priscu JC, 1998, SCIENCE, V280, P2095, DOI 10.1126/science.280.5372.2095; Priscu JC, 1999, SCIENCE, V286, P2141, DOI 10.1126/science.286.5447.2141; Royer CA, 2000, HIGH PRESSURE RES, V19, P603; SCOTT JH, 1994, J BACTERIOL, V176, P3408, DOI 10.1128/jb.176.11.3408-3411.1994; WELCH TJ, 1993, J BACTERIOL, V175, P7170, DOI 10.1128/JB.175.22.7170-7177.1993; Wirsen CO, 1999, APPL ENVIRON MICROB, V65, P5314; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Yano Y, 1998, APPL ENVIRON MICROB, V64, P479; Yayanos AA, 1998, WILEY S ECO, P47; ZOBELL CE, 1964, J BACTERIOL, V87, P710, DOI 10.1128/JB.87.3.710-719.1964; ZOBELL CE, 1952, SCIENCE, V115, P507, DOI 10.1126/science.115.2993.507; ZOBELL CE, 1962, J BACTERIOL, V84, P1228, DOI 10.1128/JB.84.6.1228-1236.1962; ZOBELL CE, 1964, K SUGAWARA RESTIVAL, P83	30	156	170	0	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2002	295	5559					1514	1516		10.1126/science.1068018	http://dx.doi.org/10.1126/science.1068018			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11859192				2022-12-28	WOS:000173981300050
J	Fazel, S; Danesh, J				Fazel, S; Danesh, J			Serious mental disorder in 23 000 prisoners: a systematic review of 62 surveys	LANCET			English	Review							ANTISOCIAL PERSONALITY-DISORDER; PSYCHIATRIC MORBIDITY; INCARCERATED WOMEN; REMAND PRISONERS; FEMALE OFFENDER; SUBSTANCE-ABUSE; PREVALENCE; INMATES; PSYCHOPATHY; ILLNESS	Background About 9 million people are imprisoned worldwide, but the number with serious mental disorders (psychosis, major depression, and antisocial personality disorder) is unknown. We did a systematic review of surveys on such disorders in general prison populations in western countries. Methods We searched for psychiatric surveys that were based on interviews of unselected prison populations and included diagnoses of psychotic illnesses or major depression within the previous 6 months, or a history of any personality disorder. We did computer-assisted searches, scanned reference lists, searched journals, and corresponded with authors. We determined prevalence rates of serious mental disorders, sex, type of prisoner (detainee or sentenced inmate), and other characteristics. Findings 62 surveys from 12 countries included 22 790 prisoners (mean age 29 years, 18 530 [81%] men, 2568 [26%] of 9776 were violent offenders). 3.7% of men (95% CI 3.3-4.1) had psychotic illnesses, 10% (9-11) major depression, and 65% (61-68) a personality disorder, including 47% (46-48) with antisocial personality disorder. 4.0% of women (3.2-5.1) had psychotic illnesses, 12% (11-14) major depression, and 42% (38-45) a personality disorder, including 21% (19-23) with antisocial personality disorder. Although there was substantial heterogeneity among studies (especially for antisocial personality disorder), only a small proportion was explained by differences in prevalence rates between detainees and sentenced inmates. Prisoners were several times more likely to have psychosis and major depression, and about ten times more likely to have antisocial personality disorder, than the general population. Interpretation Worldwide, several million prisoners probably have serious mental disorders, but how well prison services are addressing these problems is not known.	Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England; Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 2SR, England	University of Oxford; University of Cambridge	Fazel, S (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England.		Fazel, Seena/B-5307-2008	Fazel, Seena/0000-0002-5383-5365				Agbahowe SA, 1998, E AFR MED J, V75, P19; Altman D.G., 2000, STAT CONFIDENCE, Vsecond; Andersen HS, 1996, INT J LAW PSYCHIAT, V19, P61, DOI 10.1016/0160-2527(95)00025-9; Arboleda-Florez J, 1999, CURR OPIN PSYCHIATR, V12, P677, DOI 10.1097/00001504-199911000-00016; ARBOLEDAFLOREZ J, 1995, INT MED J, V2, P113; Badger D., 1999, SYSTEMATIC REV INT L; Bartholomew A A, 1967, Med J Aust, V1, P267; Birmingham L, 1996, BRIT MED J, V313, P1521, DOI 10.1136/bmj.313.7071.1521; BLAND RC, 1990, CAN J PSYCHIAT, V35, P407, DOI 10.1177/070674379003500508; BLUGLASS R, 1966, THESIS U ST ANDREWS; Brinded P. M., 1999, CRIM BEHAV MENT HEAL, V9, P144; Brinded PMJ, 1999, CRIM BEHAV MENT HEAL, V9, P131, DOI DOI 10.1002/CBM.301; Brooke D, 1996, BRIT MED J, V313, P1524, DOI 10.1136/bmj.313.7071.1524; BULTEN B, 1998, GEVANGEN TUSSEN ZORG; CHILES JA, 1990, HOSP COMMUNITY PSYCH, V41, P1132; Collins J J, 1988, Bull Am Acad Psychiatry Law, V16, P187; Cooke D. J., 1994, PSYCHOL DISTURBANCE; Danesh J, 1998, BRIT MED J, V316, P746, DOI 10.1136/bmj.316.7133.746; Daniel A E, 1988, Bull Am Acad Psychiatry Law, V16, P333; Darke S, 1998, DRUG ALCOHOL DEPEN, V52, P63, DOI 10.1016/S0376-8716(98)00058-1; DAVIDSON M, 1995, BRIT J PSYCHIAT, V167, P545, DOI 10.1192/bjp.167.4.545; Denton B, 1995, PSYCHIAT PSYCHOL LAW, V2, P173, DOI DOI 10.1111/J.1360-0443.2006.01316; DiCataldo F, 1995, B AM ACAD PSYCH LAW, V23, P573; DOOLEY E, 1990, BRIT J PSYCHIAT, V156, P40, DOI 10.1192/bjp.156.1.40; Eyestone L L, 1994, Bull Am Acad Psychiatry Law, V22, P181; FABREGAT AA, 1994, PSIQUIS, V15, P41; FAULK M, 1976, MED SCI LAW, V16, P244, DOI 10.1177/002580247601600407; Fido A A, 1993, Ann Clin Psychiatry, V5, P107, DOI 10.3109/10401239309148971; Ghubash R, 1997, J FORENSIC PSYCHIATR, V8, P440, DOI 10.1080/09585189708412023; Gibson LE, 1999, J TRAUMA STRESS, V12, P473, DOI 10.1023/A:1024767020280; GINGELL R, 1991, THESIS S FRASER U BU; GUNN J, 1991, BRIT MED J, V303, P338, DOI 10.1136/bmj.303.6798.338; GUNN J, 1978, PSYCHIAT ASPECTS IMP, P209; GUY E, 1985, CRIM JUSTICE BEHAV, V12, P29, DOI 10.1177/0093854885012001004; Haapasalo J, 2000, PSYKOLOGIA, V35, P45; HARDING TW, 1989, LANCET, V1, P1191; Harper D, 1979, ABSTR CRIM SOCIOL, V19, P237; HERRMAN H, 1991, AM J PSYCHIAT, V148, P236; HURLEY W, 1991, AUST NZ J PSYCHIAT, V25, P461, DOI 10.3109/00048679109064439; Hurwitz S., 1983, CRIMINOLOGY; Hyde P, 1987, PREVALENCE MENTAL IL; JAMES JF, 1980, HOSP COMMUNITY PSYCH, V31, P674; Jenkins R, 1997, PSYCHOL MED, V27, P775, DOI 10.1017/S0033291797005308; Jordan BK, 1996, ARCH GEN PSYCHIAT, V53, P513; JOUKAMAA M, 1995, FORENSIC SCI INT, V73, P85, DOI 10.1016/0379-0738(95)01713-S; JOUKAMAA M, 1998, NORD J PSYCHIAT S, V41, pS78; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; KREFFT KM, 1983, INT J LAW PSYCHIAT, V6, P113, DOI 10.1016/0160-2527(83)90010-9; Lamb HR, 1998, PSYCHIATR SERV, V49, P483, DOI 10.1176/ps.49.4.483; Levander S, 1997, Lakartidningen, V94, P46; Maden A, 1996, MENTAL DISORDER REMA; MADEN T, 1994, BRIT J PSYCHIAT, V164, P44, DOI 10.1192/bjp.164.1.44; Mohan D, 1997, CRIM BEHAV MENT HEAL, V7, P229, DOI DOI 10.1002/cbm.175; Moran P., 1999, ANTISOCIAL PERSONALI; Morentin B, 1998, J FORENSIC SCI, V43, P993; Motiuk L, 1992, PREVALENCE NATURE SE; Neighbors H, 1987, PREVALENCE MENTAL DI; Powell TA, 1997, LAW HUMAN BEHAV, V21, P427, DOI 10.1023/A:1024811303834; Poythress NG, 1998, J AM ACAD PSYCHIATRY, V26, P215; Rasmussen K, 1999, INT J LAW PSYCHIAT, V22, P91, DOI 10.1016/S0160-2527(98)00031-4; RASMUSSEN K, 1998, NORD PSYKIATR S, V41, P79; ROBERTSON G, 1990, MED SCI LAW, V30, P165, DOI 10.1177/002580249003000216; ROBERTSON RG, 1987, CAN J PSYCHIAT, V32, P749, DOI 10.1177/070674378703200902; Robins R, 1991, PSYCHIAT DISORDERS A; Roesch R, 1995, PSYCHOLOGY, LAW, AND CRIMINAL JUSTICE, P520; Salekin RT, 1997, J ABNORM PSYCHOL, V106, P576, DOI 10.1037/0021-843X.106.4.576; SCHOEMAKER C, 1997, PSYCHISCHE STOORNISS; SCHUCKIT MA, 1977, J NERV MENT DIS, V165, P118, DOI 10.1097/00005053-197708000-00005; Simpson AIF, 1999, NATL STUDY PSYCHIAT; Singleton N., 1998, PSYCHIAT MORBIDITY P; Smith C., 1996, CRIM BEHAV MENT HEAL, V6, P177, DOI DOI 10.1002/cbm.85; SWANK GE, 1976, AM J PSYCHIAT, V133, P1331; Teplin LA, 1996, ARCH GEN PSYCHIAT, V53, P505; TEPLIN LA, 1994, AM J PUBLIC HEALTH, V84, P290, DOI 10.2105/AJPH.84.2.290; Torrey EF, 1995, AM J PUBLIC HEALTH, V85, P1611, DOI 10.2105/AJPH.85.12.1611; van Panhuis P, 1997, PSYCHOTISCHE PATIENT; Vine R, 1994, PSYCHIAT PSYCHOL LAW, V1, P53, DOI [10.1080/13218719409524828, DOI 10.1080/13218719409524828]; Walmsley R, 2000, WORLD PRISON POPULAT; WALTERS GD, 1993, BEHAV SCI LAW, V11, P111, DOI 10.1002/bsl.2370110109; Washington P, 1985, RES COMMUNITY MENTAL, V5, P33; Watt F, 1993, J FORENSIC PSYCHI PS, V4, P75; Widiger TA, 1996, J ABNORM PSYCHOL, V105, P3, DOI 10.1037/0021-843X.105.1.3; Wilkins J., 1991, CRIMINAL BEHAVIOUR M, V1, P247, DOI DOI 10.1002/cbm.1991.1.issue-3; [No title captured]	84	1269	1324	4	196	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2002	359	9306					545	550		10.1016/S0140-6736(02)07740-1	http://dx.doi.org/10.1016/S0140-6736(02)07740-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	523FP	11867106				2022-12-28	WOS:000173943600005
J	Schulz, KF; Grimes, DA				Schulz, KF; Grimes, DA			Allocation concealment in randomised trials: defending against deciphering	LANCET			English	Article							DOUBLE-BLIND; CONSORT STATEMENT; QUALITY; BIAS; EFFICACY	Proper randomisation rests on adequate allocation concealment. An allocation concealment process keeps clinicians and participants unaware of upcoming assignments. Without it, even properly developed random allocation sequences can be subverted. Within this concealment process, the crucial unbiased nature of randomised controlled trials collides with their most vexing implementation problems. Proper allocation concealment frequently frustrates clinical inclinations, which annoys those who do the trials. Randomised controlled trials are anathema to clinicians. Many involved with trials will be tempted to decipher assignments, which subverts randomisation. For some implementing a trial, deciphering the allocation scheme might frequently become too great an intellectual challenge to resist. Whether their motives indicate innocent or pernicious intents, such tampering undermines the validity of a trial. Indeed, inadequate allocation concealment leads to exaggerated estimates of treatment effect, on average, but with scope for bias in either direction. Trial investigators will be crafty in any potential efforts to decipher the allocation sequence, so trial designers must be just as clever in their design efforts to prevent deciphering, Investigators must effectively immunise trials against selection and confounding biases with proper allocation concealment. Furthermore, investigators should report baseline comparisons on important prognostic variables. Hypothesis tests of baseline characteristics, however, are superfluous and could be harmful if they lead investigators to suppress reporting any baseline imbalances.	Family Hlth Int, Res Triangle Pk, NC 27709 USA		Schulz, KF (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.	KSchulz@fhi.org						Adetugbo K, 2000, ARCH DERMATOL, V136, P381, DOI 10.1001/archderm.136.3.381; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; ALTMAN DG, 1990, LANCET, V335, P149, DOI 10.1016/0140-6736(90)90014-V; ALTMAN DG, 1985, STATISTICIAN, V34, P125; Bellomo R, 2000, LANCET, V356, P2139; Brightling CE, 2000, LANCET, V356, P1480, DOI 10.1016/S0140-6736(00)02872-5; BULPITT CJ, 1983, RANDOMISED CONTROLLE; Chalmers I, 2001, INT J EPIDEMIOL, V30, P1156, DOI 10.1093/ije/30.5.1156; CHALMERS TC, 1987, STAT MED, V6, P315, DOI 10.1002/sim.4780060320; Dorman K, 2000, OBSTET GYNECOL, V96, P636, DOI 10.1016/S0029-7844(00)00978-9; Fisher R. A., 1966, DESIGN EXPT; GOTZSCHE PC, 1989, CONTROL CLIN TRIALS, V10, P31, DOI 10.1016/0197-2456(89)90017-2; HAAG U, 1998, DRUG INF J, V118, P7; James WPT, 2000, LANCET, V356, P2119, DOI 10.1016/S0140-6736(00)03491-7; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; KJAERGARD L, WORKSH SCI SESS 7 IN; LACHIN JM, 1988, CONTROL CLIN TRIALS, V9, P289, DOI 10.1016/0197-2456(88)90045-1; LAVORI PW, 1983, NEW ENGL J MED, V309, P1291, DOI 10.1056/NEJM198311243092105; McKeith I, 2000, LANCET, V356, P2031, DOI 10.1016/S0140-6736(00)03399-7; Meinert CL., 1986, CLIN TRIALS DESIGN C; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; POCOCK SJ, 1982, STATISTICIAN, V31, P1; SCHULZ KF, 1994, JAMA-J AM MED ASSOC, V272, P125, DOI 10.1001/jama.272.2.125; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V274, P1456; Schulz KF, 2002, ANN INTERN MED, V136, P254, DOI 10.7326/0003-4819-136-3-200202050-00022; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Schulz KF, 1996, LANCET, V348, P596, DOI 10.1016/S0140-6736(96)01201-9; SCHULZ KF, 1995, CAN MED ASSOC J, V153, P783; Schulz KF, 2002, LANCET, V359, P515, DOI 10.1016/S0140-6736(02)07683-3; Senn S., 2021, THE BLIND DAT; Smilde TJ, 2001, LANCET, V357, P577, DOI 10.1016/S0140-6736(00)04053-8; Torgerson DJ, 1999, BRIT MED J, V319, P375, DOI 10.1136/bmj.319.7206.375; 2001, LANCET, V357, P89	35	598	608	0	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2002	359	9306					614	618		10.1016/S0140-6736(02)07750-4	http://dx.doi.org/10.1016/S0140-6736(02)07750-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523FP	11867132				2022-12-28	WOS:000173943600030
J	Griffin, JD				Griffin, JD			Resistance to targeted therapy in leukaemia	LANCET			English	Editorial Material							ABL TYROSINE KINASE; INHIBITOR		Dana Farber Canc Inst, Leukemia Program, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute	Griffin, JD (corresponding author), Dana Farber Canc Inst, Leukemia Program, Boston, MA 02115 USA.	james_griffin@dfci.harvard.edu						Degos L, 2001, ONCOGENE, V20, P7140, DOI 10.1038/sj.onc.1204763; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Merx K, 2001, BLOOD, V98, p846A; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Weisberg E, 2001, DRUG RESIST UPDATE, V4, P22, DOI 10.1054/drup.2001.0180	7	15	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2002	359	9305					458	459		10.1016/S0140-6736(02)07671-7	http://dx.doi.org/10.1016/S0140-6736(02)07671-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520ML	11853786				2022-12-28	WOS:000173785600004
J	Jordt, SE; Julius, D				Jordt, SE; Julius, D			Molecular basis for species-specific sensitivity to "hot" chili peppers	CELL			English	Article							ACTIVATED ION-CHANNEL; CHICK SENSORY NEURONS; CAPSAICIN-RECEPTOR; POTASSIUM CHANNEL; K+ CHANNEL; BINDING; HEAT; SITE; THRESHOLD; FAMILY	Chili peppers produce the pungent vanilloid compound capsaicin, which offers protection from predatory mammals. Birds are indifferent to the pain-producing effects of capsaicin and therefore serve as vectors for seed dispersal. Here, we determine the molecular basis for this species-specific behavioral response by identifying a domain of the rat vanilloid receptor that confers sensitivity to capsaicin to the normally insensitive chicken ortholog. Like its mammalian counterpart, the chicken receptor is activated by heat or protons, consistent with the fact that both mammals and birds detect noxious heat and experience thermal hypersensitivity. Our findings provide a molecular basis for the ecological phenomenon of directed deterrence and suggest that the capacity to detect capsaicin-like inflammatory substances is a recent acquisition of mammalian vanilloid receptors.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Julius, D (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.		Jordt, Sven-Eric/ABE-6517-2020	Jordt, Sven-Eric/0000-0001-6171-5622				Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Clapham DE, 1999, CELL, V97, P547, DOI 10.1016/S0092-8674(00)80765-5; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; Gauldie SD, 2001, BRIT J PHARMACOL, V132, P617, DOI 10.1038/sj.bjp.0703890; GENTLE MJ, 1993, COMP BIOCHEM PHYS C, V105, P459, DOI 10.1016/0742-8413(93)90086-Z; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; HAWKINS NS, 1991, COMP BIOCHEM PHYS C, V99, P513, DOI 10.1016/0742-8413(91)90279-3; Hofmann T, 2000, J MOL MED, V78, P14, DOI 10.1007/s001090050378; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hong KH, 2000, J GEN PHYSIOL, V115, P51, DOI 10.1085/jgp.115.1.51; Horn R, 2000, NEURON, V25, P511, DOI 10.1016/S0896-6273(00)81055-7; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; JAVITCH JA, 1995, NEURON, V14, P825, DOI 10.1016/0896-6273(95)90226-0; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Jung J, 1999, J NEUROSCI, V19, P529; Kare M, 1961, Patent, Patent No. [2967128, US2967128]; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P2560, DOI 10.1152/jn.1997.78.5.2560; LEETENG E, 1966, P NATL ACAD SCI USA, V56, P926, DOI 10.1073/pnas.56.3.926; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Marin-Burgin A, 2000, EUR J NEUROSCI, V12, P3560, DOI 10.1046/j.1460-9568.2000.00275.x; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; MOORE KR, 1994, BIOTECHNIQUES, V17, P130; Nagy I, 2000, REGUL PEPTIDES, V96, P3, DOI 10.1016/S0167-0115(00)00193-2; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; PEROZO E, 1994, BIOPHYS J, V66, P345, DOI 10.1016/S0006-3495(94)80783-0; Piomelli D, 2001, TRENDS PHARMACOL SCI, V22, P17, DOI 10.1016/S0165-6147(00)01602-3; Richard S, 2000, PHYSIOL BEHAV, V70, P521, DOI 10.1016/S0031-9384(00)00298-5; Scott K, 1998, CURR OPIN NEUROBIOL, V8, P383, DOI 10.1016/S0959-4388(98)80065-2; Sprague J, 2001, EUR J PHARMACOL, V423, P121, DOI 10.1016/S0014-2999(01)01123-2; Spyridaki A, 2000, BBA-BIOENERGETICS, V1459, P69, DOI 10.1016/S0005-2728(00)00114-6; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Szallasi A, 1999, MOL PHARMACOL, V56, P581, DOI 10.1124/mol.56.3.581; Szallasi A, 1999, PHARMACOL REV, V51, P159; Tewksbury JJ, 1999, CONSERV BIOL, V13, P98, DOI 10.1046/j.1523-1739.1999.97399.x; Tewksbury JJ, 2001, NATURE, V412, P403, DOI 10.1038/35086653; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tominaga M, 2001, P NATL ACAD SCI USA, V98, P6951, DOI 10.1073/pnas.111025298; Vannier B, 1998, J BIOL CHEM, V273, P8675, DOI 10.1074/jbc.273.15.8675; WOOD JN, 1988, J NEUROSCI, V8, P3208; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	53	676	707	4	89	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 8	2002	108	3					421	430		10.1016/S0092-8674(02)00637-2	http://dx.doi.org/10.1016/S0092-8674(02)00637-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	520VB	11853675	Bronze			2022-12-28	WOS:000173801600013
J	O'Cathain, A; Walters, SJ; Nicholl, JP; Thomas, KJ; Kirkham, M				O'Cathain, A; Walters, SJ; Nicholl, JP; Thomas, KJ; Kirkham, M			Use of evidence based leaflets to promote informed choice in maternity care: randomised controlled trial in everyday practice	BRITISH MEDICAL JOURNAL			English	Article								Objective To assess the effect of leaflets on promoting informed choice in women using maternity services. Design Cluster trial, with maternity units randomised to use leaflets (intervention units) or offer usual care (control units). Data collected through postal questionnaires. Setting 13 maternity units in Wales. Participants Four separate samples of women using maternity services. Antenatal samples: women reaching 28 weeks' gestation before (n=1386) and after (n=1778) the intervention. Postnatal samples: women at eight weeks after delivery before (n=1741) and after (n=1547) the intervention. Intervention Provision of 10 pairs of Informed Choice leaflets for service users and midwives and a training session for staff in their use. Main outcome measures Change in the proportion of women who reported exercising informed choice. Secondary outcomes: changes in women's knowledge; satisfaction with information, choice, and discussion; and possible consequences of informed choice. Results There was no change in the proportion of women who reported that they exercised informed choice in the intervention units compared with the control units for either antenatal or postnatal women. There was a small increase in satisfaction with information in the antenatal samples in the intervention units compared with the control units (odds ratio 1.40, 95% confidence interval 1.05 to 1.88). Only three quarters of women in the intervention units reported being given at least one of the leaflets, indicating problems with the implementation of the intervention. Conclusion In everyday practice, evidence based leaflets were not effective in promoting informed choice in women using maternity services.	Univ Sheffield, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England; Univ Sheffield, Sch Nursing & Midwifery, Womens Informed Childbearing & Hlth Res Grp, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield	O'Cathain, A (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Regent Court, Sheffield S1 4DA, S Yorkshire, England.		Nicholl, Jon/B-8257-2008; Sandall, Jane/D-4146-2009	Sandall, Jane/0000-0003-2000-743X; Walters, Stephen/0000-0001-9000-8126				Charles Cathy, 2000, Health Expect, V3, P1, DOI 10.1046/j.1369-6513.2000.00085.x; Degner L F, 1997, Can J Nurs Res, V29, P21; DIEHR P, 1995, STAT MED, V14, P1491, DOI 10.1002/sim.4780141309; Entwistle Vikki A., 2000, Health Expect, V3, P77, DOI 10.1046/j.1369-6513.2000.00087.x; Holmes-Rovner Margaret, 2000, Health Expect, V3, P182, DOI 10.1046/j.1369-6513.2000.00093.x; KIRKHAM M, 2001, INFORMED CHOICE MATE; Murray DM, 1998, DESIGN ANAL GROUP RA; O'Connor AM, 1999, BRIT MED J, V319, P731, DOI 10.1136/bmj.319.7212.731; OLIVER S, 1996, 7 CRD NHS CTR REV DI; *SAS I, 1989, SAS STAT US GUID VER, V2; Stapleton H, 2002, BMJ-BRIT MED J, V324, P639, DOI 10.1136/bmj.324.7338.639	11	65	63	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 16	2002	324	7338					643	646A		10.1136/bmj.324.7338.643	http://dx.doi.org/10.1136/bmj.324.7338.643			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532QW	11895822	Green Published, Bronze			2022-12-28	WOS:000174487400022
J	Jacobs, SA; Khorasanizadeh, S				Jacobs, SA; Khorasanizadeh, S			Structure of HP1 chromodomain bound to a lysine 9-methylated histone H3 tail	SCIENCE			English	Article							NUCLEOSOME CORE PARTICLE; METHYLATION; DOMAIN; RECOGNITION	The chromodomain of the HP1 family of proteins recognizes histone tails with specifically methylated lysines. Here, we present structural, energetic, and mutational analyses of the complex between the Drosophila HP1 chromodomain and the histone H3 tail with a methyllysine at residue 9, a modification associated with epigenetic silencing. The histone tail inserts as a beta strand, completing the beta-sandwich architecture of the chromodomain. The methylammonium group is caged by three aromatic side chains, whereas adjacent residues form discerning contacts with one face of the chromodomain. Comparison of dimethyl- and trimethyllysine-containing complexes suggests a role for cation-pi and van der Waals interactions, with trimethylation slightly improving the binding affinity.	Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Khorasanizadeh, S (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	khorasan@virginia.edu			NIGMS NIH HHS [GM63959-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063959] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169; Ball LJ, 1997, EMBO J, V16, P2473, DOI 10.1093/emboj/16.9.2473; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; BLACK SD, 1991, ANAL BIOCHEM, V193, P72, DOI 10.1016/0003-2697(91)90045-U; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Harp JM, 2000, ACTA CRYSTALLOGR D, V56, P1513, DOI 10.1107/S0907444900011847; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; JACOBS SA, UNPUB; JANIN J, 1988, J MOL BIOL, V204, P155, DOI 10.1016/0022-2836(88)90606-7; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967	18	632	644	3	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2002	295	5562					2080	2083		10.1126/science.1069473	http://dx.doi.org/10.1126/science.1069473			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532AY	11859155				2022-12-28	WOS:000174450500051
J	Gagliardi, A; Jadad, AR				Gagliardi, A; Jadad, AR			Examination of instruments used to rate quality of health information on the internet: chronicle of a voyage with an unclear destination	BMJ-BRITISH MEDICAL JOURNAL			English	Article							WORLD-WIDE-WEB; MEDICAL INFORMATION	Objective This study updates work published in 1998, which found that of 47 rating instruments appearing on websites offering health information, 14 described how they were developed, five provided instructions for use, and none reported the interobserver reliability and construct validity of the measurements. Design All rating instrument sites noted in the original study were visited to ascertain whether they were still operating. New rating instruments were identified by duplicating and enhancing the comprehensive search of the internet and the medical and information science literature used in the previous study. Eligible instruments were evaluated as in the original study. Results 98 instruments used to assess the quality of websites in the past five years were identified. Many of the rating instruments identified in the original study were no longer available. Of 51 newly identified rating instruments, only five provided some information by which they could be evaluated. As with the six sites identified in the original study that remained available, none of these five instruments seemed to have been validated. Conclusions Many incompletely developed rating instruments continue to appear on websites providing health information, even when the organisations that gave rise to those instruments no longer exist Many researchers, organisations, and website developers are exploring alternative ways of helping people to find and use high quality information available on the internet. Whether they are needed or sustainable and whether they make a difference remain to be shown.	Univ Toronto, Fac Med, Grad Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; Univ Toronto, Univ Hlth Network, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; Univ Toronto, Univ Hlth Network, Dept Anaesthesia, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Jadad, AR (corresponding author), Toronto Gen Hosp, Univ Hlth Network, Ctr Global eHlth Innovat, Fraser Elliott Bldg,4th Floor,190 Elizabeth St, Toronto, ON M5G 2C4, Canada.	ajadad@uhnres.utoronto.ca						Abbott VP, 2000, J PUBLIC HEALTH MED, V22, P191, DOI 10.1093/pubmed/22.2.191; Berland GK, 2001, JAMA-J AM MED ASSOC, V285, P2612, DOI 10.1001/jama.285.20.2612; Eysenbach G, 1999, METHOD INFORM MED, V38, P80; Eysenbach G, 1998, BRIT MED J, V317, P1496, DOI 10.1136/bmj.317.7171.1496; Griffiths KM, 2000, BMJ-BRIT MED J, V321, P1511, DOI 10.1136/bmj.321.7275.1511; Impicciatore P, 1997, BMJ-BRIT MED J, V314, P1875, DOI 10.1136/bmj.314.7098.1875; Jadad AR, 1998, JAMA-J AM MED ASSOC, V279, P611, DOI 10.1001/jama.279.8.611; Li L, 2001, SPINE, V26, P545, DOI 10.1097/00007632-200103010-00020; MOHER D, 1995, CONTROL CLIN TRIALS, V16, P62, DOI 10.1016/0197-2456(94)00031-W; Price SL, 1999, J AM MED INFORM ASSN, P911; Rigby M, 2001, BMJ-BRIT MED J, V323, P552, DOI 10.1136/bmj.323.7312.552; Shon J, 2000, J AM MED INFORM ASSN, P794; Silberg WM, 1997, JAMA-J AM MED ASSOC, V277, P1244, DOI 10.1001/jama.277.15.1244; Suarez-Almazor ME, 2001, J RHEUMATOL, V28, P185; Tamm EP, 2000, ACAD RADIOL, V7, P137, DOI 10.1016/S1076-6332(00)80113-0; Wyatt JC, 1997, BRIT MED J, V314, P1879, DOI 10.1136/bmj.314.7098.1879	16	228	240	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2002	324	7337					569	573		10.1136/bmj.324.7337.569	http://dx.doi.org/10.1136/bmj.324.7337.569			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	530XJ	11884320	Bronze, Green Published			2022-12-28	WOS:000174384000019
J	Friml, J; Benkova, E; Blilou, I; Wisniewska, J; Hamann, T; Ljung, K; Woody, S; Sandberg, G; Scheres, B; Jurgens, G; Palme, K				Friml, J; Benkova, E; Blilou, I; Wisniewska, J; Hamann, T; Ljung, K; Woody, S; Sandberg, G; Scheres, B; Jurgens, G; Palme, K			AtPIN4 mediates sink-driven auxin gradients and root patterning in Arabidopsis	CELL			English	Article							EFFLUX CARRIER; TRANSPORT; GRAVITROPISM; PROTEIN; GENE; THALIANA; PLANTS; ACID	In contrast to animals, little is known about pattern formation in plants. Physiological and genetic data suggest the involvement of the phytohormone auxin in this process. Here, we characterize a novel member of the PIN family of putative auxin efflux carriers,Arabidopsis PIN4, that is localized in developing and mature root meristems. Atpin4 mutants are defective in establishment and maintenance of endogenous auxin gradients, fail to canalize externally applied auxin, and display various patterning defects in both embryonic and seedling roots. We propose a role for AtPIN4 in generating a sink for auxin below the quiescent center of the root meristem that is essential for auxin distribution and patterning.	Max Planck Gesell, Max Delbruck Lab, D-50829 Cologne, Germany; Masaryk Univ, Fac Sci, Dept Biochem, CS-61137 Brno, Czech Republic; ASCR, Inst Biophys, Brno 61265, Czech Republic; Univ Utrecht, Dept Mol Cell Biol, NL-3584 CH Utrecht, Netherlands; Inst Gen & Mol Biol, Dept Biotechnol, PL-87100 Torun, Poland; Univ Tubingen, Zentrum Mol Biol Pflanzen, D-72076 Tubingen, Germany; Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden; Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; Univ Freiburg, Inst Biol Zellbiol 2, D-79104 Freiburg, Germany	Max Planck Society; Masaryk University Brno; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Utrecht University; Nicolaus Copernicus University; Eberhard Karls University of Tubingen; Swedish University of Agricultural Sciences; Umea University; University of Wisconsin System; University of Wisconsin Madison; University of Freiburg	Palme, K (corresponding author), Max Planck Gesell, Max Delbruck Lab, Carl von Linne Weg 10, D-50829 Cologne, Germany.		Ljung, Karin/AAE-8691-2019; Benkova, Eva/E-2910-2012; Friml, Jiri/D-9511-2012; Palme, Klaus/A-9524-2013; Wisniewska, Justyna/D-4351-2009	Ljung, Karin/0000-0003-2901-189X; Friml, Jiri/0000-0002-8302-7596; Palme, Klaus/0000-0002-2728-3835; Scheres, Ben/0000-0001-5400-9578; Blilou, Ikram/0000-0001-8003-3782				BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; BEJSOVEC A, 1995, GENETICS, V139, P309; Bennett MJ, 1996, SCIENCE, V273, P948, DOI 10.1126/science.273.5277.948; BENNETT SRM, 1995, PLANT J, V8, P505, DOI 10.1046/j.1365-313X.1995.8040505.x; Berleth T, 2001, CURR OPIN PLANT BIOL, V4, P57, DOI 10.1016/S1369-5266(00)00136-9; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Chen RJ, 1998, P NATL ACAD SCI USA, V95, P15112, DOI 10.1073/pnas.95.25.15112; Chen Y, 2001, NATURE, V411, P607, DOI 10.1038/35079121; Dotson SB, 1996, PLANT J, V10, P383, DOI 10.1046/j.1365-313X.1996.10020383.x; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; EDLUND A, 1995, PLANT PHYSIOL, V108, P1043, DOI 10.1104/pp.108.3.1043; FRIMI J, 2000, THESIS U COLOGNE KOL; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Garbers C, 1996, EMBO J, V15, P2115, DOI 10.1002/j.1460-2075.1996.tb00565.x; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Hadfi K, 1998, DEVELOPMENT, V125, P879; KERK N, 1994, PROTOPLASMA, V183, P100, DOI 10.1007/BF01276817; Lomax Terri L., 1995, P509; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Rashotte AM, 2000, PLANT PHYSIOL, V122, P481, DOI 10.1104/pp.122.2.481; Rashotte AM, 2001, PLANT CELL, V13, P1683, DOI 10.1105/tpc.13.7.1683; RAVEN JA, 1975, NEW PHYTOL, V74, P163, DOI 10.1111/j.1469-8137.1975.tb02602.x; RUBERY PH, 1974, PLANTA, V118, P101, DOI 10.1007/BF00388387; Ruegger M, 1997, PLANT CELL, V9, P745, DOI 10.1105/tpc.9.5.745; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Sachs T, 2000, PLANT CELL PHYSIOL, V41, P649, DOI 10.1093/pcp/41.6.649; SACHS T, 1985, P LIF SCI PLANT GROW, P231; Steeves T.A., 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; Swarup R, 2001, GENE DEV, V15, P2648, DOI 10.1101/gad.210501; Teleman AA, 2001, CELL, V105, P559, DOI 10.1016/S0092-8674(01)00377-4; Uggla C, 1996, P NATL ACAD SCI USA, V93, P9282, DOI 10.1073/pnas.93.17.9282; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Wolpert L, 1996, TRENDS GENET, V12, P359, DOI 10.1016/S0168-9525(96)80019-9	39	623	667	4	137	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 8	2002	108	5					661	673		10.1016/S0092-8674(02)00656-6	http://dx.doi.org/10.1016/S0092-8674(02)00656-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	529TN	11893337	Green Published, Bronze			2022-12-28	WOS:000174314800010
J	Althorpe, SC; Fernandez-Alonso, F; Bean, BD; Ayers, JD; Pomerantz, AE; Zare, RN; Wrede, E				Althorpe, SC; Fernandez-Alonso, F; Bean, BD; Ayers, JD; Pomerantz, AE; Zare, RN; Wrede, E			Observation and interpretation of a time-delayed mechanism in the hydrogen exchange reaction	NATURE			English	Article							DIFFERENTIAL CROSS-SECTIONS; WAVE-PACKET METHOD; H+H2 REACTION; STATE; SCATTERING; DYNAMICS; RESONANCES; ENERGY	Extensive theoretical(1-13) and experimental(2,13-22) studies have shown the hydrogen exchange reaction H + H-2 --> H-2 + H to occur predominantly through a 'direct recoil' mechanism: the H-H bonds break and form concertedly while the system passes straight over a collinear transition state, with recoil from the collision causing the H-2 product molecules to scatter backward. Theoretical predictions agree well with experimental observations of this scattering process(15-20,22). Indirect exchange mechanisms involving H-3 intermediates have been suggested to occur as well(8-13), but these are difficult to test because bimolecular reactions cannot be studied by the femtosecond spectroscopies(23) used to monitor unimolecular reactions. Moreover, full quantum simulations of the time evolution of bimolecular reactions have not been performed. For the isotopic variant of the hydrogen exchange reaction, H + D-2 --> HD + D, forward scattering features(21) observed in the product angular distribution have been attributed(21,12) to possible scattering resonances associated with a quasibound collision complex. Here we extend these measurements to a wide range of collision energies and interpret the results using a full time-dependent quantum simulation of the reaction, thus showing that two different reaction mechanisms modulate the measured product angular distribution features. One of the mechanisms is direct and leads to backward scattering, the other is indirect and leads to forward scattering after a delay of about 25 femtoseconds.	Univ Durham, Dept Chem, Durham DH1 3LE, England; CNR, Ist Struttura Mat, Area Ric Roma, I-00133 Rome, Italy; Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Durham University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Struttura della Materia (ISM-CNR); Stanford University	Althorpe, SC (corresponding author), Univ Exeter, Sch Chem, Stocker Rd, Exeter EX4 4QD, Devon, England.		Fernandez-Alonso, Felix/C-2505-2008; Wrede, Eckart/E-7366-2012; Zare, Richard N./A-8410-2009	Wrede, Eckart/0000-0001-6773-8446; Fernandez-Alonso, Felix/0000-0003-0313-017X; Zare, Richard/0000-0001-5266-4253				Allison TC, 2000, CHEM PHYS LETT, V327, P439, DOI 10.1016/S0009-2614(00)00885-X; Althorpe SC, 2001, J CHEM PHYS, V114, P1601, DOI 10.1063/1.1334866; Althorpe SC, 1997, J CHEM PHYS, V107, P7816, DOI 10.1063/1.475095; AOIZ FJ, 1992, J CHEM PHYS, V97, P7423, DOI 10.1063/1.463514; Balint-Kurti GG, 1998, FARADAY DISCUSS, V110, P169, DOI 10.1039/a801712c; Boothroyd AI, 1996, J CHEM PHYS, V104, P7139, DOI 10.1063/1.471430; Casavecchia P, 2000, REP PROG PHYS, V63, P355, DOI 10.1088/0034-4885/63/3/203; DMELLO M, 1991, J CHEM PHYS, V94, P5985, DOI 10.1063/1.460432; Fernandez-Alonso F, 2002, ANNU REV PHYS CHEM, V53, P67, DOI 10.1146/annurev.physchem.53.091001.094554; Fernandez-Alonso F, 2001, J CHEM PHYS, V115, P4534, DOI 10.1063/1.1390505; Fernandez-Alonso F, 1999, J CHEM PHYS, V111, P1035, DOI 10.1063/1.479191; Fernandez-Alonso F, 2000, ANGEW CHEM INT EDIT, V39, P2748, DOI 10.1002/1521-3773(20000804)39:15<2748::AID-ANIE2748>3.3.CO;2-#; Fernandez-Alonso F, 1999, J CHEM PHYS, V111, P2490, DOI 10.1063/1.479527; Hirschfelder J, 1936, J CHEM PHYS, V4, P170, DOI 10.1063/1.1749815; HUANG YH, 1994, J PHYS CHEM-US, V98, P1868, DOI 10.1021/j100058a025; JUDSON RS, 1990, PHYS REV A, V42, P351, DOI 10.1103/PhysRevA.42.351; Liu KP, 2001, ANNU REV PHYS CHEM, V52, P139, DOI 10.1146/annurev.physchem.52.1.139; MILLER WH, 1990, ANNU REV PHYS CHEM, V41, P245; MILLER WH, 1991, J PHYS CHEM-US, V95, P12, DOI 10.1021/j100154a007; NEUHAUSER D, 1992, SCIENCE, V257, P519, DOI 10.1126/science.257.5069.519; NIEH JC, 1988, PHYS REV LETT, V60, P519, DOI 10.1103/PhysRevLett.60.519; RINNEN KD, 1991, J CHEM PHYS, V95, P214, DOI 10.1063/1.461478; SCHATZ GC, 1975, PHYS REV LETT, V35, P1266, DOI 10.1103/PhysRevLett.35.1266; Schnieder L, 1997, J CHEM PHYS, V107, P6175, DOI 10.1063/1.474283; SKODJE RT, 1994, J CHEM PHYS, V101, P1725, DOI 10.1063/1.467728; Skouteris D, 2000, COMPUT PHYS COMMUN, V133, P128, DOI 10.1016/S0010-4655(00)00167-3; TRUHLAR DG, 1976, ANNU REV PHYS CHEM, V27, P1, DOI 10.1146/annurev.pc.27.100176.000245; Wrede E, 1999, J CHEM PHYS, V110, P9971, DOI 10.1063/1.478870; Zewail AH, 2000, J PHYS CHEM A, V104, P5660, DOI 10.1021/jp001460h; ZHANG JZH, 1988, CHEM PHYS LETT, V153, P465, DOI 10.1016/0009-2614(88)85244-8	30	170	174	2	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2002	416	6876					67	70		10.1038/416067a	http://dx.doi.org/10.1038/416067a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882892				2022-12-28	WOS:000174211600038
J	Templeton, A				Templeton, A			Ooplasmic transfer - Proceed with care.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HUMAN OOCYTES		Univ Aberdeen, Aberdeen AB25 2ZD, Scotland	University of Aberdeen	Templeton, A (corresponding author), Univ Aberdeen, Aberdeen AB25 2ZD, Scotland.							Antman K, 2001, NEW ENGL J MED, V344, P762, DOI 10.1056/NEJM200103083441010; Barritt JA, 2001, HUM REPROD, V16, P513, DOI 10.1093/humrep/16.3.513; Brenner CA, 2000, FERTIL STERIL, V74, P573, DOI 10.1016/S0015-0282(00)00681-6; Cohen J, 1998, MOL HUM REPROD, V4, P269, DOI 10.1093/molehr/4.3.269; Lacham-Kaplan Orly, 2001, Reprod Biomed Online, V3, P205; Sutovsky P, 2000, BIOL REPROD, V63, P582, DOI 10.1095/biolreprod63.2.582; Tesarik J, 2001, Reprod Biomed Online, V2, P160; VANBLERKOM J, 1995, HUM REPROD, V10, P415, DOI 10.1093/oxfordjournals.humrep.a135954; 2001, LANCET, V358, P519	9	21	27	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2002	346	10					773	775		10.1056/NEJM200203073461013	http://dx.doi.org/10.1056/NEJM200203073461013			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527UA	11882736				2022-12-28	WOS:000174205000012
J	Kaptchuk, TJ				Kaptchuk, TJ			Acupuncture: Theory, efficacy, and practice	ANNALS OF INTERNAL MEDICINE			English	Review							EVENTS FOLLOWING ACUPUNCTURE; ADVERSE EVENTS; ELECTROACUPUNCTURE ANALGESIA; ALTERNATIVE MEDICINE; CHINESE-MEDICINE; PLACEBO NEEDLE; CHRONIC PAIN; BACK-PAIN; BRAIN; METAANALYSIS	Traditionally, acupuncture is embedded in naturalistic theories that are compatible with Confucianism and Taoism. Such ideas as yin-yang, qi, dampness, and wind represent East Asian conceptual frameworks that emphasize the reliability of ordinary, human sensory awareness. Many physicians who practice acupuncture reject such prescientific notions. Numerous randomized, controlled trials and more than 25 systematic reviews and meta-analyses have evaluated the clinical efficacy of acupuncture. Evidence from these trials indicates that acupuncture is effective for emesis developing after surgery or chemotherapy in adults and for nausea associated with pregnancy, Good evidence exists that acupuncture is also effective for relieving dental pain. For such conditions as chronic pain, back pain, and headache, the data are equivocal or contradictory. Clinical research on acupuncture poses unique methodologic challenges. Properly performed acupuncture seems to be a safe procedure. Basic-science research provides evidence that begins to offer plausible mechanisms for the presumed physiologic effects of acupuncture. Multiple research approaches have shown that acupuncture activates endogenous opioid mechanisms. Recent data, obtained by using functional magnetic resonance imaging, suggest that acupuncture has regionally specific, quantifiable effects on relevant brain structures. Acupuncture may stimulate gene expression of neuropeptides. The training and provision of acupuncture care in the United States are rapidly expanding.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Res & Educ Complementary & Integrat Med Thera, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kaptchuk, TJ (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Res & Educ Complementary & Integrat Med Thera, 330 Brookline Ave, Boston, MA 02215 USA.				NCCIH NIH HHS [1R01AT00402-01] Funding Source: Medline; NIAMS NIH HHS [U24 AR43441] Funding Source: Medline; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT000402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U24AR043441] Funding Source: NIH RePORTER	NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Araujo MS, 1998, FORSCH KOMPLEMENTMED, V5, P8; Astin JA, 1998, ARCH INTERN MED, V158, P2303, DOI 10.1001/archinte.158.21.2303; Barnes LL, 1998, CULT MED PSYCHIAT, V22, P413, DOI 10.1023/A:1005403825213; Bates DG, 2000, PERSPECT BIOL MED, V43, P502; Bensoussan A, 2000, ARCH FAM MED, V9, P1071, DOI 10.1001/archfami.9.10.1071; Bensoussan A, 1996, SAFER CHOICE PRACTIC; Berman BM, 1999, J FAM PRACTICE, V48, P213; BOSSUT DF, 1991, BRAIN RES, V549, P47, DOI 10.1016/0006-8993(91)90597-O; *BRIT MED ASS BOAR, 2000, AC EFF SAF PRACT; BUCINSKAITE V, 1994, BRAIN RES, V666, P128, DOI 10.1016/0006-8993(94)90294-1; CASE M, 1999, WALL STREET J   1126, pB1; CHAPMAN CR, 1983, PAIN, V16, P13, DOI 10.1016/0304-3959(83)90082-9; CHEN FP, 1990, ACUPUNCTURE ELECTRO, V15, P107, DOI 10.3727/036012990816358261; CHENG RSS, 1980, LIFE SCI, V26, P631, DOI 10.1016/0024-3205(80)90239-8; Cho ZH, 1998, P NATL ACAD SCI USA, V95, P2670, DOI 10.1073/pnas.95.5.2670; Connelly DM, 1994, TRADITIONAL ACUPUNCT; Cooper RA, 1998, JAMA-J AM MED ASSOC, V280, P795, DOI 10.1001/jama.280.9.795; DeWoskin Kenneth J., 1983, DOCTORS DIVINERS MAG; Diehl D L, 1997, J Altern Complement Med, V3, P119, DOI 10.1089/acm.1997.3.119; Dorfer L, 1999, LANCET, V354, P1023, DOI 10.1016/S0140-6736(98)12242-0; DUNG HC, 1985, CHINESE MED J-PEKING, V98, P835; EPLER DC, 1980, B HIST MED, V54, P337; Ernst E, 1995, Int J Risk Saf Med, V6, P179, DOI 10.3233/JRS-1995-6305; Ernst E, 1997, SCAND J RHEUMATOL, V26, P444, DOI 10.3109/03009749709065717; Ernst E, 1997, PAIN, V71, P123, DOI 10.1016/S0304-3959(97)03368-X; Ernst E, 1998, BRIT DENT J, V184, P443, DOI 10.1038/sj.bdj.4809654; Ernst E, 1999, ARCH OTOLARYNGOL, V125, P269, DOI 10.1001/archotol.125.3.269; Ernst E, 1998, ARCH INTERN MED, V158, P2235, DOI 10.1001/archinte.158.20.2235; Ernst E, 1996, Wien Med Wochenschr, V146, P556; Ernst E, 2001, AM J MED, V110, P481, DOI 10.1016/S0002-9343(01)00651-9; Ernst E, 1997, WIEN KLIN WOCHENSCHR, V109, P60; Ezzo J, 2000, PAIN, V86, P217, DOI 10.1016/S0304-3959(99)00304-8; Ezzo J, 2001, ARTHRITIS RHEUM, V44, P819, DOI 10.1002/1529-0131(200104)44:4<819::AID-ANR138>3.0.CO;2-P; Farquhar J., 1994, KNOWING PRACTICE CLI; Filshie J, 1998, MED ACUPUNCTURE W SC; Gao M, 1997, ACUPUNCTURE ELECTRO, V22, P161, DOI 10.3727/036012997816356662; GRACELY RH, 1985, LANCET, V1, P43; Guo HF, 1996, MOL BRAIN RES, V43, P167, DOI 10.1016/S0169-328X(96)00171-4; HAHN RA, 1982, CULT MED PSYCHIAT, V6, P219, DOI 10.1007/BF00114192; Hammerschlag R, 1998, J ALTERN COMPLEM MED, V4, P159, DOI 10.1089/acm.1998.4.159; Han JS, 1997, J ALTERN COMPLEM MED, V3, pS101, DOI DOI 10.1089/acm.1997.3.s-101; Harper D., 1998, EARLY CHINESE MED LI; HARRIS PE, 1997, COMPLEMENT THER MED, V5, P156; Hsu E, 1996, SOC SCI MED, V42, P421, DOI 10.1016/0277-9536(95)00106-9; HUAI LS, 1976, COMPREHENSIVE TXB, P17; Hui KKS, 2000, HUM BRAIN MAPP, V9, P13, DOI 10.1002/(SICI)1097-0193(2000)9:1<13::AID-HBM2>3.0.CO;2-F; JEWELL D, 2000, COCHRANE DATABASE SY; *JIANGS NEW MED I, 1977, ENC TRAD CHIN PHARM; Jobst K A, 1995, J Altern Complement Med, V1, P57; Kaptchuk TJ, 2000, J CLIN EPIDEMIOL, V53, P786, DOI 10.1016/S0895-4356(00)00206-7; Kaptchuk TJ, 1997, NEW ENGL J MED, V336, P1109; Kaptchuk TJ, 1999, JAMA-J AM MED ASSOC, V281, P1270, DOI 10.1001/jama.281.14.1270; Kaptchuk TJ, 1998, LANCET, V352, P992, DOI 10.1016/S0140-6736(05)61551-6; Kaptchuk TJ, 2001, JAMA-J AM MED ASSOC, V285, P1015, DOI 10.1001/jama.285.8.1015; KAPTCHUK TJ, 2001, FUNDAMENTALS COMPLEM, P43; KAPTCHUK TJ, 2000, NO WEAVER UNDERSTAND; KLARER S, 1997, ENCY HIST SCI TECHNO, P832; KLEIJNEN J, 1991, THORAX, V46, P799, DOI 10.1136/thx.46.11.799; KLEIN L, 1997, SERIES CURRENT BIBLI; Kleinman Arthur, 1995, WRITING MARGIN DISCO; Lao L, 1996, J Altern Complement Med, V2, P27, DOI 10.1089/acm.1996.2.27; LAW M, 1995, ARCH INTERN MED, V155, P1933, DOI 10.1001/archinte.155.18.1933; Lee A, 1999, ANESTH ANALG, V88, P1362, DOI 10.1097/00000539-199906000-00031; Lee ACC, 1999, WESTERN J MED, V171, P153; LINDE K, 2000, COCHRANE DATABASE SY; Linde K., 1999, ESSENTIALS COMPLEMEN, P57; LINDE K, 1996, FORSCH KOMPLEMENTMED, V3, P148; MacPherson H, 2001, BMJ-BRIT MED J, V323, P486, DOI 10.1136/bmj.323.7311.486; MacPherson H, 1999, J ALTERN COMPLEM MED, V5, P47, DOI 10.1089/acm.1999.5.47; MacPherson H, 1997, ACUPUNCTURE PRACTICE; McQuay HJ, 1998, EVIDENCE BASED RESOU; Melchart D, 1999, CEPHALALGIA, V19, P779, DOI 10.1046/j.1468-2982.1999.1909779.x; Melchart D, 1997, Altern Ther Health Med, V3, P33; MIURA K, 1989, TAOIST MEDITATION LO, P331; Murphy PA, 1998, OBSTET GYNECOL, V91, P149, DOI 10.1016/S0029-7844(97)00582-6; MUSSAT M, 1972, PHYSIQUE ACUPUNCTURE; Nahin RL, 2001, BRIT MED J, V322, P161, DOI 10.1136/bmj.322.7279.161; NIELSEN A, 1995, GUA SHA  TRADITIONAL; Norheim A J, 1996, J Altern Complement Med, V2, P291, DOI 10.1089/acm.1996.2.291; Park J, 2001, J NEUROL, V248, P558, DOI 10.1007/s004150170132; Park J, 2001, ARCH INTERN MED, V161, P894, DOI 10.1001/archinte.161.6.894; Park JB, 2000, ARCH OTOLARYNGOL, V126, P489, DOI 10.1001/archotol.126.4.489; PATEL M, 1989, INT J EPIDEMIOL, V18, P900, DOI 10.1093/ije/18.4.900; Peuker ET, 1999, ARCH FAM MED, V8, P553, DOI 10.1001/archfami.8.6.553; POMERANZ B, 1989, SCI BASES ACUPUNCTUR; RAMPES H, 1995, ACU MED, V12, P26; Ramsay DJ, 1998, JAMA-J AM MED ASSOC, V280, P1518; Roetz Heiner, 1993, CONFUCIAN ETHICS AXI; Rosted P, 1998, Oral Dis, V4, P100; Scheid V., 2001, INNOVATION CHINESE M; Shang C., 2001, CLIN ACUPUNCTURE SCI, P69; Smith LA, 2000, PAIN, V86, P119, DOI 10.1016/S0304-3959(00)00234-7; Streitberger K, 1998, LANCET, V352, P364, DOI 10.1016/S0140-6736(97)10471-8; SUN YM, 1984, INT J CHINESE MED, V1, P15; TERRIET G, 1990, J CLIN EPIDEMIOL, V43, P1191, DOI 10.1016/0895-4356(90)90020-P; TERRIET G, 1990, BRIT J GEN PRACT, V40, P379; Ulett GA, 1998, BIOL PSYCHIAT, V44, P129, DOI 10.1016/S0006-3223(97)00394-6; Unschuld Paul O., 1985, MED CHINA HIST IDEAS; van Tulder MW, 1999, SPINE, V24, P1113, DOI 10.1097/00007632-199906010-00011; Vernon H, 1999, Complement Ther Med, V7, P142; Vickers A. J., 1998, Complementary Therapies in Medicine, V6, P185, DOI 10.1016/S0965-2299(98)80026-5; Vickers AJ, 1996, J ROY SOC MED, V89, P303, DOI 10.1177/014107689608900602; Vincent C, 2001, BRIT MED J, V323, P467, DOI 10.1136/bmj.323.7311.467; VINCENT C, 1995, J ROY SOC MED, V88, P199; White A, 2001, BRIT MED J, V323, P485, DOI 10.1136/bmj.323.7311.485; White AR, 1999, RHEUMATOLOGY, V38, P143, DOI 10.1093/rheumatology/38.2.143; White AR, 1999, TOB CONTROL, V8, P393, DOI 10.1136/tc.8.4.393; WILLIAMS GH, 1986, LANCET, V2, P1435; Wu MT, 1999, RADIOLOGY, V212, P133, DOI 10.1148/radiology.212.1.r99jl04133; Yamashita H, 1998, JAMA-J AM MED ASSOC, V280, P1563, DOI 10.1001/jama.280.18.1563-a; Yamashita H, 2001, COMPLEMENT THER MED, V9, P98, DOI 10.1054/ctim.2001.0446; YE J, 1995, PHARM J, V255, pR37; Yong D., 1999, SMJ, V40, P260	113	555	574	13	197	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 5	2002	136	5					374	383		10.7326/0003-4819-136-5-200203050-00010	http://dx.doi.org/10.7326/0003-4819-136-5-200203050-00010			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525VT	11874310				2022-12-28	WOS:000174095300005
J	Sincich, LC; Horton, JC				Sincich, LC; Horton, JC			Divided by cytochrome oxidase: A map of the projections from V1 to V2 in Macaques	SCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; MONKEY VISUAL-CORTEX; AREA V2; FUNCTIONAL ARCHITECTURE; SEGREGATION; SYSTEM; COLOR; FORM; ORGANIZATION; CONNECTIONS	Current models partition the primate visual system into dorsal (magno) and ventral (parvo, konio) streams. Perhaps the strongest evidence for this idea has come from the pattern of projections between the primary visual area (V1) and the second visual area (V2). Prior studies describe three distinct pathways: magno to thick stripes, parvo to pate stripes, and konio to thin stripes. We now demonstrate that V1 output arises from just two sources: patch columns and interpatch columns. Patch columns project to thin stripes and interpatch columns project to pate and thick stripes. Projection of interpatches to common V2-stripe types (pate and thick) merges parvo and magno inputs, making it likely that these functional channels are distributed strongly to both dorsal and ventral streams.	Univ Calif San Francisco, Beckman Vis Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Sincich, LC (corresponding author), Univ Calif San Francisco, Beckman Vis Ctr, San Francisco, CA 94143 USA.			Horton, Jonathan/0000-0002-3952-435X	NATIONAL EYE INSTITUTE [P30EY002162, R01EY010217, F32EY013676, R56EY010217] Funding Source: NIH RePORTER; NEI NIH HHS [EY02162, EY10217, EY13676] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; CRAGG BG, 1969, VISION RES, V9, P733, DOI 10.1016/0042-6989(69)90011-X; DEYOE EA, 1985, NATURE, V317, P58, DOI 10.1038/317058a0; DEYOE EA, 1994, NATURE, V371, P151, DOI 10.1038/371151a0; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Gegenfurtner KR, 1996, VISUAL NEUROSCI, V13, P161, DOI 10.1017/S0952523800007203; Hendry SHC, 2000, ANNU REV NEUROSCI, V23, P127, DOI 10.1146/annurev.neuro.23.1.127; HENDRY SHC, 1994, SCIENCE, V264, P575, DOI 10.1126/science.8160015; HORTON JC, 1984, PHILOS T ROY SOC B, V304, P199, DOI 10.1098/rstb.1984.0021; HUBEL DH, 1987, J NEUROSCI, V7, P3378; KRUBITZER L, 1990, VISUAL NEUROSCI, V5, P609, DOI 10.1017/S0952523800000778; KUYPERS HGJ, 1965, EXP NEUROL, V11, P245, DOI 10.1016/0014-4886(65)90016-6; LEVAY S, 1990, EXP BRAIN RES, V82, P77; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3371; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; MARTIN KAC, 1988, TRENDS NEUROSCI, V11, P380, DOI 10.1016/0166-2236(88)90072-0; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; Mettler FA, 1935, J COMP NEUROL, V61, P221, DOI 10.1002/cne.900610203; Olavarria JF, 1997, CEREB CORTEX, V7, P395, DOI 10.1093/cercor/7.5.395; PETERHANS E, 1993, EUR J NEUROSCI, V5, P509, DOI 10.1111/j.1460-9568.1993.tb00517.x; RODIECK RW, 1993, J COMP NEUROL, V338, P289, DOI 10.1002/cne.903380211; ROE AW, 1995, J NEUROSCI, V15, P3689; Roe AW, 1997, CEREBR CORT, V12, P295; RYE DB, 1984, J HISTOCHEM CYTOCHEM, V32, P1145, DOI 10.1177/32.11.6548485; SHIPP S, 1985, NATURE, V315, P322, DOI 10.1038/315322a0; SINCICH LC, 2002, IN PRESS J COMP NEUR; TOOTELL RBH, 1983, SCIENCE, V220, P737, DOI 10.1126/science.6301017; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; VANESSEN DC, 1994, NEURON, V13, P1, DOI 10.1016/0896-6273(94)90455-3; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; YOUNG MP, 1992, NATURE, V358, P152, DOI 10.1038/358152a0; ZEKI S, 1988, NATURE, V335, P311, DOI 10.1038/335311a0; ZEKI SM, 1969, BRAIN RES, V14, P271, DOI 10.1016/0006-8993(69)90110-3	35	119	121	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 1	2002	295	5560					1734	1737		10.1126/science.1067902	http://dx.doi.org/10.1126/science.1067902			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872845				2022-12-28	WOS:000174212900052
J	Asai, T; Tena, G; Plotnikova, J; Willmann, MR; Chiu, WL; Gomez-Gomez, L; Boller, T; Ausubel, FM; Sheen, J				Asai, T; Tena, G; Plotnikova, J; Willmann, MR; Chiu, WL; Gomez-Gomez, L; Boller, T; Ausubel, FM; Sheen, J			MAP kinase signalling cascade in Arabidopsis innate immunity	NATURE			English	Article							BACTERIAL ELICITOR FLAGELLIN; ACTIVATED PROTEIN-KINASE; TRANSCRIPTION FACTORS; PATHOGEN DEFENSE; RESISTANCE GENE; RECEPTOR; PLANTS; THALIANA; PERCEPTION; INDUCTION	There is remarkable conservation in the recognition of pathogen-associated molecular patterns (PAMPs) by innate immune responses of plants, insects and mammals. We developed an Arabidopsis thaliana leaf cell system based on the induction of early-defence gene transcription by flagellin, a highly conserved component of bacterial flagella that functions as a PAMP in plants and mammals. Here we identify a complete plant MAP kinase cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) and WRKY22/WRKY29 transcription factors that function downstream of the flagellin receptor FLS2, a leucine-rich-repeat (LRR) receptor kinase. Activation of this MAPK cascade confers resistance to both bacterial and fungal pathogens, suggesting that signalling events initiated by diverse pathogens converge into a conserved MAPK cascade.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Inst Desarrollo Reg, Secc Biotecnol, E-02071 Albacete, Spain; Friedrich Miescher Inst, CH-4002 Basel, Switzerland	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Friedrich Miescher Institute for Biomedical Research	Sheen, J (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA.		Boller, Thomas/G-3500-2012; Gomez-Gomez, Lourdes/AAF-2371-2020	Boller, Thomas/0000-0001-6768-7503; Gomez-Gomez, Lourdes/0000-0003-2586-4457; Tena, Guillaume/0000-0001-8652-905X; Willmann, Matthew R./0000-0002-4146-8158				Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Asai T, 2000, PLANT CELL, V12, P1823, DOI 10.1105/tpc.12.10.1823; Blume B, 2000, PLANT CELL, V12, P1425, DOI 10.1105/tpc.12.8.1425; BOLLER T, 1995, ANNU REV PLANT PHYS, V46, P189, DOI 10.1146/annurev.arplant.46.1.189; Cardinale F, 2000, J BIOL CHEM, V275, P36734, DOI 10.1074/jbc.M007418200; Cohn J, 2001, CURR OPIN IMMUNOL, V13, P55, DOI 10.1016/S0952-7915(00)00182-5; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Du LQ, 2000, PLANT J, V24, P837, DOI 10.1046/j.1365-313x.2000.00923.x; Durrant WE, 2000, PLANT CELL, V12, P963, DOI 10.1105/tpc.12.6.963; Eulgem T, 1999, EMBO J, V18, P4689, DOI 10.1093/emboj/18.17.4689; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Frye CA, 2001, P NATL ACAD SCI USA, V98, P373, DOI 10.1073/pnas.011405198; Glazebrook J, 2001, CURR OPIN PLANT BIOL, V4, P301, DOI 10.1016/S1369-5266(00)00177-1; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; HART H, 2000, RESULTS PROBLEMS CEL, P85; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Jouannic S, 1999, GENE, V233, P1, DOI 10.1016/S0378-1119(99)00152-3; Khush RS, 2000, TRENDS GENET, V16, P442, DOI 10.1016/S0168-9525(00)02095-3; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Kovtun Y, 1998, NATURE, V395, P716, DOI 10.1038/27240; Lee J, 2001, PLANT CELL, V13, P1079, DOI 10.1105/tpc.13.5.1079; Ligterink W, 1997, SCIENCE, V276, P2054, DOI 10.1126/science.276.5321.2054; Madhani HD, 1998, TRENDS GENET, V14, P151, DOI 10.1016/S0168-9525(98)01425-5; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; Meindl T, 2000, PLANT CELL, V12, P1783, DOI 10.1105/tpc.12.9.1783; Mizoguchi T, 2000, RES PRO CEL, V27, P29; Nuhse TS, 2000, J BIOL CHEM, V275, P7521, DOI 10.1074/jbc.275.11.7521; Nurnberger T, 2001, TRENDS PLANT SCI, V6, P372, DOI 10.1016/S1360-1385(01)02019-2; Patharkar OR, 2000, PLANT J, V24, P679, DOI 10.1046/j.1365-313x.2000.00912.x; Peck SC, 2001, PLANT CELL, V13, P1467, DOI 10.1105/tpc.13.6.1467; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Romeis T, 2001, CURR OPIN PLANT BIOL, V4, P407, DOI 10.1016/S1369-5266(00)00193-X; Romeis T, 1999, PLANT CELL, V11, P273, DOI 10.1105/tpc.11.2.273; SAMAKOVLIS C, 1992, BIOCHEM BIOPH RES CO, V188, P1169, DOI 10.1016/0006-291X(92)91354-S; Schenk PM, 2000, P NATL ACAD SCI USA, V97, P11655, DOI 10.1073/pnas.97.21.11655; SHEEN J, IN PRESS PLANT PHYSL; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Swiderski MR, 2001, PLANT J, V26, P101, DOI 10.1046/j.1365-313x.2001.01014.x; Tena G, 2001, CURR OPIN PLANT BIOL, V4, P392, DOI 10.1016/S1369-5266(00)00191-6; Xiang CB, 1999, PLANT MOL BIOL, V40, P711, DOI 10.1023/A:1006201910593; Yang KY, 2001, P NATL ACAD SCI USA, V98, P741, DOI 10.1073/pnas.98.2.741; Zhang SQ, 1998, PLANT CELL, V10, P435, DOI 10.1105/tpc.10.3.435; Zhang SQ, 2001, TRENDS PLANT SCI, V6, P520, DOI 10.1016/S1360-1385(01)02103-3; Zhang SQ, 1998, P NATL ACAD SCI USA, V95, P7433, DOI 10.1073/pnas.95.13.7433	46	1862	2043	21	500	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2002	415	6875					977	983		10.1038/415977a	http://dx.doi.org/10.1038/415977a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875555				2022-12-28	WOS:000174075000031
J	Gewin, V				Gewin, V			Academy proposes tighter crop monitoring	NATURE			English	News Item																			0	2	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2002	415	6875					948	948		10.1038/415948b	http://dx.doi.org/10.1038/415948b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875531	Bronze			2022-12-28	WOS:000174075000010
J	Stark, AD; Bennet, GC; Stone, DH; Chishti, P				Stark, AD; Bennet, GC; Stone, DH; Chishti, P			Association between childhood fractures and poverty: population based study	BRITISH MEDICAL JOURNAL			English	Article									Royal Hosp Sick Children, Dept Orthopaed Surg, Glasgow G3 8SJ, Lanark, Scotland; Univ Glasgow, Royal Hosp Sick Children, PEACH Unit, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Glasgow	Stark, AD (corresponding author), Royal Hosp Sick Children, Dept Orthopaed Surg, Glasgow G3 8SJ, Lanark, Scotland.							*GREAT GLASG HLTH, 1995, IND DEPR; Landin LA, 1997, J PEDIATR ORTHOP B, V6, P79, DOI 10.1097/01202412-199704000-00002; Lyons RA, 2000, ARCH DIS CHILD, V82, P452, DOI 10.1136/adc.82.6.452; Lyons RA, 2000, BRIT MED J, V320, P149, DOI 10.1136/bmj.320.7228.149; Morrison A, 1999, BRIT MED J, V318, P567, DOI 10.1136/bmj.318.7183.567	5	42	42	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 23	2002	324	7335					457	457		10.1136/bmj.324.7335.457	http://dx.doi.org/10.1136/bmj.324.7335.457			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526NJ	11859047	Bronze, Green Published			2022-12-28	WOS:000174136300017
J	Weinstein, R; Mahmood, M; Scully, RE; Rybak, LD				Weinstein, R; Mahmood, M; Scully, RE; Rybak, LD			A 54-year-old woman with left, then right, central-retinal-vein occlusion - Hyperviscosity syndrome due to IgG multiple myeloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FACTOR-X DEFICIENCY; SYSTEMIC LUPUS-ERYTHEMATOSUS; MONOCLONAL GAMMOPATHIES; ANTIPHOSPHOLIPID ANTIBODIES; UNDETERMINED SIGNIFICANCE; HEMOSTATIC ABNORMALITIES; CLINICAL MANIFESTATIONS; ANTICOAGULANT ACTIVITY; POLYCLONAL GAMMOPATHY; RHEUMATOID-ARTHRITIS		St Elizabeths Med Ctr, Boston, MA USA; Tufts Univ, Sch Med, Boston, MA 02111 USA	St. Elizabeth's Medical Center; Tufts University	Weinstein, R (corresponding author), St Elizabeths Med Ctr, Boston, MA USA.							Avashia J H, 1989, J Am Optom Assoc, V60, P657; BARON M, 1982, J RHEUMATOL, V9, P843; BELLOTTI V, 1989, BRIT J HAEMATOL, V73, P221, DOI 10.1111/j.1365-2141.1989.tb00256.x; Berlin NI, 1997, J LAB CLIN MED, V130, P365, DOI 10.1016/S0022-2143(97)90035-4; BLOCH KJ, 1973, SEMIN HEMATOL, V10, P113; Chiang CC, 2000, J EMERG MED, V18, P23, DOI 10.1016/S0736-4679(99)00157-2; CLARKSON JG, 1993, ARCH OPHTHALMOL-CHIC, V111, P1087; CLINE MJ, 1963, AM J MED, V34, P213, DOI 10.1016/0002-9343(63)90054-8; Cobo-Soriano R, 1999, AM J OPHTHALMOL, V128, P725, DOI 10.1016/S0002-9394(99)00311-6; COOPER MR, 1974, BLOOD, V43, P493, DOI 10.1182/blood.V43.4.493.493; CRAWFORD J, 1985, AM J MED, V79, P13, DOI 10.1016/0002-9343(85)90540-6; Dlott J S, 1999, CAP Today, V13, P84; ELMAN MJ, 1990, OPHTHALMOLOGY, V97, P1543; FAHEY JL, 1965, J AMER MED ASSOC, V192, P464, DOI 10.1001/jama.1965.03080190030008; FUKASAWA T, 1977, AM J MED SCI, V273, P329; FURIE B, 1981, NEW ENGL J MED, V304, P827, DOI 10.1056/NEJM198104023041407; FURIE B, 1977, NEW ENGL J MED, V297, P81, DOI 10.1056/NEJM197707142970203; Gamba G, 2000, HAEMATOLOGICA, V85, P289; Gatel A, 1998, ANN INTERN MED, V128, P604, DOI 10.7326/0003-4819-128-7-199804010-00031; GLACETBERNARD A, 1994, ARCH OPHTHALMOL-CHIC, V112, P790, DOI 10.1001/archopht.1994.01090180088041; GLACETBERNARD A, 1994, OPHTHALMOLOGY, V101, P1483; GLASPY JA, 1992, HEMATOL ONCOL CLIN N, V6, P1301, DOI 10.1016/S0889-8588(18)30276-4; GOSSELIN S, 1991, ANN NEUROL, V30, P54, DOI 10.1002/ana.410300111; GREIPP PR, 1981, AM J HEMATOL, V11, P443, DOI 10.1002/ajh.2830110414; HADLER NM, 1977, ARTHRITIS RHEUM, V20, P1388, DOI 10.1002/art.1780200713; HAYASAKA S, 1993, ANN OPHTHALMOL, V25, P191; Incorvaia C, 1999, AM J OPHTHALMOL, V128, P247, DOI 10.1016/S0002-9394(99)00069-0; KEREN DF, 1993, HEMATOL ONCOL CLIN N, V7, P1153, DOI 10.1016/S0889-8588(18)30204-1; KEREN DF, 1994, HEMATOL ONCOL CLIN N, V8, pR7; Kwaan HC, 1999, SEMIN THROMB HEMOST, V25, P199, DOI 10.1055/s-2007-994921; KYLE RA, 1975, MAYO CLIN PROC, V50, P29; KYLE RA, 1987, MAYO CLIN PROC, V62, P719, DOI 10.1016/S0025-6196(12)65225-2; LACKNER H, 1973, SEMIN HEMATOL, V10, P125; Larsson J, 1999, ACTA OPHTHALMOL SCAN, V77, P634, DOI 10.1034/j.1600-0420.1999.770606.x; LEE WM, 1978, GASTROENTEROLOGY, V74, P918; MCGRATH MA, 1976, J CLIN INVEST, V58, P1155, DOI 10.1172/JCI108568; MOULOPOULOS LA, 1993, RADIOLOGY, V188, P669, DOI 10.1148/radiology.188.3.8351330; PATTERSON WP, 1990, SEMIN ONCOL, V17, P210; PERKINS HA, 1970, BLOOD-J HEMATOL, V35, P695, DOI 10.1182/blood.V35.5.695.695; Porcu P, 2000, LEUKEMIA LYMPHOMA, V39, P1, DOI 10.3109/10428190009053534; PRINCE HM, 1995, J CLIN PATHOL, V48, P387, DOI 10.1136/jcp.48.4.387; Reimann HA, 1932, J AMER MED ASSOC, V99, P1411, DOI 10.1001/jama.1932.02740690021007; REINHART WH, 1992, J LAB CLIN MED, V119, P69; RIESEN W, 1975, BIOCHEMISTRY-US, V14, P1052, DOI 10.1021/bi00676a026; Ropper AH, 1998, NEW ENGL J MED, V338, P1601, DOI 10.1056/NEJM199805283382207; RUSSELL JA, 1978, BRIT J HAEMATOL, V39, P163, DOI 10.1111/j.1365-2141.1978.tb01086.x; SARNAT RL, 1986, OPHTHALMOLOGY, V93, P124; SILBERMAN S, 1986, ANN CLIN LAB SCI, V16, P26; SINGH A, 1993, J CLIN INVEST, V91, P251, DOI 10.1172/JCI116178; Somer T, 1987, Baillieres Clin Haematol, V1, P695, DOI 10.1016/S0950-3536(87)80021-5; SOMER T, 1993, ANN MED, V25, P31, DOI 10.3109/07853899309147854; STERN JJ, 1994, AM J CLIN PATHOL, V101, P471; Tekeli O, 1999, ACTA OPHTHALMOL SCAN, V77, P628, DOI 10.1034/j.1600-0420.1999.770604.x; THIAGARAJAN P, 1980, J CLIN INVEST, V66, P397, DOI 10.1172/JCI109869; Triplett DA, 1998, LUPUS, V7, pS18, DOI 10.1177/096120339800700205; Vine AK, 2000, AM J OPHTHALMOL, V129, P640, DOI 10.1016/S0002-9394(99)00476-6; VLADUTIU AO, 1991, CLIN CHEM, V37, P1788; VRETHEM M, 1993, J NEUROL SCI, V114, P193, DOI 10.1016/0022-510X(93)90297-C; Waldenstrom J, 1944, ACTA MED SCAND, V117, P216; WISLOFF F, 1991, THROMB RES, V61, P201, DOI 10.1016/0049-3848(91)90096-F; Yasin Z, 1999, AM J HEMATOL, V62, P99, DOI 10.1002/(SICI)1096-8652(199910)62:2<99::AID-AJH6>3.3.CO;2-E	61	5	5	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2002	346	8					603	610		10.1056/NEJMcpc020006	http://dx.doi.org/10.1056/NEJMcpc020006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	522ZK	11856800				2022-12-28	WOS:000173926700009
J	Holt, JR; Gillespie, SKH; Provance, DW; Shah, K; Shokat, KM; Corey, DP; Mercer, JA; Gillespie, PG				Holt, JR; Gillespie, SKH; Provance, DW; Shah, K; Shokat, KM; Corey, DP; Mercer, JA; Gillespie, PG			A chemical-genetic strategy implicates myosin-1c in adaptation by hair cells	CELL			English	Article							MECHANOELECTRICAL TRANSDUCTION; BULLFROGS SACCULUS; I-BETA; BLOCK ADAPTATION; MOUSE UTRICLE; INNER-EAR; TIP LINKS; LOCALIZATION; KINASE; IDENTIFICATION	Myosin-1c (also known as myosin-1beta) has been proposed to mediate the slow component of adaptation by hair cells, the sensory cells of the inner ear. To test this hypothesis, we mutated tyrosine-61 of myosin-1c to glycine, conferring susceptibility to inhibition by N-6-modified ADP analogs. We expressed the mutant myosin-1c in utricular hair cells of transgenic, mice, delivered an ADP analog through a whole-cell recording pipette, and found that the analog rapidly blocked adaptation to positive and negative deflections in transgenic cells but not in wild-type cells. The speed and specificity of inhibition suggests that myosin-1c participates in adaptation in hair cells.	Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02114 USA; Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA; McLaughlin Res Inst, Great Falls, MT 59405 USA; Genom Inst Novartis Res Fdn, San Diego, CA 92121 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Virginia; McLaughlin Research Institute for Biomedical Sciences, Inc.; Novartis; University of California System; University of California San Francisco; Oregon Health & Science University	Gillespie, PG (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	gillespp@ohsu.edu	Provance, David W/D-5294-2013	Provance, David W/0000-0002-9824-0672; Corey, David/0000-0003-4497-6016; Barr-Gillespie, Peter/0000-0002-9787-5860; Mercer, John/0000-0003-0307-4438	NATIONAL CANCER INSTITUTE [R01CA070331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002368, R01DC003279] Funding Source: NIH RePORTER; NCI NIH HHS [CA70331] Funding Source: Medline; NIDCD NIH HHS [DC02368, DC03279, R01 DC002368-06, R01 DC003279-04, DC00304] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ASSAD JA, 1992, J NEUROSCI, V12, P3291; Benser ME, 1996, J NEUROSCI, V16, P5629; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Bishop A, 2000, ANNU REV BIOPH BIOM, V29, P577, DOI 10.1146/annurev.biophys.29.1.577; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; CANDE WZ, 1986, METHOD ENZYMOL, V134, P473; COOKE R, 1985, BIOPHYS J, V48, P789, DOI 10.1016/S0006-3495(85)83837-6; COREY DP, 1983, J NEUROSCI, V3, P962; CRAWFORD AC, 1991, J PHYSIOL-LONDON, V434, P369, DOI 10.1113/jphysiol.1991.sp018475; DUMONT, 2002, IN PRESS J ASS RES O, V3; Eatock RA, 2000, ANNU REV NEUROSCI, V23, P285, DOI 10.1146/annurev.neuro.23.1.285; EATOCK RA, 1987, J NEUROSCI, V7, P2821; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; FLOCK A, 1981, J NEUROCYTOL, V10, P133, DOI 10.1007/BF01181749; Garcia JA, 1998, J NEUROSCI, V18, P8637; GILLESPIE PG, 1993, NEURON, V11, P581, DOI 10.1016/0896-6273(93)90071-X; GILLESPIE PG, 1991, J CELL BIOL, V112, P625, DOI 10.1083/jcb.112.4.625; GILLESPIE PG, 1993, P NATL ACAD SCI USA, V90, P2710, DOI 10.1073/pnas.90.7.2710; Gillespie PG, 1997, NEURON, V19, P955, DOI 10.1016/S0896-6273(00)80387-6; Gillespie PG, 2001, J CELL BIOL, V155, P703, DOI 10.1083/jcb.200110032; Gillespie PG, 1999, J BIOL CHEM, V274, P31373, DOI 10.1074/jbc.274.44.31373; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hamilton BA, 1997, NEURON, V18, P711, DOI 10.1016/S0896-6273(00)80312-8; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Holt JR, 1999, ANN NY ACAD SCI, V871, P15, DOI 10.1111/j.1749-6632.1999.tb09172.x; Holt JR, 1997, J NEUROSCI, V17, P8739; Holt JR, 2000, P NATL ACAD SCI USA, V97, P11730, DOI 10.1073/pnas.97.22.11730; HOWARD J, 1987, P NATL ACAD SCI USA, V84, P3064, DOI 10.1073/pnas.84.9.3064; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; Kachar B, 2000, P NATL ACAD SCI USA, V97, P13336, DOI 10.1073/pnas.97.24.13336; Kapoor TM, 1999, P NATL ACAD SCI USA, V96, P9106, DOI 10.1073/pnas.96.16.9106; Kros CJ, 2002, NAT NEUROSCI, V5, P41, DOI 10.1038/nn784; Pestic-Dragovich L, 2000, SCIENCE, V290, P337, DOI 10.1126/science.290.5490.337; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; RUPPERT C, 1995, J CELL SCI, V108, P3775; Rybin V, 1996, NATURE, V383, P266, DOI 10.1038/383266a0; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; SHEPHERD GMG, 1994, J NEUROSCI, V14, P6217; SHERR EH, 1993, J CELL BIOL, V120, P1405, DOI 10.1083/jcb.120.6.1405; SHIODA T, 1991, BIOCHIM BIOPHYS ACTA, V1115, P30, DOI 10.1016/0304-4165(91)90007-4; Steyger PS, 1998, J NEUROSCI, V18, P4603; Walker RG, 1996, P NATL ACAD SCI USA, V93, P2203, DOI 10.1073/pnas.93.5.2203; Wu YC, 1999, J NEUROPHYSIOL, V82, P2171, DOI 10.1152/jn.1999.82.5.2171; Yamoah EN, 1996, NEURON, V17, P523, DOI 10.1016/S0896-6273(00)80184-1	44	251	261	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2002	108	3					371	381		10.1016/S0092-8674(02)00629-3	http://dx.doi.org/10.1016/S0092-8674(02)00629-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	520VB	11853671	Bronze			2022-12-28	WOS:000173801600009
J	Okazaki, IM; Kinoshita, K; Muramatsu, M; Yoshikawa, K; Honjo, T				Okazaki, IM; Kinoshita, K; Muramatsu, M; Yoshikawa, K; Honjo, T			The AID enzyme induces class switch recombination in fibroblasts	NATURE			English	Article							CYTIDINE DEAMINASE AID; B-CELLS; S-REGIONS; GENE; HYPERMUTATION; SPECIFICITY; EXPRESSION; SEQUENCES; SITES	The switch of the immunoglobulin isotype from IgM to IgG, IgE or IgA is mediated by class switch recombination (CSR). CSR changes the immunoglobulin heavy chain constant region (C-H) gene from Cmu to one of the other C-H genes(1,2). Somatic hypermutation introduces massive numbers of point mutations in the immunoglobulin variable (V) region gene, giving rise to immunoglobulin with higher affinity(3). Activation-induced cytidine deaminase (AID), a putative RNA-editing cytidine deaminase, is expressed strictly in activated B cells and is indispensable in both CSR and somatic hypermutation(4,5). But the exact function of AID is unknown. Here we show that ectopic expression of AID induces CSR in an artificial switch construct in fibroblasts at a level comparable to that in stimulated B cells. Sequences around recombination junctions in the artificial substrate have features similar to endogenous CSR junctions. Furthermore, AID-induced CSR in fibroblasts is dependent on transcription of the target S region, as shown in endogenous CSR in B cells. The results show that AID is the only B-cell-specific factor required for initiation of the CSR reaction in the activated locus.	Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Radioisotope Res Ctr, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Kyoto University	Honjo, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	honjo@mfour.med.kyoto-u.ac.jp	Muramatsu, Masamichi/C-4339-2015; Honjo, Tasuku/N-4470-2016	Muramatsu, Masamichi/0000-0002-0153-3533; Okazaki, Il-mi/0000-0001-8644-0100				Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404; Chen XC, 2001, P NATL ACAD SCI USA, V98, P13860, DOI 10.1073/pnas.241524898; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; IWASATO T, 1992, J EXP MED, V175, P1539, DOI 10.1084/jem.175.6.1539; JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159; Kinoshita K, 1998, IMMUNITY, V9, P849, DOI 10.1016/S1074-7613(00)80650-0; Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033; Kitamura T, 1998, INT J HEMATOL, V67, P351; Kuzin II, 2001, INT IMMUNOL, V13, P921, DOI 10.1093/intimm/13.7.921; Lee CG, 2001, J EXP MED, V194, P365, DOI 10.1084/jem.194.3.365; LUPTON SD, 1991, MOL CELL BIOL, V11, P3374, DOI 10.1128/MCB.11.6.3374; Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193; NEUBERGER MS, 1995, CURR OPIN IMMUNOL, V7, P248, DOI 10.1016/0952-7915(95)80010-7; OBATA M, 1981, P NATL ACAD SCI-BIOL, V78, P2437, DOI 10.1073/pnas.78.4.2437; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95, DOI 10.1002/j.1460-2075.1986.tb04182.x; Tashiro J, 2001, INT IMMUNOL, V13, P495, DOI 10.1093/intimm/13.4.495; WINTER E, 1987, EMBO J, V6, P1663, DOI 10.1002/j.1460-2075.1987.tb02415.x; XU LX, 1993, P NATL ACAD SCI USA, V90, P3705, DOI 10.1073/pnas.90.8.3705; YANCOPOULOS GD, 1986, EMBO J, V5, P3259, DOI 10.1002/j.1460-2075.1986.tb04637.x; ZHANG J, 1993, EMBO J, V12, P3529, DOI 10.1002/j.1460-2075.1993.tb06027.x	30	205	214	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2002	416	6878					340	345		10.1038/nature727	http://dx.doi.org/10.1038/nature727			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532NP	11875397				2022-12-28	WOS:000174482200048
J	Blowes, D				Blowes, D			Environmental chemistry - Tracking hexavalent Cr in groundwater	SCIENCE			English	Editorial Material							CHROMIUM		Univ Waterloo, Dept Earth Sci, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Blowes, D (corresponding author), Univ Waterloo, Dept Earth Sci, Waterloo, ON N2L 3G1, Canada.	blowes@sciborg.uwaterloo.ca						Blowes DW, 2000, J CONTAM HYDROL, V45, P123, DOI 10.1016/S0169-7722(00)00122-4; BLOWES DW, 1999, EPA600R99095B OFF RE, V2; Ellis AS, 2002, SCIENCE, V295, P2060, DOI 10.1126/science.1068368; Fruchter JS, 2000, GROUND WATER MONIT R, V20, P66, DOI 10.1111/j.1745-6592.2000.tb00267.x; Hocking G, 2000, CHEMICAL OXIDATION AND REACTIVE BARRIERS, P307; LANDIS R, 2000, EPA542B00001 SOL WAS; MACKAY DM, 1989, ENVIRON SCI TECHNOL, V23, P630, DOI 10.1021/es00064a001; *NAT AC SCI COMM G, 1994, ALT GROUND WAT CLEAN; Nieboer E., 1988, CHROMIUM NATURAL HUM, V20, P21; NIEBOER E, 1988, ADV ENV SCI TECHNOLO, V20, P399; PALMER CD, 1991, ENVIRON HEALTH PERSP, V92, P25, DOI 10.2307/3431134; Puls R. W., 1994, EPA540S94505; Van der Leeden F., 1990, WATER ENCY; YASSI A, 1988, ADV ENV SCI TECHNOLO, V20, P443	14	146	153	4	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2002	295	5562					2024	2025		10.1126/science.1070031	http://dx.doi.org/10.1126/science.1070031			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532AY	11896259				2022-12-28	WOS:000174450500029
J	Serruya, MD; Hatsopoulos, NG; Paninski, L; Fellows, MR; Donoghue, JP				Serruya, MD; Hatsopoulos, NG; Paninski, L; Fellows, MR; Donoghue, JP			Instant neural control of a movement signal	NATURE			English	Article							NEURONS		Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Serruya, MD (corresponding author), Brown Univ, Dept Neurosci, Box 1953, Providence, RI 02912 USA.							Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Kennedy PR, 1998, NEUROREPORT, V9, P1707, DOI 10.1097/00001756-199806010-00007; Maynard EM, 1997, ELECTROEN CLIN NEURO, V102, P228, DOI 10.1016/S0013-4694(96)95176-0; Maynard EM, 1999, J NEUROSCI, V19, P8083; PANINSKI L, UNPUB J NEUROSCI; PANINSKI L, 1999, SOC NEUR ABSTR; SERRUYA MD, IN PRESS BIOL CYBERN; Taylor DM, 2001, P 6 ANN IFESS C 2001, P132; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582	9	947	1014	2	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2002	416	6877					141	142		10.1038/416141a	http://dx.doi.org/10.1038/416141a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894084				2022-12-28	WOS:000174348100026
J	Gan, TJ				Gan, TJ			Postoperative nausea and vomiting - Can it be eliminated	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ANTIEMETIC PROPHYLAXIS; OUTPATIENT LAPAROSCOPY; COST-EFFECTIVENESS; SUBSTANCE-P; ONDANSETRON; PROPOFOL; SURGERY; COMBINATION; DROPERIDOL; PREVENTION		Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA	Duke University	Gan, TJ (corresponding author), Duke Univ, Med Ctr, Dept Anesthesiol, Box 3094, Durham, NC 27710 USA.							Ahmed AB, 2000, BRIT J ANAESTH, V85, P678, DOI 10.1093/bja/85.5.678; Apfel CC, 1999, ANESTHESIOLOGY, V91, P693, DOI 10.1097/00000542-199909000-00022; BAILEY PL, 1990, ANESTHESIOLOGY, V72, P977, DOI 10.1097/00000542-199006000-00005; BONICA JJ, 1958, ANESTHESIOLOGY, V19, P532, DOI 10.1097/00000542-195807000-00010; CARROLL NV, 1995, ANESTH ANALG, V80, P903, DOI 10.1097/00000539-199505000-00009; *CDCP, 1986, VIT HLTH STAT AMB IN; Cechetto DF, 2001, ANESTH ANALG, V92, P934; COHEN MM, 1994, ANESTH ANALG, V78, P7; Enqvist B, 1997, ACTA ANAESTH SCAND, V41, P1028, DOI 10.1111/j.1399-6576.1997.tb04831.x; Ernst E, 2000, BRIT J ANAESTH, V84, P367, DOI 10.1093/oxfordjournals.bja.a013442; *FDA, 2002, FDA STRENGTH WARN DR; Fortney JT, 1998, ANESTH ANALG, V86, P731, DOI 10.1097/00000539-199804000-00011; Gan TJ, 2001, ANESTH ANALG, V92, P393, DOI 10.1213/00000539-200102000-00022; Gan TJ, 1997, ANESTHESIOLOGY, V87, P779, DOI 10.1097/00000542-199710000-00010; Gan TJ, 1996, ANESTHESIOLOGY, V85, P1036, DOI 10.1097/00000542-199611000-00011; GAN TJ, IN PRESS ANESTH ANAL; Gesztesi Z, 2000, ANESTHESIOLOGY, V93, P931, DOI 10.1097/00000542-200010000-00009; GILLIS RA, 1980, BRAIN RES, V181, P476, DOI 10.1016/0006-8993(80)90633-2; Goll V, 2001, ANESTH ANALG, V92, P112, DOI 10.1097/00000539-200101000-00022; Greif R, 1999, ANESTHESIOLOGY, V91, P1246, DOI 10.1097/00000542-199911000-00014; Habib A S., 2001, Ambul Surg, V9, P59, DOI 10.1016/S0966-6532(01)00103-2; HABIB AS, 2001, ANESTHESIOLOGY, V95, pA41; Henzi I, 1999, BRIT J ANAESTH, V83, P761, DOI 10.1093/bja/83.5.761; Henzi I, 2000, ANESTH ANALG, V90, P186, DOI 10.1097/00000539-200001000-00038; Hill RP, 2000, ANESTHESIOLOGY, V92, P958, DOI 10.1097/00000542-200004000-00012; Kotani N, 2001, ANESTHESIOLOGY, V95, P349, DOI 10.1097/00000542-200108000-00015; Lee A, 1999, ANESTH ANALG, V88, P1362, DOI 10.1097/00000539-199906000-00031; Macario A, 1999, ANESTH ANALG, V89, P652, DOI 10.1097/00000539-199909000-00022; McKenzie R, 1996, ANESTH ANALG, V83, P1218, DOI 10.1097/00000539-199612000-00015; McLean S, 1996, J PHARMACOL EXP THER, V277, P900; Pueyo FJ, 1996, ANESTH ANALG, V83, P117, DOI 10.1097/00000539-199607000-00021; Rose JB, 1999, BRIT J ANAESTH, V83, P104, DOI 10.1093/bja/83.1.104; Scuderi PE, 2000, ANESTH ANALG, V91, P1408, DOI 10.1097/00000539-200012000-00020; Scuderi PE, 1999, ANESTHESIOLOGY, V90, P360, DOI 10.1097/00000542-199902000-00006; Shende D, 2001, ACTA ANAESTH SCAND, V45, P756, DOI 10.1034/j.1399-6576.2001.045006756.x; Tramer M, 1997, BRIT J ANAESTH, V78, P247, DOI 10.1093/bja/78.3.247; Tramer MR, 1999, ANAESTHESIA, V54, P226, DOI 10.1046/j.1365-2044.1999.00704.x; Tramer MR, 2001, ACTA ANAESTH SCAND, V45, P4, DOI 10.1034/j.1399-6576.2001.450102.x; Ved SA, 1996, ANESTHESIOLOGY, V85, P4, DOI 10.1097/00000542-199607000-00002; Virik K, 2001, INT J CLIN PRACT, V55, P344; Visser K, 2001, ANESTHESIOLOGY, V95, P616, DOI 10.1097/00000542-200109000-00012; Watcha MF, 2000, ANESTHESIOLOGY, V92, P931, DOI 10.1097/00000542-200004000-00007; WATCHA MF, 1992, ANESTHESIOLOGY, V77, P162, DOI 10.1097/00000542-199207000-00023; Zarate E, 2001, ANESTH ANALG, V92, P629; Zarate E, 2000, ANESTH ANALG, V90, P1352, DOI 10.1097/00000539-200006000-00017	45	198	217	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2002	287	10					1233	1236		10.1001/jama.287.10.1233	http://dx.doi.org/10.1001/jama.287.10.1233			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529YU	11886298				2022-12-28	WOS:000174329500002
J	Hartl, FU; Hayer-Hartl, M				Hartl, FU; Hayer-Hartl, M			Protein folding - Molecular chaperones in the cytosol: from nascent chain to folded protein	SCIENCE			English	Review							NEWLY SYNTHESIZED PROTEINS; IN-VIVO; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; TRIGGER FACTOR; POLYPEPTIDE-CHAINS; UNFOLDED PROTEINS; GROEL; COMPLEX	Efficient folding of many newly synthesized proteins depends on assistance from molecular chaperones, which serve to prevent protein misfolding and aggregation in the crowded environment of the cell. Nascent chain-binding chaperones, including trigger factor, Hsp70, and prefoldin, stabilize elongating chains on ribosomes in a nonaggregated state. Folding in the cytosol is achieved either on controlled chain release from these factors or after transfer of newly synthesized proteins to downstream chaperones, such as the chaperonins. These are large, cylindrical complexes that provide a central compartment for a single protein chain to fold unimpaired by aggregation. Understanding how the thousands of different proteins synthesized in a cell use this chaperone machinery has profound implications for biotechnology and medicine.	Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany	Max Planck Society	Hartl, FU (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.		Hartl, F. Ulrich/Y-8206-2019; Hayer-Hartl, Manajit/V-8078-2017	Hayer-Hartl, Manajit/0000-0001-8213-6742				Beatrix B, 2000, J BIOL CHEM, V275, P37838, DOI 10.1074/jbc.M006368200; Ben-Zvi AP, 2001, J STRUCT BIOL, V135, P84, DOI 10.1006/jsbi.2001.4352; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chatellier J, 1999, J MOL BIOL, V292, P163, DOI 10.1006/jmbi.1999.3040; Chaudhuri TK, 2001, CELL, V107, P235, DOI 10.1016/S0092-8674(01)00523-2; Chen JW, 2001, NAT STRUCT BIOL, V8, P721, DOI 10.1038/90443; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Ditzel L, 1998, CELL, V93, P125, DOI 10.1016/S0092-8674(00)81152-6; Dobson Christopher M., 1999, Current Opinion in Structural Biology, V9, P92, DOI 10.1016/S0959-440X(99)80012-8; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Ellis RJ, 2001, CURR BIOL, V11, pR1038, DOI 10.1016/S0960-9822(01)00620-0; ELLIS RJ, 1989, TRENDS BIOCHEM SCI, V14, P339, DOI 10.1016/0968-0004(89)90168-0; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; Farr GW, 2000, CELL, V100, P561, DOI 10.1016/S0092-8674(00)80692-3; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Gautschi M, 2001, P NATL ACAD SCI USA, V98, P3762, DOI 10.1073/pnas.071057198; GAUTSCHI M, IN PRESS P NATL ACAD; Geissler S, 1998, EMBO J, V17, P952, DOI 10.1093/emboj/17.4.952; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Glass JI, 2000, NATURE, V407, P757, DOI 10.1038/35037619; Gutsche I, 2001, J STRUCT BIOL, V135, P139, DOI 10.1006/jsbi.2001.4373; Hansen WJ, 1999, J CELL BIOL, V145, P265, DOI 10.1083/jcb.145.2.265; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Herbst R, 1998, BIOCHEMISTRY-US, V37, P6586, DOI 10.1021/bi972928i; Hesterkamp T, 1996, P NATL ACAD SCI USA, V93, P4437, DOI 10.1073/pnas.93.9.4437; Hohfeld J, 1997, EMBO J, V16, P6209, DOI 10.1093/emboj/16.20.6209; HORWICH AL, 1993, CELL, V74, P909, DOI 10.1016/0092-8674(93)90470-B; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Kim S, 1998, P NATL ACAD SCI USA, V95, P12860, DOI 10.1073/pnas.95.22.12860; Klumpp M, 1997, CELL, V91, P263, DOI 10.1016/S0092-8674(00)80408-0; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Leroux MR, 1999, EMBO J, V18, P6730, DOI 10.1093/emboj/18.23.6730; Leroux MR, 2001, ADV APPL MICROBIOL, V50, P219, DOI 10.1016/S0065-2164(01)50007-6; Lesley SA, 2001, PROTEIN EXPRES PURIF, V22, P159, DOI 10.1006/prep.2001.1465; Llorca O, 2001, EMBO J, V20, P4065, DOI 10.1093/emboj/20.15.4065; Llorca O, 2000, EMBO J, V19, P5971, DOI 10.1093/emboj/19.22.5971; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Martin J, 1997, P NATL ACAD SCI USA, V94, P1107, DOI 10.1073/pnas.94.4.1107; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; McCallum CD, 2000, J CELL BIOL, V149, P591, DOI 10.1083/jcb.149.3.591; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; Netzer WJ, 1997, NATURE, V388, P343, DOI 10.1038/41024; Nicola AV, 1999, NAT CELL BIOL, V1, P341, DOI 10.1038/14032; Patzelt H, 2001, P NATL ACAD SCI USA, V98, P14244, DOI 10.1073/pnas.261432298; Pellecchia M, 2000, NAT STRUCT BIOL, V7, P298; Pfund C, 1998, EMBO J, V17, P3981, DOI 10.1093/emboj/17.14.3981; Radford SE, 2000, TRENDS BIOCHEM SCI, V25, P611, DOI 10.1016/S0968-0004(00)01707-2; Richardson A, 1998, TRENDS BIOCHEM SCI, V23, P138, DOI 10.1016/S0968-0004(98)01193-1; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schiene C, 2000, CURR OPIN STRUC BIOL, V10, P40, DOI 10.1016/S0959-440X(99)00046-9; SCHIENEFISCHER C, COMMUNICATION; Sha BD, 2000, STRUCTURE, V8, P799, DOI 10.1016/S0969-2126(00)00170-2; Shtilerman M, 1999, SCIENCE, V284, P822, DOI 10.1126/science.284.5415.822; Siegers K, 1999, EMBO J, V18, P75, DOI 10.1093/emboj/18.1.75; SIEGERS K, COMMUNICATION; Siegert R, 2000, CELL, V103, P621, DOI 10.1016/S0092-8674(00)00165-3; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; Thulasiraman V, 1999, EMBO J, V18, P85, DOI 10.1093/emboj/18.1.85; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; van den Berg B, 1999, EMBO J, V18, P6927, DOI 10.1093/emboj/18.24.6927; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WIEDMANN B, 1994, NATURE, V370, P434, DOI 10.1038/370434a0; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	87	2608	2771	11	470	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1852	1858		10.1126/science.1068408	http://dx.doi.org/10.1126/science.1068408			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884745				2022-12-28	WOS:000174299500028
J	Nakatogawa, H; Ito, K				Nakatogawa, H; Ito, K			The ribosomal exit tunnel functions as a discriminating gate	CELL			English	Article							ESCHERICHIA-COLI SECA; ERYTHROMYCIN RESISTANCE; ENDOPLASMIC-RETICULUM; RNA; GENE; TRANSLATION; MUTATIONS; SITE; MECHANISM; SEQUENCE	Translation of SecM stalls unless its N-terminal part is "pulled" by the protein export machinery. Here we show that the sequence motif FXXXXWIXXXXGIRAGP that includes a specific arrest point (Pro) causes elongation arrest within the ribosome. Mutations that bypass the elongation arrest were isolated in 23S rRNA and L22 r protein. Such suppressor mutations occurred at a few specific residues of these components, which all face the narrowest constriction of the ribosomal exit tunnel. Thus, we suggest that this region of the exit tunnel interacts with nascent translation products and functions as a discriminating gate.	Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan; Kyoto Univ, Japan Sci & Technol Corp, CREST, Kyoto 6068507, Japan	Kyoto University; Japan Science & Technology Agency (JST); Kyoto University	Ito, K (corresponding author), Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan.	kito@virus.kyoto-u.ac.jp	Nakatogawa, Hitoshi/D-5155-2015	Nakatogawa, Hitoshi/0000-0002-5828-0741				Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BLOBEL G, 1970, J CELL BIOL, V45, P130, DOI 10.1083/jcb.45.1.130; CHITTUM HS, 1994, J BACTERIOL, V176, P6192, DOI 10.1128/jb.176.20.6192-6198.1994; DEGNEN GE, 1974, J BACTERIOL, V117, P477, DOI 10.1128/JB.117.2.477-487.1974; Gabashvili IS, 2001, MOL CELL, V8, P181, DOI 10.1016/S1097-2765(01)00293-3; GILMORE R, 1991, METHOD CELL BIOL, V34, P223; Gong F, 2001, P NATL ACAD SCI USA, V98, P8997, DOI 10.1073/pnas.171299298; Gregory ST, 1999, J MOL BIOL, V289, P827, DOI 10.1006/jmbi.1999.2839; Hardesty B, 2001, PROG NUCLEIC ACID RE, V66, P41; Kihara A, 1997, P NATL ACAD SCI USA, V94, P5544, DOI 10.1073/pnas.94.11.5544; McNicholas P, 1997, J MOL BIOL, V265, P128, DOI 10.1006/jmbi.1996.0723; Nakatogawa H, 2001, MOL CELL, V7, P185, DOI 10.1016/S1097-2765(01)00166-6; Oliver D, 1998, J BACTERIOL, V180, P5240, DOI 10.1128/JB.180.19.5240-5242.1998; Polacek N, 2001, NATURE, V411, P498, DOI 10.1038/35078113; Sarker S, 2000, J BACTERIOL, V182, P5592, DOI 10.1128/JB.182.19.5592-5595.2000; Sawano A, 2000, Nucleic Acids Res, V28, pE78, DOI 10.1093/nar/28.16.e78; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHIMOIKE T, 1995, J BIOL CHEM, V270, P5519, DOI 10.1074/jbc.270.10.5519; TAURA T, 1994, MOL GEN GENET, V243, P261, DOI 10.1007/BF00301061; Unge J, 1998, STRUCTURE, V6, P1577, DOI 10.1016/S0969-2126(98)00155-5; VESTER B, 1987, BIOCHIMIE, V69, P891, DOI 10.1016/0300-9084(87)90217-3; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Xiong LQ, 2000, J BACTERIOL, V182, P5325, DOI 10.1128/JB.182.19.5325-5331.2000; Xiong LQ, 1999, MOL MICROBIOL, V31, P633, DOI 10.1046/j.1365-2958.1999.01203.x; Young JC, 1996, EMBO J, V15, P172, DOI 10.1002/j.1460-2075.1996.tb00345.x	26	397	408	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 8	2002	108	5					629	636		10.1016/S0092-8674(02)00649-9	http://dx.doi.org/10.1016/S0092-8674(02)00649-9			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	529TN	11893334	Bronze			2022-12-28	WOS:000174314800007
J	Johnson, D; Campbell, CD; Lee, JA; Callaghan, TV; Gwynn-Jones, D				Johnson, D; Campbell, CD; Lee, JA; Callaghan, TV; Gwynn-Jones, D			Arctic microorganisms respond more to elevated UV-B radiation than CO2	NATURE			English	Article							MICROBIAL COMMUNITIES; EXTRACTION METHOD; HEATH ECOSYSTEM; CARBON; SOIL; NITROGEN	Surface ultraviolet-B radiation and atmospheric CO2 concentrations have increased as a result of ozone depletion and burning of fossil fuels(1,2). The effects are likely to be most apparent in polar regions(3) where ozone holes have developed and ecosystems are particularly sensitive to disturbance(4). Polar plant communities are dependent on nutrient cycling by soil microorganisms, which represent a significant and highly labile portion of soil carbon (C) and nitrogen (N). It was thought(5) that the soil microbial biomass was unlikely to be affected by exposure of their associated plant communities to increased UV-B. In contrast, increasing atmospheric CO2 concentrations were thought to have a strong effect as a result of greater below-ground C allocation(6). In addition, there is a growing belief that ozone depletion is of only minor environmental concern because the impacts of UV-B radiation on plant communities are often very subtle(7). Here we show that 5 years of exposure of a subarctic heath to enhanced UV-B radiation both alone and in combination with elevated CO2 resulted in significant changes in the C:N ratio and in the bacterial community structure of the soil microbial biomass.	Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Macaulay Land Use Res Inst, Aberdeen AB15 8QH, Scotland; Abisko Sci Res Stn, SE-98107 Abisko, Sweden; Univ Wales, Inst Biol Sci, Aberystwyth SY23 3DA, Dyfed, Wales	University of Sheffield; James Hutton Institute; Aberystwyth University	Johnson, D (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.		Johnson, David/N-3193-2013; Callaghan, Terens V./N-7640-2014	Campbell, Colin/0000-0002-5163-7656; Johnson, David/0000-0003-2299-2525				Arrow Kenneth J., 1996, CLIMATE CHANGE 1995; BJORN LO, 1996, ECOLOGICAL B, V45, P204; Bremner JM, 1982, AGRONOMY, P595, DOI DOI 10.2134/AGRONMONOGR9.2.2ED.C31; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Caldwell M, 1999, PHYSIOLOGICAL PLANT ECOLOGY, P241; CALDWELL MM, 1982, ARCTIC ALPINE RES, V14, P195, DOI 10.2307/1551152; CALLAGHAN TV, 1995, PHILOS T R SOC A, V352, P259, DOI 10.1098/rsta.1995.0069; Campbell CD, 1997, J MICROBIOL METH, V30, P33, DOI 10.1016/S0167-7012(97)00041-9; Ellenberg H., 1988, VEGETATION ECOLOGY C; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; GwynnJones D, 1997, PLANT ECOL, V128, P242; Hungate BA, 1997, NATURE, V388, P576, DOI 10.1038/41550; JOHANSON U, 1995, AMBIO, V24, P106; MOORHEAD DL, 1994, BIOL FERT SOILS, V18, P19, DOI 10.1007/BF00336439; Muller R, 1997, NATURE, V389, P709, DOI 10.1038/39564; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; SCHEINER D, 1976, WATER RES, V10, P31, DOI 10.1016/0043-1354(76)90154-8; Schlesinger WH, 2001, NATURE, V411, P466, DOI 10.1038/35078060; SONESSON M, 1974, OIKOS, V25, P121, DOI 10.2307/3543633; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6	20	78	94	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2002	416	6876					82	83		10.1038/416082a	http://dx.doi.org/10.1038/416082a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882896	Green Accepted			2022-12-28	WOS:000174211600042
J	Schwetz, BA				Schwetz, BA			New indication for Gleevec	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commiss Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commiss Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	8	9	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2002	287	9					1103	1103		10.1001/jama.287.9.1103-b	http://dx.doi.org/10.1001/jama.287.9.1103-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527KV	11879090				2022-12-28	WOS:000174186000005
J	Birchall, M; Richardson, A; Lee, L				Birchall, M; Richardson, A; Lee, L		S W Regional Canc Org Tumour Panel	Eliciting views of patients with head and neck cancer and carers on professionally derived standards for care	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objectives To examine views of patients and carers on the process of care for people with head and neck cancer; to assess whether focus groups are useful in this setting; to compare priorities and standards identified with those published by healthcare professionals; and to incorporate the expressed views Into existing national standards. Design Multicentre stud), of nine regional focus groups. Setting Area covered by two regional health authorities. Participants 40 patients who had had head and neck cancer and 18 carers. Main outcome measures Views of individuals and groups on standards. Applicability of the method for patients whose appearance and ability to communicate was altered and for recently bereaved carers. Ease of incorporation of views into national and regional standards. Results Patients and carers participated in discussions on all die principal questions. Opinions were expressed on waiting times, information available to patients, coordination of care, and crisis management. Professionally derived standards were substantially improved by the incorporation of the views of patients and carers. There were no technical problems in carrying out this study on patients with communication difficulties or altered appearance nor with recently bereaved carers. Occasionally, participants said that the meetings were therapeutic. Conclusions Professionally facilitated and analysed focus group; are effective in assessing views of patients with cancer and carers on professionally derived standards for care and can be applied in settings traditionally viewed as difficult. Views expressed by patients and carers are powerful motivators for change in the delivery of cancer care.	Univ Bristol, Div Surg, Bristol BS10 5NB, Avon, England; Res & Consultancy, London NW3 4DA, England; Horfield Practice, Bristol BS7 9RR, Avon, England	University of Bristol	Birchall, M (corresponding author), Univ Bristol, Div Surg, Bristol BS10 5NB, Avon, England.	Martin.Birchall@Bristol.ac.uk						[Anonymous], 2000, REF GUID SUSP CANC; ANSCHER MS, 1991, SOUTHERN MED J, V84, P209, DOI 10.1097/00007611-199102000-00014; Birchall M, 1999, EUR J SURG ONCOL, V25, P556, DOI 10.1053/ejso.1999.0703; Birchall MA, 1998, BRIT J CANCER, V77, P1926, DOI 10.1038/bjc.1998.319; BIRCHALL MA, 2000, HEAD NECK CANC CONSE; *BRIT ASS HEAD NEC, 1998, PROV QUAL ASS HEAD N; Calman K., 1995, POLICY FRAMEWORK COM; EDWARDS D, 1997, FACE FACE PATIENT FA; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Kurtz M E, 1995, Health Care Women Int, V16, P253; *S W TUM PAN HEAD, 2000, FIND THEIR VOIC; Thorne P, 1997, EUR J SURG ONCOL, V23, P503, DOI 10.1016/S0748-7983(97)92917-6; Wilson J, 2000, EFFECTIVE HEAD NECK; WILSON JA, 1998, EFFECTIVE HEAD NECK	14	17	17	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2002	324	7336					516	519		10.1136/bmj.324.7336.516	http://dx.doi.org/10.1136/bmj.324.7336.516			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	528DT	11872549	Green Published, Bronze			2022-12-28	WOS:000174229700019
J	Greenhalgh, T; Hughes, J; Humphrey, C; Rogers, S; Swinglehurst, D; Martin, P				Greenhalgh, T; Hughes, J; Humphrey, C; Rogers, S; Swinglehurst, D; Martin, P			A comparative case study of two models of a clinical informaticist service	BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTITIONERS; PRIMARY-CARE; HEALTH-CARE; QUESTIONS	Objectives To describe and evaluate two different models of a clinical informaticist service Design A case study approach, using various qualitative methods to illuminate the complexity of the project groups' experiences. Setting UK primary health care. Interventions Two informaticist projects to provide evidence based answers to questions arising in clinical practice and thereby support high quality clinical decision making by practitioners. Results The projects took contrasting and complementary approaches to establishing the service. One was based in an academic department of primary health care. The service was academically highly rigorous, remained true to its original proposal, included a prominent research component, and involved relatively little personal contact with practitioners. This group achieved the aim of providing general information and detailed guidance to others intending to set up a similar service. The other group was based in a service general practice and took a much more pragmatic, flexible, and facilitative approach. They achieved the aim of a credible, acceptable, and sustainable service that engaged local practitioners beyond the innovators and enthusiasts and secured continued funding. Conclusion An informaticist service should be judged on at least two aspects of quality-an academic dimension (the technical quality of the evidence based answers) and a service dimension (the facilitation of questioning behaviour and implementation). This study suggests that while the former may be best achieved within an academic environment, the latter requires a developmental approach in which pragmatic service considerations are addressed.	UCL, Sch Med, Dept Primary Care & Populat Sci, London N19 5LW, England; Kings Coll London, Sch Nursing & Midwifery, London SE1 8WA, England; Imperial Coll Sch Med, Dept Primary Care, London, England; Laindon Hlth Ctr, Basildon SS15 5TR, Essex, England	University of London; University College London; UCL Medical School; University of London; King's College London; Imperial College London	Greenhalgh, T (corresponding author), UCL, Sch Med, Dept Primary Care & Populat Sci, London N19 5LW, England.	p.greenhalgh@pcps.ucl.ac.uk	Greenhalgh, Trisha/B-1825-2015	Greenhalgh, Trisha/0000-0003-2369-8088; Swinglehurst, Deborah/0000-0003-1261-9268				Barrie AR, 1997, BRIT MED J, V315, P1512, DOI 10.1136/bmj.315.7121.1512; Brassey J, 2001, BRIT MED J, V322, P529, DOI 10.1136/bmj.322.7285.529; BUXTON V, 1998, NURS TIMES, V94, P55; Chambliss ML, 1996, J FAM PRACTICE, V43, P140; Clark J, 2000, BRIT MED J, V321, P566, DOI 10.1136/bmj.321.7260.566/a; Davidoff F, 2000, ANN INTERN MED, V132, P996, DOI 10.7326/0003-4819-132-12-200006200-00012; DENZIN M, 1994, HDB QUALITATIVE RES; Ely JW, 2000, BRIT MED J, V321, P429, DOI 10.1136/bmj.321.7258.429; Gordon P, 1998, PROJECTITIS SPENDING; GORMAN PN, 1995, MED DECIS MAKING, V15, P113, DOI 10.1177/0272989X9501500203; Greenhalgh T, 1999, BRIT J GEN PRACT, V49, P536; GREENHALGH T, 2000, READ PAPER BASICS EV, P179; Guyatt GH, 2000, BRIT MED J, V320, P954, DOI 10.1136/bmj.320.7240.954; Hayward JA, 1999, MED J AUSTRALIA, V171, P547, DOI 10.5694/j.1326-5377.1999.tb123793.x; Martin P, 2001, HLTH INFORM J, V7, P66; McColl A, 1998, BRIT MED J, V316, P361, DOI 10.1136/bmj.316.7128.361; OSHEROFF JA, 1991, ANN INTERN MED, V114, P576, DOI 10.7326/0003-4819-114-7-576; SCURA G, 1981, JAMA-J AM MED ASSOC, V245, P50, DOI 10.1001/jama.245.1.50; Swinglehurst DA, 2000, BRIT J GEN PRACT, V50, P747; Swinglehurst DA, 2001, QUAL HEALTH CARE, V10, P245, DOI 10.1136/qhc.0100245..; VEENSTRA RJ, 1992, CRIT CARE MED, V20, P1038, DOI 10.1097/00003246-199207000-00023	21	30	30	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 2	2002	324	7336					524	529		10.1136/bmj.324.7336.524	http://dx.doi.org/10.1136/bmj.324.7336.524			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	528DT	11872553	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000174229700022
J	Taitz, J; Weekers, JEM; Mosca, DT				Taitz, J; Weekers, JEM; Mosca, DT			DNA and immigration: the ethical ramifications	LANCET			English	Editorial Material									Int Org Migrat, Migrat Hlth Serv, CH-1211 Geneva 19, Switzerland; Univ Toronto, Fac Law, Toronto, ON M5S 1A1, Canada; Int Org Migrat, Migrat Hlth Serv, Nairobi, Kenya	International Organization for Migration; University of Toronto; International Organization for Migration	Weekers, JEM (corresponding author), Int Org Migrat, Migrat Hlth Serv, POB 71, CH-1211 Geneva 19, Switzerland.							*UN HIGH COMM REF, 1998, DNA TEST SORN FOUND; UNHCR, 1994, REF CHILDR GUID PROT	2	8	8	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 2	2002	359	9308					794	794		10.1016/S0140-6736(02)07889-3	http://dx.doi.org/10.1016/S0140-6736(02)07889-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526DZ	11888612				2022-12-28	WOS:000174115200037
J	Gill, GN				Gill, GN			Cell biology - A pit stop at the ER	SCIENCE			English	Editorial Material							GROWTH-FACTOR RECEPTOR; TRAFFICKING; ENDOCYTOSIS		Univ Calif San Diego, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Gill, GN (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.							Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; FRENCH AR, 1995, J BIOL CHEM, V270, P4334, DOI 10.1074/jbc.270.9.4334; Futter CE, 2001, J CELL BIOL, V155, P1251, DOI 10.1083/jcb.200108152; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kurten RC, 1996, SCIENCE, V272, P1008, DOI 10.1126/science.272.5264.1008; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; OPRESKO LK, 1995, J BIOL CHEM, V270, P4325, DOI 10.1074/jbc.270.9.4325; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Reggiori F, 2001, EMBO J, V20, P5176, DOI 10.1093/emboj/20.18.5176; Sato TK, 2001, SCIENCE, V294, P1881, DOI 10.1126/science.1065763; WILEY HS, 1991, J BIOL CHEM, V266, P11083; Yu JW, 2001, J BIOL CHEM, V276, P44179, DOI 10.1074/jbc.M108811200	17	14	14	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 1	2002	295	5560					1654	1655		10.1126/science.1070127	http://dx.doi.org/10.1126/science.1070127			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872824				2022-12-28	WOS:000174212900028
J	Reid, IR; Brown, JP; Burckhardt, P; Horowitz, Z; Richardson, P; Trechsel, U; Widmer, A; Devogelaer, J; Kaufman, J; Jaeger, P; Body, J; Meunier, PJ				Reid, IR; Brown, JP; Burckhardt, P; Horowitz, Z; Richardson, P; Trechsel, U; Widmer, A; Devogelaer, J; Kaufman, J; Jaeger, P; Body, J; Meunier, PJ			Intravenous zoledronic acid in postmenopausal women with low bone mineral density.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ORAL ALENDRONATE; OSTEOPOROSIS; THERAPY; BISPHOSPHONATE; ETIDRONATE; FRACTURES; MASS; IBANDRONATE; PAMIDRONATE; PREVENTION	Background: Bisphosphonates are effective agents for the management of osteoporosis. Their low bioavailability and low potency necessitate frequent administration on an empty stomach, which may reduce compliance. Gastrointestinal intolerance limits maximal dosing. Although intermittent intravenous treatments have been used, the optimal doses and dosing interval have not been systematically explored. Methods: We studied the effects of five regimens of zoledronic acid, the most potent bisphosphonate, on bone turnover and density in 351 postmenopausal women with low bone mineral density in a one-year, randomized, double-blind, placebo-controlled trial. Women received placebo or intravenous zoledronic acid in doses of 0.25 mg, 0.5 mg, or 1 mg at three-month intervals. In addition, one group received a total annual dose of 4 mg as a single dose, and another received two doses of 2 mg each, six months apart. Lumbar-spine bone mineral density was the primary end point. Results: There were similar increases in bone mineral density in all the zoledronic acid groups to values for the spine that were 4.3 to 5.1 percent higher than those in the placebo group (P<0.001) and values for the femoral neck that were 3.1 to 3.5 percent higher than those in the placebo group (P<0.001). Biochemical markers of bone resorption were significantly suppressed throughout the study in all zoledronic acid groups. Myalgia and pyrexia occurred more commonly in the zoledronic acid groups, but treatment-related dropout rates were similar to that in the placebo group. Conclusions: Zoledronic acid infusions given at intervals of up to one year produce effects on bone turnover and bone density as great as those achieved with daily oral dosing with bisphosphonates with proven efficacy against fractures, suggesting that an annual infusion of zoledronic acid might be an effective treatment for postmenopausal osteoporosis. (N Engl J Med 2002;346:653-61.) Copyright (C) 2002 Massachusetts Medical Society.	Univ Auckland, Dept Med, Auckland, New Zealand; CHU Laval, Ctr Rech, Quebec City, PQ G1V 4G2, Canada; CHU Vaudois, CH-1011 Lausanne, Switzerland; Novartis Pharmaceut, E Hanover, NJ USA; Novartis Pharma, Basel, Switzerland; Catholic Univ Louvain, Dept Rheumatol, Brussels, Belgium; State Univ Ghent Hosp, Dept Endocrinol, B-9000 Ghent, Belgium; Univ Bern, Inselspital, Med Poliklin, CH-3010 Bern, Switzerland; Free Univ Brussels, Inst Jules Bordet, Endocrinol & Support Care Clin, Brussels, Belgium; Hop Edouard Herriot, Dept Rheumatol & Bone Dis, Lyon, France; Osped Careggi, Unita Endocrinol, Florence, Italy; Kaiser Franz Josef Spital Stadt Wien, Abt Rheumatol & Osteol, Vienna, Austria; Osped Maggiore Matern, Ctr Fisiopatol Menopausa, Bologna, Italy; Osped Riuniti S Chiara, Pisa, Italy; Univ Klinikum Benjamin Franklin, Strahlenklin & Poliklin, Berlin, Germany; Concord Hosp, Dept Endocrinol, Concord, NSW, Australia; Graz Univ, Med Klin, Klin Abt Endokrinol & Nukl Med, A-8036 Graz, Austria; Univ Uppsala, Akad Sjukhuset, Med Kliniken, Uppsala, Sweden; St Michaels Hosp, Metab Bone Clin, Toronto, ON M5B 1W8, Canada; Ist Auxol Italiano, Ctr Studi Metab Osseo, Milan, Italy; Osped San Raffaele, Unita Metab Osso, Milan, Italy; Karolinska Sjukhuset, Endokrinol Kliniken, Stockholm, Sweden; Univ Kliniken, Kvinnokliniken, Lund, Sweden; Free Univ Brussels, Acad Hosp, Dept Rheumatol, B-1090 Brussels, Belgium	University of Auckland; Laval University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Novartis; Novartis; Universite Catholique Louvain; Ghent University; Ghent University Hospital; University of Bern; University Hospital of Bern; Institut Jules Bordet; Universite Libre de Bruxelles; Vrije Universiteit Brussel; CHU Lyon; University of Florence; Azienda Ospedaliero Universitaria Careggi; AUSL di Bologna; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Concord Repatriation General Hospital; University of Graz; Uppsala University; Uppsala University Hospital; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; IRCCS Istituto Auxologico Italiano; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Karolinska Institutet; Karolinska University Hospital; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Reid, IR (corresponding author), Univ Auckland, Dept Med, Private Bag 92019, Auckland, New Zealand.	i.reid@auckland.ac.nz	Rubinacci, Alessandro/AAF-6627-2020; Body, Jean-Jacques/G-9785-2015; Rubinacci, Alessandro/ABG-5732-2020	Rubinacci, Alessandro/0000-0003-1736-0531; Brown, Jacques/0000-0003-1910-788X				Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Body JJ, 1999, J BONE MINER RES, V14, P1557, DOI 10.1359/jbmr.1999.14.9.1557; CHESTNUT CH, 1995, AM J MED, V99, P144, DOI 10.1016/S0002-9343(99)80134-X; Christensen P. M., 2000, Bone (New York), V27, p21S; Devogelaer JP, 1996, BONE, V19, P78; Devogelaer JP, 1996, BONE, V18, P141, DOI 10.1016/8756-3282(95)00436-X; Faulkner DL, 1998, MENOPAUSE, V5, P226; GARNERO P, 1994, J CLIN ENDOCR METAB, V79, P1693, DOI 10.1210/jc.79.6.1693; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; Hui SL, 1997, J BONE MINER RES, V12, P1463, DOI 10.1359/jbmr.1997.12.9.1463; Khan SA, 1997, J BONE MINER RES, V12, P1700, DOI 10.1359/jbmr.1997.12.10.1700; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; Major P, 2001, J CLIN ONCOL, V19, P558, DOI 10.1200/JCO.2001.19.2.558; MARCUS R, 1976, BIOMETRIKA, V63, P655, DOI 10.1093/biomet/63.3.655; Masarachia P, 1996, BONE, V19, P281, DOI 10.1016/8756-3282(96)00182-2; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; PASSERI M, 1991, BONE MINER, V15, P237, DOI 10.1016/0169-6009(91)90129-N; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; Ravn P, 1996, BONE, V19, P527, DOI 10.1016/S8756-3282(96)00229-3; Recker RR, 2000, OSTEOPOROSIS INT, V11, pS209; REID IR, 1994, J CLIN ENDOCR METAB, V79, P1595, DOI 10.1210/jc.79.6.1595; Reinholz GG, 2000, CANCER RES, V60, P6001; SATO M, 1991, J CLIN INVEST, V88, P2095, DOI 10.1172/JCI115539; STORM T, 1990, NEW ENGL J MED, V322, P1265, DOI 10.1056/NEJM199005033221803; Thiebaud D, 1997, AM J MED, V103, P298, DOI 10.1016/S0002-9343(97)00249-0; THIEBAUD D, 1994, OSTEOPOROSIS INT, V4, P76, DOI 10.1007/BF01623227; THIEBAUD D, 1997, J BONE MINER RES  S1, V12, pS343; WATTS NB, 1990, NEW ENGL J MED, V323, P73, DOI 10.1056/NEJM199007123230201	28	612	658	1	24	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2002	346	9					653	661		10.1056/NEJMoa011807	http://dx.doi.org/10.1056/NEJMoa011807			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525HJ	11870242	Bronze			2022-12-28	WOS:000174062800003
J	Crowley, TJ				Crowley, TJ			Cycles, cycles everywhere	SCIENCE			English	Editorial Material									Duke Univ, Nicholas Sch Environm & Earth Sci, Div Earth & Ocean Sci, Durham, NC 27708 USA	Duke University	Crowley, TJ (corresponding author), Duke Univ, Nicholas Sch Environm & Earth Sci, Div Earth & Ocean Sci, Durham, NC 27708 USA.							*AM GEOPH UN, 2001, AM GEOPH UN FALL M S; Berger A.L., 1984, MILANKOVITCH CLIMATE; Gallup CD, 2002, SCIENCE, V295, P310, DOI 10.1126/science.1065494; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; MILANKOVITCH M, 1969, K SERB ACAD BEOGR SP, V132, P1941; Shackleton N.J., 1975, INIT REPS DEEP SEA D, V29, P801, DOI DOI 10.2973/DSDP.PROC.29.120.1975; SHACKLETON NJ, 1990, T ROY SOC EDIN-EARTH, V81, P251, DOI 10.1017/S0263593300020782	7	15	20	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2002	295	5559					1473	1474		10.1126/science.1069617	http://dx.doi.org/10.1126/science.1069617			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11859180				2022-12-28	WOS:000173981300036
J	Park, SJ; Taton, TA; Mirkin, CA				Park, SJ; Taton, TA; Mirkin, CA			Array-based electrical detection of DNA with nanoparticle probes	SCIENCE			English	Article							POLYNUCLEOTIDES; HYBRIDIZATION	A DNA array detection method is reported in which the binding of oligonucleotides functionalized with gold nanoparticles leads to conductivity changes associated with target-probe binding events. The binding events localize gold nanoparticles in an electrode gap; silver deposition facilitated by these nanoparticles bridges the gap and leads to readily measurable conductivity changes. An unusual salt concentration-dependent hybridization behavior associated with these nanoparticle probes was exploited to achieve selectivity without a thermal-stringency wash. Using this method, we have detected target DNA at concentrations as low as 500 femtomolar with a point mutation selectivity factor of similar to 100,000:1.	Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; Northwestern Univ, Inst Nanotechnol, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Mirkin, CA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.		Mirkin, Chad A/E-3911-2010; Park, So-Jung/F-9471-2017	Mirkin, Chad/0000-0002-6634-7627				Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Chrisey LA, 1996, NUCLEIC ACIDS RES, V24, P3031, DOI 10.1093/nar/24.15.3031; Eckstein F., 1991, OLIGONUCLEOTIDES ANA; Elghanian R, 1997, SCIENCE, V277, P1078, DOI 10.1126/science.277.5329.1078; Fodor SPA, 1997, SCIENCE, V277, P393, DOI 10.1126/science.277.5324.393; He L, 2000, J AM CHEM SOC, V122, P9071, DOI 10.1021/ja001215b; IKUTA S, 1987, NUCLEIC ACIDS RES, V15, P797, DOI 10.1093/nar/15.2.797; Keller G. H, 1989, DNA PROBES; Kelley SO, 1999, NUCLEIC ACIDS RES, V27, P4830, DOI 10.1093/nar/27.24.4830; Moller R, 2001, LANGMUIR, V17, P5426, DOI 10.1021/la0102408; Napier ME, 1997, BIOCONJUGATE CHEM, V8, P906, DOI 10.1021/bc9701149; Nicewarner-Pena SR, 2001, SCIENCE, V294, P137, DOI 10.1126/science.294.5540.137; Niemeyer CM, 2001, ANGEW CHEM INT EDIT, V40, P3685, DOI 10.1002/1521-3773(20011001)40:19<3685::AID-ANIE3685>3.0.CO;2-E; Park SJ, 2000, ANGEW CHEM INT EDIT, V39, P3845, DOI 10.1002/1521-3773(20001103)39:21<3845::AID-ANIE3845>3.0.CO;2-O; Storhoff JJ, 1998, J AM CHEM SOC, V120, P1959, DOI 10.1021/ja972332i; Taton TA, 2000, SCIENCE, V289, P1757, DOI 10.1126/science.289.5485.1757; Taton TA, 2001, J AM CHEM SOC, V123, P5164, DOI 10.1021/ja0102639; Velev OD, 1999, LANGMUIR, V15, P3693, DOI 10.1021/la981729c; Yu CJ, 2001, J AM CHEM SOC, V123, P11155, DOI 10.1021/ja010045f	19	1506	1645	5	383	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2002	295	5559					1503	1506						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11859188				2022-12-28	WOS:000173981300046
J	Kuhnle, A; Linderoth, TR; Hammer, B; Besenbacher, F				Kuhnle, A; Linderoth, TR; Hammer, B; Besenbacher, F			Chiral recognition in dimerization of adsorbed cysteine observed by scanning tunnelling microscopy	NATURE			English	Article							TUNNELING-MICROSCOPY; MOLECULES; SEPARATION; SURFACES; AU(111)	Stereochemistry plays a central role in controlling molecular recognition and interaction: the chemical and biological properties of molecules depend not only on the nature of their constituent atoms but also on how these atoms are positioned in space. Chiral specificity is consequently fundamental in chemical biology and pharmacology(1,2) and has accordingly been widely studied. Advances in scanning probe microscopies now make it possible to probe chiral phenomena at surfaces at the molecular level. These methods have been used to determine the chirality of adsorbed molecules(3-5), and to provide direct evidence for chiral discrimination in molecular interactions(6) and the spontaneous resolution of adsorbates into extended enantiomerically pure overlayers(3,7-9). Here we report scanning tunnelling microscopy studies of cysteine adsorbed to a (110) gold surface, which show that molecular pairs formed from a racemic mixture of this naturally occurring amino acid are exclusively homochiral, and that their binding to the gold surface is associated with local surface restructuring. Density-functional theory(10) calculations indicate that the chiral specificity of the dimer formation process is driven by the optimization of three bonds on each cysteine molecule. These findings thus provide a clear molecular-level illustration of the well known three-point contact model(11,12) for chiral recognition in a simple bimolecular system.	Aarhus Univ, Interdisciplinary Nanosci Ctr, DK-8000 Aarhus C, Denmark; Aarhus Univ, Inst Phys & Astron, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University	Besenbacher, F (corresponding author), Aarhus Univ, Interdisciplinary Nanosci Ctr, DK-8000 Aarhus C, Denmark.		Kuhnle, Angelika/C-5080-2011; Hammer, Bjørk/C-3701-2013; Besenbacher, Flemming/A-9623-2010	Hammer, Bjørk/0000-0002-7849-6347; 				Bohringer M, 1999, ANGEW CHEM INT EDIT, V38, P821, DOI 10.1002/(SICI)1521-3773(19990315)38:6<821::AID-ANIE821>3.0.CO;2-A; Booth TD, 1997, CHIRALITY, V9, P96; CHEN Q, 1999, PHYS CHEM COMM, V9; Easson LH, 1933, BIOCHEM J, V27, P1257, DOI 10.1042/bj0271257; ECKHARDT CJ, 1993, NATURE, V362, P614, DOI 10.1038/362614a0; Fang HB, 1998, J PHYS CHEM B, V102, P7311, DOI 10.1021/jp981960z; Gottschalck J, 2002, J CHEM PHYS, V116, P784, DOI 10.1063/1.1424292; GRITSCH T, 1991, SURF SCI, V257, P297, DOI 10.1016/0039-6028(91)90800-8; Gronbeck H, 2000, J AM CHEM SOC, V122, P3839, DOI 10.1021/ja993622x; LAEGSGAARD E, 1988, J MICROSC-OXFORD, V152, P663, DOI 10.1111/j.1365-2818.1988.tb01435.x; Lopinski GP, 1998, NATURE, V392, P909, DOI 10.1038/31913; Lorenzo MO, 2000, NATURE, V404, P376, DOI 10.1038/35006031; McKendry R, 1998, NATURE, V391, P566, DOI 10.1038/35339; PAYNE MC, 1992, REV MOD PHYS, V64, P1045, DOI 10.1103/RevModPhys.64.1045; PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671; Poirier GE, 1996, SCIENCE, V272, P1145, DOI 10.1126/science.272.5265.1145; Sheldon R. A., 1993, CHIROTECHNOLOGY, P39; TERSOFF J, 1985, PHYS REV B, V31, P805, DOI 10.1103/PhysRevB.31.805; Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357; [No title captured]	20	513	522	4	235	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 21	2002	415	6874					891	893		10.1038/415891a	http://dx.doi.org/10.1038/415891a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859364	Green Published			2022-12-28	WOS:000173941000040
J	Woudstra, EC; Gilbert, C; Fellows, J; Jansen, L; Brouwer, J; Erdjument-Bromage, H; Tempst, P; Svejstrup, JQ				Woudstra, EC; Gilbert, C; Fellows, J; Jansen, L; Brouwer, J; Erdjument-Bromage, H; Tempst, P; Svejstrup, JQ			A Rad26-Def1 complex coordinates repair and RNA pol II proteolysis in response to DNA damage	NATURE			English	Article							TRANSCRIPTION-COUPLED REPAIR; NUCLEOTIDE EXCISION-REPAIR; ELONGATION-FACTOR TFIIS; POLYMERASE-II; COCKAYNE-SYNDROME; SACCHAROMYCES-CEREVISIAE; INDUCED UBIQUITINATION; LARGE SUBUNIT; CELLS; DEGRADATION	Eukaryotic cells use multiple, highly conserved mechanisms to contend with ultraviolet-light-induced DNA damage(1). One important response mechanism is transcription-coupled repair (TCR), during which DNA lesions in the transcribed strand of an active gene are repaired much faster than in the genome overall(2). In mammalian cells, defective TCR gives rise to the severe human disorder Cockayne's syndrome (CS)(3). The best-studied CS gene, CSB, codes for a Swi/Snf-like DNA-dependent ATPase, whose yeast homologue is called Rad26 (ref. 4). Here we identify a yeast protein, termed Def1, which forms a complex with Rad26 in chromatin. The phenotypes of cells lacking DEF1 are consistent with a role for this factor in the DNA damage response, but Def1 is not required for TCR. Rather, def1 cells are compromised for transcript elongation, and are unable to degrade RNA polymerase II (RNAPII) in response to DNA damage. Our data suggest that RNAPII stalled at a DNA lesion triggers a coordinated rescue mechanism that requires the Rad26-Def1 complex, and that Def1 enables ubiquitination and proteolysis of RNAPII when the lesion cannot be rapidly removed by Rad26-promoted DNA repair.	Canc Res UK, Clare Hall Labs, Mech Gene Transcript Lab, S Mimms EN6 3LD, Herts, England; Leiden Univ, Leiden Inst Chem, MGC Dept Mol Genet, NL-2300 RA Leiden, Netherlands; Mem Sloan Kettering Canc Ctr, Mol Biol Programme, New York, NY 10021 USA	Cancer Research UK; Leiden University; Leiden University - Excl LUMC; Memorial Sloan Kettering Cancer Center	Svejstrup, JQ (corresponding author), Canc Res UK, Clare Hall Labs, Mech Gene Transcript Lab, Blanche Lane, S Mimms EN6 3LD, Herts, England.	j.svejstrup@cancer.org.uk		Svejstrup, Jesper/0000-0003-4964-6147; Jansen, Lars/0000-0002-2158-0345; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Tempst, Paul/0000-0002-6680-3987				ARCHAMBAULT J, 1992, MOL CELL BIOL, V12, P4142, DOI 10.1128/MCB.12.9.4142; Beaudenon SL, 1999, MOL CELL BIOL, V19, P6972; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Conaway JW, 2000, TRENDS BIOCHEM SCI, V25, P375, DOI 10.1016/S0968-0004(00)01615-7; de Boer J, 2000, CARCINOGENESIS, V21, P453, DOI 10.1093/carcin/21.3.453; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Gillette TG, 2001, GENE DEV, V15, P1528, DOI 10.1101/gad.869601; Hanawalt PC, 2001, MUTAT RES-DNA REPAIR, V485, P3, DOI 10.1016/S0921-8777(00)00071-9; Hilt W, 1996, TRENDS BIOCHEM SCI, V21, P96, DOI 10.1016/S0968-0004(96)10012-8; Jansen LET, 2000, EMBO J, V19, P6498, DOI 10.1093/emboj/19.23.6498; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; Le Page F, 2000, CELL, V101, P159, DOI 10.1016/S0092-8674(00)80827-2; Lommel L, 2000, P NATL ACAD SCI USA, V97, P9088, DOI 10.1073/pnas.150130197; Luo ZH, 2001, MUTAT RES-DNA REPAIR, V486, P259, DOI 10.1016/S0921-8777(01)00097-0; MAYNE LV, 1982, CANCER RES, V42, P1473; McKay BC, 2001, MUTAT RES-DNA REPAIR, V485, P93, DOI 10.1016/S0921-8777(00)00064-1; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Ratner JN, 1998, J BIOL CHEM, V273, P5184, DOI 10.1074/jbc.273.9.5184; Russell SJ, 1999, MOL CELL, V3, P687, DOI 10.1016/S1097-2765(01)80001-0; SCHMICKEL RD, 1977, PEDIATRICS, V60, P135; Thompson NE, 1996, METHOD ENZYMOL, V274, P513; vanGool AJ, 1997, EMBO J, V16, P4155, DOI 10.1093/emboj/16.14.4155; VANGOOL AJ, 1994, EMBO J, V13, P5361, DOI 10.1002/j.1460-2075.1994.tb06871.x; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; Verhage RA, 1996, MOL CELL BIOL, V16, P496; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; Winkler GS, 2001, J BIOL CHEM, V276, P32743, DOI 10.1074/jbc.M105303200; Wu JS, 1996, P NATL ACAD SCI USA, V93, P11552, DOI 10.1073/pnas.93.21.11552; Yu AD, 2000, MOL CELL, V5, P801, DOI 10.1016/S1097-2765(00)80320-2	30	176	178	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2002	415	6874					929	933		10.1038/415929a	http://dx.doi.org/10.1038/415929a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859374				2022-12-28	WOS:000173941000050
J	Berkman, DS; Lescano, AG; Gilman, RH; Lopez, S; Black, MM				Berkman, DS; Lescano, AG; Gilman, RH; Lopez, S; Black, MM			Effects of stunting, diarrhoeal disease, and parasitic infection during infancy on cognition in late childhood: a follow-up study	LANCET			English	Article							GIARDIA-LAMBLIA; PERUVIAN CHILDREN; PHYSICAL GROWTH; SCHOOL-CHILDREN; PUEBLO-JOVEN; RISK-FACTORS; MALNUTRITION; CRYPTOSPORIDIOSIS; ASSOCIATION; PERFORMANCE	Background Chronic malnutrition during infancy, marked by stunting, has been associated with poor cognitive function. We assessed the effect of stunting, diarrhoeal disease, and parasitic infections during infancy on cognitive function in late childhood. Methods We followed up from birth to 2 years, a cohort of 239 Peruvian children for anthropometrics, stool samples, and diarrhoeal status. At 9 years of age, we assessed cognitive function in 143 (69%) with the full-scale intelligence quotient of the Wechsler intelligence scale for children-revised (WISC-R). Findings All findings were adjusted for socioeconomic status and schooling; in addition, findings related to diarrhoea prevalence, Giardia lamblia, and Cryptosporidium parvum were adjusted for severe stunting. During the first 2 years of life, 46 (32%) of 143 children were stunted. Children with severe stunting in the second year of life scored 10 points lower on the WISC-R test (95% CI 2.4-17.5) than children without severe stunting. Children with more than one episode of G lamblia per year scored 4.1 points (0.2-8.0) lower than children with one episode or fewer per year. Neither diarrhoea prevalence nor C parvum infection was associated with WISC-R scores. Interpretation Malnutrition in early childhood, indexed by stunting, and potentially G lamblia, are associated with poor cognitive function at age 9 years. If the observed associations are causal, then intervention programmes designed to prevent malnutrition and G lamblia, early in life could lead to significant improvement in cognitive function of children in similar lower-income communities throughout the less-developed world.	Johns Hopkins Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; AB PRISMA, Lima, Peru; Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; Univ Peruana Cayetano Heredia, Lima, Peru	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University System of Maryland; University of Maryland Baltimore; Universidad Peruana Cayetano Heredia	Gilman, RH (corresponding author), Johns Hopkins Sch Publ Hlth, Dept Int Hlth, 615 N Wolfe St,Room W3503, Baltimore, MD 21205 USA.	rgilman@jhsph.edu	Lescano, Andres G/B-8479-2008; Lescano, Andres G./M-9849-2019	Lescano, Andres G/0000-0001-9779-633X; Lescano, Andres G./0000-0001-9779-633X; Black, Maureen/0000-0002-6427-4639				ARROWOOD MJ, 1989, J CLIN MICROBIOL, V27, P1490, DOI 10.1128/JCM.27.7.1490-1495.1989; *AS BEN PRISMA, 1994, VIG NUTR REG LIM 199; Black MM, 1998, AM J CLIN NUTR, V68, p464S, DOI 10.1093/ajcn/68.2.464S; BLACK RE, 1984, AM J CLIN NUTR, V39, P87, DOI 10.1093/ajcn/39.1.87; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV EX; BROOKMEYER R, 1982, BIOMETRICS, V38, P29, DOI 10.2307/2530286; Brown JL, 1996, SCI AM, V274, P38, DOI 10.1038/scientificamerican0296-38; Checkley W, 1998, AM J EPIDEMIOL, V148, P497, DOI 10.1093/oxfordjournals.aje.a009675; Checkley W, 1997, AM J EPIDEMIOL, V145, P156, DOI 10.1093/oxfordjournals.aje.a009086; CONNOLLY KJ, 1993, PARASITOLOGY, V107, pS187, DOI 10.1017/S0031182000075612; DEONIS M, 1993, B WORLD HEALTH ORGAN, V71, P703; FARTHING MJG, 1986, AM J CLIN NUTR, V43, P395, DOI 10.1093/ajcn/43.3.395; FERNANDEZCONCHA D, 1991, T ROY SOC TROP MED H, V85, P809, DOI 10.1016/0035-9203(91)90465-B; Fraser D, 2000, CLIN INFECT DIS, V30, P419, DOI 10.1086/313722; GILMAN RH, 1988, LANCET, V1, P343, DOI 10.1016/S0140-6736(88)91131-2; GILMAN RH, 1993, AM J PUBLIC HEALTH, V83, P1554, DOI 10.2105/AJPH.83.11.1554; Guerrant DI, 1999, AM J TROP MED HYG, V61, P707, DOI 10.4269/ajtmh.1999.61.707; GUERRANT RL, 1983, J INFECT DIS, V148, P986, DOI 10.1093/infdis/148.6.986; GUERRANT RL, 1992, AM J TROP MED HYG, V47, P28, DOI 10.4269/ajtmh.1992.47.28; Halterman JS, 2001, PEDIATRICS, V107, P1381, DOI 10.1542/peds.107.6.1381; Lunn PG, 1999, J NUTR, V129, P872, DOI 10.1093/jn/129.4.872; Mendez MA, 1999, J NUTR, V129, P1555, DOI 10.1093/jn/129.8.1555; NASH TE, 1993, P NATL ACAD SCI USA, V90, P5489, DOI 10.1073/pnas.90.12.5489; NOKES C, 1992, PARASITOLOGY, V104, P539, DOI 10.1017/S0031182000063800; Ortega YR, 1997, CLIN INFECT DIS, V25, P545, DOI 10.1086/513745; POWELL CA, 1995, ACTA PAEDIATR, V84, P22, DOI 10.1111/j.1651-2227.1995.tb13479.x; Sakti H, 1999, TROP MED INT HEALTH, V4, P322, DOI 10.1046/j.1365-3156.1999.00410.x; SEPULVEDA J, 1988, AM J EPIDEMIOL, V127, P365, DOI 10.1093/oxfordjournals.aje.a114810; Stephensen CB, 1999, J NUTR, V129, p534S, DOI 10.1093/jn/129.2.534S; STERLING CR, 1991, J PROTOZOOL, V38, pS23; VIDAL MFC, 1991, J CLIN MICROBIOL, V29, P636, DOI 10.1128/JCM.29.3.636-637.1991; Watkins WE, 1996, T ROY SOC TROP MED H, V90, P156, DOI 10.1016/S0035-9203(96)90121-2; Wechsler DW., 1999, INTELLIGENCE SCALE C	33	490	516	1	37	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2002	359	9306					564	571		10.1016/S0140-6736(02)07744-9	http://dx.doi.org/10.1016/S0140-6736(02)07744-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523FP	11867110				2022-12-28	WOS:000173943600009
J	Petricoin, EF; Ardekani, AM; Hitt, BA; Levine, PJ; Fusaro, VA; Steinberg, SM; Mills, GB; Simone, C; Fishman, DA; Kohn, EC; Liotta, LA				Petricoin, EF; Ardekani, AM; Hitt, BA; Levine, PJ; Fusaro, VA; Steinberg, SM; Mills, GB; Simone, C; Fishman, DA; Kohn, EC; Liotta, LA			Use of proteomic patterns in serum to identify ovarian cancer	LANCET			English	Article								Background New technologies for the detection of early-stage ovarian cancer are urgently needed. Pathological changes within an organ might be reflected in proteomic patterns in serum. We developed a bioinformatics tool and used it to identify proteomic patterns in serum that distinguish neoplastic from non-neoplastic disease within the ovary. Methods Proteomic spectra were generated by mass spectroscopy (surface-enhanced laser desorption and ionisation). A preliminary "training" set of spectra derived from analysis of serum from 50 unaffected women and 50 patients with ovarian cancer were analysed by an iterative searching algorithm that identified a proteomic pattern that completely discriminated cancer from non-cancer. The discovered pattern was then used to classify an independent set of 116 masked serum samples: 50 from women with ovarian cancer, and 66 from unaffected women or those with non-malignant disorders. Findings The algorithm identified a cluster pattern that, in the training set, completely segregated cancer from non-cancer. The discriminatory pattern correctly identified all 50 ovarian cancer cases in the masked set, including all 18 stage I cases. Of the 66 cases of non-malignant disease, 63 were recognised as not cancer. This result yielded a sensitivity of 100% (95% CI 93-100), specificity of 95% (87-99), and positive predictive, value of 94% (84-99). Interpretation These findings justify a prospective population-based assessment of proteomic pattern technology as a screening tool for all stages of ovarian cancer in high-risk and general populations.	US FDA, Natl Inst Hlth Clin Proteom Program, Dept Therapeut Prot, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA; NCI, Biostat & Data Management Sect, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; Correlog Syst Inc, Bethesda, MD USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol Therapeut, Div Canc Med, Houston, TX 77030 USA; Simone Protect Canc Inst, Lawrenceville, NJ USA; Northwestern Univ, Sch Med, Natl Ovarian Canc Early Detect Program, Chicago, IL USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; UTMD Anderson Cancer Center; Northwestern University	Petricoin, EF (corresponding author), Bldg 29A,Room 2B02,8800 Rockville Pike, Bethesda, MD 20892 USA.							Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Cohen LS, 2001, GYNECOL ONCOL, V82, P40, DOI 10.1006/gyno.2001.6253; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Herbert B.R., 1997, PROTEOME RES NEW FRO, P13; HOLLAND J, 1994, ADAPTATION NATURAL A; HOLLANDER M, 1999, NONPARAMETRIC STAT M, P189; Jacobs IJ, 1999, LANCET, V353, P1207, DOI 10.1016/S0140-6736(98)10261-1; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325; Lapuerta P, 1998, MED DECIS MAKING, V18, P70, DOI 10.1177/0272989X9801800114; Lindahl D, 1999, CLIN PHYSIOL, V19, P497; Menon U, 2000, CURR OPIN OBSTET GYN, V12, P39, DOI 10.1097/00001703-200002000-00007; Menon U., 2000, PRINCIPLES PRACTICE, P165; Ozols RF, 2000, PRINCIPLES PRACTICE, P981; Paweletz CP, 2000, DRUG DEVELOP RES, V49, P34, DOI 10.1002/(SICI)1098-2299(200001)49:1<34::AID-DDR6>3.3.CO;2-N; Richter R, 1999, J CHROMATOGR B, V726, P25, DOI 10.1016/S0378-4347(99)00012-2; Tou JT, 1974, PATTERN RECOGN, P75	20	2399	2690	6	224	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 16	2002	359	9306					572	577		10.1016/S0140-6736(02)07746-2	http://dx.doi.org/10.1016/S0140-6736(02)07746-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523FP	11867112				2022-12-28	WOS:000173943600011
J	Coulter, A				Coulter, A			After Bristol: putting patients at the centre	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SHARED DECISION-MAKING; CARE; COMMUNICATION; QUALITY; DOCTORS		Picker Inst Europe, Oxford OX1 1RX, England		Coulter, A (corresponding author), Picker Inst Europe, Oxford OX1 1RX, England.	angela.coulter@pickereurope.ac.uk	Coulter, Angela/N-6998-2019	Coulter, Angela/0000-0002-6308-8375				Cleary PD, 1997, JAMA-J AM MED ASSOC, V278, P1608, DOI 10.1001/jama.278.19.1608; Cockburn J, 1997, BRIT MED J, V315, P520, DOI 10.1136/bmj.315.7107.520; Consumers' Association, 2000, PAT INF LEAFL SICK N; Coulter A, 1999, BRIT MED J, V318, P318, DOI 10.1136/bmj.318.7179.318; Dean B, 2000, QUAL HEALTH CARE, V9, P232, DOI 10.1136/qhc.9.4.232; Di Blasi Z, 2001, LANCET, V357, P757, DOI 10.1016/S0140-6736(00)04169-6; Donelan K, 2000, HEALTH AFFAIR, V19, P226, DOI 10.1377/hlthaff.19.3.226; Elwyn G, 2000, BRIT J GEN PRACT, V50, P892; Hart Julian Tudor, 1998, Health Expect, V1, P3, DOI 10.1046/j.1369-6513.1998.00001.x; Holmes-Rovner M, 2001, BMJ-BRIT MED J, V322, P664, DOI 10.1136/bmj.322.7287.664; LAVELLEJONES C, 1993, BRIT MED J, V306, P885, DOI 10.1136/bmj.306.6882.885; MAKOUL G, 1995, SOC SCI MED, V41, P1241, DOI 10.1016/0277-9536(95)00061-B; Marshall MN, 2000, JAMA-J AM MED ASSOC, V283, P1866, DOI 10.1001/jama.283.14.1866; Mercer SW, 2001, BRIT MED J, V322, P865, DOI 10.1136/bmj.322.7290.865; Mullen PD, 1997, BRIT MED J, V314, P691, DOI 10.1136/bmj.314.7082.691; MULLIGAN J, 2000, WHAT DO PUBLIC THINK, P12; O'Connor AM, 1999, BRIT MED J, V319, P731, DOI 10.1136/bmj.319.7212.731; PYPER C, 2001, ERDIP ONLINE PATIENT; Secretary of State for Health, 2000, NHS PLAN; Sitzia J, 1997, SOC SCI MED, V45, P1829, DOI 10.1016/S0277-9536(97)00128-7; Stevenson FA, 2000, SOC SCI MED, V50, P829, DOI 10.1016/S0277-9536(99)00376-7; The Bristol Royal Infirmary Inquiry, 2001, LEARN BRIST REP PUBL; VINCENT C, 1994, LANCET, V343, P1609, DOI 10.1016/S0140-6736(94)93062-7; Volk RJ, 1999, ARCH FAM MED, V8, P333, DOI 10.1001/archfami.8.4.333	24	79	81	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2002	324	7338					648	651		10.1136/bmj.324.7338.648	http://dx.doi.org/10.1136/bmj.324.7338.648			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532QW	11895824	Green Published, Bronze			2022-12-28	WOS:000174487400026
J	Fernandez-Gonzalez, A; La Spada, AR; Treadaway, J; Higdon, JC; Harris, BS; Sidman, RL; Morgan, JI; Zuo, J				Fernandez-Gonzalez, A; La Spada, AR; Treadaway, J; Higdon, JC; Harris, BS; Sidman, RL; Morgan, JI; Zuo, J			Purkinje cell degeneration (pcd) phenotypes caused by mutations in the axotomy-induced gene, Nna1	SCIENCE			English	Article							CEREBELLAR MUTANT MOUSE; RETINAL DEGENERATION; NEUROLOGICAL MUTATION; THALAMIC NEURONS; MICE; NEURODEGENERATION; EXPRESSION	The classical recessive mouse mutant, Purkinje cell degeneration (pcd), exhibits adult-onset degeneration of cerebellar Purkinje neurons, retinal photoreceptors, olfactory bulb mitral neurons, and selected thalamic neurons, and has defective spermatogenesis. Here we identify Nna1 as the gene mutated in the original pcd and two additional pcd alleles (pcd(2J) and pcd(3J)). Nna1 encodes a putative nuclear protein containing a zinc carboxypeptidase domain initially identified by its induction in spinal motor neurons during axonal regeneration. The present study suggests an unexpected molecular link between neuronal degeneration and regeneration, and its results have potential implications for neurodegenerative diseases and male infertility.	St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; Univ Washington, Div Med Genet Med, Seattle, WA 98195 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA	St Jude Children's Research Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Jackson Laboratory; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Zuo, J (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	jian.zuo@stjude.org	Morgan, James/GRO-2905-2022; La Spada, Albert/AAG-8809-2020; Morgan, James/N-8104-2018	Morgan, James/0000-0002-8920-1065; 	NCI NIH HHS [CA 23944, CA21765, R25 CA023944] Funding Source: Medline; NCRR NIH HHS [RR 01183] Funding Source: Medline; NEI NIH HHS [EY 12950] Funding Source: Medline; NIDCD NIH HHS [DC 04761] Funding Source: Medline; NIEHS NIH HHS [ES 10772] Funding Source: Medline; NINDS NIH HHS [NS 40361] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765, R25CA023944] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR001183] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC004761] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Blake JA, 2001, NUCLEIC ACIDS RES, V29, P91, DOI 10.1093/nar/29.1.91; BLANKS JC, 1982, J COMP NEUROL, V212, P231, DOI 10.1002/cne.902120303; Campbell DB, 1996, MOL BRAIN RES, V37, P79, DOI 10.1016/0169-328X(95)00275-W; Fernandez-Gonzalez A, 2000, EUR J NEUROSCI, V12, P1573, DOI 10.1046/j.1460-9568.2000.00044.x; GOODLETT CR, 1992, BEHAV BRAIN RES, V47, P129, DOI 10.1016/S0166-4328(05)80119-6; GREER CA, 1982, BRAIN RES, V235, P156, DOI 10.1016/0006-8993(82)90206-2; Hamilton BA, 1997, NEURON, V18, P711, DOI 10.1016/S0896-6273(00)80312-8; HANDEL MA, 1981, GAMETE RES, V4, P185, DOI 10.1002/mrd.1120040303; Harris A, 2000, MOL CELL NEUROSCI, V16, P578, DOI 10.1006/mcne.2000.0900; Hatten ME, 1997, CURR OPIN NEUROBIOL, V7, P40, DOI 10.1016/S0959-4388(97)80118-3; HE GP, 1995, NATURE, V378, P92, DOI 10.1038/378092a0; Heintz N, 2000, ANNU REV PHYSIOL, V62, P779, DOI 10.1146/annurev.physiol.62.1.779; LANDIS SC, 1978, J COMP NEUROL, V177, P125, DOI 10.1002/cne.901770109; LAVAIL MM, 1982, J COMP NEUROL, V212, P217, DOI 10.1002/cne.902120302; MULLEN RJ, 1975, NATURE, V258, P528, DOI 10.1038/258528a0; MULLEN RJ, 1977, NATURE, V270, P245, DOI 10.1038/270245a0; MULLEN RJ, 1976, P NATL ACAD SCI USA, V73, P208, DOI 10.1073/pnas.73.1.208; OGORMAN S, 1985, J COMP NEUROL, V234, P277, DOI 10.1002/cne.902340302; OGORMAN S, 1985, J COMP NEUROL, V234, P298, DOI 10.1002/cne.902340303; SERVADIO A, 1995, GENOMICS, V29, P812, DOI 10.1006/geno.1995.9925; Sidman RL., 1965, CATALOG NEUROLOGICAL, DOI [10.4159/harvard.9780674424326, DOI 10.4159/HARVARD.9780674424326]	21	171	178	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1904	1906		10.1126/science.1068912	http://dx.doi.org/10.1126/science.1068912			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884758				2022-12-28	WOS:000174299500043
J	Kieffer, BL; Evans, CJ				Kieffer, BL; Evans, CJ			Opioid tolerance - In search of the holy grail	CELL			English	Review							RECEPTOR DESENSITIZATION; MORPHINE; PHOSPHORYLATION; TRAFFICKING; ENDOCYTOSIS	Tolerance, one of several behavioral adaptations to prolonged opioid treatment, has long been explained by desensitization of opioid receptor signaling and loss of surface receptors. However, recent evidence presents an alternative hypothesis, suggesting that receptor internalization could in fact reduce tolerance in vivo.	Inst Genet & Biol Mol & Cellulaire, F-67400 Illkirch Graffenstaden, France; Univ Calif Los Angeles, Inst Neuropsychiat, Los Angeles, CA 90032 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of California System; University of California Los Angeles	Kieffer, BL (corresponding author), Inst Genet & Biol Mol & Cellulaire, F-67400 Illkirch Graffenstaden, France.	briki@igbmc.u-strasbg.fr			NIDA NIH HHS [P50 DA005010] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA005010] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ARDEN JR, 1995, J NEUROCHEM, V65, P1636; Borgland S, 2001, CLIN EXP PHARMACOL P, V28, P147, DOI 10.1046/j.1440-1681.2001.03418.x; DUTTAROY A, 1995, ANESTHESIOLOGY, V82, P1226, DOI 10.1097/00000542-199505000-00018; Evans CJ, 2000, MOL PSYCHIATR, V5, P122, DOI 10.1038/sj.mp.4000739; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Gutstein HB, 1996, PHARMACOL REV, V48, P403; He L, 2002, CELL, V108, P271, DOI 10.1016/S0092-8674(02)00613-X; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Kieffer BL, 1995, CELL MOL NEUROBIOL, V15, P615, DOI 10.1007/BF02071128; Kieffer BL, 1999, TRENDS PHARMACOL SCI, V20, P19, DOI 10.1016/S0165-6147(98)01279-6; Kovoor A, 1998, MOL PHARMACOL, V54, P704; Lefkowitz R J, 1998, Adv Pharmacol, V42, P416; Nestler EJ, 1996, NEURON, V16, P897, DOI 10.1016/S0896-6273(00)80110-5; Olive MF, 1998, PSYCHOPHARMACOLOGY, V139, P251, DOI 10.1007/s002130050712; SIEGEL S, 1976, SCIENCE, V193, P323, DOI 10.1126/science.935870; Walker EA, 2001, PSYCHOPHARMACOLOGY, V154, P131, DOI 10.1007/s002130000620; Whistler JL, 1999, NEURON, V23, P737, DOI 10.1016/S0896-6273(01)80032-5; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; Yu YK, 1997, J BIOL CHEM, V272, P28869, DOI 10.1074/jbc.272.46.28869	20	128	134	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 8	2002	108	5					587	590		10.1016/S0092-8674(02)00666-9	http://dx.doi.org/10.1016/S0092-8674(02)00666-9			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	529TN	11893329	Bronze			2022-12-28	WOS:000174314800002
J	Saint Andre, AV; Blackwell, NM; Hall, LR; Hoerauf, A; Brattig, NW; Volkmann, L; Taylor, MJ; Ford, L; Hise, AG; Lass, JH; Diaconu, E; Pearlman, E				Saint Andre, AV; Blackwell, NM; Hall, LR; Hoerauf, A; Brattig, NW; Volkmann, L; Taylor, MJ; Ford, L; Hise, AG; Lass, JH; Diaconu, E; Pearlman, E			The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness	SCIENCE			English	Article							TOLL-LIKE RECEPTOR-4; ONCHOCERCA-VOLVULUS; LIPOPOLYSACCHARIDE; NEUTROPHIL; RECRUITMENT; CORNEA; ENDOBACTERIA; CHEMOTHERAPY; EXPRESSION; RESPONSES	Parasitic filarial nematodes infect more than 200 million individuals worldwide, causing debilitating inflammatory diseases such as river blindness and lymphatic filariasis. Using a murine model for river blindness in which soluble extracts of filarial nematodes were injected into the corneal stroma, we demonstrated that the predominant inflammatory response in the cornea was due to species of endosymbiotic Wolbachia bacteria. In addition, the inflammatory response induced by these bacteria was dependent on expression of functional Toll-like receptor 4 (TLR4) on host cells.	Univ Hosp Cleveland, Div Geog Med, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Dept Ophthalmol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	University Hospitals of Cleveland; University Hospitals of Cleveland; Case Western Reserve University; Bernhard Nocht Institut fur Tropenmedizin; Liverpool School of Tropical Medicine; University of Liverpool	Pearlman, E (corresponding author), Univ Hosp Cleveland, Div Geog Med, Cleveland, OH 44106 USA.	exp2@po.cwru.edu		Hise, Amy/0000-0001-5075-5792; Taylor, Mark/0000-0003-3396-9275; Blackwell, Nathan/0000-0002-7242-5812; Ford, Louise/0000-0001-7919-2866; Pearlman, Eric/0000-0003-0137-7582	NATIONAL EYE INSTITUTE [P30EY011373, R01EY010320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI054652] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brattig NW, 2000, MICROBES INFECT, V2, P1147, DOI 10.1016/S1286-4579(00)01269-7; Brattig NW, 2001, MICROBES INFECT, V3, P439, DOI 10.1016/S1286-4579(01)01399-5; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Cross HF, 2001, LANCET, V358, P1873, DOI 10.1016/S0140-6736(01)06899-4; GutierrezPena EJ, 1996, PARASITOLOGY, V113, P403, DOI 10.1017/S0031182000066543; Hall LR, 1999, J IMMUNOL, V163, P4970; Hall LR, 1999, CLIN MICROBIOL REV, V12, P445, DOI 10.1128/CMR.12.3.445; Hall LR, 2001, J IMMUNOL, V167, P919, DOI 10.4049/jimmunol.167.2.919; Hall LR, 2001, J IMMUNOL, V166, P4035, DOI 10.4049/jimmunol.166.6.4035; Hoerauf A, 2000, LANCET, V355, P1242, DOI 10.1016/S0140-6736(00)02095-X; Hoerauf A, 1999, J CLIN INVEST, V103, P11, DOI 10.1172/JCI4768; Hoerauf A, 2001, LANCET, V357, P1415, DOI 10.1016/S0140-6736(00)04581-5; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kaifi JT, 2001, J IMMUNOL, V166, P6795, DOI 10.4049/jimmunol.166.11.6795; Li J, 2000, INVEST OPHTH VIS SCI, V41, P2945; PEARLMAN E, 1995, J EXP MED, V182, P931, DOI 10.1084/jem.182.4.931; Song PI, 2001, INVEST OPHTH VIS SCI, V42, P2867; Taylor MJ, 2000, J EXP MED, V191, P1429, DOI 10.1084/jem.191.8.1429; Taylor MJ, 1999, PARASITOL TODAY, V15, P437, DOI 10.1016/S0169-4758(99)01533-1; Taylor MJ, 2001, CURR OPIN INFECT DIS, V14, P727, DOI 10.1097/00001432-200112000-00011; VONSAINTANDRE A, UNPUB; *WHO, 1995, ONCH ITS CONTR, V852	22	245	251	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2002	295	5561					1892	1895		10.1126/science.1068732	http://dx.doi.org/10.1126/science.1068732			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884755	Green Submitted			2022-12-28	WOS:000174299500039
J	Wentrup, C				Wentrup, C			From reactive intermediates to stable compounds	SCIENCE			English	Editorial Material							DIRADICALS; BIRADICALS; STATE		Univ Queensland, Sch Mol & Microbial Sci, Dept Chem, Brisbane, Qld 4072, Australia	University of Queensland	Wentrup, C (corresponding author), Univ Queensland, Sch Mol & Microbial Sci, Dept Chem, Brisbane, Qld 4072, Australia.		Wentrup, Curt/I-5206-2012	Wentrup, Curt/0000-0003-0874-7144				Abe M, 2000, J AM CHEM SOC, V122, P2019, DOI 10.1021/ja992507j; Adam W, 2000, J AM CHEM SOC, V122, P6735, DOI 10.1021/ja0003369; BERSON JA, 1994, SCIENCE, V266, P1338, DOI 10.1126/science.266.5189.1338; BUCHWALTER SL, 1975, J AM CHEM SOC, V97, P3857, DOI 10.1021/ja00846a073; Crayston JA, 2000, TETRAHEDRON, V56, P7829, DOI 10.1016/S0040-4020(00)00587-1; Gomberg M, 1900, J AM CHEM SOC, V22, P757, DOI 10.1021/ja02049a006; Gomberg M, 1900, BER DTSCH CHEM GES, V33, P3150, DOI 10.1002/cber.19000330369; Iwamura H., 1990, ADV PHYS ORG CHEM, V26, P179, DOI DOI 10.1016/S0065-3160(08)60046-5; JAIN R, 1988, J AM CHEM SOC, V110, P1356, DOI 10.1021/ja00213a006; Lu HSM, 1997, J AM CHEM SOC, V119, P1428, DOI 10.1021/ja9631155; NAKAMURA N, 1993, ANGEW CHEM INT EDIT, V32, P872, DOI 10.1002/anie.199308721; PEDERSEN S, 1994, SCIENCE, V266, P1359, DOI 10.1126/science.266.5189.1359; Scheschkewitz D, 2002, SCIENCE, V295, P1880, DOI 10.1126/science.1068167; SCHLENK W, 1915, BER DTSCH CHEM GES, V48, P66; Takano Y, 2002, J AM CHEM SOC, V124, P450, DOI 10.1021/ja015967x; Tidwell TT, 2001, ADV PHYS ORG CHEM, V36, P1, DOI 10.1016/S0065-3160(01)36002-1; Wentrup C, 2001, SCIENCE, V292, P1846, DOI 10.1126/science.1062316; Zewail AH, 2000, ANGEW CHEM INT EDIT, V39, P2587	18	25	26	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1846	1847		10.1126/science.1070364	http://dx.doi.org/10.1126/science.1070364			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884740				2022-12-28	WOS:000174299500023
J	Browne, J; Tunnacliffe, A; Burnell, A				Browne, J; Tunnacliffe, A; Burnell, A			Anhydrobiosis - Plant desiccation gene found in a nematode	NATURE			English	Article							VITRIFICATION; DEHYDRATION; SURVIVAL		Natl Univ Ireland, Dept Biol, Maynooth, Kildare, Ireland; Natl Univ Ireland, Inst Bioengn & Agroecol, Maynooth, Kildare, Ireland; Univ Cambridge, Inst Biotechnol, Cambridge CB2 1QT, England	Maynooth University; Maynooth University; University of Cambridge	Browne, J (corresponding author), Natl Univ Ireland, Dept Biol, Maynooth, Kildare, Ireland.			Tunnacliffe, Alan/0000-0001-8570-125X				Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; de Castro AG, 2000, FEBS LETT, V487, P199, DOI 10.1016/S0014-5793(00)02340-1; DURE L, 1989, PLANT MOL BIOL, V12, P475, DOI 10.1007/BF00036962; DURE L, 1993, PLANT J, V3, P363, DOI 10.1046/j.1365-313X.1993.t01-18-00999.x; Dure L, 2001, PROTEIN PEPTIDE LETT, V8, P115, DOI 10.2174/0929866013409643; HIGA LM, 1993, J EXP ZOOL, V267, P120, DOI 10.1002/jez.1402670205; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; MADIN KAC, 1975, J EXP ZOOL, V193, P335, DOI 10.1002/jez.1401930309; Solomon A, 2000, PARASITOLOGY, V121, P409, DOI 10.1017/S0031182099006563; Sun WQ, 1997, COMP BIOCHEM PHYS A, V117, P327, DOI 10.1016/S0300-9629(96)00271-X; Wolkers WF, 2001, BBA-PROTEIN STRUCT M, V1544, P196, DOI 10.1016/S0167-4838(00)00220-X	12	218	248	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2002	416	6876					38	38		10.1038/416038a	http://dx.doi.org/10.1038/416038a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882885	Green Accepted, Bronze			2022-12-28	WOS:000174211600031
J	Collier, VU; McCue, JD; Markus, A; Smith, L				Collier, VU; McCue, JD; Markus, A; Smith, L			Stress in medical residency: Status quo after a decade of reform.?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SPECIALTY CHOICES; WOMEN PHYSICIANS; NATIONAL-SURVEY; HOUSE OFFICERS; MOOD STATES; PREGNANCY; INTERNSHIP; COMPLICATIONS; DEPRESSION; DEBT	Background: Although curricular reforms have attempted to address sources of stress in medical residency, no recent studies have examined the financial or emotional situations of current medicine residents. Objective: To question medicine residents about financial status, educational debt, moonlighting, and psychological issues. Design: Survey distributed in a nonrandomized fashion to medicine residents. Setting: All 415 U.S. medicine residency programs. Results: According to the questionnaire responses submitted by the 4128 (18%) participating residents, a substantial number of residents had financial and emotional distress that could have interfered with training. The reported educational debt was at least $50 000 for 1657 (42%) of the respondents and at least $100 000 for 737 (19%). The monthly disposable income was $100 or less for 1620 (43%) of the residents, and 637 residents (16%) could not afford safe housing. Among respondents in their 2nd through 5th year of postgraduate training, 2187 (52%) had insufficient funds to purchase books and equipment, and 678 (29%) could not afford the required fees for the American Board of internal Medicine certifying examination; 2659 (33%) worked as moonlighters, and this percentage increased progressively with increasing educational debt. Four or five depressive symptoms during residency were reported by 1461 (35%) residents. Eight hundred ninety-nine residents (23%) thought they had become less humanistic over the course of their residency training; 2347 (61%) reported becoming more cynical. Female residents were more likely than male residents to report increased cynicism and multiple depressive symptoms. Increased cynicism and depressive symptoms were associated with increasing educational debt. Conclusions: Despite recent curricular reforms, an alarming number of current medicine residents report depressive symptoms, increasing cynicism, and decreasing humanism, which were associated with increasing educational debt and a need to moonlight for financial survival. Ongoing curricular reform, legislative relief from early loan repayment, and salary increases may be necessary to address these problems.	Christiana Care Hlth Syst, Dept Med, Newark, DE 19718 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; St Josephs Med Ctr, Phoenix, AZ USA; Mt Sinai Med Ctr, New York, NY 10029 USA	Christiana Care Health System; University of California System; University of California San Francisco; St. Joseph's Hospital and Medical Center; Icahn School of Medicine at Mount Sinai	Collier, VU (corresponding author), Christiana Care Hlth Syst, Dept Med, POB 6001, Newark, DE 19718 USA.	vcollier@christianacare.org						*AM MED ASS, 1998, JAMA-J AM MED ASSOC, V280, P836; *AM MED ASS ACCR C, 1993, GRAD MED ED DIR; BAZZOLI GJ, 1986, J MED EDUC, V61, P797; BLAZER DG, 1994, AM J PSYCHIAT, V151, P979; BUTTERFIELD PS, 1988, ARCH INTERN MED, V148, P1428, DOI 10.1001/archinte.148.6.1428; COLFORD JM, 1989, JAMA-J AM MED ASSOC, V261, P889, DOI 10.1001/jama.261.6.889; CROWLEY AE, 1985, JAMA-J AM MED ASSOC, V254, P1585, DOI 10.1001/jama.254.12.1585; CULLER SD, 1985, J HEALTH ECON, V4, P283, DOI 10.1016/0167-6296(85)90034-7; Daugherty SR, 1998, JAMA-J AM MED ASSOC, V279, P1194, DOI 10.1001/jama.279.15.1194; Dunn MR, 1997, JAMA-J AM MED ASSOC, V278, P750, DOI 10.1001/jama.278.9.750; Eron LD, 1955, J MED EDUC, V30, P559; FORD CV, 1984, SOUTHERN MED J, V77, P1435, DOI 10.1097/00007611-198411000-00019; FRIEDMAN FC, 1973, J MED EDUC, V48, P436; GABRAM SGA, 1995, ARCH SURG-CHICAGO, V130, P24; Garrard PS, 1998, ACAD MED, V73, P416; GIRARD DE, 1986, WESTERN J MED, V144, P93; GORDON GH, 1986, J GEN INTERN MED, V1, P228, DOI 10.1007/BF02596188; Green JAS, 1999, ADVANCED SENSORS FOR METALS PROCESSING, P11; GREEN MJ, 1995, ANN INTERN MED, V123, P512, DOI 10.7326/0003-4819-123-7-199510010-00007; GREENE J, 1999, AM MED NEWS     0628, P1; Greer JD, 1999, P SOC PHOTO-OPT INS, V3751, P30, DOI 10.1117/12.372659; Harris D L, 1990, J Am Med Womens Assoc (1972), V45, P127; Harris DL, 1990, J AM MED WOMEN ASSOC, V45, P131; Heinig SJ, 1999, ACAD MED, V74, P726, DOI 10.1097/00001888-199906000-00024; HOUGH DE, 1985, JAMA-J AM MED ASSOC, V253, P1758, DOI 10.1001/jama.253.12.1758; HSU K, 1987, AM J PSYCHIAT, V144, P1561; KASSEBAUM DG, 1992, ACAD MED, V67, P700, DOI 10.1097/00001888-199210000-00018; KASSEBAUM DG, 1994, ACAD MED, V69, P164; Kassirer JP, 1998, NEW ENGL J MED, V339, P1543, DOI 10.1056/NEJM199811193392109; KATZ VL, 1988, WESTERN J MED, V149, P704; KLEBANOFF MA, 1990, NEW ENGL J MED, V323, P1040, DOI 10.1056/NEJM199010113231506; KLEBANOFF MA, 1991, JAMA-J AM MED ASSOC, V265, P2821, DOI 10.1001/jama.265.21.2821; KLEVAN JL, 1990, AM J DIS CHILD, V144, P767, DOI 10.1001/archpedi.1990.02150310035021; Korcok M, 1998, CAN MED ASSOC J, V159, P702; Marci CD, 1998, JAMA-J AM MED ASSOC, V280, P1879; MCCUE JD, 1990, ARCH INTERN MED, V150, P1511, DOI 10.1001/archinte.150.7.1511; MCCUE JD, 1985, NEW ENGL J MED, V312, P449, DOI 10.1056/NEJM198502143120725; MCLAUGHLIN MA, 1991, ACAD MED, V66, pS43, DOI 10.1097/00001888-199109000-00036; MILLER NH, 1989, J REPROD MED, V34, P790; Miller RS, 1998, JAMA-J AM MED ASSOC, V280, P777, DOI 10.1001/jama.280.9.777; MOSS AJ, 1984, NEW ENGL J MED, V311, P1375, DOI 10.1056/NEJM198411223112111; Murphy JM, 2000, ARCH GEN PSYCHIAT, V57, P209, DOI 10.1001/archpsyc.57.3.209; Naradzay JF, 1998, JAMA-J AM MED ASSOC, V280, P1881; NARADZAY JF, 1998, JAMA-J AM MED ASSOC, V280, P1883; NESBITT D, 1988, ANN INTERN MED, V109, P154, DOI 10.7326/0003-4819-109-2-154; OSBORN LM, 1990, J FAM PRACTICE, V31, P618; OSBORN LM, 1988, P ANN C RES MED ED, V27, P120; PHELAN ST, 1992, ACAD MED, V67, P408, DOI 10.1097/00001888-199206000-00014; PHELAN ST, 1988, OBSTET GYNECOL, V72, P431; Pinhas-Hamiel O, 1999, Health Care Women Int, V20, P63, DOI 10.1080/073993399245962; REUBEN DB, 1985, ARCH INTERN MED, V145, P286, DOI 10.1001/archinte.145.2.286; Reynolds P. Preston, 1996, JGIM, V11, P83; REYNOLDS PP, 1991, B NEW YORK ACAD MED, V67, P369; SAYRES M, 1986, NEW ENGL J MED, V314, P418, DOI 10.1056/NEJM198602133140705; Schnipper J, 1995, JAMA, V273, P80, DOI 10.1001/jama.273.1.80; SCHWARTZ RW, 1985, OBSTET GYNECOL, V66, P672; SILBERGER AB, 1988, HEALTH AFFAIR, V7, P121, DOI 10.1377/hlthaff.7.2.121; SILLIMAN RA, 1987, J MED EDUC, V62, P463; SINAL S, 1988, J MED EDUC, V63, P531; SMITH JW, 1986, JAMA-J AM MED ASSOC, V255, P1155, DOI 10.1001/jama.255.9.1155; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Tamburrino M B, 1992, J Am Med Womens Assoc (1972), V47, P82; TAYLOR AD, 1987, J MED EDUC, V62, P425; ULIANA RL, 1984, J MED EDUC, V59, P118; URBACH JR, 1994, SOUTHERN MED J, V87, P794, DOI 10.1097/00007611-199408000-00005; VALKO RJ, 1975, DIS NERV SYST, V36, P26; YOGEV S, 1983, SOC SCI MED, V17, P837, DOI 10.1016/0277-9536(83)90034-5; Yom SS, 1998, JAMA-J AM MED ASSOC, V280, P1878; YOUNGSCHUMATE L, 1993, ACAD MED, V68, P792, DOI 10.1097/00001888-199310000-00019	69	200	202	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 5	2002	136	5					384	390		10.7326/0003-4819-136-5-200203050-00011	http://dx.doi.org/10.7326/0003-4819-136-5-200203050-00011			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525VT	11874311				2022-12-28	WOS:000174095300006
J	Coyle, SL				Coyle, SL		Ethics Human Rights Comm	Physician-industry relations. Part 2: Organizational issues	ANNALS OF INTERNAL MEDICINE			English	Article							CONTINUING MEDICAL-EDUCATION; PHARMACEUTICAL-INDUSTRY; PROGRAMS	This is part 2 of a 2-part paper on ethics and physician-industry relationships. Part I offers advice to individual physicians; part 2 gives recommendations to medical education providers and medical professional societies. Industry often sponsors programs for graduate and continuing medical education, as well as major events of medical professional societies. Industry is an abundant source of advances in medicine and technology and plays a crucial role in disseminating up-to-date medical information. Although industry information fills an important need, studies suggest that it is often biased. Providers of graduate and continuing medical education have a duty to present objective and balanced information to their participants; thus, they should not accept any funds that are contingent on a sponsor's ability to shape programming. Medical educators need to evaluate and control the planning, content, and delivery of education provided under their auspices, They should disclose industry sponsorship to students, faculty, and continuing medical education participants and should adopt explicit organizational policies about acceptable and unacceptable interactions with industry. Medical professional societies have a duty to promote the independent judgment and professionalism of their members. Organizers of industry-sponsored meetings should clearly separate product promotion from impartial medical education. Adopting specific policies for dealing with industry sponsorship can also help professional societies guard against outside influence. The American College of Physicians-American Society of Internal Medicine's core ethical principles for external funding and relationships serve as an example.	Amer Coll Physicians, Amer Soc Internal Med, Ctr Eth & Professionalism, Philadelphia, PA 19106 USA	American College of Physicians	Coyle, SL (corresponding author), Amer Coll Physicians, Amer Soc Internal Med, Ctr Eth & Professionalism, 190 N Independence Mall W, Philadelphia, PA 19106 USA.							*ACCR CONT MED ED, 1992, STAND COMM SUPP CONT; BICKELL NA, 1995, J GEN INTERN MED, V10, P392, DOI 10.1007/BF02599839; Bowman M A, 1988, J Contin Educ Health Prof, V8, P13, DOI 10.1002/chp.4750080104; BOWMAN MA, 1986, MOBIUS, V6, P66; Carruthers SG, 1999, AM HEART J, V138, pS256, DOI 10.1016/S0002-8703(99)70319-4; Holmer AF, 2001, JAMA-J AM MED ASSOC, V285, P2012, DOI 10.1001/jama.285.15.2012; Kitchens LW, 1998, ANN INTERN MED, V128, P576, DOI 10.7326/0003-4819-128-7-199804010-00012; LICHSTEIN PR, 1992, ARCH INTERN MED, V152, P1009, DOI 10.1001/archinte.152.5.1009; NOBLE RC, 1993, PERSPECT BIOL MED, V36, P376; Relman AS, 2001, JAMA-J AM MED ASSOC, V285, P2009, DOI 10.1001/jama.285.15.2009; Rosner F, 1995, MT SINAI J MED, V62, P427; Tenery RM, 2000, JAMA-J AM MED ASSOC, V283, P391, DOI 10.1001/jama.283.3.391; UBEL PA, 1995, J GEN INTERN MED, V10, P624, DOI 10.1007/BF02602746; VANHARRISON R, 1993, J CONTIN EDUC HEALTH, V13, P68; Waxman HS, 1999, AM J MED, V107, P1; WHITE LJ, 1990, ANN INTERN MED, V112, P624, DOI 10.7326/0003-4819-112-8-624; WOOLLARD RF, 1993, CAN MED ASSOC J, V149, P403; ZIEGLER MG, 1995, JAMA-J AM MED ASSOC, V273, P1296, DOI 10.1001/jama.273.16.1296	18	70	76	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 5	2002	136	5					403	406		10.7326/0003-4819-136-5-200203050-00015	http://dx.doi.org/10.7326/0003-4819-136-5-200203050-00015			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525VT	11874315				2022-12-28	WOS:000174095300010
J	Sundararajan, V; Mitra, N; Jacobson, JS; Grann, VR; Heitjan, DF; Neugut, AI				Sundararajan, V; Mitra, N; Jacobson, JS; Grann, VR; Heitjan, DF; Neugut, AI			Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer	ANNALS OF INTERNAL MEDICINE			English	Article							COLORECTAL-CANCER; PROGNOSTIC-FACTORS; CLINICAL-TRIALS; CLAIMS DATA; THERAPY; AGE; BIAS; CARE; SENSITIVITY; FLUOROURACIL	Background: Randomized clinical trials have demonstrated the efficacy of adjuvant 5-fluorouracil (5-FU)-based chemotherapy after surgical resection of node-positive colon cancer. Although this treatment became the standard in 1990 following a National Institutes of Health Consensus Conference, among those at least 65 years of age it is less likely to be offered to older or nonwhite patients. Objective: To determine the association between 5-FU-based chemotherapy and survival in older patients. Design: Retrospective cohort study. Setting: Combined database of the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program and Medicare. Patients: 4768 patients 65 years of age or older who received a diagnosis of node-positive colon cancer from 1992 to 1996, were covered by Medicare Parts A and B, and resided in the population covered by the SEER program. Measurements: Propensity scores to control for known predictors of receiving treatment, Cox proportional hazards models to assess the association of 5-FU therapy with survival, and sensitivity analyses to estimate the possible effects of unknown confounders. Results: Fifty-two percent of patients received 5-FU therapy. For this sample, the hazard ratio for death associated with 5-FU therapy was 0.66 (95% Cl, 0.60 to 0.73). Confounding could have accounted for this association only if an unmeasured confounder were extremely unequally distributed between the treated and untreated groups or increased mortality by at least 50%. Conclusions: 5-Fluorouracil adjuvant therapy is significantly associated with reduced mortality in older patients, similar to the association found in randomized, controlled trials among younger patients. More frequent use of 5-FU therapy in older patients would probably reduce death from colon cancer.	Columbia Univ, Joseph L Mailman Sch Publ Hlth, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA; Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA	Columbia University; Columbia University; Columbia University	Neugut, AI (corresponding author), New York Presbyterian Hosp, Div Med Oncol, PH 18-127,630 W 168th St, New York, NY 10032 USA.	ain1@columbia.edu		Sundararajan, Vijaya/0000-0001-9387-1865	NATIONAL CANCER INSTITUTE [K05CA089155, P30CA013696, T32CA009529] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA09529, P30 CA13696, K05 CA89155] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANTMAN K, 1985, J CLIN ONCOL, V3, P1142, DOI 10.1200/JCO.1985.3.8.1142; BEGG CB, 1983, CANCER, V52, P1986, DOI 10.1002/1097-0142(19831201)52:11<1986::AID-CNCR2820521103>3.0.CO;2-7; Bellemare S, 1998, ANN CHIR, V52, P711; BROWN ML, 1994, J NATL CANCER I, V86, P424, DOI 10.1093/jnci/86.6.424; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; COCHRAN WG, 1968, BIOMETRICS, V24, P295, DOI 10.2307/2528036; Cooper GS, 1999, MED CARE, V37, P436, DOI 10.1097/00005650-199905000-00003; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; EDLER L, 1986, EUR J CANCER CLIN ON, V22, P1231, DOI 10.1016/0277-5379(86)90325-1; FINDLAY MPN, 1991, EUR J CANCER, V27, P1597, DOI 10.1016/0277-5379(91)90422-A; FISHER ES, 1992, AM J PUBLIC HEALTH, V82, P243, DOI 10.2105/AJPH.82.2.243; FRANCIS AM, 1984, MED CARE, V22, P418, DOI 10.1097/00005650-198405000-00006; GIOVANAZZIBANNON S, 1994, J CLIN ONCOL, V12, P2447, DOI 10.1200/JCO.1994.12.11.2447; GREENFIELD S, 1987, JAMA-J AM MED ASSOC, V257, P2766, DOI 10.1001/jama.257.20.2766; Greenland S, 1996, INT J EPIDEMIOL, V25, P1107, DOI 10.1093/ije/25.6.1107-a; Guadagnoli E, 1997, J CLIN ONCOL, V15, P2338, DOI 10.1200/JCO.1997.15.6.2338; HALL WH, 1990, JAMA-J AM MED ASSOC, V264, P1444; Hutchins LF, 1999, NEW ENGL J MED, V341, P2061, DOI 10.1056/NEJM199912303412706; Jessup JM, 1996, CANCER-AM CANCER SOC, V78, P918; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; LOPRINZI CL, 1994, J CLIN ONCOL, V12, P601, DOI 10.1200/JCO.1994.12.3.601; MOERTEL CG, 1990, NEW ENGL J MED, V322, P352, DOI 10.1056/NEJM199002083220602; MOERTEL CG, 1995, ANN INTERN MED, V122, P321, DOI 10.7326/0003-4819-122-5-199503010-00001; *NAT CANC I, 1999, SEER CANC STAT REV 1; Nattinger AB, 1997, J CLIN EPIDEMIOL, V50, P939, DOI 10.1016/S0895-4356(97)00099-1; NEWCOMB PA, 1993, J NATL CANCER I, V85, P1580, DOI 10.1093/jnci/85.19.1580; Nieto FJ, 1996, AM J EPIDEMIOL, V143, P1059; Ooi BS, 1999, DIS COLON RECTUM, V42, P403, DOI 10.1007/BF02236362; PEDERSEN H, 1983, ACTA CHIR SCAND, V149, P329; Pitot HC, 2001, ONCOLOGY-NY, V15, P31; POTOSKY AL, 1993, MED CARE, V31, P732; Repetto L, 1998, CANCER, V82, P760, DOI 10.1002/(SICI)1097-0142(19980215)82:4<760::AID-CNCR20>3.0.CO;2-V; Retchin SM, 1997, ARCH INTERN MED, V157, P1878, DOI 10.1001/archinte.157.16.1878; ROSENBAUM PR, 1991, ANN INTERN MED, V115, P901, DOI 10.7326/0003-4819-115-11-901; Rubin DB, 1996, BIOMETRICS, V52, P249, DOI 10.2307/2533160; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; SAMET J, 1986, JAMA-J AM MED ASSOC, V255, P3385, DOI 10.1001/jama.255.24.3385; Sargent DJ, 2001, NEW ENGL J MED, V345, P1091, DOI 10.1056/NEJMoa010957; Sundararajan V, 2001, CANCER J, V7, P213; SUNDARARAJAN V, 1999, P AN M AM SOC CLIN, V18, P1228; Yancik R, 1997, CANCER, V80, P1273, DOI 10.1002/(SICI)1097-0142(19971001)80:7<1273::AID-CNCR13>3.0.CO;2-4; Zaniboni A, 1998, CANCER, V82, P2135, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2135::AID-CNCR7>3.0.CO;2-U	43	174	178	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 5	2002	136	5					349	357		10.7326/0003-4819-136-5-200203050-00007	http://dx.doi.org/10.7326/0003-4819-136-5-200203050-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525VT	11874307				2022-12-28	WOS:000174095300002
J	Velcich, A; Yang, WC; Heyer, J; Fragale, A; Nicholas, C; Viani, S; Kucherlapati, R; Lipkin, M; Yang, K; Augenlicht, L				Velcich, A; Yang, WC; Heyer, J; Fragale, A; Nicholas, C; Viani, S; Kucherlapati, R; Lipkin, M; Yang, K; Augenlicht, L			Colorectal cancer in mice genetically deficient in the mucin Muc2	SCIENCE			English	Article							ABERRANT CRYPT FOCI; APC GENE; COLON; EXPRESSION; CLONING; IDENTIFICATION; NEOPLASIA; MUTATION	The gastrointestinal tract is tined by a layer of mucus comprised of highly glycosylated proteins called mucins. To evaluate the importance of mucin in intestinal carcinogenesis, we constructed mice genetically deficient in Muc2, the most abundant secreted gastrointestinal mucin. Muc2(-/-) mice displayed aberrant intestinal crypt morphology and altered cell maturation and migration. Most notably, the mice frequently developed adenomas in the small intestine that progressed to invasive adenocarcinoma, as welt as rectal tumors. Thus, Muc2 is involved in the suppression of colorectal cancer.	Montefiore Med Ctr, Albert Einstein Canc Ctr, Dept Oncol, Bronx, NY 10467 USA; Memory Pharmaceut Corp, Montvale, NJ 07645 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Strang Canc Prevent Ctr, New York, NY 10021 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Velcich, A (corresponding author), Montefiore Med Ctr, Albert Einstein Canc Ctr, Dept Oncol, 111 E 210 St, Bronx, NY 10467 USA.		Yang, Wancai/G-3750-2010; Fragale, Alessandra/K-1071-2016; Kucherlapati, Raju/ABC-8807-2021; Yang, Wancai/O-7655-2019	Fragale, Alessandra/0000-0002-0362-1983; Yang, Wancai/0000-0001-7437-9197	NATIONAL CANCER INSTITUTE [P30CA013330, R01CA072835, R01CA090808] Funding Source: NIH RePORTER; NCI NIH HHS [CA 72835, CA 90808, P0 CA 13330] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aslam F, 2001, CANCER RES, V61, P570; BIRD RP, 1987, CANCER LETT, V37, P147, DOI 10.1016/0304-3835(87)90157-1; Engle SJ, 1999, CANCER RES, V59, P3379; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; GENDLER SJ, 1995, ANNU REV PHYSIOL, V57, P607, DOI 10.1146/annurev.ph.57.030195.003135; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; HERMISTON ML, 1995, SCIENCE, V270, P1203, DOI 10.1126/science.270.5239.1203; KIM YS, 1995, GASTROENTEROLOGY, V109, P999, DOI 10.1016/0016-5085(95)90412-3; Kim YS, 1996, GLYCOCONJUGATE J, V13, P693, DOI 10.1007/BF00702333; OTORI K, 1995, CANCER RES, V55, P4743; Pretlow T. P., 1997, Proceedings of the American Association for Cancer Research Annual Meeting, V38, P126; PRETLOW TP, 1991, CANCER RES, V51, P1564; RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143; Sands BE, 1996, ANNU REV PHYSIOL, V58, P253, DOI 10.1146/annurev.ph.58.030196.001345; SHEKELS LL, 1995, BIOCHEM J, V311, P775, DOI 10.1042/bj3110775; Shekels LL, 1998, BIOCHEM J, V330, P1301, DOI 10.1042/bj3301301; Siu IM, 1999, CANCER RES, V59, P63; STEELE GD, 1990, JAMA-J AM MED ASSOC, V264, P1444; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Van Klinken BJW, 1999, AM J PHYSIOL-GASTR L, V276, pG115, DOI 10.1152/ajpgi.1999.276.1.G115; Williams SJ, 2001, J BIOL CHEM, V276, P18327, DOI 10.1074/jbc.M008850200	22	691	716	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 1	2002	295	5560					1726	1729		10.1126/science.1069094	http://dx.doi.org/10.1126/science.1069094			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872843				2022-12-28	WOS:000174212900050
J	Carabello, BA				Carabello, BA			Aortic stenosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VALVE-REPLACEMENT; SYMPTOMATIC PATIENTS; SURGICAL-PROCEDURES; PROGRESSION; ADULTS; RISK; ECHOCARDIOGRAPHY; DETERMINANTS; PREDICTORS; PROGNOSIS		Vet Affairs Med Ctr, Med Serv 111, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baylor College of Medicine	Carabello, BA (corresponding author), Vet Affairs Med Ctr, Med Serv 111, 2002 Holcombe Blvd, Houston, TX 77030 USA.	blaseanthony.carabello@med.va.gov						BROGAN WC, 1993, J AM COLL CARDIOL, V21, P1657, DOI 10.1016/0735-1097(93)90383-C; BURWASH IG, 1994, J AM COLL CARDIOL, V24, P1342, DOI 10.1016/0735-1097(94)90118-X; CANNON JD, 1992, J AM COLL CARDIOL, V20, P1517, DOI 10.1016/0735-1097(92)90445-S; CARABELLO BA, 1980, CIRCULATION, V62, P42, DOI 10.1161/01.CIR.62.1.42; Connolly HM, 2000, CIRCULATION, V101, P1940, DOI 10.1161/01.CIR.101.16.1940; Das P, 2001, J AM COLL CARDIOL, V37, p489A; DEFILIPPI CR, 1995, AM J CARDIOL, V75, P191, DOI 10.1016/S0002-9149(00)80078-8; Faggiano P, 1996, AM HEART J, V132, P408, DOI 10.1016/S0002-8703(96)90440-8; GOLDMAN L, 1977, NEW ENGL J MED, V297, P845, DOI 10.1056/NEJM197710202971601; HESS OM, 1984, CIRCULATION, V69, P855, DOI 10.1161/01.CIR.69.5.855; HUBER D, 1981, CIRCULATION, V64, P126, DOI 10.1161/01.CIR.64.1.126; KELLY TA, 1988, AM J CARDIOL, V61, P123, DOI 10.1016/0002-9149(88)91317-3; LINDERHOLM H, 1985, ACTA MED SCAND, V218, P181; LUND O, 1990, CIRCULATION, V82, P124, DOI 10.1161/01.CIR.82.1.124; MARCUS ML, 1982, NEW ENGL J MED, V307, P1362, DOI 10.1056/NEJM198211253072202; McCrindle BW, 1996, AM J CARDIOL, V77, P286, DOI 10.1016/S0002-9149(97)89395-2; Monin JL, 2001, J AM COLL CARDIOL, V37, P2101, DOI 10.1016/S0735-1097(01)01339-0; NESTICO PF, 1983, AM J CARDIOL, V52, P1054, DOI 10.1016/0002-9149(83)90531-3; Novaro GM, 2001, CIRCULATION, V104, P2205, DOI 10.1161/hc4301.098249; OKEEFE JH, 1989, MAYO CLIN PROC, V64, P400, DOI 10.1016/S0025-6196(12)65728-0; OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844; Otto CM, 1999, NEW ENGL J MED, V341, P142, DOI 10.1056/NEJM199907153410302; Otto CM, 1997, CIRCULATION, V95, P2262, DOI 10.1161/01.CIR.95.9.2262; OTTO CM, 1989, J AM COLL CARDIOL, V13, P545, DOI 10.1016/0735-1097(89)90590-1; PELLIKKA PA, 1990, J AM COLL CARDIOL, V15, P1012, DOI 10.1016/0735-1097(90)90234-G; SCHWARZ F, 1982, CIRCULATION, V66, P1105, DOI 10.1161/01.CIR.66.5.1105	26	201	219	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2002	346	9					677	682		10.1056/NEJMcp010846	http://dx.doi.org/10.1056/NEJMcp010846			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525HJ	11870246				2022-12-28	WOS:000174062800007
J	Heywood, KJ; Garabato, ACN; Stevens, DP				Heywood, KJ; Garabato, ACN; Stevens, DP			High mixing rates in the abyssal Southern Ocean	NATURE			English	Article							ANTARCTIC BOTTOM WATER; CIRCULATION; TRANSPORT; VARIABILITY; TOPOGRAPHY; ENERGY; FLUX; FLOW	Mixing of water masses from the deep ocean to the layers above can be estimated from considerations of continuity in the global ocean overturning circulation(1-3). But averaged over ocean basins, diffusivity has been observed to be too small(4-12) to account for the global upward flux of water, and high mixing intensities have only been found in the restricted areas close to sills and narrow gaps(10,11,13-15). Here we present observations from the Scotia Sea, a deep ocean basin between the Antarctic peninsula and the tip of South America, showing a high intensity of mixing that is unprecedented over such a large area. Using a budget calculation over the whole basin, we find a diffusivity of (39 +/- 10) x 10(4) m(2) s(-1), averaged over an area of 7 x 10(5) km(2). The Scotia Sea is a basin with a rough topography(16), situated just east of the Drake passage where the strong flow of the Antarctic Circumpolar Current is constricted in width. The high basin-wide mixing intensity in this area of the Southern Ocean may help resolve the question of where the abyssal water masses are mixed towards the surface.	Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; Univ E Anglia, Sch Math, Norwich NR4 7TJ, Norfolk, England	University of East Anglia; University of East Anglia	Heywood, KJ (corresponding author), Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England.	k.heywood@uea.ac.uk	Heywood, Karen J/L-1757-2016; Stevens, David/F-2509-2010; Garabato, Alberto Naveira/AAQ-1114-2020; Jullion, Loic/B-3304-2011	Heywood, Karen J/0000-0001-9859-0026; Stevens, David/0000-0002-7283-4405; Garabato, Alberto Naveira/0000-0001-6071-605X; Jullion, Loic/0000-0001-6269-6750				Arhan M, 1999, DEEP-SEA RES PT II, V46, P475, DOI 10.1016/S0967-0645(98)00110-6; BARTON ED, 1989, DEEP-SEA RES, V36, P1121, DOI 10.1016/0198-0149(89)90082-4; BELL TH, 1975, J GEOPHYS RES, V80, P320, DOI 10.1029/JC080i003p00320; DEMADRON XD, 1994, J MAR RES, V52, P583; Egbert GD, 2000, NATURE, V405, P775, DOI 10.1038/35015531; Fukumori I, 1998, J GEOPHYS RES-OCEANS, V103, P5493, DOI 10.1029/97JC02907; Ganachaud A, 2000, NATURE, V408, P453, DOI 10.1038/35044048; GARABATO ACN, 2002, DEEP SEA RES, V2; GARABATO ACN, IN PRESS DEEP SEA RE, V1; Hogg N, 1982, J MAR RES, V40, P231; Huang RX, 1999, J PHYS OCEANOGR, V29, P727, DOI 10.1175/1520-0485(1999)029<0727:MAEOTO>2.0.CO;2; Jackett DR, 1997, J PHYS OCEANOGR, V27, P237, DOI 10.1175/1520-0485(1997)027<0237:ANDVFT>2.0.CO;2; Ledwell JR, 2000, NATURE, V403, P179, DOI 10.1038/35003164; McCarthy MC, 1997, GEOPHYS RES LETT, V24, P2801, DOI 10.1029/97GL02112; Morris MY, 2001, J PHYS OCEANOGR, V31, P3331, DOI 10.1175/1520-0485(2001)031<3331:AMITBB>2.0.CO;2; Munk W, 1998, DEEP-SEA RES PT I, V45, P1977, DOI 10.1016/S0967-0637(98)00070-3; MUNK WH, 1966, DEEP-SEA RES, V13, P207; Olbers D., 1992, HYDROGRAPHIC ATLAS S; Orsi AH, 1999, PROG OCEANOGR, V43, P55, DOI 10.1016/S0079-6611(99)00004-X; Polzin KL, 1996, NATURE, V380, P54, DOI 10.1038/380054a0; Polzin KL, 1997, SCIENCE, V276, P93, DOI 10.1126/science.276.5309.93; Roemmich D, 1996, J GEOPHYS RES-OCEANS, V101, P14039, DOI 10.1029/96JC00797; SAUNDERS PM, 1987, J PHYS OCEANOGR, V17, P631, DOI 10.1175/1520-0485(1987)017<0631:FTDG>2.0.CO;2; SJOBERG B, 1992, DEEP-SEA RES, V39, P269, DOI 10.1016/0198-0149(92)90109-7; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; TOOLE J. M., 2001, OCEAN CIRCULATION CL, P337; TOOLE JM, 1994, SCIENCE, V264, P1120, DOI 10.1126/science.264.5162.1120; Webb DJ, 2001, NATURE, V409, P37, DOI 10.1038/35051171; WHITEHEAD JA, 1982, J GEOPHYS RES-OCEANS, V87, P7903, DOI 10.1029/JC087iC10p07903; Zhang JB, 1999, J PHYS OCEANOGR, V29, P1096, DOI 10.1175/1520-0485(1999)029<1096:TRIODM>2.0.CO;2	30	86	93	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2002	415	6875					1011	1014		10.1038/4151011a	http://dx.doi.org/10.1038/4151011a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875565				2022-12-28	WOS:000174075000041
J	Prokopenko, AA; Karabanov, EB; Williams, DF				Prokopenko, AA; Karabanov, EB; Williams, DF			Age of long sediment cores from Lake Baikal	NATURE			English	Article									Univ S Carolina, Dept Geol Sci, Columbia, SC 29208 USA; Russian Acad Sci, Siberian Branch, United Inst Geol Geophys & Mineral, Novosibirsk 630090, Russia; Russian Acad Sci, Siberian Branch, Inst Geochem, Irkutsk 664033, Russia	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Russian Academy of Sciences; Sobolev Institute of Geology & Mineralogy of the Russian Academy of Sciences; Trofimuk Institute of Petroleum Geology & Geophysics; Irkutsk Science Centre of the Russian Academy of Sciences; A.P. Vinogradov Institute of Geochemistry of the Siberian Branch of the RAS; Russian Academy of Sciences	Prokopenko, AA (corresponding author), Univ S Carolina, Dept Geol Sci, Columbia, SC 29208 USA.							Antipin V, 2001, QUATERN INT, V80-1, P19, DOI 10.1016/S1040-6182(01)00016-7; BDP Members (The Baikal Drilling Project Group), 2000, RUSSIAN GEOLOGY GEOP, V41, P3; Kashiwaya K, 2001, NATURE, V410, P71, DOI 10.1038/35065057; Moore TC, 1997, GEOL SOC AM BULL, V109, P746, DOI 10.1130/0016-7606(1997)109<0746:SASPIT>2.3.CO;2; Williams DF, 1997, SCIENCE, V278, P1114, DOI 10.1126/science.278.5340.1114	5	5	5	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2002	415	6875					976	976		10.1038/415976a	http://dx.doi.org/10.1038/415976a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875553	Bronze			2022-12-28	WOS:000174075000029
J	Wadman, M				Wadman, M			Power vacuum expands as CDC director resigns	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2002	415	6875					946	946		10.1038/415946a	http://dx.doi.org/10.1038/415946a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875529	Bronze			2022-12-28	WOS:000174075000006
J	Skarbinski, J; Walker, HK; Baker, LC; Kobaladze, A; Kirtava, Z; Raffin, TA				Skarbinski, J; Walker, HK; Baker, LC; Kobaladze, A; Kirtava, Z; Raffin, TA			The burden of out-of-pocket payments for health care in Tbilisi, Republic of Georgia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INSURANCE; SYSTEM; TRANSITION; STATE	Context In the 1990s, the Republic of Georgia instituted healthcare reforms to convert the centralized, state-operated healthcare system inherited from the Soviet Union to a decentralized, market-driven system of health care delivery. Under the new system, 87% of health care expenditures are financed through out-of-pocket payments at the point of service. Objective To describe the effects of healthcare reforms on access to care and health care financing among ill residents of Tbilisi, Georgia. Design, Setting, and Participants A probability-proportionate-to-size cluster survey conducted in 1999 of 248 households containing 306 household members who had been ill in the past 6 months in Tbilisi, Georgia. Main Outcome Measures Reported healthcare utilization, out-of-pocket expenditures, and financing practices. Results Of sick household members, 51% used official health care services at hospitals and clinics; 49% did not use official services and sought advice from relatives or friends, used traditional medicines, or did nothing. Those with serious illness were more likely to seek care through official services (82%) than those with nonserious illness (27%). Ninety-three percent of respondents said costs were the major deterrent to obtaining health care. Ten percent of ill household members reported that they were unable to obtain health care because of high costs; 16% reported being unable to afford all the medications necessary to treat their illness. Sixty-one percent of ill household members used savings to pay for health care expenditures and 19% of those able to obtain care had to use strategies such as borrowing money or selling personal items to pay for health care. Total out-of-pocket health care expenditures (53%) were paid for by borrowing money or selling personal items. A significant portion of households with ill members (87%) reported an interest in purchasing health care insurance. Conclusions Economic disruption and health care reforms have led to access problems and out-of-pocket financing strategies that include reliance on personal savings, selling personal items, and borrowing money. Future reforms should consider an appropriate system for health care insurance risk pooling for the population of Tbilisi, Georgia.	Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Dept Hlth Res & Policy, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Ctr Biomed Eth, Palo Alto, CA 94304 USA; Emory Univ, Sch Med, Dept Med, Atlanta, GA USA; Tbilisi State Univ, Hlth Sci Ctr, GE-380086 Tbilisi, Georgia; Natl Informat Learning Ctr, Tbilisi, Georgia	Stanford University; Stanford University; Stanford University; Emory University; Ivane Javakhishvili Tbilisi State University	Raffin, TA (corresponding author), Stanford Univ, Med Ctr, Div Pulm & Crit Care Med, Ctr Biomed Eth, Room H3151, Stanford, CA 94305 USA.	tar@stanford.edu		Baker, Laurence/0000-0001-5032-794X				ABIDE B, 1996, TBILISI ASSESSMENT H; Ayanian JZ, 2000, JAMA-J AM MED ASSOC, V284, P2061, DOI 10.1001/jama.284.16.2061; Barr DA, 1996, AM J PUBLIC HEALTH, V86, P307, DOI 10.2105/AJPH.86.3.307; Berk ML, 2001, HEALTH AFFAIR, V20, P9, DOI 10.1377/hlthaff.20.2.9; BERK ML, 1991, HLTH AFF MILLWOOD, V14, P139; Burger EJ, 1998, AM J PUBLIC HEALTH, V88, P755, DOI 10.2105/AJPH.88.5.755; Cunningham PJ, 1998, JAMA-J AM MED ASSOC, V280, P921, DOI 10.1001/jama.280.10.921; DESHEM LD, 1996, FOOD NUTR HLTH NONF; Field MG, 1999, CROAT MED J, V40, P202; Grim CE, 1999, J HUM HYPERTENS, V13, P243, DOI 10.1038/sj.jhh.1000795; GZIRISHVILI D, 1998, 5 UN DEV PROGR; Heffler S, 2001, HEALTH AFFAIR, V20, P193, DOI 10.1377/hlthaff.20.2.193; Iglehart JK, 1999, NEW ENGL J MED, V340, P70, DOI 10.1056/NEJM199901073400122; Kalandadze T, 1999, CROAT MED J, V40, P216; KHELSURIANI N, 2000, J INFECT DIS S1, V181, pS80; Kuttner R, 1999, NEW ENGL J MED, V340, P163, DOI 10.1056/NEJM199901143400226; Lynch JW, 1997, NEW ENGL J MED, V337, P1889, DOI 10.1056/NEJM199712253372606; MARMOT MG, 1987, ANNU REV PUBL HEALTH, V8, P111, DOI 10.1146/annurev.pu.08.050187.000551; MARMOT MG, 1984, LANCET, V1, P1003; PAPPAS G, 1993, NEW ENGL J MED, V329, P103, DOI 10.1056/NEJM199307083290207; Shishkin S, 1998, Croat Med J, V39, P298; Shishkin S, 1999, CROAT MED J, V40, P195; *STAT DEP STAT, 1997, SURV HLTH COND TBIL; Twigg JL, 1999, SOC SCI MED, V49, P371, DOI 10.1016/S0277-9536(99)00088-X; *UN DEV PROGR, 1996, HUM DEV REP GEORG; *UN DEV PROGR, 2000, HUM DEV REP GEORG; *UN DEV PROGR, 1998, HUM DEV REP GEORG; *UN DEV PROGR, 1997, HUM DEV REP GEORG; *UNICEF, 1997, HELATHC REF GEORG AN; *UNICEF, 1995, SUMM REP RES FIND HO; *UNICEF, 1997, REP SURV DEM HLTH CA; *WORLD BANK, 1996, STAFF APPR REP GEORG	32	40	40	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2002	287	8					1043	1049		10.1001/jama.287.8.1043	http://dx.doi.org/10.1001/jama.287.8.1043			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	525CX	11866656				2022-12-28	WOS:000174052100036
J	Smidt, N; van der Windt, DAWM; Assendelft, WJJ; Deville, WLJM; Korthals-de Bos, IBC; Bouter, LM				Smidt, N; van der Windt, DAWM; Assendelft, WJJ; Deville, WLJM; Korthals-de Bos, IBC; Bouter, LM			Corticosteroid injections, physiotherapy, or a wait-and-see policy for lateral epicondylitis: a randomised controlled trial	LANCET			English	Article							MUSCULOSKELETAL DISORDERS; TENNIS ELBOW; PRIMARY-CARE; PREVALENCE; THERAPY; PAIN	Background Lateral epicondylitis is generally treated with corticosteroid injections or physiotherapy. Dutch clinical guidelines recommend a wait-and-see policy. We compared the efficacy of these approaches. Methods Patients with lateral epicondylitis of at least 6 weeks' duration were recruited by family doctors. We randomly allocated eligible patients to 6 weeks of treatment with corticosteroid injections, physiotherapy, or a wait-and-see policy. Outcome measures included general improvement, severity of the main complaint, pain, elbow disability, and patient satisfaction. Severity of elbow complaints, grip strength, and pressure pain threshold were assessed by a research physiotherapist who was unaware of treatment allocation. We assessed all outcomes at 3, 6, 12, 26, and 52 weeks. The principal analysis was done on an intention-to-treat basis. Findings We randomly assigned 185 patients. At 6 weeks, corticosteroid injections were significantly better than all other therapy options for all outcome measures. Success rates were 92% (57) compared with 47% (30) for physiotherapy and 32% (19) for wait-and-see policy. However, recurrence rate in the injection group was high. Long-term differences between injections and physiotherapy were significantly in favour of physiotherapy. Success rates at 52 weeks were 69% (43) for injections, 91% (58) for physiotherapy, and 83% (49) for a wait-and-see policy. Physiotherapy had better results than a wait-and-see policy, but differences were not significant. Interpretation Patients should be properly informed about the advantages and disadvantages of the treatment options for lateral epicondylitis. The decision to treat with physiotherapy or to adopt a wait-and-see policy might depend on available resources, since the relative gain of physiotherapy is small.	VU Univ Med Ctr, Fac Med, Inst Res Extramural Med, NL-1081 BT Amsterdam, Netherlands; VU Univ Med Ctr, Dept Gen Practice, NL-1081 BT Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, Div Publ Hlth, NL-1105 AZ Amsterdam, Netherlands; Netherlands Inst Hlth Serv Res, Utrecht, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Institute for Health Services Research	Smidt, N (corresponding author), VU Univ Med Ctr, Fac Med, Inst Res Extramural Med, NL-1081 BT Amsterdam, Netherlands.		Assendelft, W.J.J./H-8008-2014; assendelft, willem/AAW-1854-2021; Deville, Walter/B-5160-2013	Assendelft, W.J.J./0000-0002-2966-3778; assendelft, willem/0000-0002-2966-3778; Bouter, Lex/0000-0002-2659-5482				ALLANDER E, 1974, SCAND J RHEUMATOL, V3, P145, DOI 10.3109/03009747409097141; [Anonymous], 1994, REUMA ONDERZOEK MEER; Assendelft WJJ, 1996, BRIT J GEN PRACT, V46, P209; BECKERMAN H, 1993, BRIT J GEN PRACT, V43, P73; BINDER A, 1985, BRIT MED J, V290, P512, DOI 10.1136/bmj.290.6467.512; CHARD MD, 1989, BR J RHEUMATOL, V28, P187; Cyriax JH, 1936, J BONE JOINT SURG, V18, P921; de Wolf A N, 1984, Ned Tijdschr Geneeskd, V128, P2191; DEWOLF AN, 1995, MUSCULOSKELETAL DISO, P106; ERNST E, 1992, BRIT J CLIN PRACT, V46, P55; ERNST E, 1994, EUR J PHYS MED, V4, P50; FISCHER AA, 1987, PAIN, V30, P115, DOI 10.1016/0304-3959(87)90089-3; HAMILTON PG, 1986, J ROY COLL GEN PRACT, V36, P464; Hay EM, 1999, BRIT MED J, V319, P964, DOI 10.1136/bmj.319.7215.964; Hudak PL, 1996, ARCH PHYS MED REHAB, V77, P586, DOI 10.1016/S0003-9993(96)90300-7; Kivi P, 1982, SCAND J REHABIL MED, V15, P37; LABELLE H, 1992, J BONE JOINT SURG BR, V74, P646, DOI 10.1302/0301-620X.74B5.1388172; MENS JMA, 1993, MOD MED          JAN, P41; Murtagh J E, 1988, Aust Fam Physician, V17, P90; Nussbaum EL, 1998, PHYS THER, V78, P160, DOI 10.1093/ptj/78.2.160; Pienimaki TT., 1996, PHYSIOTHERAPY, V82, P522; RABKIN JG, 1986, PSYCHIAT RES, V19, P75, DOI 10.1016/0165-1781(86)90094-6; SMIDT N, 2001, CONSERVATIVE TRETMEN, P121; STRATFORD P, 1987, Physiotherapy Canada, V39, P250; STRATFORD PW, 1989, PHYS THER, V69, P276, DOI 10.1093/ptj/69.4.276; STRATFORD PW, 1994, CLIN J SPORT MED, V4, P88, DOI DOI 10.1097/00042752-199404000-00004; van der Windt DAWM, 1999, PAIN, V81, P257, DOI 10.1016/S0304-3959(99)00016-0; van der Windt DAWM, 1998, BRIT MED J, V317, P1292, DOI 10.1136/bmj.317.7168.1292; VERHAAR IAN, 1992, TENNIS ELBOW; Verhaar JAN, 1996, J BONE JOINT SURG BR, V78B, P128, DOI 10.1302/0301-620X.78B1.0780128	30	424	436	3	43	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 23	2002	359	9307					657	662		10.1016/S0140-6736(02)07811-X	http://dx.doi.org/10.1016/S0140-6736(02)07811-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526AZ	11879861	Green Submitted			2022-12-28	WOS:000174107400009
J	Meyerowitz, EM				Meyerowitz, EM			Comparative genomics - Plants compared to animals: The broadest comparative study of development	SCIENCE			English	Review							GENE FAMILY; DROSOPHILA-MELANOGASTER; ARABIDOPSIS-THALIANA; SIGNAL-TRANSDUCTION; ETHYLENE RECEPTORS; LATERAL ORGANS; HOMEOTIC GENE; CELL FATE; KINASE; PROTEIN	If the last common ancestor of plants and animals was unicellular, comparison of the developmental mechanisms of plants and animals would show that development was independently invented in each lineage. And if this is the case, comparison of plant and animal developmental processes would give us a truly comparative study of development, which comparisons merely among animals, or merely among plants, do not-because in each of these lineages, the fundamental mechanisms are similar by descent. Evidence from studies of developmental mechanisms in both kingdoms, and data from genome-sequencing projects, indicate that development evolved independently in the lineages leading to plants and to animals.	CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA	California Institute of Technology	Meyerowitz, EM (corresponding author), CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA.	meyerow@its.caltech.edu	Meyerowitz, Elliot M/A-7118-2009					Abdallah F, 2000, TRENDS PLANT SCI, V5, P141, DOI 10.1016/S1360-1385(00)01574-0; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Alcedo J, 1997, BIOL CHEM, V378, P583; Alvarez-Venegas R, 2001, GENE, V271, P215, DOI 10.1016/S0378-1119(01)00524-8; Anderson KV, 2000, CURR OPIN IMMUNOL, V12, P13, DOI 10.1016/S0952-7915(99)00045-X; ARTAVANISTSAKONAS S, 1991, TRENDS GENET, V7, P403, DOI 10.1016/0168-9525(91)90264-Q; BANERJEE U, 1987, CELL, V51, P151, DOI 10.1016/0092-8674(87)90020-1; Bowman JL, 2000, CURR OPIN GENET DEV, V10, P399, DOI 10.1016/S0959-437X(00)00103-9; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CAGAN RL, 1992, CELL, V69, P393, DOI 10.1016/0092-8674(92)90442-F; Clark KL, 1998, P NATL ACAD SCI USA, V95, P5401, DOI 10.1073/pnas.95.9.5401; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; DELANGE RJ, 1969, J BIOL CHEM, V244, P5669; Delwiche CF, 1997, PLANT SYST EVOL, P53; DeYoung BJ, 2001, PLANT MOL BIOL, V46, P505, DOI 10.1023/A:1010672910703; Eshed Y, 2001, CURR BIOL, V11, P1251, DOI 10.1016/S0960-9822(01)00392-X; Fletcher JC, 2000, CURR OPIN PLANT BIOL, V3, P23, DOI 10.1016/S1369-5266(99)00033-3; Gamble RL, 1998, P NATL ACAD SCI USA, V95, P7825, DOI 10.1073/pnas.95.13.7825; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; Goto K, 2001, CURR OPIN GENET DEV, V11, P449, DOI 10.1016/S0959-437X(00)00216-1; Gunthorpe D, 1999, DEV BIOL, V215, P130, DOI 10.1006/dbio.1999.9449; HAFEN E, 1987, SCIENCE, V236, P55, DOI 10.1126/science.2882603; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Jack T, 2001, PLANT MOL BIOL, V46, P515, DOI 10.1023/A:1010689126632; Jack T, 2001, TRENDS PLANT SCI, V6, P310, DOI 10.1016/S1360-1385(01)01987-2; JONES RS, 1990, GENETICS, V126, P185; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kehoe DM, 1996, SCIENCE, V273, P1409, DOI 10.1126/science.273.5280.1409; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leblanc C, 1997, CURR GENET, V31, P193, DOI 10.1007/s002940050196; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 1997, P NATL ACAD SCI USA, V94, P3554, DOI 10.1073/pnas.94.8.3554; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Mojzsis SJ, 1996, NATURE, V384, P55, DOI 10.1038/384055a0; Montagne J, 1996, DEVELOPMENT, V122, P2589; Morisato D, 2001, DEVELOPMENT, V128, P2309; Owen GI, 2000, CELL MOL LIFE SCI, V57, P809, DOI 10.1007/s000180050043; PELLEGRINI L, 1995, NATURE, V376, P490, DOI 10.1038/376490a0; Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9; Quail PH, 2000, SEMIN CELL DEV BIOL, V11, P457, DOI 10.1006/scdb.2000.0199; Riechmann JL, 1997, BIOL CHEM, V378, P1079; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Riechmann V, 2001, CURR OPIN GENET DEV, V11, P374, DOI 10.1016/S0959-437X(00)00207-0; Ringrose L, 2001, BIOESSAYS, V23, P566, DOI 10.1002/bies.1082; Rodriguez FI, 1999, SCIENCE, V283, P996, DOI 10.1126/science.283.5404.996; Rujan T, 2001, TRENDS GENET, V17, P113, DOI 10.1016/S0168-9525(00)02209-5; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Siegfried KR, 1999, DEVELOPMENT, V126, P4117; TAYLOR MV, 1995, MECH DEVELOP, V50, P29, DOI 10.1016/0925-4773(94)00323-F; Theissen G, 1996, J MOL EVOL, V43, P484, DOI 10.1007/BF02337521; Urao T, 2000, TRENDS PLANT SCI, V5, P67, DOI 10.1016/S1360-1385(99)01542-3; Veraksa A, 2000, MOL GENET METAB, V69, P85, DOI 10.1006/mgme.2000.2963; WANG DYC, 1999, P ROY SOC LOND B BIO, V266, P63; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Williams RW, 1997, P NATL ACAD SCI USA, V94, P10467, DOI 10.1073/pnas.94.19.10467; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976	59	201	208	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2002	295	5559					1482	1485		10.1126/science.1066609	http://dx.doi.org/10.1126/science.1066609			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11859185				2022-12-28	WOS:000173981300041
J	van der Merwe, PA; Davis, SJ				van der Merwe, PA; Davis, SJ			The immunological synapse - a multitasking system	SCIENCE			English	Editorial Material							ACTIVATION		Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England	University of Oxford; University of Oxford	van der Merwe, PA (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.		van der Merwe, P. Anton/F-8539-2011					Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; Davis SJ, 2001, CURR BIOL, V11, pR289, DOI 10.1016/S0960-9822(01)00165-8; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Lang P, 2001, SCIENCE, V291, P1537, DOI 10.1126/science.291.5508.1537; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Linsley PS, 1996, IMMUNITY, V4, P535, DOI 10.1016/S1074-7613(00)80480-X; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203	10	56	58	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2002	295	5559					1479	1480		10.1126/science.1069896	http://dx.doi.org/10.1126/science.1069896			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11859183				2022-12-28	WOS:000173981300039
J	Geist, M; Tarchitzky, D				Geist, M; Tarchitzky, D			Coronary spasm	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Edith Wolfson Med Ctr, IL-58100 Holon, Israel		Geist, M (corresponding author), Edith Wolfson Med Ctr, IL-58100 Holon, Israel.								0	1	1	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2002	346	8					579	579		10.1056/NEJMicm010757	http://dx.doi.org/10.1056/NEJMicm010757			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	522ZK	11856797				2022-12-28	WOS:000173926700006
J	Poon, M; Badimon, JJ; Fuster, V				Poon, M; Badimon, JJ; Fuster, V			Overcoming restenosis with sirolimus: from alphabet soup to clinical reality	LANCET			English	Editorial Material							TRANS-LUMINAL ANGIOPLASTY; SMOOTH-MUSCLE CELL; BALLOON ANGIOPLASTY; MICE LACKING; RAPAMYCIN; GROWTH; PROLIFERATION; INJURY; CYCLE; ATHEROSCLEROSIS		Mt Sinai Sch Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Fuster, V (corresponding author), Mt Sinai Sch Med, 1 Gustav L Levy Pl,Box 1030, New York, NY 10029 USA.		Fuster, Valentin/H-4319-2015	Fuster, Valentin/0000-0002-9043-9986				Bennett MR, 2001, PHARMACOL THERAPEUT, V91, P149, DOI 10.1016/S0163-7258(01)00153-X; FAXON DP, 1984, ARTERIOSCLEROSIS, V4, P189, DOI 10.1161/01.ATV.4.3.189; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Gallo R, 1999, CIRCULATION, V99, P2164, DOI 10.1161/01.CIR.99.16.2164; GREGORY CR, 1993, TRANSPLANTATION, V55, P1409, DOI 10.1097/00007890-199306000-00037; GRUNTZIG A, 1978, LANCET, V1, P263, DOI 10.1016/s0140-6736(78)90500-7; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Kim HS, 2001, J AM COLL CARDIOL, V37, P1026, DOI 10.1016/S0735-1097(01)01112-3; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Lafont A, 1998, J AM COLL CARDIOL, V32, P283; MAJESKY MW, 1991, J CLIN INVEST, V88, P904, DOI 10.1172/JCI115393; MARX SO, 1995, CIRC RES, V76, P412, DOI 10.1161/01.RES.76.3.412; Mehran R, 1996, AM J CARDIOL, V78, P618, DOI 10.1016/S0002-9149(96)00381-5; MORICE MC, 2002, RANDOMISED DOUBLE BL; Moussa I, 1996, AM J CARDIOL, V78, P13, DOI 10.1016/S0002-9149(96)00486-9; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; OBRIEN ER, 1993, CIRC RES, V73, P223, DOI 10.1161/01.RES.73.2.223; PALMAZ JC, 1985, AM J ROENTGENOL, V145, P821, DOI 10.2214/ajr.145.4.821; Poon M, 1996, J CLIN INVEST, V98, P2277, DOI 10.1172/JCI119038; RODRIGUEZ A, 1993, J AM COLL CARDIOL, V22, P1060, DOI 10.1016/0735-1097(93)90416-X; Rogue M, 2000, ATHEROSCLEROSIS, V153, P315, DOI 10.1016/S0021-9150(00)00421-4; Roque M, 2001, LAB INVEST, V81, P895, DOI 10.1038/labinvest.3780298; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; ROSS R, 1990, ANN NY ACAD SCI, V598, P102, DOI 10.1111/j.1749-6632.1990.tb42282.x; SEHGAL SN, 1995, THER DRUG MONIT, V17, P660, DOI 10.1097/00007691-199512000-00019; SIGWART U, 1987, NEW ENGL J MED, V316, P701, DOI 10.1056/NEJM198703193161201; Smith SC, 2001, J AM COLL CARDIOL, V37, P2215, DOI 10.1016/S0735-1097(01)01344-4; Sousa JE, 2001, CIRCULATION, V104, P2007, DOI 10.1161/hc4201.098056; Sousa JE, 2001, CIRCULATION, V103, P192; STEELE PM, 1985, CIRC RES, V57, P105, DOI 10.1161/01.RES.57.1.105; Sun J, 2001, CIRCULATION, V103, P2967, DOI 10.1161/01.CIR.103.24.2967; Vidal A, 2000, GENE, V247, P1, DOI 10.1016/S0378-1119(00)00092-5; Zohlnhofer D, 2001, CIRCULATION, V103, P1396, DOI 10.1161/01.CIR.103.10.1396	34	46	52	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2002	359	9306					619	622		10.1016/S0140-6736(02)07751-6	http://dx.doi.org/10.1016/S0140-6736(02)07751-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523FP	11867133				2022-12-28	WOS:000173943600031
J	Yoshida, S; Nakata, T				Yoshida, S; Nakata, T			Takayasu's arteritis	LANCET			English	Editorial Material									Sapporo Med Univ, Sch Med, Dept Radiol, Chuo Ku, Sapporo, Hokkaido 0608543, Japan	Sapporo Medical University	Yoshida, S (corresponding author), Sapporo Med Univ, Sch Med, Dept Radiol, Chuo Ku, Sapporo, Hokkaido 0608543, Japan.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 16	2002	359	9306					557	557		10.1016/S0140-6736(02)07742-5	http://dx.doi.org/10.1016/S0140-6736(02)07742-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523FP	11867108				2022-12-28	WOS:000173943600007
J	Hodgson, H				Hodgson, H			Sheila Sherlock's legacy	LANCET			English	Editorial Material							HEPATITIS		UCL Royal Free & Univ Coll Sch Med, Dept Med, London NW3 2PF, England	University of London; University College London	Hodgson, H (corresponding author), UCL Royal Free & Univ Coll Sch Med, Dept Med, London NW3 2PF, England.	h.hodgson@rfc.ucl.ac.uk						COOK GC, 1971, Q J MED, V40, P159, DOI 10.1093/oxfordjournals.qjmed.a067264; Doniach D, 1966, Clin Exp Immunol, V1, P237; MCINTYRE N, 2002, INDEPENDENT LON 0108; SHERLOCK S, 1954, LANCET, V2, P453; SHERLOCK S, 1970, LANCET, V1, P1243; SHERLOCK S, 1945, LANCET, V2, P397; SHERLOCK S, 2001, DIS LIVER BILIARY SY; 2002, NY TIMES        0110	8	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 9	2002	359	9305					460	460		10.1016/S0140-6736(02)07673-0	http://dx.doi.org/10.1016/S0140-6736(02)07673-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520ML	11853789				2022-12-28	WOS:000173785600006
J	Horton, R				Horton, R			The doctor's role in advocacy	LANCET			English	Editorial Material									The Lancet, London WC1X 8RR, England		Horton, R (corresponding author), The Lancet, London WC1X 8RR, England.							MARMOR T, 2001, FADS MED CARE POLICY	1	10	10	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 9	2002	359	9305					458	458		10.1016/S0140-6736(02)07670-5	http://dx.doi.org/10.1016/S0140-6736(02)07670-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520ML	11853787				2022-12-28	WOS:000173785600003
J	Burnett, K; Julienne, PS; Lett, PD; Tiesinga, E; Williams, CJ				Burnett, K; Julienne, PS; Lett, PD; Tiesinga, E; Williams, CJ			Quantum encounters of the cold kind	NATURE			English	Review							BOSE-EINSTEIN CONDENSATE; STATE POTASSIUM MOLECULES; SCATTERING LENGTHS; PHOTOASSOCIATIVE SPECTROSCOPY; ATTRACTIVE INTERACTIONS; COLLISIONAL PROPERTIES; RADIATIVE LIFETIME; COOLED ATOMS; ENTANGLEMENT; RESONANCE		Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; Natl Inst Stand & Technol, Atom Phys Div, Gaithersburg, MD 20899 USA	University of Oxford; National Institute of Standards & Technology (NIST) - USA	Burnett, K (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Parks Rd, Oxford OX1 3PU, England.		Williams, Carl J/B-5877-2009; Julienne, Paul S/E-9378-2012	Williams, Carl J/0000-0003-4274-3227; Julienne, Paul S/0000-0002-5494-1442				Abraham ERI, 1997, PHYS REV A, V55, pR3299, DOI 10.1103/PhysRevA.55.R3299; BAND YB, 1995, PHYS REV A, V51, pR4317, DOI 10.1103/PhysRevA.51.R4317; Bethlem HL, 2000, NATURE, V406, P491, DOI 10.1038/35020030; Bohn JL, 1999, PHYS REV A, V59, P3660, DOI 10.1103/PhysRevA.59.3660; Bradley CC, 1997, PHYS REV LETT, V78, P985, DOI 10.1103/PhysRevLett.78.985; Brennen GK, 1999, PHYS REV LETT, V82, P1060, DOI 10.1103/PhysRevLett.82.1060; Burke JP, 1998, PHYS REV LETT, V80, P2097, DOI 10.1103/PhysRevLett.80.2097; Chin C, 2000, PHYS REV LETT, V85, P2717, DOI 10.1103/PhysRevLett.85.2717; Chu S, 1998, REV MOD PHYS, V70, P685, DOI 10.1103/RevModPhys.70.685; Cohen-Tannoudji CN, 1998, REV MOD PHYS, V70, P707, DOI 10.1103/RevModPhys.70.707; Cornish SL, 2000, PHYS REV LETT, V85, P1795, DOI 10.1103/PhysRevLett.85.1795; Crubellier A, 1999, EUR PHYS J D, V6, P211, DOI 10.1007/s100530050303; Dalfovo F, 1999, REV MOD PHYS, V71, P463, DOI 10.1103/RevModPhys.71.463; Dodd RJ, 1996, PHYS REV A, V54, P661, DOI 10.1103/PhysRevA.54.661; Duan LM, 2000, PHYS REV LETT, V85, P3991, DOI 10.1103/PhysRevLett.85.3991; FATEMI FK, IN PRESS PHYS REV A; Fioretti A, 1998, PHYS REV LETT, V80, P4402, DOI 10.1103/PhysRevLett.80.4402; Gabbanini C, 2000, PHYS REV LETT, V84, P2814, DOI 10.1103/PhysRevLett.84.2814; Gerton JM, 2000, NATURE, V408, P692, DOI 10.1038/35047030; Heinzen DJ, 2000, PHYS REV LETT, V84, P5029, DOI 10.1103/PhysRevLett.84.5029; HEINZEN DJ, 1995, ATOMIC PHYSICS, V14, P369; Holland M, 2001, PHYS REV LETT, V86, P1915, DOI 10.1103/PhysRevLett.86.1915; Inouye S, 1998, NATURE, V392, P151, DOI 10.1038/32354; Jaksch D, 1999, PHYS REV LETT, V82, P1975, DOI 10.1103/PhysRevLett.82.1975; Jaksch D, 2000, PHYS REV LETT, V85, P2208, DOI 10.1103/PhysRevLett.85.2208; Javanainen J, 1999, PHYS REV A, V59, pR3186, DOI 10.1103/PhysRevA.59.R3186; Jessen PS, 1996, ADV ATOM MOL OPT PHY, V37, P95; Jones KM, 1996, EUROPHYS LETT, V35, P85, DOI 10.1209/epl/i1996-00536-9; Julienne PS, 1998, PHYS REV A, V58, pR797, DOI 10.1103/PhysRevA.58.R797; Ketterle W, 1996, ADV ATOM MOL OPT PHY, V37, P181; Leo PJ, 2000, PHYS REV LETT, V85, P2721, DOI 10.1103/PhysRevLett.85.2721; Leo PJ, 2001, PHYS REV LETT, V86, P3743, DOI 10.1103/PhysRevLett86.3743; LETT PD, 1995, ANNU REV PHYS CHEM, V46, P423, DOI 10.1146/annurev.pc.46.100195.002231; McAlexander WI, 1996, PHYS REV A, V54, pR5, DOI 10.1103/PhysRevA.54.R5; NAPOLITANO R, 1994, PHYS REV LETT, V73, P1352, DOI 10.1103/PhysRevLett.73.1352; Nikolov AN, 1999, PHYS REV LETT, V82, P703, DOI 10.1103/PhysRevLett.82.703; Nikolov AN, 2000, PHYS REV LETT, V84, P246, DOI 10.1103/PhysRevLett.84.246; Olshanii M, 1998, PHYS REV LETT, V81, P938, DOI 10.1103/PhysRevLett.81.938; Phillips WD, 1998, REV MOD PHYS, V70, P721, DOI 10.1103/RevModPhys.70.721; Pu H, 2000, PHYS REV LETT, V85, P3987, DOI 10.1103/PhysRevLett.85.3987; Roberts JL, 2001, PHYS REV LETT, V86, P4211, DOI 10.1103/PhysRevLett.86.4211; Sackett CA, 2000, NATURE, V404, P256, DOI 10.1038/35005011; Stwalley WC, 1999, J MOL SPECTROSC, V195, P194, DOI 10.1006/jmsp.1999.7838; STWALLEY WC, 1976, PHYS REV LETT, V37, P1628, DOI 10.1103/PhysRevLett.37.1628; STWALLEY WC, 1978, PHYS REV LETT, V41, P1164, DOI 10.1103/PhysRevLett.41.1164; Takekoshi T, 1999, PHYS REV A, V59, pR5, DOI 10.1103/PhysRevA.59.R5; TIESINGA E, 1993, PHYS REV A, V47, P4114, DOI 10.1103/PhysRevA.47.4114; Tiesinga E, 1996, J RES NATL INST STAN, V101, P505, DOI 10.6028/jres.101.051; Tiesinga E, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.063416; Timmermans E, 1999, PHYS REV LETT, V83, P2691, DOI 10.1103/PhysRevLett.83.2691; van Abeelen FA, 1999, PHYS REV A, V59, P578, DOI 10.1103/PhysRevA.59.578; Vardi A, 1997, J CHEM PHYS, V107, P6166, DOI 10.1063/1.474282; Wang H, 1997, PHYS REV A, V55, pR1569, DOI 10.1103/PhysRevA.55.R1569; Weiner J, 1999, REV MOD PHYS, V71, P1, DOI 10.1103/RevModPhys.71.1; Weinstein JD, 1998, NATURE, V395, P148, DOI 10.1038/25949; Wynar R, 2000, SCIENCE, V287, P1016, DOI 10.1126/science.287.5455.1016	56	75	78	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2002	416	6877					225	232		10.1038/416225a	http://dx.doi.org/10.1038/416225a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894106				2022-12-28	WOS:000174348100049
J	Radaelli, PG; Horibe, Y; Gutmann, MJ; Ishibashi, H; Chen, CH; Ibberson, RM; Koyama, Y; Hor, YS; Kiryukhin, V; Cheong, SW				Radaelli, PG; Horibe, Y; Gutmann, MJ; Ishibashi, H; Chen, CH; Ibberson, RM; Koyama, Y; Hor, YS; Kiryukhin, V; Cheong, SW			Formation of isomorphic Ir3+ and Ir4+ octamers and spin dimerization in the spinel CuIr2S4	NATURE			English	Article							METAL-INSULATOR-TRANSITION; PEIERLS TRANSITION; SYSTEM; TEMPERATURE; REFINEMENT; CUGEO3	Inorganic compounds with the AB(2)X(4) spinel structure have been studied for many years, because of their unusual physical properties. The spinel crystallographic structure, first solved by Bragg in 1915(1), has cations occupying both tetrahedral (A) and octahedral (B) sites. Interesting physics arises when the B-site cations become mixed in valence. Magnetite (Fe3O4) is a classic and still unresolved example, where the tendency to form ordered arrays of Fe2+ and Fe3+ ions competes with the topological frustration of the B-site network(2). The CuIr2S4 thiospinel is another example, well known for the presence of a metal-insulator transition at 230 K with an abrupt decrease of the electrical conductivity on cooling accompanied by the loss of localized magnetic moments(3-7). Here, we report the determination of the crystallographic structure of CuIr2S4 below the metal-insulator transition. Our results indicate that CuIr2S4 undergoes a simultaneous charge-ordering and spin-dimerization transition-a rare phenomenon in three-dimensional compounds. Remarkably, the charge-ordering pattern consists of isomorphic octamers of Ir83+S24 and Ir84+S24 (as isovalent bi-capped hexagonal rings). This extraordinary arrangement leads to an elegant description of the spinel structure, but represents an increase in complexity with respect to all the known charge-ordered structures, which are typically based on stripes, slabs or chequerboard patterns.	Rutherford Appleton Lab, ISIS Facil, Didcot OX11 0QX, Oxon, England; Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA; Waseda Univ, Dept Mat Sci & Engn, Shinjuku Ku, Tokyo 169, Japan; Waseda Univ, Kagami Mem lab Mat Sci & Technol, Shinjuku Ku, Tokyo 169, Japan; Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA; Univ Osaka Prefecture, Dept Mat Sci, Osaka 599, Japan	UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Alcatel-Lucent; Lucent Technologies; AT&T; Waseda University; Waseda University; Rutgers State University New Brunswick; Osaka Metropolitan University	Radaelli, PG (corresponding author), Rutherford Appleton Lab, ISIS Facil, Didcot OX11 0QX, Oxon, England.		Chen, Cheng-Hsuan/F-7933-2012; San Hor, Yew/S-1429-2017; Radaelli, Paolo G/C-2952-2011; Ibberson, Richard M/P-8397-2015	San Hor, Yew/0000-0002-1417-4357; Radaelli, Paolo G/0000-0002-6717-035X; Ibberson, Richard M/0000-0003-0007-706X				ANDERSON PW, 1956, PHYS REV, V102, P1008, DOI 10.1103/PhysRev.102.1008; BILLINGE SJL, 1993, PHYS REV B, V47, P14386, DOI 10.1103/PhysRevB.47.14386; Bragg WH, 1915, NATURE, V95, P561, DOI 10.1038/095561a0; Bray J. W., 1983, EXTENDED LINEAR CHAI; BRAY JW, 1975, PHYS REV LETT, V35, P744, DOI 10.1103/PhysRevLett.35.744; Burkov AT, 2000, PHYS REV B, V61, P10049, DOI 10.1103/PhysRevB.61.10049; FURUBAYASHI T, 1994, J PHYS SOC JPN, V63, P3333, DOI 10.1143/JPSJ.63.3333; HASE M, 1993, PHYS REV LETT, V70, P3651, DOI 10.1103/PhysRevLett.70.3651; HIROTA K, 1994, PHYS REV LETT, V73, P736, DOI 10.1103/PhysRevLett.73.736; IIZUMI M, 1982, ACTA CRYSTALLOGR B, V38, P2121, DOI 10.1107/S0567740882008176; Ishibashi H, 2001, J MAGN MAGN MATER, V226, P233, DOI 10.1016/S0304-8853(00)00638-7; JACOBS IS, 1976, PHYS REV B, V14, P3036, DOI 10.1103/PhysRevB.14.3036; Kumagai K, 2000, PHYSICA C, V341, P741, DOI 10.1016/S0921-4534(00)00670-5; Ludecke J, 1999, PHYS REV LETT, V82, P3633, DOI 10.1103/PhysRevLett.82.3633; MAREZIO M, 1972, PHYS REV LETT, V28, P1390, DOI 10.1103/PhysRevLett.28.1390; Matsumoto N, 1999, PHYS REV B, V60, P5258, DOI 10.1103/PhysRevB.60.5258; Matsuno J, 1997, PHYS REV B, V55, P15979, DOI 10.1103/PhysRevB.55.R15979; Nagata S, 1998, PHYS REV B, V58, P6844, DOI 10.1103/PhysRevB.58.6844; Peterson PF, 2000, J APPL CRYSTALLOGR, V33, P1192, DOI 10.1107/S0021889800007123; Proffen T, 1999, J APPL CRYSTALLOGR, V32, P572, DOI 10.1107/S0021889899003532; Rodriguez-Carvajal J, 1998, PHYS REV LETT, V81, P4660, DOI 10.1103/PhysRevLett.81.4660; Stokes H.T., 1988, ISOTROPY SUBGROUPS 2	22	289	294	5	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2002	416	6877					155	158		10.1038/416155a	http://dx.doi.org/10.1038/416155a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894088				2022-12-28	WOS:000174348100031
J	Lee, SJ; Evers, S; Roeder, D; Parlow, AF; Risteli, J; Risteli, L; Lee, YC; Feizi, T; Langen, H; Nussenzweig, MC				Lee, SJ; Evers, S; Roeder, D; Parlow, AF; Risteli, J; Risteli, L; Lee, YC; Feizi, T; Langen, H; Nussenzweig, MC			Mannose receptor-mediated regulation of serum glycoprotein homeostasis	SCIENCE			English	Article							CYSTEINE-RICH DOMAIN; DOWN-REGULATION; I PROCOLLAGEN; MACROPHAGES; LUTROPIN; BINDING; OLIGOSACCHARIDES; RECOGNITION; EXPRESSION; PROPEPTIDE	Carbohydrates are thought to function as tags that mark circulatory glycoproteins for rapid clearance. To examine the role of the mannose receptor (MR) in glycoprotein clearance, we generated mice genetically deficient in MR. MR-/- mice were defective in clearing proteins bearing accessible mannose and N-acetylglucosamine residues and had elevated levels of eight different lysosomal hydrolases. Proteomic analysis of MR-/- and control mouse sera showed that an additional 4 out of 52 proteins identified were elevated in MR-/- serum. Each of these is up-regulated during inflammation and wound heating. Thus, MR appears to operate as an essential regulator of serum glycoprotein homeostasis.	Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; F Hoffmann La Roche & Co Ltd, Infect Dis, CH-4070 Basel, Switzerland; F Hoffmann La Roche & Co Ltd, Genet, CH-4070 Basel, Switzerland; Univ Calif Los Angeles, Harbor Med Ctr, Natl Hormone & Pituitary Program, Torrance, CA 90509 USA; Univ Oulu, Dept Clin Chem, FIN-90014 Oulu, Finland; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; Univ London Imperial Coll Sci Technol & Med, Fac Med, Northwick Pk Inst Med Res, Glycosci Lab, Harrow HA1 3UJ, Middx, England; Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; Roche Holding; Roche Holding; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Oulu; Johns Hopkins University; Imperial College London; Howard Hughes Medical Institute	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave,Box 220, New York, NY 10021 USA.		Nussenzweig, Michel/AAE-7292-2019	Risteli, Leila/0000-0002-5532-5895; Feizi, Ten/0000-0001-6495-0329	NIGMS NIH HHS [GM07739] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASHWELL G, 1974, ADV ENZYMOL RAMB, V41, P99; BAENZIGER JU, 1992, P NATL ACAD SCI USA, V89, P334, DOI 10.1073/pnas.89.1.334; BENOFF S, 1993, FERTIL STERIL, V59, P854; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1357, DOI 10.1002/elps.11501401209; BROWN WM, 1992, BIOESSAYS, V14, P749, DOI 10.1002/bies.950141105; CLARK CC, 1979, J BIOL CHEM, V254, P798; EZEKOWITZ RAB, 1986, BIOCHEM BIOPH RES CO, V136, P737; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; Fiete DJ, 1998, P NATL ACAD SCI USA, V95, P2089, DOI 10.1073/pnas.95.5.2089; Grunenfelder B, 2001, P NATL ACAD SCI USA, V98, P4681, DOI 10.1073/pnas.071538098; HAUKIPURO K, 1987, ANN SURG, V206, P752, DOI 10.1097/00000658-198712000-00011; HOYLE GW, 1988, J BIOL CHEM, V263, P7487; ISHIBASHI S, 1994, J BIOL CHEM, V269, P27803; LEE YC, 1976, BIOCHEMISTRY-US, V15, P3956, DOI 10.1021/bi00663a008; Leteux C, 2000, J EXP MED, V191, P1117, DOI 10.1084/jem.191.7.1117; MELKKO J, 1990, CLIN CHEM, V36, P1328; Olivier E, 2000, BIOCHEM J, V350, P589, DOI 10.1042/0264-6021:3500589; SHEPHERD VL, 1985, J BIOL CHEM, V260, P160; SHEPHERD VL, 1990, J IMMUNOL, V145, P1530; Sohar I, 1998, BIOCHEM J, V330, P903, DOI 10.1042/bj3300903; STAHL P, 1976, NATURE, V264, P86, DOI 10.1038/264086a0; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; TAYLOR ME, 1987, AM J PHYSIOL, V252, pE690, DOI 10.1152/ajpendo.1987.252.5.E690; TAYLOR ME, 1993, J BIOL CHEM, V268, P399	24	364	396	3	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1898	1901		10.1126/science.1069540	http://dx.doi.org/10.1126/science.1069540			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884756				2022-12-28	WOS:000174299500041
J	Check, E				Check, E			Call for cloning ban splits UN	NATURE			English	News Item																			0	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2002	416	6876					3	3		10.1038/416003b	http://dx.doi.org/10.1038/416003b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882852	Bronze			2022-12-28	WOS:000174211600004
J	Lever, C; Wills, T; Cacucci, F; Burgess, N; O'Keefe, J				Lever, C; Wills, T; Cacucci, F; Burgess, N; O'Keefe, J			Long-term plasticity in hippocampal place-cell representation of environmental geometry	NATURE			English	Article							RECEPTIVE-FIELDS; CORTEX; MEMORY; RAT; LESIONS; NEURONS; INPUTS; TASK	The hippocampus is widely believed to be involved in the storage or consolidation of long-term memories(1-4). Several reports have shown short-term changes in single hippocampal unit activity during memory and plasticity experiments(5-12), but there has been no experimental demonstration of long-term persistent changes in neuronal activity in any region except primary cortical areas(13-16). Here we report that, in rats repeatedly exposed to two differently shaped environments, the hippocampal-place-cell representations of those environments gradually and incrementally diverge; this divergence is specific to environmental shape, occurs independently of explicit reward, persists for periods of at least one month, and transfers to new enclosures of the same shape. These results indicate that place cells may be a neural substrate for long-term incidental learning, and demonstrate the long-term stability of an experience-dependent firing pattern in the hippocampal formation.	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; UCL, Inst Cognit Neurosci, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Lever, C (corresponding author), UCL, Dept Anat & Dev Biol, Mortimer St, London WC1E 6BT, England.	John@maze.ucl.ac.uk	Burgess, Neil/B-2420-2009; Wills, Tom J/B-3621-2011; Lever, Colin/B-4860-2008	Burgess, Neil/0000-0003-0646-6584; Lever, Colin/0000-0002-8955-2885; Cacucci, Francesca/0000-0002-1968-5156; Wills, Thomas/0000-0002-1331-2869	MRC [G117/433] Funding Source: UKRI; Medical Research Council [G117/433] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BARNES CA, 1988, TRENDS NEUROSCI, V11, P163, DOI 10.1016/0166-2236(88)90143-9; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; CLARK SA, 1988, NATURE, V332, P444, DOI 10.1038/332444a0; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Hartley T, 2000, HIPPOCAMPUS, V10, P369, DOI 10.1002/1098-1063(2000)10:4<369::AID-HIPO3>3.0.CO;2-0; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; Jeffery KJ, 1999, EXP BRAIN RES, V127, P151, DOI 10.1007/s002210050785; JEFFERY KJ, 2000, NEURONAL MECH MEMORY, P100; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; MERZENICH MM, 1983, NEUROSCIENCE, V8, P33, DOI 10.1016/0306-4522(83)90024-6; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MULLER RU, 1987, J NEUROSCI, V7, P1951; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1975, EXP NEUROL, V48, P152, DOI 10.1016/0014-4886(75)90230-7; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; OKEEFE J, 1987, EXP BRAIN RES, V68, P1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; QUIRK GJ, 1992, J NEUROSCI, V12, P1945; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Sharp PE, 1997, BEHAV BRAIN RES, V85, P71, DOI 10.1016/S0166-4328(96)00165-9; Squire L. R., 1987, MEMORY BRAIN; SUTHERLAND RJ, 1982, NEUROSCI LETT, V31, P271, DOI 10.1016/0304-3940(82)90032-5; Tanila H, 1997, J NEUROSCI, V17, P5155; WANG XQ, 1995, NATURE, V378, P71, DOI 10.1038/378071a0; WEINBERGER NM, 1993, P NATL ACAD SCI USA, V90, P2394, DOI 10.1073/pnas.90.6.2394; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605	30	321	323	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 7	2002	416	6876					90	94		10.1038/416090a	http://dx.doi.org/10.1038/416090a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882899				2022-12-28	WOS:000174211600045
J	Schopf, JW; Kudryavtsev, AB; Agresti, DG; Wdowiak, TJ; Czaja, AD				Schopf, JW; Kudryavtsev, AB; Agresti, DG; Wdowiak, TJ; Czaja, AD			Laser-Raman imagery of Earth's earliest fossils	NATURE			English	Article							CARBONACEOUS FILAMENTS; ARCHEAN STROMATOLITES; WESTERN AUSTRALIA; NORTH-POLE; MICROFOSSILS; BACTERIA	Unlike the familiar Phanerozoic history of life, evolution during the earlier and much longer Precambrian segment of geological time centred on prokaryotic microbes(1). Because such microorganisms are minute, are preserved incompletely in geological materials, and have simple morphologies that can be mimicked by nonbiological mineral microstructures, discriminating between true microbial fossils and microscopic pseudofossil 'lookalikes' can be difficult(2,3). Thus, valid identification of fossil microbes, which is essential to understanding the prokaryote-dominated, Precambrian 85% of life's history, can require more than traditional palaeontology that is focused on morphology. By combining optically discernible morphology with analyses of chemical composition, laser-Raman spectroscopic imagery of individual microscopic fossils provides a means by which to address this need. Here we apply this technique to exceptionally ancient fossil microbe-like objects, including the oldest such specimens reported from the geological record, and show that the results obtained substantiate the biological origin of the earliest cellular fossils known.	Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Ctr Study Evolut & Origin Life, Los Angeles, CA 90095 USA; Univ Alabama, Dept Phys, Astro & Solar Syst Phys Program, Birmingham, AL 35294 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Alabama System; University of Alabama Birmingham	Schopf, JW (corresponding author), Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA.							AWRAMIK SM, 1988, PRECAMBRIAN RES, V39, P303, DOI 10.1016/0301-9268(88)90023-X; BARGHOORN ES, 1965, SCIENCE, V147, P563, DOI 10.1126/science.147.3658.563; BUICK R, 1988, PRECAMBRIAN RES, V39, P311, DOI 10.1016/0301-9268(88)90024-1; BUICK R, 1984, PRECAMBRIAN RES, V24, P157, DOI 10.1016/0301-9268(84)90056-1; House CH, 2000, GEOLOGY, V28, P707, DOI 10.1130/0091-7613(2000)28<707:CICOIP>2.0.CO;2; JW, 1992, PROTEROZOIC BIOSPHER, P81; Kudryavtsev AB, 2001, P NATL ACAD SCI USA, V98, P823, DOI 10.1073/pnas.98.3.823; MCMILLAN PF, 1988, REV MINERAL, V18, P99; Mendelson C.V., 1992, PROTEROZOIC BIOSPHER, P865, DOI 10.1017/CBO9780511601064.024; Schopf J.W., 1983, P214; Schopf J. W., 1992, PROTEROZOIC BIOSPHER, P587; Schopf J. W., 1992, PROTEROZOIC BIOSPHER, P25; SCHOPF JW, 1973, NATURE, V242, P537, DOI 10.1038/242537a0; SCHOPF JW, 1987, SCIENCE, V237, P70, DOI 10.1126/science.11539686; SCHOPF JW, 1993, SCIENCE, V260, P640, DOI 10.1126/science.260.5108.640; TUINSTRA F, 1970, J CHEM PHYS, V53, P1126, DOI 10.1063/1.1674108; WALSH MM, 1985, NATURE, V314, P530, DOI 10.1038/314530a0; Williams K.P.J., 1997, RENISHAW RAMAN DATAB	18	419	441	0	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2002	416	6876					73	76		10.1038/416073a	http://dx.doi.org/10.1038/416073a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882894				2022-12-28	WOS:000174211600040
J	Templeton, AR				Templeton, AR			Out of Africa again and again	NATURE			English	Article							NESTED CLADISTIC-ANALYSIS; HUMAN MITOCHONDRIAL-DNA; GEOGRAPHICAL-DISTRIBUTION; POPULATION HISTORY; SEQUENCE VARIATION; EVOLUTION; HAPLOTYPES; ORIGIN; PHYLOGEOGRAPHY; HYPOTHESES	The publication of a haplotype tree of human mitochondrial DNA variation in 1987 provoked a controversy about the details of recent human evolution that continues to this day. Now many haplotype trees are available, and new analytical techniques exist for testing hypotheses about recent evolutionary history using haplotype trees. Here I present formal statistical analysis of human haplotype trees for mitochondrial DNA, Y-chromosomal DNA, two X-linked regions and six autosomal regions. A coherent picture of recent human evolution emerges with two major themes. First is the dominant role that Africa has played in shaping the modern human gene pool through at least two-not one-major expansions after the original range extension of Homo erectus out of Africa. Second is the ubiquity of genetic interchange between human populations, both in terms of recurrent gene flow constrained by geographical distance and of major population expansion events resulting in interbreeding, not replacement.	Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Templeton, AR (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	temple_a@biology.wustl.edu	Templeton, Alan R./F-5963-2011	Templeton, Alan/0000-0002-0167-845X				Aguirre E, 2001, QUATERN INT, V75, P11, DOI 10.1016/S1040-6182(00)00073-2; Alonso S, 2001, P NATL ACAD SCI USA, V98, P864, DOI 10.1073/pnas.011244998; Bar-Yosef O, 2001, QUATERN INT, V75, P19, DOI 10.1016/S1040-6182(00)00074-4; Bernatchez L, 2001, EVOLUTION, V55, P351, DOI 10.1111/j.0014-3820.2001.tb01300.x; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CRANDALL KA, 1993, GENETICS, V134, P959; Donnelly P, 1995, ANNU REV GENET, V29, P401, DOI 10.1146/annurev.ge.29.120195.002153; EXCOFFIER L, 1989, AM J HUM GENET, V44, P73; EXCOFFIER L, 1990, J MOL EVOL, V30, P125, DOI 10.1007/BF02099939; Gabunia L, 2000, SCIENCE, V288, P1019, DOI 10.1126/science.288.5468.1019; Gomez A, 2000, P ROY SOC B-BIOL SCI, V267, P2189, DOI 10.1098/rspb.2000.1268; Haile-Selassie Y, 2001, NATURE, V412, P178, DOI 10.1038/35084063; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; Harding RM, 1997, AM J HUM GENET, V60, P772; Harris EE, 1999, P NATL ACAD SCI USA, V96, P3320, DOI 10.1073/pnas.96.6.3320; Hou YM, 2000, SCIENCE, V287, P1622, DOI 10.1126/science.287.5458.1622; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jin L, 1999, P NATL ACAD SCI USA, V96, P3796, DOI 10.1073/pnas.96.7.3796; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; MADDISON DR, 1991, SYST ZOOL, V40, P355, DOI 10.2307/2992327; Nielson M, 2001, EVOLUTION, V55, P147; OTTE M, 1999, ARCHAEOGENETICS DNA, P41; Pickford M, 2001, CR ACAD SCI II A, V332, P145, DOI 10.1016/S1251-8050(01)01528-2; Posada D, 2000, MOL ECOL, V9, P487, DOI 10.1046/j.1365-294x.2000.00887.x; POSADA D, 2000, TCS 1 06; Rana BK, 1999, GENETICS, V151, P1547; Rannala B, 2001, HUM MUTAT, V18, P87, DOI 10.1002/humu.1158; RELETHFORD JH, 2001, GENETICS SEARCH MODE; Rogers EJ, 2000, HUM MOL GENET, V9, P2675, DOI 10.1093/hmg/9.18.2675; Saragusti I, 2001, QUATERN INT, V75, P85, DOI 10.1016/S1040-6182(00)00080-X; SMITH FH, 1989, YEARB PHYS ANTHROPOL, V32, P35; Stoneking M, 1996, CURR OPIN GENET DEV, V6, P731, DOI 10.1016/S0959-437X(96)80028-1; SYKES B, 1995, AM J HUM GENET, V57, P1463; Takahata N, 2001, MOL BIOL EVOL, V18, P172, DOI 10.1093/oxfordjournals.molbev.a003791; TEMPLETON AR, 1995, GENETICS, V140, P767; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; TEMPLETON AR, 1992, GENETICS, V132, P619; TEMPLETON AR, 1993, AM ANTHROPOL, V95, P51, DOI 10.1525/aa.1993.95.1.02a00030; TEMPLETON AR, 1992, SCIENCE, V255, P737, DOI 10.1126/science.1590849; Templeton AR, 1998, AM ANTHROPOL, V100, P632, DOI 10.1525/aa.1998.100.3.632; Templeton AR, 2001, MOL ECOL, V10, P779, DOI 10.1046/j.1365-294x.2001.01199.x; Templeton AR., 1997, CONCEPTUAL ISSUES MO, P329; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1993, AM J HUM GENET, V53, P563; Turner TF, 2000, GENETICS, V154, P777; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Weidenreich Franz, 1946, APES GIANTS MAN; WOLPOFF MH, 1994, INTERD CONT, P175; Wolpoff MH, 2000, AM J PHYS ANTHROPOL, V112, P129, DOI 10.1002/(SICI)1096-8644(200005)112:1<129::AID-AJPA11>3.0.CO;2-K; Zhang J, 2000, GENETICS, V156, P1949	50	385	405	0	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 7	2002	416	6876					45	51		10.1038/416045a	http://dx.doi.org/10.1038/416045a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	527WU	11882887				2022-12-28	WOS:000174211600033
J	Pope, CA; Burnett, RT; Thun, MJ; Calle, EE; Krewski, D; Ito, K; Thurston, GD				Pope, CA; Burnett, RT; Thun, MJ; Calle, EE; Krewski, D; Ito, K; Thurston, GD			Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ASSOCIATION; PREVENTION; COHORT; INDEX	Context Associations have been found between day-to-day particulate air pollution and increased risk of various adverse health outcomes, including cardiopulmonary mortality, However, studies of health effects of long-term particulate air pollution have been less conclusive. Objective To assess the relationship between long-term exposure to fine particulate air pollution and all-cause, lung cancer, and cardiopulmonary mortality. Design, Setting, and Participants Vital status and cause of death data were collected by the American Cancer Society as part of the Cancer Prevention II study, an ongoing prospective mortality study, which enrolled approximately 1.2 million adults in 1982. Participants completed a questionnaire detailing individual risk factor data (age, sex, race, weight, height, smoking history, education, marital status, diet, alcohol consumption, and occupational exposures). The risk factor data for approximately 500000 adults were linked with air pollution data for metropolitan areas throughout the United States and combined with vital status and cause of death data through December 31, 1998. Main Outcome Measure All-cause, lung cancer, and cardiopulmonary mortality. Results Fine particulate and sulfur oxide-related pollution were associated with all-cause, lung cancer, and cardiopulmonary mortality. Each 10-mug/m(3) elevation in fine particulate air pollution was associated with approximately a 4%, 6%, and 8% increased risk of all-cause, cardiopulmonary, and lung cancer mortality, respectively, Measures of coarse particle fraction and total suspended particles were not consistently associated with mortality. Conclusion Long-term exposure to combustion-related fine particulate air pollution is an important environmental risk factor for cardiopulmonary and lung cancer mortality.	Brigham Young Univ, Dept Econ, Provo, UT 84602 USA; Hlth Canada, Ottawa, ON K1A 0L2, Canada; Univ Ottawa, Ottawa, ON, Canada; Amer Canc Soc, Atlanta, GA 30329 USA; NYU, Sch Med, Tuxedo Pk, NY USA	Brigham Young University; Health Canada; University of Ottawa; American Cancer Society; New York University	Pope, CA (corresponding author), Brigham Young Univ, Dept Econ, 142 FOB, Provo, UT 84602 USA.	cap3@cmail.byu.edu	Pope, C. Arden/ABD-5522-2021		NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260, R01ES009560] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES09560-01A1, ES00260, R01 ES009560, P30 ES000260] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bascom R, 1996, AM J RESP CRIT CARE, V153, P3, DOI 10.1164/ajrccm.153.1.8542133; Burnett R, 2001, ENVIRON HEALTH PERSP, V109, P375, DOI 10.2307/3434784; BURNETT RT, 1995, ENVIRONMETRICS, V6, P85, DOI 10.1002/env.3170060108; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; CALLE EE, 1993, AM J EPIDEMIOL, V137, P235, DOI 10.1093/oxfordjournals.aje.a116664; CEPA/FPAC Working Group, 1998, NAT AMB AIR QUAL OBJ; Chao A, 2000, JNCI-J NATL CANCER I, V92, P1888, DOI 10.1093/jnci/92.23.1888; CIOCCO A, 1961, AM J PUBLIC HEALTH N, V51, P155, DOI 10.2105/AJPH.51.2.155; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Committee on the Medical Effects of Air Pollutants, 1995, NONB PART HLTH; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; *ENV PROT AG, 1996, EPA600P95001CF; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Firket J., 1931, 1930 B ACAD ROYAL ME, V11, P683; Fleming TR, 1991, COUNTING PROCESSES S; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Kaiser J, 1997, SCIENCE, V277, P466, DOI 10.1126/science.277.5325.466; Krewski D., 2000, REANALYSIS HARVARD 6; LOGAN WPD, 1953, LANCET, V264, P336; *MATH SOFT, 2000, S PLUS 2000 PROGR GU; *NAT RES COUNC, 2001, RES PRIOR AIRB PART, V3; *NAT RES COUNC, 1998, RES PRIOR AIRB PART, V1; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; Pope III C.A., 1999, AIR POLLUTION HLTH, V31, P673, DOI DOI 10.1016/B978-012352335-8/50106-X; Priestly M. B., 1981, SPECTRAL ANAL TIME S; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; SIEMIATYCKI J, 1991, RISK FACTORS CANC WO, P45; *US POST SERV, 1989, 1989 NAT 5 DIG ZIP C; *WHO EUR REG, 1995, EURICPEHAZ9405PB01	30	5593	5888	51	1370	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2002	287	9					1132	1141		10.1001/jama.287.9.1132	http://dx.doi.org/10.1001/jama.287.9.1132			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527KV	11879110	Green Accepted			2022-12-28	WOS:000174186000028
J	Andrews, PA				Andrews, PA			Recent developments - Renal transplantation	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ORGAN DONATION; MYCOPHENOLATE-MOFETIL; ALLOGRAFT REJECTION; DONORS; IMMUNOSUPPRESSION; CYCLOSPORINE; REDUCTION; SURVIVAL; DIALYSIS		St Helier Hosp, SW Thames Renal & Transplant Unit, Carshalton SM5 1AA, Surrey, England	St Helier Hospital	Andrews, PA (corresponding author), St Helier Hosp, SW Thames Renal & Transplant Unit, Carshalton SM5 1AA, Surrey, England.	pandrews@sthelier.sghms.ac.uk						Aakhus S, 1999, NEPHROL DIAL TRANSPL, V14, P648, DOI 10.1093/ndt/14.3.648; Andrews PA, 2001, TRANSPLANT P, V33, P1121, DOI 10.1016/S0041-1345(00)02456-8; Arlen DJ, 2001, TRANSPLANTATION, V71, P669, DOI 10.1097/00007890-200103150-00017; Bresnahan BA, 2001, TRANSPLANTATION, V72, P256, DOI 10.1097/00007890-200107270-00016; Briggs JD, 1997, NEPHROL DIAL TRANSPL, V12, P2251, DOI 10.1093/ndt/12.11.2251; Cameron JS, 1999, KIDNEY INT, V55, P724, DOI 10.1046/j.1523-1755.1999.00286.x; Cho YW, 1998, NEW ENGL J MED, V338, P221, DOI 10.1056/NEJM199801223380403; Clark MA, 1999, J LAW MED ETHICS, V27, P137, DOI 10.1111/j.1748-720X.1999.tb01446.x; Denton MD, 1999, LANCET, V353, P1083, DOI 10.1016/S0140-6736(98)07493-5; Jakobsen A, 1996, TRANSPLANT P, V28, P3581; Jerius JT, 2000, J UROLOGY, V163, P423, DOI 10.1016/S0022-5347(05)67891-3; Kahan BD, 2000, LANCET, V356, P194, DOI 10.1016/S0140-6736(00)02480-6; Kim FJ, 2000, UROL CLIN N AM, V27, P777, DOI 10.1016/S0094-0143(05)70125-7; Knoll GA, 1999, BRIT MED J, V318, P1104, DOI 10.1136/bmj.318.7191.1104; Kootstra G, 1997, TRANSPLANTATION, V63, P917, DOI 10.1097/00007890-199704150-00001; Lee CM, 1999, J AM COLL SURGEONS, V189, P82, DOI 10.1016/S1072-7515(99)00073-3; Levy GA, 2001, BIODRUGS, V15, P279, DOI 10.2165/00063030-200115050-00001; Mange KC, 2001, NEW ENGL J MED, V344, P726, DOI 10.1056/NEJM200103083441004; Mele TS, 2000, IMMUNOPHARMACOLOGY, V47, P215, DOI 10.1016/S0162-3109(00)00190-9; Michielsen P, 1996, J ROY SOC MED, V89, P663, DOI 10.1177/014107689608901203; Miranda B, 1999, NEPHROL DIAL TRANSPL, V14, P15; Nashan B, 1997, LANCET, V350, P1193, DOI 10.1016/S0140-6736(97)09278-7; Nashan B, 1999, TRANSPLANTATION, V67, P110, DOI 10.1097/00007890-199901150-00019; Navis G, 1997, LANCET, V349, P1852, DOI 10.1016/S0140-6736(97)22026-X; Nicholson ML, 2000, NEPHROL DIAL TRANSPL, V15, P1124, DOI 10.1093/ndt/15.8.1124; Ojo AO, 2000, TRANSPLANTATION, V69, P2405, DOI 10.1097/00007890-200006150-00033; Patel S, 2001, J BONE MINER RES, V16, P1863, DOI 10.1359/jbmr.2001.16.10.1863; Schnitzler MA, 1999, NEW ENGL J MED, V341, P1440, DOI 10.1056/NEJM199911043411906; Takemoto S, 1988, Clin Transpl, P345; *UK TRANSPL, 2001, REN TRANSPL AUD 1990; *US REN DAT SYST, 2001, ANN DAT REP 2001; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; *WORK PART BRIT TR, 2000, UK GUID LIV DON KIDN; 2000, TRANSPLANT ACTIVITY	34	37	42	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2002	324	7336					530	534		10.1136/bmj.324.7336.530	http://dx.doi.org/10.1136/bmj.324.7336.530			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	528DT	11872555	Green Published			2022-12-28	WOS:000174229700023
J	Raviglione, MC; Pio, A				Raviglione, MC; Pio, A			Evolution of WHO policies for tuberculosis control, 1948-2001	LANCET			English	Review							DEVELOPING-COUNTRIES; EPIDEMIOLOGY; VACCINATION; SITUATION; THERAPY; IMPACT; TB	We examine the evolution of WHO managerial policies for tuberculosis control during 1948-2001 to provide a new framework that will accelerate control expansion in the near future. In the first period (1948-63), a vertical approach to tuberculosis control was the policy adopted by WHO and the international community. However, although this approach was successful in more-developed countries, it largely failed in resource-poor settings. As a result, involvement of general health services was soon deemed essential. During 1989-98, a new framework for effective tuberculosis control was created and a new five-element strategy was branded with the name of DOTS. This period was characterised by the recognition of tuberculosis control as a public-health priority, the intensification of tuberculosis control efforts worldwide, and the return of tuberculosis to the political agenda of governments. However, although nominal adoption of DOTS increased rapidly due to massive promotion by WHO and partners, expansion to provide full access was too slow and only 23% of all infectious cases in 1999 were managed under DOTS. A truly multisectoral approach based on advocacy and social mobillsation, community involvement, and engagement of private-for-profit practitioners is becoming the way forward for tuberculosis control. HIV-associated tuberculosis and multidrug-resistant tuberculosis must be tackled as priority issues. We conclude that, based on the lessons of the past, the future of tuberculosis control should be focused on a pragmatic approach combining a specialised, well-defined management system with a fully integrated service delivery. A multisectoral approach that builds on global and national partnerships is the key to future tuberculosis control.	WHO, Stop TB Dept, TB Strategy & Operat, CH-1211 Geneva 27, Switzerland	World Health Organization	Raviglione, MC (corresponding author), WHO, Stop TB Dept, TB Strategy & Operat, 20 Ave Appla, CH-1211 Geneva 27, Switzerland.			RAVIGLIONE, Mario/0000-0002-9331-2067				BANERJI D, 1965, MED CARE, V3, P151, DOI 10.1097/00005650-196507000-00005; BAYER R, 1995, LANCET, V345, P1545, DOI 10.1016/S0140-6736(95)91090-5; BERMAN PA, 1995, HLTH POLICY, V1, P13; CAIRNCROSS S, 1997, LANCET S3, V349, pS20; Cauthen GM, 1988, WHOTB88154; COMSTOCK GW, 1994, CLIN INFECT DIS, V19, P528, DOI 10.1093/clinids/19.3.528; Dye C, 2000, P NATL ACAD SCI USA, V97, P8180, DOI 10.1073/pnas.140102797; Dye C, 2001, P ROY SOC B-BIOL SCI, V268, P45, DOI 10.1098/rspb.2000.1328; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; Espinal MA, 1999, INT J TUBERC LUNG D, V3, P561; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; FOX W, 1962, Bull Int Union Tuberc, V32, P307; FOX W, 1958, Tubercle, V39, P269, DOI 10.1016/S0041-3879(58)80088-4; Girardi E, 2000, AIDS, V14, P1985, DOI 10.1097/00002030-200009080-00015; Gupta R, 2001, SCIENCE, V293, P1049, DOI 10.1126/science.1061861; KOCHI A, 1991, TUBERCLE, V72, P1, DOI 10.1016/0041-3879(91)90017-M; Mahler H, 1966, B INT UNION TUBERC, V37, P77; MICHEL CC, 1993, PHLEBOLOGY, V8, P1; Miller B, 2000, INT J TUBERC LUNG D, V4, P593; Murray C J, 1990, Bull Int Union Tuberc Lung Dis, V65, P6; NARAIN JP, 1992, TUBERCLE LUNG DIS, V73, P311, DOI 10.1016/0962-8479(92)90033-G; Pablos-Mendez A, 1998, NEW ENGL J MED, V338, P1641, DOI 10.1056/NEJM199806043382301; Raviglione MC, 1997, LANCET, V350, P624, DOI 10.1016/S0140-6736(97)04146-9; RAVIGLIONE MC, 1995, JAMA-J AM MED ASSOC, V273, P220, DOI 10.1001/jama.273.3.220; Schatz A, 1944, P SOC EXP BIOL MED, V57, P244, DOI 10.3181/00379727-57-14769; Styblo K, 1980, Adv Tuberc Res, V20, P1; STYBLO K, 1976, TUBERCLE, V57, P17, DOI 10.1016/0041-3879(76)90015-5; STYBLO K, 1989, REV INFECT DIS, V11, pS339; SUDRE P, 1992, B WORLD HEALTH ORGAN, V70, P149; *WHO, 1973, HDB RES DEC WORLD HL, V1, P85; *WHO, 1964, WHO TECHN REP SER, V290; *WHO, 2001, WHOCDSSTB200111; WHO, 1998, WHOTB98245; *WHO, 1974, TECHN REP SER, V552; *WHO, 1978, 6 GEN PROGR WORK COV; WHO, 2001, REP M GROUND LARV BL; WHO, 1998, WHOTB98255; WHO, 2000, WHOCDSSTB20006; *WHO, 1947, 6 WHO; World Bank, 1993, WORLD DEV REP 1993 I, P63; World Health Organization, 1994, WHOTB94179; World Health Organization, 1991, WHA441991REC1 WHO; 2001, LANCET, V357, P1	43	169	181	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 2	2002	359	9308					775	780		10.1016/S0140-6736(02)07880-7	http://dx.doi.org/10.1016/S0140-6736(02)07880-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526DZ	11888605				2022-12-28	WOS:000174115200029
J	Goodman, MB; Ernstrom, GG; Chelur, DS; O'Hagan, R; Yao, CA; Chalfie, M				Goodman, MB; Ernstrom, GG; Chelur, DS; O'Hagan, R; Yao, CA; Chalfie, M			MEC-2 regulates C-elegans DEG/ENaC channels needed for mechanosensation	NATURE			English	Article							CAENORHABDITIS-ELEGANS; MEMBRANE-PROTEIN; STOMATIN; NEURONS; AMILORIDE; SUBUNITS; DEGENERATION; SENSITIVITY; MUTATIONS; MEMBER	Touch sensitivity in animals relies on nerve endings in the skin that convert mechanical force into electrical signals. In the nematode Caenorhabditis elegans, gentle touch to the body wall is sensed by six mechanosensory neurons(1) that express two amiloride-sensitive Na+ channel proteins (DEG/ENaC). These proteins, MEC-4 and MEC-10, are required for touch sensation and can mutate to cause neuronal degeneration(2,3). Here we show that these mutant or 'd' forms of MEC-4 and MEC-10 produce a constitutively active, amiloride-sensitive ionic current when co-expressed in Xenopus oocytes, but not on their own. MEC-2, a stomatin-related protein needed for touch sensitivity(4), increased the activity of mutant channels about 40-fold and allowed currents to be detected with wild-type MEC-4 and MEC-10. Whereas neither the central, stomatin-like domain of MEC-2 nor human stomatin retained the activity of full-length MEC-2, both produced amiloride-sensitive currents with MEC-4d. Our findings indicate that MEC-2 regulates MEC-4/MEC-10 ion channels and raise the possibility that similar ion channels may be formed by stomatin-like proteins and DEG/ENaC proteins that are co-expressed in both vertebrates and invertebrates(5-8). Some of these channels may mediate mechanosensory responses.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Chalfie, M (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	mc21@columbia.edu	Goodman, Miriam B./H-3036-2019; O'Hagan, Robert/AAE-9789-2020	Goodman, Miriam B./0000-0002-5810-1272; O'Hagan, Robert/0000-0001-7580-1441	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030997] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM030997] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; CHALFIE M, 1989, SCIENCE, V243, P1027, DOI 10.1126/science.2646709; Chillaron J, 1997, J BIOL CHEM, V272, P9543; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Fricke B, 2000, CELL TISSUE RES, V299, P327; Garcia-Anoveros J, 1998, NEURON, V20, P1231, DOI 10.1016/S0896-6273(00)80503-6; Garcia-Anoveros J, 2001, J NEUROSCI, V21, P2678, DOI 10.1523/JNEUROSCI.21-08-02678.2001; Gu GQ, 1996, P NATL ACAD SCI USA, V93, P6577, DOI 10.1073/pnas.93.13.6577; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HUANG M, 1995, THESIS COLUMBIA U; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; HUANG MX, 1995, NATURE, V378, P292, DOI 10.1038/378292a0; KLECKNER N, 1991, METHOD ENZYMOL, V204, P139; Lai CC, 1996, J CELL BIOL, V133, P1071, DOI 10.1083/jcb.133.5.1071; LANDE WM, 1982, J CLIN INVEST, V70, P1273, DOI 10.1172/JCI110726; Mannsfeldt AG, 1999, MOL CELL NEUROSCI, V13, P391, DOI 10.1006/mcne.1999.0761; McNicholas CM, 1997, J GEN PHYSIOL, V109, P681, DOI 10.1085/jgp.109.6.681; MULLER AHJ, 1993, MECH DEVELOP, V42, P77, DOI 10.1016/0925-4773(93)90100-C; PALMER LG, 1985, J MEMBRANE BIOL, V87, P191, DOI 10.1007/BF01871218; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Rajaram S, 1999, GENETICS, V153, P1673; Salzer U, 2001, BLOOD, V97, P1141, DOI 10.1182/blood.V97.4.1141; Sedensky MM, 2001, AM J PHYSIOL-CELL PH, V280, pC1340, DOI 10.1152/ajpcell.2001.280.5.C1340; Snyers L, 1999, FEBS LETT, V449, P101, DOI 10.1016/S0014-5793(99)00417-2; Snyers L, 1998, J BIOL CHEM, V273, P17221, DOI 10.1074/jbc.273.27.17221; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687	30	254	268	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2002	415	6875					1039	1042		10.1038/4151039a	http://dx.doi.org/10.1038/4151039a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875573				2022-12-28	WOS:000174075000049
J	Oldham, JM; Burns; Oldman				Oldham, JM; Burns; Oldman			A 44-year-old woman with borderline personality disorder	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COGNITIVE-BEHAVIORAL TREATMENT; HEALTH-CARE UTILIZATION; FOLLOW-UP; PARTIAL HOSPITALIZATION; WOMEN; SYMPTOMATOLOGY; PSYCHOTHERAPY; NEUROGENESIS; ALONENESS; THERAPY		New York State Psychiat Inst & Hosp, New York, NY 10032 USA	New York State Psychiatry Institute	Oldham, JM (corresponding author), New York State Psychiat Inst & Hosp, 1051 Riverside Dr, New York, NY 10032 USA.							ADLER G, 1979, INT J PSYCHOANAL, V60, P83; Adler G., 1985, BORDERLINE PSYCHOPAT; AKISKAL HS, 1981, PSYCHIAT CLIN N AM, V4, P25; American Psychiatric Association, 2002, PRACT GUID TREATM PA; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; [Anonymous], 2001, BORDERLINE PERSONALI; Bateman A, 1999, AM J PSYCHIAT, V156, P1563, DOI 10.1176/ajp.156.10.1563; Bateman A, 2001, AM J PSYCHIAT, V158, P36, DOI 10.1176/appi.ajp.158.1.36; Bender DS, 2001, AM J PSYCHIAT, V158, P295, DOI 10.1176/appi.ajp.158.2.295; CLARK LA, 2001, HDB PERSONALITY DISO; DeLaFuente JM, 1997, J PSYCHIATR RES, V31, P531, DOI 10.1016/S0022-3956(97)00001-0; Driessen M, 2000, ARCH GEN PSYCHIAT, V57, P1115, DOI 10.1001/archpsyc.57.12.1115; Gabbard, 2000, PSYCHODYNAMIC PSYCHI; Gross CP, 2000, ARCH INTERN MED, V160, P553; Gunderson JG, 1996, AM J PSYCHIAT, V153, P752; Hay JL, 2000, PSYCHO-ONCOL, V9, P91, DOI 10.1002/(SICI)1099-1611(200003/04)9:2<91::AID-PON437>3.0.CO;2-8; Hudziak JJ, 1996, AM J PSYCHIAT, V153, P1598; Johnson T M, 1993, J Am Board Fam Pract, V6, P385; Kandel ER, 1998, AM J PSYCHIAT, V155, P457, DOI 10.1176/ajp.155.4.457; KANDEL ER, 1979, NEW ENGL J MED, V301, P1028, DOI 10.1056/NEJM197911083011904; Kernberg O.F., 1975, BORDERLINE CONDITION; KLEIN DF, 1982, AM J PSYCHIAT, V139, P1520; Koerner K, 2000, PSYCHIAT CLIN N AM, V23, P151, DOI 10.1016/S0193-953X(05)70149-0; Leyton M, 2001, AM J PSYCHIAT, V158, P775, DOI 10.1176/appi.ajp.158.5.775; Linehan M., 1993, COGNITIVE BEHAV TREA; Linehan MM, 1999, AM J ADDICTION, V8, P279; LINEHAN MM, 1994, AM J PSYCHIAT, V151, P1771; LINEHAN MM, 1993, ARCH GEN PSYCHIAT, V50, P971; LINEHAN MM, 1991, ARCH GEN PSYCHIAT, V48, P1060; Links PS, 2000, PSYCHIAT CLIN N AM, V23, P137, DOI 10.1016/S0193-953X(05)70148-9; LOOSEN PT, 1985, PSYCHONEUROENDOCRINO, V10, P237, DOI 10.1016/0306-4530(85)90002-2; Lyoo IK, 1998, J AFFECT DISORDERS, V50, P235, DOI 10.1016/S0165-0327(98)00104-9; Madsen TM, 2000, BIOL PSYCHIAT, V47, P1043, DOI 10.1016/S0006-3223(00)00228-6; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Masterson J., 1972, TREATMENT BORDERLINE; MASTERSON JF, 1975, INT J PSYCHOANAL, V56, P163; MCGLASHAN TH, 1986, ARCH GEN PSYCHIAT, V43, P20; New AS, 1999, PSYCHIAT RES, V85, P145, DOI 10.1016/S0165-1781(99)00007-4; NOWLIS DP, 1990, J FAM PRACTICE, V30, P329; OLDHAM JM, 1994, JAMA-J AM MED ASSOC, V272, P1770, DOI 10.1001/jama.272.22.1770; OLDHAM JM, 2001, INTEGRATED TREATMENT; PARIS J, 1987, COMPR PSYCHIAT, V28, P530, DOI 10.1016/0010-440X(87)90019-8; Paris J., 1994, BORDERLINE PERSONALI; Perry JC, 1999, AM J PSYCHIAT, V156, P1312; PLAKUN EM, 1985, COMPR PSYCHIAT, V26, P448, DOI 10.1016/0010-440X(85)90081-1; Rinne T, 2000, BIOL PSYCHIAT, V47, P548, DOI 10.1016/S0006-3223(99)00181-X; Sansone RA, 2000, GEN HOSP PSYCHIAT, V22, P174, DOI 10.1016/S0163-8343(00)00074-8; Sansone RA, 1996, SOUTHERN MED J, V89, P1162, DOI 10.1097/00007611-199612000-00006; Sansone RA, 2000, J NERV MENT DIS, V188, P45, DOI 10.1097/00005053-200001000-00008; Sansone RA, 1998, J CLIN PSYCHIAT, V59, P108, DOI 10.4088/JCP.v59n0303; Siever LJ, 1996, IMPULSIVITY COMPULSI; SILK KR, 1994, BIOL NEUROBEHAVIORAL; SKODOL AE, IN PRESS AM J PSYCHI; Soloff PH, 2000, BIOL PSYCHIAT, V47, P540, DOI 10.1016/S0006-3223(99)00202-4; SOLOFF PH, 1986, ARCH GEN PSYCHIAT, V43, P691; Soloff PH, 2000, PSYCHIAT CLIN N AM, V23, P169, DOI 10.1016/S0193-953X(05)70150-7; Stein DJ, 1996, BIOL PSYCHIAT, V40, P508, DOI 10.1016/0006-3223(95)00470-X; STEIN DJ, 1993, PSYCHIAT RES, V48, P257, DOI 10.1016/0165-1781(93)90076-S; STEINER M, 1988, CAN J PSYCHIAT, V33, P350, DOI 10.1177/070674378803300507; Stone M. H, 1990, FATE BORDERLINE PATI; WEISSMAN MM, 1993, J PERS DISORD, V7, P44; WIDIGER TA, 1997, PSYCHIATRY, P1291; Zanarini MC, 1997, J PERS DISORD, V11, P93, DOI 10.1521/pedi.1997.11.1.93; Zanarini MC, 1998, HARVARD REV PSYCHIAT, V6, P201, DOI 10.3109/10673229809000330; Zanarini MC, 1993, BORDERLINE PERSONALI; ZIMMERMAN M, 1994, ARCH GEN PSYCHIAT, V51, P225	66	6	6	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2002	287	8					1029	1037		10.1001/jama.287.8.1029	http://dx.doi.org/10.1001/jama.287.8.1029			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525CX	11866652				2022-12-28	WOS:000174052100032
J	Bernal, W; Donaldson, N; Wyncoll, D; Wendon, J				Bernal, W; Donaldson, N; Wyncoll, D; Wendon, J			Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study	LANCET			English	Article							FULMINANT HEPATIC-FAILURE; EARLY INDICATORS; LACTIC-ACIDOSIS; ORGAN FAILURE; SEPTIC SHOCK; ACETAMINOPHEN; TRANSPLANTATION; METABOLISM; PROGNOSIS; OVERDOSE	Background Although the King's College Hospital (KCH) selection criteria for emergency liver transplantation in paracetamol-induced acute liver failure are widely used, strategies to improve sensitivity and facilitate earlier transplantation are required. We investigated the use of arterial blood lactate measurement for the identification of transplantation candidates. Methods In a single-centre study, we measured arterial blood lactate early (median 4 h) and after fluid resuscitation (median 12 h) in patients admitted to a tertiary-referral intensive-care unit. Threshold values that best identified individuals likely to die without transplantation were derived in a retrospective initial sample of 103 patients with paracetamol-induced acute liver failure and applied to a prospective validation sample of 107 patients. Predictive value and speed of identification were compared with those of KCH criteria. Findings In the initial sample, median lactate was significantly higher in non-surviving patients than in survivors both in the early samples (8.5 [range 1.7-21.0] vs 1.4 [0.53-7.9] mmol/L, p<0.0001) and after fluid resuscitation (5.5 [1.3-18.6] vs 1.3 [0.26-3.2], p<0.0001). Applied to the validation sample, a threshold value of 3.5 mmol/L early after admission had sensitivity 67%, specificity 95%, positive likelihood ratio 13, and negative likelihood ratio 0.35; the corresponding values for a threshold of 3.0 mmol/L after fluid resuscitation were 76%, 97%, 30, and 0.24. Combined early and postresuscitation lactate concentrations had similar predictive ability to KCH criteria but identified non-surviving patients earlier (4 [3.13] vs 10 [3.5-19.5] h, p=0.01). Addition of postresuscitation lactate concentration to KCH criteria increased sensitivity from 76% to 91% and lowered negative likelihood ratio from 0.25 to 0.10. Interpretation Arterial blood lactate measurement rapidly and accurately identifies patients who will die from paracetamol-induced acute liver failure. Its use could improve the speed and accuracy of selection of appropriate candidates for transplantation.	Kings Coll Hosp London, Inst Liver Studies, London SE5 9RS, England; Kings Coll Hosp London, Dept Res & Dev, London SE5 9RS, England; St Thomas Hosp, Dept Intens Care, London, England; Guys Kings & St Thomas Hosp, London, England	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Wendon, J (corresponding author), Kings Coll Hosp London, Inst Liver Studies, Denmark Hill, London SE5 9RS, England.	julia.wendon@kcl.ac.uk						ALMENOFF PL, 1989, CRIT CARE MED, V17, P870, DOI 10.1097/00003246-198909000-00004; Anand AC, 1997, J HEPATOL, V26, P62, DOI 10.1016/S0168-8278(97)80010-4; BAKKER J, 1991, CHEST, V99, P956, DOI 10.1378/chest.99.4.956; Bakker J, 1996, AM J SURG, V171, P221, DOI 10.1016/S0002-9610(97)89552-9; Bernal W, 1998, HEPATOLOGY, V27, P1050, DOI 10.1002/hep.510270421; BIHARI D, 1985, CRIT CARE MED, V13, P1034, DOI 10.1097/00003246-198512000-00010; BIHARI D, 1985, J HEPATOL, V1, P405, DOI 10.1016/S0168-8278(85)80778-9; BIHARI DJ, 1986, SEMIN LIVER DIS, V6, P119, DOI 10.1055/s-2008-1040595; Chiolero R, 1999, ANN SURG, V229, P505, DOI 10.1097/00000658-199904000-00009; Clemmesen JO, 2000, J HEPATOL, V33, P941, DOI 10.1016/S0168-8278(00)80126-9; De Jonghe B, 1999, J CRIT CARE, V14, P7, DOI 10.1016/S0883-9441(99)90002-3; ESTERLINE RL, 1989, BIOCHEM PHARMACOL, V38, P2387, DOI 10.1016/0006-2952(89)90481-4; GRAY TA, 1987, Q J MED, V65, P811; Levraut J, 1998, AM J RESP CRIT CARE, V157, P1021, DOI 10.1164/ajrccm.157.4.9705037; MAKIN AJ, 1995, GASTROENTEROLOGY, V109, P1907, DOI 10.1016/0016-5085(95)90758-0; MANIKIS P, 1995, AM J EMERG MED, V13, P619, DOI 10.1016/0735-6757(95)90043-8; Mitchell I, 1998, CRIT CARE MED, V26, P279, DOI 10.1097/00003246-199802000-00026; MIZOCK BA, 1992, CRIT CARE MED, V20, P80, DOI 10.1097/00003246-199201000-00020; OGRADY J, 2000, COMPREHENSIVE CLIN H; OGRADY JG, 1991, BRIT MED J, V303, P221, DOI 10.1136/bmj.303.6796.221; OGRADY JG, 1989, GASTROENTEROLOGY, V97, P439, DOI 10.1016/0016-5085(89)90081-4; RECORD CO, 1981, METABOLISM, V30, P638, DOI 10.1016/0026-0495(81)90076-7; Riordan SM, 2000, LIVER TRANSPLANT, V6, P170, DOI 10.1016/S1527-6465(00)80006-4; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; Shakil AO, 2000, LIVER TRANSPLANT, V6, P163, DOI 10.1016/S1527-6465(00)80005-2; SUBRAMANIAN S, 2000, YB INTENSIVE CARE EM, P743; WENDON J, 1995, PRACTICE LIVER TRANS, P93; Williams R, 1997, ACUTE LIVER FAILURE, P1	28	311	320	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 16	2002	359	9306					558	563		10.1016/S0140-6736(02)07743-7	http://dx.doi.org/10.1016/S0140-6736(02)07743-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523FP	11867109				2022-12-28	WOS:000173943600008
J	Ridwan, B; Mascini, E; van der Reijden, N; Verhoef, J; Bonten, M				Ridwan, B; Mascini, E; van der Reijden, N; Verhoef, J; Bonten, M			What action should be taken to prevent spread of vancomycin resistant enterococci in European hospitals?	BRITISH MEDICAL JOURNAL			English	Article							NETHERLANDS; COMMUNITY; ANIMALS; HUMANS; TRANSMISSION; BACTEREMIA; INFECTIONS; MORTALITY; AVOPARCIN; CARRIAGE		Eijkman Winkler Inst Microbiol Infect Dis & Infla, Dept Internal Med, Utrecht, Netherlands; Univ Med Ctr Utrecht, Div Hosp Hyg & Infect Prevent, Eijkman Winkler Inst Microbiol Infect Dis & Infla, NL-3584 CX Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Bonten, M (corresponding author), Eijkman Winkler Inst Microbiol Infect Dis & Infla, Dept Internal Med, Utrecht, Netherlands.							BATES J, 1994, J ANTIMICROB CHEMOTH, V34, P507, DOI 10.1093/jac/34.4.507; Bonten M J, 2000, Ned Tijdschr Geneeskd, V144, P2545; Coque TM, 1996, ANTIMICROB AGENTS CH, V40, P2605, DOI 10.1128/AAC.40.11.2605; Devriese LA, 1996, ANTIMICROB AGENTS CH, V40, P2285, DOI 10.1128/AAC.40.10.2285; Edmond MB, 1996, CLIN INFECT DIS, V23, P1234, DOI 10.1093/clinids/23.6.1234; Endtz HP, 1997, J CLIN MICROBIOL, V35, P3026, DOI 10.1128/JCM.35.12.3026-3031.1997; Garbutt JM, 2000, CLIN INFECT DIS, V30, P466, DOI 10.1086/313694; Gerberding J, 1999, AM J INFECT CONTROL, V27, P520; Gonzales RD, 2001, LANCET, V357, P1179, DOI 10.1016/S0140-6736(00)04376-2; Klare I, 1999, MICROB DRUG RESIST, V5, P45, DOI 10.1089/mdr.1999.5.45; MASCINI E, 2001, MED CONTACT, V56, P1008; MOELLERING RC, 1992, CLIN INFECT DIS, V14, P1173, DOI 10.1093/clinids/14.6.1173; Montecalvo MA, 1999, ANN INTERN MED, V131, P269, DOI 10.7326/0003-4819-131-4-199908170-00006; Murray BE, 2000, NEW ENGL J MED, V342, P710, DOI 10.1056/NEJM200003093421007; Ostrowsky BE, 2001, NEW ENGL J MED, V344, P1427, DOI 10.1056/NEJM200105103441903; Schouten MA, 2000, EUR J CLIN MICROBIOL, V19, P816, DOI 10.1007/s100960000390; SHAY DK, 1995, J INFECT DIS, V172, P993, DOI 10.1093/infdis/172.4.993; Stobberingh E, 1999, ANTIMICROB AGENTS CH, V43, P2215, DOI 10.1128/AAC.43.9.2215; van den Bogaard AE, 2000, J ANTIMICROB CHEMOTH, V46, P146, DOI 10.1093/jac/46.1.146; van der Steen L F, 2000, Ned Tijdschr Geneeskd, V144, P2568; vandenBogaard AE, 1997, J ANTIMICROB CHEMOTH, V40, P454, DOI 10.1093/jac/40.3.454; vandenBogaard AE, 1997, NEW ENGL J MED, V337, P1558, DOI 10.1056/NEJM199711203372117; Verhoef J, 1999, EUR J CLIN MICROBIOL, V18, P461, DOI 10.1007/s100960050324; Willems RJL, 2001, LANCET, V357, P853, DOI 10.1016/S0140-6736(00)04205-7; 1995, INFECT CONTROL HOSP, V16, P105	25	38	39	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 16	2002	324	7338					666	668		10.1136/bmj.324.7338.666	http://dx.doi.org/10.1136/bmj.324.7338.666			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532QW	11895829	Green Published, Green Submitted			2022-12-28	WOS:000174487400032
J	Lewis, JH; Schonlau, M; Munoz, JA; Asch, SM; Rosen, MR; Yang, H; Escarce, JJ				Lewis, JH; Schonlau, M; Munoz, JA; Asch, SM; Rosen, MR; Yang, H; Escarce, JJ			Compliance among pharmacies in California with a prescription-drug discount program for Medicare beneficiaries	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMPACT	Background: Several states have developed prescription-drug discount programs for Medicare beneficiaries. In California, Senate Bill 393, enacted in 1999, requires pharmacies participating in the state Medicaid program (Medi-Cal) to charge customers who present a Medicare card amounts based on Medi-Cal rates. Because Medicare beneficiaries may not be accustomed to presenting their Medicare cards at pharmacies, we assessed the compliance of pharmacies with Senate Bill 393. Methods: Fifteen Medicare beneficiaries who received special training and acted as ``standardized patients'' visited a random sample of pharmacies in the San Francisco Bay area and Los Angeles County in April and May 2001. According to a script, they asked for the prices of three commonly prescribed drugs: rofecoxib, sertraline, and atorvastatin. The script enabled us to determine whether and when, during their interactions with pharmacists or salespeople, the discounts specified in Senate Bill 393 were offered. Pharmacies at which the appropriate discounts were offered were considered compliant. Results: The patients completed visits to 494 pharmacies. Seventy-five percent of the pharmacies complied with the prescription-drug discount program; at only 45 percent, however, was the discount offered before it was specifically requested. The discount was offered at 91 percent of pharmacies that were part of a chain, as compared with 58 percent of independent pharmacies (P<0.001). Compliance was higher in the San Francisco Bay area than in Los Angeles County (84 percent vs. 72 percent, P=0.004) and was higher in high-income than low-income neighborhoods (81 percent vs. 69 percent, P=0.002). A Medicare beneficiary taking all three drugs would have saved an average of $55.70 per month as compared with retail prices (a savings of 20 percent). Conclusions: Discounts required under California's prescription-drug discount program for Medicare beneficiaries offer substantial savings. Many patients, however, especially those who use independent pharmacies or who live in low-income neighborhoods, may not receive the discounts. (N Engl J Med 2002;346:830-5.) Copyright (C) 2002 Massachusetts Medical Society.	RAND Corp, Hlth, Santa Monica, CA 90407 USA; Greater Los Angeles Vet Affairs Hlth Care Syst, Los Angeles, CA USA	RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Lewis, JH (corresponding author), RAND Corp, Hlth, 1700 Main St, Santa Monica, CA 90407 USA.							Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Ansell BJ, 1999, JAMA-J AM MED ASSOC, V282, P2051, DOI 10.1001/jama.282.21.2051; *BUR CENS, 2000, STAT ABSTR US 2000, P13; *CAL BOARD PHARM, 2002, CAL STAT BOARD PHARM; *CAL DEP HLTH SERV, 2001, PRESCR DRUG DISC PRO; Cochran W.G., 2007, SAMPLING TECHNIQUES; Davis M, 1999, HEALTH AFFAIR, V18, P231, DOI 10.1377/hlthaff.18.1.231; Frank RG, 2001, HEALTH AFFAIR, V20, P115, DOI 10.1377/hlthaff.20.2.115; GIBSON MJ, 1999, MUCH MED BENEFICIARI; Glassman P A, 2000, Jt Comm J Qual Improv, V26, P644; HOSMER DW, 1989, APPL LOGISTIC REGRES; Hughes SL, 1995, ARTHRIT CARE RES, V8, P257, DOI 10.1002/art.1790080409; Lebowitz BD, 1997, JAMA-J AM MED ASSOC, V278, P1186, DOI 10.1001/jama.278.14.1186; *LEG COUNS CAL, 2002, OFF CAL LEG INF; Mueller C, 1997, AM J PUBLIC HEALTH, V87, P1626, DOI 10.2105/AJPH.87.10.1626; Newhouse JP, 2000, JAMA-J AM MED ASSOC, V283, P2161, DOI 10.1001/jama.283.16.2161; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; Poisal JA, 2001, HEALTH AFFAIR, V20, P74, DOI 10.1377/hlthaff.20.2.74; Soumerai SB, 1999, NEW ENGL J MED, V340, P976; Stuart B, 2001, HEALTH AFFAIR, V20, P86, DOI 10.1377/hlthaff.20.2.86; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	21	6	6	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2002	346	11					830	835		10.1056/NEJMsa122601	http://dx.doi.org/10.1056/NEJMsa122601			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529YM	11893795	Bronze			2022-12-28	WOS:000174328900007
J	Pandolfini, C; Bonati, M				Pandolfini, C; Bonati, M			Follow up of quality of public oriented health information on the world wide web: systematic re-evaluation	BRITISH MEDICAL JOURNAL			English	Article									Mario Negri Inst Pharmacol Res, Lab Mother & Child Hlth, I-20157 Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Pandolfini, C (corresponding author), Mario Negri Inst Pharmacol Res, Lab Mother & Child Hlth, Via Eritrea 62, I-20157 Milan, Italy.		Pandolfini, Chiara/K-5693-2016; Bonati, Maurizio/K-8980-2016	Pandolfini, Chiara/0000-0001-9809-2991; Bonati, Maurizio/0000-0003-3997-3726				Delamothe T, 2000, BRIT MED J, V321, P843, DOI 10.1136/bmj.321.7265.843; Griffiths KM, 2000, BMJ-BRIT MED J, V321, P1511, DOI 10.1136/bmj.321.7275.1511; Impicciatore P, 1997, BMJ-BRIT MED J, V314, P1875, DOI 10.1136/bmj.314.7098.1875; Pandolfini C, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.1.e1; Risk A, 2001, J MED INTERNET RES, V3, DOI 10.2196/jmir.3.4.e28	5	32	33	1	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 9	2002	324	7337					582	583		10.1136/bmj.324.7337.582	http://dx.doi.org/10.1136/bmj.324.7337.582			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	530XJ	11884324	Green Published, Bronze			2022-12-28	WOS:000174384000023
J	Zhao, XM; Herr, W				Zhao, XM; Herr, W			A regulated two-step mechanism of TBP binding to DNA: A solvent-exposed surface of TBP inhibits TATA box recognition	CELL			English	Article							RNA-POLYMERASE-II; GENERAL TRANSCRIPTION FACTORS; YEAST TFIIA/TBP/DNA COMPLEX; CRYSTAL-STRUCTURE; PREINITIATION COMPLEX; BASAL TRANSCRIPTION; FUNCTIONAL DOMAINS; IN-VIVO; PROTEIN; ELEMENT	The TATA box binding protein TBP plays a universally important role in eukaryotic nuclear transcription. By mutagenesis, we have discovered a solvent-exposed surface of the structured TBP core domain that is important for inhibition of the DNA binding and DNA-bending activities of full-length wild-type TBP. Full-length wild-type TBP initially binds the TATA box to form an unstable complex containing unbent DNA, and then it slowly forms a stable complex containing bent DNA. TFIIB greatly accelerates formation of a bent TFIIB-TBP-TATA box complex, and the inhibitory DNA binding surface of TBP contributes to the cooperativity of binding to TFIIB. Using TBP and TFIIB, we show that TBP can bind the TATA box through a regulated two-step mechanism, involving a transition from unbent complex to bent complex.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Herr, W (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.		Herr, Winship/E-6491-2012	Herr, Winship/0000-0002-3606-4546	NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER; NCI NIH HHS [CA13106] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Berk AJ, 2000, CELL, V103, P5, DOI 10.1016/S0092-8674(00)00098-2; BURATOWSKI S, 1994, CELL, V77, P1, DOI 10.1016/0092-8674(94)90226-7; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; Gillitzer E, 2000, EMBO J, V19, P3069, DOI 10.1093/emboj/19.12.3069; HA I, 1993, GENE DEV, V7, P1021, DOI 10.1101/gad.7.6.1021; Hansen SK, 1997, CELL, V91, P71, DOI 10.1016/S0092-8674(01)80010-6; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; HISATAKE K, 1993, NATURE, V363, P744, DOI 10.1038/363744a0; HOFFMANN A, 1990, NATURE, V346, P387, DOI 10.1038/346387a0; HOOPES BC, 1992, J BIOL CHEM, V267, P11539; HORIKOSHI M, 1992, P NATL ACAD SCI USA, V89, P1060, DOI 10.1073/pnas.89.3.1060; Jackson-Fisher AJ, 1999, MOL CELL, V3, P717, DOI 10.1016/S1097-2765(01)80004-6; Juo ZS, 1996, J MOL BIOL, V261, P239, DOI 10.1006/jmbi.1996.0456; KAO CC, 1990, SCIENCE, V248, P1646, DOI 10.1126/science.2194289; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; KIM TK, 1995, J BIOL CHEM, V270, P10976, DOI 10.1074/jbc.270.18.10976; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; LAI JS, 1992, GENE DEV, V6, P2058, DOI 10.1101/gad.6.11.2058; Lee M, 2001, GENETICS, V158, P87; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; LIEBERMAN PM, 1991, GENE DEV, V5, P2441, DOI 10.1101/gad.5.12b.2441; MARTINEZ E, 1995, P NATL ACAD SCI USA, V92, P11864, DOI 10.1073/pnas.92.25.11864; Mittal V, 1997, SCIENCE, V275, P1136, DOI 10.1126/science.275.5303.1136; Nikolov DB, 1996, P NATL ACAD SCI USA, V93, P4862, DOI 10.1073/pnas.93.10.4862; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; PETERSON MG, 1990, SCIENCE, V248, P1625, DOI 10.1126/science.2363050; Ruppert SML, 1996, HYBRIDOMA, V15, P55, DOI 10.1089/hyb.1996.15.55; STARR DB, 1995, J MOL BIOL, V250, P434; STRUBIN M, 1992, CELL, V68, P721, DOI 10.1016/0092-8674(92)90147-5; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; Tang H, 1996, P NATL ACAD SCI USA, V93, P1119, DOI 10.1073/pnas.93.3.1119; TANSEY WP, 1995, P NATL ACAD SCI USA, V92, P10550, DOI 10.1073/pnas.92.23.10550; TANSEY WP, 1994, GENE DEV, V8, P2756, DOI 10.1101/gad.8.22.2756; Tansey WP, 1997, SCIENCE, V275, P829, DOI 10.1126/science.275.5301.829; Tsai FTF, 2000, EMBO J, V19, P25, DOI 10.1093/emboj/19.1.25; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0	39	58	59	1	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 8	2002	108	5					615	627		10.1016/S0092-8674(02)00648-7	http://dx.doi.org/10.1016/S0092-8674(02)00648-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	529TN	11893333	Bronze			2022-12-28	WOS:000174314800006
J	Schwetz, BA				Schwetz, BA			Drug for pediatric liver disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commiss Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commiss Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	8	9	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2002	287	9					1103	1103		10.1001/jama.287.9.1103-b	http://dx.doi.org/10.1001/jama.287.9.1103-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527KV	11879090				2022-12-28	WOS:000174186000006
J	Hargreaves, S				Hargreaves, S			A body of evidence: torture among asylum seekers to the West	LANCET			English	Editorial Material														Hargreaves, Sally/0000-0003-2974-4348				Burnett A, 2001, BRIT MED J, V322, P606, DOI 10.1136/bmj.322.7286.606; *PHYS HUM RIGHTS, 2001, EX AS SEEK HLTH PROF; Silove D, 2002, COMPR PSYCHIAT, V43, P49, DOI 10.1053/comp.2002.29843	3	9	9	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 2	2002	359	9308					793	794		10.1016/S0140-6736(02)07888-1	http://dx.doi.org/10.1016/S0140-6736(02)07888-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	526DZ	11888611				2022-12-28	WOS:000174115200036
J	Margreiter, R				Margreiter, R		European Tacrolimus Ciclosporin M	Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study	LANCET			English	Article							ALLOGRAFT REJECTION; CYCLOSPORINE PHARMACOKINETICS; GRAFT FAILURE; HYPERLIPIDEMIA; RECIPIENTS; IMPACT; TRIAL; IMMUNOSUPPRESSION; FORMULATION; FK506	Background In previous comparative studies tacrolimus was superior to the standard formulation of ciclosporin in preventing acute rejection after renal transplantation. We have compared the microemulsion formulation of ciclosporin with tacrolimus in a multicentre randomised trial. Methods The 6-month open study involved 560 patients in 50 European centres. 287 patients were randomly assigned tacrolimus and 273 ciclosporin microemulsion plus azathioprine and corticosteroids. The initial oral daily doses were 0.30 mg/kg for tacrolimus, and 8-10 mg/kg for ciclosporin. The primary endpoint was the proportion of patients with biopsy-proven acute rejection and the time to this event. Findings The two study groups were similar in terms of baseline characteristics. Three patients did not receive study treatment or did not undergo transplantation (one tacrolimus, two ciclosporin). The rate of biopsy-confirmed acute rejection was significantly tower with tacrolimus than with ciclosporin microemulsion (56 patients [19.6%] vs 101 [37.3%]; 17.7% difference [95% CI 10.3-25.1]; p<0.0001). Biopsy-confirmed corticosteroid-resistant rejection was also significantly lower with tacrolimus (27 [9.4%] vs 57 [21.0%]; 11.6% difference [5.7-17.5]; p<0.0001). Cross-over between therapies because of biopsy-proven rejection was judged necessary in one of 286 (0.3%) tacrolimus-group patients and 27 of 271 (10.0%) ciclosporin-group patients (p<0.0001). There were no significant differences in survival of patients or grafts or in renal function. The overall frequency of adverse events was similar in the two groups, though hypertension and hypercholesterolaemia were more common in the ciclosporin group and tremor and hypomagnesaemia were more frequent in the tacrolimus. group. Interpretation Tacrolimus was significantly more effective than ciclosporin microemulsion in preventing acute rejection after renal transplantation and had a superior cardiovascular-risk profile.	Univ Innsbruck Hosp, Dept Transplant Surg, A-6020 Innsbruck, Austria	Medical University of Innsbruck	Margreiter, R (corresponding author), Univ Innsbruck Hosp, Dept Transplant Surg, Anichstr 35, A-6020 Innsbruck, Austria.							BASADONNA GP, 1993, TRANSPLANTATION, V55, P993, DOI 10.1097/00007890-199305000-00007; DIMENY E, 1995, EUR J CLIN INVEST, V25, P574, DOI 10.1111/j.1365-2362.1995.tb01748.x; FELLSTROM B, 1999, RANSPLANT P S7A, V21, pS14; Jensik SC, 1998, TRANSPLANT P, V30, P1216, DOI 10.1016/S0041-1345(98)00216-4; Knoll GA, 1999, BRIT MED J, V318, P1104, DOI 10.1136/bmj.318.7191.1104; Kobashigawa JA, 1997, TRANSPLANTATION, V63, P331, DOI 10.1097/00007890-199702150-00001; KOVARIK JM, 1994, TRANSPLANTATION, V58, P658; Kovarik JM, 1996, TRANSPLANTATION, V62, P759, DOI 10.1097/00007890-199609270-00010; LINDHOLM A, 1993, TRANSPLANTATION, V56, P307, DOI 10.1097/00007890-199308000-00010; MATAS AJ, 1994, TRANSPLANTATION, V57, P857, DOI 10.1097/00007890-199403270-00015; Mayer AD, 1997, TRANSPLANTATION, V64, P436, DOI 10.1097/00007890-199708150-00012; Nashan B, 1997, LANCET, V350, P1193, DOI 10.1016/S0140-6736(97)09278-7; NIESE D, 1995, TRANSPLANT P, V27, P1849; Opelz G, 1998, KIDNEY INT, V53, P217, DOI 10.1046/j.1523-1755.1998.00744.x; Peschke B, 1999, CLIN NEPHROL, V51, P290; Pirsch JD, 1997, TRANSPLANTATION, V63, P977, DOI 10.1097/00007890-199704150-00013; Silkensen JR, 2000, J AM SOC NEPHROL, V11, P582, DOI 10.1681/ASN.V113582; SOLEZ K, 1993, KIDNEY INT, V44, P411, DOI 10.1038/ki.1993.259; Wissing KM, 2000, TRANSPLANTATION, V70, P464, DOI 10.1097/00007890-200008150-00012; 1964, RECOMMENDATIONS GUID	20	360	382	0	13	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 2	2002	359	9308					741	746		10.1016/S0140-6736(02)07875-3	http://dx.doi.org/10.1016/S0140-6736(02)07875-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526DZ	11888584				2022-12-28	WOS:000174115200008
J	Rodriguez-Fornells, A; Rotte, M; Heinze, HJ; Nosselt, T; Munte, TF				Rodriguez-Fornells, A; Rotte, M; Heinze, HJ; Nosselt, T; Munte, TF			Brain potential and functional MRI evidence for how to handle two languages with one brain	NATURE			English	Article							LEXICAL ACCESS; WORD; INDEPENDENCE; RECOGNITION; BILINGUALS; REPETITION; SENTENCES; ANATOMY; CORTEX; FMRI	Bilingual individuals need effective mechanisms to prevent interference from one language while processing material in the other(1). Here we show, using event-related brain potentials and functional magnetic resonance imaging (fMRI), that words from the nontarget language are rejected at an early stage before semantic analysis in bilinguals. Bilingual Spanish/Catalan and monolingual Spanish subjects were instructed to press a button when presented with words in one language, while ignoring words in the other language and pseudowords. The brain potentials of bilingual subjects in response to words of the non-target language were not sensitive to word frequency, indicating that the meaning of non-target words was not accessed in bilinguals. The fMRI activation patterns of bilinguals included a number of areas previously implicated in phonological and pseudoword processing(2-5), suggesting that bilinguals use an indirect phonological access route to the lexicon of the target language to avoid interference(6).	Otto von Guericke Univ, Dept Neuropsychol, D-39106 Magdeburg, Germany; Otto von Guericke Univ, Klin Neurol 2, D-39120 Magdeburg, Germany	Otto von Guericke University; Otto von Guericke University	Munte, TF (corresponding author), Otto von Guericke Univ, Dept Neuropsychol, Univ Pl 2,Gebaude 24, D-39106 Magdeburg, Germany.		Münte, Thomas/C-2077-2014; Rodriguez-Fornells, Antoni/L-5878-2014	Rodriguez-Fornells, Antoni/0000-0002-3249-6931; Noesselt, Toemme/0000-0002-9611-9713				Alameda J.R., 1995, DICCIONARIO FRECUENC; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; Chee MWL, 1999, NEURON, V23, P127, DOI 10.1016/S0896-6273(00)80759-X; Cocosco C. A., 1997, NEUROIMAGE, V5, P425; COLTHEART M, 1993, PSYCHOL REV, V100, P589, DOI 10.1037/0033-295X.100.4.589; Comrie B, 1987, WORLDS MAJOR LANGUAG; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Dijkstra T, 2000, J MEM LANG, V42, P445, DOI 10.1006/jmla.1999.2697; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; GERARD LD, 1989, J EXP PSYCHOL LEARN, V15, P305, DOI 10.1037/0278-7393.15.2.305; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Luck SJ, 1996, NATURE, V383, P616, DOI 10.1038/383616a0; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MACNAMARA J, 1971, J VERB LEARN VERB BE, V10, P480, DOI 10.1016/S0022-5371(71)80018-X; NOBRE AC, 1995, J NEUROSCI, V15, P1090; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Penfield W., 1959, SPEECH BRAIN MECH; Perani D, 1998, BRAIN, V121, P1841, DOI 10.1093/brain/121.10.1841; Petersen S E, 1989, J Cogn Neurosci, V1, P153, DOI 10.1162/jocn.1989.1.2.153; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; Rafel i Fontanals J., 1998, DICCIONARI FREQUENCI; RUGG MD, 1990, MEM COGNITION, V18, P367, DOI 10.3758/BF03197126; SCARBOROUGH DL, 1984, J VERB LEARN VERB BE, V23, P84, DOI 10.1016/S0022-5371(84)90519-X; Schmitt BM, 2000, PSYCHOPHYSIOLOGY, V37, P473, DOI 10.1017/S0048577200981782; Talairach J., 1988, COPLANAR STEREOTAXIC; Thompson-Schill SL, 1999, NEURON, V23, P513, DOI 10.1016/S0896-6273(00)80804-1; Weber-Fox C., 1997, J COGNITIVE NEUROSCI, V8, P231; Winer B.J., 1991, STAT PRINCIPLES EXPT; Xu B, 2001, CEREB CORTEX, V11, P267, DOI 10.1093/cercor/11.3.267; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767	30	196	204	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2002	415	6875					1026	1029		10.1038/4151026a	http://dx.doi.org/10.1038/4151026a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	525MF	11875570				2022-12-28	WOS:000174075000046
J	Schiemeier, Q; Wegner, R				Schiemeier, Q; Wegner, R			Foreign researchers turn their backs on Germany	NATURE			English	News Item																			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2002	415	6875					945	945		10.1038/415945b	http://dx.doi.org/10.1038/415945b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875527	Bronze			2022-12-28	WOS:000174075000004
J	Smith, NGC; Eyre-Walker, A				Smith, NGC; Eyre-Walker, A			Adaptive protein evolution in Drosophila	NATURE			English	Article							DELETERIOUS MUTATIONS; SELECTION; SEQUENCE; PROGRAM	For over 30 years a central question in molecular evolution has been whether natural selection plays a substantial role in evolution at the DNA sequence level(1,2). Evidence has accumulated over the last decade that adaptive evolution does occur at the protein level(3,4), but it has remained unclear how prevalent adaptive evolution is. Here we present a simple method by which the number of adaptive substitutions can be estimated and apply it to data from Drosophila simulans and D. yakuba. We estimate that 45% of all amino-acid substitutions have been fixed by natural selection, and that on average one adaptive substitution occurs every 45 years in these species.	Univ Sussex, Ctr Study Evolut, Brighton BN1 9QG, E Sussex, England; Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England	University of Sussex; University of Sussex	Eyre-Walker, A (corresponding author), Univ Sussex, Ctr Study Evolut, Brighton BN1 9QG, E Sussex, England.	a.c.eyre-walker@sussex.ac.uk	Eyre-Walker, Adam/G-6216-2011	Eyre-Walker, Adam/0000-0001-5527-8729				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Begun DJ, 2001, MOL BIOL EVOL, V18, P1343, DOI 10.1093/oxfordjournals.molbev.a003918; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; CHARLESWORTH B, 1994, GENET RES, V63, P213, DOI 10.1017/S0016672300032365; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Fay JC, 2001, GENETICS, V158, P1227; Gillespie J.H., 1992, CAUSES MOL EVOLUTION; HALDANE J. B. S., 1957, JOUR GENETICS, V55, P511, DOI 10.1007/BF02984069; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Kimura M., 1983, NEUTRAL THEORY MOL E; Kliman RM, 1999, J MOL EVOL, V49, P343, DOI 10.1007/PL00006557; KREITMAN M, 1995, ANNU REV ECOL SYST, V26, P403, DOI 10.1146/annurev.es.26.110195.002155; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; POWELL JR, 1995, EVOL BIOL, V28, P87; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; XIA X, 2000, DATA ANAL MOL BIOL E; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7	20	492	496	3	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2002	415	6875					1022	1024		10.1038/4151022a	http://dx.doi.org/10.1038/4151022a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875568				2022-12-28	WOS:000174075000044
J	Steinbrook, R				Steinbrook, R			Protecting research subjects - The crisis at Johns Hopkins.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		CAROME M, 2001, COMMUNICATION   0722; CASSEL C, 2001, ADDENUM REPORT J HOP; CASSEL C, 2001, COMMUNICATION   0808; *CLIN INV CONS FOR, 2000, MECH DEEP INSP IND A; DANG CV, 2002, COMMUNICATION   1212; *J HOPK BAYV MED C, 2000, MECH DEEP INSP IND A; KRACOV DA, 2002, COMMUNICATION   0207; MCNEILLY PJ, 2001, COMMUNICATION   0719; MCNEILLY PJ, 2001, COMMUNICATION   1003; MILLER ED, 2001, COMMUNICATION   0721; *NIH US MED SCH, 2002, FYS 1970 2000; SHAFFER JD, 2001, FDA FORM 483 INSPECT; 2001, J HOPKINS MED   0716	13	131	134	1	6	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2002	346	9					716	720		10.1056/NEJM200202283460924	http://dx.doi.org/10.1056/NEJM200202283460924			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525HJ	11870258				2022-12-28	WOS:000174062800031
J	Kyle, RA; Therneau, TM; Rajkumar, SV; Offord, JR; Larson, DR; Plevak, MF; Melton, L				Kyle, RA; Therneau, TM; Rajkumar, SV; Offord, JR; Larson, DR; Plevak, MF; Melton, L			A long-term study of prognosis in monoclonal gammopathy of undetermined significance	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MALIGNANT TRANSFORMATION; NATURAL-HISTORY; MINNESOTA; COMMUNITY	Background: A monoclonal gammopathy of undetermined significance (MGUS) occurs in up to 2 percent of persons 50 years of age or older. Reliable predictors of progression have not been identified, and information on prognosis is limited. Methods: We identified 1384 patients residing in southeastern Minnesota in whom MGUS was diagnosed at the Mayo Clinic from 1960 through 1994. The primary end point was progression to multiple myeloma or another plasma-cell cancer. Results: During 11,009 person-years of follow-up, MGUS progressed in 115 of the 1384 patients to multiple myeloma, IgM lymphoma, primary amyloidosis, macroglobulinemia, chronic lymphocytic leukemia, or plasmacytoma (relative risk of progression, 25.0, 2.4, 8.4, 46.0, 0.9, and 8.5, respectively). The overall relative risk of progression was 7.3 in these patients as compared with the white population of the Iowa Surveillance, Epidemiology, and End Results program. In 32 additional patients, the monoclonal protein concentration increased to more than 3 g per deciliter or the percentage of plasma cells in the bone marrow increased to more than 10 percent (smoldering multiple myeloma) but without progression to overt myeloma or related disorders. The cumulative probability of progression was 12 percent at 10 years, 25 percent at 20 years, and 30 percent at 25 years. The initial concentration of serum monoclonal protein was a significant predictor of progression at 20 years. Conclusions: The risk of progression of MGUS to multiple myeloma or related disorders is about 1 percent per year. Copyright (C) 2002 Massachusetts Medical Society.	Mayo Clin & Mayo Fdn, Div Hematol & Internal Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Biostat Sect, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Clin Epidemiol Sect, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Kyle, RA (corresponding author), Mayo Clin & Mayo Fdn, Div Hematol & Internal Med, 200 1st St SW, Rochester, MN 55905 USA.		Rajkumar, S. Vincent/AAV-1834-2021	Rajkumar, S. Vincent/0000-0002-5862-1833	NATIONAL CANCER INSTITUTE [P01CA062242] Funding Source: NIH RePORTER; NCI NIH HHS [CA62242] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AXELSSON U, 1966, ACTA MED SCAND, V179, P235; Baldini L, 1996, BLOOD, V87, P912, DOI 10.1182/blood.V87.3.912.bloodjournal873912; BERRY G, 1983, BIOMETRICS, V39, P173, DOI 10.2307/2530817; BLADE J, 1992, BRIT J HAEMATOL, V81, P391, DOI 10.1111/j.1365-2141.1992.tb08245.x; COX DR, 1972, J R STAT SOC B, V34, P187; Fonseca R, 1999, BLOOD, V94, p663A; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; HALLEN J, 1963, ACTA MED SCAND, V173, P737; Hallen J, 1966, Acta Med Scand Suppl, V462, P1; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kyle R, 1997, MANUAL CLIN LAB IMMU, P156; KYLE RA, 1972, BLOOD-J HEMATOL, V40, P719, DOI 10.1182/blood.V40.5.719.719; KYLE RA, 1978, AM J MED, V64, P814, DOI 10.1016/0002-9343(78)90522-3; KYLE RA, 1993, MAYO CLIN PROC, V68, P26, DOI 10.1016/S0025-6196(12)60015-9; KYLE RA, 1992, BLOOD, V79, P1817; Kyle RA, 1999, BLOOD, V94, p537A; Melton LJ, 1997, NEW ENGL J MED, V337, P1466, DOI 10.1056/NEJM199711133372012; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; *NAT CANC I CAN ST, 2001, SURV EP END RES PROG; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; SALEUN JP, 1982, J CLIN PATHOL, V35, P63, DOI 10.1136/jcp.35.1.63; VANDEPOEL MHW, 1995, BRIT J HAEMATOL, V91, P121	22	978	1013	0	31	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2002	346	8					564	569		10.1056/NEJMoa01133202	http://dx.doi.org/10.1056/NEJMoa01133202			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	522ZK	11856795				2022-12-28	WOS:000173926700004
J	Sandstrom, M; Jalilehvand, F; Persson, I; Gelius, U; Frank, P; Hall-Roth, I				Sandstrom, M; Jalilehvand, F; Persson, I; Gelius, U; Frank, P; Hall-Roth, I			Deterioration of the seventeenth-century warship Vasa by internal formation of sulphuric acid	NATURE			English	Article							X-RAY-ABSORPTION; ASCIDIA-CERATODES; SULFUR; SPECTROSCOPY; SULFATE; CELLS	The seventeenth-century Swedish warship, Vasa, was recovered in good condition after 333 years in the cold brackish water of Stockholm harbour. After extensive treatment to stabilize and dry the ship's timbers(1), the ship has been on display in the Vasa Museum since 1990. However, high acidity and a rapid spread of sulphate salts were recently observed on many wooden surfaces(2), which threaten the continued preservation of the Vasa. Here we show that, in addition to concentrations of sulphate mostly on the surface of oak beams, elemental sulphur has accumulated within the beams (0.2-4 per cent by mass), and also sulphur compounds of intermediate oxidation states exist. The overall quantity of elemental sulphur could produce up to 5,000 kg of sulphuric acid when fully oxidized. We suggest that the oxidation of the reduced sulphur-which probably originated from the penetration of hydrogen sulphide into the timbers as they were exposed to the anoxic water-is being catalysed by iron species released from the completely corroded original iron bolts, as well as from those inserted after salvage. Treatments to arrest acid wood hydrolysis of the Vasa and other wooden marine-archaeological artefacts should therefore focus on the removal of sulphur and iron compounds.	Stockholm Univ, Dept Struct Chem, SE-10691 Stockholm, Sweden; Stanford Univ, Stanford Linear Accelerator Ctr, Stanford Synchrotron Radiat Lab, Stanford, CA 94309 USA; Swedish Univ Agr Sci, Dept Chem, SE-75007 Uppsala, Sweden; Uppsala Univ, Angstrom Lab, Dept Phys, SE-75121 Uppsala, Sweden; Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Vasa Museum, SE-10252 Stockholm, Sweden	Stockholm University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Swedish University of Agricultural Sciences; Uppsala University; Stanford University	Sandstrom, M (corresponding author), Stockholm Univ, Dept Struct Chem, SE-10691 Stockholm, Sweden.			Persson, Ingmar/0000-0002-1061-7536				AHRLAND S, 1990, ACTA AGR SCAND, V40, P101, DOI 10.1080/00015129009438008; [Anonymous], 2003, WOOD CHEM ULTRASTRUC; BAIRD C, 1999, ENV CHEM, P427; BARKMAN L, 1977, NBS SPEC PUBL, V479, P155; BERNSON A, 1996, COMPREHENSIVE SUMMAR, V182, P1; BLANCHETTE RA, 1990, ADV CHEM SER, V225, P141; EMERY JA, 1974, WOOD SCI TECHNOL, V8, P123, DOI 10.1007/BF00351367; Frank P, 1999, INORG CHEM, V38, P260, DOI 10.1021/ic980792m; FRANK P, 1987, BIOCHEMISTRY-US, V26, P4975, DOI 10.1021/bi00390a014; GELIUS U, 1990, J ELECTRON SPECTROSC, V52, P747, DOI 10.1016/0368-2048(90)85063-F; GEORGE GN, 1989, J AM CHEM SOC, V111, P3182, DOI 10.1021/ja00191a012; GRAY FM, 1997, RSC MAT MONOGRAPHS, P1; Guilminot E., 2000, EUR FED CORROS PUBL, V28, P300; HAFORS B, 2001, CONSERVATION SWEDISH, P1; HEDMAN B, 1986, NUCL INSTRUM METH A, V246, P797, DOI 10.1016/0168-9002(86)90196-8; JALILEHVAND F, 2000, STRUCTURE HYDRATED I, P1; JESPERSEN K, 1989, P ICOM WORK GROUPS W, P141; KILMINSTER K, 2001, THESIS U W AUSTR; LOWSON RT, 1982, CHEM REV, V82, P461, DOI 10.1021/cr00051a001; PETERSON CE, 1990, ADV CHEM SER, V225, P433; Pickering IJ, 2001, BIOCHEMISTRY-US, V40, P8138, DOI 10.1021/bi0105532; PUIGDOMENECH I, 2001, MEDUSA HYDRA; SANDSTROM M, IN PRESS P 8 ICOM CC; SMITH TA, 1994, J AM CHEM SOC, V116, P3836, DOI 10.1021/ja00088a020; Stumm W., 1996, AQUATIC CHEM CHEM EQ, DOI [10.5860/choice.33-6312, DOI 10.5860/CHOICE.33-6312]	25	138	141	3	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 21	2002	415	6874					893	897		10.1038/415893a	http://dx.doi.org/10.1038/415893a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859365				2022-12-28	WOS:000173941000041
J	Shiba, T; Takatsu, H; Nogi, T; Matsugaki, N; Kawasaki, M; Igarashi, N; Suzuki, M; Kato, R; Earnest, T; Nakayama, K; Wakatsuki, S				Shiba, T; Takatsu, H; Nogi, T; Matsugaki, N; Kawasaki, M; Igarashi, N; Suzuki, M; Kato, R; Earnest, T; Nakayama, K; Wakatsuki, S			Structural basis for recognition of acidic-cluster dileucine sequence by GGA1	NATURE			English	Article							EAR HOMOLOGY DOMAIN; GAMMA-ADAPTIN; VHS DOMAIN; PROTEINS INTERACT; BINDING; TRANSPORT; FAMILY; TRAFFICKING; RECEPTORS; INSIGHTS	GGAs (Golgi-localizing, g-adaptin ear homology domain, ARF-interacting proteins) are critical for the transport of soluble proteins from the trans-Golgi network (TGN) to endosomes/lysosomes by means of interactions with TGN-sorting receptors, ADP-ribosylation factor (ARF), and clathrin(1,2). The amino-terminal VHS domains of GGAs form complexes with the cytoplasmic domains of sorting receptors by recognizing acidic-cluster dileucine (ACLL) sequences(1-6). Here we report the X-ray structure of the GGA1 VHS domain alone, and in complex with the carboxyterminal peptide of cation-independent mannose 6-phosphate receptor containing an ACLL sequence. The VHS domain forms a super helix with eight alpha-helices, similar to the VHS domains of TOM1 and Hrs. Unidirectional movements of helices alpha6 and alpha8, and some of their side chains, create a set of electrostatic and hydrophobic interactions for correct recognition of the ACLL peptide. This recognition mechanism provides the basis for regulation of protein transport from the TGN to endosomes/lysosomes, which is shared by sortilin and low-density lipoprotein receptor-related protein.	High Energy Accelerator Res Org, Inst Mat Struct Sci, Photon Factory, Tsukuba, Ibaraki 3050801, Japan; Fdn Advancement Int Sci, Tsukuba, Ibaraki 3050062, Japan; Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 3058572, Japan; Univ Tsukuba, Ctr Gene Res, Tsukuba, Ibaraki 3058572, Japan; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley Ctr Struct Biol,Adv Light Source, Berkeley, CA 94720 USA	High Energy Accelerator Research Organization (KEK); University of Tsukuba; University of Tsukuba; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Wakatsuki, S (corresponding author), High Energy Accelerator Res Org, Inst Mat Struct Sci, Photon Factory, Tsukuba, Ibaraki 3050801, Japan.	soichi.wakatsuki@kek.jp	Nakayama, Kazuhisa/ABF-2924-2020; Nogi, Terukazu/GPF-7203-2022; Suzuki, Mamoru/G-6576-2016	Nogi, Terukazu/0000-0001-8663-3519; Suzuki, Mamoru/0000-0001-7071-5093; Nakayama, Kazuhisa/0000-0001-7701-7183; Igarashi, Noriyuki/0000-0003-2617-3690; Kato, Ryuichi/0000-0003-2087-2896; Kawasaki, Masato/0000-0002-8319-2102; Matsugaki, Naohiro/0000-0001-9640-1949; Wakatsuki, Soichi/0000-0001-5896-7968				Black MW, 2001, CURR BIOL, V11, pR460, DOI 10.1016/S0960-9822(01)00281-0; Boman AL, 2000, MOL BIOL CELL, V11, P1241, DOI 10.1091/mbc.11.4.1241; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen HJ, 1997, J BIOL CHEM, V272, P7003, DOI 10.1074/jbc.272.11.7003; Costaguta G, 2001, MOL BIOL CELL, V12, P1885, DOI 10.1091/mbc.12.6.1885; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LESLIE AGW, 1992, JOINT CCP4 ESF EACMB, V26; Lohi O, 1998, FEBS LETT, V440, P255, DOI 10.1016/S0014-5793(98)01401-X; Mao YX, 2000, CELL, V100, P447, DOI 10.1016/S0092-8674(00)80680-7; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Misra S, 2000, BIOCHEMISTRY-US, V39, P11282, DOI 10.1021/bi0013546; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Otwinowski Z., 1993, DATA COLLECTION PROC, P56; Poussu A, 2000, J BIOL CHEM, V275, P7176, DOI 10.1074/jbc.275.10.7176; Puertollano R, 2001, SCIENCE, V292, P1712, DOI 10.1126/science.1060750; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; ROUSSEL A, 1991, SILICON GRAPHICS GEO; Takatsu H, 2000, BIOCHEM BIOPH RES CO, V271, P719, DOI 10.1006/bbrc.2000.2700; Takatsu H, 2001, J BIOL CHEM, V276, P28541, DOI 10.1074/jbc.C100218200; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Zhdankina O, 2001, YEAST, V18, P1, DOI 10.1002/1097-0061(200101)18:1<1::AID-YEA644>3.0.CO;2-5; Zhu YX, 2001, SCIENCE, V292, P1716, DOI 10.1126/science.1060896	29	122	126	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2002	415	6874					937	941		10.1038/415937a	http://dx.doi.org/10.1038/415937a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859376				2022-12-28	WOS:000173941000052
J	Shin, T; Kraemer, D; Pryor, J; Liu, L; Rugila, J; Howe, L; Buck, S; Murphy, K; Lyons, L; Westhusin, M				Shin, T; Kraemer, D; Pryor, J; Liu, L; Rugila, J; Howe, L; Buck, S; Murphy, K; Lyons, L; Westhusin, M			A cat cloned by nuclear transplantation	NATURE			English	Article							SOMATIC-CELLS; ADULT		Texas A&M Univ, Coll Vet Med, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA; Texas A&M Univ, Coll Vet Med, Dept Small Anim Med & Surg, College Stn, TX 77843 USA; Texas A&M Univ, Coll Vet Med, Dept Pathobiol, College Stn, TX 77843 USA; Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of California System; University of California Davis	Shin, T (corresponding author), Texas A&M Univ, Coll Vet Med, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA.		Westhusin, Mark/AAX-2351-2020	Westhusin, Mark/0000-0002-6126-6211				Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0	5	377	451	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 21	2002	415	6874					859	859		10.1038/nature723	http://dx.doi.org/10.1038/nature723			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859353				2022-12-28	WOS:000173941000029
J	Stromberg, B; Dahlquist, G; Ericson, A; Finnstrom, O; Koster, M; Stjernqvist, K				Stromberg, B; Dahlquist, G; Ericson, A; Finnstrom, O; Koster, M; Stjernqvist, K			Neurological sequelae in children born after in-vitro fertilisation: a population-based study	LANCET			English	Article							INVITRO FERTILIZATION; CONGENITAL-MALFORMATIONS; CRYOPRESERVED EMBRYOS; PREGNANCIES; GROWTH; SWEDEN; HEALTH	Background There is an absence of population-based long-term studies on the risk of neurological sequelae in children born after in-vitro fertilisation (IVF). Our aim was to compare the frequency of such problems between IVF-born children and controls. Methods We did a population-based retrospective cohort study in which we compared development of neurological problems in 5680 children born after IVF, with 11 360 matched controls. For 2060 twins born after IVF, a second set of controls (n=4120), all twins, were selected. We obtained data on neurological problems from the records of the Swedish habilitation centres. Findings Children born after IVF are more likely to need habilitation services than controls (odds ratio 1.7, 95% Cl 1.3-2.2). For singletons, the risk was 1.4 (1.0-2.1). The most common neurological diagnosis was cerebral palsy, for which children born after IVF had an increased risk of 3.7 (2.0-6.6), and IVF singletons of 2.8 (1.3-5.8). Suspected developmental delay was increased four-fold (1.9-8.3) in children born after IVF. Twins born after IVF did not differ from control twins with respect to risk of neurological sequelae. Low-birthweight and premature infants were more likely to need habilitation than fullterm babies. Maternal age did not affect risk. Interpretation Our study suggests that children born after IVF have an increased risk of developing neurological problems, especially cerebral palsy. These risks are largely due to the high frequency of twin pregnancies, low birthweight, and prematurity among babies born after IVF. To limit these risks, we recommend that only one embryo should be transferred during IVF.	Univ Childrens Hosp, Dept Women & Child Hlth, S-75185 Uppsala, Sweden; Umea Univ, Dept Clin Sci, Umea, Sweden; Natl Board Hlth & Welf, Ctr Epidemiol, Stockholm, Sweden; Linkoping Univ Hosp, Dept Paediat, S-58185 Linkoping, Sweden; Lund Univ, Dept Psychol, Lund, Sweden	Umea University; National Board of Health & Welfare; Linkoping University; Lund University	Stromberg, B (corresponding author), Univ Childrens Hosp, Dept Women & Child Hlth, S-75185 Uppsala, Sweden.	bo.stromberg@kbh.uu.se						BERAL V, 1990, BMJ-BRIT MED J, V300, P1229; Bergh T, 1999, LANCET, V354, P1579, DOI 10.1016/S0140-6736(99)04345-7; Bonduelle M, 1996, HUM REPROD, V11, P131, DOI 10.1093/humrep/11.suppl_4.131; BRANDES JM, 1992, PEDIATRICS, V90, P424; Cornel M C, 1990, Ned Tijdschr Geneeskd, V134, P1357; DAHLQUIST G, 2000, CHILDREN BORN IN VIT; DEMOUZON J, 1997, J ASSIST REPROD GE S, V14, P251; Dhont M, 1997, J ASSIST REPROD GEN, V14, P575, DOI 10.1023/A:1022576500894; Ericson A, 2001, HUM REPROD, V16, P504, DOI 10.1093/humrep/16.3.504; GISSLER M, 1995, HUM REPROD, V10, P1856, DOI 10.1093/oxfordjournals.humrep.a136191; Hagberg B, 1996, ACTA PAEDIATR, V85, P48, DOI 10.1111/j.1651-2227.1996.tb14277.x; HAGBERG B, 1993, ACTA PAEDIATR, V82, P387, DOI 10.1111/j.1651-2227.1993.tb12704.x; Hagberg B, 2001, ACTA PAEDIATR, V90, P271, DOI 10.1080/080352501300067532; LANCASTER PAL, 1987, LANCET, V2, P1392; LOGEROTLEBRUN H, 1995, FERTIL STERIL, V64, P746; RIZK B, 1991, HUM REPROD, V6, P1259, DOI 10.1093/oxfordjournals.humrep.a137523; Saunders K, 1996, PEDIATRICS, V97, P688; TALLO CP, 1995, J PEDIATR-US, V127, P794, DOI 10.1016/S0022-3476(95)70175-3; von During V, 1995, Tidsskr Nor Laegeforen, V115, P2054; WANG JX, 1994, HUM REPROD, V9, P141, DOI 10.1093/oxfordjournals.humrep.a138304; Wennerholm UB, 1998, LANCET, V351, P1085, DOI 10.1016/S0140-6736(97)08247-0; Wennerholm UB, 1997, HUM REPROD, V12, P1819, DOI 10.1093/humrep/12.8.1819; 2000, STAT HLTH DIS	23	357	379	1	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2002	359	9305					461	465		10.1016/S0140-6736(02)07674-2	http://dx.doi.org/10.1016/S0140-6736(02)07674-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520ML	11853790				2022-12-28	WOS:000173785600007
J	von Bubnoff, N; Schneller, F; Peschel, C; Duyster, J				von Bubnoff, N; Schneller, F; Peschel, C; Duyster, J			BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective study	LANCET			English	Article							CHRONIC MYELOID-LEUKEMIA; KINASE INHIBITOR STI571; TYROSINE KINASE; CELL-LINES; AMPLIFICATION; MECHANISMS; INDUCTION	Background BCR-ABL, a constitutively activated tyrosine kinase, is the oncogene that causes Philadelphia-chromosome-positive (Ph+) leukaemia. STI571, a competitive inhibitor at the ATP-binding site of BCR-ABL, has been shown to have high activity in this type of leukaemia. However, most patients with advanced disease relapse despite continued treatment with STI571. We aimed to find out whether point mutations in BCR-ABL cause resistance to STI571. Methods We analysed clinical samples from eight patients resistant to STI571-who had advanced-stage Ph+ leukaemia-for mutations within the ATP-binding site and activation loop of BCR-ABL. Analysis was done before treatment with STI571 and at time of relapse. Findings We identified five distinct point mutations in the BCR-ABL kinase domain in seven patients. All point mutations arose at positions that have proved to be important for drug binding and have conferred resistance to STI571 in vitro. All patients with mutations had lymphoid leukaemia. Interpretation Different mutations within the kinase domain of BCR-ABL can be responsible for refractoriness of Ph+ leukaemia to STI571. Mutation in the BCR-ABL kinase domain might be a frequent mechanism of STI571 resistance in lymphoid disease.	Tech Univ Munich, Dept Internal Med 3, Lab Leukemogenesis, D-81675 Munich, Germany	Technical University of Munich; University of Munich	Duyster, J (corresponding author), Tech Univ Munich, Dept Internal Med 3, Lab Leukemogenesis, Ismaningerstr 22, D-81675 Munich, Germany.	justus.duyster@lrz.tum.de	von Bubnoff, Nikolas/AAG-1845-2021; von Bubnoff, Nikolas/F-2351-2017	von Bubnoff, Nikolas/0000-0001-9593-8947				Bai RY, 2000, BLOOD, V96, P4319, DOI 10.1182/blood.V96.13.4319; Barthe C, 2001, SCIENCE, V293; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Faderl S, 1999, NEW ENGL J MED, V341, P164, DOI 10.1056/NEJM199907153410306; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hochhaus A, 2001, SCIENCE, V293, P2163; le Coutre P, 2000, BLOOD, V95, P1758, DOI 10.1182/blood.V95.5.1758.005a41_1758_1766; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; Mahon FX, 2000, BLOOD, V96, P1070, DOI 10.1182/blood.V96.3.1070.015k17_1070_1079; NAGAR B, 2000, IN PRESS CRYSTAL STR; NOWELL PC, 1960, SCIENCE, V132, P1497; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Weisberg E, 2000, BLOOD, V95, P3498, DOI 10.1182/blood.V95.11.3498.011k27_3498_3505	16	398	417	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2002	359	9305					487	491		10.1016/S0140-6736(02)07679-1	http://dx.doi.org/10.1016/S0140-6736(02)07679-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520ML	11853795				2022-12-28	WOS:000173785600012
J	Breinig, F; Tipper, DJ; Schmitt, MJ				Breinig, F; Tipper, DJ; Schmitt, MJ			Kre1p, the plasma membrane receptor for the yeast K1 viral toxin	CELL			English	Article							SACCHAROMYCES-CEREVISIAE STRAIN-28; CELL-WALL RECEPTOR; KILLER-TOXIN; PREPROTOXIN; PROTEINS; MUTANTS; VIRUSES; DSRNA; GLYCOPROTEIN; EXPRESSION	Saccharomyces cerevisiae K1 killer strains are infected by the M1 double-stranded RNA virus encoding a secreted protein toxin that kills sensitive cells by disrupting cytoplasmic membrane function. Toxin binding to spheroplasts is mediated by Kre1p, a cell wall protein initially attached to the plasma membrane by its C-terminal GPI anchor. Kre1p binds toxin directly. Both cells and spheroplasts of Deltakre1 mutants are completely toxin resistant; binding to cell walls and spheroplasts is reduced to 10% and <0.5%, respectively. Expression of K28-Kre1p, an inactive C-terminal fragment of Kre1p retaining its toxin affinity and membrane anchor, fully restored toxin binding and sensitivity to spheroplasts, while intact cells remained resistant. Kre1p is apparently the toxin membrane receptor required for subsequent lethal ion channel formation.	Univ Saarland, D-66041 Saarbrucken, Germany; Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA	Saarland University; University of Massachusetts System; University of Massachusetts Worcester	Schmitt, MJ (corresponding author), Univ Saarland, D-66041 Saarbrucken, Germany.		/AHE-2458-2022	Breinig, Frank/0000-0003-1557-4691				Ahmed A, 1999, CELL, V99, P283, DOI 10.1016/S0092-8674(00)81659-1; ALAIDROOS K, 1978, CAN J MICROBIOL, V24, P228, DOI 10.1139/m78-041; BOONE C, 1990, J CELL BIOL, V110, P1833, DOI 10.1083/jcb.110.5.1833; BOSTIAN KA, 1984, CELL, V36, P741, DOI 10.1016/0092-8674(84)90354-4; BROWN JL, 1993, GENETICS, V133, P837; DELAPENA P, 1981, J BIOL CHEM, V256, P420; Eisfeld K, 2000, MOL MICROBIOL, V37, P926, DOI 10.1046/j.1365-2958.2000.02063.x; Gordon VM, 1999, J BIOL CHEM, V274, P27274, DOI 10.1074/jbc.274.38.27274; Hamada K, 1999, J BACTERIOL, V181, P3886, DOI 10.1128/JB.181.13.3886-3889.1999; Hamada K, 1998, MOL GEN GENET, V258, P53, DOI 10.1007/s004380050706; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HUTCHINS K, 1983, J BACTERIOL, V154, P161, DOI 10.1128/JB.154.1.161-169.1983; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; MARTINAC B, 1990, P NATL ACAD SCI USA, V87, P6228, DOI 10.1073/pnas.87.16.6228; Mortimer R K, 1975, Methods Cell Biol, V11, P221, DOI 10.1016/S0091-679X(08)60325-8; Nelson KL, 1997, J BIOL CHEM, V272, P12170, DOI 10.1074/jbc.272.18.12170; PFEIFFER P, 1982, J GEN MICROBIOL, V128, P2699; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; ROEMER T, 1995, MOL GEN GENET, V249, P209, DOI 10.1007/BF00290368; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; Sambrook J., 2002, MOL CLONING LAB MANU; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHMITT M, 1987, J GEN MICROBIOL, V133, P3347; SCHMITT M, 1988, J BACTERIOL, V170, P2192, DOI 10.1128/jb.170.5.2192-2196.1988; Schmitt MJ, 1995, ARCH MICROBIOL, V164, P435; SCHMITT MJ, 1990, MOL CELL BIOL, V10, P4807, DOI 10.1128/MCB.10.9.4807; SCHMITT MJ, 1990, ANTIMICROB AGENTS CH, V34, P1615, DOI 10.1128/AAC.34.8.1615; SCHMITT MJ, 1995, VIROLOGY, V213, P341, DOI 10.1006/viro.1995.0007; SCHMITT MJ, 1999, RRD VIROLOGY III, V1, P525; Sesti F, 2001, CELL, V105, P637, DOI 10.1016/S0092-8674(01)00376-2; Shahinian S, 2000, MOL MICROBIOL, V35, P477, DOI 10.1046/j.1365-2958.2000.01713.x; STURLEY SL, 1986, EMBO J, V5, P3381, DOI 10.1002/j.1460-2075.1986.tb04654.x; TIPPER DJ, 1991, MOL MICROBIOL, V5, P2331, DOI 10.1111/j.1365-2958.1991.tb02078.x; Wickner RB, 1996, MICROBIOL REV, V60, P250, DOI 10.1128/MMBR.60.1.250-265.1996; WICKNER RB, 1976, GENETICS, V82, P429; Wickner RB, 1995, MYCOTA, VII, P211; YOUNG TW, 1978, A VAN LEEUW J MICROB, V44, P59, DOI 10.1007/BF00400077; ZHU YS, 1993, YEAST, V9, P251, DOI 10.1002/yea.320090305	38	86	91	1	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 8	2002	108	3					395	405		10.1016/S0092-8674(02)00634-7	http://dx.doi.org/10.1016/S0092-8674(02)00634-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	520VB	11853673	Bronze			2022-12-28	WOS:000173801600011
J	Nemoto, S; Finkel, T				Nemoto, S; Finkel, T			Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway	SCIENCE			English	Article							TRANSCRIPTION FACTOR; OXIDATIVE STRESS; LIFE-SPAN; SURVIVAL; ELEGANS; FKHR; AKT; AFX	Genetic determinants of longevity include the forkhead-related transcription factor DAF-16 in the worm Caenorhabditis elegans and the p66shc locus in mice. We demonstrate that p66shc regulates intracellular oxidant levels in mammalian cells and that hydrogen peroxide can negatively regulate forkhead activity. In p66shc(-/-) cells, the activity of the mammalian forkhead homolog FKHRL1 is increased and redox-dependent forkhead inactivation is reduced. In addition, expression of FKHRL1 results in an increase in both hydrogen peroxide scavenging and oxidative stress resistance. These results demonstrate an important functional relation between three distinct elements linked to aging: forkhead proteins, p66shc, and intracellular oxidants.	NHLBI, Cardiovasc Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Finkel, T (corresponding author), NHLBI, Cardiovasc Branch, NIH, Bldg 10-6N-240,10 Ctr Dr, Bethesda, MD 20892 USA.		Franzeck, Fabian C/B-5055-2011					Barsyte D, 2001, FASEB J, V15, P627, DOI 10.1096/fj.99-0966com; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; HANG H, 2001, J BIOL CHEM, V276, P26357; Harman D., 1957, J GERONTOL, V2, P298; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Leenders H, 2000, EUR J IMMUNOL, V30, P2980, DOI 10.1002/1521-4141(200010)30:10<2980::AID-IMMU2980>3.0.CO;2-9; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Murakami S, 2001, CURR BIOL, V11, P1517, DOI 10.1016/S0960-9822(01)00453-5; NEMOTO S, UNPUB; Salinas M, 2001, MOL CELL NEUROSCI, V17, P67, DOI 10.1006/mcne.2000.0921; Sonoda Y, 1999, J BIOL CHEM, V274, P10566, DOI 10.1074/jbc.274.15.10566; Takaishi H, 1999, P NATL ACAD SCI USA, V96, P11836, DOI 10.1073/pnas.96.21.11836; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Taub J, 1999, NATURE, V399, P162, DOI 10.1038/20208; Wang XT, 2001, J BIOL CHEM, V276, P28364, DOI 10.1074/jbc.M102693200; YEE RYN, 2001, CURR BIOL, V11, P1950; Zheng WH, 2000, J BIOL CHEM, V275, P39152, DOI 10.1074/jbc.M002417200	24	706	736	4	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 29	2002	295	5564					2450	2452		10.1126/science.1069004	http://dx.doi.org/10.1126/science.1069004			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	536QD	11884717				2022-12-28	WOS:000174712600055
J	Brierley, AS; Fernandes, PG; Brandon, MA; Armstromg, F; Millard, NW; McPhail, SD; Stevenson, P; Pebody, M; Perrett, J; Squires, M; Bone, DG; Griffiths, G				Brierley, AS; Fernandes, PG; Brandon, MA; Armstromg, F; Millard, NW; McPhail, SD; Stevenson, P; Pebody, M; Perrett, J; Squires, M; Bone, DG; Griffiths, G			Antarctic krill under sea ice: Elevated abundance in a narrow band just south of ice edge	SCIENCE			English	Article							NORTHERN WEDDELL SEA; EUPHAUSIA-SUPERBA; ACOUSTIC OBSERVATIONS; EXTENT; ZONE	We surveyed Antarctic krill (Euphausia superba) under sea ice using the autonomous underwater vehicle Autosub-2. Krill were concentrated within a band under ice between 1 and 13 kilometers south of the ice edge. Within this band, krill densities were fivefold greater than that of open water. The under-ice environment has tong been considered an important habitat for krill, but sampling difficulties have previously prevented direct observations under ice over the scale necessary for robust krill density estimation. Autosub-2 enabled us to make continuous high-resolution measurements of krill density under ice reaching 27 kilometers beyond the ice edge.	British Antarctic Survey, Cambridge CB3 0ET, England; Marine Lab Aberdeen, Fisheries Res Serv, Aberdeen AB11 9DB, Scotland; Open Univ, Dept Earth Sci, Milton Keynes MK7 6AA, Bucks, England; Southampton Oceanog Ctr, Southampton SO14 3ZH, Hants, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Open University - UK; NERC National Oceanography Centre; University of Southampton	Brierley, AS (corresponding author), Univ St Andrews, Gatty Marine Lab, St Andrews KY16 8LB, Fife, Scotland.		Brierley, Andrew S/G-8019-2011; Fernandes, Paul/H-2972-2013; Brandon, Mark A/A-5804-2010	Brierley, Andrew S/0000-0002-6438-6892; Fernandes, Paul/0000-0003-4135-115X; Brandon, Mark A/0000-0002-7779-0958				Arrigo KR, 1998, J GEOPHYS RES-OCEANS, V103, P15587, DOI 10.1029/98JC00930; Brierley A.S., 1999, CCAMLR Science, V6, P47; Brierley AS, 2000, CAN J FISH AQUAT SCI, V57, P24, DOI 10.1139/cjfas-57-S3-24; BRIERLEY AS, IN PRESS FISHERIES R; DALY KL, 1991, MAR ECOL PROG SER, V79, P37, DOI 10.3354/meps079037; DALY KL, 1988, DEEP-SEA RES, V35, P21, DOI 10.1016/0198-0149(88)90055-6; delaMare WK, 1997, NATURE, V389, P57, DOI 10.1038/37956; FERNANDES PG, 1999, ICES CM 1999 M, V1; GODLEWSKA M, 1993, POLAR BIOL, V13, P507; ICHII T, 1990, P NIPR S POLAR BIOL, V3, P36; Loeb V, 1997, NATURE, V387, P897, DOI 10.1038/43174; Marr J.W.S., 1962, DISCOVERY REP, VXXXII, P33; McGehee DE, 1998, DEEP-SEA RES PT II, V45, P1273, DOI 10.1016/S0967-0645(98)00036-8; Millard NW, 1998, UNDERWATER TECHNOL, V23, P7, DOI 10.3723/175605498783259894; Murray AWA, 1996, ICES J MAR SCI, V53, P415, DOI 10.1006/jmsc.1996.0058; Ona E, 1996, ICES J MAR SCI, V53, P677, DOI 10.1006/jmsc.1996.0087; PARK NS, 1991, KOREAN J MED CHEM, V1, P36; Quetin Langdon B., 1996, Antarctic Research Series, V70, P357; Reid K, 2001, P ROY SOC B-BIOL SCI, V268, P377, DOI 10.1098/rspb.2000.1371; SIEGEL V, 1990, POLAR BIOL, V10, P549; SIEGEL V, 1992, POLAR BIOL, V12, P15; SPRONG I, 1992, POLAR BIOL, V12, P261; TURNER DR, 1995, DEEP-SEA RES PT II, V42, P907, DOI 10.1016/0967-0645(95)00056-V; Vaughan DG, 2001, SCIENCE, V293, P1777, DOI 10.1126/science.1065116; WATKINS JL, 1997, WGEMM9746 CCAMLR; Worby A.P., 1999, OBSERVING ANTARCTIC	26	189	201	3	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1890	1892		10.1126/science.1068574	http://dx.doi.org/10.1126/science.1068574			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884754				2022-12-28	WOS:000174299500038
J	Peier, AM; Moqrich, A; Hergarden, AC; Reeve, AJ; Andersson, DA; Story, GM; Earley, TJ; Dragoni, I; McIntyre, P; Bevan, S; Patapoutian, A				Peier, AM; Moqrich, A; Hergarden, AC; Reeve, AJ; Andersson, DA; Story, GM; Earley, TJ; Dragoni, I; McIntyre, P; Bevan, S; Patapoutian, A			A TRP channel that senses cold stimuli and menthol	CELL			English	Article							CAPSAICIN-RECEPTOR; CA2+ CHANNEL; PAIN; NOCICEPTORS; HOMOLOG; CLONING; PROTEIN; HEAT	A distinct subset of sensory neurons are thought to directly sense changes in thermal energy through their termini in the skin. Very little is known about the molecules that mediate thermoreception by these neurons. Vanilloid Receptor 1 (VR1), a member of the TRP family of channels, is activated by noxious heat. Here we describe the cloning and characterization of TRPM8, a distant relative of VR1. TRPM8 is specifically expressed in a subset of pain- and temperature-sensing neurons. Cells overexpressing the TRPM8 channel can be activated by cold temperatures and by a cooling agent, menthol. Our identification of a cold-sensing TRP channel in a distinct subpopulation of sensory neurons implicates an expanded role for this family of ion channels in somatic sensory detection.	Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Novartis Inst Med Sci, London WC1E 6BN, England	Novartis; Scripps Research Institute; Novartis	Patapoutian, A (corresponding author), Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA.		Bevan, Stuart/A-8821-2008; Mcintyre, Peter/N-4109-2013; Andersson, David A/C-3435-2008	Andersson, David A/0000-0001-7451-8548; moqrich, aziz/0000-0002-1937-1675; McIntyre, Peter/0000-0001-9506-5998; Bevan, Stuart John/0000-0002-8977-1797				Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Askwith CC, 2001, P NATL ACAD SCI USA, V98, P6459, DOI 10.1073/pnas.111155398; AXEL R, 1995, SCI AM, V273, P154, DOI 10.1038/scientificamerican1095-154; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Funayama M, 1996, MOL BRAIN RES, V43, P259, DOI 10.1016/S0169-328X(96)00208-2; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Hensel H, 1981, THERMORECEPTION TEMP; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Nagamine K, 1998, GENOMICS, V54, P124, DOI 10.1006/geno.1998.5551; Reid G, 2001, NATURE, V413, P480, DOI 10.1038/35097164; Reid G, 2001, NEUROSCI LETT, V297, P171, DOI 10.1016/S0304-3940(00)01694-3; Savidge JR, 2001, NEUROSCIENCE, V102, P177, DOI 10.1016/S0306-4522(00)00447-4; SCHAFER K, 1986, J GEN PHYSIOL, V88, P757, DOI 10.1085/jgp.88.6.757; Scott SA, 1992, SENSORY NEURONS DIVE; Simone DA, 1997, J NEUROPHYSIOL, V77, P2049, DOI 10.1152/jn.1997.77.4.2049; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suto K, 1999, NEUROSCIENCE, V92, P1131, DOI 10.1016/S0306-4522(99)00063-9; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tsavaler L, 2001, CANCER RES, V61, P3760; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229	28	1542	1628	10	140	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 8	2002	108	5					705	715		10.1016/S0092-8674(02)00652-9	http://dx.doi.org/10.1016/S0092-8674(02)00652-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	529TN	11893340	Bronze			2022-12-28	WOS:000174314800013
J	Soutoglou, E; Talianidis, I				Soutoglou, E; Talianidis, I			Coordination of PIC assembly and chromatin remodeling during differentiation-induced gene activation	SCIENCE			English	Article							EPITHELIAL-CELL LINE; RNA-POLYMERASE-II; TRANSCRIPTION FACTORS; ORDERED RECRUITMENT; PROMOTER; ACETYLATION; EXPRESSION; CACO-2; FORMS	We analyzed the ordered recruitment of factors to the human alpha(1) antitrypsin promoter around the initial activation of the gene during enterocyte differentiation. We found that a complete preinitiation complex, including phosphorylated RNA pol II, was assembled at the promoter long before transcriptional activation. The histone acetyltransferases CBP and P/CAF were recruited subsequently, but local histone hyperacetylation was delayed. After transient recruitment of the human Brahma homolog hBrm, remodeling of the neighboring nucleosome coincided with transcription initiation. The results suggest that, at this promoter, chromatin reconfiguration is a defining step of the initiation process, acting after the assembly of the Pol II machinery.	Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece	Foundation for Research & Technology - Hellas (FORTH)	Talianidis, I (corresponding author), Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, POB 1527, Iraklion 71110, Crete, Greece.		Talianidis, Iannis/F-7556-2016	Talianidis, Iannis/0000-0002-1209-3609; Soutoglou, Evi/0000-0002-3724-5613				Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Bell B, 1999, EXP CELL RES, V246, P11, DOI 10.1006/excr.1998.4294; Bhoite LT, 2001, GENE DEV, V15, P2457, DOI 10.1101/gad.921601; Cosma MP, 2001, MOL CELL, V7, P1213, DOI 10.1016/S1097-2765(01)00266-0; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; Dilworth FJ, 2000, MOL CELL, V6, P1049, DOI 10.1016/S1097-2765(00)00103-9; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; GREENBERG ME, 1999, CURRENT PROTOCOLS MO, V1, pCH4; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Hu CB, 1999, AM J PHYSIOL-GASTR L, V276, pG1181, DOI 10.1152/ajpgi.1999.276.5.G1181; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; MCPHERSON CE, 1993, CELL, V75, P387, DOI 10.1016/0092-8674(93)80079-T; MONACI P, 1988, EMBO J, V7, P2075, DOI 10.1002/j.1460-2075.1988.tb03047.x; PERLMUTTER DH, 1989, J BIOL CHEM, V264, P9485; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; PETERSON MD, 1992, J CELL SCI, V102, P581; Soutoglou E, 2000, MOL CELL, V5, P745, DOI 10.1016/S1097-2765(00)80253-1; Soutoglou E, 2001, EMBO J, V20, P1984, DOI 10.1093/emboj/20.8.1984; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Syntichaki P, 2000, NATURE, V404, P414, DOI 10.1038/35006136	26	263	264	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1901	1904		10.1126/science.1068356	http://dx.doi.org/10.1126/science.1068356			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884757				2022-12-28	WOS:000174299500042
J	Taleyarkhan, RP; West, CD; Cho, JS; Lahey, RT; Nigmatulin, RI; Block, RC				Taleyarkhan, RP; West, CD; Cho, JS; Lahey, RT; Nigmatulin, RI; Block, RC			Evidence for nuclear emissions during acoustic cavitation	SCIENCE			English	Article							CONDENSATION COEFFICIENT; SONOLUMINESCENCE; BUBBLE; WATER; FUSION	In cavitation experiments with deuterated acetone, tritium decay activity above background levels was detected. In addition, evidence for neutron emission near 2.5 million electron volts was also observed, as would be expected for deuterium-deuterium fusion. Control experiments with normal acetone did not result in tritium activity or neutron emissions. Hydrodynamic shock code simulations supported the observed data and indicated highly compressed, hot (10(6) to 10(7) kelvin) bubble implosion conditions, as required for nuclear fusion reactions.	Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; Oak Ridge Associated Univ, Oak Ridge, TN 37830 USA; Rensselaer Polytech Inst, Troy, NY 12180 USA; Russian Acad Sci, Ufa Bashkortostan Branch, Inst Mech, Ufa 450000, Russia	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; Rensselaer Polytechnic Institute; Mavlyutov Institute of Mechanics of Ufa Federal Research Centre of Russian Academy of Sciences; Russian Academy of Sciences	Taleyarkhan, RP (corresponding author), Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA.	zrt@ornl.gov	Cho, Jung Sang/E-9238-2017; Nigmatulin, Robert I/A-7415-2016	Cho, Jung Sang/0000-0001-5584-1526; 				Akhatov I, 2001, PHYS FLUIDS, V13, P2805, DOI 10.1063/1.1401810; Akhatov I. Sh., 1986, Fluid Dynamics, V21, P161, DOI 10.1007/BF01051120; BARBER BP, 1994, PHYS REV LETT, V72, P1380, DOI 10.1103/PhysRevLett.72.1380; BOSCH HS, 1992, NUCL FUSION, V32, P611, DOI 10.1088/0029-5515/32/4/I07; CHODES N, 1974, J ATMOS SCI, V31, P1351, DOI 10.1175/1520-0469(1974)031<1351:ADOTCC>2.0.CO;2; CRUM L, 1990, FRONTIERS NONLINEAR; Crum LA, 1997, SCIENCE, V276, P1348, DOI 10.1126/science.276.5317.1348; DELGADINO G, IN PRESS CHEM ENG CO; Frenzel H, 1934, Z PHYS CHEM B-CHEM E, V27, P421; Gaitan F, 1999, PHYS WORLD, V12, P20; Gross R., 1984, FUSION ENERGY; HAGEN DE, 1989, J ATMOS SCI, V46, P803, DOI 10.1175/1520-0469(1989)046<0803:CCMFWI>2.0.CO;2; HAHN B, 1961, NUOVO CIMENTO, V22, P650, DOI 10.1007/BF02774902; HAHN B, 1963, NUOVO CIMENTO, V27, P334; Hiller RA, 1998, PHYS REV LETT, V80, P1090, DOI 10.1103/PhysRevLett.80.1090; KAISER J, 1995, SCI NEWS, V147, P262; Knoll G. F., 1989, RAD DETECTION MEASUR; LAHEY RT, 2002, P 3 INT C TRANSP PHE; Lee JH, 1998, NUCL INSTRUM METH A, V402, P147, DOI 10.1016/S0168-9002(97)01073-5; LIEBERMAN D, 1959, PHYS FLUIDS, V2, P466, DOI 10.1063/1.1724419; Lohse D, 1998, NATURE, V392, P21, DOI 10.1038/32047; McNamara WB, 1999, NATURE, V401, P772, DOI 10.1038/44536; Metcalf H, 1998, SCIENCE, V279, P1322, DOI 10.1126/science.279.5355.1322; Moraga FJ, 2000, PHYS REV E, V62, P2233, DOI 10.1103/PhysRevE.62.2233; Moss WC, 1996, PHYS LETT A, V211, P69, DOI 10.1016/0375-9601(95)00934-5; NIGMATULIN R, 1991, DYNAMICS MULTIPHASE, V1, P244; NIGMATULIN R, 1995, NUREGCP0142 NUCL REG; PAUL B, 1962, RAKETNAYA TECHNIKA, V9, P3; SHAPIRA D, 2002, COMMENTS POSSIBLE OB; TALEYARKHAN RP, COMMENTS SHAPIRA SAL; Tian Y, 1996, J ACOUST SOC AM, V100, P3976, DOI 10.1121/1.417339; TOMITA Y, 1990, ACUSTICA, V71, P161; TRUNIN RF, 1992, KHIM FIZ, V11, P424; WEST C, 1969, ACUSTICA, V21, P112; WEST C, 1968, J PHYS D APPL PHYS, V1, P247, DOI 10.1088/0022-3727/1/2/315; WEST DC, 1967, NATURE, V215, P727, DOI 10.1038/215727a0; ZELDOVICH YB, 1966, PHYSICS SHOCK WAVES, V2; ZELDOVICH YB, 1966, PHYSICS SHOCK WAVES, V1	38	240	320	7	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2002	295	5561					1868	1873		10.1126/science.1067589	http://dx.doi.org/10.1126/science.1067589			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884748				2022-12-28	WOS:000174299500031
J	Blandford, RD				Blandford, RD			Astronomy - Wood out of a stone	SCIENCE			English	Editorial Material							ENERGY; EXTRACTION		CALTECH, Div Theoret Astrophys, Pasadena, CA 91125 USA	California Institute of Technology	Blandford, RD (corresponding author), CALTECH, Div Theoret Astrophys, Pasadena, CA 91125 USA.	rdb@caltech.edu						Balbus SA, 1998, REV MOD PHYS, V70, P1, DOI 10.1103/RevModPhys.70.1; Burgarella D., 1993, ASTROPHYSICAL JETS; HARTMAN RC, 1992, ASTROPHYS J, V385, pL1, DOI 10.1086/186263; JENNISON RC, 1953, NATURE, V172, P996, DOI 10.1038/172996a0; Koide S, 2002, SCIENCE, V295, P1688, DOI 10.1126/science.1068240; Krolik J. H., 1999, ACTIVE GALACTIC NUCL; MESZAROS P, IN PRESS ANN REV AST; Mirabel IF, 1998, NATURE, V392, P673, DOI 10.1038/33603; Thorne K.S., 1986, BLACK HOLES MEMBRANE; Weisskopf MC, 2000, ASTROPHYS J, V536, pL81, DOI 10.1086/312733; Wilms J, 2001, MON NOT R ASTRON SOC, V328, pL27, DOI 10.1046/j.1365-8711.2001.05066.x; Wilson AS, 2001, ASTROPHYS J, V547, P740, DOI 10.1086/318412	12	4	5	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2002	295	5560					1653	1654		10.1126/science.1070255	http://dx.doi.org/10.1126/science.1070255			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872823				2022-12-28	WOS:000174212900027
J	Noble, D				Noble, D			Modeling the heart - from genes to cells to the whole organ	SCIENCE			English	Review								Successful physiological analysis requires an understanding of the functional interactions between the key components of cells, organs, and systems, as well as how these interactions change in disease states. This information resides neither in the genome nor even in the individual proteins that genes code for. It lies at the level of protein interactions within the context of subcellular, cellular, tissue, organ, and system structures. There is therefore no alternative to copying nature and computing these interactions to determine the logic of healthy and diseased states. The rapid growth in biological databases; models of cells, tissues, and organs; and the development of powerful computing hardware and algorithms have made it possible to explore functionality in a quantitative manner all the way from the level of genes to the physiological function of whole organs and regulatory systems. This review illustrates this development in the case of the heart. Systems physiology of the 21st century is set to become highly quantitative and, therefore, one of the most computer-intensive disciplines.	Univ Oxford, Physiol Lab, Oxford OX1 3PT, England	University of Oxford	Noble, D (corresponding author), Univ Oxford, Physiol Lab, Parks Rd, Oxford OX1 3PT, England.	denis.noble@physiol.ox.ac						Antzelevitch C, 2001, PHILOS T R SOC A, V359, P1201, DOI 10.1098/rsta.2001.0826; BOCK G, IN PRESS NOVARTIS FD, V247; BOCK GR, 2001, NOVARTIS FDN S, V239; Boyett MR, 2001, PHILOS T R SOC A, V359, P1091, DOI 10.1098/rsta.2001.0818; Bradley CP, 1997, ANN BIOMED ENG, V25, P96, DOI 10.1007/BF02738542; Brenner S, 1998, CIBA F SYMP, V213, P106; Ch'en FFT, 1998, PROG BIOPHYS MOL BIO, V69, P515, DOI 10.1016/S0079-6107(98)00023-6; Clancy CE, 1999, NATURE, V400, P566, DOI 10.1038/23034; Costa KD, 2001, PHILOS T R SOC A, V359, P1233, DOI 10.1098/rsta.2001.0828; DIFRANCESCO D, 1985, PHILOS T ROY SOC B, V307, P353, DOI 10.1098/rstb.1985.0001; Gerstein M, 2002, SCIENCE, V295, P284, DOI 10.1126/science.1068664; Kohl P, 2001, PHILOS T R SOC A, V359, P1173, DOI 10.1098/rsta.2001.0824; Kohl P, 2000, PHILOS T R SOC A, V358, P579, DOI 10.1098/rsta.2000.0547; Kovacs SJ, 2001, PHILOS T ROY SOC A, V359, P1299, DOI 10.1098/rsta.2001.0832; LeGrice I, 2001, PHILOS T R SOC A, V359, P1217, DOI 10.1098/rsta.2001.0827; McQueen DM, 2000, COMPUT GRAPHICS-US, V34, P56, DOI 10.1145/563788.604453; Muzikant AL, 2002, CURR OPIN DRUG DISC, V5, P127; Nickerson DP, 2001, PHILOS T R SOC A, V359, P1159, DOI 10.1098/rsta.2001.0823; Noble D., 1999, Journal of Physiology (Cambridge), V518P, p2P; Noble D, 1999, DRUG DISCOV TODAY, V4, P10, DOI 10.1016/S1359-6446(98)01277-X; Noble D, 2001, PHILOS T ROY SOC A, V359, P1127, DOI 10.1098/rsta.2001.0820; Noble D, 2000, EMERGING THERAPEUTIC, V4, P39; NOBLE D, IN PRESS ANN NY ACAD; Nygren A, 2001, PHILOS T ROY SOC A, V359, P1111, DOI 10.1098/rsta.2001.0819; Panfilov A, 2001, PHILOS T R SOC A, V359, P1315, DOI 10.1098/rsta.2001.0833; Smith NP, 2001, PHILOS T R SOC A, V359, P1251, DOI 10.1098/rsta.2001.0829; Watanabe Y, 2000, BRIT J PHARMACOL, V131, P80, DOI 10.1038/sj.bjp.0703527; Winslow RL, 2001, PHILOS T R SOC A, V359, P1187, DOI 10.1098/rsta.2001.0825; Yan GX, 1998, CIRCULATION, V98, P1928, DOI 10.1161/01.CIR.98.18.1928	29	412	438	0	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2002	295	5560					1678	1682		10.1126/science.1069881	http://dx.doi.org/10.1126/science.1069881			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872832				2022-12-28	WOS:000174212900036
J	Ariens, RAS; de Lange, M; Snieder, H; Boothby, M; Spector, TD; Grant, PJ				Ariens, RAS; de Lange, M; Snieder, H; Boothby, M; Spector, TD; Grant, PJ			Activation markers of coagulation and fibrinolysis in twins: heritability of the prethrombotic state	LANCET			English	Article							ANTITHROMBIN-III COMPLEX; D-DIMER LEVELS; PLASMINOGEN-ACTIVATOR; GENETIC INFLUENCES; PLASMA-LEVELS; FRAGMENT; THROMBOSIS; DETERMINANTS; INHIBITOR-1; MECHANISM	Background Activation markers of coagulation and fibrinolysis are increased in individuals at risk of coronary-artery disease and other thrombotic disorders-a condition defined as the prethrombotic state. We aimed to find out the extent to which the prethrombotic state is determined by genetic factors. Methods We analysed concentrations of prothrombin, prothrombin fragment 1+2, thrombin-antithrombin complex, crosslinked fibrin degradation product D-dimer, and thrombin-activatable fibrinolysis inhibitor by ELISA in 118 monozygotic and 112 dizygotic unselected female twins aged 21-73 years from the St Thomas' UK Adult Twin Registry. We used quantitative genetic-model fitting to estimate heritability. Findings We found significant heritabilities in concentrations of the activation markers in plasma. Genetic factors contributed 45, 40, and 65% of the variation in concentrations of fragment 1+2, thrombin-antithrombin complex, and D-dimer, respectively. Age was important only in fragment 1+2 concentrations, in which it accounted for 12% of the variation. The remaining variation could be attributed to unique environmental factors. Variation in concentrations of precursor prothrombin in plasma was determined by 57% heritability, and that of zymogen thrombin-activatable fibrinolysis inhibitor showed a very strong genetic component (82%). Interpretation The activation mechanisms of the coagulation and fibrinolytic systems, and therefore the prethrombotic state, are controlled to a substantial degree by genetic factors. Genes influencing activation of haemostasis are likely to be an important component of the overall thrombotic tendency in the general population.	Univ Leeds, Sch Med, Acad Unit Mol Vasc Med, Leeds LS2 9JT, W Yorkshire, England; St Thomas Hosp, Twin Res & Genet Epidemiol Unit, London, England; Med Coll Georgia, Georgia Prevent Inst, Augusta, GA 30912 USA	University of Leeds; Guy's & St Thomas' NHS Foundation Trust; University System of Georgia; Augusta University	Ariens, RAS (corresponding author), Univ Leeds, Gen Infirm, Acad Unit Mol Vasc Med, G Floor,Martin Wing, Leeds LS1 3EX, W Yorkshire, England.		Spector, Tim D/F-6533-2012; Grant, Peter/HIR-3733-2022	Ariens, Robert/0000-0002-6310-5745				BAJZAR L, 1995, J BIOL CHEM, V270, P14477, DOI 10.1074/jbc.270.24.14477; Bajzar L, 2000, ARTERIOSCL THROM VAS, V20, P2511, DOI 10.1161/01.ATV.20.12.2511; BAUER KA, 1988, BLOOD, V71, P1418; BOUNAMEAUX H, 1991, LANCET, V337, P196, DOI 10.1016/0140-6736(91)92158-X; Cesari M, 1999, ARTERIOSCL THROM VAS, V19, P316, DOI 10.1161/01.ATV.19.2.316; Colman RW, 1999, THROMB HAEMOSTASIS, V82, P1568; de Lange M, 2001, LANCET, V357, P101, DOI 10.1016/S0140-6736(00)03541-8; DECLERCK PJ, 1987, THROMB HAEMOSTASIS, V58, P1024; DEVINE DV, 1986, BLOOD, V68, P317; Falconer D. S., 1989, Introduction to quantitative genetics.; Forman BM, 1996, ANN NY ACAD SCI, V804, P266, DOI 10.1111/j.1749-6632.1996.tb18621.x; FRIEDLANDER Y, 1995, AM J HUM GENET, V56, P1194; GULBA DC, 1988, LANCET, V2, P97; Hong YL, 1997, ARTERIOSCL THROM VAS, V17, P2776, DOI 10.1161/01.ATV.17.11.2776; Mackman N, 1997, THROMB HAEMOSTASIS, V78, P747; MERLINI PA, 1994, CIRCULATION, V90, P61, DOI 10.1161/01.CIR.90.1.61; Neale MC, 1992, METHODOLOGY GENETIC; ORSTAVIK KH, 1985, AM J HUM GENET, V37, P89; PELZER H, 1991, THROMB HAEMOSTASIS, V65, P153; PELZER H, 1988, THROMB HAEMOSTASIS, V59, P101; Rauch U, 2000, CURR OPIN HEMATOL, V7, P273, DOI 10.1097/00062752-200009000-00003; Snieder H, 1998, J CLIN ENDOCR METAB, V83, P1875, DOI 10.1210/jc.83.6.1875; SNIEDER H, 2000, ADV TWIN SIB PAIR AN, P119; Souto JC, 2000, CIRCULATION, V101, P1546, DOI 10.1161/01.CIR.101.13.1546; Souto JC, 2000, AM J HUM GENET, V67, P1452, DOI 10.1086/316903; Spector TD, 1996, BRIT MED J, V312, P940; Stewart RJ, 2000, J BIOL CHEM, V275, P36612, DOI 10.1074/jbc.M005483200; TEITEL JM, 1982, BLOOD, V59, P1086; VANDERPOLL T, 1990, NEW ENGL J MED, V322, P1622, DOI 10.1056/NEJM199006073222302	29	92	95	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 23	2002	359	9307					667	671		10.1016/S0140-6736(02)07813-3	http://dx.doi.org/10.1016/S0140-6736(02)07813-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526AZ	11879863				2022-12-28	WOS:000174107400011
J	Sheridan, E; Aitken, C; Jeffries, D; Hird, M; Thayalasekaran, P				Sheridan, E; Aitken, C; Jeffries, D; Hird, M; Thayalasekaran, P			Congenital rubella syndrome: a risk in immigrant populations	LANCET			English	Article								An infant with congenital rubella syndrome was born to a young mother who had recently arrived In the UK. The infection was not detected before birth, and transmission to another infant was documented. This case highlights the emerging importance of rubella as an imported Infection in the developed world and the need to maintain a high Index of suspicion for this disorder in recent immigrants from countries with no immunisation programme. Targeted immunisation for such groups is recommended.	Royal London Hosp, Dept Med Microbiol, London E1 1BB, England; Royal London Hosp, Directorate Womens & Childrens Hlth, London E1 1BB, England; St Bartholomews Hosp, Dept Virol, London, England; Wapping Hlth Ctr, London, England	Barts Health NHS Trust; Royal London Hospital; Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London	Sheridan, E (corresponding author), Royal London Hosp, Dept Med Microbiol, London E1 1BB, England.			Sheridan, Elizabeth/0000-0002-7804-3217				COOPER LZ, 1965, MMWR-MORBID MORTAL W, V14, P44; Cutts FT, 1999, INT J EPIDEMIOL, V28, P1176, DOI 10.1093/ije/28.6.1176; MILLER E, 1990, BRIT MED J, V301, P1391, DOI 10.1136/bmj.301.6765.1391; Miller E, 1997, Commun Dis Rep CDR Rev, V7, pR26; Plotkin SA, 2001, VACCINE, V19, P3311, DOI 10.1016/S0264-410X(01)00073-1	5	32	32	1	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 23	2002	359	9307					674	675		10.1016/S0140-6736(02)07805-4	http://dx.doi.org/10.1016/S0140-6736(02)07805-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526AZ	11879866				2022-12-28	WOS:000174107400014
J	Day, R				Day, R			Adverse reactions to TNF-alpha inhibitors in rheumatoid arthritis	LANCET			English	Editorial Material							CLINICAL-TRIALS; INFLIXIMAB; ETANERCEPT; EFFICACY; SAFETY		Univ New S Wales, St Vincents Hosp, Dept Clin Pharmacol & Toxicol, Sydney, NSW 2010, Australia; Univ New S Wales, Dept Clin Pharmacol, Sydney, NSW 2010, Australia	St Vincents Hospital Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Day, R (corresponding author), Univ New S Wales, St Vincents Hosp, Dept Clin Pharmacol & Toxicol, Sydney, NSW 2010, Australia.	r.day@unsw.edu.au	Day, Richard/D-8699-2011	Day, Richard/0000-0002-6045-6937				Arnason BGW, 1999, NEUROLOGY, V53, P457, DOI 10.1212/wnl.53.3.457; Doran MF, 2000, ARTHRITIS RHEUM, V43, pS167; Furst DE, 2002, ANN RHEUM DIS, V61, P2; Harriman G, 1999, ANN RHEUM DIS, V58, P61; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Klareskog L, 2001, ARTHRITIS RHEUM, V44, pS77; KOCHANEK K, 2001, US NATL VITAL STAT R, V49, P1; Lipani JA, 2001, J RHEUMATOL, V28, P1170; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Markham A, 2000, DRUGS, V59, P1341, DOI 10.2165/00003495-200059060-00010; Marotte H, 2001, LANCET, V358, P1784, DOI 10.1016/S0140-6736(01)06810-6; Moreland LW, 2001, J RHEUMATOL, V28, P1238; Silman A, 2000, ANN RHEUM DIS, V59, P419, DOI 10.1136/ard.59.6.419; Singh G, 1999, ARTHRITIS RHEUM, V42, pS242; vanOosten BW, 1996, NEUROLOGY, V47, P1531, DOI 10.1212/WNL.47.6.1531; Wallis WJ, 2001, ARTHRITIS RHEUM, V44, pS78; Woodworth TG, 2001, J RHEUMATOL, V28, P1163	17	100	106	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2002	359	9306					540	541		10.1016/S0140-6736(02)07718-8	http://dx.doi.org/10.1016/S0140-6736(02)07718-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523FP	11867103				2022-12-28	WOS:000173943600002
J	Monroe, C				Monroe, C			Quantum information processing with atoms and photons	NATURE			English	Review							CURRENT SITUATION; KEY DISTRIBUTION; GROUND-STATE; SINGLE ATOMS; CRYPTOGRAPHY; ENTANGLEMENT; TELEPORTATION; UNIVERSAL; LIGHT; GATES		Univ Michigan, FOCUS Ctr, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Monroe, C (corresponding author), Univ Michigan, FOCUS Ctr, Ann Arbor, MI 48109 USA.	crmonroe@umich.edu	Monroe, Christopher R/G-8105-2011					BENIOFF P, 1982, PHYS REV LETT, V48, P1581, DOI 10.1103/PhysRevLett.48.1581; BENIOFF P, 1980, J STAT PHYS, V22, P563, DOI 10.1007/BF01011339; BENNETT C, 1984, IEEE INT C COMP SYST, V11, P175; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; BENNETT CH, 1992, PHYS REV LETT, V68, P3121, DOI 10.1103/PhysRevLett.68.3121; Bennett CH, 1996, PHYS REV LETT, V76, P722, DOI 10.1103/PhysRevLett.76.722; Blatt R., 1988, European Journal of Physics, V9, P250, DOI 10.1088/0143-0807/9/4/002; Boschi D, 1998, PHYS REV LETT, V80, P1121, DOI 10.1103/PhysRevLett.80.1121; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; Bouwmeester D, 1998, NATURE, V394, P841, DOI 10.1038/29678; Braunstein SI, 1998, NATURE, V394, P840, DOI 10.1038/29674; Braunstein SL, 2000, PHYS REV LETT, V84, P3486, DOI 10.1103/PhysRevLett.84.3486; BRAUNSTEIN SL, 1995, FUN TALK TELEPORATIO; Brennen GK, 1999, PHYS REV LETT, V82, P1060, DOI 10.1103/PhysRevLett.82.1060; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Budker D, 1999, PHYS REV LETT, V83, P1767, DOI 10.1103/PhysRevLett.83.1767; CIRAC JI, 1995, PHYS REV LETT, V74, P4091, DOI 10.1103/PhysRevLett.74.4091; Cirac JI, 1997, PHYS REV LETT, V78, P3221, DOI 10.1103/PhysRevLett.78.3221; Cirac JI, 2000, NATURE, V404, P579, DOI 10.1038/35007021; DEMILLE D, 2001, QUANTPH0109083; DEUTSCH D, 1985, P ROY SOC LOND A MAT, V400, P97, DOI 10.1098/rspa.1985.0070; DiVincenzo DP, 2000, FORTSCHR PHYS, V48, P771, DOI 10.1002/1521-3978(200009)48:9/11<771::AID-PROP771>3.0.CO;2-E; DIVINCENZO DP, 1995, PHYS REV A, V51, P1015, DOI 10.1103/PhysRevA.51.1015; Doherty AC, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.013401; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; EKERT AK, 1991, PHYS REV LETT, V67, P661, DOI 10.1103/PhysRevLett.67.661; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; FEYNMAN RP, 1960, ENG SCI          FEB; Fleischhauer M, 2000, PHYS REV LETT, V84, P5094, DOI 10.1103/PhysRevLett.84.5094; FRANSON JD, 1994, APPL OPTICS, V33, P2949, DOI 10.1364/AO.33.002949; Furusawa A, 1998, SCIENCE, V282, P706, DOI 10.1126/science.282.5389.706; Grover LK, 1997, PHYS REV LETT, V79, P325, DOI 10.1103/PhysRevLett.79.325; Guthohrlein GR, 2001, NATURE, V414, P49, DOI 10.1038/35102129; Hald J, 1999, PHYS REV LETT, V83, P1319, DOI 10.1103/PhysRevLett.83.1319; Hamann SE, 1998, PHYS REV LETT, V80, P4149, DOI 10.1103/PhysRevLett.80.4149; Haycock DL, 2000, PHYS REV LETT, V85, P3365, DOI 10.1103/PhysRevLett.85.3365; Hood CJ, 2000, SCIENCE, V287, P1447, DOI 10.1126/science.287.5457.1447; Hughes RJ, 2000, J MOD OPTIC, V47, P533, DOI 10.1080/095003400148367; Jaksch D, 1999, PHYS REV LETT, V82, P1975, DOI 10.1103/PhysRevLett.82.1975; Jaksch D, 2000, PHYS REV LETT, V85, P2208, DOI 10.1103/PhysRevLett.85.2208; Jennewein T, 2000, PHYS REV LETT, V84, P4729, DOI 10.1103/PhysRevLett.84.4729; Jessen PS, 1996, ADV ATOM MOL OPT PHY, V37, P95; Jozsa R, 1998, GEOMETRIC UNIVERSE, P369; JOZSA R, 1997, QUANTPH9707034; Julsgaard B, 2001, NATURE, V413, P400, DOI 10.1038/35096524; Kahn David, 1967, CODEBREAKERS STORY S; Kielpinski D, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.032310; Kuzmich A, 2000, PHYS REV LETT, V85, P1594, DOI 10.1103/PhysRevLett.85.1594; Kwiat PG, 1999, PHYS REV A, V60, pR773, DOI 10.1103/PhysRevA.60.R773; LANDAUER R, 1997, P DREX 4 S QUANT NON, P44; LARSON DJ, 1986, PHYS REV LETT, V57, P70, DOI 10.1103/PhysRevLett.57.70; Law CK, 1997, J MOD OPTIC, V44, P2067, DOI 10.1080/095003497152357; Liu C, 2001, NATURE, V409, P490, DOI 10.1038/35054017; LLOYD S, 1995, PHYS REV LETT, V75, P346, DOI 10.1103/PhysRevLett.75.346; Lukin MD, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.037901; Lukin MD, 2001, NATURE, V413, P273, DOI 10.1038/35095000; MAIR A, 2001, QUANTPH0108046; MARAND C, 1995, OPT LETT, V20, P1695, DOI 10.1364/OL.20.001695; Monroe C, 1996, SCIENCE, V272, P1131, DOI 10.1126/science.272.5265.1131; Morigi G, 2001, EUR PHYS J D, V13, P261, DOI 10.1007/s100530170275; Muller A, 1996, EUROPHYS LETT, V33, P335, DOI 10.1209/epl/i1996-00343-4; Naik DS, 2000, PHYS REV LETT, V84, P4733, DOI 10.1103/PhysRevLett.84.4733; Orzel C, 2001, SCIENCE, V291, P2386, DOI 10.1126/science.1058149; Perrin H, 1998, EUROPHYS LETT, V42, P395, DOI 10.1209/epl/i1998-00261-y; Phillips DF, 2001, PHYS REV LETT, V86, P783, DOI 10.1103/PhysRevLett.86.783; Pinkse PWH, 2000, NATURE, V404, P365, DOI 10.1038/35006006; Preskill J, 1999, PHYS TODAY, V52, P24, DOI 10.1063/1.882692; Raithel G, 1998, PHYS REV LETT, V81, P3615, DOI 10.1103/PhysRevLett.81.3615; RIVEST RL, 1978, COMMUN ACM, V21, P120, DOI [10.1145/359340.359342, 10.1145/357980.358017]; Sackett CA, 2000, NATURE, V404, P256, DOI 10.1038/35005011; Schrodinger E, 1935, NATURWISSENSCHAFTEN, V23, P807, DOI 10.1007/BF01491891; Schroedinger E., 1935, NATURWISSENSCHAFTEN, V23, P823, DOI [DOI 10.1007/BF01491914, 10.1007/BF01491914]; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; SHOR PW, 1995, PHYS REV A, V52, pR2493, DOI 10.1103/PhysRevA.52.R2493; Shor PW, 1997, SIAM J COMPUT, V26, P1484, DOI [10.1137/S0097539795293172, 10.1137/S0036144598347011]; Spekkens RW, 1999, PHYS REV A, V59, P3868, DOI 10.1103/PhysRevA.59.3868; Steane A, 1997, APPL PHYS B-LASERS O, V64, P623, DOI 10.1007/s003400050225; Steane AM, 1996, PHYS REV LETT, V77, P793, DOI 10.1103/PhysRevLett.77.793; Tittel W, 2000, PHYS REV LETT, V84, P4737, DOI 10.1103/PhysRevLett.84.4737; Turchette QA, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.063418; vanEnk SJ, 1997, PHYS REV LETT, V78, P4293, DOI 10.1103/PhysRevLett.78.4293; Vuletic V, 1998, PHYS REV LETT, V81, P5768, DOI 10.1103/PhysRevLett.81.5768; Wolf FA, 1981, TAKING QUANTUM LEAP; Ye J, 1999, PHYS REV LETT, V83, P4987, DOI 10.1103/PhysRevLett.83.4987; 2000, FORTSCHR PHYS, V48	94	432	446	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2002	416	6877					238	246		10.1038/416238a	http://dx.doi.org/10.1038/416238a			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894108	Green Published			2022-12-28	WOS:000174348100051
J	Schneider, EC; Zaslavsky, AM; Epstein, AM				Schneider, EC; Zaslavsky, AM; Epstein, AM			Racial disparities in the quality of care for enrollees in medicare managed care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH-CARE; AFRICAN-AMERICANS; BREAST-CANCER; RACE; PHYSICIANS; RETINOPATHY; INCENTIVES; INSURANCE; SERVICES; ACCESS	Context Substantial racial disparities in the use of some health services exist; however, much less is known about racial disparities in the quality of care. Objective To assess racial disparities in the quality of care for enrollees in Medicare managed care health plans. Design and Setting Observational study, using the 1998 Health Plan Employer Data and Information Set (HEDIS), which summarized performance in calendar year 1997 for 4 measures of quality of care (breast cancer screening, eye examinations for patients with diabetes, beta-blocker use after myocardial infarction, and follow-up after hospitalization for mental illness). Participants A total of 305574 (7.7%) beneficiaries who were enrolled in Medicare managed care health plans had data for at least 1 of the 4 HEDIS measures and were aged 65 years or older. Main Outcome Measures Rates of breast cancer screening, eye examinations for patients with diabetes, beta-blocker use after myocardial infarction, and follow-up after hospitalization for mental illness. Results Blacks were less likely than whites to receive breast cancer screening (62.9% vs 70.9%; P<.001), eye examinations for patients with diabetes (43.6% vs 50.4%; P=.02), beta-blocker medication after myocardial infarction (64.1% vs 73.8%; P<.005), and follow-up after hospitalization for mental illness (33.2 vs 54.0%; P<.001). After adjustment for potential confounding factors, racial disparities were still statistically significant for eye examinations for patients with diabetes, beta-blocker use after myocardial infarction, and follow-up after hospitalization for mental illness. Conclusion Among Medicare beneficiaries enrolled in managed care health plans, blacks received poorer quality of care than whites.	Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Gen Med, Sect Hlth Policy, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Schneider, EC (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	eschneid@hsph.harvard.edu		Schneider, Eric/0000-0002-1132-5084	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [P01HS010803] Funding Source: NIH RePORTER; AHRQ HHS [P01HS10803] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		AYANIAN JZ, 1993, JAMA-J AM MED ASSOC, V269, P2642, DOI 10.1001/jama.269.20.2642; AYANIAN JZ, 1993, NEW ENGL J MED, V329, P326, DOI 10.1056/NEJM199307293290507; BINDMAN A, 1998, SPECIAL SUPPLEMENT H, P611; Bindman AB, 1998, JAMA-J AM MED ASSOC, V279, P675, DOI 10.1001/jama.279.9.675; BLUMENTHAL D, 1995, HEALTH SERV RES, V30, P253; DAVIS K, 1994, HEALTH AFFAIR, V13, P178, DOI 10.1377/hlthaff.13.4.178; Diette GB, 1999, ARCH INTERN MED, V159, P2697, DOI 10.1001/archinte.159.22.2697; Epstein AM, 1998, JAMA-J AM MED ASSOC, V279, P1691, DOI 10.1001/jama.279.21.1691; Fink R, 1998, HEALTH SERV RES, V33, P741; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; Gornick ME, 1996, NEW ENGL J MED, V335, P791, DOI 10.1056/NEJM199609123351106; Grumbach K, 1999, HEALTH SERV RES, V34, P485; Grumbach K, 1998, NEW ENGL J MED, V339, P1516, DOI 10.1056/NEJM199811193392106; *HLTH CAR FIN ADM, 1998, 301998 HEDIS HLTH CA; *HLTH CAR FIN ADM, 2001, MED MAN CAR CONTR MM; HUNTER CP, 1993, J NATL CANCER I, V85, P1129, DOI 10.1093/jnci/85.14.1129; JAVITT JC, 1991, OPHTHALMOLOGY, V98, P1565; Jencks SF, 2000, JAMA-J AM MED ASSOC, V284, P1670, DOI 10.1001/jama.284.13.1670; Komaromy M, 1996, NEW ENGL J MED, V334, P1305, DOI 10.1056/NEJM199605163342006; Miller B, 1997, J GERONTOL B-PSYCHOL, V52, pS325, DOI 10.1093/geronb/52B.6.S325; Miller RH, 1998, HEALTH SERV RES, V33, P653; MOY E, 1995, JAMA-J AM MED ASSOC, V273, P1515, DOI 10.1001/jama.273.19.1515; Phillips KA, 2000, HEALTH AFFAIR, V19, P102, DOI 10.1377/hlthaff.19.1.102; *PRES ADV COMM CON, 1998, QUAL FIRST BETT HLTH; *RES TRIANGL I, 2001, SUDAAN VERS 7 5; Roetzheim RG, 1999, J NATL CANCER I, V91, P1409, DOI 10.1093/jnci/91.16.1409; Schneider EC, 2001, JAMA-J AM MED ASSOC, V286, P1455, DOI 10.1001/jama.286.12.1455; SCHOEN C, 1998, FINDINGS KAISER COMM, P1; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Schulman KA, 1999, NEW ENGL J MED, V340, P1130; Schuster MA, 1998, MILBANK Q, V76, P517, DOI 10.1111/1468-0009.00105; *STAT CORP, 1999, STATA VERS 6; Walker EA, 1997, J DIABETES COMPLICAT, V11, P298, DOI 10.1016/S1056-8727(96)00121-3; Williams RL, 2001, MED CARE, V39, P1260, DOI 10.1097/00005650-200111000-00012; Wood D, 1998, JAMA-J AM MED ASSOC, V279, P29, DOI 10.1001/jama.279.1.29; Yood MU, 1999, J NATL CANCER I, V91, P1487, DOI 10.1093/jnci/91.17.1487; Zaslavsky AM, 2000, MED CARE, V38, P981, DOI 10.1097/00005650-200010000-00002; 1998, COMPETITIVE EDGE DAT	38	408	408	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2002	287	10					1288	1294		10.1001/jama.287.10.1288	http://dx.doi.org/10.1001/jama.287.10.1288			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529YU	11886320				2022-12-28	WOS:000174329500027
J	Goodacre, S; Irons, R				Goodacre, S; Irons, R			ABC of clinical electrocardiography - Atrial arrhythmias	BRITISH MEDICAL JOURNAL			English	Review									No Gen Hosp, Dept Accid & Emergency, Sheffield S5 7AU, S Yorkshire, England; Prince Wales Hosp, Bridgend, Wales	Northern General Hospital	Goodacre, S (corresponding author), No Gen Hosp, Dept Accid & Emergency, Sheffield S5 7AU, S Yorkshire, England.			Goodacre, Steve/0000-0003-0803-8444					0	21	21	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 9	2002	324	7337					594	597		10.1136/bmj.324.7337.594	http://dx.doi.org/10.1136/bmj.324.7337.594			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	530XJ	11884328	Green Published			2022-12-28	WOS:000174384000027
J	Anand, P				Anand, P			Public health - Decision-making when science is ambiguous	SCIENCE			English	Editorial Material									Open Univ, Dept Econ, Milton Keynes MK7 6AA, Bucks, England	Open University - UK	Anand, P (corresponding author), Open Univ, Dept Econ, Milton Keynes MK7 6AA, Bucks, England.			Anand, Paul/0000-0002-7701-6903				Anand P., 1993, ANAND; ELLSBERG D, 1961, Q J ECON, V75, P643, DOI 10.2307/1884324; Levi Isaac, 2000, RISK DECISION POLICY, V5, P111; LUCE RD, 1972, GAMES DECISIONS INTR	4	18	19	2	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1839	1839		10.1126/science.1061744	http://dx.doi.org/10.1126/science.1061744			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	529KW	11884737				2022-12-28	WOS:000174299500019
J	Becchetti, FD				Becchetti, FD			Evidence for nuclear reactions in imploding bubbles	SCIENCE			English	Editorial Material									Univ Michigan, Dept Phys, Randall Lab, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Becchetti, FD (corresponding author), Univ Michigan, Dept Phys, Randall Lab, Ann Arbor, MI 48109 USA.	fdb@umich.edu						CHOWN M, 2001, MAGIC FURNACE; Hampel W, 1999, PHYS LETT B, V447, P127, DOI 10.1016/S0370-2693(98)01579-2; Metcalf H, 1998, SCIENCE, V279, P1322, DOI 10.1126/science.279.5355.1322; Nemoto K, 2001, APPL PHYS LETT, V78, P595, DOI 10.1063/1.1343845; ROBERTS DA, 1990, PHYS REV C, V42, pR1809, DOI 10.1103/PhysRevC.42.R1809; Rolfs C. E., 1988, CAULDRONS COSMOS; Taleyarkhan RP, 2002, SCIENCE, V295, P1868, DOI 10.1126/science.1067589; Thomas JL, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.074302	8	3	4	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2002	295	5561					1850	1850		10.1126/science.1070165	http://dx.doi.org/10.1126/science.1070165			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884743				2022-12-28	WOS:000174299500026
J	Tenson, T; Ehrenberg, M				Tenson, T; Ehrenberg, M			Regulatory nascent peptides in the ribosomal tunnel	CELL			English	Review							POLYPEPTIDE-CHAIN; STRUCTURAL BASIS; PROTEIN; RESISTANCE; MECHANISM	Accumulating evidence for nascent-peptide-mediated regulation of translation suggests that all nascent peptides do not necessarily interact with the ribosome In a similar manner. Recent studies have helped to elucidate the exit route of the nascent chain and its interactions with the ribosome.	Univ Tartu, Inst Mol & Cell Biol, Tartu, Estonia; Uppsala Univ, BMC, ICM, S-75124 Uppsala, Sweden	University of Tartu; Uppsala University	Tenson, T (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Riia 23, Tartu, Estonia.	ttenson@ebc.ee; ehrenberg@xray.bmc.uu.se	Tenson, Tanel/I-6431-2015	Tenson, Tanel/0000-0002-0260-3601				Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Choi KM, 1998, EUR J BIOCHEM, V255, P409, DOI 10.1046/j.1432-1327.1998.2550409.x; Clark PL, 2001, J BIOL CHEM, V276, P25411, DOI 10.1074/jbc.M008490200; Gabashvili IS, 2001, MOL CELL, V8, P181, DOI 10.1016/S1097-2765(01)00293-3; Hardesty B, 2001, PROG NUCLEIC ACID RE, V66, P41; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Komar AA, 1997, J BIOL CHEM, V272, P10646; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; Lovett PS, 1996, MICROBIOL REV, V60, P366, DOI 10.1128/MMBR.60.2.366-385.1996; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Potter MD, 2001, TRENDS CELL BIOL, V11, P112, DOI 10.1016/S0962-8924(00)01905-X; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Richardson J. P., 1996, ESCHERICHIA COLI SAL, P822; Tenson T, 2001, PEPTIDES, V22, P1661, DOI 10.1016/S0196-9781(01)00501-0; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117	20	188	194	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 8	2002	108	5					591	594		10.1016/S0092-8674(02)00669-4	http://dx.doi.org/10.1016/S0092-8674(02)00669-4			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	529TN	11893330	Bronze			2022-12-28	WOS:000174314800003
J	Aboulker, JP; Babiker, A; Campagnucci, A; Darbyshire, JH; Debre, M; Giaquinto, C; Gibb, DM; Harper, L; Saidi, Y; Walker, AS				Aboulker, JP; Babiker, A; Campagnucci, A; Darbyshire, JH; Debre, M; Giaquinto, C; Gibb, DM; Harper, L; Saidi, Y; Walker, AS		PENTA	Comparison of dual nucleoside-analogue reverse-transcriptase inhibitor regimens with and without nelfinavir in children with HIV-1 who have not previously been treated: the PENTA 5 randomised trial	LANCET			English	Article							ANTIRETROVIRAL THERAPY; INFECTED CHILDREN; COMBINATION; RESISTANCE; RITONAVIR	Introduction Treatment options for children with HIV-1 are limited. We aimed to compare activity and safety of three dual-nucleoside analogue reverse-transcriptase inhibitor (NRTI) regimens with or without a protease inhibitor in previously untreated children with HIV-1. Methods In our multicentre trial, we randomly assigned 36 children to zidovudine and lamivudine, 45 to zidovudine and abacavir, and 47 to lamivudine and abacavir. Children who were symptomfree (n=55) were also randomly assigned to receive nelfinavir or placebo. Children with more advanced disease received open-label nelfinavir (73). Primary endpoints were change in plasma HIV-1 RNA at 24 and 48 weeks for the NRTI comparison and occurrence of serious adverse events for both randomised comparisons. Analyses were by intention to treat. Findings Children had a median CD4 percentage of 22% (IQR 15-29) and a mean HIV-1 RNA concentration of 5.0 log copies/mL (SD 0.8). One child was lost to follow-up and one died of sepsis. At 48 weeks, in the zidovudine/lamivudine, zidovudine/abacavir, and lamivudine/abacavir groups, mean HIV-1 RNA had decreased by 1.71, 2.19, and 2.63 log copies/mL, respectively (estimated in absence of nelfinavir) (P=0.02 after adjustment for baseline factors). One child had a hypersensitivity reaction to abacavir; and three with possible reactions stopped abacavir. There were 24 serious adverse events-six in the symptom-free children (all on nelfinavir), but none were attributed to nelfinavir. Interpretation Regimens containing abacavir were more effective than zidovudine/lamivudine. Such regimens could be combined with protease inhibitors and non-nucleoside reverse transcriptase inhibitors for safe and effective treatment of previously untreated children with HIV-1.	MRC, Clin Trials Unit, HIV Div, London NW1 2DA, England; Glaxo SmithKline, Stevenage, Herts, England	Medical Research Council Clinical Trials Unit; GlaxoSmithKline	Gibb, DM (corresponding author), MRC, Clin Trials Unit, HIV Div, London NW1 2DA, England.	D.Gibb@ctu.mrc.ac.uk	Canani, Roberto Berni/AAC-4810-2022; Giaquinto, Carlo/AAB-5016-2020	Canani, Roberto Berni/0000-0002-5169-9574; Marcelino, Rute/0000-0002-4535-9725; Guarino, Alfredo/0000-0003-0199-0336				Aboulker JP, 1998, AIDS, V12, pF151; AMEMIYA T, 1973, ECONOMETRICA, V41, P997, DOI 10.2307/1914031; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; [Anonymous], 1994, Morbidity and Mortality Weekly Report, V43, P1; BURGER DM, 2000, AIDS S4, V14, pP258; Carpenter CCJ, 1997, JAMA-J AM MED ASSOC, V277, P1962, DOI 10.1001/jama.277.24.1962; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Harindra V, 1997, LANCET, V349, P1838, DOI 10.1016/S0140-6736(05)61720-5; Hughes W, 1999, ANTIMICROB AGENTS CH, V43, P609, DOI 10.1128/AAC.43.3.609; Katlama C, 2000, AIDS, V14, P781, DOI 10.1097/00002030-200005050-00003; KAYE S, 2000, AIDS S, V14, P354; Kline MW, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.4.e47; Krogstad P, 1999, CLIN INFECT DIS, V28, P1109, DOI 10.1086/514759; Litalien C., 2000, 13 INT AIDS C; Miller V, 1998, AIDS, V12, P705, DOI 10.1097/00002030-199807000-00006; Nachman SA, 2000, JAMA-J AM MED ASSOC, V283, P492, DOI 10.1001/jama.283.4.492; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Saag MS, 1998, AIDS, V12, pF203, DOI 10.1097/00002030-199816000-00002; SAEZLLORENS, 2001, PEDIATRICS, V107, P125; SAEZLLORENS X, 2001, 8 C RETR OPP INF CHI; Sharland M, 2000, EUR J PEDIATR, V159, P649, DOI 10.1007/PL00008400; Starr SE, 1999, NEW ENGL J MED, V341, P1874, DOI 10.1056/NEJM199912163412502; Tisdale M, 1997, ANTIMICROB AGENTS CH, V41, P1094, DOI 10.1128/AAC.41.5.1094; WADE AM, 1994, STAT MED, V13, P2359, DOI 10.1002/sim.4780132207; Watson DC, 1999, PEDIATR INFECT DIS J, V18, P682, DOI 10.1097/00006454-199908000-00006; Wiznia A, 2000, AIDS RES HUM RETROV, V16, P1113, DOI 10.1089/088922200414956; YOULE M, 2000, AIDS S, V14	27	85	87	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 2	2002	359	9308					733	740						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526DZ	11888583				2022-12-28	WOS:000174115200007
J	Sackett, DL; Haynes, RB				Sackett, DL; Haynes, RB			Evidence base of clinical diagnosis - The architecture of diagnostic research	BRITISH MEDICAL JOURNAL			English	Article							VENTRICULAR SYSTOLIC DYSFUNCTION; HEART-FAILURE		Trout Res & Educ Ctr Irish Lake, Markdale, ON N0C 1H0, Canada; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada	McMaster University	Sackett, DL (corresponding author), Trout Res & Educ Ctr Irish Lake, RR1, Markdale, ON N0C 1H0, Canada.			Haynes, Robert Brian/0000-0002-1453-3196				Hobbs R, 2000, BMJ-BRIT MED J, V321, P188, DOI 10.1136/bmj.321.7255.188; Landray MJ, 2000, BRIT MED J, V320, P985, DOI 10.1136/bmj.320.7240.985; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, P83; SACKETT DL, 2000, EVIDENCE BASED MED P, P82; Selvais PL, 1998, EUR J CLIN INVEST, V28, P636; Talwar S, 2000, HEART, V83, P278, DOI 10.1136/heart.83.3.278; Wells PS, 1998, J INTERN MED, V243, P15	7	470	481	1	26	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 2	2002	324	7336					539	541		10.1136/bmj.324.7336.539	http://dx.doi.org/10.1136/bmj.324.7336.539			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	528DT	11872558	Green Published			2022-12-28	WOS:000174229700025
J	Miller, FD; Kaplan, DR				Miller, FD; Kaplan, DR			TRK makes the retrograde	SCIENCE			English	Editorial Material							SYMPATHETIC NEURONS; GROWTH; SIGNAL		McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ H3A 2B4, Canada; McGill Univ, Montreal Neurol Inst, Brain Tumor Res Ctr, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University	Miller, FD (corresponding author), McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, 3801 Rue Univ, Montreal, PQ H3A 2B4, Canada.	freda.mitler@mcgill.ca; david.kaptan@mcgill.ca						Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; MacInnis BL, 2002, SCIENCE, V295, P1536, DOI 10.1126/science.1064913; McPherson PS, 2001, TRAFFIC, V2, P375, DOI 10.1034/j.1600-0854.2001.002006375.x; Miller FD, 2001, NEURON, V32, P767, DOI 10.1016/S0896-6273(01)00529-3; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Senger DL, 1997, J CELL BIOL, V138, P411, DOI 10.1083/jcb.138.2.411; Verveer PJ, 2000, SCIENCE, V290, P1567, DOI 10.1126/science.290.5496.1567; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720	10	39	43	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2002	295	5559					1471	+		10.1126/science.1069897	http://dx.doi.org/10.1126/science.1069897			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11859179				2022-12-28	WOS:000173981300035
J	Misra, S; Puertollano, R; Kato, Y; Bonifacino, JS; Hurley, JH				Misra, S; Puertollano, R; Kato, Y; Bonifacino, JS; Hurley, JH			Structural basis for acidic-cluster-dileucine sorting-signal recognition by VHS domains	NATURE			English	Article							FACTOR-II RECEPTOR; GAMMA-ADAPTIN; CYTOPLASMIC TAIL; PROTEINS; FAMILY; BINDING; TRAFFICKING; TRANSPORT; GGA2	Specific sorting signals direct transmembrane proteins to the compartments of the endosomal-lysosomal system(1). Acidic-cluster-dileucine signals present within the cytoplasmic tails of sorting receptors, such as the cation-independent and cation-dependent mannose-6-phosphate receptors, are recognized by the GGA (Golgi-localized, gamma-ear-containing, ADP-ribosylation-factor-binding) proteins(2-5). The VHS (Vps27p, Hrs and STAM) domains(6) of the GGA proteins are responsible for the highly specific recognition of these acidic-cluster-dileucine signals(7-10). Here we report the structures of the VHS domain of human GGA3 complexed with signals from both mannose-6-phosphate receptors. The signals bind in an extended conformation to helices 6 and 8 of the VHS domain. The structures highlight an Asp residue separated by two residues from a dileucine sequence as critical recognition elements. The side chains of the Asp-X-X-Leu-Leu sequence interact with subsites consisting of one electropositive and two shallow hydrophobic pockets, respectively. The rigid spatial alignment of the three binding subsites leads to high specificity.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Hurley, JH (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	jh8e@nih.gov	KATO, Yukio/D-8396-2015	Bonifacino, Juan S./0000-0002-5673-6370; Misra, Saurav/0000-0002-1385-8554	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001607] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036118] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Boman AL, 2000, MOL BIOL CELL, V11, P1241, DOI 10.1091/mbc.11.4.1241; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen HJ, 1997, J BIOL CHEM, V272, P7003, DOI 10.1074/jbc.272.11.7003; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; JOHNSON KF, 1992, J CELL BIOL, V119, P249, DOI 10.1083/jcb.119.2.249; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Lohi O, 1998, FEBS LETT, V440, P255, DOI 10.1016/S0014-5793(98)01401-X; Mao YX, 2000, CELL, V100, P447, DOI 10.1016/S0092-8674(00)80680-7; MERESSE S, 1993, J CELL BIOL, V120, P67, DOI 10.1083/jcb.120.1.67; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Misra S, 2000, BIOCHEMISTRY-US, V39, P11282, DOI 10.1021/bi0013546; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Poussu A, 2000, J BIOL CHEM, V275, P7176, DOI 10.1074/jbc.275.10.7176; Puertollano R, 2001, SCIENCE, V292, P1712, DOI 10.1126/science.1060750; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Takatsu H, 2001, J BIOL CHEM, V276, P28541, DOI 10.1074/jbc.C100218200; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Zhu YX, 2001, SCIENCE, V292, P1716, DOI 10.1126/science.1060896	26	141	143	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2002	415	6874					933	937		10.1038/415933a	http://dx.doi.org/10.1038/415933a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859375				2022-12-28	WOS:000173941000051
J	Goodare, H				Goodare, H			Commentary: Of course patients should be told	BRITISH MEDICAL JOURNAL			English	Editorial Material											Goodare, H (corresponding author), 1 Heron Way, Horsham RH13 6DF, W Sussex, England.							BAGENAL FS, 1990, LANCET, V336, P606; BYDDER S, 2000, BRIT MED J, V321, P1530; Goodare H, 1996, FIGHTING SPIRIT STOR; TOBIAS J, 1995, CANC WHAT EVERY PATI, P63	4	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2002	324	7334					420	421						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524HC	11855387				2022-12-28	WOS:000174006300027
J	Brennan, T; Blank, L; Cohen, J; Kimball, H; Smelser, N; Copeland, R; Lavizzo-Mourey, R; McDonald, W; Brenning, G; Davidson, C; Jaeger, P; Malliani, A; Muller, H; Sereni, D; Sutorius, E; Cruess, R; Cruess, S; Merino, J; Hernandez, M				Brennan, T; Blank, L; Cohen, J; Kimball, H; Smelser, N; Copeland, R; Lavizzo-Mourey, R; McDonald, W; Brenning, G; Davidson, C; Jaeger, P; Malliani, A; Muller, H; Sereni, D; Sutorius, E; Cruess, R; Cruess, S; Merino, J; Hernandez, M		Med Professionalism Project	Medical professionalism in the new millennium: a physicians' charter	LANCET			English	Article									ABIM Fdn, Philadelphia, PA 19106 USA; Brigham & Womens Hosp, Boston, MA USA; Assoc Amer Med Coll, Washington, DC USA; Amer Board Internal Med, Philadelphia, PA USA; Univ Calif Berkeley, Berkeley, CA 94720 USA; So Cardiopulm Associates, La Grange, GA USA; Robert Wood Johnson Fdn, Princeton, NJ 08540 USA; Amer Soc Internal Med, Amer Coll Phys, Philadelphia, PA USA	American Board of Internal Medicine; Harvard University; Brigham & Women's Hospital; Association of American Medical Colleges; American Board of Internal Medicine; University of California System; University of California Berkeley; Robert Wood Johnson Foundation (RWJF); American College of Physicians	Blank, L (corresponding author), ABIM Fdn, 510 Walnut St,Suite 1700, Philadelphia, PA 19106 USA.								0	308	324	3	34	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 9	2002	359	9305					520	522		10.1016/s0140-6736(02)07684-5	http://dx.doi.org/10.1016/s0140-6736(02)07684-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520ML	11853819	Green Published			2022-12-28	WOS:000173785600034
J	Macfarlane, R; Hart, J; Henry, JA				Macfarlane, R; Hart, J; Henry, JA			A man with a massive uvula	LANCET			English	Editorial Material							COCAINE		St Marys Hosp, Imperial Coll Sch Med, Acad Dept Accid & Emergency Med, London W2 1NY, England	Imperial College London	Henry, JA (corresponding author), St Marys Hosp, Imperial Coll Sch Med, Acad Dept Accid & Emergency Med, Praed St, London W2 1NY, England.			Macfarlane, Rebecca/0000-0003-1121-4808				BEZMALINOVIC Z, 1988, NEW ENGL J MED, V319, P1420; GINSBERG GG, 1993, GASTROINTEST ENDOSC, V39, P838, DOI 10.1016/S0016-5107(93)70283-7; Mayo-Smith Michael F., 1997, Journal of Emergency Medicine, V15, P483, DOI 10.1016/S0736-4679(97)00077-2; MELECA RJ, 1997, LARYNGOSCOPE, V107, P260; TAYLOR RF, 1989, CHEST, V95, P476, DOI 10.1378/chest.95.2.476	5	4	4	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 9	2002	359	9305					492	492		10.1016/S0140-6736(02)07680-8	http://dx.doi.org/10.1016/S0140-6736(02)07680-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520ML	11853796				2022-12-28	WOS:000173785600013
J	Yoo, JY; Huso, DL; Nathans, D; Desiderio, S				Yoo, JY; Huso, DL; Nathans, D; Desiderio, S			Specific ablation of Stat3 beta distorts the pattern of Stat3-responsive gene expression and impairs recovery from endotoxic shock	CELL			English	Article							ACUTE-PHASE RESPONSE; ACTIVATING POLYPEPTIDE-II; EPIDERMAL-GROWTH-FACTOR; SIGNALING PATHWAY; FACTOR RECEPTOR; C-JUN; TRANSCRIPTION; MICE; CELLS; MECHANISMS	Alternative splicing of the gene for Stat3, a transcription factor activated by the IL-6 family of cytokines, produces two isoforms: Stat3alpha and a dominant-negative variant, Stat3beta. Stat3beta-deficient mice were generated by gene targeting. Despite intact expression and phosphorylation of Stat3alpha, overall Stat3 activity was impaired in Stat3beta(-/-) cells. Global comparison of transcription in Stat3beta(+/+) and Stat3beta(-/-) cells revealed stable differences. Stat3beta-deficient mice exhibit diminished recovery from endotoxic shock and hyper-responsiveness of a subset of endotoxin-inducible genes in liver. The hepatic response to endotoxin in wild-type mice is accompanied by a transient increase in the ratio of Stat3beta to Stat3alpha. These findings indicate a critical role for Stat3beta in the control of systemic inflammation.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Div Comparat Med, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University	Desiderio, S (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	sdesider@jhmi.edu						AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Alonzi T, 2001, MOL CELL BIOL, V21, P1621, DOI 10.1128/MCB.21.5.1621-1632.2001; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Barasch J, 1999, CELL, V99, P377, DOI 10.1016/S0092-8674(00)81524-X; Besser D, 1999, MOL CELL BIOL, V19, P1401; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Brett D, 2000, FEBS LETT, V474, P83, DOI 10.1016/S0014-5793(00)01581-7; Caldenhoven E, 1996, J BIOL CHEM, V271, P13221, DOI 10.1074/jbc.271.22.13221; Chapman RS, 1999, GENE DEV, V13, P2604, DOI 10.1101/gad.13.19.2604; Cotran R. S., 1999, PATHOLOGIC BASIS DIS; Fernandez-Cobo M, 1998, SHOCK, V10, P97, DOI 10.1097/00024382-199808000-00003; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Hauser PJ, 1998, CELL GROWTH DIFFER, V9, P847; Hillis GS, 1997, J PATHOL, V182, P373; Hogan B, 1994, MANIPULATING MOUSE E; Hsiao EC, 2000, MOL CELL BIOL, V20, P3742, DOI 10.1128/MCB.20.10.3742-3751.2000; Ihle James, 1998, V865, P1; Ivanov VN, 2001, MOL CELL, V7, P517, DOI 10.1016/S1097-2765(01)00199-X; KAO J, 1992, J BIOL CHEM, V267, P20239; KAO J, 1994, J BIOL CHEM, V269, P9774; Karima R, 1999, MOL MED TODAY, V5, P123, DOI 10.1016/S1357-4310(98)01430-0; Kunisada K, 2000, P NATL ACAD SCI USA, V97, P315, DOI 10.1073/pnas.97.1.315; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279; Mascareno E, 1998, P NATL ACAD SCI USA, V95, P5590, DOI 10.1073/pnas.95.10.5590; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Narimatsu M, 2001, MOL CELL BIOL, V21, P6615, DOI 10.1128/MCB.21.19.6615-6625.2001; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; OKEYAN A, 1997, AM J PHYSIOL, V273, pR293; Park OK, 1996, P NATL ACAD SCI USA, V93, P13704, DOI 10.1073/pnas.93.24.13704; Park OK, 2000, J BIOL CHEM, V275, P32244, DOI 10.1074/jbc.M005082200; Patel BKR, 1998, P NATL ACAD SCI USA, V95, P172, DOI 10.1073/pnas.95.1.172; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Ramadori G, 1999, SEMIN LIVER DIS, V19, P141, DOI 10.1055/s-2007-1007106; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; Ridger VC, 2001, J IMMUNOL, V166, P3484, DOI 10.4049/jimmunol.166.5.3484; Sano S, 2001, IMMUNITY, V15, P261, DOI 10.1016/S1074-7613(01)00180-7; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Sasse J, 1997, MOL CELL BIOL, V17, P4677, DOI 10.1128/MCB.17.8.4677; Schaefer TS, 1997, MOL CELL BIOL, V17, P5307, DOI 10.1128/MCB.17.9.5307; SCHAEFER TS, 1995, P NATL ACAD SCI USA, V92, P9097, DOI 10.1073/pnas.92.20.9097; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Sharp PA, 1997, CELL, V91, P875, DOI 10.1016/S0092-8674(00)80479-1; Shi W, 1996, INT IMMUNOL, V8, P1205, DOI 10.1093/intimm/8.8.1205; Takeda K, 1998, J IMMUNOL, V161, P4652; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Takemoto S, 1997, P NATL ACAD SCI USA, V94, P13897, DOI 10.1073/pnas.94.25.13897; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang DM, 1996, MOL CELL BIOL, V16, P6141; Warren GW, 2001, J INTERF CYTOK RES, V21, P821, DOI 10.1089/107999001753238060; Yoo JY, 2001, J BIOL CHEM, V276, P26421, DOI 10.1074/jbc.M009935200; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zhu C, 1997, MOL CELL BIOL, V17, P4957, DOI 10.1128/MCB.17.9.4957	56	110	119	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2002	108	3					331	344		10.1016/S0092-8674(02)00636-0	http://dx.doi.org/10.1016/S0092-8674(02)00636-0			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	520VB	11853668	Bronze			2022-12-28	WOS:000173801600006
J	Spechler, SJ				Spechler, SJ			Barrett's esophagus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; HIGH-GRADE DYSPLASIA; GASTRIC-ACID BREAKTHROUGH; ENDOSCOPIC SURVEILLANCE; FOLLOW-UP; EARLY ADENOCARCINOMA; COST-EFFECTIVENESS; CANCER-RISK; DIAGNOSIS; PREVALENCE		Dept Vet Affairs Med Ctr, Div Gastroenterol 111B1, Dallas, TX 75216 USA; Univ Texas, SW Med Ctr, Dallas, TX USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Spechler, SJ (corresponding author), Dept Vet Affairs Med Ctr, Div Gastroenterol 111B1, 4500 S Lancaster Rd, Dallas, TX 75216 USA.							Am Soc Gastrointestinal Endoscopy, 1999, GASTROINTEST ENDOSC, V49, P834; [Anonymous], 1998, GASTROINTEST ENDOSC, V48, P663; Bulkley G, 2000, J GASTROINTEST SURG, V4, P115; Buttar NS, 2001, GASTROENTEROLOGY, V120, P1630, DOI 10.1053/gast.2001.25111; Cameron AJ, 1997, GASTROENTEROL CLIN N, V26, P487, DOI 10.1016/S0889-8553(05)70308-3; Chiba N, 1997, GASTROENTEROLOGY, V112, P1798, DOI 10.1053/gast.1997.v112.pm9178669; Chow WH, 1998, CANCER RES, V58, P588; DeVault KR, 1999, AM J GASTROENTEROL, V94, P1434; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2; Dulai GS, 2002, GASTROENTEROLOGY, V122, P26, DOI 10.1053/gast.2002.30297; Eckardt VF, 2001, AM J MED, V111, P33, DOI 10.1016/S0002-9343(01)00745-8; Fitzgerald RC, 1996, J CLIN INVEST, V98, P2120, DOI 10.1172/JCI119018; Garewal H, 1999, AM J GASTROENTEROL, V94, P2829, DOI 10.1016/S0002-9270(99)00480-3; GUANREI Y, 1988, ENDOSCOPY, V20, P95, DOI 10.1055/s-2007-1018145; Hinder RA, 1999, GASTROENTEROL CLIN N, V28, P987, DOI 10.1016/S0889-8553(05)70101-1; Hirota WK, 1999, GASTROENTEROLOGY, V116, P277, DOI 10.1016/S0016-5085(99)70123-X; Katz PO, 1998, ALIMENT PHARM THER, V12, P1231; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; LEVINE DS, 1993, GASTROENTEROLOGY, V105, P40, DOI 10.1016/0016-5085(93)90008-Z; Macdonald CE, 2000, BMJ-BRIT MED J, V321, P1252, DOI 10.1136/bmj.321.7271.1252; Montgomery E, 2001, HUM PATHOL, V32, P368, DOI 10.1053/hupa.2001.23510; Ouatu-Lascar R, 1999, GASTROENTEROLOGY, V117, P327, DOI 10.1053/gast.1999.0029900327; Ouatu-Lascar R, 1998, AM J GASTROENTEROL, V93, P711; Overholt BF, 1999, GASTROINTEST ENDOSC, V49, P1, DOI 10.1016/S0016-5107(99)70437-2; Peghini PL, 1998, GASTROENTEROLOGY, V115, P1335, DOI 10.1016/S0016-5085(98)70010-1; Peters FTM, 1999, GUT, V45, P489, DOI 10.1136/gut.45.4.489; Peters FTM, 2000, GUT, V47, P154; Peters FTM, 2000, SCAND J GASTROENTERO, V35, P1238; PETERS JH, 1994, J THORAC CARDIOV SUR, V108, P813, DOI 10.1016/S0022-5223(94)70178-4; Provenzale D, 1999, AM J GASTROENTEROL, V94, P2043; Reid BJ, 2000, AM J GASTROENTEROL, V95, P1669, DOI 10.1111/j.1572-0241.2000.02196.x; REID BJ, 1988, HUM PATHOL, V19, P166, DOI 10.1016/S0046-8177(88)80344-7; Reid BJ, 2000, AM J GASTROENTEROL, V95, P3089, DOI 10.1111/j.1572-0241.2000.03182.x; Rudolph RE, 2000, ANN INTERN MED, V132, P612, DOI 10.7326/0003-4819-132-8-200004180-00003; Sampliner RE, 1998, AM J GASTROENTEROL, V93, P1028; Schnell TG, 2001, GASTROENTEROLOGY, V120, P1607, DOI 10.1053/gast.2001.25065; Shaheen NJ, 2000, GASTROENTEROLOGY, V119, P333, DOI 10.1053/gast.2000.9302; Sharma P, 1998, AM J GASTROENTEROL, V93, P1033; Sharma P, 1998, AM J GASTROENTEROL, V93, P332, DOI 10.1016/S0002-9270(97)00100-7; Shirvani VN, 2000, GASTROENTEROLOGY, V118, P487, DOI 10.1016/S0016-5085(00)70254-X; Skacel M, 2000, AM J GASTROENTEROL, V95, P3383; Soni A, 2000, AM J GASTROENTEROL, V95, P2086; Sonnenberg A, 2002, ALIMENT PHARM THERAP, V16, P41, DOI 10.1046/j.1365-2036.2002.01146.x; Souza RF, 2002, GASTROENTEROLOGY, V122, P299, DOI 10.1053/gast.2002.30993; Spechler SJ, 1999, GASTROENTEROLOGY, V117, P218, DOI 10.1016/S0016-5085(99)70571-8; Spechler SJ, 2001, JAMA-J AM MED ASSOC, V285, P2331, DOI 10.1001/jama.285.18.2331; SPECHLER SJ, 1994, LANCET, V344, P1533, DOI 10.1016/S0140-6736(94)90349-2; Stein H.J, 1996, DIS ESOPHAGUS, V9, P3; Streitz JM, 1998, AM J GASTROENTEROL, V93, P911; STREITZ JM, 1993, J THORAC CARDIOV SUR, V105, P383; Swisher SG, 2000, J THORAC CARDIOV SUR, V119, P1126, DOI 10.1067/mtc.2000.105644; Ter RB, 1997, GASTROENTEROL CLIN N, V26, P549, DOI 10.1016/S0889-8553(05)70313-7; Theisen J, 2000, J GASTROINTEST SURG, V4, P50, DOI 10.1016/S1091-255X(00)80032-3; van den Boogert J, 1999, AM J GASTROENTEROL, V94, P1153, DOI 10.1016/S0002-9270(99)00114-8; Weston AP, 2000, AM J GASTROENTEROL, V95, P1888; Weston AP, 2001, AM J GASTROENTEROL, V96, P1355, DOI 10.1111/j.1572-0241.2001.03851.x; Wright TA, 1996, GUT, V39, P574, DOI 10.1136/gut.39.4.574; Ye WM, 2001, GASTROENTEROLOGY, V121, P1286, DOI 10.1053/gast.2001.29569	58	436	452	1	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2002	346	11					836	842		10.1056/NEJMcp012118	http://dx.doi.org/10.1056/NEJMcp012118			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529YM	11893796				2022-12-28	WOS:000174328900008
J	Aphasizhev, R; Sbicego, S; Peris, M; Jang, SH; Aphasizheva, I; Simpson, AM; Rivlin, A; Simpson, L				Aphasizhev, R; Sbicego, S; Peris, M; Jang, SH; Aphasizheva, I; Simpson, AM; Rivlin, A; Simpson, L			Trypanosome mitochondrial 3 ' terminal uridylyl transferase (TUTase): The key enzyme in U-insertion/deletion RNA editing	CELL			English	Article							MAMMALIAN POLY(A) POLYMERASE; LEISHMANIA-TARENTOLAE; MESSENGER-RNA; GUIDE RNA; NUCLEOTIDYLTRANSFERASE SUPERFAMILY; KINETOPLASTID MITOCHONDRIA; GLUTAMATE-DEHYDROGENASE; BRUCEI MITOCHONDRIA; MUTATIONAL ANALYSIS; LIGASE ACTIVITIES	A 3' terminal RNA uridylyltransferase was purified from mitochondria of Leishmania tarentolae and the gene cloned and expressed from this species and from Trypanosoma brucei. The enzyme is specific for 3' U-addition in the presence of Mg2+. TUTase is present in vivo in at least two stable configurations: one contains a similar to500 kDa TUTase oligomer and the other a similar to700 kDa TUTase complex. Anti-TUTase antiserum specifically coprecipitates a small portion of the p45 and p50 RNA ligases and approximately 40% of the guide RNAs. Inhibition of TUTase expression in procyclic T. brucei by RNAi downregulates RNA editing and appears to affect parasite viability.	Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Taegu Univ, Dept Mol Biol, Kyung San 712714, Kyung Pook, South Korea; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Simpson, L (corresponding author), Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA.			Afasizhev, Ruslan/0000-0002-4595-6618; Afasizheva, Inna/0000-0003-2695-2950	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI009102, R01AI009102] Funding Source: NIH RePORTER; NIAID NIH HHS [AI09102] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADLER BK, 1991, MOL CELL BIOL, V11, P5878, DOI 10.1128/MCB.11.12.5878; Alfonzo JD, 1997, NUCLEIC ACIDS RES, V25, P3751, DOI 10.1093/nar/25.19.3751; ANDREWS NC, 1986, P NATL ACAD SCI USA, V83, P221, DOI 10.1073/pnas.83.2.221; Aphasizhev R, 2001, J BIOL CHEM, V276, P21280, DOI 10.1074/jbc.M100297200; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1609, DOI 10.1093/nar/27.7.1609; BAKALARA N, 1989, J BIOL CHEM, V264, P18679; Bard J, 2000, SCIENCE, V289, P1346, DOI 10.1126/science.289.5483.1346; Blanc V, 1999, J BIOL CHEM, V274, P24289, DOI 10.1074/jbc.274.34.24289; Blom D, 2001, NUCLEIC ACIDS RES, V29, P2950, DOI 10.1093/nar/29.14.2950; BLUM B, 1990, CELL, V62, P391, DOI 10.1016/0092-8674(90)90375-O; BRALY P, 1974, J PROTOZOOL, V21, P782, DOI 10.1111/j.1550-7408.1974.tb03752.x; Bringaud F, 1997, MOL CELL BIOL, V17, P3915, DOI 10.1128/MCB.17.7.3915; CAMPBELL DA, 1989, MOL BIOCHEM PARASIT, V36, P197, DOI 10.1016/0166-6851(89)90192-8; CARRUTHERS VB, 1992, P NATL ACAD SCI USA, V89, P8818, DOI 10.1073/pnas.89.18.8818; CHEN J, 1992, MOL CELL BIOL, V12, P3470, DOI 10.1128/MCB.12.8.3470; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Estevez AM, 1999, GENE, V240, P247, DOI 10.1016/S0378-1119(99)00437-0; Estevez AM, 1999, MOL BIOCHEM PARASIT, V100, P5, DOI 10.1016/S0166-6851(99)00024-9; FRECH GC, 1995, EMBO J, V14, P178, DOI 10.1002/j.1460-2075.1995.tb06988.x; GREIDER CW, 1991, MOL CELL BIOL, V11, P4572, DOI 10.1128/MCB.11.9.4572; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P345, DOI 10.1016/S0968-0004(00)89071-4; Igo RP, 2000, MOL CELL BIOL, V20, P8447, DOI 10.1128/MCB.20.22.8447-8457.2000; Kapushoc ST, 1999, RNA, V5, P656, DOI 10.1017/S1355838299982250; Koller J, 1997, J BIOL CHEM, V272, P3749, DOI 10.1074/jbc.272.6.3749; LaCount DJ, 2000, MOL BIOCHEM PARASIT, V111, P67, DOI 10.1016/S0166-6851(00)00300-5; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Madison-Antenucci S, 1998, EMBO J, V17, P6368, DOI 10.1093/emboj/17.21.6368; Martin G, 1999, PROTEIN SCI, V8, P2380; Martin G, 1998, RNA, V4, P226; Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x; Martin G, 2000, EMBO J, V19, P4193, DOI 10.1093/emboj/19.16.4193; McManus MT, 2000, MOL CELL BIOL, V20, P883, DOI 10.1128/MCB.20.3.883-891.2000; McManus MT, 2001, RNA, V7, P167, DOI 10.1017/S1355838201002072; MILCHEV GI, 1978, EUR J BIOCHEM, V84, P113, DOI 10.1111/j.1432-1033.1978.tb12147.x; Militello KT, 2000, MOL CELL BIOL, V20, P2308, DOI 10.1128/MCB.20.7.2308-2316.2000; Missel A, 1997, MOL CELL BIOL, V17, P4895, DOI 10.1128/MCB.17.9.4895; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Panigrahi AK, 2001, MOL CELL BIOL, V21, P6833, DOI 10.1128/MCB.21.20.6833-6840.2001; Panigrahi AK, 2001, MOL CELL BIOL, V21, P380, DOI 10.1128/MCB.21.2.380-389.2001; Peris M, 1997, MOL BIOCHEM PARASIT, V85, P9, DOI 10.1016/S0166-6851(96)02795-8; Rusche LN, 1997, EMBO J, V16, P4069, DOI 10.1093/emboj/16.13.4069; Rusche LN, 2001, MOL CELL BIOL, V21, P979, DOI 10.1128/MCB.21.4.979-989.2001; SABATINI R, 1995, J BIOL CHEM, V270, P7233, DOI 10.1074/jbc.270.13.7233; SACHS A, 1993, J BIOL CHEM, V268, P22955; Schnaufer A, 2001, SCIENCE, V291, P2159, DOI 10.1126/science.1058655; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Simpson L, 1998, NUCLEIC ACIDS RES, V26, P170, DOI 10.1093/nar/26.1.170; Trippe R, 1998, NUCLEIC ACIDS RES, V26, P3119, DOI 10.1093/nar/26.13.3119; Vanhamme L, 1998, J BIOL CHEM, V273, P21825, DOI 10.1074/jbc.273.34.21825; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; WHITE TC, 1987, NUCLEIC ACIDS RES, V15, P3275, DOI 10.1093/nar/15.8.3275; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; ZABEL P, 1981, NUCLEIC ACIDS RES, V9, P2433, DOI 10.1093/nar/9.11.2433	53	112	117	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 8	2002	108	5					637	648		10.1016/S0092-8674(02)00647-5	http://dx.doi.org/10.1016/S0092-8674(02)00647-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	529TN	11893335	Bronze			2022-12-28	WOS:000174314800008
J	Sigal, LH				Sigal, LH			Misconceptions about Lyme disease: Confusions hiding behind III-chosen terminology	ANNALS OF INTERNAL MEDICINE			English	Article							BORRELIA-BURGDORFERI; ERYTHEMA MIGRANS; INCORRECT DIAGNOSIS; MANIFESTATIONS; MANAGEMENT; THERAPY; ILLNESS; CELLS; OVERDIAGNOSIS; FIBROMYALGIA		Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Sigal, LH (corresponding author), 1 Robert Wood Johnson Pl,MEB 484, New Brunswick, NJ 08903 USA.							AgueroRosenfeld ME, 1996, J CLIN MICROBIOL, V34, P1; AGUEROROSENFELD ME, 1993, J CLIN MICROBIOL, V31, P3090, DOI 10.1128/JCM.31.12.3090-3095.1993; AMES L, 1986, NY TIMES        0706; Barbour AG, 1996, J INFECT DIS, V173, P403, DOI 10.1093/infdis/173.2.403; BARBOUR AG, 1993, SCIENCE, V260, P1610, DOI 10.1126/science.8503006; Brouqui P, 1996, ANTIMICROB AGENTS CH, V40, P1552, DOI 10.1128/AAC.40.6.1552; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P590; DATTWYLER RJ, 1990, LANCET, V336, P1404, DOI 10.1016/0140-6736(90)93103-V; ETTESTAD PJ, 1995, J INFECT DIS, V171, P356, DOI 10.1093/infdis/171.2.356; FALVO C, 1987, NY TIMES        0904, P26; Gaudino EA, 1997, ARCH NEUROL-CHICAGO, V54, P1372, DOI 10.1001/archneur.1997.00550230045015; GEORGILIS K, 1992, J INFECT DIS, V166, P440, DOI 10.1093/infdis/166.2.440; Girschick HJ, 1996, RHEUMATOL INT, V16, P125, DOI 10.1007/BF01409985; GREENBERG D, 1985, NY TIMES        0707; HALPERIN JJ, 1995, AM J MED, V98, pS52, DOI 10.1016/S0002-9343(99)80044-8; Hilton E, 1997, J CLIN MICROBIOL, V35, P774, DOI 10.1128/JCM.35.3.774-776.1997; HSU VM, 1993, ARTHRITIS RHEUM, V36, P1493, DOI 10.1002/art.1780361103; ILOWITE NT, 1995, AM J MED, V98, pS63, DOI 10.1016/S0002-9343(99)80046-1; Kalish RA, 2001, J INFECT DIS, V183, P453, DOI 10.1086/318082; Kirkland KB, 1997, ARCH INTERN MED, V157, P2635, DOI 10.1001/archinte.157.22.2635; KLEMPNER MS, 1993, J INFECT DIS, V167, P1074, DOI 10.1093/infdis/167.5.1074; Klempner MS, 2001, NEW ENGL J MED, V345, P85, DOI 10.1056/NEJM200107123450202; MA Y, 1991, INFECT IMMUN, V59, P671, DOI 10.1128/IAI.59.2.671-678.1991; NADELMAN RB, 1995, AM J MED, V98, pS15, DOI 10.1016/S0002-9343(99)80040-0; PACHNER AR, 1988, ANN NY ACAD SCI, V539, P56, DOI 10.1111/j.1749-6632.1988.tb31838.x; PACHNER AR, 1995, AM J MED, V98, pS30, DOI 10.1016/S0002-9343(99)80042-4; Patel R, 2000, CLIN INFECT DIS, V31, P1107, DOI 10.1086/318138; Reid MC, 1998, ANN INTERN MED, V128, P354, DOI 10.7326/0003-4819-128-5-199803010-00003; Seltzer EG, 2000, JAMA-J AM MED ASSOC, V283, P609, DOI 10.1001/jama.283.5.609; SIGAL L, 1993, LYME DIS NEW JERSEY, P127; Sigal LH, 1998, ARTHRITIS RHEUM-US, V41, P195, DOI 10.1002/1529-0131(199802)41:2&lt;195::AID-ART3&gt;3.0.CO;2-Y; SIGAL LH, 1992, PEDIATRICS, V90, P523; Sigal LH, 1996, ARCH INTERN MED, V156, P1493, DOI 10.1001/archinte.156.14.1493; SIGAL LH, 1993, RHEUM DIS CLIN N AM, V19, P79; SIGAL LH, 1995, AM J MED, V98, pS25, DOI 10.1016/S0002-9343(99)80041-2; Sigal LH, 1997, B RHEUM DIS, V46, P1; SIGAL LH, 1995, J INFECT DIS, V171, P423, DOI 10.1093/infdis/171.2.423; Sigal LH, 1997, ANNU REV IMMUNOL, V15, P63, DOI 10.1146/annurev.immunol.15.1.63; SIGAL LH, 1995, RHEUM DIS CLIN N AM, V21, P217; Sigal LH, 1999, RHEUM DIS CLIN N AM, V25, P861, DOI 10.1016/S0889-857X(05)70107-1; SIGAL LH, 1994, AM J MED, V96, P365, DOI 10.1016/0002-9343(94)90068-X; SIGAL LH, 1990, AM J MED, V88, P577, DOI 10.1016/0002-9343(90)90520-N; Sigal LH, 1995, B RHEUM DIS, V44, P1; STEERE AC, 1985, NEW ENGL J MED, V312, P869, DOI 10.1056/NEJM198504043121401; STEERE AC, 1983, ANN INTERN MED, V99, P76, DOI 10.7326/0003-4819-99-1-76; STEERE AC, 1993, JAMA-J AM MED ASSOC, V269, P1812, DOI 10.1001/jama.269.14.1812; STEERE AC, 1989, NEW ENGL J MED, V321, P586, DOI 10.1056/NEJM198908313210906; STEERE AC, 1983, ANN INTERN MED, V99, P22, DOI 10.7326/0003-4819-99-1-22; STEERE AC, 1995, AM J MED, V98, pS44, DOI 10.1016/S0002-9343(99)80043-6; Wharton M, 1990, MMWR Recomm Rep, V39, P1	50	23	23	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 5	2002	136	5					413	419		10.7326/0003-4819-136-5-200203050-00024	http://dx.doi.org/10.7326/0003-4819-136-5-200203050-00024			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525VT	11874324				2022-12-28	WOS:000174095300018
J	Townsend, A; Drakesmith, H				Townsend, A; Drakesmith, H			Role of HFE in iron metabolism, hereditary haemochromatosis, anaemia of chronic disease, and secondary iron overload	LANCET			English	Article							HEMOCHROMATOSIS PROTEIN HFE; TRANSFERRIN RECEPTOR; HLA-H; EXPRESSION; TRANSPORTER; GENE; MICE; ASSOCIATION; ABSORPTION; MODEL	Hereditary haemochromatosis Is an iron overloading disorder caused by common mutations in the HFE gene. However, Information with respect to the function of HFE protein does not explain how mutations in HFE lead to hereditary haemochromatosis. We propose a molecular model In which HFE has two mutually exclusive activities in cells: Inhibition of uptake. or inhibition of release of iron. The balance between serum transferrin saturation and serum transferrin-receptor concentrations determines which of these functions predominates. With this input, HFE enables the intestinal crypt cells and reticuloendothelial system to interpret the body's iron requirements and regulate iron absorption and distribution. In our model, mutations in HFE result in overabsorption of dietary iron, and patterns of tissue iron deposition in agreement with clinical observations of hereditary haemochromatosis.	Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England	University of Oxford	Townsend, A (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England.			Townsend, Alain/0000-0002-3702-0107; Drakesmith, Alexander/0000-0002-8503-6103				Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; Bastin JM, 1998, BRIT J HAEMATOL, V103, P931, DOI 10.1046/j.1365-2141.1998.01102.x; BLOCK M, 1965, AM J PATHOL, V47, P89; Camaschella C, 2000, NAT GENET, V25, P14, DOI 10.1038/75534; Cazzola M, 1999, BRIT J HAEMATOL, V106, P752, DOI 10.1046/j.1365-2141.1999.01600.x; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; DRAKESMITH H, IN PRESS NATURE; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Feder JN, 1997, J BIOL CHEM, V272, P14025, DOI 10.1074/jbc.272.22.14025; Fleming RE, 1999, P NATL ACAD SCI USA, V96, P3143, DOI 10.1073/pnas.96.6.3143; Gross CN, 1998, J BIOL CHEM, V273, P22068, DOI 10.1074/jbc.273.34.22068; Lebron JA, 1998, CELL, V93, P111, DOI 10.1016/S0092-8674(00)81151-4; Lebron JA, 1999, J MOL BIOL, V294, P239, DOI 10.1006/jmbi.1999.3252; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Levy JE, 2000, J CLIN INVEST, V105, P1209, DOI 10.1172/JCI9635; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Montosi G, 2000, BLOOD, V96, P1125, DOI 10.1182/blood.V96.3.1125.015k19_1125_1129; Moura E, 1998, BLOOD, V92, P2511, DOI 10.1182/blood.V92.7.2511.2511_2511_2519; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Njajou OT, 2001, NAT GENET, V28, P213, DOI 10.1038/90038; Parkkila S, 1997, P NATL ACAD SCI USA, V94, P2534, DOI 10.1073/pnas.94.6.2534; Parkkila S, 1997, P NATL ACAD SCI USA, V94, P13198, DOI 10.1073/pnas.94.24.13198; Raja KB, 1999, BLOOD, V94, P3185, DOI 10.1182/blood.V94.9.3185.421a20_3185_3192; Roy CN, 1999, J BIOL CHEM, V274, P9022, DOI 10.1074/jbc.274.13.9022; Santos M, 1996, J EXP MED, V184, P1975, DOI 10.1084/jem.184.5.1975; Sheldon J. H., 1935, HAEMOCHROMATOSIS; TAYLOR MRH, 1966, BRIT J HAEMATOL, V12, P747, DOI 10.1111/j.1365-2141.1966.tb00161.x; Waheed A, 1999, P NATL ACAD SCI USA, V96, P1579, DOI 10.1073/pnas.96.4.1579; West AP, 2000, J BIOL CHEM, V275, P38135, DOI 10.1074/jbc.C000664200; Zhou XY, 1998, P NATL ACAD SCI USA, V95, P2492, DOI 10.1073/pnas.95.5.2492; Zoller H, 1999, LANCET, V353, P2120, DOI 10.1016/S0140-6736(98)11179-0	31	63	66	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 2	2002	359	9308					786	790		10.1016/S0140-6736(02)07885-6	http://dx.doi.org/10.1016/S0140-6736(02)07885-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526DZ	11888608				2022-12-28	WOS:000174115200032
J	Broadus, AE; Scully, RE; List, JF; Braaten, KM; Kronenberg, HM				Broadus, AE; Scully, RE; List, JF; Braaten, KM; Kronenberg, HM			A 47-year-old woman with late recurrent hyperparathyroidism. Metastatic parathyroid carcinoma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CALCIUM-SENSING RECEPTOR; HYPERPLASIA; EXPRESSION		Yale Univ, Sch Med, Dept Endocrinol & Metab, New Haven, CT 06510 USA	Yale University	Broadus, AE (corresponding author), Yale Univ, Sch Med, Dept Endocrinol & Metab, 333 Cedar St, New Haven, CT 06510 USA.							Al-Sobhi S, 1999, CLIN NUCL MED, V24, P21, DOI 10.1097/00003072-199901000-00005; ARNOLD A, 1995, J CLIN INVEST, V95, P2047, DOI 10.1172/JCI117890; CARCANGIU ML, 1984, AM J SURG PATHOL, V8, P655, DOI 10.1097/00000478-198409000-00005; Cheng I, 1999, GASTROENTEROLOGY, V116, P118, DOI 10.1016/S0016-5085(99)70235-0; DEPAPP AE, 1994, AM J MED, V97, P399, DOI 10.1016/0002-9343(94)90312-3; FLYNN SD, 1988, SURGERY, V104, P963; GAGEL RF, 2001, ENDOCRINOLOGY, V3, P2518; KOLLMORGEN CF, 1994, SURGERY, V116, P111; Livolsi Virginia A., 1994, P1; MALLETTE LE, 1974, AM J MED, V57, P642, DOI 10.1016/0002-9343(74)90018-7; Marx SJ, 2000, NEW ENGL J MED, V343, P1863, DOI 10.1056/NEJM200012213432508; Marx SJ, 2001, NEW ENGL J MED, V344, P696; MERZ DC, 1994, PARATHYROIDS BASIC C, P591; Mitchell BK, 1996, SURGERY, V120, P1039, DOI 10.1016/S0039-6060(96)80052-3; Moka D, 2000, SURGERY, V128, P29, DOI 10.1067/msy.2000.107066; NORTON JA, 1987, SURGERY, V102, P958; OBARA T, 1993, SURGERY, V114, P1040; Ray JM, 1997, J CLIN INVEST, V99, P2328, DOI 10.1172/JCI119413; Regal M, 1999, J ENDOCRINOL INVEST, V22, P191, DOI 10.1007/BF03343540; ROSAI J, 1992, ATLAS TUMOR PATHOL, P219; Shane E, 2001, J CLIN ENDOCR METAB, V86, P485, DOI 10.1210/jc.86.2.485; Sidhu S, 2000, AUST NZ J SURG, V70, P285, DOI 10.1046/j.1440-1622.2000.01799.x; STERNBERG SS, 1999, DIAGNOSTIC SURG PATH, V1, P565; STEWART AF, 1987, ENDOCRINOL METAB, P1317; WANG CA, 1976, ANN SURG, V183, P271, DOI 10.1097/00000658-197603000-00010; ZANIEWSKI M, 1986, ARCH INTERN MED, V146, P478, DOI 10.1001/archinte.146.3.478	26	4	4	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2002	346	9					694	700		10.1056/NEJMcpc020007	http://dx.doi.org/10.1056/NEJMcpc020007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525HJ	11870248				2022-12-28	WOS:000174062800009
J	Gladstone, GR; Waite, JH; Grodent, D; Lewis, WS; Crary, FJ; Elsner, RF; Weisskopf, MC; Majeed, T; Jahn, JM; Bhardwaj, A; Clarke, JT; Young, DT; Dougherty, MK; Espinosa, SA; Cravens, TE				Gladstone, GR; Waite, JH; Grodent, D; Lewis, WS; Crary, FJ; Elsner, RF; Weisskopf, MC; Majeed, T; Jahn, JM; Bhardwaj, A; Clarke, JT; Young, DT; Dougherty, MK; Espinosa, SA; Cravens, TE			A pulsating auroral X-ray hot spot on Jupiter	NATURE			English	Article							IO FLUX TUBE; MIDDLE MAGNETOSPHERE; ENERGETIC OXYGEN; UV AURORA; EMISSION; STRATOSPHERE; TEMPERATURE; ABUNDANCES; FEATURES; GALILEO	Jupiter's X-ray aurora has been thought to be excited by energetic sulphur and oxygen ions precipitating from the inner magnetosphere into the planet's polar regions(1-3). Here we report high-spatial-resolution observations that demonstrate that most of Jupiter's northern auroral X-rays come from a 'hot spot' located significantly poleward of the latitudes connected to the inner magnetosphere. The hot spot seems to be fixed in magnetic latitude and longitude and occurs in a region where anomalous infrared(4-7) and ultraviolet(8) emissions have also been observed. We infer from the data that the particles that excite the aurora originate in the outer magnetosphere. The hot spot X-rays pulsate with an approximately 45-min period, a period similar to that reported for high-latitude radio and energetic electron bursts observed by near-Jupiter spacecraft(9,10). These results invalidate the idea that jovian auroral X-ray emissions are mainly excited by steady precipitation of energetic heavy ions from the inner magnetosphere. Instead, the X-rays seem to result from currently unexplained processes in the outer magnetosphere that produce highly localized and highly variable emissions over an extremely wide range of wavelengths.	SW Res Inst, San Antonio, TX 78228 USA; Univ Michigan, Ann Arbor, MI 48109 USA; NASA, George C Marshall Space Flight Ctr, Huntsville, AL 35812 USA; Vikram Sarabhai Space Ctr, Trivandrum 695022, Kerala, India; Boston Univ, Boston, MA 02215 USA; Univ London Imperial Coll Sci & Technol, Blackett Lab, London SW7 2BZ, England; Max Planck Inst Aeron, D-37191 Katlenburg Lindau, Germany; Univ Kansas, Lawrence, KS 66045 USA	Southwest Research Institute; University of Michigan System; University of Michigan; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; Department of Space (DoS), Government of India; Indian Space Research Organisation (ISRO); Vikram Sarabhai Space Center (VSSC); Boston University; Imperial College London; Max Planck Society; University of Kansas	Gladstone, GR (corresponding author), SW Res Inst, 6220 Culebra Rd, San Antonio, TX 78228 USA.		Majeed, Tariq/AAX-5469-2020; Clarke, John/C-8644-2013; Bhardwaj, Anil/B-4579-2011	Majeed, Tariq/0000-0002-0072-5891; Bhardwaj, Anil/0000-0003-1693-453X				Bhardwaj A, 2000, REV GEOPHYS, V38, P295, DOI 10.1029/1998RG000046; Bunce EJ, 2001, PLANET SPACE SCI, V49, P261, DOI 10.1016/S0032-0633(00)00147-1; CALDWELL J, 1988, ICARUS, V74, P331, DOI 10.1016/0019-1035(88)90045-0; Clarke JT, 1998, J GEOPHYS RES-PLANET, V103, P20217, DOI 10.1029/98JE01130; CONNERNEY JEP, 1993, SCIENCE, V262, P1035, DOI 10.1126/science.262.5136.1035; Connerney JEP, 1998, J GEOPHYS RES-SPACE, V103, P11929, DOI 10.1029/97JA03726; Cravens TE, 1997, GEOPHYS RES LETT, V24, P105, DOI 10.1029/96GL03780; DROSSART P, 1986, ICARUS, V66, P610, DOI 10.1016/0019-1035(86)90094-1; GEHRELS N, 1983, J GEOPHYS RES-SPACE, V88, P5537, DOI 10.1029/JA088iA07p05537; HERBERT F, 1987, J GEOPHYS RES, V92, P3141, DOI 10.1029/JA092iA04p03141; KHURANA KK, 1989, J GEOPHYS RES, V94, P5241, DOI 10.1029/JA094iA05p05241; KOSTIUK T, 1993, J GEOPHYS RES-PLANET, V98, P18823, DOI 10.1029/93JE01332; Krimigis SM, 2002, NATURE, V415, P994, DOI 10.1038/415994a; Krupp N, 2001, PLANET SPACE SCI, V49, P283, DOI 10.1016/S0032-0633(00)00149-5; LEAHY DA, 1983, ASTROPHYS J, V266, P160, DOI 10.1086/160766; Liu WH, 1999, ASTROPHYS J, V526, P538, DOI 10.1086/307994; LIVENGOOD TA, 1993, J GEOPHYS RES-PLANET, V98, P18813, DOI 10.1029/93JE01043; MACDOWALL RJ, 1993, PLANET SPACE SCI, V41, P1059, DOI 10.1016/0032-0633(93)90109-F; Mauk BH, 1996, J GEOPHYS RES-SPACE, V101, P7685, DOI 10.1029/96JA00006; Maurellis AN, 2000, GEOPHYS RES LETT, V27, P1339, DOI 10.1029/1999GL010723; METZGER AE, 1983, J GEOPHYS RES-SPACE, V88, P7731, DOI 10.1029/JA088iA10p07731; Prange R, 1998, J GEOPHYS RES-PLANET, V103, P20195, DOI 10.1029/98JE01128; Smith E. J., 1976, JUPITER, P788; Vincent MB, 2000, ICARUS, V143, P205, DOI 10.1006/icar.1999.6233; Waite JH, 2001, NATURE, V410, P787, DOI 10.1038/35071018; Wilson RJ, 2000, GEOPHYS RES LETT, V27, P835, DOI 10.1029/1999GL010750	26	161	161	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2002	415	6875					1000	1003		10.1038/4151000a	http://dx.doi.org/10.1038/4151000a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875561	Bronze, Green Published			2022-12-28	WOS:000174075000037
J	Hutchinson, JR; Garcia, M				Hutchinson, JR; Garcia, M			Tyrannosaurus was not a fast runner	NATURE			English	Article							LEG MUSCLES; MECHANICS; ALLOMETRY; MAMMALS; POSTURE; MASS	The fastest gait and speed of the largest theropod (carnivorous) dinosaurs, such as Tyrannosaurus, is controversial. Some studies contend that Tyrannosaurus was limited to walking, or at best an 11 m s(-1) top speed(1-4), whereas others argue for at least 20 m s(-1) running speeds(5-7). We demonstrate a method of gauging running ability by estimating the minimum mass of extensor (supportive) muscle needed for fast running. The model's predictions are validated for living alligators and chickens. Applying the method to small dinosaurs corroborates other studies by showing that they could have been competent runners. However, models show that in order to run quickly, an adult Tyrannosaurus would have needed an unreasonably large mass of extensor muscle, even with generous assumptions. Therefore, it is doubtful that Tyrannosaurus and other huge dinosaurs (similar to6,000 kg) were capable runners or could reach high speeds.	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Hutchinson, JR (corresponding author), Stanford Univ, Biomech Engn Div, Stanford, CA 94305 USA.	jrhutch@stanford.edu	Hutchinson, John/AAH-1593-2020	Hutchinson, John/0000-0002-6767-7038				ALEXANDER RM, 1985, ZOOL J LINN SOC-LOND, V83, P1, DOI 10.1111/j.1096-3642.1985.tb00871.x; ALEXANDER RM, 1985, J EXP BIOL, V115, P231; ALEXANDER RM, 1981, J ZOOL, V194, P539, DOI 10.1111/j.1469-7998.1981.tb04600.x; ALEXANDER RM, 1983, J ZOOL, V201, P135, DOI 10.1111/j.1469-7998.1983.tb04266.x; ALEXANDER RM, 1979, J ZOOL, V187, P169; ALEXANDER RM, 1989, DYAMICS DINOSAURS OT; Bakker RT., 1986, DINOSAUR HERESIES; Bennett MB, 1996, J ZOOL, V238, P435, DOI 10.1111/j.1469-7998.1996.tb05404.x; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; BLICKHAN R, 1989, J BIOMECH, V22, P1217, DOI 10.1016/0021-9290(89)90224-8; CARRANO M, IN PRESS J MORPHOL; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; Christiansen Per, 2000, Gaia (Lisboa), V15, P241; COOMBS WP, 1975, PALAEOGEOGR PALAEOCL, V17, P1, DOI 10.1016/0031-0182(75)90027-9; Farlow JO, 2000, AM ZOOL, V40, P640, DOI 10.1668/0003-1569(2000)040[0640:TL]2.0.CO;2; Farlow JO, 1995, J VERTEBR PALEONTOL, V15, P713, DOI 10.1080/02724634.1995.10011257; Gatesy SM, 1999, J MORPHOL, V240, P115, DOI 10.1002/(SICI)1097-4687(199905)240:2<115::AID-JMOR3>3.0.CO;2-Y; GRAND TI, 1977, AM J PHYS ANTHROPOL, V47, P211, DOI 10.1002/ajpa.1330470204; Hallgrimsson B, 2000, BIOL J LINN SOC, V70, P571, DOI 10.1111/j.1095-8312.2000.tb00218.x; Horner J.R, 1993, COMPLETE T REX; Hutchinson J.R., 2001, THESIS U CALIFORNIA; IRBY GV, 1999, MUS N ARIZONA B, V60, P109; JOHNSTON IA, 1985, J EXP BIOL, V115, P239; MENDEZ J, 1960, METABOLISM, V9, P184; Paul G., 1988, PREDATORY DINOSAURS; Paul Gregory S., 2000, Gaia (Lisboa), V15, P257; Roberts Thomas J., 2001, Bulletin of the Museum of Comparative Zoology, V156, P283; Roberts TJ, 1998, J EXP BIOL, V201, P2753	28	129	133	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2002	415	6875					1018	1021		10.1038/4151018a	http://dx.doi.org/10.1038/4151018a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875567				2022-12-28	WOS:000174075000043
J	Margolis, DJ; Knauss, J; Bilker, W				Margolis, DJ; Knauss, J; Bilker, W			Hormone replacement therapy and prevention of pressure ulcers and venous leg ulcers	LANCET			English	Article								Pressure ulcers and venous leg ulcers are common chronic wounds. Oestrogens in the form of hormone replacement therapy (HRT) might have an effect on wound healing, but this possibility has not been studied In detail. Using a case-cohort study including elderly patients in the UK General Practice Research Database, we showed that patients who received HRT were less likely to develop a venous leg ulcer (age-adjusted relative risk 0.65 [95% CI 0.61-0.69]) or a pressure ulcer (0.68 [0.62-0.76]) than those who did not use HRT. Therefore, we believe that HRT could be beneficial for the prevention of these wounds.	Univ Penn, Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Margolis, DJ (corresponding author), Univ Penn, Sch Med, Dept Dermatol, 815 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.		Bilker, Warren/AAS-3515-2021		NIAMS NIH HHS [AR-44695, AR-02212] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR044695, R01AR044695, K24AR002212] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ashcroft GS, 1999, AM J PATHOL, V155, P1137, DOI 10.1016/S0002-9440(10)65217-0; Calvin M, 2000, MATURITAS, V34, P195, DOI 10.1016/S0378-5122(99)00079-1; Krasner D., 2001, CHRONIC WOUND CARE C; MARGOLIS DJ, IN PRESS ANN EPIDEMI; PRENTICE RL, 1986, BIOMETRIKA, V73, P1	5	69	71	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 23	2002	359	9307					675	677		10.1016/S0140-6736(02)07806-6	http://dx.doi.org/10.1016/S0140-6736(02)07806-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526AZ	11879867				2022-12-28	WOS:000174107400015
J	Rosendaal, FR; Bovill, EG				Rosendaal, FR; Bovill, EG			Heritability of clotting factors and the revival of the prothrombotic state	LANCET			English	Editorial Material							ACTIVATION		Leiden Univ, Med Ctr, Dept Clin Epidemiol & Haematol, NL-2300 RC Leiden, Netherlands; Univ Vermont, Dept Pathol, Burlington, VT 05405 USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Vermont	Rosendaal, FR (corresponding author), Leiden Univ, Med Ctr, Dept Clin Epidemiol & Haematol, NL-2300 RC Leiden, Netherlands.		Rosendaal, Frits/Q-3842-2017	Rosendaal, Frits/0000-0003-2558-7496				Andreescu ACM, 2002, THROMB HAEMOSTASIS, V87, P47, DOI 10.1055/s-0037-1612942; ASTRUP T, 1958, THROMB DIATH HAEMOST, V2, P347, DOI 10.1055/s-0038-1656192; BAUER KA, 1987, BLOOD, V70, P343; de Lange M, 2001, LANCET, V357, P101, DOI 10.1016/S0140-6736(00)03541-8; Kamphuisen PW, 1998, THROMB HAEMOSTASIS, V79, P323; Rosendaal FR, 1999, THROMB HAEMOSTASIS, V82, P610; ROSENDAAL FR, 2001, BLOOD, V98, P789; Souto JC, 2000, CIRCULATION, V101, P1546, DOI 10.1161/01.CIR.101.13.1546; TEITEL JM, 1982, BLOOD, V59, P1086; VIRCHOW R, 1856, PHLOGOSE THROMBOSE G	10	26	26	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 23	2002	359	9307					638	639		10.1016/S0140-6736(02)07779-6	http://dx.doi.org/10.1016/S0140-6736(02)07779-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526AZ	11879854				2022-12-28	WOS:000174107400002
J	Schulz, KF; Grimes, DA				Schulz, KF; Grimes, DA			Blinding in randomised trials: hiding who got what	LANCET			English	Article							EMPIRICAL-EVIDENCE; QUALITY; BIAS; OBSTETRICS; EFFICACY; REDUCE	Blinding embodies a rich history spanning over two centuries. Most researchers worldwide understand blinding terminology, but confusion lurks beyond a general comprehension. Terms such as single blind, double blind, and triple blind mean different things to different people. Moreover, many medical researchers confuse blinding with allocation concealment. Such confusion indicates misunderstandings of both. The term blinding refers to keeping trial participants. investigators (usually health-care providers), or assessors (those collecting outcome data) unaware of the assigned Intervention. so that they will not be Influenced by that knowledge. Blinding usually reduces differential assessment of outcomes (information bias), but can also Improve compliance and retention of trial participants while reducing biased supplemental care or treatment (sometimes called co-intervention). Many investigators and readers naively consider a randomised trial as high quality simply because It Is double blind. as If double-blinding Is the sine qua non of a randomised controlled trial. Although double blinding (blinding Investigators, participants, and outcome assessors) Indicates a strong design. trials that are not double blinded should not automatically be deemed Inferior. Rather than solely relying on terminology like double blinding, researchers should explicitly state who was blinded. and how. We recommend placing greater credence In results when investigators at least blind outcome assessments, except with objective outcomes. such as death. which leave little room for bias. If Investigators properly report their blinding efforts, readers can judge them. Unfortunately, many articles do not contain proper reporting. If an article claims blinding without any accompanying clarification. readers should remain sceptical about its effect on bias reduction.	Family Hlth Int, Res Triangle Pk, NC 27709 USA		Schulz, KF (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.	KSchulz@thi.org						Adetugbo K, 2000, ARCH DERMATOL, V136, P381, DOI 10.1001/archderm.136.3.381; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Altman DG, 1991, PRACTICAL STAT MED R; [Anonymous], 1998, Fed Regist, V63, P49583; BAKER KR, 1991, AM J OBSTET GYNECOL, V165, P679; Bellomo R, 2000, LANCET, V356, P2139; *CAN COOP STUD GRO, 1978, NEW ENGL J MED, V299, P53; Carley SD, 2000, BMJ-BRIT MED J, V321, P20, DOI 10.1136/bmj.321.7252.20; Chalmers I, 1997, BRIT MED J, V314, P74, DOI 10.1136/bmj.314.7073.74a; Cheng K, 2000, PEDIATR PULM, V29, P1; DAV SJ, 2000, BRIT MED J, V321, P504; DERSIMONIAN R, 1982, NEW ENGL J MED, V306, P1332, DOI 10.1056/NEJM198206033062204; Devereaux PJ, 2001, JAMA-J AM MED ASSOC, V285, P2000, DOI 10.1001/jama.285.15.2000; Franklin B, 1785, RAPPORT COMMISSAIRES; GOTZSCHE PC, 1989, CONTROL CLIN TRIALS, V10, P31, DOI 10.1016/0197-2456(89)90017-2; James WPT, 2000, LANCET, V356, P2119, DOI 10.1016/S0140-6736(00)03491-7; Kaptchuk TJ, 1998, B HIST MED, V72, P389, DOI 10.1353/bhm.1998.0159; Khan KS, 1996, FERTIL STERIL, V65, P939, DOI 10.1016/S0015-0282(16)58265-X; LASAGNA L, 1955, J Chronic Dis, V1, P353, DOI 10.1016/0021-9681(55)90090-4; Meinert CL., 1986, CLIN TRIALS DESIGN C; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; MOSTELLER F, 1980, CONTROL CLIN TRIALS, V1, P37, DOI 10.1016/S0197-2456(80)80006-7; NOSEWORTHY JH, 1994, NEUROLOGY, V44, P16, DOI 10.1212/WNL.44.1.16; Pocock SJ., 2013, CLIN TRIALS PRACTICA; Quitkin FM, 2000, AM J PSYCHIAT, V157, P327, DOI 10.1176/appi.ajp.157.3.327; Roddy RE, 1998, NEW ENGL J MED, V339, P504, DOI 10.1056/NEJM199808203390803; SACKETT DL, 1986, CLIN RES, V34, pA711; SCHULZ KF, 1994, JAMA-J AM MED ASSOC, V272, P125, DOI 10.1001/jama.272.2.125; Schulz KF, 2002, ANN INTERN MED, V136, P254, DOI 10.7326/0003-4819-136-3-200202050-00022; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Schulz KF, 1996, BRIT MED J, V312, P742; SINEI SKA, 1990, BRIT J OBSTET GYNAEC, V97, P412, DOI 10.1111/j.1471-0528.1990.tb01828.x; WOLF S, 1950, J CLIN INVEST, V29, P100, DOI 10.1172/JCI102225	34	540	547	0	39	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 23	2002	359	9307					696	700		10.1016/S0140-6736(02)07816-9	http://dx.doi.org/10.1016/S0140-6736(02)07816-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526AZ	11879884				2022-12-28	WOS:000174107400031
J	Andrus, CFT; Crowe, DE; Sandweiss, DH; Reitz, EJ; Romanek, CS				Andrus, CFT; Crowe, DE; Sandweiss, DH; Reitz, EJ; Romanek, CS			Otolith delta O-18 record of mid-Holocene sea surface temperatures in Peru	SCIENCE			English	Article							EL-NINO; EARLY HISTORY; HOLOCENE; BP; FRACTIONATION; VARIABILITY; PACIFIC; CLIMATE; COMPLEX; ONSET	Peruvian sea catfish (Galeichthys peruvianus) sagittal otoliths preserve a record of modern and mid-Holocene sea surface temperatures (SSTs). Oxygen isotope profiles in otoliths excavated from Ostra [6010 +/- 90 years before the present (yr B.P.); 8degrees55'S] indicate that summer SSTs were similar to3degreesC warmer than those of the present. Siches ototiths (6450 +/- 110 yr B.P.; 4degrees40'S) recorded mean annual temperatures similar to3degrees to 4degreesC warmer than were measured under modern conditions. Trophic level and population diversity and equitability data from these faunal assemblages and other Peruvian archaeological sites support the isotope interpretations and suggest that upwelling of the Peru-Chile current intensified after similar to5000 yr B.P.	Univ Georgia, Dept Geol, Athens, GA 30602 USA; Univ Maine, Dept Anthropol, Orono, ME 04469 USA; Univ Maine, Inst Quaternary Res, Orono, ME 04469 USA; Univ Georgia, Dept Anthropol, Athens, GA 30602 USA; Univ Georgia, Georgia Museum Nat Hist, Athens, GA 30602 USA; Savannah River Ecol Lab, Aiken, SC 29802 USA	University System of Georgia; University of Georgia; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; United States Department of Energy (DOE); Savannah River Ecology Laboratory	Andrus, CFT (corresponding author), Univ Georgia, Dept Geol, Athens, GA 30602 USA.	andrus@gly.uga.edu	Sandweiss, Daniel/K-5808-2019	Andrus, Fred/0000-0002-4075-8380				Andrus CFT, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000652; Andrus CFT, 2000, J ARCHAEOL SCI, V27, P33, DOI 10.1006/jasc.1999.0417; Bush ABG, 2001, QUATERNARY RES, V55, P25, DOI 10.1006/qres.2000.2198; Clement AC, 2000, PALEOCEANOGRAPHY, V15, P731, DOI 10.1029/1999PA000466; COOKE R, 1993, ARQUELOGIA CONT, V4, P57; DeVries TJ, 1997, SCIENCE, V276, P965, DOI 10.1126/science.276.5314.965; FROESE R, 2001, FISHBASE; Gagan MK, 1998, SCIENCE, V279, P1014, DOI 10.1126/science.279.5353.1014; GROSSMAN EL, 1986, CHEM GEOL, V59, P59, DOI 10.1016/0168-9622(86)90057-6; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Ivany LC, 2000, NATURE, V407, P887, DOI 10.1038/35038044; Liu ZY, 2000, GEOPHYS RES LETT, V27, P2265, DOI 10.1029/2000GL011452; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; PERRIER C, 1994, GEOGR PHYS QUATERN, V48, P23, DOI 10.7202/032970ar; POZORSKI S, 1986, J FIELD ARCHAEOL, V13, P381, DOI 10.1179/jfa.1986.13.4.381; Pozorski S., 1979, ANN CARNEGIE MUS, V48, P337; Reitz EJ, 2001, INT J OSTEOARCHAEOL, V11, P163, DOI 10.1002/oa.554; REITZ EJ, UNPUB; Rodbell DT, 1999, SCIENCE, V283, P516, DOI 10.1126/science.283.5401.516; Romanek CS, 1996, COMP BIOCHEM PHYS A, V114, P71, DOI 10.1016/0300-9629(95)02094-2; Sandweiss DH, 1996, SCIENCE, V273, P1531, DOI 10.1126/science.273.5281.1531; Sandweiss DH, 1997, SCIENCE, V276, P966; Sandweiss DH, 1998, J COASTAL RES, V14, P367; Shannon C. E., 1949, MATH THEORY COMMUNIC; SHULMEISTER J, 1995, HOLOCENE, V5, P10, DOI 10.1177/095968369500500102; THOMPSON LG, 1995, SCIENCE, V269, P46, DOI 10.1126/science.269.5220.46; Thorrold SR, 1997, GEOCHIM COSMOCHIM AC, V61, P2909, DOI 10.1016/S0016-7037(97)00141-5; Tudhope AW, 2001, SCIENCE, V291, P1511, DOI 10.1126/science.1057969; Wells L. E., 1999, GEOARCHAE686 OLOGY, V14, P755, DOI DOI 10.1002/(SICI)1520-6548(199912)14:8<LESSTHAN>755::AID-GEA5<GREATERTHAN>3.0.CO;2-7; Wells LE, 1997, SCIENCE, V276, P966	30	104	111	3	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2002	295	5559					1508	1511		10.1126/science.1062004	http://dx.doi.org/10.1126/science.1062004			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11859190				2022-12-28	WOS:000173981300048
J	Hendy, EJ; Gagan, MK; Alibert, CA; McCulloch, MT; Lough, JM; Isdale, PJ				Hendy, EJ; Gagan, MK; Alibert, CA; McCulloch, MT; Lough, JM; Isdale, PJ			Abrupt decrease in tropical Pacific Sea surface salinity at end of Little Ice Age	SCIENCE			English	Article							GREAT-BARRIER-REEF; STABLE-ISOTOPE RECORD; TEMPERATURE VARIABILITY; SOUTHWEST PACIFIC; CLIMATE-CHANGE; CORAL; CIRCULATION; AUSTRALIA; OCEAN; RECONSTRUCTION	A 420-year history of strontium/calcium, uranium/calcium, and oxygen isotope ratios in eight coral cores from the Great Barrier Reef, Australia, indicates that sea surface temperature and salinity were higher in the 18th century than in the 20th century. An abrupt freshening after 1870 occurred simultaneously throughout the southwestern Pacific, coinciding with cooling tropical temperatures. Higher salinities between 1565 and 1870 are best explained by a combination of advection and wind-induced evaporation resulting from a strong latitudinal temperature gradient and intensified circulation. The global Little Ice Age glacial expansion may have been driven, in part, by greater poleward transport of water vapor from the tropical Pacific.	Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Australian National University; Australian Institute of Marine Science	Hendy, EJ (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia.		Gagan, Michael/L-5014-2018; Hendy, Erica J/H-4488-2016; Lough, Janice M/L-1682-2013; McCulloch, Malcolm T/C-3651-2009	Gagan, Michael/0000-0002-8279-323X; Hendy, Erica J/0000-0001-5949-4349; Lough, Janice M/0000-0002-3789-1009; McCulloch, Malcolm T/0000-0003-1538-1558				Alibert C, 1997, PALEOCEANOGRAPHY, V12, P345, DOI 10.1029/97PA00318; Bottomley M, 1990, GLOBAL OCEAN SURFACE; Bradley RS., 1993, HOLOCENE, V3, P367, DOI [10.1177/095968369300300409, DOI 10.1177/095968369300300409]; Briffa KR, 1998, NATURE, V393, P450, DOI 10.1038/30943; Crowley T. J., 1991, PALEOCLIMATOLOGY; Crowley TJ, 1999, PALEOCEANOGRAPHY, V14, P605, DOI 10.1029/1999PA900032; Crowley TJ, 2000, SCIENCE, V289, P270, DOI 10.1126/science.289.5477.270; Delcroix T, 1996, DEEP-SEA RES PT I, V43, P1123, DOI 10.1016/0967-0637(96)00048-9; Druffel ERM, 1999, J GEOPHYS RES-OCEANS, V104, P23607, DOI 10.1029/1999JC900212; DRUFFEL ERM, 1993, J GEOPHYS RES, V98, P20; Evans MN, 2000, PALEOCEANOGRAPHY, V15, P551, DOI 10.1029/2000PA000498; Gagan MK, 1998, SCIENCE, V279, P1014, DOI 10.1126/science.279.5353.1014; Grove JM, 1988, LITTLE ICE AGE; HENDY EJ, UNPUB; Isdale PJ, 1998, HOLOCENE, V8, P1, DOI 10.1191/095968398670905088; Jones PD, 2001, SCIENCE, V292, P662, DOI 10.1126/science.1059126; Jones PD, 1998, HOLOCENE, V8, P455, DOI 10.1191/095968398667194956; Kreutz KJ, 1997, SCIENCE, V277, P1294, DOI 10.1126/science.277.5330.1294; Lamb H.H., 1995, CLIMATE HIST MODERN, P211; Linsley BK, 2000, SCIENCE, V290, P1145, DOI 10.1126/science.290.5494.1145; LINSLEY BK, 1994, J GEOPHYS RES-OCEANS, V99, P9977, DOI 10.1029/94JC00360; Lough JM, 1997, INT J CLIMATOL, V17, P55, DOI 10.1002/(SICI)1097-0088(199701)17:1<55::AID-JOC109>3.0.CO;2-Z; Mann ME, 1998, NATURE, V392, P779, DOI 10.1038/33859; MCCULLOCH MT, 1994, GEOCHIM COSMOCHIM AC, V58, P2747, DOI 10.1016/0016-7037(94)90142-2; MIN GR, 1995, GEOCHIM COSMOCHIM AC, V59, P2025; Quinn TM, 1998, PALEOCEANOGRAPHY, V13, P412, DOI 10.1029/98PA00401; QUINN TM, 1993, QUATERNARY SCI REV, V12, P407, DOI 10.1016/S0277-3791(05)80005-8; Rayner N. A., 1996, VERSION 2 2 GLOBAL S; Rind D, 1998, J GEOPHYS RES-ATMOS, V103, P5943, DOI 10.1029/97JD03649; Rind D, 2000, QUATERNARY SCI REV, V19, P381, DOI 10.1016/S0277-3791(99)00070-0; Sokolov S, 2000, J MAR RES, V58, P223, DOI 10.1357/002224000321511151; STUIVER M, 1986, RADIOCARBON, V28, P980, DOI 10.1017/S0033822200060264; SWART PK, 1980, NATURE, V283, P557, DOI 10.1038/283557a0; THOMPSON LG, 1986, SCIENCE, V234, P361, DOI 10.1126/science.234.4774.361; Wolanski E., 1994, PHYSICAL OCEANOGRAPH	35	222	234	3	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2002	295	5559					1511	1514		10.1126/science.1067693	http://dx.doi.org/10.1126/science.1067693			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11859191				2022-12-28	WOS:000173981300049
J	von Gunten, CF				von Gunten, CF			Secondary and tertiary palliative care in US hospitals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TERMINALLY ILL PATIENTS; LIFE; END; CONSULTATION; SERVICE; EXPERIENCE; MANAGEMENT; ILLNESS; FAMILY; UNIT	Palliative care services provide secondary and tertiary levels of palliative care, the interdisciplinary care of patients in which the goal is comfort and quality of life. Primary palliative care refers to the basic skills and competencies required of all physicians and other health care professionals. Secondary palliative care refers to the specialist clinicians and organizations that provide consultation and specialty care. Tertiary palliative care refers to the academic medical centers where specialist knowledge for the most complex cases is practiced, researched, and taught. The case of Reverend J, a man with advanced cancer admitted to an acute palliative care unit in a teaching hospital, illustrates the use of secondary and tertiary clinical palliative care services in hospitals and health care systems.	San Diego Hospice, Ctr Palliat Studies, San Diego, CA USA; Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA	University of California System; University of California San Diego	von Gunten, CF (corresponding author), 4311 3rd Ave, San Diego, CA 92103 USA.							Axelsson B, 1998, PALLIATIVE MED, V12, P41, DOI 10.1191/026921698671336362; BILLINGS JA, IN PRESS J PALLIAT M; Byock I, 1997, DYING WELL PROSPECT; Campbell M L, 1996, AACN Clin Issues, V7, P159, DOI 10.1097/00044067-199602000-00015; Campbell ML, 1997, CRIT CARE MED, V25, P197, DOI 10.1097/00003246-199701000-00034; CAMPBELL ML, 1991, HEART LUNG, V20, P345; CARLSON RW, 1988, JAMA-J AM MED ASSOC, V259, P378, DOI 10.1001/jama.259.3.378; Cassell, 1994, NATURE SUFFERING GOA; Cohen SR, 2001, PALLIATIVE MED, V15, P363, DOI 10.1191/026921601680419401; Dowdy MD, 1998, CRIT CARE MED, V26, P252, DOI 10.1097/00003246-199802000-00020; DOYLE D, 1997, OXFORD TXB PALLIATIV; Emanuel EJ, 1999, NEW ENGL J MED, V341, P956, DOI 10.1056/NEJM199909233411306; Emanuel EJ, 2000, ANN INTERN MED, V132, P451, DOI 10.7326/0003-4819-132-6-200003210-00005; EMANUEL LL, 2002, EPEC CURRICULUM ED P; FERRELL E, 2002, END LIFE NURSING ED; Field MJ, 1997, APPROACHING DEATH IM; Frankl VE, 1963, MANS SEARCH MEANING; Jurchak M, 2000, J CLIN ETHIC, V11, P49; Kellar N, 1996, J NURS ADMIN, V26, P16, DOI 10.1097/00005110-199603000-00011; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Lanser P, 2001, Healthc Benchmarks, V8, P68; Lanser P, 2001, HEALTHC BENCHMARKS, V8, P62; Lilly CM, 2000, AM J MED, V109, P469, DOI 10.1016/S0002-9343(00)00524-6; Lothian ST, 1999, AM J HEALTH-SYST PH, V56, P1119, DOI 10.1093/ajhp/56.11.1119; Lynn J, 2000, JAMA-J AM MED ASSOC, V284, P2508, DOI 10.1001/jama.284.19.2508; Manfredi PL, 2000, J PAIN SYMPTOM MANAG, V20, P166, DOI 10.1016/S0885-3924(00)00163-9; MEIER D, 2002, PLANNING HOSP BASED; MUIRE C, 1999, TOPICS PALLIATIVE CA, V4, P131; Ng K, 1998, J PAIN SYMPTOM MANAG, V16, P307, DOI 10.1016/S0885-3924(98)00097-9; PAN CS, IN PRESS J PALLIAT M; RABOW MW, IN PRESS J PALLIAT M; Saunders C, 1984, MANAGEMENT TERMINAL, P232; SAUNDERS DC, 1982, MED CLIN N AM, V66, P1169, DOI 10.1016/S0025-7125(16)31390-6; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; TENO J, 2002, TOOLKIT INSTRUMENTS; TENO J, 2002, BROWN SITE DEATH ATL; von Gunten C F, 1998, J Palliat Med, V1, P45; von Gunten C F, 2000, J Palliat Med, V3, P441; von Gunten C F, 1998, J Palliat Med, V1, P265, DOI 10.1089/jpm.1998.1.265; von Gunten C F, 1995, Am J Hosp Palliat Care, V12, P38, DOI 10.1177/104990919501200413; von Gunten C F, 2000, J Palliat Med, V3, P157, DOI 10.1089/10966210050085223; VONGUNTEN CF, 2002, CAPC MANUAL EVERYTHI; Weiss SC, 2001, LANCET, V357, P1311, DOI 10.1016/S0140-6736(00)04515-3; Weissman DE, 1997, ARCH INTERN MED, V157, P733, DOI 10.1001/archinte.157.7.733; WENNBERG G, 2002, DARTMOUTH ATLAS HLTH; Wilkinson EK, 1999, PALLIATIVE MED, V13, P197, DOI 10.1191/026921699673563105	47	123	125	0	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2002	287	7					875	881		10.1001/jama.287.7.875	http://dx.doi.org/10.1001/jama.287.7.875			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	522XP	11851580				2022-12-28	WOS:000173922500027
J	Aitchison, JD; Rout, MP				Aitchison, JD; Rout, MP			A tense time for the nuclear envelope	CELL			English	Review							CYTOPLASMIC DYNEIN; PORE COMPLEXES; MEMBRANE; MITOSIS; BREAKDOWN; PROTEINS; LAMIN	When many cells divide, the nuclear envelope poses a problem: the spindle microtubules can't access the chromosomes. Two recent papers in Cell describe how the spindle solves this problem by literally pulling open the nucleus at the beginning of mitosis.	Rockefeller Univ, New York, NY 10021 USA; Inst Syst Biol, Seattle, WA USA	Rockefeller University; Institute for Systems Biology (ISB)	Rout, MP (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.		Rout, Michael/Y-7090-2018	Rout, Michael/0000-0003-2010-706X				Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; BUSSON S, 1997, CELL STRUCT FUNCT, V22, P621; Collas P, 2000, TRENDS CELL BIOL, V10, P5, DOI 10.1016/S0962-8924(99)01697-9; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; Dilworth DJ, 2001, J CELL BIOL, V153, P1465, DOI 10.1083/jcb.153.7.1465; ELLENBERG J, 1997, BIOCHEM BIOPH RES CO, V238, P240; GANT TM, 1997, ANNU REV GENET, V31, P277; Georgatos SD, 1997, J CELL SCI, V110, P2129; Georgatos SD, 2001, EMBO J, V20, P2989, DOI 10.1093/emboj/20.12.2989; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Karcher RL, 2002, TRENDS CELL BIOL, V12, P21, DOI 10.1016/S0962-8924(01)02184-5; Lee KK, 2000, MOL BIOL CELL, V11, P3089, DOI 10.1091/mbc.11.9.3089; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; ROBBINS E, 1964, J CELL BIOL, V21, P429, DOI 10.1083/jcb.21.3.429; Robinson JT, 1999, J CELL BIOL, V146, P597, DOI 10.1083/jcb.146.3.597; Salina D, 2002, CELL, V108, P97, DOI 10.1016/S0092-8674(01)00628-6; Terasaki M, 2001, MOL BIOL CELL, V12, P503, DOI 10.1091/mbc.12.2.503; VIGERS GPA, 1991, J CELL BIOL, V112, P545, DOI 10.1083/jcb.112.4.545; Wilson KL, 2001, CELL, V104, P647, DOI 10.1016/S0092-8674(02)01452-6; Worman HJ, 2000, J MEMBRANE BIOL, V177, P1, DOI 10.1007/s002320001096	20	11	12	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 8	2002	108	3					301	304		10.1016/S0092-8674(02)00638-4	http://dx.doi.org/10.1016/S0092-8674(02)00638-4			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	520VB	11853664	Bronze			2022-12-28	WOS:000173801600002
J	Akula, SM; Pramod, NP; Wang, FZ; Chandran, B				Akula, SM; Pramod, NP; Wang, FZ; Chandran, B			Integrin alpha 3 beta 1 (CD 49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells	CELL			English	Article							TYROSINE PHOSPHORYLATION; HUMAN-HERPESVIRUS-8; ADHESION; VIRUS; ALPHA-V-BETA-3; SURFACE; MEDIATE	Human herpesvirus-8 (HHV-8) is implicated in the pathogenesis of Kaposi's sarcoma. HHV-8 envelope glycoprotein B possesses the RGD motif known to interact with integrin molecules, and HHV-8 infectivity was inhibited by RGD peptides, antibodies against RGD-dependent alpha3 and beta1 integrins, and by soluble alpha3beta1 integrin. Expression of human alpha3 integrin increased the infectivity of virus for Chinese hamster ovary cells. Anti-gB antibodies immunoprecipitated the virus-alpha3 and -beta1 complexes, and virus binding studies suggest a role for alpha3beta1 in HHV-8 entry. Further, HHV-8 infection induced the integrin-mediated activation of focal adhesion kinase (FAK). These findings implicate a role for alpha3beta1 integrin and the associated signaling pathways in HHV-8 entry into the target cells.	Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Chandran, B (corresponding author), Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.				NATIONAL CANCER INSTITUTE [R01CA082056, R01CA075911] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016443] Funding Source: NIH RePORTER; NCI NIH HHS [CA 75911, CA 82056] Funding Source: Medline; NCRR NIH HHS [RR16443] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Akula SM, 2001, VIROLOGY, V282, P245, DOI 10.1006/viro.2000.0851; Akula SM, 2001, VIROLOGY, V284, P235, DOI 10.1006/viro.2001.0921; Anderson HA, 1996, MOL BIOL CELL, V7, P1825, DOI 10.1091/mbc.7.11.1825; Antman K, 2000, NEW ENGL J MED, V342, P1027, DOI 10.1056/NEJM200004063421407; Barillari G, 1999, BLOOD, V94, P663; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Cerimele F, 2001, J VIROL, V75, P2435, DOI 10.1128/JVI.75.5.2435-2443.2001; COMPTON T, 1992, VIROLOGY, V191, P387, DOI 10.1016/0042-6822(92)90200-9; Ganem D, 1998, CURR CLIN TOPICS INF, V18, P237; Gavrilovskaya IN, 1998, P NATL ACAD SCI USA, V95, P7074, DOI 10.1073/pnas.95.12.7074; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Guerrero CA, 2000, P NATL ACAD SCI USA, V97, P14644, DOI 10.1073/pnas.250299897; Hewish MJ, 2000, J VIROL, V74, P228, DOI 10.1128/JVI.74.1.228-236.2000; Li E, 2001, J VIROL, V75, P5405, DOI 10.1128/JVI.75.11.5405-5409.2001; McLean GW, 2000, J BIOL CHEM, V275, P23333, DOI 10.1074/jbc.M909322199; Meng YX, 1999, VIROLOGY, V261, P106, DOI 10.1006/viro.1999.9853; NEMEROW GR, 1984, VIROLOGY, V132, P186, DOI 10.1016/0042-6822(84)90102-8; Nemerow GR, 2000, VIROLOGY, V274, P1, DOI 10.1006/viro.2000.0468; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Renne R, 1998, J VIROL, V72, P5182, DOI 10.1128/JVI.72.6.5182-5188.1998; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043; SCHULZ TF, 1998, HUMAN TUMOR VIRUSES, V8, P87; Shaw AM, 2000, VIROLOGY, V268, P159, DOI 10.1006/viro.1999.0164; Spear PG, 2000, VIROLOGY, V275, P1, DOI 10.1006/viro.2000.0529; Triantafilou K, 2000, J VIROL, V74, P5856, DOI 10.1128/JVI.74.13.5856-5862.2000; Vieira J, 2001, J VIROL, V75, P1378, DOI 10.1128/JVI.75.3.1378-1386.2001; Wang FZ, 2001, J VIROL, V75, P7517, DOI 10.1128/JVI.75.16.7517-7527.2001; WEITZMAN JB, 1995, J CELL SCI, V108, P3635; WU CY, 1995, J CELL SCI, V108, P2511; Zhu LJ, 1999, VIROLOGY, V262, P237, DOI 10.1006/viro.1999.9900	31	302	315	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 8	2002	108	3					407	419		10.1016/S0092-8674(02)00628-1	http://dx.doi.org/10.1016/S0092-8674(02)00628-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	520VB	11853674	Bronze			2022-12-28	WOS:000173801600012
J	Bernier-Villamor, V; Sampson, DA; Matunis, MJ; Lima, CD				Bernier-Villamor, V; Sampson, DA; Matunis, MJ; Lima, CD			Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1	CELL			English	Article							CRYSTAL-STRUCTURE; ANOMALOUS DIFFRACTION; TUMOR-SUPPRESSOR; PROTEIN; INSIGHTS; IDENTIFICATION; DEGRADATION; HOMOLOG; DOMAIN; MAD	E2 enzymes catalyze attachment of ubiquitin and ubiquitin-like proteins to lysine residues directly or through E3-mediated reactions. The small ubiquitin-like modifier SUMO regulates nuclear transport, stress response, and signal transduction in eukaryotes and is essential for cell-cycle progression in yeast. In contrast to most ubiquitin conjugation, the SUMO E2 enzyme Ubc9 is sufficient for substrate recognition and lysine modification of known SUMO targets. Crystallographic analysis of a complex between mammalian Ubc9 and a C-terminal domain of RanGAP1 at 2.5 Angstrom reveals structural determinants for recognition of consensus SUMO modification sequences found within SUMO-conjugated proteins. Structure-based mutagenesis and biochemical analysis of Ubc9 and RanGAP1 reveal distinct motifs required for substrate binding and SUMO modification of p53, IkappaBalpha, and RanGAP1.	Cornell Univ, Weill Med Coll, Dept Biochem, Struct Biol Program, New York, NY 10021 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA	Cornell University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lima, CD (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, Struct Biol Program, New York, NY 10021 USA.	lima@pinky.med.cornell.edu		Lima, Christopher/0000-0002-9163-6092; Matunis, Michael/0000-0002-9350-6611	NIGMS NIH HHS [GM60980] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060980] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Gonen H, 1999, J BIOL CHEM, V274, P14823, DOI 10.1074/jbc.274.21.14823; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hillig RC, 1999, MOL CELL, V3, P781, DOI 10.1016/S1097-2765(01)80010-1; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; JEFFREY PD, 1995, SCIENCE, V267, P1498, DOI 10.1126/science.7878469; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Johnson EW, 1997, J BACK MUSCULOSKELET, V9, P3, DOI 10.3233/BMR-1997-9102; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kamitani T, 1998, J BIOL CHEM, V273, P26675, DOI 10.1074/jbc.273.41.26675; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; MELUH PB, 1995, MOL BIOL CELL, V6, P793, DOI 10.1091/mbc.6.7.793; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Saitoh H, 1997, TRENDS BIOCHEM SCI, V22, P374, DOI 10.1016/S0968-0004(97)01102-X; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; Sternsdorf T, 1997, J CELL BIOL, V139, P1621, DOI 10.1083/jcb.139.7.1621; Takahashi Y, 1999, BIOCHEM BIOPH RES CO, V259, P582, DOI 10.1006/bbrc.1999.0821; Takahashi Y, 2001, GENE, V275, P223, DOI 10.1016/S0378-1119(01)00662-X; Tanaka K, 1999, MOL CELL BIOL, V19, P8660; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tong H, 1997, J BIOL CHEM, V272, P21381, DOI 10.1074/jbc.272.34.21381; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	46	436	453	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2002	108	3					345	356		10.1016/S0092-8674(02)00630-X	http://dx.doi.org/10.1016/S0092-8674(02)00630-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	520VB	11853669	Bronze			2022-12-28	WOS:000173801600007
J	Pennartz, CMA; de Jeu, MTG; Bos, NPA; Schaap, J; Geurtsen, AMS				Pennartz, CMA; de Jeu, MTG; Bos, NPA; Schaap, J; Geurtsen, AMS			Diurnal modulation of pacemaker potentials and calcium current in the mammalian circadian clock	NATURE			English	Article							RAT SUPRACHIASMATIC NUCLEUS; CELLULAR MECHANISMS; MEMBRANE-PROPERTIES; GRANULE NEURONS; MULTIPLE TYPES; GUINEA-PIG; CHANNELS; SLICES; CELLS; RHYTHMICITY	The central biological clock of the mammalian brain is located in the suprachiasmatic nucleus. This hypothalamic region contains neurons that generate a circadian rhythm on a single-cell basis. Clock cells transmit their circadian timing signals to other brain areas by diurnal modulation of their spontaneous firing rate. The intracellular mechanism underlying rhythm generation is thought to consist of one or more self-regulating molecular loops, but it is unknown how these loops interact with the plasma membrane to modulate the ionic conductances that regulate firing behaviour. Here we demonstrate a diurnal modulation of Ca2+ current in suprachiasmatic neurons. This current strongly contributes to the generation of spontaneous oscillations in membrane potential, which occur selectively during daytime and are tightly coupled to spike generation. Thus, day-night modulation of Ca2+ current is a central step in transducing the intracellular cycling of molecular clocks to the rhythm in spontaneous firing rate.	Netherlands Inst Brain Res, Grad Sch Neurosci Amsterdam, NL-1105 AZ Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam	Pennartz, CMA (corresponding author), Netherlands Inst Brain Res, Grad Sch Neurosci Amsterdam, Meibergdreef 33, NL-1105 AZ Amsterdam, Netherlands.		Elassaiss-Schaap, Jeroen/Q-5451-2016; Pennartz, Cyriel/B-7508-2015	Pennartz, Cyriel/0000-0001-8328-1175				ADAMS ME, 1993, MOL PHARMACOL, V44, P681; Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Avery RB, 1996, J NEUROSCI, V16, P5567; BLAXTER TJ, 1989, J PHYSIOL-LONDON, V412, P93, DOI 10.1113/jphysiol.1989.sp017605; BLOCK GD, 1993, INT REV CYTOL, V146, P83, DOI 10.1016/S0074-7696(08)60381-2; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Colwell CS, 2000, EUR J NEUROSCI, V12, P571, DOI 10.1046/j.1460-9568.2000.00939.x; de Jeu M, 1998, NEUROREPORT, V9, P3725, DOI 10.1097/00001756-199811160-00028; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; DSouza T, 1996, NATURE, V382, P165, DOI 10.1038/382165a0; Fisher TE, 1996, TRENDS NEUROSCI, V19, P440; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; GREEN DJ, 1982, BRAIN RES, V245, P198, DOI 10.1016/0006-8993(82)90361-4; HUANG RC, 1993, J NEUROPHYSIOL, V70, P1692, DOI 10.1152/jn.1993.70.4.1692; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; Jiang ZG, 1997, J PHYSIOL-LONDON, V499, P141, DOI 10.1113/jphysiol.1997.sp021917; KASAI H, 1992, J PHYSIOL-LONDON, V448, P161, DOI 10.1113/jphysiol.1992.sp019035; Ko GYP, 2001, NEURON, V29, P255, DOI 10.1016/S0896-6273(01)00195-7; MICHEL S, 1993, SCIENCE, V259, P239, DOI 10.1126/science.8421785; MOGUL DJ, 1991, J PHYSIOL-LONDON, V433, P259, DOI 10.1113/jphysiol.1991.sp018425; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; NEDERGAARD S, 1993, J PHYSIOL-LONDON, V466, P727; OROURKE B, 1992, SCIENCE, V257, P245, DOI 10.1126/science.1321495; Pennartz CMA, 1998, J PHYSIOL-LONDON, V506, P775, DOI 10.1111/j.1469-7793.1998.775bv.x; Pennartz CMA, 1997, J NEUROPHYSIOL, V78, P1811, DOI 10.1152/jn.1997.78.4.1811; RANDALL A, 1995, J NEUROSCI, V15, P2995; REPPERT SM, 2001, ANNU REV PHYSIOL, V63, P547; SCHWARTZ WJ, 1987, P NATL ACAD SCI USA, V84, P1694, DOI 10.1073/pnas.84.6.1694; TAKAHASHI JS, 1982, SCIENCE, V217, P1104, DOI 10.1126/science.6287576; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7	30	186	189	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 21	2002	416	6878					286	290		10.1038/nature728	http://dx.doi.org/10.1038/nature728			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532NP	11875398				2022-12-28	WOS:000174482200033
J	Sanchez, PA				Sanchez, PA			Ecology - Soil fertility and hunger in Africa	SCIENCE			English	Editorial Material							IMPROVED FALLOWS; ADOPTION; KENYA		Int Ctr Res Agroforestry, Nairobi, Kenya	CGIAR; World Agroforestry (ICRAF)	Sanchez, PA (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.							BURESH RJ, 1997, SPEC PUBL SOIL SCI S, V51; *CONS GROUP INT AG, 2001, CONTR MAD CGIAR ITS; Franzel S, 1999, AGROFOREST SYST, V47, P305, DOI 10.1023/A:1006292119954; Gyiele, 1999, EC ASSESSMENT SOIL N; *INT FOOD POL RES, 2001, SUST FOOD SEC ALL 20; Jama B, 2000, AGROFOREST SYST, V49, P201, DOI 10.1023/A:1006339025728; Kwesiga FR, 1999, AGROFOREST SYST, V47, P49, DOI 10.1023/A:1006256323647; Lynam JK, 1998, AGR ECOSYST ENVIRON, V71, P1; *MICH STAT U, 2001, PARTN CUT HUNG AFR 2; Narayan D, 2000, VOICES POOR; PINSTRUPANDERSE.P, 2000, FOOD SECURITY PROBLE; PINSTRUPANDERSE.P, 1999, WORLD FOOD PROSPECTS; Place F, 1999, AGROFOREST SYST, V47, P323, DOI 10.1023/A:1006248304024; ROMELSEE R, 2001, 20013 INT CTR RES AG; Sanchez P. A., 2002, P23; Sanchez P. A., 2001, Tradeoffs or synergies? Agricultural intensification, economic development and the environment, P325, DOI 10.1079/9780851994352.0325; Sanchez P.A., 1997, SSSA SPECIAL PUBLICA, P1, DOI DOI 10.2136/SSSASPECPUB51.C1; Sanchez PA, 1997, PHILOS T R SOC B, V352, P949, DOI 10.1098/rstb.1997.0074; SMALING EMA, 1998, AGR ECOSYST ENV, V71; [No title captured]	20	624	648	2	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2002	295	5562					2019	2020		10.1126/science.1065256	http://dx.doi.org/10.1126/science.1065256			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532AY	11896257				2022-12-28	WOS:000174450500025
J	Bell, FI; McEwen, IJ; Viney, C				Bell, FI; McEwen, IJ; Viney, C			Fibre science - Supercontraction stress in wet spider dragline	NATURE			English	Article							AMPULLATE SILK FIBERS; BEHAVIOR; ARANEAE		Heriot Watt Univ, Dept Chem, Edinburgh EH14 4AS, Midlothian, Scotland	Heriot Watt University	Bell, FI (corresponding author), Heriot Watt Univ, Dept Chem, Edinburgh EH14 4AS, Midlothian, Scotland.	c.viney@hw.ac.uk						Craig CL, 2000, MOL BIOL EVOL, V17, P1904, DOI 10.1093/oxfordjournals.molbev.a026292; Craven JP, 2000, COMPOS PART A-APPL S, V31, P653, DOI 10.1016/S1359-835X(00)00042-7; GOSLINE J, 1995, BIOMIMETICS DESIGN P, P237; GOSLINE JM, 1984, NATURE, V309, P551, DOI 10.1038/309551a0; LEWIS RV, 1992, ACCOUNTS CHEM RES, V25, P392, DOI 10.1021/ar00021a002; O'Brien JP, 1998, ADV MATER, V10, P1185, DOI 10.1002/(SICI)1521-4095(199810)10:15<1185::AID-ADMA1185>3.0.CO;2-T; STAUFFER SL, 1994, J ARACHNOL, V22, P5; THIEL B, 1994, MATER RES SOC SYMP P, V330, P21; Tillinghast E.K., 1987, P203; WORK RW, 1985, J EXP BIOL, V118, P379; WORK RW, 1977, TEXT RES J, V47, P650, DOI 10.1177/004051757704701003; WORK RW, 1981, J ARACHNOL, V9, P299; Yang ZT, 2000, J AM CHEM SOC, V122, P9019, DOI 10.1021/ja0017099	13	94	96	4	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2002	416	6876					37	37		10.1038/416037a	http://dx.doi.org/10.1038/416037a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882884	Bronze			2022-12-28	WOS:000174211600030
J	Hansen, M; Kurinczuk, JJ; Bower, C; Webb, S				Hansen, M; Kurinczuk, JJ; Bower, C; Webb, S			The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONGENITAL-MALFORMATIONS; CHILDREN BORN; REPRODUCTION; ICSI	Background: It is not known whether infants conceived with use of intracytoplasmic sperm injection or in vitro fertilization have a higher risk of birth defects than infants conceived naturally. Methods: We obtained data from three registries in Western Australia on births, births after assisted conception, and major birth defects in infants born between 1993 and 1997. We assessed the prevalence of major birth defects diagnosed by one year of age in infants conceived naturally or with use of intracytoplasmic sperm injection or in vitro fertilization. Results: Twenty-six of the 301 infants conceived with intracytoplasmic sperm injection (8.6 percent) and 75 of the 837 infants conceived with in vitro fertilization (9.0 percent) had a major birth defect diagnosed by one year of age, as compared with 168 of the 4000 naturally conceived infants (4.2 percent; P<0.001 for the comparison between either type of technology and natural conception). As compared with natural conception, the odds ratio for a major birth defect by one year of age, after adjustment for maternal age and parity, the sex of the infant, and correlation between siblings, was 2.0 (95 percent confidence interval, 1.3 to 3.2) with intracytoplasmic sperm injection, and 2.0 (95 percent confidence interval, 1.5 to 2.9) with in vitro fertilization. Infants conceived with use of assisted reproductive technology were more likely than naturally conceived infants to have multiple major defects and to have chromosomal and musculoskeletal defects. Conclusions: Infants conceived with use of intracytoplasmic sperm injection or in vitro fertilization have twice as high a risk of a major birth defect as naturally conceived infants.	Univ Leicester, Dept Epidemiol & Publ Hlth, Leicester LE1 6TP, Leics, England; Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; Univ Western Australia, Ctr Child Hlth Res, Perth, WA 6009, Australia; Hlth Dept Western Australia, Perth, WA, Australia; Western Australian Birth Defects Registry, Perth, WA, Australia	University of Leicester; Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Western Australia	Kurinczuk, JJ (corresponding author), Univ Leicester, Dept Epidemiol & Publ Hlth, 22-28 Princess Rd W, Leicester LE1 6TP, Leics, England.	jjk6@le.ac.uk	Esteves, Sandro C./G-4416-2012; Hansen, Michele L/E-1512-2014	Esteves, Sandro C./0000-0002-1313-9680; Hansen, Michele L/0000-0002-6817-2031				Bergh T, 1999, LANCET, V354, P1579, DOI 10.1016/S0140-6736(99)04345-7; Bower C, 2001, TERATOLOGY, V63, P23, DOI 10.1002/1096-9926(200101)63:1<23::AID-TERA1004>3.0.CO;2-S; BOWER C, 2000, REPORT BIRTH DEFECTS; Buitendijk SE, 1999, INT J TECHNOL ASSESS, V15, P52, DOI 10.1017/S0266462399015160; *COLL STAT, 1999, STAT STAT SOFTW REL; CUMMINS JM, 1995, HUM REPROD, V10, P138, DOI 10.1093/humrep/10.suppl_1.138; DEJONGE CJ, 1995, HUM REPROD, V10, P2518, DOI 10.1093/oxfordjournals.humrep.a135733; GEE V, 2000, 16 HLTH DEP W AUSTR; Hawkins MM, 1999, LANCET, V354, P1906, DOI 10.1016/S0140-6736(05)76874-4; Kurinczuk JJ, 1997, BRIT MED J, V315, P1260, DOI 10.1136/bmj.315.7118.1260; LANCASTER PAL, 1985, CLIN OBSTET GYNAECOL, V12, P847; Licata D, 1993, Paediatr Perinat Epidemiol, V7, P222; *MATCHW TECHN, 1996, AUTOMATCH GEN LINK S; RIZK B, 1991, HUM REPROD, V6, P1259, DOI 10.1093/oxfordjournals.humrep.a137523; Silver RI, 1999, J UROLOGY, V161, P1954, DOI 10.1016/S0022-5347(05)68863-5; Simpson JL, 1998, INT CONGR SER, V1183, P199; *SPSS, 1999, SPSS WIND; te Velde ER, 1998, LANCET, V351, P1524, DOI 10.1016/S0140-6736(98)22021-6; Van Steirteghem A, 1998, NEW ENGL J MED, V338, P194, DOI 10.1056/NEJM199801153380312; Wennerholm UB, 2000, HUM REPROD, V15, P944, DOI 10.1093/humrep/15.4.944	20	763	801	1	74	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2002	346	10					725	730		10.1056/NEJMoa010035	http://dx.doi.org/10.1056/NEJMoa010035			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527UA	11882727	Green Published			2022-12-28	WOS:000174205000002
J	Chen, XX; Dam, MA; Ono, K; Mal, A; Shen, HB; Nutt, SR; Sheran, K; Wudl, F				Chen, XX; Dam, MA; Ono, K; Mal, A; Shen, HB; Nutt, SR; Sheran, K; Wudl, F			A thermally re-mendable cross-linked polymeric material	SCIENCE			English	Article							DIELS-ALDER REACTION; DIFFERENTIAL SCANNING CALORIMETRY; POLY(METHYL METHACRYLATE); COMPOSITES; MECHANICS; FRACTURE; REPAIR; DSC	We have developed a transparent organic polymeric material that can repeatedly mend or "re-mend" itself under mild conditions. The material is a tough solid at room temperature and below with mechanical properties equaling those of commercial epoxy resins. At temperatures above 120degreesC, approximately 30% (as determined by solid-state nuclear magnetic resonance spectroscopy) of "intermonomer" linkages disconnect but then reconnect upon cooling, This process is fully reversible and can be used to restore a fractured part of the polymer multiple times, and it does not require additional ingredients such as a catalyst, additional monomer, or special surface treatment of the fractured interface.	Univ Calif Los Angeles, Exot Mat Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Mech & Aerosp Engn, Los Angeles, CA 90095 USA; Univ So Calif, Dept Mat Sci, Los Angeles, CA 90089 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Southern California	Wudl, F (corresponding author), Univ Calif Los Angeles, Exot Mat Inst, 405 Hilgard Ave, Los Angeles, CA 90095 USA.	wudl@chem.ucla.edu						BARTON JM, 1985, ADV POLYM SCI, V72, P111; BUCKNALL CB, 1980, POLYM ENG SCI, V20, P432, DOI 10.1002/pen.760200609; CHUJO Y, 1990, MACROMOLECULES, V23, P2636, DOI 10.1021/ma00212a007; DRY C, 1993, P SOC PHOTO-OPT INS, V1916, P438, DOI 10.1117/12.148501; Dry C, 1996, COMPOS STRUCT, V35, P263, DOI 10.1016/0263-8223(96)00033-5; ENGLE LP, 1993, J MACROMOL SCI R M C, VC33, P239, DOI 10.1080/15321799308021436; Goodman S. H., 1998, HDB THERMOSET PLASTI; Gousse C, 1998, MACROMOLECULES, V31, P314, DOI 10.1021/ma9710141; Imai Y, 2000, MACROMOLECULES, V33, P4343, DOI 10.1021/ma991899b; ISAACS NS, 1997, PHYSICAL ORGANIC CHE; Jones JR, 1999, MACROMOLECULES, V32, P5786, DOI 10.1021/ma990638z; JUD K, 1981, J MATER SCI, V16, P204, DOI 10.1007/BF00552073; KAISER T, 1989, PROG POLYM SCI, V14, P373, DOI 10.1016/0079-6700(89)90007-5; KENNEDY JP, 1979, J POLYM SCI POL CHEM, V17, P2039, DOI 10.1002/pol.1979.170170714; KINLOCH AJ, 1985, ADV POLYM SCI, V72, P45; LIN CB, 1990, POLYM ENG SCI, V30, P1399, DOI 10.1002/pen.760302109; Mark J. E., 1999, POLYM DATA HDB, p[91, 464]; McElhanon JR, 2001, ORG LETT, V3, P2681, DOI 10.1021/ol0101281; MCMASTER RC, 1982, NONDESTRUCTIVE TESTI; Murakami Y., 1987, STRESS INTENSITY FAC, V1, P18; Pyda M, 2000, J POLYM SCI POL PHYS, V38, P622, DOI 10.1002/(SICI)1099-0488(20000215)38:4<622::AID-POLB14>3.0.CO;2-U; Raghavan J, 1999, J APPL POLYM SCI, V71, P775, DOI 10.1002/(SICI)1097-4628(19990131)71:5<775::AID-APP11>3.3.CO;2-9; Ribeiro M, 1999, J THERM ANAL CALORIM, V57, P253, DOI 10.1023/A:1010112801307; Rickborn B., 1998, ORG REACTIONS, V52, P1; SAUER JA, 1990, ADV POLYM SCI, V91, P69; Song M, 2001, J THERM ANAL CALORIM, V63, P699, DOI 10.1023/A:1010131802572; TALREJA R, 1994, DAMAGE MECH COMPOSIT, P139; WANG PP, 1994, J POLYM SCI POL PHYS, V32, P1217, DOI 10.1002/polb.1994.090320709; White SR, 2001, NATURE, V409, P794, DOI 10.1038/35057232; Wool R. P., 1995, POLYM INTERFACES STR, P445	30	1845	1939	59	1391	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 1	2002	295	5560					1698	1702		10.1126/science.1065879	http://dx.doi.org/10.1126/science.1065879			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872836				2022-12-28	WOS:000174212900042
J	Mauk, BH; Clarke, JT; Grodent, D; Waite, JH; Paranicas, CP; Williams, DJ				Mauk, BH; Clarke, JT; Grodent, D; Waite, JH; Paranicas, CP; Williams, DJ			Transient aurora on Jupiter from injections of magnetospheric electrons	NATURE			English	Article							INNER MAGNETOSPHERE; PARTICLE SIGNATURES; IO FOOTPRINT; MODELS; FIELD	Energetic electrons and ions that are trapped in Earth's magnetosphere can suddenly be accelerated towards the planet(1-5). Some dynamic features of Earth's aurora (the northern and southern lights) are created by the fraction of these injected particles that travels along magnetic field lines and hits the upper atmosphere(4). Jupiter's aurora appears similar to Earth's in some respects; both appear as large ovals circling the poles and both show transient events(6-11). But the magnetospheres of Jupiter and Earth are so different-particularly in the way they are powered-that it is not known whether the magnetospheric drivers(12) of Earth's aurora also cause them on Jupiter. Here we show a direct relationship between Earth-like injections of electrons in Jupiter's magnetosphere and a transient auroral feature in Jupiter's polar region. This relationship is remarkably similar to what happens at Earth, and therefore suggests that despite the large differences between planetary magnetospheres, some processes that generate aurorae are the same throughout the Solar System.	Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; Boston Univ, Dept Astron, Boston, MA 02215 USA; Boston Univ, Ctr Space Phys, Boston, MA 02215 USA; Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Boston University; Boston University; University of Michigan System; University of Michigan	Mauk, BH (corresponding author), Johns Hopkins Univ, Appl Phys Lab, 11100 Johns Hopkins Rd, Laurel, MD 20723 USA.		Mauk, Barry H/E-8420-2017; Clarke, John/C-8644-2013; Paranicas, Christopher/B-1470-2016	Mauk, Barry H/0000-0001-9789-3797; Paranicas, Christopher/0000-0002-4391-8255				Ajello J, 1998, J GEOPHYS RES-PLANET, V103, P20125, DOI 10.1029/98JE00832; [Anonymous], 1991, AURORAL PHYS; ARNOLDY RL, 1969, J GEOPHYS RES, V74, P5019, DOI 10.1029/JA074i021p05019; Ballester GE, 1996, SCIENCE, V274, P409, DOI 10.1126/science.274.5286.409; Clarke JT, 1996, SCIENCE, V274, P404, DOI 10.1126/science.274.5286.404; CONNERNEY JEP, 1981, J GEOPHYS RES-SPACE, V86, P8370, DOI 10.1029/JA086iA10p08370; Connerney JEP, 1998, J GEOPHYS RES-SPACE, V103, P11929, DOI 10.1029/97JA03726; DEFOREST SE, 1971, J GEOPHYS RES, V76, P3587, DOI 10.1029/JA076i016p03587; Grodent D, 2001, J GEOPHYS RES-SPACE, V106, P12933, DOI 10.1029/2000JA900129; Khurana KK, 1997, J GEOPHYS RES-SPACE, V102, P11295, DOI 10.1029/97JA00563; KIVELSON M, 1995, INTRO SPACE PHYSICS; KONRADI A, 1967, J GEOPHYS RES, V72, P3829, DOI 10.1029/JZ072i015p03829; KONRADI A, 1975, J GEOPHYS RES, V80, P543, DOI 10.1029/JA080i004p00543; Li XL, 1998, GEOPHYS RES LETT, V25, P3763, DOI 10.1029/1998GL900001; MAUK BH, 1983, J GEOPHYS RES-SPACE, V88, P3055, DOI 10.1029/JA088iA04p03055; Mauk BH, 1997, GEOPHYS RES LETT, V24, P2949, DOI 10.1029/97GL03026; Mauk BH, 1999, J GEOPHYS RES-SPACE, V104, P22759, DOI 10.1029/1999JA900097; MCILWAIN CE, 1972, EARTHS MAGNETOSPHERI, P268, DOI DOI 10.1007/978-94-010-2896-7; Meng CI., 1991, AURORAL PHYS; Satoh T, 1996, ICARUS, V122, P1, DOI 10.1006/icar.1996.0106; Satoh T, 1999, ICARUS, V141, P236, DOI 10.1006/icar.1999.6173; Vasavada AR, 1999, J GEOPHYS RES-PLANET, V104, P27133, DOI 10.1029/1999JE001055; Waite JH, 2000, ADV SPACE RES-SERIES, V26, P1453, DOI 10.1016/S0273-1177(00)00089-2; Waite JH, 2001, NATURE, V410, P787, DOI 10.1038/35071018	24	86	86	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2002	415	6875					1003	1005		10.1038/4151003a	http://dx.doi.org/10.1038/4151003a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875562	Green Published, Bronze			2022-12-28	WOS:000174075000038
J	Pugh, PJ; Grech, ED				Pugh, PJ; Grech, ED			Syphilitic aortitis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield	Pugh, PJ (corresponding author), Royal Hallamshire Hosp, Glossop Rd, Sheffield S10 2JF, S Yorkshire, England.								0	10	11	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2002	346	9					676	676		10.1056/NEJMicm010343	http://dx.doi.org/10.1056/NEJMicm010343			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525HJ	11870245				2022-12-28	WOS:000174062800006
J	Andrews, SJ; Brooks, PT; Hanbury, DC; King, CM; Prendergast, CM; Boustead, GB; McNicholas, TA				Andrews, SJ; Brooks, PT; Hanbury, DC; King, CM; Prendergast, CM; Boustead, GB; McNicholas, TA			Ultrasonography and abdominal radiography versus intravenous urography in investigation of urinary tract infection in men: prospective incident cohort study	BRITISH MEDICAL JOURNAL			English	Article							EXCRETORY UROGRAPHY; PLAIN FILM; WOMEN; ULTRASOUND; CHILDREN; CYSTOSCOPY; MANAGEMENT; INFANTS; REPLACE	Objectives To compare ultrasonography and abdominal radiography with intravenous urography in the investigation of urinary tract infection in men. Design Prospective study in two hospital departments. Radiological procedures and urological assessments performed on different days by different clinicians Setting District general hospital. Participants Consecutive series of men (n=114) referred to the department of urology for investigation of proved urinary tract infection. Interventions Ultrasonography, and intravenous urography of renal tract and assessment of urinary flow rate. Clinical assessment, cytoscopy. urodynamic Studies, and transrectal Ultrasonography with biopsy. Main outcome measures Sensitivity and specificity of ultrasonography and abdominal radiography compared with intravenous urography. Results Important abnormalities were seen in 53 of 100 fully evaluated patients, die most common being a poorly emptying bladder (34). The combination of plain radiographs of kidneys, Ureter, and bladder and ultrasonography detected more abnormalities than intravenous urography alone. No important abnormality was missed by this combination (sensitivity 100% and specificity 93%). Conclusions Ultrasonography with abdominal radiography, is as accurate as intravenous urography, in detecting important urological abnormalities in men presenting with urinary tract infection. This combination is safer than intravenous urography and should be the initial investigation for such patients. Additional determination Of urinary flow rate is useful for the assessment Of an incompletely emptying bladder.	Lister Hosp, Dept Urol, Stevenage SG1 4AB, Herts, England; Lister Hosp, Dept Radiol, Stevenage, Herts, England	Lister Hospital; Lister Hospital	Hanbury, DC (corresponding author), Lister Hosp, Dept Urol, Stevenage SG1 4AB, Herts, England.		McNicholas, Tom A/C-2268-2014	McNicholas, Tom A/0000-0001-9971-8765				ALON U, 1986, PEDIATRICS, V78, P58; ANSELL G, 1996, COMPLICATIONS DIAGNO; BOOTH CM, 1981, BRIT J UROL, V53, P270, DOI 10.1111/j.1464-410X.1981.tb06104.x; BUSCH R, 1984, J UROLOGY, V132, P282, DOI 10.1016/S0022-5347(17)49595-4; ENGEL G, 1980, J UROLOGY, V123, P190, DOI 10.1016/S0022-5347(17)55849-8; FAIR WR, 1979, J UROLOGY, V121, P313, DOI 10.1016/S0022-5347(17)56766-X; FAIRCHILD TN, 1982, J UROLOGY, V128, P344, DOI 10.1016/S0022-5347(17)52918-3; FOWLER JE, 1981, NEW ENGL J MED, V304, P462, DOI 10.1056/NEJM198102193040805; GARRAWAY WM, 1991, LANCET, V338, P469, DOI 10.1016/0140-6736(91)90543-X; GOWER PE, 1989, BRIT MED J, V298, P1595, DOI 10.1136/bmj.298.6688.1595; HULAND H, 1982, J UROLOGY, V128, P682, DOI 10.1016/S0022-5347(17)53133-X; KANGARLOO H, 1985, RADIOLOGY, V154, P367, DOI 10.1148/radiology.154.2.3880909; KENDA R, 1989, PEDIATR RADIOL, V19, P299, DOI 10.1007/BF02467297; Lepor H., 1998, CAMPBELLS UROLOGY, P1453; LEWISJONES HG, 1989, BRIT J RADIOL, V62, P977, DOI 10.1259/0007-1285-62-743-977; LINDSELL D, 1986, ARCH DIS CHILD, V61, P81, DOI 10.1136/adc.61.1.81; LIPSKY BA, 1989, ANN INTERN MED, V110, P138, DOI 10.7326/0003-4819-110-2-138; MASKELL R, 1989, BRIT J UROL, V63, P7, DOI 10.1111/j.1464-410X.1989.tb05113.x; MCNICHOLAS MMJ, 1991, BRIT J RADIOL, V64, P221, DOI 10.1259/0007-1285-64-759-221; Nickel JC, 1999, UROL CLIN N AM, V26, P737, DOI 10.1016/S0094-0143(05)70215-9; PEAD L, 1981, J INFECTION, V3, P71, DOI 10.1016/S0163-4453(81)92386-0; SCHAEFFER AJ, 1998, CAMPBELLS UROLOGY, P533; SHERWOOD T, 1984, BRIT MED J, V288, P827, DOI 10.1136/bmj.288.6420.827; SPENCER J, 1990, BRIT MED J, V301, P221, DOI 10.1136/bmj.301.6745.221	24	18	19	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 23	2002	324	7335					454	456A		10.1136/bmj.324.7335.454	http://dx.doi.org/10.1136/bmj.324.7335.454			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526NJ	11859046	Green Published			2022-12-28	WOS:000174136300016
J	Emery, AEH				Emery, AEH			The muscular dystrophies	LANCET			English	Review							CAUSE AUTOSOMAL-DOMINANT; ENCODING LAMIN A/C; SKELETAL-MUSCLE; GENE; MUTATIONS; DUCHENNE; IDENTIFICATION; EXPRESSION; PHENOTYPE; DIAGNOSIS	The muscular dystrophies are inherited myogenic disorders characterised by progressive muscle wasting and weakness of variable distribution and severity. They can be subdivided into several groups, Including congenital forms, in accordance with the distribution of predominant muscle weakness: Duchenne and Becker; Emery-Dreifuss; distal; facioscapulo-humeral; oculopharyngeal; and limb-girdle which is the most heterogeneous group. In several dystrophies the heart can be seriously affected, sometimes in the absence of clinically significant weakness. The genes and their protein products that cause most of these disorders have now been identified. This information Is essential to establish an accurate diagnosis and for reliable genetic counselling and prenatal diagnosis. There is, as yet, no way of greatly affecting the long-term course of any of these diseases. However, advances in gene manipulation and stem-cell therapy suggest cautious optimism for finding an effective treatment In the not-too-distant future.	Royal Devon & Exeter Hosp, Dept Neurol, Peninsula Med Sch, Exeter EX2 5DW, Devon, England	University of Exeter	Emery, AEH (corresponding author), Royal Devon & Exeter Hosp, Dept Neurol, Peninsula Med Sch, Exeter EX2 5DW, Devon, England.	enmc@enmc.org						Allamand V, 2000, GENE THER, V7, P1385, DOI 10.1038/sj.gt.3301247; BACHY J, 1996, PULMONARY REHABILITA; Barton-Davis ER, 1999, J CLIN INVEST, V104, P375, DOI 10.1172/JCI7866; BECKER P E, 1955, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V193, P427, DOI 10.1007/BF00343141; BECKER P. E., 1962, REV CANADIENNE BIOL, V21, P551; BERTORINI TE, 1984, NEUROLOGY, V34, P1436, DOI 10.1212/WNL.34.11.1436; Betz RC, 2001, NAT GENET, V28, P218, DOI 10.1038/90050; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Bonne G, 2000, ANN NEUROL, V48, P170, DOI 10.1002/1531-8249(200008)48:2<170::AID-ANA6>3.0.CO;2-J; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Brais B, 1999, SEMIN NEUROL, V19, P59, DOI 10.1055/s-2008-1040826; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Brown SE, 1997, DYSTROPHIN GENE PROT; Burton EA, 2001, CONT NEUROS, P239; Bushby KMD, 1999, LANCET, V353, P557, DOI 10.1016/S0140-6736(98)05279-9; BUSHBY KMD, 2001, MUSCULAR DYSTROPHIES, P109; Bushby KMD, 2001, MUSCULAR DYSTROPHY M; Carlson CG, 1998, NEUROBIOL DIS, V5, P3, DOI 10.1006/nbdi.1998.0188; Chen YW, 2000, J CELL BIOL, V151, P1321, DOI 10.1083/jcb.151.6.1321; *COPD, 1999, CHEST, V116, P521; Darin N, 2000, NEUROMUSCULAR DISORD, V10, P1, DOI 10.1016/S0960-8966(99)00055-3; di Barletta MR, 2000, AM J HUM GENET, V66, P1407, DOI 10.1086/302869; DRACHMAN DB, 1974, LANCET, V2, P1409; Dubowitz V, 2000, Neuromuscul Disord, V10, P313, DOI 10.1016/S0960-8966(00)00126-7; Duchenne G., 1868, ARCH GEN MED, V11, P305; Duchenne G., 1868, ARCH GEN MED 6 SER, V11, P179; Duchenne G., 1868, ARCH GEN MED, V11, P421; Duchenne G., 1868, ARCH GEN MED, V11, P5; Duchenne G., 1868, ARCH GEN MED, V11, P552; Duchenne G.B.A., 1861, ELECTRISATION LOCALI, P354; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Emery A.E.H., 1993, DUCHENNE MUSCULAR DY; EMERY AEH, 1980, BRIT MED J, V280, P355, DOI 10.1136/bmj.280.6211.355; EMERY AEH, 1966, J NEUROL NEUROSUR PS, V29, P338, DOI 10.1136/jnnp.29.4.338; EMERY AEH, 1989, J MED GENET, V26, P637, DOI 10.1136/jmg.26.10.637; Emery AEH, 1995, HIST GENETIC DIS DUC; EMERY AEH, 2002, IN PRESS NEUROMUSCUL; *ENM, 1999, WHOS WHO NEUR DIS EN; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Fukuyama Y, 1960, PAEDIAT U TOKYO, V4, P5; Grain L, 2001, NEUROMUSCULAR DISORD, V11, P186, DOI 10.1016/S0960-8966(00)00185-1; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Hattori N, 1999, NEUROMUSCULAR DISORD, V9, P220, DOI 10.1016/S0960-8966(99)00005-X; Hayashi YK, 1998, NAT GENET, V19, P94, DOI 10.1038/ng0598-94; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Howell JM, 1999, NEUROMUSCULAR DISORD, V9, P102; HOWELL JM, 1997, NEUROMUSCULAR DISORD, V7, P273; Kapsa R, 2001, HUM GENE THER, V12, P629, DOI 10.1089/104303401300057324; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; KUNKEL LM, 1985, P NATL ACAD SCI USA, V82, P4778, DOI 10.1073/pnas.82.14.4778; Laforet P, 2001, NEUROMUSCULAR DISORD, V11, P616; Merlini L, 2001, MUSCULAR DYSTROPHIES, P284; Meryon E, 1852, Med Chir Trans, V35, P73; Meryon E., 1851, LANCET, V2, P588; Moll J, 2001, NATURE, V413, P302, DOI 10.1038/35095054; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; Morris GE, 2001, TRENDS MOL MED, V7, P572, DOI 10.1016/S1471-4914(01)02128-1; Muchir A, 2000, HUM MOL GENET, V9, P1453, DOI 10.1093/hmg/9.9.1453; MUNTONI F, 1995, LANCET, V345, P591, DOI 10.1016/S0140-6736(95)90504-9; Muntoni Francesco, 2002, Neuromuscul Disord, V12, P69, DOI 10.1016/S0960-8966(01)00209-7; Nonaka I, 1999, CURR OPIN NEUROL, V12, P493, DOI 10.1097/00019052-199910000-00002; Norwood FLM, 2000, STRUCTURE, V8, P481, DOI 10.1016/S0969-2126(00)00132-5; Olivieri NF, 1997, LANCET, V350, P491, DOI 10.1016/S0140-6736(05)63080-2; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; Pogue R, 2001, NEUROMUSCULAR DISORD, V11, P80, DOI 10.1016/S0960-8966(00)00154-1; Rafael JA, 1998, NAT GENET, V19, P79, DOI 10.1038/ng0598-79; RAY PN, 1985, NATURE, V318, P672, DOI 10.1038/318672a0; Sewry CA, 2001, NEUROPATH APPL NEURO, V27, P281, DOI 10.1046/j.0305-1846.2001.00323.x; Sewry CA, 2000, MICROSC RES TECHNIQ, V48, P142, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<142::AID-JEMT3>3.0.CO;2-9; Shackleton S, 2000, NAT GENET, V24, P153, DOI 10.1038/72807; Simonds AK, 1998, THORAX, V53, P949, DOI 10.1136/thx.53.11.949; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; TOME FMS, 1994, CR ACAD SCI III-VIE, V317, P351; Torrente Y, 2000, HUM MOL GENET, V9, P1843, DOI 10.1093/hmg/9.12.1843; Ueyama H, 2001, NEUROMUSCULAR DISORD, V11, P139, DOI 10.1016/S0960-8966(00)00168-1; VANOMMEN GJB, 1993, NEUROMUSCULAR DISORD, V3, P231, DOI 10.1016/0960-8966(93)90065-R; Wang B, 2000, P NATL ACAD SCI USA, V97, P13714, DOI 10.1073/pnas.240335297; Weatherall DJ, 2001, NAT REV GENET, V2, P245, DOI 10.1038/35066048; Whitelaw E, 2001, NAT GENET, V27, P361, DOI 10.1038/86850; Xiao X, 2000, J VIROL, V74, P1436, DOI 10.1128/JVI.74.3.1436-1442.2000; YOHANKA S, 2001, NEUROMUSCULAR DISORD, V11, P411	81	1013	1072	4	182	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 23	2002	359	9307					687	695		10.1016/S0140-6736(02)07815-7	http://dx.doi.org/10.1016/S0140-6736(02)07815-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526AZ	11879882				2022-12-28	WOS:000174107400029
J	Knottnerus, JA; van Weel, C; Muris, JWM				Knottnerus, JA; van Weel, C; Muris, JWM			Evidence base of clinical diagnosis - Evaluation of diagnostic procedures	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTICE; MORTALITY; BIASES		Netherlands Sch Primary Care Res, NL-6200 MD Maastricht, Netherlands; Radboud Univ Nijmegen Med Ctr, Dept Gen Practice, NL-6500 HB Nijmegen, Netherlands; Maastricht Univ, Dept Gen Practice, NL-6200 MD Maastricht, Netherlands	Maastricht University; Radboud University Nijmegen; Maastricht University	Knottnerus, JA (corresponding author), Netherlands Sch Primary Care Res, POB 616, NL-6200 MD Maastricht, Netherlands.	andre.knottnerus@hag.unimaas.nl	Knottnerus, Johannes A/A-3829-2009; Knottnerus, Andre/F-4866-2013; van Weel, Chris/D-4375-2009	van Weel, Chris/0000-0003-3653-4701; Muris, Jean/0000-0002-8780-476X				BEGG CB, 1987, STAT MED, V6, P411, DOI 10.1002/sim.4780060402; Benavente O, 1998, BMJ-BRIT MED J, V317, P1477, DOI 10.1136/bmj.317.7171.1477; Buntinx F, 1996, BMJ-BRIT MED J, V313, P1285; Elstein AS, 1999, ACAD MED, V74, P791, DOI 10.1097/00001888-199907000-00012; Feinstein AR, 1987, CLINIMETRICS; Feinstein AR, 1985, CLIN EPIDEMIOLOGY AR; FIJTEN GHF, 1993, RECTAL BLEEDING DANG; GUYATT GH, 1986, J CHRON DIS, V39, P295, DOI 10.1016/0021-9681(86)90051-2; Harms LM, 1997, J CLIN EPIDEMIOL, V50, P779, DOI 10.1016/S0895-4356(97)00066-8; IRWIG L, 1995, J CLIN EPIDEMIOL, V48, P119, DOI 10.1016/0895-4356(94)00099-C; KNOTTNERUS JA, 1992, MED DECIS MAKING, V12, P93, DOI 10.1177/0272989X9201200202; Knottnerus JA, 1997, BRIT MED J, V315, P1109; KNOTTNERUS JA, 1992, J CLIN EPIDEMIOL, V45, P1143; LICHTENSTEIN JL, 1980, J CLIN GASTROENTEROL, V2, P31, DOI 10.1097/00004836-198003000-00006; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Moons KGM, 1997, MED DECIS MAKING, V17, P447, DOI 10.1177/0272989X9701700410; Panzer RI, 1991, DIAGNOSTIC STRATEGIE; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; REID MC, 1995, JAMA-J AM MED ASSOC, V274, P645, DOI 10.1001/jama.274.8.645; SACKETT DL, IN PRESS ARCHITECTUR; Sackett DL, 1985, CLIN EPIDEMIOLOGY BA; SCHWARTZ WB, 1981, NEW ENGL J MED, V305, P917, DOI 10.1056/NEJM198110153051604; SHAPIRO S, 1982, JNCI-J NATL CANCER I, V69, P349; SHEPS SB, 1984, JAMA-J AM MED ASSOC, V252, P2418, DOI 10.1001/jama.252.17.2418; SPIEGELHALTER DJ, 1987, SCAND J GASTROENTERO, V22, P152, DOI 10.3109/00365528709090984; Stoffers HEJH, 1997, MED DECIS MAKING, V17, P61, DOI 10.1177/0272989X9701700107; van Weel C, 1999, LANCET, V353, P916, DOI 10.1016/S0140-6736(98)08024-6; van Wijk MAM, 2001, ANN INTERN MED, V134, P274, DOI 10.7326/0003-4819-134-4-200102200-00010; VERBEEK ALM, 1984, LANCET, V1, P1222	29	249	260	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2002	324	7335					477	480		10.1136/bmj.324.7335.477	http://dx.doi.org/10.1136/bmj.324.7335.477			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526NJ	11859054	Green Published			2022-12-28	WOS:000174136300024
J	Trewavas, A				Trewavas, A			Mindless mastery	NATURE			English	Editorial Material									Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JH, Midlothian, Scotland	University of Edinburgh	Trewavas, A (corresponding author), Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JH, Midlothian, Scotland.							Bazzaz FA, 2000, PLANTS CHANGING ENV; SILVERTOWN J, 1989, ANNU REV ECOL SYST, V20, P349, DOI 10.1146/annurev.es.20.110189.002025; STENHOUSE D, 1974, EVOLUTION INTELLIGEN; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0	4	64	66	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 21	2002	415	6874					841	841		10.1038/415841a	http://dx.doi.org/10.1038/415841a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859344	Bronze			2022-12-28	WOS:000173941000021
J	Barakat, LA; Quentzel, HL; Jernigan, JA; Kirschke, DL; Griffith, K; Spear, SM; Kelley, K; Barden, D; Mayo, D; Stephens, DS; Popovic, T; Marston, C; Zaki, SR; Guarner, J; Shieh, WJ; Carver, HW; Meyer, RF; Swerdlow, DL; Mast, EE; Hadler, JL				Barakat, LA; Quentzel, HL; Jernigan, JA; Kirschke, DL; Griffith, K; Spear, SM; Kelley, K; Barden, D; Mayo, D; Stephens, DS; Popovic, T; Marston, C; Zaki, SR; Guarner, J; Shieh, WJ; Carver, HW; Meyer, RF; Swerdlow, DL; Mast, EE; Hadler, JL		Anthrax Bioterrorism Invest Team	Fatal inhalational anthrax in a 94-year-old Connecticut woman	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BIOTERRORISM; SVERDLOVSK; DEATH	We describe the 11th case of bioterrorism-related inhalational anthrax reported in the United States. The presenting clinical features of this 94-year-old woman were subtle and nondistinctive. The diagnosis was recognized because blood cultures were obtained prior to administration of antibiotics, emphasizing the importance of this diagnostic test in evaluating ill patients who have been exposed to Bacillus anthracis. The patient's clinical course was characterized by progression of respiratory insufficiency, pleural effusions and pulmonary edema, and, ultimately, death. Although her B anthracis bacteremia was rapidly sterilized after initiation of antibiotic therapy, viable B anthracis was present in postmortem mediastinal lymph node specimens. The source of exposure to B anthracis in this patient is not known. Exposure to mail that was cross-contaminated as it passed through postal facilities contaminated with B anthracis spores is one hypothesis under investigation.	Griffin Hosp, Dept Infect Dis, Derby, CT 06418 USA; Ctr Dis Control & Prevent, Atlanta, GA USA; Emory Univ, Sch Med, Atlanta, GA USA; Connecticut State Med Examiners Off, Hartford, CT USA; Connecticut Dept Hlth, Hartford, CT USA	Centers for Disease Control & Prevention - USA; Emory University	Quentzel, HL (corresponding author), Griffin Hosp, Dept Infect Dis, 130 Div St, Derby, CT 06418 USA.	hquentzel@aol.com	Stephens, David S/A-8788-2012; Guarner, Jeannette/B-8273-2013	Guarner, Jeannette/0000-0001-5610-3541; Jernigan, John/0000-0001-8163-925X				Borio L, 2001, JAMA-J AM MED ASSOC, V286, P2554, DOI 10.1001/jama.286.20.2554; Brachman P S, 1980, Ann N Y Acad Sci, V353, P83, DOI 10.1111/j.1749-6632.1980.tb18910.x; BRACHMAN PS, 1966, BACTERIOL REV, V30, P646, DOI 10.1128/MMBR.30.3.646-659.1966; BRACHMAN PS, 1961, NEW ENGL J MED, V265, P203, DOI 10.1056/NEJM196108032650501; Bush LM, 2001, NEW ENGL J MED, V345, P1607, DOI 10.1056/NEJMoa012948; Castle SC, 2000, CLIN INFECT DIS, V31, P578, DOI 10.1086/313947; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P909; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P1049; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; GLASSMAN HN, 1966, BACTERIOL REV, V30, P657, DOI 10.1128/MMBR.30.3.657-659.1966; GLEISER CA, 1963, BRIT J EXP PATHOL, V44, P416; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Mayer TA, 2001, JAMA-J AM MED ASSOC, V286, P2549, DOI 10.1001/jama.286.20.2549; MESELSON M, 1994, SCIENCE, V266, P1202, DOI 10.1126/science.7973702; Miller RA, 1996, SCIENCE, V273, P70, DOI 10.1126/science.273.5271.70; WALKER DH, 1994, AM J PATHOL, V144, P1135	18	100	104	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2002	287	7					863	868		10.1001/jama.287.7.863	http://dx.doi.org/10.1001/jama.287.7.863			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	522XP	11851578	Bronze			2022-12-28	WOS:000173922500025
J	Bhargava, B; Tripuraneni, P				Bhargava, B; Tripuraneni, P			Role of intracoronary brachytherapy for in-stent restenosis?	LANCET			English	Editorial Material							INHIBITS RECURRENCE; RADIATION THERAPY; BETA-RADIATION; ANGIOPLASTY; RADIOTHERAPY; IMPLANTATION; TRIAL		All India Inst Med Sci, Cardiothorac Sci Ctr, New Delhi 110029, India; Scripps Res Inst, Dept Radiat Oncol, La Jolla, CA USA	All India Institute of Medical Sciences (AIIMS) New Delhi; Scripps Research Institute	Bhargava, B (corresponding author), All India Inst Med Sci, Cardiothorac Sci Ctr, New Delhi 110029, India.							Bonan R, 1999, J INVASIVE CARDIOL, V11, P749; GRUBE E, 2001, SCI SESS AM HEART AS; Hoffmann R, 1996, CIRCULATION, V94, P1247, DOI 10.1161/01.CIR.94.6.1247; KUNTZ R, 2001, J AM COLL CARDIOL SA, V37; LANSKY A, 2000, 10 T CATH THER M WAS; Leon MB, 2001, NEW ENGL J MED, V344, P250, DOI 10.1056/NEJM200101253440402; LEON MB, 2000, J AM COLL CARDIOL SA, V35; Minar E, 2000, CIRCULATION, V102, P2694, DOI 10.1161/01.CIR.102.22.2694; MORICE M, 2001, 23 C EUR SOC CARD SE; Popma JJ, 2000, J AM COLL CARDIOL, V36, P311; Raizner AE, 2000, CIRCULATION, V102, P951, DOI 10.1161/01.CIR.102.9.951; Sapirstein W, 2001, NEW ENGL J MED, V344, P297, DOI 10.1056/NEJM200101253440410; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; SERRUYS PW, 2000, CIRCULATION S2, V102, P18; Sousa JE, 2001, CIRCULATION, V103, P192; Teirstein PS, 1997, NEW ENGL J MED, V336, P1697, DOI 10.1056/NEJM199706123362402; VANDENBR.HA, 1968, AMER J ROENTGENOL RA, V103, P723, DOI 10.2214/ajr.103.4.723; Verin V, 2001, NEW ENGL J MED, V344, P243, DOI 10.1056/NEJM200101253440401; Waksman R, 2001, CIRCULATION, V103, P2332; Waksman R, 2000, CIRCULATION, V101, P2165, DOI 10.1161/01.CIR.101.18.2165; Waksman R, 2000, J AM COLL CARDIOL, V36, P65, DOI 10.1016/S0735-1097(00)00681-1; Waksman R, 2000, CIRCULATION, V101, P1895, DOI 10.1161/01.CIR.101.16.1895; WAKSMAN R, 1995, CIRCULATION, V92, P1383, DOI 10.1161/01.CIR.92.6.1383; Waksman R, 2001, J VASC INTERV RADIOL, V12, P915, DOI 10.1016/S1051-0443(07)61569-3; WAKSMAN R, 2001, J AM COLL CARDIOL SA, V37	25	5	5	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 16	2002	359	9306					543	544		10.1016/S0140-6736(02)07720-6	http://dx.doi.org/10.1016/S0140-6736(02)07720-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523FP	11867105				2022-12-28	WOS:000173943600004
J	Schep, G; Bender, MHM; van de Tempel, G; Wijn, PFF; de Vries, WR; Eikelboom, BC				Schep, G; Bender, MHM; van de Tempel, G; Wijn, PFF; de Vries, WR; Eikelboom, BC			Detection and treatment of claudication due to functional iliac obstruction in top endurance athletes: a prospective study	LANCET			English	Article							ARTERY ENDOFIBROSIS	Background Endurance athletes often have restrictions in flow in their iliac arteries during exercise. Such restrictions have previously been ascribed solely to intravascular lesions. We postulate that flow could also be restricted by functional kinking in the arteries, and that surgical release of these kinks might be an effective treatment. Methods We prospectively studied 80 endurance athletes Who had complaints suggestive of flow restriction in the iliac arteries of one (n=74) or both 6) legs (total 92 legs). Using vascular diagnostic tools, we examined athletes while they were doing activities that often provoke flow restrictions. Restrictions were determined by measurement of systolic pressure in the ankle after exercise: peak systolic velocities were measured with echo-doppler. Kinks were detected with echo-doppler and magnetic-resonance angiography. When functional kinking was diagnosed as the cause of the restriction, the athlete was offered surgery to release the iliac arteries, as part of our prospective study. Findings We recorded flow restrictions in the iliac arteries of 58 of 92 (63%) legs. In 40 of these legs (69%), kinks were the most important cause of the restriction, making these legs suitable for surgical release. We operated on 23 of 58 (40%) legs. All athletes who had an operation subjectively improved. Maximum workload in a cycling test and ankle pressure significantly improved after the operation. 20 (87%) athletes were able to successfully return to their desired high level of competition. Interpretation Our sports-specific protocol is effective in detecting kinking of the iliac arteries as a cause for flow restriction in athletes who have few intravascular abnormalities when investigated with conventional vascular diagnostic tools. Surgical treatment directed at the kinking was less invasive and therefore a better alternative to vascular reconstruction in these athletes.	St Joseph Hosp, Dept Sports Med, NL-5500 MB Veldhoven, Netherlands; St Joseph Hosp, Dept Surg, NL-5500 MB Veldhoven, Netherlands; Algemeen Stedelijk Ziekenhuis, Dept Vasc Surg, Aalst, Belgium; Eindhoven Univ Technol, Dept Appl Phys, NL-5600 MB Eindhoven, Netherlands; Univ Med Ctr, Dept Med Physiol & Sports Med, Utrecht, Netherlands; Univ Med Ctr, Dept Surg, Utrecht, Netherlands	Eindhoven University of Technology; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Schep, G (corresponding author), St Joseph Hosp, Dept Sports Med, POB 7777, NL-5500 MB Veldhoven, Netherlands.	gschep@sjz.nl						Abraham P, 1997, SPORTS MED, V24, P221, DOI 10.2165/00007256-199724040-00001; ABRAHAM P, 1993, AM J SPORT MED, V21, P861, DOI 10.1177/036354659302100618; Abraham P, 1997, AM J SPORT MED, V25, P581, DOI 10.1177/036354659702500424; Bosch JL, 1997, RADIOLOGY, V204, P87, DOI 10.1148/radiology.204.1.9205227; Bradshaw C, 2000, MED SCI SPORT EXER, V32, pS34, DOI 10.1097/00005768-200003001-00006; Chevalier J M, 1986, Ann Vasc Surg, V1, P297, DOI 10.1016/S0890-5096(06)60123-4; CHEVALIER JM, 1991, J TRAUMATOL SPORT, V8, P176; CHEVALIER JM, 1997, ENCY MEDICOCHIRURGIC; DESVAUX B, 1995, J SPORT MED PHYS FIT, V35, P127; FitzGibbon GM, 1996, J AM COLL CARDIOL, V28, P616, DOI 10.1016/0735-1097(96)00206-9; JAGER KA, 1985, ULTRASOUND MED BIOL, V11, P515, DOI 10.1016/0301-5629(85)90164-4; LEGEMATE DA, 1991, ULTRASOUND MED BIOL, V17, P769, DOI 10.1016/0301-5629(91)90159-T; LOPEZ JF, 1989, SURG RADIOL ANAT, V11, P275, DOI 10.1007/BF02098696; ROUSSELET MC, 1990, HUM PATHOL, V21, P524, DOI 10.1016/0046-8177(90)90009-T; RUURDA JP, 2000, NED TIJDSCHR HEELKD, V9, P124; Schep G, 1999, INT J SPORTS MED, V20, P421; Schep G, 2000, MED SCI SPORT EXER, V32, P1970, DOI 10.1097/00005768-200011000-00023; SCHEP G, 2000, NED TIJDSCHR HEELKD, V9, P127; SCHEP G, 2001, THESIS U UTRECHT, P19; STRANDNESS DE, 1994, VASCULAR DIS SURG IN, P139; VONHAYEK H, 1935, Z ANAT ENTWICKL GESC, V105, P25	21	76	78	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2002	359	9305					466	473		10.1016/S0140-6736(02)07675-4	http://dx.doi.org/10.1016/S0140-6736(02)07675-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520ML	11853791				2022-12-28	WOS:000173785600008
J	Xiong, JP; Stehle, T; Zhang, RG; Joachimiak, A; Frech, M; Goodman, SL; Arnaout, MA				Xiong, JP; Stehle, T; Zhang, RG; Joachimiak, A; Frech, M; Goodman, SL; Arnaout, MA			Crystal structure of the extracellular segment of integrin alpha V beta 3 in complex with an Arg-Gly-Asp ligand	SCIENCE			English	Article							CD11B A-DOMAIN; BINDING-SITE; I-DOMAIN; SUBUNIT; ECHISTATIN	The structural basis for the divalent cation-dependent binding of heterodimeric alphabeta integrins to their ligands, which contain the prototypical Arg-Gly-Asp sequence, is unknown. Interaction with ligands triggers tertiary and quaternary structural rearrangements in integrins that are needed for cell signaling. Here we report the crystal structure of the extracellular segment of integrin alphaVbeta3 in complex with a cyclic peptide presenting the Arg-Gly-Asp sequence. The ligand binds at the major interface between the alphaV and beta3 subunits and makes extensive contacts with both. Both tertiary and quaternary changes are observed in the presence of ligand. The tertiary rearrangements take place in betaA, the ligand-binding domain of beta3; in the complex, betaA acquires two cations, one of which contacts the ligand Asp directly and the other stabilizes the ligand-binding surface. Ligand binding induces small changes in the orientation of alphaV relative to beta3.	Massachusetts Gen Hosp, Struct Biol Program, Leukocyte Biol & Inflammat Program, Renal Unit, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Lab Dev Immunol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Argonne Natl Lab, Div Biosci, Struct Biol Ctr, Argonne, IL 60439 USA; Merck KGaA, Dept Target Res, D-64271 Darmstadt, Germany; Merck KGaA, Biomed Res, D-64271 Darmstadt, Germany	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; United States Department of Energy (DOE); Argonne National Laboratory; Merck KGaA; Merck KGaA	Arnaout, MA (corresponding author), Massachusetts Gen Hosp, Struct Biol Program, Leukocyte Biol & Inflammat Program, Renal Unit, 149 13th St, Charlestown, MA 02129 USA.	arnaout@receptor.mgh.harvard.edu						ANDRIEUX A, 1991, J BIOL CHEM, V266, P14202; ATKINSON RA, 1994, INT J PEPT PROT RES, V43, P563; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Li R, 1998, J CELL BIOL, V143, P1523, DOI 10.1083/jcb.143.6.1523; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2393, DOI 10.1073/pnas.041618598; MICHISHITA M, 1993, CELL, V72, P857, DOI 10.1016/0092-8674(93)90575-B; MOULD AP, 1995, FEBS LETT, V363, P118, DOI 10.1016/0014-5793(95)00301-O; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; QU AD, 1995, P NATL ACAD SCI USA, V92, P10277, DOI 10.1073/pnas.92.22.10277; SAUDEK V, 1991, BIOCHEMISTRY-US, V30, P7369, DOI 10.1021/bi00244a003; Takahashi E, 1997, CIRC RES, V81, P268, DOI 10.1161/01.RES.81.2.268; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2000, J BIOL CHEM, V275, P38762, DOI 10.1074/jbc.C000563200	19	1332	1425	7	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2002	296	5565					151	155		10.1126/science.1069040	http://dx.doi.org/10.1126/science.1069040			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539FA	11884718				2022-12-28	WOS:000174858800051
J	Chin, AI; Dempsey, PW; Bruhn, K; Miller, JF; Xu, Y; Cheng, GH				Chin, AI; Dempsey, PW; Bruhn, K; Miller, JF; Xu, Y; Cheng, GH			Involvement of receptor-interacting protein 2 in innate and adaptive immune responses	NATURE			English	Article							MICE; CYTOKINE; KINASE; DEATH; CELLS	Host defences to microorganisms rely on a coordinated interplay between the innate and adaptive responses of immunity(1). Infection with intracellular bacteria triggers an immediate innate response requiring macrophages, neutrophils and natural killer cells, whereas subsequent activation of an adaptive response through development of T-helper subtype 1 cells (T(H)1) proceeds during persistent infection(1). To understand the physiological role of receptor-interacting protein 2 (Rip2), also known as RICK and CARDIAK, we generated mice with a targeted disruption of the gene coding for Rip2. Here we show that Rip2-deficient mice exhibit a profoundly decreased ability to defend against infection by the intracellular pathogen Listeria monocytogenes. Rip2-deficient macrophages infected with L. monocytogenes or treated with lipopolysaccharide (LPS) have decreased activation of NF-kappaB, whereas dominant negative Rip2 inhibited NF-kappaB activation mediated by Toll-like receptor 4 and Nod1. In vivo, Rip2-deficient mice were resistant to the lethal effects of LPS-induced endotoxic shock. Furthermore, Rip2 deficiency results in impaired interferon-gamma production in both T(H)1 and natural killer cells, attributed in part to defective interleukin-12-induced Stat4 activation. Our data reflect requirements for Rip2 in multiple pathways regulating immune and inflammatory responses.	Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; Univ Calif San Diego, Div Biol, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California San Diego	Cheng, GH (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA.		Bruhn, Kevin/F-9772-2013	Xu, Yang/0000-0001-5574-921X				Dai WJ, 1997, J IMMUNOL, V158, P5297; DiTirro J, 1998, INFECT IMMUN, V66, P2284, DOI 10.1128/IAI.66.5.2284-2289.1998; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Inohara N, 1998, J BIOL CHEM, V273, P18675; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; KHAN KD, 1993, P NATL ACAD SCI USA, V90, P6806, DOI 10.1073/pnas.90.14.6806; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Medzhitov R, 1998, SEMIN IMMUNOL, V10, P351, DOI 10.1006/smim.1998.0136; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; REINER SL, 1994, J IMMUNOL METHODS, V175, P275, DOI 10.1016/0022-1759(94)90370-0; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.immunol.13.1.251; Yang JF, 1999, EUR J IMMUNOL, V29, P548, DOI 10.1002/(SICI)1521-4141(199902)29:02<548::AID-IMMU548>3.0.CO;2-Z; Yip HC, 1999, J IMMUNOL, V162, P3942	22	320	329	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2002	416	6877					190	194		10.1038/416190a	http://dx.doi.org/10.1038/416190a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894097				2022-12-28	WOS:000174348100041
J	Myers, J; Prakash, M; Froelicher, V; Do, D; Partington, S; Atwood, JE				Myers, J; Prakash, M; Froelicher, V; Do, D; Partington, S; Atwood, JE			Exercise capacity and mortality among men referred for exercise testing	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALL-CAUSE MORTALITY; ACUTE MYOCARDIAL-INFARCTION; PHYSICAL-ACTIVITY; PROGNOSTIC VALUE; HEART-FAILURE; FITNESS; DISEASE; SURVIVAL; PREDICTOR; NOMOGRAM	Background: Exercise capacity is known to be an important prognostic factor in patients with cardiovascular disease, but it is uncertain whether it predicts mortality equally well among healthy persons. There is also uncertainty regarding the predictive power of exercise capacity relative to other clinical and exercise-test variables. Methods: We studied a total of 6213 consecutive men referred for treadmill exercise testing for clinical reasons during a mean (+/-SD) of 6.2+/-3.7 years of follow-up. Subjects were classified into two groups: 3679 had an abnormal exercise-test result or a history of cardiovascular disease, or both, and 2534 had a normal exercise-test result and no history of cardiovascular disease. Overall mortality was the end point. Results: There were a total of 1256 deaths during the follow-up period, resulting in an average annual mortality of 2.6 percent. Men who died were older than those who survived and had a lower maximal heart rate, lower maximal systolic and diastolic blood pressure, and lower exercise capacity. After adjustment for age, the peak exercise capacity measured in metabolic equivalents (MET) was the strongest predictor of the risk of death among both normal subjects and those with cardiovascular disease. Absolute peak exercise capacity was a stronger predictor of the risk of death than the percentage of the age-predicted value achieved, and there was no interaction between the use or nonuse of beta-blockade and the predictive power of exercise capacity. Each 1-MET increase in exercise capacity conferred a 12 percent improvement in survival. Conclusions: Exercise capacity is a more powerful predictor of mortality among men than other established risk factors for cardiovascular disease. (N Engl J Med 2002;346:793-801.) Copyright (C) 2002 Massachusetts Medical Society.	Vet Affairs Palo Alto Hlth Care Syst, Cardiol Div 111C, Palo Alto, CA 94304 USA; Stanford Univ, Med Ctr, Div Cardiovasc Med, Palo Alto, CA 94304 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Myers, J (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Cardiol Div 111C, 3081 Miranda Ave, Palo Alto, CA 94304 USA.	drj993@aol.com	Prakash, Mysore N/AFW-6802-2022	Froelicher, Victor/0000-0001-8831-4853				AARONSON KD, 1995, J HEART LUNG TRANSPL, V14, P981; American College of Sports Medicine, 2000, GUID EX TEST PRESCR; Blair S. N., 1994, Physical activity, fitness, and health: international proceedings and consensus statement., P579; BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093; Blair SN, 2001, MED SCI SPORT EXER, V33, P762; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; CHANG JA, 1994, CURR PROB CARDIOLOGY, V19, P537; Dorn J, 1999, CIRCULATION, V100, P1764, DOI 10.1161/01.CIR.100.17.1764; EKELUND LG, 1988, NEW ENGL J MED, V319, P1379, DOI 10.1056/NEJM198811243192104; Froelicher V, 2001, PRIMARY CARE, V28, P1, DOI 10.1016/S0095-4543(05)70004-X; FROELICHER V, 1996, PHYSICIANS COMPUTERS, V14, P40; FROELICHER V, 1998, VETERANS HLTH SY MAR, P53; Froelicher VF, 1999, CHEST, V116, P1442, DOI 10.1378/chest.116.5.1442; FROELICHER VF, 2000, EXERCISE HEART; Gibbons RJ, 1997, J AM COLL CARDIOL, V30, P260; Goraya TY, 2000, ANN INTERN MED, V132, P862, DOI 10.7326/0003-4819-132-11-200006060-00003; HASKELL WL, 1992, MED SCI SPORT EXER, V24, pS201, DOI 10.1249/00005768-199206001-00004; KANNEL WB, 1985, AM HEART J, V109, P876, DOI 10.1016/0002-8703(85)90653-2; LACHTERMAN B, 1990, ANN INTERN MED, V113, P333; LACHTERMAN B, 1990, ANN INTERN MED, V112, P11, DOI 10.7326/0003-4819-112-1-11; LAKKA TA, 1994, NEW ENGL J MED, V330, P1549, DOI 10.1056/NEJM199406023302201; MORRIS CK, 1993, J AM COLL CARDIOL, V22, P175, DOI 10.1016/0735-1097(93)90832-L; MORROW K, 1993, ANN INTERN MED, V118, P689, DOI 10.7326/0003-4819-118-9-199305010-00005; MURRAY DP, 1988, BRIT HEART J, V60, P474; Myers J, 1998, ANN INTERN MED, V129, P286, DOI 10.7326/0003-4819-129-4-199808150-00004; MYERS J, 1994, AM J CARDIOL, V73, P591, DOI 10.1016/0002-9149(94)90340-9; MYERS J, 1991, J AM COLL CARDIOL, V17, P1334, DOI 10.1016/S0735-1097(10)80144-5; Myers J, 1996, ESSENTIALS CARDIOPUL; National Center for Chronic Disease Prevention and Health Promotion, 1996, PHYS ACT HLTH REP SU; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; REID MC, 1995, JAMA-J AM MED ASSOC, V274, P645, DOI 10.1001/jama.274.8.645; Roger VL, 1998, CIRCULATION, V98, P2836, DOI 10.1161/01.CIR.98.25.2836; RONNEVIK PK, 1992, EUR HEART J, V13, P1468, DOI 10.1093/oxfordjournals.eurheartj.a060087; Shaw L J, 2000, Cardiol Rev, V8, P65, DOI 10.1097/00045415-200008010-00011; SHUE P, 1998, J NONINVASIVE TESTIN, V2, P21; Stelken AM, 1996, J AM COLL CARDIOL, V27, P345, DOI 10.1016/0735-1097(95)00464-5; WEINER DA, 1995, AM J CARDIOL, V75, P865, DOI 10.1016/S0002-9149(99)80677-8; Williams PT, 2001, MED SCI SPORT EXER, V33, P754, DOI 10.1097/00005768-200105000-00012; WOLTHUIS RA, 1977, AM J CARDIOL, V39, P697, DOI 10.1016/S0002-9149(77)80131-8; YANG JC, 1991, ARCH INTERN MED, V151, P349, DOI 10.1001/archinte.151.2.349	41	2565	2679	3	157	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2002	346	11					793	801		10.1056/NEJMoa011858	http://dx.doi.org/10.1056/NEJMoa011858			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529YM	11893790				2022-12-28	WOS:000174328900002
J	Tong, S; Meagher, S; Vollenhoven, B				Tong, S; Meagher, S; Vollenhoven, B			Sonography - Dizygotic twin survival in early pregnancy	NATURE			English	Article									Monash Univ, Monash Med Ctr, Dept Obstet & Gynaecol, Clayton, Vic 3168, Australia; Epworth Med Fdn, Monash IVF, Monash Ultrasound Women, Richmond, Vic 3121, Australia	Monash University; Epworth Medical Foundation	Tong, S (corresponding author), Monash Univ, Monash Med Ctr, Dept Obstet & Gynaecol, Clayton, Vic 3168, Australia.			Tong, Stephen/0000-0002-2319-0586				Durfee SM, 1999, J CLIN ULTRASOUND, V27, P55; Frates MC, 2001, J ULTRAS MED, V20, P821; Gilfillan CP, 1996, J CLIN ENDOCR METAB, V81, P1557, DOI 10.1210/jc.81.4.1557; Short R. V., 1977, The ovary. I. General aspects., P1; Short R. V., 1978, CIBA F S, V64, P377; [No title captured]	6	9	10	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2002	416	6877					142	142		10.1038/416142a	http://dx.doi.org/10.1038/416142a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894085	Bronze			2022-12-28	WOS:000174348100027
J	Brookmeyer, R; Blades, N				Brookmeyer, R; Blades, N			Prevention of inhalational anthrax in the US outbreak	SCIENCE			English	Article									Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Brookmeyer, R (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA.							Brookmeyer R, 2001, Biostatistics, V2, P233, DOI 10.1093/biostatistics/2.2.233; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; MESELSON M, 1994, SCIENCE, V266, P1202, DOI 10.1126/science.7973702	4	53	54	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1861	1861		10.1126/science.1068474	http://dx.doi.org/10.1126/science.1068474			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884746				2022-12-28	WOS:000174299500029
J	Mullin, T				Mullin, T			Mixing and de-mixing	SCIENCE			English	Editorial Material									Univ Manchester, Dept Phys & Astron, Manchester M13 9PL, Lancs, England	University of Manchester	Mullin, T (corresponding author), Univ Manchester, Dept Phys & Astron, Manchester M13 9PL, Lancs, England.							Burtally N, 2002, SCIENCE, V295, P1877, DOI 10.1126/science.1066850; Mullin T, 2000, PHYS REV LETT, V84, P4741, DOI 10.1103/PhysRevLett.84.4741; Shinbrot T, 2001, NATURE, V410, P251, DOI 10.1038/35065689; WERNER BT, 1993, NATURE, V361, P142, DOI 10.1038/361142a0	4	45	52	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1851	1851		10.1126/science.1070258	http://dx.doi.org/10.1126/science.1070258			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884744				2022-12-28	WOS:000174299500027
J	Williams, SR; Stuart, GJ				Williams, SR; Stuart, GJ			Dependence of EPSP efficacy on synapse location in neocortical pyramidal neurons	SCIENCE			English	Article							DENDRITIC I-H; TIME-COURSE; INTEGRATION; DYNAMICS; CELLS	Neurons receive thousands of synaptic inputs throughout elaborate dendritic trees. Here we determine the somatic impact of excitatory postsynaptic potentials (EPSPs) generated at known dendritic sites in neocortical pyramidal neurons. As inputs became more distal, somatic EPSP amplitude decreased, whereas use-dependent depression increased. Despite marked attenuation (>40-fold), when coactivated within a narrow time window (similar to10 milliseconds), distal EPSPs could directly influence action potential output following dendritic spike generation. These findings reveal that distal EPSPs are ineffective sources of background somatic excitation, but through coincidence detection have a powerful transient signaling role.	Australian Natl Univ, John Curtin Sch Med Res, Div Neurosci, Canberra, ACT 0200, Australia	Australian National University; John Curtin School of Medical Research	Stuart, GJ (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Div Neurosci, Canberra, ACT 0200, Australia.		stuart, greg j/F-7328-2011	stuart, greg/0000-0001-9395-2219; Williams, Stephen/0000-0001-5352-7947				BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; GILBERT CD, 1992, NEURON, V9, P1, DOI 10.1016/0896-6273(92)90215-Y; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hausser M, 1997, J NEUROSCI, V17, P7606; IANSEK R, 1973, J PHYSIOL-LONDON, V234, P665, DOI 10.1113/jphysiol.1973.sp010366; Jaffe DB, 1999, J NEUROPHYSIOL, V82, P3268, DOI 10.1152/jn.1999.82.6.3268; kandel, 1977, NERVOUS SYSTEM, V1; Koch C, 1996, CEREB CORTEX, V6, P93, DOI 10.1093/cercor/6.2.93; Llinas R, 1998, PHILOS T ROY SOC B, V353, P1841, DOI 10.1098/rstb.1998.0336; London M, 2001, NAT NEUROSCI, V4, P853, DOI 10.1038/nn0901-853; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Rall W., 1995, THEORETICAL FDN DEND, P122; REDMAN S, 1983, J PHYSIOL-LONDON, V343, P117, DOI 10.1113/jphysiol.1983.sp014884; REDMAN SJ, 1973, J PHYSIOL-LONDON, V234, P637, DOI 10.1113/jphysiol.1973.sp010365; Rhodes PA, 2001, J PHYSIOL-LONDON, V536, P167, DOI 10.1111/j.1469-7793.2001.00167.x; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; SHEPHERD GM, 1985, P NATL ACAD SCI USA, V82, P2192, DOI 10.1073/pnas.82.7.2192; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Williams SR, 1999, J PHYSIOL-LONDON, V521, P467, DOI 10.1111/j.1469-7793.1999.00467.x	23	259	269	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1907	1910		10.1126/science.1067903	http://dx.doi.org/10.1126/science.1067903			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884759				2022-12-28	WOS:000174299500044
J	Greffet, JJ; Carminati, R; Joulain, K; Mulet, JP; Mainguy, SP; Chen, Y				Greffet, JJ; Carminati, R; Joulain, K; Mulet, JP; Mainguy, SP; Chen, Y			Coherent emission of light by thermal sources	NATURE			English	Article								A thermal light-emitting source, such as a black body or the incandescent filament of a light bulb, is often presented as a typical example of an incoherent source and is in marked contrast to a laser. Whereas a laser is highly monochromatic and very directional, a thermal source has a broad spectrum and is usually quasi-isotropic. However, as is the case with many systems, different behaviour can be expected on a microscopic scale. It has been shown recently(1,2) that the field emitted by a thermal source made of a polar material is enhanced by more than four orders of magnitude and is partially coherent at a distance of the order of 10 to 100 nm. Here we demonstrate that by introducing a periodic microstructure into such a polar material (SiC) a thermal infrared source can be fabricated that is coherent over large distances (many wavelengths) and radiates in well defined directions. Narrow angular emission lobes similar to antenna lobes are observed and the emission spectra of the source depends on the observation angle-the so-called Wolf effect(3,4). The origin of the coherent emission lies in the diffraction of surface-phonon polaritons by the grating.	CNRS, Microstruct & Microelect Lab, F-92220 Bagneux, France; CNRS, Lab EM2C, F-92295 Chatenay Malabry, France; CEA, CESTA, F-33114 Le Barp, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA	Greffet, JJ (corresponding author), Univ Rochester, Inst Opt, Rochester, NY 14627 USA.		Greffet, Jean-Jacques/S-3495-2019; Greffet, Jean-Jacques/Q-2427-2015; Joulain, Karl/F-2808-2017; Carminati, Remi/H-6882-2014; Chen, Yong/A-1700-2009	Greffet, Jean-Jacques/0000-0002-4048-2150; Greffet, Jean-Jacques/0000-0002-4048-2150; Joulain, Karl/0000-0001-6968-8390; Carminati, Remi/0000-0002-5839-1820; Chen, Yong/0000-0002-2903-8753				Carminati R, 1999, PHYS REV LETT, V82, P1660, DOI 10.1103/PhysRevLett.82.1660; Greffet JJ, 1998, J OPT SOC AM A, V15, P2735, DOI 10.1364/JOSAA.15.002735; HESKETH PJ, 1986, NATURE, V324, P549, DOI 10.1038/324549a0; LeGall J, 1997, PHYS REV B, V55, P10105, DOI 10.1103/PhysRevB.55.10105; Mandel L, 1995, OPTICAL COHERENCE QU; MORRIS GM, 1987, OPT COMMUN, V62, P5, DOI 10.1016/0030-4018(87)90056-3; Mulet JP, 2001, APPL PHYS LETT, V78, P2931, DOI 10.1063/1.1370118; Shchegrov AV, 2000, PHYS REV LETT, V85, P1548, DOI 10.1103/PhysRevLett.85.1548; WHALE MD, 2000, P C HEAT TRANSF TRAN, P339; WOLF E, 1987, NATURE, V326, P363, DOI 10.1038/326363a0; Wolf E, 1996, REP PROG PHYS, V59, P771, DOI 10.1088/0034-4885/59/6/002; ZHIZHIN GN, 1982, APPL SPECTROSC REV, V18, P171, DOI 10.1080/05704928208055768	12	1006	1035	6	280	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2002	416	6876					61	64		10.1038/416061a	http://dx.doi.org/10.1038/416061a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882890				2022-12-28	WOS:000174211600036
J	Mohr, JJ; Forsberg, R				Mohr, JJ; Forsberg, R			Remote sensing: Searching for new islands in sea ice - Coastlines concealed in polar seas are now more accessible to cartography.	NATURE			English	Article									Tech Univ Denmark, Orsted DTU, DK-2800 Lyngby, Denmark; Natl Survey & Cadastre, DK-2400 Copenhagen NV, Denmark	Technical University of Denmark	Mohr, JJ (corresponding author), Tech Univ Denmark, Orsted DTU, Orsteds Plads B-348, DK-2800 Kgs Lyngby, Denmark.			Forsberg, Rene/0000-0002-7288-9545				Massonnet D, 1998, REV GEOPHYS, V36, P441, DOI 10.1029/97RG03139; Mohr JJ, 2001, IEEE T GEOSCI REMOTE, V39, P842, DOI 10.1109/36.917909; SORENSEN K, 2000, GEOLOGY GREENLAND SU, V186, P7	3	6	6	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2002	416	6876					35	35		10.1038/416035a	http://dx.doi.org/10.1038/416035a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882882				2022-12-28	WOS:000174211600028
J	Coulehan, J				Coulehan, J			Blockers	ANNALS OF INTERNAL MEDICINE			English	Editorial Material											Coulehan, J (corresponding author), 4 Townsend Court, Setauket, NY 11733 USA.								0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 5	2002	136	5					407	409		10.7326/0003-4819-136-5-200203050-00016	http://dx.doi.org/10.7326/0003-4819-136-5-200203050-00016			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525VT	11874316				2022-12-28	WOS:000174095300011
J	Coyle, SL				Coyle, SL		Ethics Human Right Comm	Physician-industry relations. Part 1: Individual physicians	ANNALS OF INTERNAL MEDICINE			English	Article							CONFLICT-OF-INTEREST; PHARMACEUTICAL-INDUSTRY; DRUG COMPANIES; ATTITUDES; MEDICINE; REPRESENTATIVES; INFORMATION; RESIDENTS; SAMPLES; ALLIANCE	This is part 1 of a 2-part paper on ethics and physician-industry relationships. Part I offers advice to individual physicians; part 2 gives recommendations to medical education providers and medical professional societies. Physicians and industry have a shared interest in advancing medical knowledge. Nonetheless, the primary ethic of the physician is to promote the patient's best interests, while the primary ethic of industry is to promote profitability. Although partnerships between physicians and industry can result in impressive medical advances, they also create opportunities for bias and can result in unfavorable public perceptions. Many physicians and physicians-in-training think they are impervious to commercial influence. However, recent studies show that accepting industry hospitality and gifts, even drug samples, can compromise judgment about medical information and subsequent decisions about patient care. It is up to the physician to judge whether a gift is acceptable. A very general guideline is that it is ethical to accept modest gifts that advance medical practice. It is clearly unethical to accept gifts or services that obligate the physician to reciprocate. Conflicts of interest can arise from other financial ties between physicians and industry, whether to outside companies or self-owned businesses. Such ties include honorariums for speaking or writing about a company's product, payment for participating in clinic-based research, and referrals to medical resources. All of these relationships have the potential to influence a physician's attitudes and practices. This paper explores the ethical quandaries involved and offers guidelines for ethical business relationships.	Amer Coll Physicians, Amer Soc Internal Med, Ctr Eth & Professinalism, Philadelphia, PA 19106 USA	American College of Physicians	Coyle, SL (corresponding author), Amer Coll Physicians, Amer Soc Internal Med, Ctr Eth & Professinalism, 190 N Independence Mall W, Philadelphia, PA 19106 USA.							Angell M, 2000, NEW ENGL J MED, V342, P1516, DOI 10.1056/NEJM200005183422009; AVORN J, 1982, AM J MED, V73, P4, DOI 10.1016/0002-9343(82)90911-1; Backer EL, 2000, J FAM PRACTICE, V49, P811; BANKS JW, 1992, ACAD MED, V67, P610, DOI 10.1097/00001888-199209000-00017; Blake R L Jr, 1995, J Am Board Fam Pract, V8, P457; Bodenheimer T, 2000, NEW ENGL J MED, V342, P1539, DOI 10.1056/NEJM200005183422024; BOWER AD, 1987, J FAM PRACTICE, V24, P612; BRENNAN TA, 1994, NEW ENGL J MED, V331, P673, DOI 10.1056/NEJM199409083311012; Brotzman G L, 1992, Fam Med, V24, P431; BROTZMAN GL, 1993, J GEN INTERN MED, V8, P130, DOI 10.1007/BF02599757; Caudill TS, 1996, ARCH FAM MED, V5, P201, DOI 10.1001/archfami.5.4.201; Chew LD, 2000, J GEN INTERN MED, V15, P478, DOI 10.1046/j.1525-1497.2000.08014.x; Cho MK, 1996, ANN INTERN MED, V124, P485, DOI 10.7326/0003-4819-124-5-199603010-00004; CHREN MM, 1989, JAMA-J AM MED ASSOC, V262, P3448, DOI 10.1001/jama.262.24.3448; CHREN MM, 1994, JAMA-J AM MED ASSOC, V271, P684, DOI 10.1001/jama.271.9.684; Davidoff F, 2001, ANN INTERN MED, V135, P463, DOI 10.7326/0003-4819-135-6-200109180-00016; DAVIDSON RA, 1986, J GEN INTERN MED, V1, P155, DOI 10.1007/BF02602327; Drazen JM, 2000, NEW ENGL J MED, V343, P1643, DOI 10.1056/NEJM200011303432212; Freedman Benjamin, 1987, IRB, V9, P7, DOI 10.2307/3563623; Friedberg M, 1999, JAMA-J AM MED ASSOC, V282, P1453, DOI 10.1001/jama.282.15.1453; Gibbons RV, 1998, J GEN INTERN MED, V13, P151, DOI 10.1046/j.1525-1497.1998.00048.x; GIRARD DE, 1992, ARCH INTERN MED, V152, P920, DOI 10.1001/archinte.152.5.920; Harris I, 2001, Minn Med, V84, P17; HODGES B, 1995, CAN MED ASSOC J, V153, P553; Honig P, 2000, JAMA-J AM MED ASSOC, V284, P2187; Kitchens LW, 1998, ANN INTERN MED, V128, P576, DOI 10.7326/0003-4819-128-7-199804010-00012; LEXCHIN J, 1993, CAN MED ASSOC J, V149, P1401; LICHSTEIN PR, 1992, ARCH INTERN MED, V152, P1009, DOI 10.1001/archinte.152.5.1009; LIND SE, 1990, NEW ENGL J MED, V323, P192, DOI 10.1056/NEJM199007193230310; Lo B, 2000, JAMA-J AM MED ASSOC, V283, P801, DOI 10.1001/jama.283.6.801; Madhavan S, 1997, J CLIN PHARM THER, V22, P207, DOI 10.1046/j.1365-2710.1997.94975949.x; Mainous A G 3rd, 1995, Arch Fam Med, V4, P335, DOI 10.1001/archfami.4.4.335; MCKINNEY WP, 1990, JAMA-J AM MED ASSOC, V264, P1693, DOI 10.1001/jama.264.13.1693; Mick T, 1991, JAMA, V265, P662, DOI 10.1001/jama.265.5.659; MICK T, 1991, JAMA-J AM MED ASSOC, V265, P662; MITCHELL JM, 1995, J HEALTH ECON, V14, P263, DOI 10.1016/0167-6296(95)00003-Z; MORELLI D, 1992, J FAM PRACTICE, V34, P42; *NAT AC PR COMM QU, 2001, CROSS QUAL CHASM NEW; NOBLE RC, 1993, PERSPECT BIOL MED, V36, P376; ORLOWSKI JP, 1992, CHEST, V102, P270, DOI 10.1378/chest.102.1.270; Orlowski JP, 1996, J CLIN ETHIC, V7, P184; REEDER M, 1993, ANN EMERG MED, V22, P1593, DOI 10.1016/S0196-0644(05)81266-1; Relman AS, 2001, JAMA-J AM MED ASSOC, V285, P2009, DOI 10.1001/jama.285.15.2009; ROCHON PA, 1994, ARCH INTERN MED, V154, P157, DOI 10.1001/archinte.154.2.157; Sandberg WS, 1997, ACAD MED, V72, P916, DOI 10.1097/00001888-199710000-00018; Schulman KA, 1996, ANN INTERN MED, V124, P906, DOI 10.7326/0003-4819-124-10-199605150-00008; Shaughnessy AF, 1997, ANN PHARMACOTHER, V31, P1296, DOI 10.1177/106002809703101103; Shimm D.S., 1996, CONFLICTS INTEREST C, P321; Steinman MA, 2001, AM J MED, V110, P551, DOI 10.1016/S0002-9343(01)00660-X; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; Stryer D, 1996, J GEN INTERN MED, V11, P575, DOI 10.1007/BF02599024; Tenery RM, 2000, JAMA-J AM MED ASSOC, V283, P391, DOI 10.1001/jama.283.3.391; Titmuss R., 1971, GIFT RELATIONSHIP HU; WAUD DR, 1992, NEW ENGL J MED, V327, P351, DOI 10.1056/NEJM199207303270511; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373; Westfall JM, 1997, JAMA-J AM MED ASSOC, V278, P141, DOI 10.1001/jama.278.2.141; WHITE LJ, 1990, ANN INTERN MED, V112, P624, DOI 10.7326/0003-4819-112-8-624; WOOLLARD RF, 1993, CAN MED ASSOC J, V149, P403; ZIEGLER MG, 1995, JAMA-J AM MED ASSOC, V273, P1296, DOI 10.1001/jama.273.16.1296; 2001, ACP ASIM OBSERVER, V21, P34; 2001, SALES FORCES SCRIPTS	61	157	168	2	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 5	2002	136	5					396	402		10.7326/0003-4819-136-5-200203050-00014	http://dx.doi.org/10.7326/0003-4819-136-5-200203050-00014			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525VT	11874314				2022-12-28	WOS:000174095300009
J	[Anonymous]				[Anonymous]			Health-care ethics in Zimbabwe	LANCET			English	Editorial Material														Hargreaves, Sally/0000-0003-2974-4348				JOHNSON RW, 2002, SUNDAY TIMES    0120; 2002, LANCET, V359, P455	2	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 2	2002	359	9308					791	792						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526DZ	11888609				2022-12-28	WOS:000174115200033
J	Clarke, JT; Ajello, J; Ballester, G; Ben Jaffel, L; Connerney, J; Gerard, JC; Gladstone, GR; Grodent, D; Pryor, W; Trauger, J; Waite, JH				Clarke, JT; Ajello, J; Ballester, G; Ben Jaffel, L; Connerney, J; Gerard, JC; Gladstone, GR; Grodent, D; Pryor, W; Trauger, J; Waite, JH			Ultraviolet emissions from the magnetic footprints of Io, Ganymede and Europa on Jupiter	NATURE			English	Article							GALILEO SPACECRAFT; FLUX TUBE; AURORA; SYSTEM; FIELD	Io leaves a magnetic footprint on Jupiter's upper atmosphere that appears as a spot of ultraviolet emission that remains fixed underneath Io as Jupiter rotates(1-3). The specific physical mechanisms responsible for generating those emissions are not well understood, but in general the spot seems to arise because of an electromagnetic interaction between Jupiter's magnetic field and the plasma surrounding Io, driving currents of around 1 million amperes down through Jupiter's ionosphere(4-6). The other galilean satellites may also leave footprints, and the presence or absence of such footprints should illuminate the underlying physical mechanism by revealing the strengths of the currents linking the satellites to Jupiter. Here we report persistent, faint, far-ultraviolet emission from the jovian footprints of Ganymede and Europa. We also show that Io's magnetic footprint extends well beyond the immediate vicinity of Io's flux-tube interaction with Jupiter, and much farther than predicted theoretically(4-6); the emission persists for several hours downstream. We infer from these data that Ganymede and Europa have persistent interactions with Jupiter's magnetic field despite their thin atmospheres.	Boston Univ, Boston, MA 02215 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Michigan, Ann Arbor, MI 48109 USA; CNRS, Inst Astrophys Paris, F-75014 Paris, France; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Univ Liege, B-4000 Liege, Belgium; SW Res Inst, San Antonio, TX 78228 USA; Univ Colorado, Boulder, CO 80303 USA	Boston University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Michigan System; University of Michigan; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Liege; Southwest Research Institute; University of Colorado System; University of Colorado Boulder	Clarke, JT (corresponding author), Boston Univ, 725 Commonwealth Ave, Boston, MA 02215 USA.		Clarke, John/C-8644-2013; connerney, john/I-5127-2013	GERARD, Jean-Claude/0000-0002-8565-8746				Ballester GE, 1996, SCIENCE, V274, P409, DOI 10.1126/science.274.5286.409; BELCHER JW, 1987, SCIENCE, V238, P170, DOI 10.1126/science.238.4824.170; BETHE H, 1977, QUANTUM MECH 1 2 ELE, P285; Bunce EJ, 2001, PLANET SPACE SCI, V49, P1089, DOI 10.1016/S0032-0633(01)00004-6; Clarke JT, 1996, SCIENCE, V274, P404, DOI 10.1126/science.274.5286.404; Clarke JT, 1998, J GEOPHYS RES-PLANET, V103, P20217, DOI 10.1029/98JE01130; CONNERNEY J, 1996, B AM ASTRON SOC, V27, P1147; CONNERNEY JEP, 1993, SCIENCE, V262, P1035, DOI 10.1126/science.262.5136.1035; Connerney JEP, 1998, J GEOPHYS RES-SPACE, V103, P11929, DOI 10.1029/97JA03726; Cowley SWH, 2001, PLANET SPACE SCI, V49, P1067, DOI 10.1016/S0032-0633(00)00167-7; Crary FJ, 1997, GEOPHYS RES LETT, V24, P2135, DOI 10.1029/97GL02248; Crary FJ, 1997, J GEOPHYS RES-SPACE, V102, P37, DOI 10.1029/96JA02409; Dols V, 2000, ICARUS, V147, P251, DOI 10.1006/icar.2000.6415; Feldman PD, 2000, ASTROPHYS J, V535, P1085, DOI 10.1086/308889; Frank LA, 1996, SCIENCE, V274, P394, DOI 10.1126/science.274.5286.394; GOLDREICH P, 1969, ASTROPHYS J, V156, P59, DOI 10.1086/149947; Hall DT, 1998, ASTROPHYS J, V499, P475, DOI 10.1086/305604; Hill TW, 2001, J GEOPHYS RES-SPACE, V106, P8101, DOI 10.1029/2000JA000302; Kivelson MG, 1996, NATURE, V384, P537, DOI 10.1038/384537a0; Kurth WS, 2000, GEOPH MONOG SERIES, V119, P213; NEUBAUER FM, 1980, J GEOPHYS RES-SPACE, V85, P1171, DOI 10.1029/JA085iA03p01171; Prange R, 1996, NATURE, V379, P323, DOI 10.1038/379323a0; Prange R, 1998, J GEOPHYS RES-PLANET, V103, P20195, DOI 10.1029/98JE01128; Russell CT, 2000, ADV SPACE RES, V26, P1665, DOI 10.1016/S0273-1177(00)00114-9; Wilkinson MH, 1998, J GEOPHYS RES-PLANET, V103, P19985, DOI 10.1029/98JE00584	25	170	170	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2002	415	6875					997	1000		10.1038/415997a	http://dx.doi.org/10.1038/415997a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875560	Green Published			2022-12-28	WOS:000174075000036
J	Fallowfield, L; Jenkins, V; Farewell, V; Saul, J; Duffy, A; Eves, R				Fallowfield, L; Jenkins, V; Farewell, V; Saul, J; Duffy, A; Eves, R			Efficacy of a Cancer Research UK communication skills training model for oncologists: a randomised controlled trial	LANCET			English	Article							PRIMARY-CARE PHYSICIANS; PATIENT COMMUNICATION; BAD-NEWS; IMPROVE; HEALTH	Background Doctors' communication with patients is commonly hampered by lack of training in this core skill. This study aimed to assess the efficacy of an intensive 3-day Training course on communication skills in a randomised controlled trial with a two-by-two factorial design and several outcomes. Methods 160 oncologists from 34 UK cancer centres were randomly allocated to four groups: written feedback followed by course; course alone; written feedback alone: and control. At each of Two assessment periods, consultations with six to ten consecutive, consenting patients per doctor were videotaped. 2407 patients participated. Outcome measures included objective and subjective ratings made by researchers, doctors. and patients. The primary outcomes were objective improvements after the intervention in key communication skills. Course content included structured feedback, videotape review of consultations, role-play with simulated patients, interactive group demonstrations. and discussion led by a trained facilitator. Findings In Poisson regression analysis of counts of communication behaviours, course attendance significantly improved key outcomes. The estimated effect sizes corresponded to higher rates of use of focused questions :difference between course attenders [n=80] and nonattenders [n=80] 34%, p=0.003), focused and open questions (27%, p=0.005), expressions of empathy (69%, p=0.003), and appropriate responses to patients cues (38%. p=0.026), and a 24% lower rate of use of leading questions p=0.11). there was little evidence for the effectiveness of written feedback. Interpretation The communication problems of senior doctors working in cancer medicine ore not resolved by time and clinical experience. This trial shows that training courses significantly improve key communication skills. More resources should be allocated to address doctors' training needs in this vital area.	Univ Sussex, Sch Biol Sci, Canc Res UK Psychosocial Oncol Grp, Brighton BN1 9QG, E Sussex, England; MRC, Biostat Unit, London W1N 4AL, England	Cancer Research UK; University of Sussex; MRC Biostatistics Unit	Fallowfield, L (corresponding author), Univ Sussex, Sch Biol Sci, Canc Res UK Psychosocial Oncol Grp, Brighton BN1 9QG, E Sussex, England.			Farewell, Vernon/0000-0001-6704-5295; Fallowfield, Lesley/0000-0003-0577-4518				Audit Commission, 1993, WHAT SEEMS MATT COMM; Baile WF, 1999, CANCER-AM CANCER SOC, V86, P887, DOI 10.1002/(SICI)1097-0142(19990901)86:5<887::AID-CNCR27>3.0.CO;2-X; BIRD J, 1990, METHODS TEACHING CON, P65; Cook RJ, 1996, J ROY STAT SOC A STA, V159, P93, DOI 10.2307/2983471; Department of Health, 2000, NHS CANC PLAN; FALLOWFIELD L, 1995, BRIT J CANCER, V71, P1132, DOI 10.1038/bjc.1995.220; Fallowfield L, 2001, BRIT J CANCER, V84, P1011, DOI 10.1054/bjoc.2001.1724; FALLOWFIELD L, 1993, LANCET, V341, P476, DOI 10.1016/0140-6736(93)90219-7; Fallowfield L, 1998, J CLIN ONCOL, V16, P1961, DOI 10.1200/JCO.1998.16.5.1961; FALLOWFIELD LJ, 1997, ANN NY ACAD SCI, P525; Fellowes D, 2001, BREAST CANCER RES TR, V66, P73, DOI 10.1023/A:1010684903199; Ford S, 2000, SOC SCI MED, V50, P553, DOI 10.1016/S0277-9536(99)00308-1; LEVINSON W, 1993, J GEN INTERN MED, V8, P318, DOI 10.1007/BF02600146; Levinson W, 1997, JAMA-J AM MED ASSOC, V277, P553, DOI 10.1001/jama.277.7.553; ONG LML, 1995, SOC SCI MED, V40, P903, DOI 10.1016/0277-9536(94)00155-M; Ong LML, 1998, PSYCHO-ONCOL, V7, P387, DOI 10.1002/(SICI)1099-1611(1998090)7:5<387::AID-PON316>3.3.CO;2-7; Parle M, 1997, SOC SCI MED, V44, P231, DOI 10.1016/S0277-9536(96)00148-7; Poulson J, 1998, NEW ENGL J MED, V338, P1844, DOI 10.1056/NEJM199806183382512; Ramirez AJ, 1996, LANCET, V347, P724, DOI 10.1016/S0140-6736(96)90077-X; REID W, 1993, 4 HLTH SERV COMM; SPIRO H, 1992, ANN INTERN MED, V116, P843, DOI 10.7326/0003-4819-116-10-843; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423	22	581	588	2	56	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 23	2002	359	9307					650	656		10.1016/S0140-6736(02)07810-8	http://dx.doi.org/10.1016/S0140-6736(02)07810-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526AZ	11879860				2022-12-28	WOS:000174107400008
J	Holzer, M; Cerchiari, E; Martens, P; Roine, R; Sterz, F; Eisenburger, P; Havel, C; Kofler, J; Oschatz, E; Rohrbach, K; Scheinecker, W; Schorkhuber, W; Behringer, W; Zeiner, A; Valentin, A; De Meyer, M; Takunen, O; Tiainen, M; Hachimi-Idrissi, S; Huyghens, L; Fischer, M; Walger, P; Bartsch, A; Foedisch, M; Cerchiari, E; Bonizzoli, M; Pagni, E; Laggner, AN; Kaff, A; Schneider, B; Mullner, M				Holzer, M; Cerchiari, E; Martens, P; Roine, R; Sterz, F; Eisenburger, P; Havel, C; Kofler, J; Oschatz, E; Rohrbach, K; Scheinecker, W; Schorkhuber, W; Behringer, W; Zeiner, A; Valentin, A; De Meyer, M; Takunen, O; Tiainen, M; Hachimi-Idrissi, S; Huyghens, L; Fischer, M; Walger, P; Bartsch, A; Foedisch, M; Cerchiari, E; Bonizzoli, M; Pagni, E; Laggner, AN; Kaff, A; Schneider, B; Mullner, M		Hypothermia Cardiac Arrest Study G	Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CEREBRAL BLOOD-FLOW; RESUSCITATIVE HYPOTHERMIA; CARDIOPULMONARY BYPASS; MODERATE HYPOTHERMIA; DOGS; ISCHEMIA; REPERFUSION; METABOLISM; SURVIVAL; TRIAL	Background: Cardiac arrest with widespread cerebral ischemia frequently leads to severe neurologic impairment. We studied whether mild systemic hypothermia increases the rate of neurologic recovery after resuscitation from cardiac arrest due to ventricular fibrillation. Methods: In this multicenter trial with blinded assessment of the outcome, patients who had been resuscitated after cardiac arrest due to ventricular fibrillation were randomly assigned to undergo therapeutic hypothermia (target temperature, 32degreesC to 34degreesC, measured in the bladder) over a period of 24 hours or to receive standard treatment with normothermia. The primary end point was a favorable neurologic outcome within six months after cardiac arrest; secondary end points were mortality within six months and the rate of complications within seven days. Results: Seventy-five of the 136 patients in the hypothermia group for whom data were available (55 percent) had a favorable neurologic outcome (cerebral-performance category, 1 [good recovery] or 2 [moderate disability]), as compared with 54 of 137 (39 percent) in the normothermia group (risk ratio, 1.40; 95 percent confidence interval, 1.08 to 1.81). Mortality at six months was 41 percent in the hypothermia group (56 of 137 patients died), as compared with 55 percent in the normothermia group (76 of 138 patients; risk ratio, 0.74; 95 percent confidence interval, 0.58 to 0.95). The complication rate did not differ significantly between the two groups. Conclusions: In patients who have been successfully resuscitated after cardiac arrest due to ventricular fibrillation, therapeutic mild hypothermia increased the rate of a favorable neurologic outcome and reduced mortality. Copyright (R) 2002 Massachusetts Medical Society.	Univ Vienna, Klin Notfallmed, Vienna, Austria; Osped Niguarda Ca Granda, Milan, Italy; AZ Sint Jan, Brugge, Belgium; Univ Helsinki Hosp, Helsinki, Finland; Krankenhaus Rudolfstiftung, Vienna, Austria; Helsinki Yliopistollisen Keskussairaalan, Helsinki, Finland; Free Univ Brussels, Acad Ziekenhuis, Brussels, Belgium; Univ Bonn, Fak Med, D-5300 Bonn, Germany; Evangel Waldkrankenhaus, Bonn, Germany; Azienda Ospedalieria Careggi, Florence, Italy; Rettungs & Krankenbeforderungsdienst Stadt Wien, Vienna, Austria; Univ Vienna, Inst Med Stat, Vienna, Austria	University of Vienna; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Helsinki; Helsinki University Central Hospital; Rudolfstiftung Hospital; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of Bonn; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Vienna	Sterz, F (corresponding author), Univ Vienna, Allgemeines Krankenhaus Stadt Wien, Klin Notfallmed, Wahringer Gurtel 18-20-6D, A-1090 Vienna, Austria.		Hachimi Idrissi, Said/I-6422-2018; Kofler, Julia/AAJ-8032-2021	Hachimi Idrissi, Said/0000-0002-8455-1410; Fischer, Matthias/0000-0003-4728-8497				ABRAMSON NS, 1991, NEW ENGL J MED, V324, P1225; Benson DW, 1958, ANESTH ANALG, V38, P423; Bernard SA, 1997, ANN EMERG MED, V30, P146, DOI 10.1016/S0196-0644(97)70133-1; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; CHOPP M, 1989, J CEREBR BLOOD F MET, V9, P141, DOI 10.1038/jcbfm.1989.21; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; COIMBRA C, 1992, ACTA PHYSIOL SCAND, V146, P543, DOI 10.1111/j.1748-1716.1992.tb09462.x; Colbourne F, 1999, J CEREBR BLOOD F MET, V19, P742, DOI 10.1097/00004647-199907000-00003; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; DEMPSEY RJ, 1987, NEUROSURGERY, V21, P177, DOI 10.1227/00006123-198708000-00007; deVreedeSwagemakers JJM, 1997, J AM COLL CARDIOL, V30, P1500, DOI 10.1016/S0735-1097(97)00355-0; HEGNAUER AH, 1954, AM J PHYSIOL, V178, P138, DOI 10.1152/ajplegacy.1954.178.1.138; Hickey RW, 2000, CRIT CARE MED, V28, P3511, DOI 10.1097/00003246-200010000-00027; *HUM MED EV UN, 1995, INT C HARM ICH 135 9, P1; JENNETT B, 1975, LANCET, V1, P480; KRAMER RS, 1968, J THORAC CARDIOV SUR, V56, P699, DOI 10.1016/S0022-5223(19)42797-9; KUBOYAMA K, 1993, CRIT CARE MED, V21, P1348, DOI 10.1097/00003246-199309000-00019; LEONOV Y, 1990, J CEREBR BLOOD F MET, V10, P57, DOI 10.1038/jcbfm.1990.8; LEONOV Y, 1990, STROKE, V21, P1600, DOI 10.1161/01.STR.21.11.1600; Markarian GZ, 1996, NEUROSURGERY, V38, P542; MEZROW CK, 1992, ANN THORAC SURG, V54, P609, DOI 10.1016/0003-4975(92)91002-Q; Nagao K, 2000, J AM COLL CARDIOL, V36, P776, DOI 10.1016/S0735-1097(00)00779-8; NATALE JE, 1989, STROKE, V20, P770, DOI 10.1161/01.STR.20.6.770; NEGOVSKY VA, 1988, CRIT CARE MED, V16, P942, DOI 10.1097/00003246-198810000-00004; RAVITCH MM, 1961, NEW ENGL J MED, V264, P36, DOI 10.1056/NEJM196101052640109; Safar P, 2001, NEW ENGL J MED, V345, P66; Safar P, 1996, STROKE, V27, P105, DOI 10.1161/01.STR.27.1.105; SAFAR P, 1988, CARDIOPULMONARY CERE, P267; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; STERZ F, 1992, RESUSCITATION, V24, P27, DOI 10.1016/0300-9572(92)90171-8; STERZ F, 1991, CRIT CARE MED, V19, P379, DOI 10.1097/00003246-199103000-00017; WEINRAUCH V, 1992, STROKE, V23, P1454, DOI 10.1161/01.STR.23.10.1454; WILLIAMS GR, 1958, ANN SURG, V148, P462, DOI 10.1097/00000658-195809000-00014; Yanagawa Y, 1998, RESUSCITATION, V39, P61, DOI 10.1016/S0300-9572(98)00118-X; Zeiner A, 2000, STROKE, V31, P86, DOI 10.1161/01.STR.31.1.86; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	37	3475	3580	3	127	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2002	346	8					549	556						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	522ZK	11856793				2022-12-28	WOS:000173926700002
J	Yanovski, SZ; Yanovski, JA				Yanovski, SZ; Yanovski, JA			Drug therapy - Obesity	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							TERM WEIGHT CONTROL; FENFLURAMINE PLUS PHENTERMINE; DOUBLE-BLIND; CLINICAL-TRIAL; BEHAVIOR-MODIFICATION; DIETARY-SUPPLEMENTS; CALORIC RESTRICTION; RECOMBINANT LEPTIN; LIPASE INHIBITOR; BINGE EATERS		NIDDK, Div Digest Dis & Nutr, NIH, Bethesda, MD 20892 USA; NICHHD, Unit Growth & Obes, Dev Endocrinol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Yanovski, SZ (corresponding author), NIDDK, Obest & Eating Disorders Program, 6707 Democracy Blvd, Bethesda, MD 20892 USA.	sy29f@nih.gov		Yanovski, Jack/0000-0001-8542-1637	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000641] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000641] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alger SA, 1999, OBES RES, V7, P469, DOI 10.1002/j.1550-8528.1999.tb00435.x; Allison DB, 2001, CRIT REV FOOD SCI, V41, P1, DOI 10.1080/20014091091661; Anderson JW, 2000, OBES RES, V8, p88S; [Anonymous], 2000, Diabetes Care, V23, P1619; Apfelbaum M, 1999, AM J MED, V106, P179, DOI 10.1016/S0002-9343(98)00411-2; ASTRUP A, 1992, INT J OBESITY, V16, P269; Astrup A, 2000, ENDOCRINE, V13, P207, DOI 10.1385/ENDO:13:2:207; Atkinson RL, 1997, OBES RES, V5, P578, DOI 10.1002/j.1550-8528.1997.tb00579.x; Bach DS, 1999, OBES RES, V7, P363, DOI 10.1002/j.1550-8528.1999.tb00419.x; BAILEY CJ, 1992, DIABETES CARE, V15, P755, DOI 10.2337/diacare.15.6.755; Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906; Billington CJ, 2000, ARCH INTERN MED, V160, P898, DOI 10.1001/archinte.160.7.898; BLACKBURN G, 1995, OBES RES, V3, pS211, DOI 10.1002/j.1550-8528.1995.tb00466.x; Boozer CN, 2001, INT J OBESITY, V25, P316, DOI 10.1038/sj.ijo.0801539; Boozer CN, 2001, OBES RES, V9, P68; BOWEN RL, 2000, OBES RES, V8, P118; Bray GA, 1999, OBES RES, V7, P189, DOI 10.1002/j.1550-8528.1999.tb00701.x; Bray GA, 1999, ENDOCR REV, V20, P805, DOI 10.1210/er.20.6.805; BRAY GA, 1998, HDB OBESITY, P1; BREUM L, 1994, INT J OBESITY, V18, P99; Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901; Connolly HM, 1999, CURR PROB CARDIOLOGY, V24, P751; Connolly HM, 1997, NEW ENGL J MED, V337, P1783; DALY PA, 1993, INT J OBESITY, V17, pS73; Davidson MH, 1999, JAMA-J AM MED ASSOC, V281, P1174; DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902; Devlin MJ, 2000, INT J EAT DISORDER, V28, P325, DOI 10.1002/1098-108X(200011)28:3<325::AID-EAT10>3.3.CO;2-V; Dhurandhar NV, 1996, FASEB J, V10, P3231; ENZI G, 1976, J INT MED RES, V4, P305, DOI 10.1177/030006057600400504; EPSTEIN LH, 1994, HEALTH PSYCHOL, V13, P373, DOI 10.1037/0278-6133.13.5.373; Fanghanel G, 2000, INT J OBESITY, V24, P144, DOI 10.1038/sj.ijo.0801098; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Finer N, 2000, DIABETES OBES METAB, V2, P105, DOI 10.1046/j.1463-1326.2000.00071.x; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Fleming GA, 2000, NEW ENGL J MED, V343, P1886, DOI 10.1056/NEJM200012213432510; FLETCHER SW, 1993, ANN INTERN MED, V119, P764, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00026; Fontbonne A, 1996, DIABETES CARE, V19, P920, DOI 10.2337/diacare.19.9.920; Foster GD, 1997, J CONSULT CLIN PSYCH, V65, P79, DOI 10.1037/0022-006X.65.1.79; Freemark M, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.4.e55; From the Centers for Disease Control and Prevention, 1997, JAMA-J AM MED ASSOC, V277, P1111; Fujioka K, 2000, DIABETES OBES METAB, V2, P175, DOI 10.1046/j.1463-1326.2000.00081.x; GADDE KM, 1999, OBES RES S1, V7, pS51; Glauser TA, 1999, EPILEPSIA, V40, pS71, DOI 10.1111/j.1528-1157.1999.tb00922.x; Goldstein D J, 1993, Obes Res, V1, P92; GOLDSTEIN DJ, 1994, INT J OBESITY, V18, P129; Griffen L, 1998, ARCH INTERN MED, V158, P1278, DOI 10.1001/archinte.158.11.1278; Guler H. P., 2001, International Journal of Obesity, V25, pS111; Gurley BJ, 2000, AM J HEALTH-SYST PH, V57, P963, DOI 10.1093/ajhp/57.10.963; GuyGrand B, 1995, OBES RES, V3, pS491, DOI 10.1002/j.1550-8528.1995.tb00217.x; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Haller CA, 2000, NEW ENGL J MED, V343, P1833, DOI 10.1056/NEJM200012213432502; Hauptman J, 2000, ARCH FAM MED, V9, P160, DOI 10.1001/archfami.9.2.160; Heck AM, 2000, PHARMACOTHERAPY, V20, P270, DOI 10.1592/phco.20.4.270.34882; Heffernan MA, 2000, AM J PHYSIOL-ENDOC M, V279, pE501, DOI 10.1152/ajpendo.2000.279.3.E501; Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568; Hill JO, 1999, AM J CLIN NUTR, V69, P1108; Hollander PA, 1998, DIABETES CARE, V21, P1288, DOI 10.2337/diacare.21.8.1288; Hukshorn CJ, 2000, J CLIN ENDOCR METAB, V85, P4003, DOI 10.1210/jc.85.11.4003; Inoue S, 1995, OBES RES, V3, pS549, DOI 10.1002/j.1550-8528.1995.tb00226.x; James WPT, 2000, LANCET, V356, P2119, DOI 10.1016/S0140-6736(00)03491-7; Kernan WN, 2000, NEW ENGL J MED, V343, P1826, DOI 10.1056/NEJM200012213432501; Khan LK, 2001, ANN INTERN MED, V134, P282, DOI 10.7326/0003-4819-134-4-200102200-00011; Lewis CJ, 2001, CRIT REV FOOD SCI, V41, P43, DOI 10.1080/20014091091724; Lustig RH, 1999, J PEDIATR-US, V135, P162, DOI 10.1016/S0022-3476(99)70017-X; McCann S, 2000, OBES RES, V8, p58S; McGuire MT, 1999, OBES RES, V7, P334, DOI 10.1002/j.1550-8528.1999.tb00416.x; McKay R H, 1973, Curr Med Res Opin, V1, P489, DOI 10.1185/03007997309111712; McMahon FG, 2000, ARCH INTERN MED, V160, P2185, DOI 10.1001/archinte.160.14.2185; *MED EC, 2001, PHYS DESK REF; Molnar D, 2000, INT J OBESITY, V24, P1573, DOI 10.1038/sj.ijo.0801433; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; MUNRO JF, 1968, BRIT MED J, V1, P352, DOI 10.1136/bmj.1.5588.352; *NAT CTR HLTH STAT, 2000, PREV OV OB AD US 199; *NAT HEART LUNG BL, 2000, NIH PUBL, V4048; Pasquali R, 2000, J CLIN ENDOCR METAB, V85, P2767, DOI 10.1210/jc.85.8.2767; *PENN BIOM RES CTR, 2001, PENN BIOM RES CTR SC; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; ROAN S, 2000, LOS ANGELES TIM 1225, pS1; Ryan DH, 2000, ENDOCRINE, V13, P193, DOI 10.1385/ENDO:13:2:193; Serdula MK, 1999, JAMA-J AM MED ASSOC, V282, P1353, DOI 10.1001/jama.282.14.1353; Shapira NA, 2000, J CLIN PSYCHIAT, V61, P368, DOI 10.4088/JCP.v61n0508; SILVERSTONE J T, 1965, Br J Clin Pract, V19, P395; Sjostrom L, 1998, LANCET, V352, P167, DOI 10.1016/S0140-6736(97)11509-4; Smith G, 2000, MATER WORLD, V8, P10; STALLONE DD, 1992, DRUG DEVELOP RES, V26, P1, DOI 10.1002/ddr.430260102; STEEL JM, 1973, PRACTITIONER, V211, P232; STRYDOM AJC, 1992, CLIN CHEM, V38, P323; Stuart RB, 1996, OBES RES, V4, P411, DOI 10.1002/j.1550-8528.1996.tb00249.x; Teter CJ, 2000, ANN PHARMACOTHER, V34, P1262; TOUBRO S, 1993, INT J OBESITY, V17, pS69; TROIANO RP, 1995, ARCH PEDIAT ADOL MED, V149, P1085, DOI 10.1001/archpedi.1995.02170230039005; Wadden T A, 1995, Obes Res, V3, P549; Wadden TA, 2000, MED CLIN N AM, V84, P441, DOI 10.1016/j.psc.2004.09.008; Wadden TA, 2001, ARCH INTERN MED, V161, P218, DOI 10.1001/archinte.161.2.218; Wadden TA, 2000, OBES RES, V8, P431, DOI 10.1038/oby.2000.53; WEINTRAUB M, 1992, CLIN PHARMACOL THER, V51, P615, DOI 10.1038/clpt.1992.73; WEINTRAUB M, 1992, CLIN PHARMACOL THER, V51, P586, DOI 10.1038/clpt.1992.69; WEINTRAUB M, 1992, CLIN PHARMACOL THER, V51, P642, DOI 10.1038/clpt.1992.76; WEINTRAUB M, 1992, CLIN PHARMACOL THER, V51, P608, DOI 10.1038/clpt.1992.72; WEINTRAUB M, 1992, CLIN PHARMACOL THER, V51, P634, DOI 10.1038/clpt.1992.75; WEINTRAUB M, 1992, CLIN PHARMACOL THER, V51, P619, DOI 10.1038/clpt.1992.74; WEINTRAUB M, 1992, CLIN PHARMACOL THER, V51, P595, DOI 10.1038/clpt.1992.70; WEINTRAUB M, 1992, CLIN PHARMACOL THER, V51, P602, DOI 10.1038/clpt.1992.71; WILHELM C, 2000, CHEM MARKET REP 0515, pFR23; Wirth A, 2001, JAMA-J AM MED ASSOC, V286, P1331, DOI 10.1001/jama.286.11.1331; Yanovski SZ, 1996, JAMA-J AM MED ASSOC, V276, P1907, DOI 10.1001/jama.276.23.1907; 1998, MED LETT DRUGS THER, V40, P32; 2001, OBESITY MED RES  MAR; 2001, OBESITY MED RES  JUN	109	472	504	0	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2002	346	8					591	602		10.1056/NEJMra012586	http://dx.doi.org/10.1056/NEJMra012586			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	522ZK	11856799				2022-12-28	WOS:000173926700008
J	Healy, DL; Saunders, K				Healy, DL; Saunders, K			Follow-up of children born after in-vitro fertilisation	LANCET			English	Editorial Material									Monash Univ, Dept Obstet & Gynaecol, Melbourne, Vic 3168, Australia; Monash Univ, Dept Paediat, Melbourne, Vic 3168, Australia	Monash University; Monash University	Healy, DL (corresponding author), Monash Univ, Dept Obstet & Gynaecol, Melbourne, Vic 3168, Australia.							JONES HW, 2001, FERTIL STERIL, V75, P1; STANLEY FJ, 2000, CLINS DEV MED, V151, P67; Sutcliffe AG, 2001, LANCET, V357, P2080, DOI 10.1016/S0140-6736(00)05180-1; WHITTEMORE AS, 1992, AM J EPIDEMIOL, V136, P1184, DOI 10.1093/oxfordjournals.aje.a116427	4	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 9	2002	359	9305					459	460		10.1016/S0140-6736(02)07672-9	http://dx.doi.org/10.1016/S0140-6736(02)07672-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520ML	11853788				2022-12-28	WOS:000173785600005
J	Esberger, D; Jones, S; Morris, F				Esberger, D; Jones, S; Morris, F			ABC of clinical electrocardiography - Junctional tachycardias	BRITISH MEDICAL JOURNAL			English	Article									Queens Med Ctr, Nottingham NG7 2UH, England; No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England	University of Nottingham; Northern General Hospital	Esberger, D (corresponding author), Queens Med Ctr, Nottingham NG7 2UH, England.								0	7	7	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 16	2002	324	7338					662	665		10.1136/bmj.324.7338.662	http://dx.doi.org/10.1136/bmj.324.7338.662			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532QW	11895828	Green Published			2022-12-28	WOS:000174487400031
J	Anglin, JR; Ketterle, W				Anglin, JR; Ketterle, W			Bose-Einstein condensation of atomic gases	NATURE			English	Review							QUANTUM KINETIC-THEORY; DARK SOLITONS; SCISSORS MODE; VORTEX RINGS; DYNAMICS; SUPERFLUIDITY; STATES; DEGENERACY; MOLECULES; RESONANCE		MIT, Elect Res Lab, MIT Harvard Ctr Ultracold Atoms, Cambridge, MA 02139 USA; MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Anglin, JR (corresponding author), MIT, Elect Res Lab, MIT Harvard Ctr Ultracold Atoms, Cambridge, MA 02139 USA.							Abo-Shaeer JR, 2001, SCIENCE, V292, P476, DOI 10.1126/science.1060182; Al Khawaja U, 2001, NATURE, V411, P918, DOI 10.1038/35082010; Anderson BP, 2001, PHYS REV LETT, V86, P2926, DOI 10.1103/PhysRevLett.86.2926; ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; Anglin JR, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.240401; ANGLIN JR, 2001, CONDMAT0110389; [Anonymous], 1947, J PHYS-USSR; ARIMONDO E, 1992, LASER MANIPULATION A; Barrett MD, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.010404; Bijlsma MJ, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.063609; Bloch I, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.021402; Bouyer P, 1997, PHYS REV A, V56, pR1083, DOI 10.1103/PhysRevA.56.R1083; Bradley CC, 1997, PHYS REV LETT, V78, P985, DOI 10.1103/PhysRevLett.78.985; BRADLEY CC, 1995, PHYS REV LETT, V75, P1687, DOI 10.1103/PhysRevLett.75.1687; Burger S, 2001, PHYS REV LETT, V86, P4447, DOI 10.1103/PhysRevLett.86.4447; Burger S, 1999, PHYS REV LETT, V83, P5198, DOI 10.1103/PhysRevLett.83.5198; Burnett K, 1999, P INT SCH PHYS, V140, P265; Busch T, 1999, PHYS REV A, V60, pR2669, DOI 10.1103/PhysRevA.60.R2669; Castin Y, 1998, PHYS REV A, V57, P3008, DOI 10.1103/PhysRevA.57.3008; Cataliotti FS, 2001, SCIENCE, V293, P843, DOI 10.1126/science.1062612; Cornish SL, 2000, PHYS REV LETT, V85, P1795, DOI 10.1103/PhysRevLett.85.1795; Courteille P, 1998, PHYS REV LETT, V81, P69, DOI 10.1103/PhysRevLett.81.69; Dalfovo F, 1999, REV MOD PHYS, V71, P463, DOI 10.1103/RevModPhys.71.463; Dalfovo F, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.011601; DAVIS KB, 1995, PHYS REV LETT, V75, P3969, DOI 10.1103/PhysRevLett.75.3969; DeMarco B, 1999, SCIENCE, V285, P1703, DOI 10.1126/science.285.5434.1703; Denschlag J, 2000, SCIENCE, V287, P97, DOI 10.1126/science.287.5450.97; Dettmer S, 2001, PHYS REV LETT, V87, part. no., DOI 10.1103/PhysRevLett.87.160406; Donley EA, 2001, NATURE, V412, P295, DOI 10.1038/35085500; Dos Santos FP, 2001, PHYS REV LETT, V86, P3459, DOI 10.1103/PhysRevLett.86.3459; Feder DL, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.190401; Feder DL, 2001, PHYS REV LETT, V86, P564, DOI 10.1103/PhysRevLett.86.564; Fetter AL, 2001, J PHYS-CONDENS MAT, V13, pR135, DOI 10.1088/0953-8984/13/12/201; Fried DG, 1998, PHYS REV LETT, V81, P3811, DOI 10.1103/PhysRevLett.81.3811; Gardiner CW, 1997, PHYS REV A, V56, P1414, DOI 10.1103/PhysRevA.56.1414; Gardiner CW, 1998, PHYS REV LETT, V81, P5266, DOI 10.1103/PhysRevLett.81.5266; Gorlitz A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.130402; GRANADE SR, 2001, CONDMAT0111344; GROSS EP, 1961, NUOVO CIMENTO, V20, P454, DOI 10.1007/BF02731494; Guery-Odelin D, 1998, EUROPHYS LETT, V44, P25, DOI 10.1209/epl/i1998-00425-9; Guery-Odelin D, 1999, PHYS REV LETT, V83, P4452, DOI 10.1103/PhysRevLett.83.4452; Gustavson TL, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.020401; HADZIBABIC Z, 2001, CONDMAT0112425; Haljan PC, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.210403; Hall DS, 1998, PHYS REV LETT, V81, P1539, DOI 10.1103/PhysRevLett.81.1539; Hansel W, 2001, NATURE, V413, P498, DOI 10.1038/35097032; Heinzen DJ, 2000, PHYS REV LETT, V84, P5029, DOI 10.1103/PhysRevLett.84.5029; Heinzen DJ, 1999, P INT SCH PHYS, V140, P351; Ho TL, 1998, PHYS REV LETT, V81, P742, DOI 10.1103/PhysRevLett.81.742; Hodby E, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.010405; Hodby E, 2001, PHYS REV LETT, V86, P2196, DOI 10.1103/PhysRevLett.86.2196; Horak P, 1997, PHYS REV LETT, V79, P4974, DOI 10.1103/PhysRevLett.79.4974; Inouye S, 1998, NATURE, V392, P151, DOI 10.1038/32354; Kagan Y, 1997, PHYS REV LETT, V79, P3331, DOI 10.1103/PhysRevLett.79.3331; Ketterle W, 1996, PHYS REV A, V54, P656, DOI 10.1103/PhysRevA.54.656; Ketterle W, 1999, P INT SCH PHYS, V140, P67; Kim JH, 1997, PHYS REV LETT, V78, P3665, DOI 10.1103/PhysRevLett.78.3665; Kocharovsky VV, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.023609; KOHL M, 2001, CONDMAT0106642; Law CK, 1998, PHYS REV LETT, V81, P5257, DOI 10.1103/PhysRevLett.81.5257; Madison KW, 2001, PHYS REV LETT, V86, P4443, DOI 10.1103/PhysRevLett.86.4443; Madison KW, 2000, PHYS REV LETT, V84, P806, DOI 10.1103/PhysRevLett.84.806; Marago OM, 2000, PHYS REV LETT, V84, P2056, DOI 10.1103/PhysRevLett.84.2056; MASUHARA N, 1988, PHYS REV LETT, V61, P935, DOI 10.1103/PhysRevLett.61.935; Matthews MR, 1999, PHYS REV LETT, V83, P2498, DOI 10.1103/PhysRevLett.83.2498; Mewes MO, 1996, PHYS REV LETT, V77, P416, DOI 10.1103/PhysRevLett.77.416; Miesner HJ, 1998, SCIENCE, V279, P1005, DOI 10.1126/science.279.5353.1005; Modugno G, 2001, SCIENCE, V294, P1320, DOI 10.1126/science.1066687; Monien H, 1998, PHYS REV A, V58, pR3395, DOI 10.1103/PhysRevA.58.R3395; MOSS S, 2001, FORMATION DECAY BOSE; Myatt CJ, 1997, PHYS REV LETT, V78, P586, DOI 10.1103/PhysRevLett.78.586; Olshanii M, 1998, PHYS REV LETT, V81, P938, DOI 10.1103/PhysRevLett.81.938; Onofrio R, 2000, PHYS REV LETT, V85, P2228, DOI 10.1103/PhysRevLett.85.2228; Orzel C, 2001, SCIENCE, V291, P2386, DOI 10.1126/science.1058149; OTT H, 2001, PHYS REV LETT; Petrov DS, 2000, PHYS REV LETT, V85, P3745, DOI 10.1103/PhysRevLett.85.3745; PITAEVSKII LP, 1961, ZH EKSP TEOR FIZ, V13, P451; Raman C, 1999, PHYS REV LETT, V83, P2502, DOI 10.1103/PhysRevLett.83.2502; Robert A, 2001, SCIENCE, V292, P461, DOI 10.1126/science.1060622; Ruostekoski J, 2001, PHYS REV LETT, V86, P3934, DOI 10.1103/PhysRevLett.86.3934; Sackett CA, 1999, PHYS REV LETT, V82, P876, DOI 10.1103/PhysRevLett.82.876; Schreck F, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.080403; SHLYAPNIKOV GV, 1994, PHYS REV LETT, V73, P3247, DOI 10.1103/PhysRevLett.73.3247; Sinha S, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.190402; Stenger J, 1998, NATURE, V396, P345, DOI 10.1038/24567; Stoof HTC, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.120407; Stoof HTC, 1999, P INT SCH PHYS, V140, P537; TIESINGA E, 1993, PHYS REV A, V47, P4114, DOI 10.1103/PhysRevA.47.4114; Timmermans E, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.240403; Timmermans E, 1998, PHYS REV LETT, V80, P3419, DOI 10.1103/PhysRevLett.80.3419; Truscott AG, 2001, SCIENCE, V291, P2570, DOI 10.1126/science.1059318; Vuletic V, 2000, PHYS REV LETT, V84, P3787, DOI 10.1103/PhysRevLett.84.3787; Walser R, 1999, PHYS REV A, V59, P3878, DOI 10.1103/PhysRevA.59.3878; Williams JE, 1999, NATURE, V401, P568, DOI 10.1038/44095; Winiecki T, 2000, J PHYS B-AT MOL OPT, V33, P4069, DOI 10.1088/0953-4075/33/19/317; Wyatt AFG, 1998, NATURE, V391, P56, DOI 10.1038/34134; Wynar R, 2000, SCIENCE, V287, P1016, DOI 10.1126/science.287.5455.1016; Zaremba E, 1999, J LOW TEMP PHYS, V116, P277, DOI 10.1023/A:1021846002995	100	295	302	6	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2002	416	6877					211	218		10.1038/416211a	http://dx.doi.org/10.1038/416211a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894104				2022-12-28	WOS:000174348100047
J	Blake, C; Wall, J				Blake, C; Wall, J			A velocity dipole in the distribution of radio galaxies	NATURE			English	Article							ANISOTROPY; CATALOG	The motion of our Galaxy through the Universe is reflected in a systematic shift in the temperature of the cosmic microwave background(1)-because of the Doppler effect, the temperature of the background is about 0.1 per cent higher in the direction of motion, with a correspondingly lower temperature in the opposite direction. This effect is known as dipole anisotropy. If our standard cosmological model is correct, a related dipole effect should also be present as an enhancement in the surface density of distant galaxies in the direction of motion(2). The main obstacle to finding this signal is the uneven distribution of galaxies in the local supercluster, which drowns out the small cosmological signal. Here we report a detection of the expected cosmological dipole anisotropy in the distribution of galaxies. We use a survey of radio galaxies that are mainly located at cosmological distances, so the contamination from nearby clusters is small. When local radio galaxies are removed from the sample, the resulting dipole is in the same direction as the temperature anisotropy of the microwave background, and close to the expected amplitude. The result therefore confirms the standard cosmological interpretation of the microwave background.	Univ Oxford, Nucl & Astrophys Lab, Oxford OX1 3RH, England	University of Oxford	Blake, C (corresponding author), Univ Oxford, Nucl & Astrophys Lab, Keble Rd, Oxford OX1 3RH, England.		Blake, Chris/AAC-4603-2019	Blake, Chris/0000-0002-5423-5919				Baleisis A, 1998, MON NOT R ASTRON SOC, V297, P545, DOI 10.1046/j.1365-8711.1998.01536.x; Condon JJ, 1998, ASTRON J, V115, P1693, DOI 10.1086/300337; CORWIN HG, 1994, ASTRON J, V108, P2128, DOI 10.1086/117225; DUNLOP JS, 1990, MON NOT R ASTRON SOC, V247, P19; ELLIS GFR, 1984, MON NOT R ASTRON SOC, V206, P377, DOI 10.1093/mnras/206.2.377; LAHAV O, 1987, MON NOT R ASTRON SOC, V225, P213, DOI 10.1093/mnras/225.2.213; Lineweaver C. H., 1997, P 16 MOR ASTR M, P69; Rowan-Robinson M, 2000, MON NOT R ASTRON SOC, V314, P375, DOI 10.1046/j.1365-8711.2000.03313.x; Saunders W, 2000, MON NOT R ASTRON SOC, V317, P55, DOI 10.1046/j.1365-8711.2000.03528.x; Scharf CA, 2000, ASTROPHYS J, V544, P49, DOI 10.1086/317174; SMOOT GF, 1977, PHYS REV LETT, V39, P898, DOI 10.1103/PhysRevLett.39.898	11	104	105	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2002	416	6877					150	152		10.1038/416150a	http://dx.doi.org/10.1038/416150a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894086	Green Submitted			2022-12-28	WOS:000174348100029
J	Burtally, N; King, PJ; Swift, MR				Burtally, N; King, PJ; Swift, MR			Spontaneous air-driven separation in vertically vibrated fine granular mixtures	SCIENCE			English	Article							SIZE SEGREGATION; CONVECTION; PATTERNS; POWDER; DYNAMICS; BEDS; HEAP	We report the observation of the spontaneous separation of vertically vibrated mixtures of fine bronze and glass spheres of similar diameters. At tow frequencies and at sufficient vibrational amplitudes, a sharp boundary forms between a tower region of glass and an upper region of the heavier bronze. The boundary undergoes various oscillations, including periodic tilting motion, but remains extremely sharp. At higher frequencies, the bronze separates as a mid-height layer between upper and lower glass regions, and the oscillations are largely absent. The mechanism responsible for the separation can be traced to the effect of air on the granular motion.	Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England	University of Nottingham	King, PJ (corresponding author), Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England.							Aoki KM, 1996, PHYS REV E, V54, P874, DOI 10.1103/PhysRevE.54.874; BARKER GC, 1993, NATURE, V364, P486, DOI 10.1038/364486a0; Bizon C, 1998, PHYS REV LETT, V80, P57, DOI 10.1103/PhysRevLett.80.57; Duran J, 2000, PHYS REV LETT, V84, P5126, DOI 10.1103/PhysRevLett.84.5126; DURAN J, 1994, PHYS REV E, V50, P5138, DOI 10.1103/PhysRevE.50.5138; EVESQUE P, 1989, PHYS REV LETT, V62, P44, DOI 10.1103/PhysRevLett.62.44; FARADAY M, 1831, PHIL T R SOC LONDON, V52, P299; HERRMANN HJ, 1998, PHYSICS DRY GRANULAR; Hong DC, 2001, PHYS REV LETT, V86, P3423, DOI 10.1103/PhysRevLett.86.3423; Hsiau SS, 1998, POWDER TECHNOL, V96, P219, DOI 10.1016/S0032-5910(97)03377-9; Jaeger HM, 1996, REV MOD PHYS, V68, P1259, DOI 10.1103/RevModPhys.68.1259; KNIGHT JB, 1993, PHYS REV LETT, V70, P3728, DOI 10.1103/PhysRevLett.70.3728; Knight JB, 1996, PHYS REV E, V54, P5726, DOI 10.1103/PhysRevE.54.5726; Kumar K, 1999, PHYSICA A, V270, P97, DOI 10.1016/S0378-4371(99)00134-X; McNamara S, 1996, PHYS REV E, V53, P5089, DOI 10.1103/PhysRevE.53.5089; McNamara S, 2000, PHYS REV E, V61, P4054, DOI 10.1103/PhysRevE.61.4054; MELO F, 1994, PHYS REV LETT, V72, P172, DOI 10.1103/PhysRevLett.72.172; Mobius ME, 2001, NATURE, V414, P270, DOI 10.1038/35104697; Ottino JM, 2000, ANNU REV FLUID MECH, V32, P55, DOI 10.1146/annurev.fluid.32.1.55; PAK HK, 1995, PHYS REV LETT, V74, P4643, DOI 10.1103/PhysRevLett.74.4643; Rajchenbach J, 2000, ADV PHYS, V49, P229, DOI 10.1080/000187300243372; ROSATO A, 1987, PHYS REV LETT, V58, P1038, DOI 10.1103/PhysRevLett.58.1038; Shinbrot T, 1998, PHYS REV LETT, V81, P4365, DOI 10.1103/PhysRevLett.81.4365; Thomas B, 1998, PHYS REV LETT, V81, P574, DOI 10.1103/PhysRevLett.81.574; WASGREN CR, 1996, J APPL MECH, V63, P712	25	133	140	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1877	1879		10.1126/science.1066850	http://dx.doi.org/10.1126/science.1066850			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884749				2022-12-28	WOS:000174299500033
J	Moran, NA				Moran, NA			Microbial minimalism: Genome reduction in bacterial pathogens	CELL			English	Review							GENE-SET; EVOLUTION; SEQUENCE; CELL	When bacterial lineages make the transition from free-living or facultatively parasitic life cycles to permanent associations with hosts, they undergo a major loss of genes and DNA. Complete genome sequences are providing an understanding of how extreme genome reduction affects evolutionary directions and metabolic capabilities of obligate pathogens and symbionts.	Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	University of Arizona	Moran, NA (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.		Moran, Nancy A/G-1591-2010					Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Andersson JO, 2001, MOL BIOL EVOL, V18, P829, DOI 10.1093/oxfordjournals.molbev.a003864; Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Glass JI, 2000, NATURE, V407, P757, DOI 10.1038/35037619; Goebel W, 2001, TRENDS MICROBIOL, V9, P267, DOI 10.1016/S0966-842X(01)02040-6; Himmelreich R, 1997, NUCLEIC ACIDS RES, V25, P701, DOI 10.1093/nar/25.4.701; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Koonin EV, 2000, ANNU REV GENOM HUM G, V1, P99, DOI 10.1146/annurev.genom.1.1.99; Maniloff J, 1996, P NATL ACAD SCI USA, V93, P10004, DOI 10.1073/pnas.93.19.10004; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Moran NA, 2000, TRENDS ECOL EVOL, V15, P321, DOI 10.1016/S0169-5347(00)01902-9; MORAN NA, 2001, IN PRESS GENOME BIOL; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Silva FJ, 2001, TRENDS GENET, V17, P615, DOI 10.1016/S0168-9525(01)02483-0; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987	20	513	534	1	48	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 8	2002	108	5					583	586		10.1016/S0092-8674(02)00665-7	http://dx.doi.org/10.1016/S0092-8674(02)00665-7			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	529TN	11893328	Bronze			2022-12-28	WOS:000174314800001
J	Korbling, M; Katz, RL; Khanna, A; Ruifrok, AC; Rondon, G; Albitar, M; Champlin, RE; Estrov, Z				Korbling, M; Katz, RL; Khanna, A; Ruifrok, AC; Rondon, G; Albitar, M; Champlin, RE; Estrov, Z			Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEMATOPOIETIC PROGENITOR CELLS; BONE-MARROW; STROMAL CELLS; TRANSPLANTATION; DIFFERENTIATE; COLLECTIONS; LEUKEMIA	Background: Bone marrow contains stem cells with the potential to differentiate into mature cells of various organs. We determined whether circulating stem cells have a similar potential. Methods: Biopsy specimens from the liver, gastrointestinal tract, and skin were obtained from 12 patients who had undergone transplantation of hematopoietic stem cells from peripheral blood (11 patients) or bone marrow (1 patient). Six female patients had received transplants from a male donor. Five had received a sex-matched transplant, and one had received an autologous transplant. Hematopoietic stem-cell engraftment was verified by cytogenetic analysis or restriction-fragment-length polymorphism analysis. The biopsies were studied for the presence of donor-derived epithelial cells or hepatocytes with the use of fluorescence in situ hybridization of interphase nuclei and immunohistochemical staining for cytokeratin, CD45 (leukocyte common antigen), and a hepatocyte-specific antigen. Results: All six recipients of sex-mismatched transplants showed evidence of complete hematopoietic donor chimerism. XY-positive epithelial cells or hepatocytes accounted for 0 to 7 percent of the cells in histologic sections of the biopsy specimens. These cells were detected in liver tissue as early as day 13 and in skin tissue as late as day 354 after the transplantation of peripheral-blood stem cells. The presence of donor cells in the biopsy specimens did not seem to depend on the intensity of tissue damage induced by graft-versus-host disease. Conclusions: Circulating stem cells can differentiate into mature hepatocytes and epithelial cells of the skin and gastrointestinal tract.	Univ Texas, MD Anderson Canc Ctr, Dept Blood & Marrow Transplantat, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Bioimmunotherapy, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Korbling, M (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Blood & Marrow Transplantat, Box 423,1515 Holcombe Blvd, Houston, TX 77030 USA.							Alison MR, 2000, NATURE, V406, P257, DOI 10.1038/35018642; Almeida-Porada G, 2000, BLOOD, V96, p494A; Anderson DJ, 2001, NAT MED, V7, P393, DOI 10.1038/86439; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Bensinger WI, 2001, NEW ENGL J MED, V344, P175, DOI 10.1056/NEJM200101183440303; BRUGGER W, 1994, BLOOD, V83, P636; Farace F, 2000, BLOOD, V96, p494A; Fernandez M, 1997, BONE MARROW TRANSPL, V20, P265, DOI 10.1038/sj.bmt.1700890; Ferrari G, 1998, SCIENCE, V281, P923; Fuchs E, 2000, CELL, V100, P143, DOI 10.1016/S0092-8674(00)81691-8; Giralt S, 1997, BLOOD, V89, P4531, DOI 10.1182/blood.V89.12.4531; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Huss R, 2000, STEM CELLS, V18, P252, DOI 10.1634/stemcells.18-4-252; KNOWLTON RG, 1986, BLOOD, V68, P378; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; KORBLING M, 1995, BLOOD, V85, P1659, DOI 10.1182/blood.V85.6.1659.bloodjournal8561659; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Lazarus HM, 1997, J HEMATOTHER, V6, P447, DOI 10.1089/scd.1.1997.6.447; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124; Zanjani ED, 2000, BLOOD, V96, p494A	25	620	709	0	13	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2002	346	10					738	746		10.1056/NEJMoa3461002	http://dx.doi.org/10.1056/NEJMoa3461002			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527UA	11882729				2022-12-28	WOS:000174205000004
J	Ostendorff, HP; Peirano, RI; Peters, MA; Schluter, A; Bossenz, M; Scheffner, M; Bach, I				Ostendorff, HP; Peirano, RI; Peters, MA; Schluter, A; Bossenz, M; Scheffner, M; Bach, I			Ubiquitination-dependent cofactor exchange on LIM homeodomain transcription factors	NATURE			English	Article							DROSOPHILA; DOMAIN; CHIP; COREGULATOR; RECEPTORS; PROTEINS; BINDING; COMPLEX; HORMONE; FAMILY	The interactions of distinct cofactor complexes with transcription factors are decisive determinants for the regulation of gene expression. Depending on the bound cofactor, transcription factors can have either repressing or transactivating activities(1). To allow a switch between these different states, regulated cofactor exchange has been proposed(2,3); however, little is known about the molecular mechanisms that are involved in this process. LIM homeodomain (LIM-HD) transcription factors associate with RLIM (RING finger LIM domain-binding protein) and with CLIM (cofactor of LIM-HD proteins; also known as NLI, Ldb and Chip) cofactors. The co-repressor RLIM inhibits the function of LIM-HD transcription factors, whereas interaction with CLIM proteins is important for the exertion of the biological activity conferred by LIM-HD transcription-factors(4,5). Here we identify RLIM as a ubiquitin protein ligase that is able to target CLIM cofactors for degradation through the 26S proteasome pathway. Furthermore, we demonstrate a ubiquitination-dependent association of RLIM with LIM-HD proteins in the presence of CLIM cofactors. Our data provide a mechanistic basis for cofactor exchange on DNA-bound transcription factors, and probably represent a general mechanism of transcriptional regulation.	Univ Hamburg, ZMNH, D-20251 Hamburg, Germany; Univ Cologne, Fak Med, Inst Biochem 1, D-50931 Cologne, Germany	University of Hamburg; University of Cologne	Bach, I (corresponding author), Univ Hamburg, ZMNH, Martinistr 85, D-20251 Hamburg, Germany.		Scheffner, Martin/K-2940-2012	Scheffner, Martin/0000-0003-2229-0128; Ostendorff, Heather/0000-0002-1481-8263				Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; Bach I, 1999, NAT GENET, V22, P394, DOI 10.1038/11970; Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; BACH I, 1993, EMBO J, V12, P4229, DOI 10.1002/j.1460-2075.1993.tb06107.x; BACH I, 1995, P NATL ACAD SCI USA, V92, P2720, DOI 10.1073/pnas.92.7.2720; Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; Boehm J, 2001, EMBO J, V20, P4153, DOI 10.1093/emboj/20.15.4153; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Glass CK, 2000, GENE DEV, V14, P121; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Jurata LW, 1997, MOL CELL BIOL, V17, P5688, DOI 10.1128/MCB.17.10.5688; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Mannervik M, 1999, SCIENCE, V284, P606, DOI 10.1126/science.284.5414.606; Milan M, 1999, MOL CELL, V4, P267, DOI 10.1016/S1097-2765(00)80374-3; Milan M, 1998, GENE DEV, V12, P2912, DOI 10.1101/gad.12.18.2912; Morcillo P, 1997, GENE DEV, V11, P2729, DOI 10.1101/gad.11.20.2729; Ostendorff HP, 2000, GENOMICS, V69, P120, DOI 10.1006/geno.2000.6311; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; ROBERSON MS, 1994, MOL CELL BIOL, V14, P2985, DOI 10.1128/MCB.14.5.2985; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Tiedt R, 2001, EMBO J, V20, P4143, DOI 10.1093/emboj/20.15.4143; van Meyel DJ, 2000, DEVELOPMENT, V127, P1823; van Meyel DJ, 1999, MOL CELL, V4, P259, DOI 10.1016/S1097-2765(00)80373-1; WINDLE JJ, 1990, MOL ENDOCRINOL, V4, P597, DOI 10.1210/mend-4-4-597; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E	27	131	147	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2002	416	6876					99	103		10.1038/416099a	http://dx.doi.org/10.1038/416099a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882901				2022-12-28	WOS:000174211600047
J	Pfisterer, AB; Schmid, B				Pfisterer, AB; Schmid, B			Diversity-dependent production can decrease the stability of ecosystem functioning	NATURE			English	Article							PLANT DIVERSITY; BIODIVERSITY; COMMUNITIES	There is concern that species loss may adversely affect ecosystem functioning and stability. But although there is evidence that biodiversity loss can lead to reductions in biomass production(1-4), there is no direct evidence that biodiversity loss affects ecosystem resistance (ability to withstand perturbation) or resilience (recovery from perturbation). Yet theory(5,6), laboratory experiments(7-11) and indirect experimental evidence(12-14) strongly suggest that diversity and stability are related. Here we report results from a field experiment with factorially crossed perturbation and diversity manipulations. We simulated drought perturbation on constructed grassland ecosystems containing 1, 2, 4, 8 or 32 plant species. Under unperturbed conditions, the species-poor systems achieved lower biomass production than the species-rich systems. However, the species-poor systems were more resistant to perturbation than the species-rich systems. The species-poor systems also showed a larger initial resilience following perturbation, although the original relationship between diversity and productivity was fully restored after 1 year. Our results confirm that biodiversity increases biomass production, but they also point to the fact that such diversity-production associations may lead to an inverse relationship between biodiversity and the stability of ecosystem functioning.	Univ Zurich, Inst Umweltwissensch, CH-8057 Zurich, Switzerland	University of Zurich	Schmid, B (corresponding author), Univ Zurich, Inst Umweltwissensch, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	bschmid@uwinst.unizh.ch	Schmid, Bernhard/C-8625-2009	Schmid, Bernhard/0000-0002-8430-3214				Burnham KP., 2004, MODEL SELECTION MULT, V2, DOI 10.1007/b97636; Diemer Matthias, 1997, Bulletin of the Geobotanical Institute ETH, V63, P95; DODD ME, 1994, PHILOS T R SOC B, V346, P185, DOI 10.1098/rstb.1994.0140; Griffiths BS, 2000, OIKOS, V90, P279, DOI 10.1034/j.1600-0706.2000.900208.x; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Herbert DA, 1999, ECOLOGY, V80, P908, DOI 10.1890/0012-9658(1999)080[0908:HDTAHF]2.0.CO;2; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; LAWTON JH, 1993, ECOL STU AN, V99, P255; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; May R.M., 1973, STABILITY COMPLEXITY; McGradySteed J, 1997, NATURE, V390, P162, DOI 10.1038/36561; Mulder CPH, 2001, P NATL ACAD SCI USA, V98, P6704, DOI 10.1073/pnas.111055298; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; PAYNE RW, 1993, GENSTAT 5 REFERENCE; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; Sankaran M, 1999, NATURE, V401, P691, DOI 10.1038/44368; Stephan A, 2000, J ECOL, V88, P988, DOI 10.1046/j.1365-2745.2000.00510.x; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	21	303	331	18	257	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2002	416	6876					84	86		10.1038/416084a	http://dx.doi.org/10.1038/416084a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882897				2022-12-28	WOS:000174211600043
J	Tan, GH; Sussmane, JB				Tan, GH; Sussmane, JB			Massive air embolism in a neonate with pulmonary hypoplasia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Miami Childrens Hosp, Miami, FL 33155 USA		Tan, GH (corresponding author), Miami Childrens Hosp, Miami, FL 33155 USA.								0	2	2	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2002	346	10					751	751		10.1056/NEJMicm010470	http://dx.doi.org/10.1056/NEJMicm010470			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527UA	11882731				2022-12-28	WOS:000174205000006
J	Bender, J				Bender, J			From theater to laboratory	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Stanford Univ, Stanford, CA 94305 USA	Stanford University	Bender, J (corresponding author), Stanford Univ, Stanford, CA 94305 USA.							Carlino A, 1999, BOOKS BODY ANATOMICA; Hunt Lynn, 1993, INVENTION PORNOGRAPH; RICHARDSON R, 2000, DEATH DISSECTION DES	3	6	6	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2002	287	9					1179	1179		10.1001/jama.287.9.1179	http://dx.doi.org/10.1001/jama.287.9.1179			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527KV	11879119	hybrid			2022-12-28	WOS:000174186000036
J	Feder, G; Crook, AM; Magee, P; Banerjee, S; Timmis, AD; Hemingway, H				Feder, G; Crook, AM; Magee, P; Banerjee, S; Timmis, AD; Hemingway, H			Ethnic differences in invasive management of coronary disease: prospective cohort study of patients undergoing angiography	BRITISH MEDICAL JOURNAL			English	Article							ARTERY DISEASE; CARDIOVASCULAR PROCEDURES; MYOCARDIAL-INFARCTION; ASIANS; REVASCULARIZATION; BIRMINGHAM; MORTALITY; SURVIVAL; ENGLAND; SURGERY	Objectives To compare rates of revascularisation in south Asian and white patients undergoing coronary angiography in relation to the appropriateness of revascularisation and clinical outcome. Design Prospective cohort study of patients with two and a half years' follow up; appropriateness of revascularisation rated by nine experts with no knowledge of ethnicity of patient. Setting Tertiary cardiac centre in London with referral from five contiguous health authorities. Participants Consecutive patients (502 south Asian, 2974 white) undergoing coronary angiography in the appropriateness of coronary, revascularisation study (ACRE). Main outcome measures Coronary revascularisation, non-fatal myocardial infarction, mortality. Results There was no difference between south Asian and white patients in the proportions deemed appropriate for revascularisation (72% (361) v 68% (2022)) or in the proportions for whom the physician's intended management was revascularisation (39% (196) v 41% (1218)). Among patients appropriate for revascularisation, age adjusted rates of coronary angioplasty (hazard ratio 0.69, 95% confidence interval 0.47 to 1.00, P=0.058) and coronary artery bypass grafting (0.74, 0.58 to 0.91, P=0.007) were lower in south Asian than in white patients. These differences were smaller but still present after adjustment for socioeconomic status and after restriction of analysis to those patients for whom the intended management was revascularisation. There were no differences in mortality and non-fatal myocardial infarction between south Asian and white patients (1.07,0.78 to 1.47). Conclusion Among patients deemed appropriate for coronary artery bypass grafting, south Asian patients are less likely than white patients to receive it. This difference is not explained by physician bias.	Queen Marys Sch Med & Dent, Barts & London, Dept Gen Practice & Primary Care, London EN1 4NS, England; Kensington & Chelsea & Westminster Hlth Author, Dept Res & Dev, London W2 6LX, England; London NHS Trust Cardiac Directorate, London E2 9JX, England	University of London; Queen Mary University London	Feder, G (corresponding author), Queen Marys Sch Med & Dent, Barts & London, Dept Gen Practice & Primary Care, London EN1 4NS, England.		Hemingway, Harry/C-1219-2009	Hemingway, Harry/0000-0003-2279-0624; Feder, Gene/0000-0002-7890-3926				Acheson D., 1998, INDEPENDENT INQUIRY; AITER DA, 1999, NEW ENGL J MED, V341, P1359; [Anonymous], CORONARY ANGIOGRAPHY; Aspinall PJ, 2000, PUBLIC HEALTH, V114, P254, DOI 10.1016/S0033-3506(00)00340-1; Banerjee S, 2000, AM J CARDIOL, V85, P309, DOI 10.1016/S0002-9149(99)00738-9; Barnhart JM, 2000, CLIN CARDIOL, V23, P580, DOI 10.1002/clc.4960230807; Carlisle DM, 1998, AM J PUBLIC HEALTH, V88, P1089, DOI 10.2105/AJPH.88.7.1089; Chaturvedi N, 1997, LANCET, V350, P1578, DOI 10.1016/S0140-6736(97)06243-0; DHAWAN J, 1994, POSTGRAD MED J, V70, P625, DOI 10.1136/pgmj.70.827.625; ERENS B, 2001, HLTH SURVEY ENGLAND; Fang J, 1996, NEW ENGL J MED, V335, P1545, DOI 10.1056/NEJM199611213352101; Goldsmith I, 1999, EUR HEART J, V20, P1094, DOI 10.1053/euhj.1998.1450; Hemingway H, 2001, NEW ENGL J MED, V344, P645, DOI 10.1056/NEJM200103013440906; Hemingway H, 1999, J PUBLIC HEALTH MED, V21, P421, DOI 10.1093/pubmed/21.4.421; Kravitz RL, 1999, ANN INTERN MED, V130, P231, DOI 10.7326/0003-4819-130-3-199902020-00028; LOWRY PJ, 1984, BRIT HEART J, V52, P610, DOI 10.1136/hrt.52.6.610; MacLeod MCM, 1999, HEART, V81, P252, DOI 10.1136/hrt.81.3.252; Morrison C, 1997, BMJ-BRIT MED J, V314, P541, DOI 10.1136/bmj.314.7080.541; MUKHTAR HT, 1995, BRIT HEART J, V73, P122; NAISH J, 1997, HLTH INFORMATICS J, V3, P100; Peniston RL, 2000, AM HEART J, V139, P840, DOI 10.1016/S0002-8703(00)90016-4; RINGQVIST I, 1983, J CLIN INVEST, V71, P1854, DOI 10.1172/JCI110941; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; SHAUKAT N, 1993, BRIT MED J, V307, P717, DOI 10.1136/bmj.307.6906.717; Sheifer SE, 2000, AM HEART J, V139, P848, DOI 10.1016/S0002-8703(00)90017-6; Trevino F M, 1999, Ethn Health, V4, P153, DOI 10.1080/13557859998119; Whittle J, 1997, J GEN INTERN MED, V12, P267, DOI 10.1046/j.1525-1497.1997.012005267.x; Wild S, 1997, BRIT MED J, V314, P705, DOI 10.1136/bmj.314.7082.705	28	84	84	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 2	2002	324	7336					511	516		10.1136/bmj.324.7336.511	http://dx.doi.org/10.1136/bmj.324.7336.511			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	528DT	11872548	Green Published, Bronze			2022-12-28	WOS:000174229700018
J	Gurnett, DA; Kurth, WS; Hospodarsky, GB; Persoon, AM; Zarka, P; Lecacheux, A; Bolton, SJ; Desch, MD; Farrell, WM; Kaiser, ML; Ladreiter, HP; Rucker, HO; Galopeau, P; Louarn, P; Young, DT; Pryor, WR; Dougherty, MK				Gurnett, DA; Kurth, WS; Hospodarsky, GB; Persoon, AM; Zarka, P; Lecacheux, A; Bolton, SJ; Desch, MD; Farrell, WM; Kaiser, ML; Ladreiter, HP; Rucker, HO; Galopeau, P; Louarn, P; Young, DT; Pryor, WR; Dougherty, MK			Control of Jupiter's radio emission and aurorae by the solar wind	NATURE			English	Article							KILOMETRIC RADIATION	Radio emissions from Jupiter provided the first evidence that this giant planet has a strong magnetic field(1,2) and a large magnetosphere(3). Jupiter also has polar aurorae(4), which are similar in many respects to Earth's aurorae(5). The radio emissions are believed to be generated along the high-latitude magnetic field lines by the same electrons that produce the aurorae, and both the radio emission in the hectometric frequency range and the aurorae vary considerably(6,7). The origin of the variability, however, has been poorly understood. Here we report simultaneous observations using the Cassini and Galileo spacecraft of hectometric radio emissions and extreme ultraviolet auroral emissions from Jupiter. Our results show that both of these emissions are triggered by interplanetary shocks propagating outward from the Sun. When such a shock arrives at Jupiter, it seems to cause a major compression and reconfiguration of the magnetosphere, which produces strong electric fields and therefore electron acceleration along the auroral field lines, similar to the processes that occur during geomagnetic storms at the Earth.	Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA; Observ Paris, Space Res Dept, F-92195 Meudon, France; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Austrian Acad Sci, Space Res Inst, A-8010 Graz, Austria; Univ Versailles, CETP, F-78140 Velizy Villacoublay, France; CNRS, Ctr Etud Spatiale Rayonnements, F-31028 Toulouse, France; Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; Univ London Imperial Coll Sci & Technol, Blackett Lab, London SW7 2BZ, England	University of Iowa; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Austrian Academy of Sciences; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); University of Michigan System; University of Michigan; University of Colorado System; University of Colorado Boulder; Imperial College London	Gurnett, DA (corresponding author), Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA.		Kurth, William/AAA-7334-2019; Hospodarsky, George B/A-7996-2015; Bolton, Scott/M-4392-2019; Farrell, William/I-4865-2013	Kurth, William/0000-0002-5471-6202; Hospodarsky, George B/0000-0001-9200-9878; bolton, scott/0000-0002-9115-0789				BIGG EK, 1964, NATURE, V203, P1008, DOI 10.1038/2031008a0; BROADFOOT AL, 1979, SCIENCE, V204, P979, DOI 10.1126/science.204.4396.979; BURKE FB, 1955, J GEOPHYS RES, V60, P213; Carr T.D., 1983, PHYS JOVIAN MAGNETOS, P226, DOI [10.1017/cbo9780511564574.009, DOI 10.1017/CBO9780511564574.009]; CHAMBERLAIN JW, 1961, PHYSICS AURORA AIRGL; Clarke JT, 1998, J GEOPHYS RES-PLANET, V103, P20217, DOI 10.1029/98JE01130; CLARKE JT, 1980, ASTROPHYS J, V241, P179; DESCH MD, 1984, J GEOPHYS RES-SPACE, V89, P6819, DOI 10.1029/JA089iA08p06819; DOUGHERTY MK, UNPUB SPACE SCI REV; DRAKE FD, 1959, ASTRON J, V64, P329, DOI 10.1086/108047; Ergun RE, 2000, ASTROPHYS J, V538, P456, DOI 10.1086/309094; ESPOSITO LW, IN PRESS SPACE SCI R; GALLAGHER DL, 1979, J GEOPHYS RES-SPACE, V84, P6501, DOI 10.1029/JA084iA11p06501; GOLDREICH P, 1969, ASTROPHYS J, V156, P59, DOI 10.1086/149947; GURNETT DA, 1992, SPACE SCI REV, V60, P341, DOI 10.1007/BF00216861; GURNETT DA, 1974, J GEOPHYS RES, V79, P4227, DOI 10.1029/JA079i028p04227; GURNETT DA, IN PRESS SPACE SCI R; HUFF RL, 1988, J GEOPHYS RES, V93, P11445, DOI 10.1029/JA093iA10p11445; LADREITER HP, 1994, PLANET SPACE SCI, V42, P919, DOI 10.1016/0032-0633(94)90052-3; LOUARN P, 1990, J GEOPHYS RES-SPACE, V95, P5983, DOI 10.1029/JA095iA05p05983; Queinnec J, 1998, J GEOPHYS RES-SPACE, V103, P26649, DOI 10.1029/98JA02435; SCARF FL, 1979, SCIENCE, V204, P991, DOI 10.1126/science.204.4396.991; VOOTS GR, 1977, J GEOPHYS RES-SPACE, V82, P2259, DOI 10.1029/JA082i016p02259; WARWICK JW, 1979, SCIENCE, V204, P995, DOI 10.1126/science.204.4396.995; WARWICK JW, 1967, SPACE SCI REV, V6, P841; WU CS, 1979, ASTROPHYS J, V230, P621, DOI 10.1086/157120; YOUNG DT, UNPUB SPACE SCI REV; Zarka P, 1998, J GEOPHYS RES-PLANET, V103, P20159, DOI 10.1029/98JE01323; ZARKA P, 1983, NATURE, V306, P767, DOI 10.1038/306767a0	29	119	121	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2002	415	6875					985	987		10.1038/415985a	http://dx.doi.org/10.1038/415985a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875556	Bronze, Green Published			2022-12-28	WOS:000174075000032
J	Reichler, MR; Reves, R; Bur, S; Thompson, V; Mangura, BT; Ford, J; Valway, SE; Onorato, IM				Reichler, MR; Reves, R; Bur, S; Thompson, V; Mangura, BT; Ford, J; Valway, SE; Onorato, IM		Contact Invest Study Grp	Evaluation of investigations conducted to detect and prevent transmission of tuberculosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OUTBREAK	Context Contact investigations are routinely conducted by health departments throughout the United States for all cases of active pulmonary tuberculosis (TB) to identify secondary cases of active TB and latent TB infection and to initiate therapy as needed in these contacts. Little is known about the actual procedures followed, or the results. Objectives To evaluate contact investigations conducted by US health departments and the outcomes of these investigations. Design, Setting, and Subjects Review of health department records for all contacts of 349 patients with culture-positive pulmonary TB aged 15 years or older reported from 5 study areas in the United States during 1996. Main Outcome Measures Number of contacts identified, fully screened, and infected per TB patient; rates of TB infection and disease among contacts of TB patients; and type and completeness of data collected during contact investigations. Results A total of 3824 contacts were identified for 349 patients with active pulmonary TB. Of the TB patients, 45 (13%) had no contacts identified. Of the contacts, 55% completed screening, 27% had an initial but no postexposure tuberculin skin test, 12% were not screened, and 6% had a history of prior TB or prior positive tuberculin skin test. Of 2095 contacts who completed screening, 68% had negative skin test results, 24% had initial positive results with no prior test result available, 7% had documented skin test conversions, and 1% had active TB at the time of investigation. Close contacts younger than 15 years (76% screened vs 65% for older age groups; P<.001) or exposed to a TB patient with a positive smear (74% screened vs 59% for those with a negative smear; P<.001) were more likely to be fully screened. Close contacts exposed to TB patients with both a positive smear and a cavitary chest radiograph were more likely to have TB infection or disease (62% vs 33% for positive smear only vs 44% for cavitary radiograph only vs 37% for neither characteristic; P<.001). A number of factors associated with TB patient infectiousness, contact susceptibility to infection, contact risk of progression to active TB, and amount of contact exposure to the TB patient were not routinely recorded in health department records. Conclusions Improvement is needed in the complex, multistep process of contact investigations to ensure that contacts of patients with active pulmonary TB are identified and appropriately screened.	Ctr Dis Control & Prevent, DTBE, Div TB Eliminat, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA; Denver Publ Hlth, Denver, CO USA; Maryland Dept Hlth & Mental Hyg, Baltimore, MD USA; Massachusetts Dept Publ Hlth, Jamaica Plain, MA USA; Mississippi Dept Hlth, Jackson, MS USA; New Jersey Dept Hlth & Senior Serv, Trenton, NJ USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Natl TB Ctr, Newark, NJ 07103 USA	Centers for Disease Control & Prevention - USA; Maryland Department of Health & Mental Hygiene; Massachusetts Department of Public Health; New Jersey Department of Health & Senior Services; Rutgers State University New Brunswick; Rutgers State University Medical Center	Reichler, MR (corresponding author), Ctr Dis Control & Prevent, DTBE, Div TB Eliminat, Natl Ctr HIV STD & TB Prevent, Mailstop E-10,1600 Clifton Rd, Atlanta, GA 30333 USA.	mrr3@cdc.gov						[Anonymous], 1994, Morbidity and Mortality Weekly Report, V43, P1; Barnes PF, 1997, JAMA-J AM MED ASSOC, V278, P1159, DOI 10.1001/jama.278.14.1159; BASS J, 1992, AM REV RESPIR DIS, V146, P1623; Bock NN, 1998, CLIN INFECT DIS, V27, P1221, DOI 10.1086/514986; *CDCP, 1990, MMWR-MORBID MORTAL W, V39, P9; *CDCP, 1999, CONT INV TUB, P7; *CDCP, 1990, MMWR-MORBID MORTAL W, V39, P1; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P317; ETKIND S, 1993, LUNG BIOL HLTH DIS, V144, P275; Fitzpatrick LK, 2001, CLIN INFECT DIS, V33, P1801, DOI 10.1086/323671; Mangura BT, 1998, CHEST, V113, P234, DOI 10.1378/chest.113.1.234; Marks SM, 2000, AM J RESP CRIT CARE, V162, P2033, DOI 10.1164/ajrccm.162.6.2004022; REICHLER MR, IN PRESS SO MED J; Sterling TR, 2000, INT J TUBERC LUNG D, V4, P1066	14	185	190	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2002	287	8					991	995		10.1001/jama.287.8.991	http://dx.doi.org/10.1001/jama.287.8.991			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525CX	11866646	Bronze			2022-12-28	WOS:000174052100026
J	Stuck, AE; Egger, M; Hammer, A; Minder, CE; Beck, JC				Stuck, AE; Egger, M; Hammer, A; Minder, CE; Beck, JC			Home visits to prevent nursing home admission and functional decline in elderly people - Systematic review and meta-regression analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED CONTROLLED TRIAL; COMPREHENSIVE GERIATRIC ASSESSMENT; DWELLING OLDER-PEOPLE; PRIMARY-CARE; COMMUNITY; METAANALYSIS; INTERVENTION; ADULTS; RISK; HETEROGENEITY	Context The effects of home visitation programs to prevent functional decline in elderly persons have been inconsistent, and the value of these programs is controversial. Objective To evaluate the effect of preventive home visits on functional status, nursing home admission, and mortality. Data Sources Studies published in English, French, German, Italian, or Spanish reporting randomized trials of the effects of preventive in-home visits in older people (mean age >70 years) living in the community were identified through searches of MEDLINE, PSYCHINFO, and EMBASE (January 1985-November 2001). We also searched the Cochrane Controlled Trials Register, checked reference lists of earlier reviews and book chapters, searched conference proceedings and specialty journals, and contacted experts. Study Selection We screened 1349 abstracts and excluded those that did not test in-home interventions or in which the mean age of the study population was younger than 70 years. After further exclusions, 17 articles describing 18 trials were analyzed. Data Extraction Two reviewers independently screened abstracts. Discrepancies were resolved by consensus with a third reviewer. For each included trial, we extracted data on the study population and the characteristics of the intervention. Two of us extracted information on 3 end points: nursing home admissions, mortality, and functional status. One of us assessed trial quality, including an examination of the method of randomization, blinding of caregivers and research staff ascertaining outcomes, and proportion of patients included in analyses of the 3 end points. Data Synthesis The 18 trials included 13447 individuals aged 65 years and older. The effect on nursing home admissions depended on the number of visits performed during follow-up. The pooled relative risk (RR) was 0.66 (95% confidence interval [CI], 0.48-0.92) for trials in the upper tertile (>9 visits) but was 1.05 (95% Cl, 0.85-1.30) in the lower tertile (0-4 visits). Functional decline was reduced in trials that used multidimensional assessment with follow-up (RR, 0.76; 95% Cl, 0.64-0.91) but not in other trials (RR, 1.01; 95% Cl, 0.92-1.11). Functional decline was reduced (RR, 0.78; 95% Cl, 0.64-0.95) in trials with a control group mortality rate in the lower tertile (3.4%-5.8%) but not (RR, 0.98; 95% CI, 0.84-1.13) in those with a control-group mortality rate in the upper tertile (8.3%-10.7%). A beneficial effect on mortality was evident in younger study populations (RR, 0.76; 95% Cl, 0.65-0.88 for ages 72.7-77.5 years) but not in older study populations (RR, 1.09; 95% Cl, 0.92-1.28 for ages 80.2-81.6 years). Conclusion Preventive home visitation programs appear to be effective, provided the interventions are based on multidimensional geriatric assessment and include multiple follow-up home visits and target persons at lower risk for death. Benefits on survival were seen in young-old rather than old-old populations.	Spital Bern Ziegler, Zenrum Geriatrie Rehabil, Dept Geriatr & Rehabil, CH-3001 Bern, Switzerland; Univ Bristol, Dept Social Med, MRC, Hlth Serv Res Collaborat, Bristol, Avon, England; Univ Bern, Dept Social & Prevent Med, CH-3012 Bern, Switzerland; Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90024 USA	University of Bristol; University of Bern; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Stuck, AE (corresponding author), Spital Bern Ziegler, Zenrum Geriatrie Rehabil, Dept Geriatr & Rehabil, Morillonstr 75, CH-3001 Bern, Switzerland.	andreas.stuck@spitalbern.ch		Egger, Matthias/0000-0001-7462-5132				Alessi CA, 1997, J AM GERIATR SOC, V45, P1044, DOI 10.1111/j.1532-5415.1997.tb05964.x; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Bula CJ, 1999, J AM GERIATR SOC, V47, P389; Byles JE, 2000, AUST NZ J PUBL HEAL, V24, P117, DOI 10.1111/j.1467-842X.2000.tb00131.x; CARPENTER GI, 1990, BMJ-BRIT MED J, V300, P1253, DOI 10.1136/bmj.300.6734.1253; CLARKE M, 1992, AM J EPIDEMIOL, V136, P1517, DOI 10.1093/oxfordjournals.aje.a116473; Deeks JJ, 2001, SYSTEMATIC REV HLTH, P285, DOI DOI 10.1002/9780470693926.CH15; Dickinson E, 1996, BRIT MED J, V312, P862; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M, 2001, BRIT MED J, V323, P724; Elkan R, 2001, BMJ-BRIT MED J, V323, P719, DOI 10.1136/bmj.323.7315.719; Eriksson B G, 1987, Compr Gerontol C, V1, P49; FABACHER D, 1994, J AM GERIATR SOC, V42, P630, DOI 10.1111/j.1532-5415.1994.tb06862.x; Gunner-Svensson F, 1984, Scand J Prim Health Care, V2, P49, DOI 10.3109/02813438409017704; Hannan EL, 2001, JAMA-J AM MED ASSOC, V285, P2736, DOI 10.1001/jama.285.21.2736; HASSELBLAD V, 1995, PSYCHOL BULL, V117, P167, DOI 10.1037/0033-2909.117.1.167; Hebert R, 2001, AGE AGEING, V30, P265, DOI 10.1093/ageing/30.3.265; HENDRIKSEN C, 1984, BMJ-BRIT MED J, V289, P1522, DOI 10.1136/bmj.289.6457.1522; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Lau J, 1998, LANCET, V351, P123, DOI 10.1016/S0140-6736(97)08468-7; Leveille SG, 1998, J AM GERIATR SOC, V46, P1191, DOI 10.1111/j.1532-5415.1998.tb04533.x; Manton KG, 2001, P NATL ACAD SCI USA, V98, P6354, DOI 10.1073/pnas.111152298; MCEWAN RT, 1990, BRIT J GEN PRACT, V40, P94; Newbury JW, 2001, MED J AUSTRALIA, V175, P104, DOI 10.5694/j.1326-5377.2001.tb143541.x; PATHY MSJ, 1992, LANCET, V340, P890, DOI 10.1016/0140-6736(92)93294-W; Ro O C, 1985, Scand J Prim Health Care, V3, P133, DOI 10.3109/02813438509013933; SOLOMON D, 1988, J AM GERIATR SOC, V36, P342; Sorensen K H, 1988, Compr Gerontol B, V2, P85; Stuck AE, 2000, ARCH INTERN MED, V160, P977, DOI 10.1001/archinte.160.7.977; STUCK AE, 1993, LANCET, V342, P1032, DOI 10.1016/0140-6736(93)92884-V; STUCK AE, 1995, NEW ENGL J MED, V333, P1184, DOI 10.1056/NEJM199511023331805; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; THOMPSON SG, 1994, BMJ-BRIT MED J, V309, P1351, DOI 10.1136/bmj.309.6965.1351; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; van Haastregt JCM, 2000, BMJ-BRIT MED J, V321, P994, DOI 10.1136/bmj.321.7267.994; van Haastregt JCM, 2000, BMJ-BRIT MED J, V320, P754, DOI 10.1136/bmj.320.7237.754; VANROSSUM E, 1993, BMJ-BRIT MED J, V307, P27, DOI 10.1136/bmj.307.6895.27; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1; VETTER NJ, 1984, BRIT MED J, V288, P369, DOI 10.1136/bmj.288.6414.369; VETTER NJ, 1992, BMJ-BRIT MED J, V304, P888, DOI 10.1136/bmj.304.6831.888; Wagner E H, 2001, Jt Comm J Qual Improv, V27, P63; Wagner EH, 2001, BMJ-BRIT MED J, V323, P945, DOI 10.1136/bmj.323.7319.945; Wagner EH, 1996, J AM GERIATR SOC, V44, P1251, DOI 10.1111/j.1532-5415.1996.tb01378.x	43	451	456	1	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2002	287	8					1022	1028		10.1001/jama.287.8.1022	http://dx.doi.org/10.1001/jama.287.8.1022			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	525CX	11866651				2022-12-28	WOS:000174052100031
J	McManus, RJ; Mant, J; Meulendijks, CFM; Salter, RA; Pattison, HM; Roalfe, AK; Hobbs, FDR				McManus, RJ; Mant, J; Meulendijks, CFM; Salter, RA; Pattison, HM; Roalfe, AK; Hobbs, FDR		Midlands Res Practice Consortium	Comparison of estimates and calculations of risk of coronary heart disease by doctors and nurses using different calculation tools in general practice: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRIMARY PREVENTION; CARDIOVASCULAR RISK; BLOOD-PRESSURE; MEN; MORTALITY; WOMEN	Objective To assess the effect of using different risk calculation tools on how general practitioners and practice nurses evaluate the risk of coronary heart disease with clinical data routinely available in patients' records. Design Subjective estimates of the risk of coronary, heart disease and results of four different methods of calculation of risk were compared with each other and a reference standard that bad been calculated with the Framingham equation: calculations were based on a sample of patients' records, randomly selected from groups at risk of coronary heart disease. Setting General practices in central England. Participants 18 general practitioner's and 18 practice nurses. Main outcome measures Agreement off results of risk estimation and risk calculation with reference calculation: agreement of general practitioners with practice nurses; sensitivity and specificity of the different methods of risk calculation to detect patients at high or low risk of coronary heart disease. Results Only a minority of patients' records contained all of the risk factors required lot the formal calculation of the risk of coronary heart disease (concentrations of high density lipoprotein (HDL) cholesterol were present in only 21%), Agreement of risk calculations with the reference standard was moderate (kappa = 0.33-0.65 for practice nurses and 0.33 to 0.65 for general practitioners. depending on calculation tool), showing a trend for underestimation of risk. Moderate agreement was seen between the risks calculated by general practitioners and practice nurses for the same patients (kappa = 0.47 to 0.58). The British charts gave the most sensitive results for risk of coronary heart disease (practice nurses 79% general practitioners 80%), and it also gave the most specific results for practice nurses (100%), whereas the Sheffield table was the most specific method for general practitioners Conclusions Routine calculation of the risk of coronary heart disease in primary care is hampered by poor availability, of data on risk factors. General practitioners and practice nurse; are able to evaluate the risk of coronary heart disease with only moderate accuracy. Data about risk factors need to be collected systematically. to allow the use of the most appropriate calculation tools.	Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England; Univ Med Ctr Nijmegen, Dept Med Technol Assessment, NL-6500 HB Nijmegen, Netherlands	University of Birmingham; Radboud University Nijmegen	Hobbs, FDR (corresponding author), Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England.	f.d.r.hobbs@bham.ac.uk	Pattison, Helen/D-2702-2009	Pattison, Helen/0000-0002-9483-4342; hobbs, richard/0000-0001-7976-7172				ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; *DEP HLTH, 1998, OUR HLTH NAT; *DEP HLTH, 2000, NAT SERV FRAM COR HE; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; ERENS R, 1999, HLTH SURVEY ENGLAND, P1; GROVER SA, 1995, BRIT MED J, V310, P975, DOI 10.1136/bmj.310.6985.975; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Isles CG, 2000, BMJ-BRIT MED J, V320, P690, DOI 10.1136/bmj.320.7236.690; KANNEL WB, 1986, AM HEART J, V112, P825, DOI 10.1016/0002-8703(86)90481-3; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lloyd-Jones DM, 1999, LANCET, V353, P89, DOI 10.1016/S0140-6736(98)10279-9; MACMAHON SW, 1986, J HYPERTENS, V4, pS14; Meade TW, 1998, LANCET, V351, P233; Mehta RH, 1998, BMJ-BRIT MED J, V316, P838, DOI 10.1136/bmj.316.7134.838; Montgomery AA, 2000, BRIT J GEN PRACT, V50, P127; Murray CJL, 1997, LANCET, V350, P144; *NAT CHOL ED PROGR, 1994, CIRCULATION, V89, P1329; *NAT HLTH COMM, 1998, GUID MAN MILDL RAIS; PEDERSEN TR, 1994, LANCET, V344, P1383; Peters TJ, 1999, BRIT J GEN PRACT, V49, P987; Prescott E, 1998, BMJ-BRIT MED J, V316, P1043; Ramsay LE, 1996, LANCET, V348, P387, DOI 10.1016/S0140-6736(96)05516-X; Shepherd J, 1996, LANCET, V348, P1339; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Taggart DP, 1998, HEART, V80, P1; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wallis EJ, 2000, BMJ-BRIT MED J, V320, P671, DOI 10.1136/bmj.320.7236.671; Wood D, 1998, EUR HEART J, V19, pA12; Wood D, 1998, EUR HEART J, V19, P1434	30	56	57	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2002	324	7335					459	464		10.1136/bmj.324.7335.459	http://dx.doi.org/10.1136/bmj.324.7335.459			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526NJ	11859049	Green Published			2022-12-28	WOS:000174136300019
J	Olff, H; Ritchie, ME; Prins, HHT				Olff, H; Ritchie, ME; Prins, HHT			Global environmental controls of diversity in large herbivores	NATURE			English	Article							PRODUCTIVITY; PATTERNS	Large mammalian herbivores occupy half of the earth's land surface and are important both ecologically and economically(1), but their diversity is threatened by human activities(2). We investigated how the diversity of large herbivores changes across gradients of global precipitation and soil fertility. Here we show that more plant-available moisture reduces the nutrient content of plants but increases productivity, whereas more plant-available nutrients increase both of these factors. Because larger herbivore species tolerate lower plant nutrient content but require greater plant abundance, the highest potential herbivore diversity should occur in locations with intermediate moisture and high nutrients. These areas are dry enough to yield high quality plants and support smaller herbivores, but productive enough to support larger herbivores. These predictions fit with observed patterns of body size and diversity for large mammalian herbivores in North America, Africa and Australia, and yield a global map of regions with potentially high herbivore diversity. Thus, gradients of precipitation, temperature and soil fertility might explain the global distribution of large herbivore diversity and help to identify crucial areas for conservation and restoration.	Univ Wageningen & Res Ctr, Trop Nat Conservat & Vertebrate Ecol Grp, NL-6708 PD Wageningen, Netherlands; Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Wageningen University & Research; Syracuse University	Olff, H (corresponding author), Univ Wageningen & Res Ctr, Trop Nat Conservat & Vertebrate Ecol Grp, Bornsesteeg 69, NL-6708 PD Wageningen, Netherlands.	han.olff@staf.ton.wau.nl	Olff, Han/A-8516-2008	Olff, Han/0000-0003-2154-3576; Prins, Herbert/0000-0003-1131-5107				ALCAMO J, 1994, WATER AIR SOIL POLL, V76, P37, DOI 10.1007/BF00478336; BELL RHV, 1982, ECOL STUD, V42, P193; BELOVSKY GE, 1986, AM ZOOL, V26, P51; Belovsky GE, 1997, EVOL ECOL, V11, P641, DOI 10.1023/A:1018430201230; BREMAN H, 1983, SCIENCE, V221, P1341, DOI 10.1126/science.221.4618.1341; BREMAN H, 1991, PRODUCTIVITE PATURAG, P322; COE M, 1983, NITROGEN ECOLOGICAL, P345; Danell K, 1996, ECOGRAPHY, V19, P404, DOI 10.1111/j.1600-0587.1996.tb00251.x; DUTOIT JT, 1989, AM NAT, V133, P736, DOI 10.1086/284949; EAST R, 1984, AFR J ECOL, V22, P245, DOI 10.1111/j.1365-2028.1984.tb00700.x; Eisenberg J.F., 1981, P1; HUSTON M, 1993, SCIENCE, V262, P1676, DOI 10.1126/science.262.5140.1676; Huston M. A., 1994, BIOL DIVERSITY; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; KINYAMARIO JI, 1992, AFR J ECOL, V30, P33, DOI 10.1111/j.1365-2028.1992.tb00476.x; MCNAUGHTON SJ, 1989, NATURE, V341, P142, DOI 10.1038/341142a0; MILCHUNAS DG, 1995, OECOLOGIA, V101, P366, DOI 10.1007/BF00328824; Murray Martyn G., 1995, P231; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; OWENSMITH N, 1987, PALEOBIOLOGY, V13, P351; OWENSMITH N, 1988, INFLUENCE VERY LARGE; Prins H.H.T., 1998, P449; PRINS HHT, 1992, ENVIRON CONSERV, V19, P117, DOI 10.1017/S0376892900030587; Prins HHT, 1996, ECOLOGY BEHAV AFRICA; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Van Soest PJ, 1982, NUTR ECOLOGY RUMINAN; Van Wijngaarden W, 1985, ITC PUBLICATION, V4; VOETEN MM, 1999, TROPICAL RESOURCE MA, V29; Walker BH, 1997, J BIOGEOGR, V24, P813, DOI 10.1046/j.1365-2699.1997.00123.x; WESTERN D, 1981, AFR J ECOL, V19, P7, DOI 10.1111/j.1365-2028.1981.tb00648.x	30	250	263	5	104	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 21	2002	415	6874					901	904		10.1038/415901a	http://dx.doi.org/10.1038/415901a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859367	Green Published			2022-12-28	WOS:000173941000043
J	Clark, PU; Mitrovica, JX; Milne, GA; Tamisiea, ME				Clark, PU; Mitrovica, JX; Milne, GA; Tamisiea, ME			Sea-level fingerprinting as a direct test for the source of global meltwater pulse IA	SCIENCE			English	Article							LAURENTIDE ICE-SHEET; LAST GLACIAL MAXIMUM; YOUNGER DRYAS EVENT; RECORD; MODEL; OCEAN; CIRCULATION; CORALS; RISE; DEGLACIATION	The ice reservoir that served as the source for the meltwater pulse IA remains enigmatic and controversial. We show that each of the melting scenarios that have been proposed for the event produces a distinct variation, or fingerprint, in the global distribution of meltwater. We compare sea-level fingerprints associated with various melting scenarios to existing sea-level records from Barbados and the Sunda Shelf and conclude that the southern Laurentide Ice Sheet could not have been the sole source of the meltwater pulse, whereas a substantial contribution from the Antarctic Ice Sheet is consistent with these records.	Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada; Oregon State Univ, Dept Geosci, Corvallis, OR 97331 USA; Univ Durham, Dept Geol Sci, Durham DH1 3LE, England	University of Toronto; Oregon State University; Durham University	Mitrovica, JX (corresponding author), Univ Toronto, Dept Phys, 60 St George St, Toronto, ON M5S 1A7, Canada.	jxm@physics.utoronto.ca						ANDREWS JT, 1994, QUATERNARY RES, V41, P26, DOI 10.1006/qres.1994.1003; BARD E, 1990, NATO ADV SCI I C-MAT, V308, P405; BARD E, 1990, NATURE, V345, P405, DOI 10.1038/345405a0; Bard E, 1996, NATURE, V382, P241, DOI 10.1038/382241a0; BARD E, 1993, RADIOCARBON, V35, P191, DOI 10.1017/S0033822200013886; BIRCHFIELD EG, 1994, J GEOPHYS RES-OCEANS, V99, P12459, DOI 10.1029/94JC00523; Cabanes C, 2001, SCIENCE, V294, P840, DOI 10.1126/science.1063556; CLARK JA, 1987, SEA LEVEL CHANGES, P356; Clark PU, 2002, QUATERNARY SCI REV, V21, P1, DOI 10.1016/S0277-3791(01)00118-4; Clark PU, 1996, PALEOCEANOGRAPHY, V11, P563, DOI 10.1029/96PA01419; Conrad CP, 1997, GEOPHYS RES LETT, V24, P1503, DOI 10.1029/97GL01338; DOUGLAS BC, 1991, J GEOPHYS RES-OCEANS, V96, P6981, DOI 10.1029/91JC00064; Dyke A.S., 1987, GEOGR PHYS QUATERNAI, V2, P237, DOI [10.7202/032681ar, DOI 10.7202/032681AR]; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; FAIRBANKS RG, 1992, RADIOCARBON AFTER FOUR DECADES, P473; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; FARRELL WE, 1976, GEOPHYS J ROY ASTR S, V46, P647, DOI 10.1111/j.1365-246X.1976.tb01252.x; Hanebuth T, 2000, SCIENCE, V288, P1033, DOI 10.1126/science.288.5468.1033; KEIGWIN LD, 1991, J GEOPHYS RES-OCEANS, V96, P16811, DOI 10.1029/91JC01624; KEIGWIN LD, 1995, PALEOCEANOGRAPHY, V10, P973, DOI 10.1029/95PA02643; KENNETT JP, 1975, SCIENCE, V188, P147, DOI 10.1126/science.188.4184.147; LEVENTER A, 1982, EARTH PLANET SC LETT, V59, P11, DOI 10.1016/0012-821X(82)90112-1; LINDSTROM DR, 1993, NATURE, V365, P214, DOI 10.1038/365214a0; Manabe S, 1997, PALEOCEANOGRAPHY, V12, P321, DOI 10.1029/96PA03932; Milne GA, 1999, GEOPHYS J INT, V139, P464, DOI 10.1046/j.1365-246x.1999.00971.x; MITROVICA JX, 1991, J GEOPHYS RES-SOL EA, V96, P20053, DOI 10.1029/91JB01284; Mitrovica JX, 2001, NATURE, V409, P1026, DOI 10.1038/35059054; NAKIBOGLU SM, 1990, GLACIAL ISOSTASY SEA, P237; PELTIER WR, 1994, SCIENCE, V265, P195, DOI 10.1126/science.265.5169.195; PLAG HP, 2001, MEM NATL I POLAR RES, P301; Ruddiman W.F., 1987, GEOLOGY N AM K, V1987. Ice dynamics and deglaciation models when ice sheets collapsed. In: Ruddiman, W.F., Wright, H.E. (Eds.), North America and adjacent oceans during the last deglaciati, P183; SAKAI K, 1995, J GEOPHYS RES-OCEANS, V100, P13455, DOI 10.1029/95JC00616; SHEMESH A, 1995, PALEOCEANOGRAPHY, V10, P179, DOI 10.1029/94PA03060; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; TUSHINGHAM M, 1991, J GEOPHYS RES, V96, P4497, DOI DOI 10.1029/90JB01583; Woodward R S, 1888, US GEOL SURV B, V48, P87	36	234	239	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 29	2002	295	5564					2438	2441						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	536QD	11896236				2022-12-28	WOS:000174712600052
J	Wiebe, S; Nicolle, MW				Wiebe, S; Nicolle, MW			Recent developments - Recent developments in neurology	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MODERATE ALCOHOL-CONSUMPTION; ISCHEMIC-STROKE; FOLLOW-UP; RISK; MORTALITY; EPILEPSY; THERAPY; SURGERY; DUTCH		Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada	Western University (University of Western Ontario)	Wiebe, S (corresponding author), London Hlth Sci Ctr, Univ Campus,339 Windermere Rd, London, ON N6A 5A5, Canada.	swiebe@uwo.ca						Alamowitch S, 2001, LANCET, V357, P1154, DOI 10.1016/S0140-6736(00)04332-4; Backskai BJ, 2001, NAT MED, V7, P369, DOI 10.1038/85525; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; Berger K, 1999, NEW ENGL J MED, V341, P1557, DOI 10.1056/NEJM199911183412101; BRYANT J, 2001, HEALTH TECHNOL ASSES, V5, P1; Buchan AM, 2000, NEUROLOGY, V54, P679, DOI 10.1212/WNL.54.3.679; Callenbach PMC, 2001, PEDIATRICS, V107, P1259, DOI 10.1542/peds.107.6.1259; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; D'Arcy CA, 2000, JAMA-J AM MED ASSOC, V283, P3110, DOI 10.1001/jama.283.23.3110; Gage BF, 2000, STROKE, V31, P822, DOI 10.1161/01.STR.31.4.822; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Goodkin DE, 2000, NEUROLOGY, V54, P2352; Grogan PM, 2001, NEUROLOGY, V56, P830, DOI 10.1212/WNL.56.7.830; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Kappos L, 1998, LANCET, V352, P1491, DOI 10.1016/S0140-6736(98)10039-9; King J, 2001, NEUROLOGY, V56, P1496; Koudstaal PJ, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000185.pub2, DOI 10.1002/14651858.CD000185.PUB2]; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Lhatoo SD, 2001, ANN NEUROL, V49, P336; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Padua L, 2001, NEUROLOGY, V56, P1459, DOI 10.1212/WNL.56.11.1459; Ramsey MJ, 2000, LARYNGOSCOPE, V110, P335, DOI 10.1097/00005537-200003000-00001; Sacco RL, 1999, JAMA-J AM MED ASSOC, V281, P53, DOI 10.1001/jama.281.1.53; Shackleton DP, 1999, J NEUROL NEUROSUR PS, V66, P636, DOI 10.1136/jnnp.66.5.636; Shepherd J, 1999, AM J CARDIOL, V84, P1192, DOI 10.1016/S0002-9149(99)00533-0; Smetana GW, 2000, ARCH INTERN MED, V160, P2729, DOI 10.1001/archinte.160.18.2729; Sperling MR, 1999, ANN NEUROL, V46, P45, DOI 10.1002/1531-8249(199907)46:1<45::AID-ANA8>3.0.CO;2-I; Wardlaw JM, 2000, COCHRANE DB SYST REV; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439	32	3	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2002	324	7338					656	660		10.1136/bmj.324.7338.656	http://dx.doi.org/10.1136/bmj.324.7338.656			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532QW	11895826	Green Published			2022-12-28	WOS:000174487400029
J	Soubeyran, P; Kowanetz, K; Szymkiewicz, I; Langdon, WY; Dikic, I				Soubeyran, P; Kowanetz, K; Szymkiewicz, I; Langdon, WY; Dikic, I			Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors	NATURE			English	Article							GROWTH-FACTOR RECEPTOR; C-CBL; ADAPTER PROTEIN; SH3 DOMAIN; TYROSINE PHOSPHORYLATION; VESICLE FORMATION; ENDOPHILIN; C-CBL/SLI-1; CIN85; PYK2	Cbl is a multi-adaptor protein involved in ligand-induced down-regulation of receptor tyrosine kinases. It is thought that Cbl-mediated ubiquitination of active receptors is essential for receptor degradation and cessation of receptor-induced signal transduction(1-5). Here we demonstrate that Cbl additionally regulates epidermal growth factor (EGF) receptor endocytosis. Cbl rapidly recruits CIN85 (Cbl-interacting protein of 85K; ref. 6) and endophilins (regulatory components of clathrin-coated vesicles(7-10)) to form a complex with activated EGF receptors, thus controlling receptor internalization. CIN85 was constitutively associated with endophilins, whereas CIN85 binding to the distal carboxy terminus of Cbl was increased on EGF stimulation. Inhibition of these interactions was sufficient to block EGF receptor internalization, delay receptor degradation and enhance EGF-induced gene transcription, without perturbing Cbl-directed receptor ubiquitination. Thus, the evolutionary divergent C terminus of Cbl uses a mechanism that is functionally separable from the ubiquitin ligase activity of Cbl to mediate ligand-dependent down-regulation of receptor tyrosine kinases.	Ludwig Inst Canc Res, S-75124 Uppsala, Sweden; Univ Western Australia, Dept Pathol, Crawley, WA 6009, Australia	Ludwig Institute for Cancer Research; University of Western Australia	Dikic, I (corresponding author), Ludwig Inst Canc Res, Box 595,Husargatan 3, S-75124 Uppsala, Sweden.		Pilecka, Iwona/AAT-9114-2021; Dikic, Ivan/O-4650-2015; Soubeyran, Philippe/P-1758-2018	Pilecka, Iwona/0000-0002-5057-346X; Dikic, Ivan/0000-0001-8156-9511; Soubeyran, Philippe/0000-0002-5876-3217				Bogler O, 2000, NEURO-ONCOLOGY, V2, P6, DOI 10.1093/neuonc/2.1.6; Borinstein SC, 2000, CELL SIGNAL, V12, P769, DOI 10.1016/S0898-6568(00)00129-7; de Melker AA, 2001, J CELL SCI, V114, P2167; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; GALISTEO ML, 1995, J BIOL CHEM, V270, P20242, DOI 10.1074/jbc.270.35.20242; Gout I, 2000, EMBO J, V19, P4015, DOI 10.1093/emboj/19.15.4015; Ivankovic-Dikic I, 2000, NAT CELL BIOL, V2, P574, DOI 10.1038/35023515; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kirsch KH, 2001, J BIOL CHEM, V276, P4957, DOI 10.1074/jbc.M005784200; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Micheva KD, 1997, FEBS LETT, V414, P308, DOI 10.1016/S0014-5793(97)01016-8; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Scaife RM, 2000, J CELL SCI, V113, P215; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Sorkin A, 1996, J BIOL CHEM, V271, P13377, DOI 10.1074/jbc.271.23.13377; Take H, 2000, BIOCHEM BIOPH RES CO, V268, P321, DOI 10.1006/bbrc.2000.2147; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Watanabe S, 2000, BIOCHEM BIOPH RES CO, V278, P167, DOI 10.1006/bbrc.2000.3760; Waterman H, 2001, FEBS LETT, V490, P142, DOI 10.1016/S0014-5793(01)02117-2; Yoon CH, 2000, MOL BIOL CELL, V11, P4019, DOI 10.1091/mbc.11.11.4019	27	463	491	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2002	416	6877					183	187		10.1038/416183a	http://dx.doi.org/10.1038/416183a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894095				2022-12-28	WOS:000174348100039
J	Paramothayan, S; Jones, PW				Paramothayan, S; Jones, PW			Corticosteroid therapy in pulmonary sarcoidosis - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							DOUBLE-BLIND; INHALED BUDESONIDE; QUALITY; TRIALS	Context Corticosteroids are used in pulmonary sarcoidosis to reduce symptoms and minimize long-term damage. Spontaneous recovery is a common feature. Both the decision to initiate therapy and the treatment response may be influenced by disease severity, so trials need to use a randomized controlled design. Objective To assess the effect of oral and inhaled corticosteroids on chest radiograph results, symptoms, pulmonary function, and long-term outcome in pulmonary sarcoidosis. Data Sources MEDLINE, EMBASE, CINAHL, and the Cochrane Controlled Trials Register were searched all years through December 2001. Bibliographies of review articles and retrieved articles were searched, and pharmaceutical companies and authors of identified trials were contacted for other studies. There was no language restriction. Study Selection Trials were randomized and included a control group. Participants were adults with histologic evidence of pulmonary sarcoidosis. Treatments included the use of oral and inhaled corticosteroids for at least 8 weeks. The search identified 150 studies, 9 met the inclusion criteria, but only 8 provided usable data. Data Extraction Two reviewers assessed trial quality using the Jadad score, which evaluates the quality of randomization, blinding, and reasons for withdrawal. Data were extracted and sent to primary authors for verification. Data Synthesis In patients with stage 2 and 3 disease, oral corticosteroids improved findings on the chest radiograph after 6 to 24 months (Peto odds ratio, 2.54; 95% confidence interval [Cl], 1.69-3.81; P<.001). Forced vital capacity improved with oral corticosteroids (weighted mean difference [WMD], 4.2% predicted; 95% Cl, 0.4%-7.9% predicted) and diffusing capacity also improved (WMD, 5.7% predicted; 95% Cl, 1.0%-10.5% predicted). In 2 small studies of inhaled corticosteroids, there was no effect on chest radiograph and inconsistent effects on lung function in one and only a small improvement in symptoms in the other. There were no data following corticosteroid withdrawal to assess any disease-modifying effect. Conclusions Oral corticosteroids improved results on the chest radiograph following 6 to 24 months of treatment and produced a small improvement in vital capacity and diffusing capacity. Trials of inhaled corticosteroids were small and results too inconsistent to make firm conclusions concerning their efficacy. There are no data to suggest that corticosteroid therapy alters long-term disease progression.	St George Hosp, Sch Med, Div Physiol Med, London SW17 0RE, England	St Georges University London	Jones, PW (corresponding author), St George Hosp, Sch Med, Div Physiol Med, Cranmer Terrace, London SW17 0RE, England.							ALBERTS C, 1995, EUR RESPIR J, V8, P682; du Bois RM, 1999, EUR RESPIR J, V13, P1345, DOI 10.1034/j.1399-3003.1999.13f19.x; Erkkila S, 1988, Sarcoidosis, V5, P106; EULE E, 1977, Z ERKR ATMUGSORGANE, V149, P142; Gibson GJ, 1996, THORAX, V51, P238, DOI 10.1136/thx.51.3.238; ISRAEL HL, 1973, AM REV RESPIR DIS, V107, P609, DOI 10.1164/arrd.1973.107.4.609; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JAMES DG, 1967, LANCET, V2, P526; Khan KS, 1996, ARCH INTERN MED, V156, P661, DOI 10.1001/archinte.156.6.661; Lynch Joseph P. Iii, 1997, Comprehensive Therapy, V23, P197; MILMAN N, 1994, J INTERN MED, V236, P285, DOI 10.1111/j.1365-2796.1994.tb00798.x; Pietinalho A, 1999, CHEST, V116, P424, DOI 10.1378/chest.116.2.424; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; SELROOS O, 1979, SCAND J RESPIR DIS, V60, P215; SHARMA OP, 1990, DISEASE A MONTH, V36, P469; ZAKI MH, 1987, NEW YORK STATE J MED, V87, P496	16	111	119	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2002	287	10					1301	1307		10.1001/jama.287.10.1301	http://dx.doi.org/10.1001/jama.287.10.1301			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529YU	11886322				2022-12-28	WOS:000174329500029
J	Wilson, P				Wilson, P			How to find the good and avoid the bad or ugly: a short guide to tools for rating quality of health information on the internet	BMJ-BRITISH MEDICAL JOURNAL			English	Article									European Commiss, Directorate Gen Informat Soc Applicat, B-1049 Brussels, Belgium		Wilson, P (corresponding author), European Commiss, Directorate Gen Informat Soc Applicat, B-1049 Brussels, Belgium.	petra.wilson@cec.eu.int						DARMONI SJ, 2001, BMJ-BRIT MED J, V322, P1366; Delamothe T, 2000, BRIT MED J, V321, P843, DOI 10.1136/bmj.321.7265.843; Eysenbach G, 1999, BRIT MED J, V319, P1294, DOI 10.1136/bmj.319.7220.1294; Gagliardi A, 2002, BMJ-BRIT MED J, V324, P569, DOI 10.1136/bmj.324.7337.569; Jadad AR, 1998, JAMA-J AM MED ASSOC, V279, P611, DOI 10.1001/jama.279.8.611; McLellan F, 1998, LANCET, V352, P39; Rigby M, 2001, BMJ-BRIT MED J, V323, P552, DOI 10.1136/bmj.323.7312.552; Risk A, 2001, J MED INTERNET RES, V3, DOI 10.2196/jmir.3.4.e28	8	153	158	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2002	324	7337					598	600		10.1136/bmj.324.7337.598	http://dx.doi.org/10.1136/bmj.324.7337.598			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	530XJ	11884329	Green Published			2022-12-28	WOS:000174384000028
J	Drake, MJ; Righter, K				Drake, MJ; Righter, K			Determining the composition of the Earth	NATURE			English	Review							SIDEROPHILE ELEMENTS; OXYGEN-ISOTOPE; HIGH-PRESSURE; WATER; ORIGIN; TEMPERATURE; SILICATE; EQUILIBRIUM; MOON		Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA	University of Arizona	Drake, MJ (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.	drake@lpl.arizona.edu		Righter, Kevin/0000-0002-6075-7908				Abe Y., 2000, ORIGIN EARTH MOON, P413; ALLEGRE CJ, 1995, EARTH PLANET SC LETT, V134, P515, DOI 10.1016/0012-821X(95)00123-T; ANDERSON DL, 1989, SCIENCE, V243, P367, DOI 10.1126/science.243.4889.367; Brearley A.J., 1998, REV MINERALOGY, V36; Brown PG, 2000, SCIENCE, V290, P320, DOI 10.1126/science.290.5490.320; CAMERON AGW, 2000, ORIGIN EARTH MOON, P133; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; CHOPELAS A, 1992, GEOPHYS RES LETT, V19, P1983, DOI 10.1029/92GL02144; Chou CL, 1978, P LUNAR PLANET SCI, V9, P219; CLAYTON RN, 1991, GEOCHIM COSMOCHIM AC, V55, P2317, DOI 10.1016/0016-7037(91)90107-G; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.earth.21.1.115; Clayton RN, 1999, GEOCHIM COSMOCHIM AC, V63, P2089, DOI 10.1016/S0016-7037(99)00090-3; CLAYTON RN, 2001, LPI CONTRIBUTION, V1088; DELOULE E, 1995, GEOCHIM COSMOCHIM AC, V59, P4695, DOI 10.1016/0016-7037(95)00313-4; Deloule E, 1998, GEOCHIM COSMOCHIM AC, V62, P3367, DOI 10.1016/S0016-7037(98)00232-4; DRAKE MJ, 1989, GEOCHIM COSMOCHIM AC, V53, P2101, DOI 10.1016/0016-7037(89)90328-1; Drake MJ, 2000, GEOCHIM COSMOCHIM AC, V64, P2363, DOI 10.1016/S0016-7037(00)00372-0; DREIBUS G, 1998, LUNAR PLANET SCI C, V29; FELDMAN PD, 2001, B AM ASTRON SOC, V33, P1120; ITO E, 1989, J GEOPHYS RES-SOLID, V94, P10637, DOI 10.1029/JB094iB08p10637; Jagoutz E., 1979, P LUNAR PLANET SCI, V2, P2031; Kellogg LH, 1999, SCIENCE, V283, P1881, DOI 10.1126/science.283.5409.1881; LECLUSE C, 1994, GEOCHIM COSMOCHIM AC, V58, P2927, DOI 10.1016/0016-7037(94)90126-0; Meisel T, 2001, GEOCHIM COSMOCHIM AC, V65, P1311, DOI 10.1016/S0016-7037(00)00566-4; Morgan JW, 2001, METEORIT PLANET SCI, V36, P1257, DOI 10.1111/j.1945-5100.2001.tb01959.x; Okuchi T, 1997, SCIENCE, V278, P1781, DOI 10.1126/science.278.5344.1781; OWEN T, 2000, ORIGIN EARTH MOON, P459; PALME H, 1985, GEOCHIM COSMOCHIM AC, V49, P2123, DOI 10.1016/0016-7037(85)90070-5; PEPIN RO, 1989, ORIGIN EVOLUTION PLA, P291; Righter K, 2000, GEOCHIM COSMOCHIM AC, V64, P3581, DOI 10.1016/S0016-7037(00)00466-X; Righter K, 1997, PHYS EARTH PLANET IN, V100, P115, DOI 10.1016/S0031-9201(96)03235-9; Righter K, 1997, EARTH PLANET SC LETT, V146, P541, DOI 10.1016/S0012-821X(96)00243-9; Righter K, 1999, EARTH PLANET SC LETT, V171, P383, DOI 10.1016/S0012-821X(99)00156-9; RINGWOOD AE, 1979, ORIGIN EARTH MOON; Robert F, 2001, SCIENCE, V293, P1056, DOI 10.1126/science.1064051; Robert F, 2000, SPACE SCI REV, V92, P201, DOI 10.1023/A:1005291127595; Stern SA, 2000, ASTROPHYS J, V544, pL169, DOI 10.1086/317312; SWINDLE TD, 2001, LPI CONTRIBUTION, V1088; TACKLEY PJ, 1993, NATURE, V361, P699, DOI 10.1038/361699a0; Taylor SR, 1992, SOLAR SYSTEM EVOLUTI; Wade J, 2001, NATURE, V409, P75, DOI 10.1038/35051064; WANKE H, 1981, PHILOS T R SOC A, V303, P287, DOI 10.1098/rsta.1981.0203; WEICHERT U, 2001, LPI CONTRIBUTION, V1080; WOOD BJ, 1991, NATURE, V351, P309, DOI 10.1038/351309a0; Zinner E., 1988, METEORITES EARLY SOL	46	295	301	4	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 7	2002	416	6876					39	44		10.1038/416039a	http://dx.doi.org/10.1038/416039a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882886				2022-12-28	WOS:000174211600032
J	Levine, JS; Branch, DW; Rauch, J				Levine, JS; Branch, DW; Rauch, J			Medical progress: The antiphospholipid syndrome.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SYSTEMIC-LUPUS-ERYTHEMATOSUS; RECURRENT PREGNANCY LOSS; BETA-2-GLYCOPROTEIN-I APOLIPOPROTEIN-H; PRELIMINARY CLASSIFICATION CRITERIA; HEPARIN-INDUCED THROMBOCYTOPENIA; RANDOMIZED CONTROLLED TRIAL; CONNECTIVE-TISSUE DISEASES; LOW-DENSITY-LIPOPROTEIN; ANTICARDIOLIPIN ANTIBODIES; VENOUS THROMBOSIS		Univ Chicago, Dept Med, Nephrol Sect, Chicago, IL 60637 USA; Univ Utah, Dept Obstet & Gynecol, Salt Lake City, UT USA; McGill Univ, Ctr Hlth, Res Inst, Dept Med,Div Rheumatol, Montreal, PQ, Canada	University of Chicago; Utah System of Higher Education; University of Utah; McGill University	Rauch, J (corresponding author), Montreal Gen Hosp, Res Inst, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	joyce.rauch@mcgill.ca						ALARCONSEGOVIA D, 1989, MEDICINE, V68, P353, DOI 10.1097/00005792-198911000-00003; ALARCONSEGOVIA D, 1992, SEMIN ARTHRITIS RHEU, V21, P275, DOI 10.1016/0049-0172(92)90021-5; ALARCONSEGOVIA D, 1989, J RHEUMATOL, V16, P482; AlSayegh FA, 1997, J RHEUMATOL, V24, P1716; *AM COLL OBSTR GYN, 2001, ACOG PRACT B, V24; AMES PRJ, 1994, LUPUS, V3, P371, DOI 10.1177/096120339400300503; Arnout J, 1996, THROMB HAEMOSTASIS, V75, P536; ARVIEUX J, 1991, J IMMUNOL METHODS, V143, P223, DOI 10.1016/0022-1759(91)90047-J; ASHERSON RA, 1989, MEDICINE, V68, P366, DOI 10.1097/00005792-198911000-00004; Asherson RA, 1998, MEDICINE, V77, P195, DOI 10.1097/00005792-199805000-00005; BEVERS EM, 1991, THROMB HAEMOSTASIS, V66, P629; Branch DW, 1997, OBSTET GYNECOL, V89, P549; BRANCH DW, 1992, OBSTET GYNECOL, V80, P614; Branch DW, 2000, AM J OBSTET GYNECOL, V182, P122, DOI 10.1016/S0002-9378(00)70500-X; BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185; Cabral AR, 1996, AM J MED, V101, P472, DOI 10.1016/S0002-9343(96)00254-9; Carreras LO, 2000, J AUTOIMMUN, V15, P163, DOI 10.1006/jaut.2000.0401; CERVERA R, 1993, MEDICINE, V72, P113, DOI 10.1097/00005792-199303000-00005; CLIFFORD K, 1994, HUM REPROD, V9, P1328, DOI 10.1093/oxfordjournals.humrep.a138703; COWCHOCK FS, 1992, AM J OBSTET GYNECOL, V166, P1318, DOI 10.1016/0002-9378(92)91596-3; Crofford LJ, 2000, ARTHRITIS RHEUM, V43, P1891, DOI 10.1002/1529-0131(200008)43:8<1891::AID-ANR28>3.0.CO;2-R; DEGROOT PG, 1995, VESSELS, V1, P22; DERKSEN RHWM, 1993, ANN RHEUM DIS, V52, P689, DOI 10.1136/ard.52.9.689; DEWOLF F, 1982, AM J OBSTET GYNECOL, V142, P829, DOI 10.1016/S0002-9378(16)32527-3; Di Simone N, 2000, ARTHRITIS RHEUM-US, V43, P140, DOI 10.1002/1529-0131(200001)43:1<140::AID-ANR18>3.0.CO;2-P; Douketis JD, 1999, THROMB HAEMOSTASIS, V82, P1028; Erkan D, 2001, ARTHRITIS RHEUM, V44, P1466, DOI 10.1002/1529-0131(200106)44:6<1466::AID-ART242>3.0.CO;2-C; Esmon NL, 2000, J AUTOIMMUN, V15, P221, DOI 10.1006/jaut.2000.0407; Finazzi G, 1996, AM J MED, V100, P530, DOI 10.1016/S0002-9343(96)00060-5; GALLI M, 1992, THROMB HAEMOSTASIS, V68, P297; GALLI M, 1990, LANCET, V335, P1544, DOI 10.1016/0140-6736(90)91374-J; Galli M, 2000, J AUTOIMMUN, V15, P101, DOI 10.1006/jaut.2000.0413; GINSBERG JS, 1995, BLOOD, V86, P3685, DOI 10.1182/blood.V86.10.3685.bloodjournal86103685; Ginsberg JS, 2001, CHEST, V119, p122S, DOI 10.1378/chest.119.1_suppl.122S; GINSBURG KS, 1992, ANN INTERN MED, V117, P997, DOI 10.7326/0003-4819-117-12-997; GLUECK HI, 1985, ARCH INTERN MED, V145, P1389, DOI 10.1001/archinte.145.8.1389; Gruel Y, 2000, J AUTOIMMUN, V15, P265, DOI 10.1006/jaut.2000.0424; HARRIS EN, 1983, LANCET, V2, P1211; HASERICK JR, 1952, ANN INTERN MED, V37, P559, DOI 10.7326/0003-4819-37-3-559; Horkko S, 1996, J CLIN INVEST, V98, P815, DOI 10.1172/JCI118854; HUGHES GRV, 1986, J RHEUMATOL, V13, P486; HUGHSON MD, 1995, HUM PATHOL, V26, P716, DOI 10.1016/0046-8177(95)90218-X; HUNT JE, 1992, LUPUS, V1, P75, DOI 10.1177/096120339200100204; KANDIAH DA, 1994, LUPUS, V3, P207, DOI 10.1177/096120339400300401; KHAMASHTA MA, 1995, NEW ENGL J MED, V332, P993, DOI 10.1056/NEJM199504133321504; KINCAIDSMITH P, 1988, Q J MED, V69, P795; Kitchens CS, 1998, AM J MED, V104, P381, DOI 10.1016/S0002-9343(98)00061-8; Kutteh WH, 1996, AM J OBSTET GYNECOL, V174, P1584, DOI 10.1016/S0002-9378(96)70610-5; LEAKER B, 1991, BRIT J RHEUMATOL, V30, P422; Levine JS, 1999, J AUTOIMMUN, V12, P143; LEVINE JS, 2001, RHEUMATOLOGY KIDNEY, P132; LEVINE SR, 1992, STROKE, V23, pI29; Lie JT, 1996, ANTIPHOSPHOLIPID SYN, P89; Lima F, 1996, CLIN EXP RHEUMATOL, V14, P131; LOCKSHIN MD, 1985, NEW ENGL J MED, V313, P152, DOI 10.1056/NEJM198507183130304; LOTZ BP, 1993, S AFR MED J, V83, P663; LOVE PE, 1990, ANN INTERN MED, V112, P682, DOI 10.7326/0003-4819-112-9-682; McIntyre JA, 2000, J AUTOIMMUN, V15, P185, DOI 10.1006/jaut.2000.0425; MCNEIL HP, 1991, ADV IMMUNOL, V49, P193; MCNEIL HP, 1990, P NATL ACAD SCI USA, V87, P4120, DOI 10.1073/pnas.87.11.4120; Merkel PA, 1996, AM J MED, V101, P576, DOI 10.1016/S0002-9343(96)00335-X; Meroni PL, 1998, LUPUS, V7, pS44, DOI 10.1177/096120339800700211; Meroni PL, 2000, J AUTOIMMUN, V15, P237, DOI 10.1006/jaut.2000.0412; Moll S, 1997, ANN INTERN MED, V127, P177, DOI 10.7326/0003-4819-127-3-199708010-00001; Nochy D, 1999, J AM SOC NEPHROL, V10, P507; OOSTING JD, 1993, BLOOD, V81, P2618; Oshiro BT, 1996, OBSTET GYNECOL, V87, P489, DOI 10.1016/0029-7844(95)00498-X; Pangborn MC, 1941, P SOC EXP BIOL MED, V48, P484, DOI 10.3181/00379727-48-13365P; Pattison NS, 2000, AM J OBSTET GYNECOL, V183, P1008, DOI 10.1067/mob.2000.106754; Petri M, 2000, J AUTOIMMUN, V15, P145, DOI 10.1006/jaut.2000.0409; Petri M, 1996, LUPUS, V5, pS16, DOI 10.1177/096120339600500105; PIETTE JC, 1993, J RHEUMATOL, V20, P1802; Prandoni P, 1996, THROMB HAEMOSTASIS, V75, P859; Price BE, 1996, J IMMUNOL, V157, P2201; Rai R, 1997, BRIT MED J, V314, P253, DOI 10.1136/bmj.314.7076.253; Rance A, 1997, THROMB HAEMOSTASIS, V77, P221; Rand JH, 1997, NEW ENGL J MED, V337, P1327; Rand JH, 1997, NEW ENGL J MED, V337, P154, DOI 10.1056/NEJM199707173370303; RODGERS GM, 1999, WINTROBES CLIN HEMAT, P1781; ROSOVE MH, 1992, ANN INTERN MED, V117, P303, DOI 10.7326/0003-4819-117-4-303; Roubey RAS, 1996, ARTHRITIS RHEUM-US, V39, P1444, DOI 10.1002/art.1780390903; Roubey RAS, 2000, J AUTOIMMUN, V15, P217, DOI 10.1006/jaut.2000.0397; Schulman S, 1998, AM J MED, V104, P332, DOI 10.1016/S0002-9343(98)00060-6; SHI W, 1993, BLOOD, V81, P1255; SSHERSON RA, 1992, SYSTEMIC LUPUS ERYTH, V2, P587; SULLIVAN A, 2001, CONTEMP OBSTET GYNEC, V46, P100; Tincani A, 2000, J AUTOIMMUN, V15, P195, DOI 10.1006/jaut.2000.0399; TRIPLETT DA, 1999, LAB TECHNIQUES THROM, P183; VAARALA O, 1993, LANCET, V341, P923, DOI 10.1016/0140-6736(93)91213-6; VAARALA O, 1995, CIRCULATION, V91, P23, DOI 10.1161/01.CIR.91.1.23; VIANNA JL, 1994, AM J MED, V96, P3, DOI 10.1016/0002-9343(94)90108-2; VIARD JP, 1992, AM J MED, V93, P181, DOI 10.1016/0002-9343(92)90049-H; Wahl DG, 1997, LUPUS, V6, P467, DOI 10.1177/096120339700600510; Wassermann A, 1906, DEUT MED WOCHENSCHR, V32, P0745, DOI 10.1055/s-0028-1142018; Wilson WA, 1999, ARTHRITIS RHEUM, V42, P1309, DOI 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F; WURM H, 1984, INT J BIOCHEM, V16, P511, DOI 10.1016/0020-711X(84)90168-X; Yetman DL, 1996, FERTIL STERIL, V66, P540, DOI 10.1016/S0015-0282(16)58565-3	97	1047	1118	3	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2002	346	10					752	763		10.1056/NEJMra002974	http://dx.doi.org/10.1056/NEJMra002974			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527UA	11882732				2022-12-28	WOS:000174205000008
J	McKemy, DD; Neuhausser, WM; Julius, D				McKemy, DD; Neuhausser, WM; Julius, D			Identification of a cold receptor reveals a general role for TRP channels in thermosensation	NATURE			English	Article							CULTURED SENSORY NEURONS; ROOT GANGLION NEURONS; CAPSAICIN-RECEPTOR; ION CHANNELS; NOXIOUS HEAT; MENTHOL; PAIN; NOCICEPTORS; INPUT	The cellular and molecular mechanisms that enable us to sense cold are not well understood. Insights into this process have come from the use of pharmacological agents, such as menthol, that elicit a cooling sensation. Here we have characterized and cloned a menthol receptor from trigeminal sensory neurons that is also activated by thermal stimuli in the cool to cold range. This cold- and menthol-sensitive receptor, CMR1, is a member of the TRP family of excitatory ion channels, and we propose that it functions as a transducer of cold stimuli in the somatosensory system. These findings, together with our previous identification of the heat-sensitive channels VR1 and VRL-1, demonstrate that TRP channels detect temperatures over a wide range and are the principal sensors of thermal stimuli in the mammalian peripheral nervous system.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Julius, D (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.							Askwith CC, 2001, P NATL ACAD SCI USA, V98, P6459, DOI 10.1073/pnas.111155398; BESSOU P, 1969, J NEUROPHYSIOL, V32, P1025, DOI 10.1152/jn.1969.32.6.1025; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; BRAUN HA, 1980, PFLUG ARCH EUR J PHY, V386, P1, DOI 10.1007/BF00584180; Cain DM, 2001, J NEUROPHYSIOL, V85, P1561, DOI 10.1152/jn.2001.85.4.1561; Campero M, 2001, J PHYSIOL-LONDON, V535, P855, DOI 10.1111/j.1469-7793.2001.t01-1-00855.x; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; CRAIG AD, 1994, SCIENCE, V265, P252, DOI 10.1126/science.8023144; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; DODT E, 1952, ACTA PHYSIOL SCAND, V26, P358, DOI 10.1111/j.1748-1716.1952.tb00917.x; Eccles R, 2000, APPETITE, V34, P29, DOI 10.1006/appe.1999.0291; ECCLES R, 1994, J PHARM PHARMACOL, V46, P618, DOI 10.1111/j.2042-7158.1994.tb03871.x; Eckert SP, 1997, J NEUROSCI METH, V77, P183, DOI 10.1016/S0165-0270(97)00125-8; FIELDS HL, 1987, PAIN, P13; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; HENSEL H, 1951, ACTA PHYSIOL SCAND, V24, P27, DOI 10.1111/j.1748-1716.1951.tb00824.x; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; KENSHALO DR, 1977, J NEUROPHYSIOL, V40, P319, DOI 10.1152/jn.1977.40.2.319; KRESS M, 1992, J NEUROPHYSIOL, V68, P581, DOI 10.1152/jn.1992.68.2.581; LEWIS CA, 1979, J PHYSIOL-LONDON, V286, P417, DOI 10.1113/jphysiol.1979.sp012629; Nagy I, 1999, NEUROSCIENCE, V88, P995, DOI 10.1016/S0306-4522(98)00535-1; Okazawa M, 2000, NEUROREPORT, V11, P2151, DOI 10.1097/00001756-200007140-00018; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; PIERAU FK, 1974, BRAIN RES, V73, P156, DOI 10.1016/0006-8993(74)91015-4; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; Rainville P, 1999, EXP BRAIN RES, V125, P28, DOI 10.1007/s002210050654; RAJA SN, 1999, TXB PAIN, P00011; Reid G, 2001, NATURE, V413, P480, DOI 10.1038/35097164; Reid G, 2001, NEUROSCI LETT, V297, P171, DOI 10.1016/S0304-3940(00)01694-3; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; SCHAFER K, 1986, J GEN PHYSIOL, V88, P757, DOI 10.1085/jgp.88.6.757; Simone DA, 1997, J NEUROPHYSIOL, V77, P2049, DOI 10.1152/jn.1997.77.4.2049; Simone DA, 1996, NEUROSCI LETT, V213, P53, DOI 10.1016/0304-3940(96)12838-X; Suto K, 1999, NEUROSCIENCE, V92, P1131, DOI 10.1016/S0306-4522(99)00063-9; SWANDULLA D, 1987, PFLUG ARCH EUR J PHY, V409, P52, DOI 10.1007/BF00584749; TAKEUCHI S, 1994, BIOCHEM BIOPH RES CO, V201, P1333, DOI 10.1006/bbrc.1994.1850; Tsavaler L, 2001, CANCER RES, V61, P3760; WAHREN LK, 1989, PAIN, V38, P313, DOI 10.1016/0304-3959(89)90218-2; WEI ET, 1983, J PHARM PHARMACOL, V35, P110, DOI 10.1111/j.2042-7158.1983.tb04279.x; WEI ET, 1981, FED PROC, V40, P1491; YARNITSKY D, 1990, BRAIN, V113, P893, DOI 10.1093/brain/113.4.893; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	50	1760	1915	19	199	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2002	416	6876					52	58		10.1038/nature719	http://dx.doi.org/10.1038/nature719			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882888				2022-12-28	WOS:000174211600034
J	Reif, K; Ekland, EH; Ohl, L; Nakano, H; Lipp, M; Forster, R; Cyster, JG				Reif, K; Ekland, EH; Ohl, L; Nakano, H; Lipp, M; Forster, R; Cyster, JG			Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position	NATURE			English	Article							SECONDARY LYMPHOID ORGANS; DENDRITIC CELLS; HELPER-FREE; HIGH-TITER; CHEMOKINE; LOCALIZATION; EXPRESSION; FOLLICLES; MIGRATION; MICE	B lymphocytes re-circulate between B-cell-rich compartments (follicles or B zones) in secondary lymphoid organs, surveying for antigen. After antigen binding, B cells move to the boundary of B and T zones to interact with T-helper cells(1-3). Despite the importance of B-T-cell interactions for the induction of antibody responses, the mechanism causing B-cell movement to the T zone has not been defined. Here we show that antigen-engaged B cells have increased expression of CCR7, the receptor for the T-zone chemokines(4,5) CCL19 and CCL21, and that they exhibit increased responsiveness to both chemoattractants. In mice lacking lymphoid CCL19 and CCL21 chemokines, or with B cells that lack CCR7, antigen engagement fails to cause movement to the T zone. Using retroviral-mediated gene transfer we demonstrate that increased expression of CCR7 is sufficient to direct B cells to the T zone. Reciprocally, overexpression of CXCR5, the receptor for the B-zone chemokine CXCL13, is sufficient to overcome antigen-induced B-cell movement to the T zone. These findings define the mechanism of B-cell relocalization in response to antigen, and establish that cell position in vivo can be determined by the balance of responsiveness to chemoattractants made in separate but adjacent zones.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Erlangen Nurnberg, Surg Clin, D-91054 Erlangen, Germany; Toho Univ, Sch Med, Dept Immunol, Tokyo 1438540, Japan; Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Erlangen Nuremberg; Toho University; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 513 Parnassus Ave, San Francisco, CA 94143 USA.		Reif, Karin/AAD-4692-2020; Förster, Reinhold/D-6770-2011; Lipp, Martin/G-2235-2010	Reif, Karin/0000-0001-5490-8389; Forster, Reinhold/0000-0001-6190-7923; Lipp, Martin/0000-0002-0087-2672				Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; BASTEN A, 1991, IMMUNOL REV, V122, P5, DOI 10.1111/j.1600-065X.1991.tb00593.x; Blelloch R, 1999, CURR OPIN CELL BIOL, V11, P608, DOI 10.1016/S0955-0674(99)00028-9; Cyster JG, 1995, IMMUNITY, V3, P691, DOI 10.1016/1074-7613(95)90059-4; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Foxman EF, 1999, J CELL BIOL, V147, P577, DOI 10.1083/jcb.147.3.577; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Kellermann SA, 1999, J IMMUNOL, V162, P3859; LIU YJ, 1988, EUR J IMMUNOL, V18, P355, DOI 10.1002/eji.1830180306; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; MandikNayak L, 1997, J EXP MED, V186, P1257, DOI 10.1084/jem.186.8.1257; Nakano H, 1997, EUR J IMMUNOL, V27, P215, DOI 10.1002/eji.1830270132; Nakano H, 2001, J IMMUNOL, V166, P361, DOI 10.4049/jimmunol.166.1.361; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Ngo VN, 1998, J EXP MED, V188, P181, DOI 10.1084/jem.188.1.181; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Randolph DA, 1999, SCIENCE, V286, P2159, DOI 10.1126/science.286.5447.2159; Schmidt KN, 1998, J EXP MED, V187, P929, DOI 10.1084/jem.187.6.929; Van Parijs L, 1999, IMMUNITY, V11, P763, DOI 10.1016/S1074-7613(00)80150-8; Vassileva G, 1999, J EXP MED, V190, P1183, DOI 10.1084/jem.190.8.1183; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	30	406	432	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2002	416	6876					94	99		10.1038/416094a	http://dx.doi.org/10.1038/416094a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882900				2022-12-28	WOS:000174211600046
J	Maron, BJ; Gohman, TE; Kyle, SB; Estes, NAM; Link, MS				Maron, BJ; Gohman, TE; Kyle, SB; Estes, NAM; Link, MS			Clinical profile and spectrum of commotio cordis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUDDEN-DEATH; SPORTS ACTIVITIES; CARDIAC-ARREST; YOUNG; IMPACT	Context Although blunt, nonpenetrating chest blows causing sudden cardiac death (commotio cordis) are often associated with competitive sports, dangers implicit in such blows can extend into many other life activities. Objective To describe the comprehensive spectrum of commotio cordis events. Design and Setting Analysis of confirmed cases from the general community assembled in the US Commotio Cordis Registry occurring up to September 1, 2001. Main Outcome Measure Commotio cordis event. Results Of 128 confirmed cases, 122 (95%) were in males and the mean (SD) age was 13.6 (8.2) years (median, 14 years; range, 3 months to 45 years); only 28 (22%) cases were aged 18 years or older. Commotio cordis events occurred most commonly during organized sporting events (79 [62%]), such as baseball, but 49 (38%) occurred as part of daily routine and recreational activities. Fatal blows were inflicted with a wide range of velocities but often occurred inadvertently and under circumstances not usually associated with risk for sudden death in informal settings near the home or playground. Twenty-two (28%) participants were wearing commercially available chest barriers, including 7 in whom the projectile made direct contact with protective padding (baseball catchers and lacrosse/hockey goalies), and 2 in whom the projectile was a baseball specifically designed to reduce risk. Only 21 (16%) individuals survived their event, with particularly prompt cardiopulmonary resuscitation/defibrillation (most commonly reversing ventricular fibrillation) the only identifiable factor associated with a favorable outcome. Conclusions The expanded spectrum of commotio cordis illustrates the potential dangers implicit in striking the chest, regardless of the intent or force of the blow. These findings also suggest that the safety of young athletes will be enhanced by developing more effective preventive strategies (such as chest wall barriers) to achieve protection from ventricular fibrillation following precordial blows.	Minneapolis Heart Inst Fdn, Cardiovasc Res Div, Minneapolis, MN 55407 USA; Tufts Univ New England Med Ctr, Cardiac Arrhythmia Ctr, Boston, MA 02111 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA; US Consumer Prod Safety Commiss, Washington, DC USA	Minneapolis Heart Institute Foundation; Tufts Medical Center; Tufts University	Maron, BJ (corresponding author), Minneapolis Heart Inst Fdn, Cardiovasc Res Div, 920 E 28th St,Suite 60, Minneapolis, MN 55407 USA.							ABRUNZO TJ, 1991, AM J DIS CHILD, V145, P1279, DOI 10.1001/archpedi.1991.02160110071023; BURKE AP, 1991, AM HEART J, V121, P568, DOI 10.1016/0002-8703(91)90727-Y; Curfman GD, 1998, NEW ENGL J MED, V338, P1841, DOI 10.1056/NEJM199806183382511; ESTES NAM, 1995, NEW ENGL J MED, V333, P380, DOI 10.1056/NEJM199508103330611; KAPLAN JA, 1993, J TRAUMA, V34, P151, DOI 10.1097/00005373-199301000-00030; KING AI, 1986, BASEBALL RELATED CHE; Link MS, 1999, CIRCULATION, V100, P413, DOI 10.1161/01.CIR.100.4.413; Link MS, 1998, NEW ENGL J MED, V338, P1805, DOI 10.1056/NEJM199806183382504; Link MS, 1998, CHEST, V114, P326, DOI 10.1378/chest.114.1.326; Link MS, 2001, J AM COLL CARDIOL, V37, P649, DOI 10.1016/S0735-1097(00)01142-6; Link MS, 2001, J AM COLL CARDIOL, V37, p135A; LINK MS, 2001, PACE, V24, P614; Maron BJ, 1997, AM J CARDIOL, V79, P840, DOI 10.1016/S0002-9149(96)00887-9; MARON BJ, 1995, NEW ENGL J MED, V333, P337, DOI 10.1056/NEJM199508103330602; Maron BJ, 1999, J CARDIOVASC ELECTR, V10, P114, DOI 10.1111/j.1540-8167.1999.tb00648.x; MARON BJ, 1993, NEW ENGL J MED, V329, P55, DOI 10.1056/NEJM199307013290113; Maron BJ, 2002, AM J CARDIOL, V89, P210, DOI 10.1016/S0002-9149(01)02202-0; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; Nesbitt AD, 2001, LANCET, V357, P1195, DOI 10.1016/S0140-6736(00)04338-5; SWIFT EW, 1993, SPORTS ILLUSTRA 1206, P68; THIENE G, 1988, NEW ENGL J MED, V318, P129, DOI 10.1056/NEJM198801213180301; VANCAMP SP, 1995, MED SCI SPORT EXER, V27, P641; Washington RL, 2001, PEDIATRICS, V107, P782, DOI 10.1542/peds.107.4.782	23	221	231	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2002	287	9					1142	1146		10.1001/jama.287.9.1142	http://dx.doi.org/10.1001/jama.287.9.1142			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527KV	11879111	Bronze			2022-12-28	WOS:000174186000029
J	Dickert, N; Emanuel, E; Grady, C				Dickert, N; Emanuel, E; Grady, C			Paying research subjects: An analysis of current policies	ANNALS OF INTERNAL MEDICINE			English	Article							PAYMENT	Background: Few data are available on guidelines used by research organizations to make decisions about paying subjects. Objective: To analyze existing guidance regarding payment of research subjects and to identify common characteristics and areas for further research. Design: Descriptive content analysis of policies. Measurements: Written policies and rules of thumb about paying subjects from 32 U.S. research organizations. Results: Of 32 organizations, 37.5% had written guidelines about paying subjects; all but 1 reported having rules of thumb. Few (18.8%) were able to provide a confident estimate of the proportion of studies that pay subjects. Organizations reported that investigators and institutional review boards make payment decisions and that both healthy and ill subjects in some studies are paid for their time (87%), for inconvenience (84%), for travel (68%), as incentive (58%), or for incurring risk (32%). Most organizations require that payment be prorated (84%) and described in the consent document (94%). Conclusions: Most organizations pay some research subjects, but few have written policies on payment. Because investigators and institutional review boards make payment decisions with little specific guidance, standards vary.	WG Magnuson Clin Ctr, Dept Clin Bioeth, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Grady, C (corresponding author), WG Magnuson Clin Ctr, Dept Clin Bioeth, NIH, Bldg 1C118, Bethesda, MD 20892 USA.	cgrady@nih.gov			CLINICAL CENTER [Z01CL010504] Funding Source: NIH RePORTER	CLINICAL CENTER		Ackerman Terrence F, 1989, IRB, V11, P1, DOI 10.2307/3564170; APPELBAUM PS, 1987, HASTINGS CENT REP, V17, P20, DOI 10.2307/3562038; Department of Health and Human Services Office of Inspector General, 2000, RECR HUM SUBJ PRESS; Dickert N, 1999, NEW ENGL J MED, V341, P198, DOI 10.1056/NEJM199907153410312; Grady Christine, 2001, American Journal of Bioethics, V1, P40, DOI 10.1162/152651601300169031; Lemmens Trudo, 1999, Account Res, V7, P3, DOI 10.1080/08989629908573939; Lemmens Trudo, 2001, American Journal of Bioethics, V1, P51, DOI 10.1162/152651601300169095; Levine Robert J, 1979, IRB, V1, P7, DOI 10.2307/3564246; Macklin Ruth, 1981, IRB, V3, P1, DOI 10.2307/3564136; McGee G, 1997, JAMA-J AM MED ASSOC, V278, P199, DOI 10.1001/jama.278.3.199; McNeill P, 1997, BIOETHICS, V11, P390, DOI 10.1111/1467-8519.00079; *OFF PROT RES RISK, 1993, OFF IRB GUID, P3; WARTOFSKY M, 1976, RES INVOLVING PRISON; Yaes RJ, 1999, NEW ENGL J MED, V341, P1551; 1998, GUIDANCE INVESTIGATI	15	92	92	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 5	2002	136	5					368	373		10.7326/0003-4819-136-5-200203050-00009	http://dx.doi.org/10.7326/0003-4819-136-5-200203050-00009			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525VT	11874309				2022-12-28	WOS:000174095300004
J	Shanafelt, TD; Bradley, KA; Wipf, JE; Back, AL				Shanafelt, TD; Bradley, KA; Wipf, JE; Back, AL			Burnout and self-reported patient care in an internal medicine residency program	ANNALS OF INTERNAL MEDICINE			English	Article							HOUSE STAFF; DEPRESSION; PHYSICIANS; STRESS; SATISFACTION; MANAGEMENT; DISORDERS; QUESTIONS; DISTRESS; VALIDITY	Background: Burnout is a syndrome of depersonalization, emotional exhaustion, and a sense of low personal accomplishment. Little is known about burnout in residents or its relationship to patient care. Objective: To determine the prevalence of burnout in medical residents and explore its relationship to self-reported patient care practices. Design: Cross-sectional study using an anonymous, mailed survey. Setting: University-based residency program in Seattle, Washington. Participants: 115 internal medicine residents. Measurements: Burnout was measured by using the Maslach Burnout Inventory and was defined as scores in the high range for medical professionals on the depersonalization or emotional exhaustion subscales. Five questions developed for this study assessed self-reported patient care practices that suggested suboptimal care (for example, "I did not fully discuss treatment options or answer a patient's questions" or "I made ... errors that were not due to a lack of knowledge or inexperience"). Depression and at-risk alcohol use were assessed by using validated screening questionnaires. Results: Of 115 (76%) responding residents, 87 (76%) met the criteria for burnout. Compared with non-burned-out residents, burned-out residents were significantly more likely to self-report providing at least one type of suboptimal patient care at least monthly (53% vs. 21%; P=0.004). In multivariate analyses, burnout-but not sex, depression, or at-risk alcohol use-was strongly associated with self-report of one or more suboptimal patient care practices at least monthly (odds ratio, 8.3 [95% Cl, 2.6 to 26.5]). When each domain of burnout was evaluated separately, only a high score for depersonalization was associated with self-reported suboptimal patient care practices (in a dose-response relationship). Conclusion: Burnout was common among resident physicians and was associated with self-reported suboptimal patient care practices.	Univ Washington, Vet Affairs NW Hlth Serv Res & Dev Ctr Excellence, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Back, AL (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, 1660 S Columbian Way S-111, Seattle, WA 98108 USA.	tonyback@u.washington.edu			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K23AA000313] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		[Anonymous], 1995, BURNOUT HELPING TEAC; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; Burack JH, 1999, J GEN INTERN MED, V14, P49, DOI 10.1046/j.1525-1497.1999.00280.x; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; CLARK DC, 1987, JAMA-J AM MED ASSOC, V257, P2921, DOI 10.1001/jama.257.21.2921; COLFORD JM, 1989, JAMA-J AM MED ASSOC, V261, P889, DOI 10.1001/jama.261.6.889; DECKARD GJ, 1992, J INFECT DIS, V165, P224, DOI 10.1093/infdis/165.2.224; EISENBERG J, 1986, DOCTORS DECISIONS CO; FIRTHCOZENS J, 1987, BRIT MED J, V295, P533, DOI 10.1136/bmj.295.6597.533; GALLERY ME, 1992, ANN EMERG MED, V21, P58, DOI 10.1016/S0196-0644(05)82238-3; GIRARD DE, 1986, WESTERN J MED, V144, P93; Goldberg R, 1996, ACAD EMERG MED, V3, P1156, DOI 10.1111/j.1553-2712.1996.tb03379.x; Grassi L, 2000, PSYCHOTHER PSYCHOSOM, V69, P329, DOI 10.1159/000012416; Gundersen L, 2001, ANN INTERN MED, V135, P145, DOI 10.7326/0003-4819-135-2-200107170-00023; HAFFERTY FW, 1994, ACAD MED, V69, P861, DOI 10.1097/00001888-199411000-00001; HSU K, 1987, AM J PSYCHIAT, V144, P1561; HUGHES PH, 1991, JAMA-J AM MED ASSOC, V265, P2069, DOI 10.1001/jama.265.16.2069; KELLER KL, 1989, ANN EMERG MED, V18, P42; Kenagy JW, 1999, JAMA-J AM MED ASSOC, V281, P661, DOI 10.1001/jama.281.7.661; Kilfedder CJ, 2001, J ADV NURS, V34, P383, DOI 10.1046/j.1365-2648.2001.01769.x; Kohn KT, 2000, ERR IS HUMAN BUILDIN; KORAN LM, 1988, WESTERN J MED, V148, P97; Lee RT, 1996, J APPL PSYCHOL, V81, P123, DOI 10.1037/0021-9010.81.2.123; Leiter MP, 1998, SOC SCI MED, V47, P1611, DOI 10.1016/S0277-9536(98)00207-X; LEITER MP, 1994, ANXIETY STRESS COPIN, V7, P357, DOI 10.1080/10615809408249357; Lemkau J, 1994, Fam Pract Res J, V14, P213; Levey RE, 2001, ACAD MED, V76, P142, DOI 10.1097/00001888-200102000-00010; LICHTENSTEIN R, 1984, MED CARE, V22, P56, DOI 10.1097/00005650-198401000-00005; Lichtenstein R L, 1984, Med Care Rev, V41, P139, DOI 10.1177/107755878404100301; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C., 1986, MASLACH BURNOUT INVE, V2nd ed.; MCAULIFFE WE, 1986, NEW ENGL J MED, V315, P805, DOI 10.1056/NEJM198609253151305; MCCUE JD, 1991, ARCH INTERN MED, V151, P2273, DOI 10.1001/archinte.151.11.2273; NESBITT D, 1988, ANN INTERN MED, V109, P154, DOI 10.7326/0003-4819-109-2-154; Parker PA, 1995, J BEHAV MED, V18, P581, DOI 10.1007/BF01857897; Purdy R R, 1987, Fam Med, V19, P203; RAFFERTY JP, 1986, J CLIN PSYCHOL, V42, P488, DOI 10.1002/1097-4679(198605)42:3<488::AID-JCLP2270420315>3.0.CO;2-S; RAMIREZ AJ, 1995, BRIT J CANCER, V71, P1263, DOI 10.1038/bjc.1995.244; REUBEN DB, 1985, ARCH INTERN MED, V145, P286, DOI 10.1001/archinte.145.2.286; REUBEN DB, 1984, PSYCHOSOMATICS, V25, P815, DOI 10.1016/S0033-3182(84)72942-2; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SMITH JW, 1986, JAMA-J AM MED ASSOC, V255, P1155, DOI 10.1001/jama.255.9.1155; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Yao DC, 2000, JAMA-J AM MED ASSOC, V284, P1099, DOI 10.1001/jama.284.9.1099	45	1326	1362	3	153	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 5	2002	136	5					358	367		10.7326/0003-4819-136-5-200203050-00008	http://dx.doi.org/10.7326/0003-4819-136-5-200203050-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	525VT	11874308				2022-12-28	WOS:000174095300003
J	Quere, I; Perneger, TV; Zittoun, J; Bellet, H; Gris, JC; Daures, JP; Schved, JF; Mercier, E; Laroche, JP; Dauzat, M; Bounameaux, H; Janbon, C; de Moerloose, P				Quere, I; Perneger, TV; Zittoun, J; Bellet, H; Gris, JC; Daures, JP; Schved, JF; Mercier, E; Laroche, JP; Dauzat, M; Bounameaux, H; Janbon, C; de Moerloose, P			Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study	LANCET			English	Article							FACTOR-V-LEIDEN; THERMOLABILE METHYLENETETRAHYDROFOLATE REDUCTASE; FOLIC-ACID; ENDOTHELIAL DYSFUNCTION; FATTY-ACIDS; FOLATE; HYPERHOMOCYSTEINEMIA; PROTHROMBIN; C677T; POLYMORPHISM	Background Moderate hyperhomocysteinaemia is a risk factor for venous thromboembolism. We do not know whether this risk depends on homocysteine itself or on components of the homocysteine remethylation pathway, such as methylfolate. We did a case-control study to analyse the relation between the major components of the homocysteine remethylation pathway and risk of venous thromboembolism. Methods We measured concentrations of homocysteine, methionine, and folate in plasma, total folate and methylfolate in red-blood cells, and 5, 10-methylenetetrahydrofolate reductase (MTHFR) C677T genotype and other known risk factors for venous thromboembolic, disease in 243 patients with deep vein thrombosis or pulmonary embolism and controls matched for sex and age. Findings Concentrations in plasma of homocysteine differed significantly between cases and controls. We noted a strong concentration-dependent association between concentrations of methylfolate in red-blood cells and risk of venous thromboembolism. The adjusted conditional odds ratio ranged from 1.0 for methylfoate 249 mug/L or greater to 7.1 (3.2-15.8) for methylfolate 141 mug/L or less. Methionine concentrations below the median were also independently associated with raised risk of venous thromboembolic disease, as were established risk factors such as high body-mass index, history of cancer, family history of thromboembolism, oral contraceptive use, and factor V Leiden mutation. Furthermore, the association between concentrations of methylfolate in red-blood cells and risk of thromboembolism varied according to MTHFR C677T genotype. Interpretation Measurement of methylfolate concentrations in red-blood cells might help to identify people at risk of venous thromboembolism.	Univ Hosp St Eloi, Dept Internal Med, Montpellier, France; Univ Hosp St Eloi, Haematol Lab, Montpellier, France; Univ Hosp St Eloi, Biochem Lab, Montpellier, France; Univ Hosp Henri Mondor, Haematol Lab, Creteil, France; Univ Hosp, Physiol Lab, Nimes, France; Univ Hosp, Haematol Lab, Nimes, France; Univ Clin Res Inst, Montpellier, France; Univ Hosp Geneva, Qual Care Unit, Geneva, Switzerland; Univ Hosp Geneva, Div Angiol & Haemostasis, Geneva, Switzerland	Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite de Montpellier; CHU de Nimes; Universite de Montpellier; CHU de Nimes; University of Geneva; University of Geneva	Quere, I (corresponding author), Hop St Eloi, Serv Med Interne B, 2 Av Bertin Sans, F-34295 Montpellier, France.	i-quere@chu-montpellier.fr	Dauzat, Michel/Q-7200-2019; Quere, Isabelle/AAB-8519-2020; GRIS, Jean-Christophe/AAA-2923-2019	Dauzat, Michel/0000-0002-9496-3857; Quere, Isabelle/0000-0002-1492-9764; GRIS, Jean-Christophe/0000-0002-9899-9910; Schved, Jean-Francois/0000-0003-0332-3254; Mercier, Eric/0000-0001-7917-1918				Alhenc-Gelas M, 1999, THROMB HAEMOSTASIS, V81, P506; AMUNDSEN T, 1995, ARTERIOSCL THROM VAS, V15, P1321, DOI 10.1161/01.ATV.15.9.1321; Andriamampandry M, 1998, CR ACAD SCI III-VIE, V321, P415, DOI 10.1016/S0764-4469(98)80306-5; Bolton-Smith C, 2000, BRIT J NUTR, V83, P389; BRATTSTROM LE, 1988, SCAND J CLIN LAB INV, V48, P215, DOI 10.3109/00365518809167487; Cattaneo M, 1999, THROMB RES, V93, P1, DOI 10.1016/S0049-3848(98)00136-4; D'Angelo A, 2000, THROMB HAEMOSTASIS, V83, P563; Dauzat M, 1997, J CLIN ULTRASOUND, V25, P343, DOI 10.1002/(SICI)1097-0096(199709)25:7<343::AID-JCU1>3.0.CO;2-A; de Moerloose P, 2000, BRIT J HAEMATOL, V110, P125, DOI 10.1046/j.1365-2141.2000.02039.x; De Stefano V, 2000, SEMIN THROMB HEMOST, V26, P305, DOI 10.1055/s-2000-8473; Den Heijer M, 2000, DEV CARDIOVASC MED, V230, P239; DENHEIJER M, 1995, LANCET, V345, P882, DOI 10.1016/S0140-6736(95)90008-X; Durand P, 1997, ARTERIOSCL THROM VAS, V17, P1939, DOI 10.1161/01.ATV.17.10.1939; Durand P, 1996, ATHEROSCLEROSIS, V121, P231, DOI 10.1016/0021-9150(95)06724-8; Egerton W, 1996, AM J CARDIOL, V77, P759, DOI 10.1016/S0002-9149(97)89213-2; Eichinger S, 1998, THROMB HAEMOSTASIS, V80, P566; Gemmati D, 1999, ARTERIOSCL THROM VAS, V19, P1761, DOI 10.1161/01.ATV.19.7.1761; HOFFBRAND AV, 1966, J CLIN PATHOL, V19, P17, DOI 10.1136/jcp.19.1.17; Kluijtmans LAJ, 1998, THROMB HAEMOSTASIS, V79, P254, DOI 10.1055/s-0037-1614974; Kraaijenhagen RA, 1998, BAILLIERE CLIN HAEM, V11, P541, DOI 10.1016/S0950-3536(98)80083-8; LINDGREN A, 1995, STROKE, V26, P795, DOI 10.1161/01.STR.26.5.795; Ma J, 1996, CIRCULATION, V94, P2410, DOI 10.1161/01.CIR.94.10.2410; Meiklejohn DJ, 2001, STROKE, V32, P57, DOI 10.1161/01.STR.32.1.57; Molloy AM, 1997, LANCET, V349, P1591, DOI 10.1016/S0140-6736(96)12049-3; Morrison HI, 1996, JAMA-J AM MED ASSOC, V275, P1893, DOI 10.1001/jama.275.24.1893; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; Pita ML, 2000, THROMB HAEMOSTASIS, V84, P420; Quere I, 1998, THROMB HAEMOSTASIS, V80, P707; Ridker PM, 1997, CIRCULATION, V95, P1777; Title LM, 2000, J AM COLL CARDIOL, V36, P758, DOI 10.1016/S0735-1097(00)00809-3; Usui M, 1999, CLIN SCI, V96, P235, DOI 10.1042/CS19980382; Zittoun J, 1998, METABOLISM, V47, P1413, DOI 10.1016/S0026-0495(98)90315-8; ZITTOUN J, 1993, EUR J CLIN PHARMACOL, V44, P569, DOI 10.1007/BF02440861	33	82	86	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 2	2002	359	9308					747	752		10.1016/S0140-6736(02)07876-5	http://dx.doi.org/10.1016/S0140-6736(02)07876-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526DZ	11888585				2022-12-28	WOS:000174115200009
J	Senior, K				Senior, K			Microbleeds may predict cerebral bleeding after stroke	LANCET			English	News Item																		Nighoghossian N, 2002, STROKE, V33, P735, DOI 10.1161/hs0302.104615	1	19	19	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 2	2002	359	9308					769	769		10.1016/S0140-6736(02)07911-4	http://dx.doi.org/10.1016/S0140-6736(02)07911-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526DZ	11888596				2022-12-28	WOS:000174115200019
J	Ferguson, AD; Chakraborty, R; Smith, BS; Esser, L; van der Helm, D; Deisenhofer, J				Ferguson, AD; Chakraborty, R; Smith, BS; Esser, L; van der Helm, D; Deisenhofer, J			Structural basis of gating by the outer membrane transporter FecA	SCIENCE			English	Article							INDUCED CONFORMATIONAL CHANGE; ENTEROBACTIN RECEPTOR FEPA; FERRIC CITRATE TRANSPORT; ELECTRON-DENSITY MAPS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; ANOMALOUS DIFFRACTION; IRON TRANSPORT; PROTEIN TONB; FHUA	Siderophore-mediated acquisition systems facilitate iron uptake. We present the crystallographic structure of the integral outer membrane receptor FecA from Escherichia coli with and without ferric citrate at 2.5 and 2.0 angstrom resolution. FecA is composed of three distinct domains: the barrel, plug, and NH2-terminal extension. Binding of ferric citrate triggers a conformational change of the extracellular loops that close the external pocket of FecA. Ligand-induced allosteric transitions are propagated through the outer membrane by the plug domain, signaling the occupancy of the receptor in the periplasm. These data establish the structural basis of gating for receptors dependent on the cytoplasmic membrane protein TonB. By compiling available data for this family of receptors, we propose a mechanism for the energy-dependent transport of siderophores.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; E Tennessee State Univ, Coll Publ & Allied Hlth, Dept Hlth Sci, Johnson City, TN 37614 USA; NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Oklahoma System; University of Oklahoma - Norman; East Tennessee State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Victoria	Deisenhofer, J (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	johann.deisenhofer@utsouthwestern.edu						ANGERER A, 1995, MOL MICROBIOL, V18, P163, DOI 10.1111/j.1365-2958.1995.mmi_18010163.x; Bonhivers M, 1996, EMBO J, V15, P1850, DOI 10.1002/j.1460-2075.1996.tb00535.x; Bos C, 1998, J BACTERIOL, V180, P605; Braun M, 1999, MOL MICROBIOL, V33, P1037, DOI 10.1046/j.1365-2958.1999.01546.x; Braun V, 1998, MET IONS BIOL SYST, V35, P67; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Cadieux N, 1999, P NATL ACAD SCI USA, V96, P10673, DOI 10.1073/pnas.96.19.10673; Cadieux N, 2000, J BACTERIOL, V182, P5954, DOI 10.1128/JB.182.21.5954-5961.2000; Crosa JH, 1997, MICROBIOL MOL BIOL R, V61, P319, DOI 10.1128/.61.3.319-336.1997; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DOUBLIE S, 1997, METHOD ENZYMOL, V276, P532; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; ESSER L, COMMUNICATION; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Ferguson AD, 2001, STRUCTURE, V9, P707, DOI 10.1016/S0969-2126(01)00631-1; Ferguson AD, 2000, PROTEIN SCI, V9, P956, DOI 10.1110/ps.9.5.956; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Jiang XQ, 1997, SCIENCE, V276, P1261, DOI 10.1126/science.276.5316.1261; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KADNER RJ, 1995, J BACTERIOL, V177, P4829, DOI 10.1128/jb.177.17.4829-4835.1995; Kim I, 1997, MOL MICROBIOL, V23, P333, DOI 10.1046/j.1365-2958.1997.2401593.x; KIM WY, 1995, IEEE T CIRC SYST VID, V5, P1, DOI 10.1109/76.350773; Klug CS, 1998, BIOCHEMISTRY-US, V37, P9016, DOI 10.1021/bi980144e; Koshland DE, 1998, NAT MED, V4, P1112, DOI 10.1038/2605; Larsen RA, 1999, MOL MICROBIOL, V31, P1809, DOI 10.1046/j.1365-2958.1999.01317.x; Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6; Locher KP, 1997, J BIOL CHEM, V272, P1448, DOI 10.1074/jbc.272.3.1448; Moeck GS, 1997, J BIOL CHEM, V272, P28391, DOI 10.1074/jbc.272.45.28391; Moeck GS, 2001, J BACTERIOL, V183, P2755, DOI 10.1128/JB.183.9.2755-2764.2001; NICHOLLS A, 1991, PROTEIN-STRUCT FUNCT, V11, P282; OCHS M, 1995, MOL MICROBIOL, V15, P119, DOI 10.1111/j.1365-2958.1995.tb02226.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Roosenberg JM, 2000, CURR MED CHEM, V7, P159, DOI 10.2174/0929867003375353; SCHRAMM E, 1987, J BACTERIOL, V169, P3350, DOI 10.1128/jb.169.7.3350-3357.1987; Scott DC, 2001, J BIOL CHEM, V276, P13025, DOI 10.1074/jbc.M011282200; SHWEKY I, 1994, INORG CHEM, V33, P5161, DOI 10.1021/ic00101a001; Smith BS, 1998, ACTA CRYSTALLOGR D, V54, P697, DOI 10.1107/S0907444997020222; Usher KC, 2001, P NATL ACAD SCI USA, V98, P10676, DOI 10.1073/pnas.181353398; Weeks CM, 1999, ACTA CRYSTALLOGR D, V55, P492, DOI 10.1107/S0907444998012633	40	289	297	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2002	295	5560					1715	1719		10.1126/science.1067313	http://dx.doi.org/10.1126/science.1067313			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872840				2022-12-28	WOS:000174212900047
J	Guttman, DS; Vinatzer, BA; Sarkar, SF; Ranall, MV; Kettler, G; Greenberg, JT				Guttman, DS; Vinatzer, BA; Sarkar, SF; Ranall, MV; Kettler, G; Greenberg, JT			A functional screen for the type III (Hrp) secretome of the plant pathogen Pseudomonas syringae	SCIENCE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; PROGRAMMED CELL-DEATH; AVIRULENCE; PROTEIN; GENE; IDENTIFICATION; EFFECTOR; AVRRPT2; ARABIDOPSIS; YOPE	Type III secreted "effector" proteins of bacterial, pathogens play central roles in virulence, yet are notoriously difficult to identify. We used an in vivo genetic screen to identify 13 effectors secreted by the type III apparatus (called Hrp, for "hypersensitive response and pathogenicity") of the plant pathogen Pseudomonas syringae. Although sharing little overall homology, the amino-terminal regions of these effectors had strikingly similar amino acid compositions. This feature facilitated the bioinformatic prediction of 38 P. syringae effectors, including 15 previously unknown proteins, The secretion of two of these putative effectors was shown to be type III-dependent. Effectors showed high interstrain variation, supporting a rote for some effectors in adaptation to different hosts.	Univ Toronto, Dept Bot, Toronto, ON M5S 3B2, Canada; Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	University of Toronto; University of Chicago	Guttman, DS (corresponding author), Univ Toronto, Dept Bot, 25 Willcocks St, Toronto, ON M5S 3B2, Canada.	guttman@botany.utoronto.ca		Greenberg, Jean/0000-0002-7213-7618				Alfano JR, 2000, P NATL ACAD SCI USA, V97, P4856, DOI 10.1073/pnas.97.9.4856; Alfano JR, 1997, J BACTERIOL, V179, P5655, DOI 10.1128/jb.179.18.5655-5662.1997; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Axtell MJ, 2001, MOL PLANT MICROBE IN, V14, P181, DOI 10.1094/MPMI.2001.14.2.181; Barbieri AM, 2001, INFECT IMMUN, V69, P5329, DOI 10.1128/IAI.69.9.5329-5334.2001; Bowen D, 1998, SCIENCE, V280, P2129, DOI 10.1126/science.280.5372.2129; Collmer A, 1998, CURR OPIN PLANT BIOL, V1, P329, DOI 10.1016/1369-5266(88)80055-4; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Gabriel DW, 1999, PHYSIOL MOL PLANT P, V55, P205, DOI 10.1006/pmpp.1999.0230; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Gaudriault S, 1997, MOL MICROBIOL, V26, P1057, DOI 10.1046/j.1365-2958.1997.6442015.x; Glazebrook J, 1997, ANNU REV GENET, V31, P547, DOI 10.1146/annurev.genet.31.1.547; Glazebrook J, 1996, GENETICS, V143, P973; Greenberg JT, 1997, ANNU REV PLANT PHYS, V48, P525, DOI 10.1146/annurev.arplant.48.1.525; GREENBERG JT, 1994, CELL, V77, P551, DOI 10.1016/0092-8674(94)90217-8; Guttman DS, 1998, NATURE, V393, P263, DOI 10.1038/30492; Guttman DS, 2001, MOL PLANT MICROBE IN, V14, P145, DOI 10.1094/MPMI.2001.14.2.145; HERBERS K, 1992, NATURE, V356, P172, DOI 10.1038/356172a0; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; INNES RW, 1993, J BACTERIOL, V175, P4859, DOI 10.1128/JB.175.15.4859-4869.1993; Jackson RW, 1999, P NATL ACAD SCI USA, V96, P10875, DOI 10.1073/pnas.96.19.10875; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; Kenny B, 2000, CELL MICROBIOL, V2, P579, DOI 10.1046/j.1462-5822.2000.00082.x; Lee VT, 1999, MOL MICROBIOL, V31, P1619, DOI 10.1046/j.1365-2958.1999.01270.x; Liao CH, 1997, CAN J MICROBIOL, V43, P425, DOI 10.1139/m97-060; Lloyd SA, 2001, MOL MICROBIOL, V39, P520, DOI 10.1046/j.1365-2958.2001.02271.x; Makino K, 1999, GENES GENET SYST, V74, P227, DOI 10.1266/ggs.74.227; MANSFIELD J, 1994, MOL PLANT MICROBE IN, V7, P726, DOI 10.1094/MPMI-7-0726; Mudgett MB, 2000, P NATL ACAD SCI USA, V97, P13324, DOI 10.1073/pnas.230450797; Mudgett MB, 1999, MOL MICROBIOL, V32, P927, DOI 10.1046/j.1365-2958.1999.01403.x; Nambu T, 1999, J BACTERIOL, V181, P1555, DOI 10.1128/JB.181.5.1555-1561.1999; OCHMAN H, 1993, METHOD ENZYMOL, V218, P309; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; RAHME LG, 1992, J BACTERIOL, V174, P3499, DOI 10.1128/JB.174.11.3499-3507.1992; SALMERON JM, 1993, MOL GEN GENET, V239, P6, DOI 10.1007/BF00281595; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Stevens C, 1998, MOL MICROBIOL, V29, P165, DOI 10.1046/j.1365-2958.1998.00918.x; van Dijk K, 1999, J BACTERIOL, V181, P4790, DOI 10.1128/JB.181.16.4790-4797.1999; Yokoyama K, 2000, GENE, V258, P127, DOI 10.1016/S0378-1119(00)00416-9	43	299	326	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2002	295	5560					1722	1726		10.1126/science.295.5560.1722	http://dx.doi.org/10.1126/science.295.5560.1722			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872842				2022-12-28	WOS:000174212900049
J	O'Nions, K; Pitman, R; Marsh, C				O'Nions, K; Pitman, R; Marsh, C			Science of nuclear warheads	NATURE			English	Article									Minist Def, London SW1A 2EU, England; Minist Def, London WC2N 5BP, England; AWE, Reading RG7 4PR, Berks, England		O'Nions, K (corresponding author), Minist Def, Room 240,Old War Off Bldg, London SW1A 2EU, England.							ASAY JR, 1976, APPL PHYS LETT, V29, P284, DOI 10.1063/1.89066; Birrell AR, 2000, IEEE T PLASMA SCI, V28, P1660, DOI 10.1109/27.901251; BORING M, 2000, LOS ALAMOS SCI, V26, P90; Crowley BJB, 2001, J QUANT SPECTROSC RA, V71, P257, DOI 10.1016/S0022-4073(01)00073-5; DAVIESOSTERKAMP S, 1989, PSYCHIC NEUROLOGICAL, P163; ELLIOTT LA, 1965, PROC R SOC LON SER-A, V284, P397, DOI 10.1098/rspa.1965.0070; Evans AM, 1996, LASER PART BEAMS, V14, P113, DOI 10.1017/S0263034600009873; FOSTER JM, 1991, PHYS REV LETT, V67, P3255, DOI 10.1103/PhysRevLett.67.3255; FOSTER JM, 2001, B AM PHYS SOC, V46, P248; GARDNER HR, 1961, PLUTONIUM 1960, P513; GIDON S, 1988, APPL OPTICS, V27, P2315, DOI 10.1364/AO.27.002315; Gowing M., 1974, INDEPENDENCE DETERRE, V2; Gowing Margaret, 1974, INDEPENDENCE DETERRE, V1; HANSEN C, 1998, US NUCL WEAPONS SECR; HECKER S.S., 2000, CHALLENGES PLUTONIUM, V26, P290; Jeanloz R, 2000, PHYS TODAY, V53, P44, DOI 10.1063/1.1341914; Kodama R, 2001, NATURE, V412, P798, DOI 10.1038/35090525; Martin J. C., 1996, ADV PULSED POWER TEC, V3; Orme J.T., 1976, PLUTONIUM 1975 OTHER, P761; PERRY TSJ, 1996, J QUANT SPECTROS RAD, V54, P317; SPEIGHT CS, 1989, REV SCI INSTRUM, V60, P3802, DOI 10.1063/1.1140443; *STAT OFF, 1998, STRAT DEF REV CM3999; Wolfer W.G., 2000, LOS ALAMOS SCI, V26, P274; YOUNGS DL, 1984, PHYSICA, V32, P32	24	16	16	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 21	2002	415	6874					853	857		10.1038/415853a	http://dx.doi.org/10.1038/415853a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859352				2022-12-28	WOS:000173941000028
J	St Peter, SD; Imber, CJ; Friend, PJ				St Peter, SD; Imber, CJ; Friend, PJ			Liver and kidney preservation by perfusion	LANCET			English	Review							HEART-BEATING DONORS; CONTINUOUS HYPOTHERMIC PERFUSION; CADAVERIC RENAL-TRANSPLANTATION; ISCHEMICALLY DAMAGED KIDNEYS; ACUTE TUBULAR-NECROSIS; DELAYED GRAFT FUNCTION; SIMPLE COLD-STORAGE; HEPATIC BLOOD-FLOW; MACHINE-PERFUSION; RAT-LIVER	The clinical boundaries of transplantation have been set in an era of simple cold storage. Research In organ preservation has led to the development of flush solutions that buffer the harsh molecular conditions which develop during ischaemia, and provide stored organs that are fit to sustain life after transplantation. Although simple and efficient, this method might be reaching its limit with respect to the duration, preservation, and the quality of organs that can be preserved. In addition, flush preservation does not allow for adequate viability assessment. There is good evidence that preservation times will be extended by the provision of continuous cellular substrate. Stimulation of In-vivo conditions by ex-vivo perfusion could also mean that marginal organs will be salvaged for transplantation. Perfusion will also allow for assessing the viability of organs before transplantation in a continuous fashion. The cumulative effect of these benefits would include expansion of the donor pool, less risk of primary non-function, and extension of the safe preservation period. Use of non-heart-beating donors, international organ sharing, and precise calculation of the risk of primary organ failure could become standard.	Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Oxford OX3 9DU, England	University of Oxford	Friend, PJ (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Oxford OX3 9DU, England.		Friend, Peter/AAH-6512-2019					ABOUNA GM, 1969, BRIT J SURG, V56, P289, DOI 10.1002/bjs.1800560413; ABOUNA GM, 1987, TRANSPLANT P, V19, P2051; Adham M, 1997, TRANSPLANT INT, V10, P299, DOI 10.1111/j.1432-2277.1997.tb00708.x; ALIJANI MR, 1985, TRANSPLANTATION, V40, P659, DOI 10.1097/00007890-198512000-00017; Arias-Diaz J, 1997, TRANSPLANT P, V29, P3486, DOI 10.1016/S0041-1345(97)01117-2; Balupuri S, 2000, CLIN CHEM LAB MED, V38, P1103, DOI 10.1515/CCLM.2000.164; BARBER WH, 1991, TRANSPLANT P, V23, P2394; BARBER WH, 1990, TRANSPLANT P, V22, P446; BARBER WH, 1988, TRANSPLANT P, V20, P865; BARRY JM, 1981, TRANSPLANTATION, V32, P485, DOI 10.1097/00007890-198112000-00006; BARRY JM, 1980, J UROLOGY, V123, P14, DOI 10.1016/S0022-5347(17)55751-1; BELL R, 1993, AUST NZ J SURG, V63, P44, DOI 10.1111/j.1445-2197.1993.tb00033.x; BELZER FO, 1970, J SURG RES, V10, P55, DOI 10.1016/0022-4804(70)90010-7; BELZER FO, 1967, LANCET, V2, P536; BIBO JC, 1995, TRANSPLANT P, V27, P2959; BONVENTRE JV, 1992, ANNU REV MED, V43, P523, DOI 10.1146/annurev.me.43.020192.002515; BOOSTER MH, 1993, TRANSPLANT P, V25, P3012; BOUDJEMA K, 1990, TRANSPLANTATION, V50, P943, DOI 10.1097/00007890-199012000-00008; BRETAN PN, 1989, TRANSPLANT P, V21, P1266; BRETTSCH.L, 1968, SURG GYNECOL OBSTETR, V126, P263; Brettschneider Cgg L., 1968, ORGAN PERFUSION PRES, P271; Burdick JF, 1997, TRANSPLANTATION, V64, P1730, DOI 10.1097/00007890-199712270-00018; CALDWELLKENKEL JC, 1991, HEPATOLOGY, V13, P83, DOI 10.1016/0270-9139(91)90219-L; CARPENTER BJ, 1985, TRANSPLANT P, V17, P1282; CARREL A, 1935, SCIENCE, V14, P621; CASAVILLA A, 1995, TRANSPLANTATION, V59, P197, DOI 10.1097/00007890-199501270-00008; CHO SI, 1981, J SURG RES, V30, P361, DOI 10.1016/0022-4804(81)90172-4; CISNEROS C, 1991, TRANSPLANT P, V23, P1976; CLARK EA, 1973, LANCET, V1, P361; CLAVIEN PA, 1992, TRANSPLANTATION, V53, P957, DOI 10.1097/00007890-199205000-00001; CODD JE, 1979, TRANSPLANTATION, V28, P447, DOI 10.1097/00007890-197912000-00002; COLLINS GM, 1969, LANCET, V2, P1219, DOI 10.1016/S0140-6736(69)90753-3; CYWES R, 1991, HEPATOLOGY, V14, pA57; DAEMEN JHC, 1995, TRANSPLANT P, V27, P2906; Daemen JHC, 1997, TRANSPLANT P, V29, P3489, DOI 10.1016/S0041-1345(97)00991-3; DALESSANDRO AM, 1995, TRANSPLANTATION, V59, P977, DOI 10.1097/00007890-199504150-00009; DEBRUIJN KM, 1984, TRANSPLANT P, V16, P141; DEVLIN J, 1995, TRANSPLANTATION, V60, P627, DOI 10.1097/00007890-199510150-00001; DIVONIN A L, 1991, Anesteziologiya i Reanimatologiya, P36; Dutkowski P, 1998, J SURG RES, V80, P365, DOI 10.1006/jsre.1998.5491; Endoh T, 1996, TRANSPL P, V28, P110; FEINFELD DA, 1978, NEPHRON, V21, P38, DOI 10.1159/000181369; FELKER TE, 1991, HEPATOLOGY, V14, P340, DOI 10.1002/hep.1840140222; FRASER R, 1980, BRIT J EXP PATHOL, V61, P222; Fukae K, 1996, J THORAC CARDIOV SUR, V111, P478, DOI 10.1016/S0022-5223(96)70459-2; FULLER BJ, 1990, TRANSPLANTATION, V50, P511, DOI 10.1097/00007890-199009000-00030; Garcia-Valdecasas JC, 1999, EUR SURG RES, V31, P447, DOI 10.1159/000008724; Gomez M, 1997, TRANSPLANT P, V29, P3478, DOI 10.1016/S0041-1345(97)01116-0; Gonzalez FX, 1997, TRANSPLANT P, V29, P3480, DOI 10.1016/S0041-1345(97)00987-1; GOODMAN MN, 1973, AM J PHYSIOL, V225, P1384, DOI 10.1152/ajplegacy.1973.225.6.1384; GORES GJ, 1986, HEPATOLOGY, V6, P511, DOI 10.1002/hep.1840060331; GOTO T, 1989, TRANSPLANT P, V21, P2305; Haddad P, 1999, CRYOBIOLOGY, V39, P69, DOI 10.1006/cryo.1999.2186; HALLORAN P, 1987, TRANSPLANTATION, V43, P827, DOI 10.1097/00007890-198743060-00011; HEIL JE, 1987, TRANSPLANT P, V19, P2046; Hellinger A, 1997, LANGENBECK ARCH CHIR, V382, P175, DOI 10.1007/s004230050050; HENRY ML, 1990, TRANSPLANT P, V22, P388; HOSHINO T, 1989, TRANSPLANT P, V21, P3519; IKEDA T, 1990, TRANSPLANTATION, V50, P564, DOI 10.1097/00007890-199010000-00006; IU S, 1987, TRANSPLANTATION, V44, P562, DOI 10.1097/00007890-198710000-00021; KAMADA N, 1980, TRANSPLANTATION, V30, P43, DOI 10.1097/00007890-198007000-00009; KAMIIKE W, 1988, TRANSPLANTATION, V45, P138, DOI 10.1097/00007890-198801000-00030; KARAYALCIN K, 1993, TRANSPLANTATION, V56, P1336, DOI 10.1097/00007890-199312000-00009; Katsuramaki I, 1998, TRANSPL P, V30, P3748, DOI 10.1016/S0041-1345(98)01220-2; Kestens P J, 1966, Bull Soc Int Chir, V25, P647; Kievit JK, 1997, TRANSPLANT P, V29, P3591, DOI 10.1016/S0041-1345(97)01036-1; Kim JS, 1997, TRANSPLANT P, V29, P3452, DOI 10.1016/S0041-1345(97)00975-5; Kobayashi J, 1998, TRANSPLANT P, V30, P3761, DOI 10.1016/S0041-1345(98)01224-X; KOHLHAW K, 1992, TRANSPLANT P, V24, P2699; KOHN M, 1971, TRANSPLANTATION, V11, P461, DOI 10.1097/00007890-197105000-00005; Kozaki K, 1997, TRANSPLANT P, V29, P3476, DOI 10.1016/S0041-1345(97)00986-X; Kozaki K, 2000, TRANSPLANT P, V32, P5, DOI 10.1016/S0041-1345(99)00852-0; Kozaki K, 2000, TRANSPL P, V32, P275, DOI 10.1016/S0041-1345(99)00955-0; KOZAKI K, 1995, TRANSPLANT P, V27, P757; KOZAKI M, 1991, TRANSPLANT P, V23, P2575; Land W, 1996, TRANSPLANT REV, V10, P236; Lange R, 1996, TRANSPLANTATION, V62, P1255, DOI 10.1097/00007890-199611150-00013; LANIR A, 1987, TRANSPLANTATION, V43, P786, DOI 10.1097/00007890-198743060-00002; LIEBAU G, 1971, SURGERY, V70, P459; LOCKETT CJ, 1995, TRANSPLANT INT, V8, P440, DOI 10.1007/BF00335595; LOTKE PA, 1970, SURGERY, V67, P488; MANDELBAUM I, 1965, ARCH SURG-CHICAGO, V91, P771; MANIS T, 1985, TRANSPLANT P, V17, P1483; MARCHIORO TL, 1963, SURGERY, V54, P900; MATSUNO N, 1994, TRANSPLANT P, V26, P2421; MATSUNO N, 1994, TRANSPLANTATION, V57, P293; Matsuno N, 1996, TRANSPLANT P, V28, P1551; Matsuno N, 1999, TRANSPLANT P, V31, P2004, DOI 10.1016/S0041-1345(99)00245-6; MATSUNO N, 1993, TRANSPLANT P, V25, P3095; Matsuno N, 2000, TRANSPLANT P, V32, P173, DOI 10.1016/S0041-1345(99)00919-7; MCANULTY JF, 1991, TRANSPLANT P, V23, P691; MCANULTY JF, 1989, TRANSPLANTATION, V47, P37, DOI 10.1097/00007890-198901000-00009; MCKEOWN CMB, 1988, TRANSPLANTATION, V46, P178, DOI 10.1097/00007890-198808000-00001; Melendez HV, 2000, TRANSPLANTATION, V70, P560, DOI 10.1097/00007890-200008270-00002; MENDEZ R, 1987, TRANSPLANT P, V19, P2047; MERION RM, 1990, TRANSPLANTATION, V50, P230, DOI 10.1097/00007890-199008000-00011; Minor T, 1998, TRANSPLANTATION, V65, P1262, DOI 10.1097/00007890-199805150-00019; MORA NP, 1987, TRANSPLANT P, V19, P3840; MORIMOTO T, 1991, TRANSPLANTATION, V52, P424, DOI 10.1097/00007890-199109000-00006; Motoyama S, 1998, GASTROENTEROLOGY, V114, P153, DOI 10.1016/S0016-5085(98)70643-2; Motoyama S, 2000, LIVER, V20, P200, DOI 10.1034/j.1600-0676.2000.020003200.x; MOZES MF, 1985, TRANSPLANT P, V17, P1474; NAJARIAN JS, 1994, TRANSPLANTATION, V57, P812, DOI 10.1097/00007890-199403270-00007; OPELZ G, 1982, TRANSPLANTATION, V33, P64, DOI 10.1097/00007890-198201000-00013; PEGG DE, 1984, TRANSPLANTATION, V38, P78; PETIE CR, 1973, ARCH SURG-CHICAGO, V107, P461; PIENAAR BH, 1990, TRANSPLANTATION, V49, P258, DOI 10.1097/00007890-199002000-00005; Polyak MMR, 2000, TRANSPLANTATION, V69, P249, DOI 10.1097/00007890-200001270-00010; PRIES JM, 1981, J LAB CLIN MED, V97, P412; Richter S, 2000, TRANSPLANTATION, V69, P20, DOI 10.1097/00007890-200001150-00005; RIEDEL GL, 1983, AM J PHYSIOL, V245, pG769, DOI 10.1152/ajpgi.1983.245.6.G769; ROSENTHAL JT, 1991, TRANSPLANTATION, V51, P1115; ROSENTHAL JT, 1984, TRANSPLANTATION, V37, P425; SANFILIPPO F, 1984, TRANSPLANTATION, V38, P643, DOI 10.1097/00007890-198412000-00019; SCHILLING M, 1993, TRANSPLANT P, V25, P2534; SCHON MR, 1993, TRANSPLANTATION, V56, P24; Schon MR, 2001, ANN SURG, V233, P114, DOI 10.1097/00000658-200101000-00017; Schroeder RA, 1999, ISCHAEMIA-REPERFUSION INJURY, P113; SHIRAKURA R, 1992, TRANSPLANT P, V24, P1329; SICULAR ARTHUR, 1961, JOUR SURG RES, V1, P16, DOI 10.1016/S0022-4804(61)80017-6; SIDO B, 1995, TRANSPLANTATION, V60, P462, DOI 10.1097/00007890-199509000-00010; Slapak M, 1967, TRANSPLANTATION, V5, P1154, DOI [10.1097/00007890-196707001-00052, DOI 10.1097/00007890-196707001-00052]; Smrekova R, 2000, TRANSPLANTATION, V70, P430, DOI 10.1097/00007890-200008150-00007; SPEES EK, 1984, TRANSPLANT P, V16, P177; STARNES HF, 1991, GASTROENTEROLOGY, V101, P1345, DOI 10.1016/0016-5085(91)90087-2; SUMIMOTO K, 1988, TRANSPLANTATION, V46, P506, DOI 10.1097/00007890-198810000-00007; SUNDBERG AGM, 1993, PHARMACOL TOXICOL, V72, P321, DOI 10.1111/j.1600-0773.1993.tb01658.x; SUNG DTW, 1973, AM J SURG, V126, P441, DOI 10.1016/S0002-9610(73)80142-4; Tabet J, 1997, TRANSPLANT P, V29, P3482, DOI 10.1016/S0041-1345(97)00988-3; Takada Y, 1997, TRANSPLANTATION, V63, P369, DOI 10.1097/00007890-199702150-00007; Tate H C, 1982, Transplantation, V34, P233; Taylor PE, 1996, TRANSPLANT P, V28, P201; Tisone G, 1996, TRANSPLANT P, V28, P1655; TOLEDOPEREYRA LH, 1982, TRANSPLANTATION, V34, P110, DOI 10.1097/00007890-198208000-00013; Tsukamoto S, 1996, TRANSPLANT P, V28, P197; TURNER MD, 1970, CRYOBIOLOGY, V6, P293, DOI 10.1016/S0011-2240(70)80083-9; Vajdova K, 2000, HEPATOLOGY, V32, P289, DOI 10.1053/jhep.2000.8895; Valero R, 1998, TRANSPLANTATION, V66, P170, DOI 10.1097/00007890-199807270-00005; VANDERVLIET JA, 1984, TRANSPLANT P, V16, P180; VAUGHN WK, 1981, TRANSPLANTATION, V32, P490, DOI 10.1097/00007890-198112000-00008	140	150	177	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 16	2002	359	9306					604	613		10.1016/S0140-6736(02)07749-8	http://dx.doi.org/10.1016/S0140-6736(02)07749-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523FP	11867131				2022-12-28	WOS:000173943600029
J	Braich, RS; Chelyapov, N; Johnson, C; Rothemund, PWK; Adleman, L				Braich, RS; Chelyapov, N; Johnson, C; Rothemund, PWK; Adleman, L			Solution of a 20-variable 3-SAT problem on a DNA computer	SCIENCE			English	Article							MOLECULAR COMPUTATION; MACHINE	A 20-variable instance of the NP-complete three-satisfiability (3-SAT) problem was solved on a simple DNA computer. The unique answer was found after an exhaustive search of more than 1 million (2(20)) possibilities. This computational problem may be the largest yet solved by nonelectronic means. Problems of this size appear to be beyond the normal range of unaided human computation.	Univ So Calif, Lab Mol Sci, Los Angeles, CA 90089 USA; CALTECH, Pasadena, CA 91125 USA	University of Southern California; California Institute of Technology	Adleman, L (corresponding author), Univ So Calif, Lab Mol Sci, Los Angeles, CA 90089 USA.	Adleman@USC.edu						ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; BAUM EB, 1995, SCIENCE, V268, P583, DOI 10.1126/science.7725109; Benenson Y, 2001, NATURE, V414, P430, DOI 10.1038/35106533; Braich R.S., 2001, LECT NOTES COMPUTER, V2054, P27; BRAICH RS, UNPUB; CORMEN TH, 1990, INTRO ALGORITHMS, P916; Faulhammer D, 2000, P NATL ACAD SCI USA, V97, P1385, DOI 10.1073/pnas.97.4.1385; Guarnieri F, 1996, SCIENCE, V273, P220, DOI 10.1126/science.273.5272.220; HEAD T, 1987, B MATH BIOL, V49, P737, DOI 10.1016/S0092-8240(87)90018-8; Kenney M, 1998, BIOTECHNIQUES, V25, P516, DOI 10.2144/98253pf01; Landweber LF, 1999, BIOSYSTEMS, V52, P3, DOI 10.1016/S0303-2647(99)00027-1; LIPTON RJ, 1995, SCIENCE, V268, P542, DOI 10.1126/science.7725098; Liu QH, 2000, NATURE, V403, P175, DOI 10.1038/35003155; Mao CD, 2000, NATURE, V407, P493, DOI 10.1038/35035038; MORIMOTO N, 1999, DIMACS SERIES DISCRE, V48, P193; ROTHEMUND PWK, 1996, DIMACS SERIES DISCRE, V27, P75; Roweis S, 1998, J COMPUT BIOL, V5, P615, DOI 10.1089/cmb.1998.5.615; Sakamoto K, 2000, SCIENCE, V288, P1223, DOI 10.1126/science.288.5469.1223; SMITH WD, 1996, DIMACS SERIES DISCRE, V27, P121; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; [No title captured]; [No title captured]	24	363	438	4	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2002	296	5567					499	502		10.1126/science.1069528	http://dx.doi.org/10.1126/science.1069528			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544UE	11896237				2022-12-28	WOS:000175179400037
J	Cohen, AL; Owens, KE; Layne, GD; Shimizu, N				Cohen, AL; Owens, KE; Layne, GD; Shimizu, N			The effect of algal symbionts on the accuracy of Sr/Ca paleotemperatures from coral	SCIENCE			English	Article							SEA-SURFACE TEMPERATURE; ASTRANGIA-DANAE; EXPERIMENTAL ECOLOGY; PORITES CORALS; STRONTIUM; RATIOS; RECONSTRUCTIONS; CALCIFICATION; CALIBRATION; THERMOMETRY	The strontium-to-calcium ratio (Sr/Ca) of reef coral skeleton is commonly used as a paleothermometer to estimate sea surface temperatures (SSTs) at crucial times in Earth's climate history. However, these estimates are disputed, because uptake of Sr into coral skeleton is thought to be affected by algal symbionts (zooxanthellae) living in the host tissue. Here, we show that significant distortion of the Sr/Ca temperature record in coral skeleton occurs in the presence of algal symbionts. Seasonally resolved Sr/Ca in coral without symbionts reflects local SSTs with a temperature sensitivity equivalent to that of laboratory aragonite precipitated at equilibrium and the nighttime skeletal deposits of symbiotic reef corals. However, up to 65% of the Sr/Ca variability in symbiotic skeleton is related to symbiont activity and does not reflect water temperature.	Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Cohen, AL (corresponding author), Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA.		Facility, NENIMF/B-8811-2015					Alibert C, 1997, PALEOCEANOGRAPHY, V12, P345, DOI 10.1029/97PA00318; BARD E, 2001, GEOCHEM GEOPHYS GEOS, V2; BECK JW, 1992, SCIENCE, V257, P644, DOI 10.1126/science.257.5070.644; Charles CD, 2001, CLIM DYNAM, V17, P489, DOI 10.1007/s003820000126; Cohen AL, 2001, PALEOCEANOGRAPHY, V16, P20, DOI 10.1029/1999PA000478; CROWLEY TJ, 1994, NATURE, V371, P664, DOI 10.1038/371664a0; Crowley TJ, 1999, PALEOCEANOGRAPHY, V14, P605, DOI 10.1029/1999PA900032; Crowley TJ, 2000, CLIM DYNAM, V16, P241, DOI 10.1007/s003820050325; DEVILLIERS S, 1994, GEOCHIM COSMOCHIM AC, V58, P197, DOI 10.1016/0016-7037(94)90457-X; DEVILLIERS S, 1995, SCIENCE, V269, P1247, DOI 10.1126/science.269.5228.1247; GUILDERSON TP, 1994, SCIENCE, V263, P663, DOI 10.1126/science.263.5147.663; HOEGHGUILDBERG O, 2001, COMMUNICATION    NOV; HOFFERT MI, 1992, NATURE, V360, P573, DOI 10.1038/360573a0; Hughen KA, 1999, GEOPHYS RES LETT, V26, P3129, DOI 10.1029/1999GL006062; IP YK, 1991, J EXP ZOOL, V258, P273, DOI 10.1002/jez.1402580219; JACQUES TG, 1980, MAR BIOL, V60, P167, DOI 10.1007/BF00389160; JACQUES TG, 1983, MAR BIOL, V76, P135, DOI 10.1007/BF00392730; KINSMAN DJJ, 1969, GEOCHIM COSMOCHIM AC, V33, P1, DOI 10.1016/0016-7037(69)90089-1; McCulloch MT, 2000, CHEM GEOL, V169, P107, DOI 10.1016/S0009-2541(00)00260-6; Mitsuguchi T, 1996, SCIENCE, V274, P961, DOI 10.1126/science.274.5289.961; PETERS EC, 1985, J EXP MAR BIOL ECOL, V92, P215, DOI 10.1016/0022-0981(85)90096-6; PETERS EC, 1988, P BIOL SOC WASH, V101, P234; Schrag DP, 1999, PALEOCEANOGRAPHY, V14, P97, DOI 10.1029/1998PA900025; Shen CC, 1996, GEOCHIM COSMOCHIM AC, V60, P3849, DOI 10.1016/0016-7037(96)00205-0; Sinclair DJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1889, DOI 10.1016/S0016-7037(98)00112-4; SMITH SV, 1979, SCIENCE, V204, P404, DOI 10.1126/science.204.4391.404; SZMANTFROELICH A, 1980, BIOL BULL, V158, P257, DOI 10.2307/1540935; THOMPSON G, 1970, EARTH PLANET SC LETT, V8, P439, DOI 10.1016/0012-821X(70)90148-2; WEBER JN, 1973, GEOCHIM COSMOCHIM AC, V37, P2173, DOI 10.1016/0016-7037(73)90015-X; WOOD EM, 1983, CORALS WORLD	30	118	131	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 12	2002	296	5566					331	333		10.1126/science.1069330	http://dx.doi.org/10.1126/science.1069330			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541TJ	11884719				2022-12-28	WOS:000175000300053
J	Pasko, VP; Stanley, MA; Mathews, JD; Inan, US; Wood, TG				Pasko, VP; Stanley, MA; Mathews, JD; Inan, US; Wood, TG			Electrical discharge from a thundercloud top to the lower ionosphere	NATURE			English	Article							SPRITES94 AIRCRAFT CAMPAIGN; LIGHTNING DISCHARGES; PHYSICAL-MECHANISMS; BLUE STARTERS	For over a century, numerous undocumented reports have appeared about unusual large-scale luminous phenomena above thunderclouds(1-6) and, more than 80 years ago, it was suggested that an electrical discharge could bridge the gap between a thundercloud and the upper atmosphere(7,8). Since then, two classes of vertically extensive optical flashes above thunderclouds have been identified-sprites(9-11) and blue jets(12-14). Sprites initiate near the base of the ionosphere, develop very rapidly downwards at speeds which can exceed 10(7) m s(-1) (ref. 15), and assume many different geometrical forms(16-19). In contrast, blue jets develop upwards from cloud tops at speeds of the order of 10(5) m s(-1) and are characterized by a blue conical shape(12-14). But no experimental data related to sprites or blue jets have been reported which conclusively indicate that they establish a direct path of electrical contact between a thundercloud and the lower ionosphere. Here we report a video recording of a blue jet propagating upwards from a thundercloud to an altitude of about 70 km, taken at the Arecibo Observatory, Puerto Rico. Above an altitude of 42 km- normally the upper limit for blue jets and the lower terminal altitude for sprites-the flash exhibited some features normally observed in sprites. As we observed this phenomenon above a relatively small thunderstorm cell, we speculate that it may be common and therefore represent an unaccounted for component of the global electric circuit.	Penn State Univ, CSSL Lab, University Pk, PA 16802 USA; New Mexico Inst Min & Technol, Langmuir Lab, Socorro, NM 87801 USA; Stanford Univ, STAR Lab, Stanford, CA 94305 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; New Mexico Institute of Mining Technology; Stanford University	Pasko, VP (corresponding author), Penn State Univ, CSSL Lab, University Pk, PA 16802 USA.	vpasko@psu.edu; stanleym@lanl.gov	Wood, Thomas/GWZ-2481-2022; Pasko, Victor P/S-6024-2016; Inan, Umran/V-3634-2019	Wood, Thomas/0000-0001-8962-8571; Inan, Umran/0000-0001-5837-5807				CROSKEY CL, 1990, ADV SPACE RES-SERIES, V10, P49, DOI 10.1016/0273-1177(90)90008-N; FRANZ RC, 1990, SCIENCE, V249, P48, DOI 10.1126/science.249.4964.48; Gerken EA, 2000, GEOPHYS RES LETT, V27, P2637, DOI 10.1029/2000GL000035; HALE LC, 1981, GEOPHYS RES LETT, V8, P927, DOI 10.1029/GL008i008p00927; HAMMERSTROM JG, 1993, AVIAT WEEK SPAC 0830; HEAVNER MJ, 2000, THESIS U ALASKA; Lyons WA, 1996, J GEOPHYS RES-ATMOS, V101, P29641, DOI 10.1029/96JD01866; LYONS WA, 2000, EOS T AM GEOPHYS UN, V81, pF131; MOUDRY DR, 2001, NAT RAD SCI M URSI G, P107; PASKO VP, 1999, EOS T AGU S, V80, pF218; PASKO VP, 2001, EOS, V82, pF150; Petrov NI, 1999, TECH PHYS+, V44, P472, DOI 10.1134/1.1259327; ROBLE RG, 1991, J ATMOS TERR PHYS, V53, P831, DOI 10.1016/0021-9169(91)90097-Q; Rodger CJ, 1999, REV GEOPHYS, V37, P317, DOI 10.1029/1999RG900006; Rycroft MJ, 2000, J ATMOS SOL-TERR PHY, V62, P1563, DOI 10.1016/S1364-6826(00)00112-7; SENTMAN DD, 1995, GEOPHYS RES LETT, V22, P1205, DOI 10.1029/95GL00583; Stanley M, 1999, GEOPHYS RES LETT, V26, P3201, DOI 10.1029/1999GL010673; Stenbaek-Nielsel HC, 2000, GEOPHYS RES LETT, V27, P3829, DOI 10.1029/2000GL003827; Sukhorukov AI, 1996, GEOPHYS RES LETT, V23, P1625, DOI 10.1029/96GL01367; UMAN MA, 1987, LIGHTNING DISCHARGE; VAUGHAN OH, 1989, J GEOPHYS RES-ATMOS, V94, P13179, DOI 10.1029/JD094iD11p13179; VAUGHAN OH, 1982, WEATHERWISE      APR, P70; Wescott EM, 1996, GEOPHYS RES LETT, V23, P2153, DOI 10.1029/96GL01969; WESCOTT EM, 1995, GEOPHYS RES LETT, V22, P1209, DOI 10.1029/95GL00582; Wescott EM, 2001, J GEOPHYS RES-SPACE, V106, P21549, DOI 10.1029/2000JA000429; Wescott EM, 1998, J ATMOS SOL-TERR PHY, V60, P713, DOI 10.1016/S1364-6826(98)00018-2; WILSON CTR, 1956, PROC R SOC LON SER-A, V236, P297, DOI 10.1098/rspa.1956.0137; Wilson CTR, 1925, P PHYS SOC LOND, V37, p32D; WOOD CA, 1951, WEATHER, V6, P64; WRIGHT JB, 1951, WEATHER, V6, P230	30	212	220	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2002	416	6877					152	154		10.1038/416152a	http://dx.doi.org/10.1038/416152a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894087				2022-12-28	WOS:000174348100030
J	Eysenbach, G; Kohler, C				Eysenbach, G; Kohler, C			How do consumers search for and appraise health information on the world wide web? Qualitative study using focus groups, usability tests, and in-depth interviews	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objectives To describe techniques for retrieval and appraisal used by consumers when they search for health information on the internet. Design Qualitative study using focus groups, naturalistic observation of consumers searching the world wide web in a usability laboratory, and in-depth interviews. Participants A total of 21 users of the internet participated in three focus group sessions. 17 participants were given a series of health questions and observed in a usability laboratory setting while retrieving health information from the web; this was followed by in-depth interviews. Setting Heidelberg, Germany. Results Although their search technique was often suboptimal, internet users successfully found health information to answer questions in an average of 5 minutes 42 seconds (median 4 minutes 18 seconds) per question. Participants in focus groups said that when assessing the credibility of a website they primarily looked for the source, a professional design, a scientific or official touch, language, and ease of use. However, in the observational study, no participants checked any "about us" sections of websites, disclaimers, or disclosure statements. In the post-search interviews, it emerged that very few participants had noticed and remembered which websites they had retrieved information from. Conclusions Further observational studies are needed to design and evaluate educational and technological innovations for guiding consumers to high quality health information on the web.	Heidelberg Univ, Dept Clin Social Med, Unit Cybermed & eHlth, D-69115 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Eysenbach, G (corresponding author), Heidelberg Univ, Dept Clin Social Med, Unit Cybermed & eHlth, Bergheimer Str 58, D-69115 Heidelberg, Germany.	ey@yi.com	Norfadzila, Syarifah/G-9607-2012; Eysenbach, Gunther/AAJ-7158-2020	Eysenbach, Gunther/0000-0001-6479-5330				Boyer C, 1998, COMPUT BIOL MED, V28, P603, DOI 10.1016/S0010-4825(98)00037-7; Eysenbach G, 2000, BMJ-BRIT MED J, V320, P1713, DOI 10.1136/bmj.320.7251.1713; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Nielsen J., 1993, USABILITY ENG; Pennbridge J, 1999, WESTERN J MED, V171, P302; *PEW INT AM LIF, 2000, ONL HLTH CAR REV WEB; Quintana Y, 2001, CAN FAM PHYSICIAN, V47, P1759; Rippen H, 2000, J MED INTERNET RES, V2, DOI 10.2196/jmir.2.2.e9; Strauss A., 1990, BASICS QUALITATIVE R	9	1133	1149	11	304	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2002	324	7337					573	577		10.1136/bmj.324.7337.573	http://dx.doi.org/10.1136/bmj.324.7337.573			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	530XJ	11884321	Bronze, Green Published			2022-12-28	WOS:000174384000020
J	Jormakka, M; Tornroth, S; Byrne, B; Iwata, S				Jormakka, M; Tornroth, S; Byrne, B; Iwata, S			Molecular basis of proton motive force generation: Structure of formate dehydrogenase-N	SCIENCE			English	Article							ESCHERICHIA-COLI; WOLINELLA-SUCCINOGENES; MOLYBDENUM-COFACTOR; NITRATE REDUCTASE; CRYSTAL-STRUCTURE; MOLYBDOPTERIN; OXIDATION; SELENOCYSTEINE; HYDROGENASE; MECHANISM	The structure of the membrane protein formate dehydrogenase-N (Fdn-N), a major component of Escherichia coli nitrate respiration, has been determined at 1.6 angstroms. The structure demonstrates 11 redox centers, including molybdopterin-guanine dinucleotides, five [4Fe-4S] clusters, two heme b groups, and a menaquinone analog. These redox centers are aligned in a single chain, which extends almost 90 angstroms through the enzyme. The menaquinone reduction site associated with a possible proton pathway was also characterized. This structure provides critical insights into the proton motive force generation by redox loop, a common mechanism among a wide range of respiratory enzymes.	Univ London Imperial Coll Sci Technol & Med, Div Biomed Sci, London SW7 2AZ, England; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England; Univ Uppsala, BMC, Dept Biochem, S-75123 Uppsala, Sweden	Imperial College London; Imperial College London; Uppsala University	Iwata, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Biomed Sci, London SW7 2AZ, England.		Törnroth-Horsefield, Susanna/B-2702-2010	Tornroth-Horsefield, Susanna/0000-0002-9435-8243; Byrne, Bernadette/0000-0001-9598-9832				Benoit S, 1998, J BACTERIOL, V180, P6625, DOI 10.1128/JB.180.24.6625-6634.1998; BERG BL, 1991, J BIOL CHEM, V266, P22380; BERKS BC, 1995, MOL MICROBIOL, V15, P319, DOI 10.1111/j.1365-2958.1995.tb02246.x; Berks BC, 1995, BBA-BIOENERGETICS, V1232, P97, DOI 10.1016/0005-2728(95)00092-5; BIEL S, IN PRESS EUR J BIOCH; Blasco F, 2001, CELL MOL LIFE SCI, V58, P179, DOI 10.1007/PL00000846; Boyington JC, 1997, SCIENCE, V275, P1305, DOI 10.1126/science.275.5304.1305; Dias JM, 1999, STRUCTURE, V7, P65, DOI 10.1016/S0969-2126(99)80010-0; Esnouf R. M., 1997, J MOL GRAPHICS, V15, P133; Gross R, 1998, MOL MICROBIOL, V30, P639, DOI 10.1046/j.1365-2958.1998.01100.x; GUIGLIARELLI B, 1992, EUR J BIOCHEM, V207, P61, DOI 10.1111/j.1432-1033.1992.tb17020.x; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; JONES RW, 1980, FEMS MICROBIOL LETT, V8, P167, DOI 10.1111/j.1574-6968.1980.tb05072.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Khangulov SV, 1998, BIOCHEMISTRY-US, V37, P3518, DOI 10.1021/bi972177k; Kisker C, 1997, ANNU REV BIOCHEM, V66, P233, DOI 10.1146/annurev.biochem.66.1.233; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KROGER A, 1979, EUR J BIOCHEM, V94, P465, DOI 10.1111/j.1432-1033.1979.tb12914.x; Lancaster CRD, 1999, NATURE, V402, P377, DOI 10.1038/46483; Meek L, 2000, J BACTERIOL, V182, P3429, DOI 10.1128/JB.182.12.3429-3436.2000; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Richardson DJ, 2000, MICROBIOL-SGM, V146, P551, DOI 10.1099/00221287-146-3-551; Rothery RA, 1998, J BIOL CHEM, V273, P7462, DOI 10.1074/jbc.273.13.7462; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Schindelin H, 1996, SCIENCE, V272, P1615, DOI 10.1126/science.272.5268.1615; SIEKER LC, 1972, NATURE, V235, P40, DOI 10.1038/235040a0	28	373	384	2	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1863	1868		10.1126/science.1068186	http://dx.doi.org/10.1126/science.1068186			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884747				2022-12-28	WOS:000174299500030
J	Brasier, MD; Green, OR; Jephcoat, AP; Kleppe, AK; Van Kranendonk, MJ; Lindsay, JF; Steele, A; Grassineau, NV				Brasier, MD; Green, OR; Jephcoat, AP; Kleppe, AK; Van Kranendonk, MJ; Lindsay, JF; Steele, A; Grassineau, NV			Questioning the evidence for Earth's oldest fossils	NATURE			English	Article							NORTH-POLE; CHERT; MICROFOSSILS; GRAPHITE; CARBON; OXYGEN	Structures resembling remarkably preserved bacterial and cyanobacterial microfossils from similar to3,465-million-year-old Apex cherts of the Warrawoona Group in Western Australia(1-4) currently provide the oldest morphological evidence for life on Earth and have been taken to support an early beginning for oxygen-producing photosynthesis(5). Eleven species of filamentous prokaryote, distinguished by shape and geometry, have been put forward as meeting the criteria required of authentic Archaean microfossils(1-5), and contrast with other microfossils dismissed as either unreliable or unreproducible(1,3,6,7). These structures are nearly a billion years older than putative cyanobacterial biomarkers(8), genomic arguments for cyanobacteria(9), an oxygenic atmosphere(10) and any comparably diverse suite of microfossils(5). Here we report new research on the type and re-collected material, involving mapping, optical and electron microscopy, digital image analysis, micro-Raman spectroscopy and other geochemical techniques. We reinterpret the purported microfossil-like structure as secondary artefacts formed from amorphous graphite within multiple generations of metalliferous hydrothermal vein chert and volcanic glass. Although there is no support for primary biological morphology, a Fischer-Tropsch-type synthesis of carbon compounds and carbon isotopic fractionation is inferred for one of the oldest known hydrothermal systems on Earth.	Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; Geol Survey Western Australia, Perth, WA 6004, Australia; Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; Univ Portsmouth, Sch Earth Environm & Phys Sci, Portsmouth PO1 3QL, Hants, England; Royal Holloway Univ London, Dept Geol, Egham TW20 0EX, Surrey, England	University of Oxford; Geological Survey of Western Australia; Australian National University; University of Portsmouth; University of London; Royal Holloway University London	Brasier, MD (corresponding author), Univ Oxford, Dept Earth Sci, Parks Rd, Oxford OX1 3PR, England.	martinb@earth.ox.ac.uk	Steele, Andrew/A-3573-2013	Steele, Andrew/0000-0001-9643-2841; Van Kranendonk, Martin/0000-0002-0611-2703; Grassineau, Nathalie/0000-0001-7958-7104				[Anonymous], 1992, PROTEROZOIC BIOSPHER; [Anonymous], CRADLE LIFE; AWRAMIK SM, 1979, CAN J EARTH SCI, V16, P484, DOI 10.1139/e79-044; BAKER RTK, 1978, CHEM PHYS CARBON, P2; BUICK R, 1981, ALCHERINGA, V5, P161, DOI 10.1080/03115518108566999; BUICK R, 1990, Palaios, V5, P441, DOI 10.2307/3514837; Catling DC, 2001, SCIENCE, V293, P839, DOI 10.1126/science.1061976; CLAYTON RN, 1963, GEOCHIM COSMOCHIM AC, V27, P43, DOI 10.1016/0016-7037(63)90071-1; deRonde CEJ, 1996, GEOLOGY, V24, P791, DOI 10.1130/0091-7613(1996)024<0791:BYOOCF>2.3.CO;2; Grotzinger JP, 1996, NATURE, V383, P423, DOI 10.1038/383423a0; Hedges SB, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-4; Holm NG, 2001, EARTH PLANET SC LETT, V191, P1, DOI 10.1016/S0012-821X(01)00397-1; KAGI H, 1994, GEOCHIM COSMOCHIM AC, V58, P3527, DOI 10.1016/0016-7037(94)90104-X; Kudryavtsev AB, 2001, P NATL ACAD SCI USA, V98, P823, DOI 10.1073/pnas.98.3.823; LANCET MS, 1970, SCIENCE, V170, P980, DOI 10.1126/science.170.3961.980; MATTHEWS DE, 1978, ANAL CHEM, V50, P1465, DOI 10.1021/ac50033a022; Mendelson C.V., 1992, P867; Nijman W, 1998, PRECAMBRIAN RES, V88, P25, DOI 10.1016/S0301-9268(97)00062-4; OEHLER JH, 1976, GEOL SOC AM BULL, V87, P1143, DOI 10.1130/0016-7606(1976)87<1143:HCOSG>2.0.CO;2; ROBERT F, 1988, GEOCHIM COSMOCHIM AC, V52, P1473, DOI 10.1016/0016-7037(88)90218-9; Schopf J. W., 1992, PROTEROZOIC BIOSPHER, P25; SCHOPF JW, 1987, SCIENCE, V237, P70, DOI 10.1126/science.11539686; SCHOPF JW, 1993, SCIENCE, V260, P640, DOI 10.1126/science.260.5108.640; Schopf JW, 1994, EARLY LIFE EARTH, P193; Shen YA, 2001, NATURE, V410, P77, DOI 10.1038/35065071; Summons RE, 1999, NATURE, V400, P554, DOI 10.1038/23005; TUINSTRA F, 1970, J CHEM PHYS, V53, P1126, DOI 10.1063/1.1674108; VANKRANENDONK MJ, IN PRESS PRECAMBRIAN; Westall F, 2001, PRECAMBRIAN RES, V106, P93, DOI 10.1016/S0301-9268(00)00127-3; WOPENKA B, 1993, AM MINERAL, V78, P533	30	593	632	0	179	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 7	2002	416	6876					76	81		10.1038/416076a	http://dx.doi.org/10.1038/416076a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882895				2022-12-28	WOS:000174211600041
J	Lewith, GT; Watkins, AD; Hyland, ME; Shaw, S; Broomfield, JA; Dolan, G; Holgate, ST				Lewith, GT; Watkins, AD; Hyland, ME; Shaw, S; Broomfield, JA; Dolan, G; Holgate, ST			Use of ultramolecular potencies of allergen to treat asthmatic people allergic to house dust mite: double blind randomised controlled clinical trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NEGATIVE AFFECT; PLACEBO; HOMEOPATHY; VALIDATION	Objective To evaluate the efficacy of homoeopathic immunotherapy on lung function and respiratory symptoms in asthmatic people allergic to house dust mite. Design Double blind randomised controlled trial. Setting 38 general practices in Hampshire and Dorset Participants 242 people with asthma and positive results to skin prick test for house dust mite; 202 completed clinic based assessments, and 186 completed diary based assessments. Intervention After a four week baseline assessment participants were randomised to receive oral homoeopathic immunotherapy or placebo and dien assessed over 16 weeks with three clinic visits mid diary assessments every other week. Outcome measure Clinic based assessments: forced expiratory volume in one second (FEN,), quality of life, mid mood. Diary based assessments: morning mid evening peak expiratory flow, visual analogue scale of severity of asthma, quality of life, and daily mood. Results There was no difference in most outcomes between placebo and homoeopathic immunotherapy. There was a different pattern of change over the trial for three of the diary assessments: morning peak expiratory flow (P=0.025), visual analogue scale (P=0.017), and mood (P=0.035). At week three there was significant deterioration for visual analogue scale (P=0.047) mid mood (P=0.013) in the homoeopathic immunotherapy group compared with the placebo group. Any improvement in participants' asthma was independent of belief in complementary medicine. Conclusion Homoeopathic immunotherapy is not effective in the treatment of patients with asthma. The cliff rent patterns of change between homoeopathic immunotherapy and placebo over the course of the stud), are unexplained.	Southampton Gen Hosp, Southampton SO16 6YD, Hants, England; Univ Plymouth, Dept Psychol, Plymouth PL4 8AA, Devon, England; Univ Plymouth, Sch Math & Stat, Plymouth PL4 8AA, Devon, England	University of Southampton; University of Plymouth; University of Plymouth	Lewith, GT (corresponding author), Southampton Gen Hosp, Southampton SO16 6YD, Hants, England.	GL3@soton.ac.uk		Hyland, Michael/0000-0003-3879-0469; Lewith, George/0000-0002-2364-3960				Aabel S, 2000, Br Homeopath J, V89, P169, DOI 10.1054/homp.1999.0440; British Medical Association, 1993, COMPL MED NEW APPR G; DUTARTRE D, 1990, ACT HOMEOPATHIQUE, V1, P21; Eizayaga FX, 1996, BR HOMEOPATH J, V85, P28; Ernst E, 1998, PEDIATR ASTHMA ALLER, V12, P29, DOI 10.1089/pai.1998.12.29; Finnigan M, 1991, COMPLEMENT MED RES, V5, P83; FINNIGAN MD, 1991, COMPLEMENT MED RES, V5, P79; FISHER P, 1994, BRIT MED J, V309, P107, DOI 10.1136/bmj.309.6947.107; HAHNEMANN S, 1980, ORGANON MED, P156; HIGGINS BG, 1992, AM REV RESPIR DIS, V145, P588, DOI 10.1164/ajrccm/145.3.588; *HOUS LORDS SEL CO, 2000, 6 HOUS LORDS SEL COM; HYLAND ME, 1995, BRIT J CLIN PSYCHOL, V34, P601, DOI 10.1111/j.2044-8260.1995.tb01494.x; HYLAND ME, 1995, THORAX, V50, P724, DOI 10.1136/thx.50.7.724; LETTS M, 1998, JURYS OUT NATL ASTHM; Linde K, 1997, LANCET, V350, P834, DOI 10.1016/S0140-6736(97)02293-9; *NAT ASS HLTH AUTH, 1993, COMPL THER NHS; *NHLBI WHO, 1996, NAT HEART LUNG BLOOD; Nolleveaux, 1992, HOMEOPATHIE FRANCAIS, V80, P24; *OFF TECHN ASS, 1990, OTAH405; Office of Technology Assessment, 1990, UNC CANC TREATM; PIOCOCK SJ, 1983, CLIN TRIALS PRACTICA; QUANJER PH, 1983, B EUR PHYSIOPATH RES, V19, P1; REILLY D, 1994, LANCET, V344, P1601, DOI 10.1016/S0140-6736(94)90407-3; REILLY DT, 1986, LANCET, V2, P881; Taylor MA, 2000, BMJ-BRIT MED J, V321, P471, DOI 10.1136/bmj.321.7259.471; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1020, DOI 10.1037/0022-3514.54.6.1020; WATSON D, 1985, PSYCHOL BULL, V98, P219, DOI 10.1037/0033-2909.98.2.219; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WATT J, 1988, TALKING HLTH CONVENN; *WORK PART EUR COM, 1983, B EUR PHYSIOPATHO S5, V19, P1; 2001, BMJ, V322, P169	31	67	68	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2002	324	7336					520	523		10.1136/bmj.324.7336.520	http://dx.doi.org/10.1136/bmj.324.7336.520			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	528DT	11872551	Green Published, Bronze			2022-12-28	WOS:000174229700021
J	Mallal, S; Nolan, D; Witt, C; Masel, G; Martin, AM; Moore, C; Sayer, D; Castley, A; Mamotte, C; Maxwell, D; James, I; Christiansen, FT				Mallal, S; Nolan, D; Witt, C; Masel, G; Martin, AM; Moore, C; Sayer, D; Castley, A; Mamotte, C; Maxwell, D; James, I; Christiansen, FT			Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir	LANCET			English	Article							HEAT-SHOCK PROTEINS; DISEASE ASSOCIATIONS; ACTIVATION; POLYMORPHISM; RECOGNITION; GENE; HLA	Background The use of abacavir-a potent HIV-1 nucleoside-analogue reverse-transcriptase inhibitor-is complicated by a potentially life-threatening hypersensitivity syndrome in about 5% of cases. Genetic factors influencing the immune response to abacavir might confer susceptibility. We aimed to find associations between MHC alleles and abacavir hypersensitivity in HIV-1-positive individuals treated with abacavir. Methods MHC region typing was done in the first 200 Western Australian HIV Cohort Study participants exposed to abacavir. Definite abacavir hypersensitivity was identified in 18 cases, and was excluded in 167 individuals with more than 6 weeks' exposure to the drug (abacavir tolerant). 15 individuals experienced some symptoms but did not meet criteria for abacavir hypersensitivity. p values were corrected for comparisons of multiple HLA alleles (p.) by multiplication of the raw p value by the estimated number of HLA alleles present within the loci examined. Findings HLA-B*5701 was present in 14 (78%) of the 18 Patients with abacavir hypersensitivity, and in four (2%) of the 167 abacavir tolerant patients (odds ratio 117 [95% CI 29-481], p(c)<0.0001), and the HLA-DR7 and HLA-DQ3 combination was found in 13 (72%) of hypersensitive and five (3%) of tolerant patients (73 [20-268], p <0.0001). HLAB*5701, HLA-DR7, and HLA-DQ3 were present in combination in 13 (72%) hypersensitive patients and none of the tolerant patients (822 [43-15 675], p,<0.0001). Other MHC markers also present on the 57.1 ancestral haplotype to which the three markers above belong confirmed the presence of haplotype-specific linkage disequilibrium, and mapped potential susceptibility loci to a region bounded by C4A6 and HLA-C. Within the entire abacavir-exposed cohort (n=200), presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 had a positive predictive value for hypersensitivity of 100%, and a negative predictive value of 97%. Interpretation Genetic susceptibility to abacavir hypersensitivity is carried on the 57.1 ancestral haplotype. in our population, withholding abacavir In those with HLA-B*5701, HLA-DR7, and HLA-DQ3 should reduce the prevalence of hypersensitivity from 9% to 2.5% without inappropriately denying abacavir to any patient.	Royal Perth Hosp, Ctr Clin Immunol & Biomed Stat, Perth, WA 6000, Australia; Murdoch Univ, Perth, WA, Australia; Royal Perth Hosp, Dept Clin Immunol & Biochem Genet, Perth, WA 6000, Australia; Univ Western Australia, Dept Pathol, Nedlands, WA 6009, Australia	Royal Perth Hospital; University of Western Australia; Murdoch University; Royal Perth Hospital; University of Western Australia; University of Western Australia	Mallal, S (corresponding author), Royal Perth Hosp, Ctr Clin Immunol & Biomed Stat, 2nd Floor,N Block, Perth, WA 6000, Australia.	mallal@prodigal.murdoch.edu.au	Mallal, Simon Alexander/HDM-9561-2022; Mamotte, Cyril/AAF-9603-2020	Mallal, Simon Alexander/0000-0002-7036-1309; Mamotte, Cyril/0000-0003-1831-3921				BREWERTON DA, 1973, LANCET, V1, P904; Cheong KY, 2001, HUM IMMUNOL, V62, P1363, DOI 10.1016/S0198-8859(01)00351-2; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; DAWKINS RL, 1983, IMMUNOL REV, V70, P5, DOI 10.1111/j.1600-065X.1983.tb00707.x; DAWKINS RL, 1991, BAILLIERE CLIN ENDOC, V5, P285, DOI 10.1016/S0950-351X(05)80128-4; Escaut L, 1999, AIDS, V13, P1419, DOI 10.1097/00002030-199907300-00026; Faletto MB, 1997, ANTIMICROB AGENTS CH, V41, P1099, DOI 10.1128/AAC.41.5.1099; Hetherington S, 2001, CLIN THER, V23, P1603, DOI 10.1016/S0149-2918(01)80132-6; HETHERINGTON S, 2001, 1 IAS C HIV PATH TRE; Johnson AA, 2001, J BIOL CHEM, V276, P40847, DOI 10.1074/jbc.M106743200; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; More SH, 2001, INT IMMUNOL, V13, P1121, DOI 10.1093/intimm/13.9.1121; Multhoff G, 1998, BIOL CHEM, V379, P295; Ota M, 1997, TISSUE ANTIGENS, V49, P448, DOI 10.1111/j.1399-0039.1997.tb02778.x; Park BK, 2001, TOXICOLOGY, V158, P11, DOI 10.1016/S0300-483X(00)00397-8; Peyriere H, 2001, ANN PHARMACOTHER, V35, P1291; Pirmohamed M, 2001, NEUROLOGY, V56, P890, DOI 10.1212/WNL.56.7.890; Schnyder B, 2000, J IMMUNOL, V164, P6647, DOI 10.4049/jimmunol.164.12.6647; SVEJGAARD A, 1994, TISSUE ANTIGENS, V43, P18, DOI 10.1111/j.1399-0039.1994.tb02291.x; White AJ, 2001, SEX TRANSM INFECT, V77, P158, DOI 10.1136/sti.77.3.158; Wilson A. G., 1992, Human Molecular Genetics, V1, P353, DOI 10.1093/hmg/1.5.353; Zanni MP, 1998, J CLIN INVEST, V102, P1591, DOI 10.1172/JCI3544	22	1002	1061	0	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 2	2002	359	9308					727	732		10.1016/S0140-6736(02)07873-X	http://dx.doi.org/10.1016/S0140-6736(02)07873-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526DZ	11888582				2022-12-28	WOS:000174115200006
J	Aitken, RJ; Graves, JAM				Aitken, RJ; Graves, JAM			Human spermatozoa: The future of sex	NATURE			English	Editorial Material									Univ Newcastle, Hunter Med Res Inst, Callaghan, NSW 2308, Australia; Univ Newcastle, Discipline Biol Sci, Callaghan, NSW 2308, Australia; Australian Natl Univ, Res Sch Biol Sci, Canberra, ACT 2601, Australia	Hunter Medical Research Institute; University of Newcastle; University of Newcastle; Australian National University	Aitken, RJ (corresponding author), Univ Newcastle, Hunter Med Res Inst, Callaghan, NSW 2308, Australia.		Aitken, Robert John/AAY-8238-2020; Graves, Jennifer A.M./A-1387-2008	Aitken, Robert John/0000-0002-9152-156X; Graves, Jennifer/0000-0001-6480-7856				Aitken RJ, 1999, J REPROD FERTIL, V115, P1; Graves JAM, 2000, BIOL REPROD, V63, P667, DOI 10.1095/biolreprod63.3.667b; JUST W, 1995, NAT GENET, V11, P117, DOI 10.1038/ng1095-117; Kamp C, 2001, MOL HUM REPROD, V7, P987, DOI 10.1093/molehr/7.10.987; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757	5	83	90	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2002	415	6875					963	963		10.1038/415963a	http://dx.doi.org/10.1038/415963a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875544				2022-12-28	WOS:000174075000022
J	Fay, JC; Wyckoff, GJ; Wu, CI				Fay, JC; Wyckoff, GJ; Wu, CI			Testing the neutral theory of molecular evolution with genomic data from Drosophila	NATURE			English	Article							POPULATION-GENETICS; ADAPTIVE EVOLUTION; SUBSTITUTIONS; MELANOGASTER; DIVERGENCE; PROTEIN; NUCLEAR; GENES	Although positive selection has been detected in many genes, its overall contribution to protein evolution is debatable(1). If the bulk of molecular evolution is neutral, then the ratio of amino-acid (A) to synonymous (S) polymorphism should, on average, equal that of divergence(2). A comparison of the A/S ratio of polymorphism in Drosophila melanogaster with that of divergence from Drosophila simulans shows that the A/S ratio of divergence is twice as high-a difference that is often attributed to positive selection. But an increase in selective constraint owing to an increase in effective population size could also explain this observation, and, if so, all genes should be affected similarly. Here we show that the difference between polymorphism and divergence is limited to only a fraction of the genes, which are also evolving more rapidly, and this implies that positive selection is responsible. A higher A/S ratio of divergence than of polymorphism is also observed in other species, which suggests a rate of adaptive evolution that is far higher than permitted by the neutral theory of molecular evolution.	Univ Chicago, Comm Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Fay, JC (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome Sci, Berkeley, CA 94720 USA.			Wyckoff, Gerald/0000-0003-2604-2666; Fay, Justin/0000-0003-1893-877X				Akashi H, 1997, GENE, V205, P269, DOI 10.1016/S0378-1119(97)00400-9; Andolfatto P, 2001, MOL BIOL EVOL, V18, P279, DOI 10.1093/oxfordjournals.molbev.a003804; Begun DJ, 2000, GENETICS, V154, P1231; Begun DJ, 2001, MOL BIOL EVOL, V18, P1343, DOI 10.1093/oxfordjournals.molbev.a003918; EANES WF, 1993, P NATL ACAD SCI USA, V90, P7475, DOI 10.1073/pnas.90.16.7475; Fay JC, 2001, GENETICS, V158, P1227; Hey J, 1997, GENETICS, V145, P833; KIMURA M, 1977, NATURE, V267, P275, DOI 10.1038/267275a0; Kimura M., 1983, NEUTRAL THEORY MOL E; Kliman RM, 2000, GENETICS, V156, P1913; LACHAISE D, 1988, EVOL BIOL, V22, P159; LANGLEY CH, 1974, J MOL EVOL, V3, P161, DOI 10.1007/BF01797451; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McVean GAT, 2001, GENETICS, V157, P245; Moriyama EN, 1996, MOL BIOL EVOL, V13, P261, DOI 10.1093/oxfordjournals.molbev.a025563; Nei M., 1987, MOL EVOLUTIONARY GEN; OHTA T, 1995, J MOL EVOL, V40, P56, DOI 10.1007/BF00166595; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Tsaur SC, 1998, MOL BIOL EVOL, V15, P1040, DOI 10.1093/oxfordjournals.molbev.a026002; Weinreich DM, 2000, GENETICS, V156, P385; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7	23	264	271	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2002	415	6875					1024	1026		10.1038/4151024a	http://dx.doi.org/10.1038/4151024a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875569				2022-12-28	WOS:000174075000045
J	Treasure, T				Treasure, T			Surgeons' knots: old skills, new training	LANCET			English	Editorial Material									St George Hosp, Dept Cardiothorac Surg, London SW17 0RE, England	St Georges University London	Treasure, T (corresponding author), St George Hosp, Dept Cardiothorac Surg, London SW17 0RE, England.							Ind TEJ, 2001, BRIT J OBSTET GYNAEC, V108, P1013, DOI 10.1016/S0306-5456(01)00251-0; Pickersgill T, 2001, BRIT MED J, V323, P1266, DOI 10.1136/bmj.323.7324.1266; Ribeiro BF, 2001, ARCH SURG-CHICAGO, V136, P1076, DOI 10.1001/archsurg.136.9.1076; Senior MA, 2001, ANN ROY COLL SURG, V83, P358; TVTHERLEIGH MG, 2001, ANN R COLL SURG ENG, V83, P69; UNSWORTHWHITE MJ, 1995, ANN THORAC SURG, V59, P664; Vass A, 2001, BRIT MED J, V323, P1205, DOI 10.1136/bmj.323.7323.1205	7	7	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 23	2002	359	9307					642	642		10.1016/S0140-6736(02)07782-6	http://dx.doi.org/10.1016/S0140-6736(02)07782-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526AZ	11879857				2022-12-28	WOS:000174107400005
J	Wessel, J; Buscher, U				Wessel, J; Buscher, U			Denial of pregnancy: population based study	BRITISH MEDICAL JOURNAL			English	Article									Humboldt Univ, Charite, Dept Obstet, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Buscher, U (corresponding author), Humboldt Univ, Charite, Dept Obstet, Campus Virchow Klinikum, D-13353 Berlin, Germany.							BREZINKA C, 1994, J PSYCHOSOM OBST GYN, V15, P1, DOI 10.3109/01674829409025623; BRYCH C, 1994, THESIS MED U HANOVER; MILDEN R, 1985, Journal of Psychosomatic Obstetrics and Gynecology, V4, P255, DOI 10.3109/01674828509016727; Spielvogel AM, 1995, BIRTH-ISS PERINAT C, V22, P220, DOI 10.1111/j.1523-536X.1995.tb00262.x; Wessel J, 1997, GEBURTSH FRAUENHEILK, V57, P116, DOI 10.1055/s-2007-1023052	5	37	36	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 23	2002	324	7335					458	458		10.1136/bmj.324.7335.458	http://dx.doi.org/10.1136/bmj.324.7335.458			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	526NJ	11859048	Green Published, Bronze			2022-12-28	WOS:000174136300018
J	Tessler, N; Medvedev, V; Kazes, M; Kan, SH; Banin, U				Tessler, N; Medvedev, V; Kazes, M; Kan, SH; Banin, U			Efficient near-infrared polymer nanocrystat light-emitting diodes	SCIENCE			English	Article							CORE/SHELL NANOCRYSTALS; SEMICONDUCTING POLYMER; ELECTROLUMINESCENCE; COMPOSITES; TRANSPORT	Conjugated polymers and indium arsenide-based nanocrystals were used to create near-infrared plastic light-emitting diodes. Emission was tunable from 1 to 1.3 micrometers-a range that effectively covers the short-wavelength telecommunications band-by means of the quantum confinement effects in the nanocrystals. The external efficiency value (photons out divided by electrons in) is similar to0.5% (that is, >1% internal) and is mainly limited by device architecture. The near-infrared emission did not overlap the charge-induced absorption bands of the polymer.	Technion Israel Inst Technol, Dept Elect Engn, Ctr Microelect, IL-32000 Haifa, Israel; Technion Israel Inst Technol, Commun & Informat Technol Ctr, IL-32000 Haifa, Israel; Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Ctr Nanosci & Nanotechnol, IL-91904 Jerusalem, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Tessler, N (corresponding author), Technion Israel Inst Technol, Dept Elect Engn, Ctr Microelect, IL-32000 Haifa, Israel.		Tessler, Nir/A-9849-2008	Tessler, Nir/0000-0002-5354-3231; Banin, Uri/0000-0003-1698-2128				Baldo MA, 2000, NATURE, V403, P750, DOI 10.1038/35001541; Cao YW, 1999, ANGEW CHEM INT EDIT, V38, P3692, DOI 10.1002/(SICI)1521-3773(19991216)38:24<3692::AID-ANIE3692>3.0.CO;2-W; Cao YW, 2000, J AM CHEM SOC, V122, P9692, DOI 10.1021/ja001386g; COLVIN VL, 1994, NATURE, V370, P354, DOI 10.1038/370354a0; Curry RJ, 1999, APPL PHYS LETT, V75, P1380, DOI 10.1063/1.124700; Curry RJ, 2001, OPT MATER, V17, P161, DOI 10.1016/S0925-3467(01)00077-5; DABBOUSI BO, 1995, APPL PHYS LETT, V66, P1316, DOI 10.1063/1.113227; DESURVIRE E, 1994, ERBIUM DOPED FIBER A; Dodabalapur A, 1998, APPL PHYS LETT, V73, P142, DOI 10.1063/1.121736; GREENHAM NC, 1994, ADV MATER, V6, P491, DOI 10.1002/adma.19940060612; Greenham NC, 1996, PHYS REV B, V54, P17628, DOI 10.1103/PhysRevB.54.17628; Kao K. C., 1981, INT SERIES SCI SOLID, V14; Kawamura Y, 2000, CHEM LETT, P280, DOI 10.1246/cl.2000.280; Malliaras GG, 1998, J APPL PHYS, V83, P5399, DOI 10.1063/1.367369; Mattoussi H, 1998, J APPL PHYS, V83, P7965, DOI 10.1063/1.367978; Schlamp MC, 1997, J APPL PHYS, V82, P5837, DOI 10.1063/1.366452; Sirringhaus H, 1998, SCIENCE, V280, P1741, DOI 10.1126/science.280.5370.1741; Slooff LH, 1998, J APPL PHYS, V83, P497, DOI 10.1063/1.366721; Slooff LH, 2001, APPL PHYS LETT, V78, P2122, DOI 10.1063/1.1359782; Tessler N, 2000, APPL PHYS LETT, V77, P1897, DOI 10.1063/1.1310630; TESSLER N, 2001, ELSEVIER ENCY MAT SC, P4402; Yoffe AD, 2001, ADV PHYS, V50, P1, DOI 10.1080/00018730010006608	22	1201	1242	5	229	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2002	295	5559					1506	1508		10.1126/science.1068153	http://dx.doi.org/10.1126/science.1068153			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11859189				2022-12-28	WOS:000173981300047
J	Yu, JL; Rak, JW; Coomber, BL; Hicklin, DJ; Kerbel, RS				Yu, JL; Rak, JW; Coomber, BL; Hicklin, DJ; Kerbel, RS			Effect of p53 status on tumor response to antiangiogenic therapy	SCIENCE			English	Article							CANCER; CELLS; ANGIOGENESIS; HYPOXIA; CHEMOTHERAPY; RESISTANCE; SELECTION; AGENTS; ARREST; P21	The p53 tumor suppressor gene is inactivated in the majority of human cancers. Tumor cells deficient in p53 display a diminished rate of apoptosis under hypoxic conditions, a circumstance that might reduce their reliance on vascular supply, and hence their responsiveness to antiangiogenic therapy. Here, we report that mice bearing tumors derived from p53(-/-) HCT116 human colorectal cancer cells were less responsive to antiangiogenic combination therapy than mice bearing isogenic p53(+/+) tumors. Thus, although antiangiogenic therapy targets genetically stable endothelial cells in the tumor vasculature, genetic alterations that decrease the vascular dependence of tumor cells can influence the therapeutic response of tumors to this therapy.	Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A1, Canada; McMaster Univ, Hamilton Civ Hosp, Res Ctr, Hamilton, ON L8V 1C3, Canada; Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada; ImClone Syst Inc, New York, NY 10014 USA	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; McMaster University; University of Guelph; Eli Lilly	Kerbel, RS (corresponding author), Sunnybrook & Womens Coll Hlth Sci Ctr, Room S-218,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.				NCI NIH HHS [CA-41233] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA041233] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akakura N, 2001, CANCER RES, V61, P6548; Blagosklonny MV, 2001, INT J ONCOL, V19, P257; Boehm T, 1997, NATURE, V390, P404, DOI 10.1038/37126; Browder T, 2000, CANCER RES, V60, P1878; Brown JM, 2000, DRUG RESIST UPDATE, V3, P7, DOI 10.1054/drup.2000.0120; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chaplin DJ, 1999, ANTICANCER RES, V19, P189; Dang LH, 2001, P NATL ACAD SCI USA, V98, P15155, DOI 10.1073/pnas.251543698; Denny WA, 2000, EXPERT OPIN INV DRUG, V9, P2889, DOI 10.1517/13543784.9.12.2889; EZEKOWITZ RAB, 1992, NEW ENGL J MED, V326, P1456, DOI 10.1056/NEJM199205283262203; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Folkman J, 2000, NAT REV MOL CELL BIO, V1, P76, DOI 10.1038/35036100; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Griggs J, 2001, LANCET ONCOL, V2, P82, DOI 10.1016/S1470-2045(00)00224-2; Kaban LB, 1999, PEDIATRICS, V103, P1145, DOI 10.1542/peds.103.6.1145; Kerbel RS, 2001, CANCER METAST REV, V20, P79, DOI 10.1023/A:1013172910858; KERBEL RS, 1991, BIOESSAYS, V13, P31, DOI 10.1002/bies.950130106; KERBEL RS, IN PRESS NATURE REV; Klement G, 2000, J CLIN INVEST, V105, pR15, DOI 10.1172/JCI8829; LORD EM, 1993, CANCER RES, V53, P5721; Masunaga S, 2000, INT J RADIAT ONCOL, V47, P799, DOI 10.1016/S0360-3016(00)00477-6; Rak J, 1996, EUR J CANCER, V32A, P2438, DOI 10.1016/S0959-8049(96)00396-6; Rak J, 1996, CANCER METAST REV, V15, P231, DOI 10.1007/BF00437476; Semenza GL, 2000, CRIT REV BIOCHEM MOL, V35, P71, DOI 10.1080/10409230091169186; WALDMAN T, 1995, CANCER RES, V55, P5187; Yu J., UNPUB; Yu JL, 2001, AM J PATHOL, V158, P1325, DOI 10.1016/S0002-9440(10)64083-7	28	363	390	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2002	295	5559					1526	1528		10.1126/science.1068327	http://dx.doi.org/10.1126/science.1068327			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11859195				2022-12-28	WOS:000173981300054
J	Zens, MS; Webb, CO				Zens, MS; Webb, CO			Sizing up the shape of life	SCIENCE			English	Editorial Material							HISTORY		Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06511 USA	Dartmouth College; Yale University	Zens, MS (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	scot.zens@dartmouth.edu; campbell.webb@yale.edu	Webb, Campbell/B-1488-2009	Webb, Campbell/0000-0003-1031-3249				[Anonymous], 1985, ATTRIBUTES TREES CRO; Brown J.H., 1995, MACROECOLOGY; Caspersen JP, 2000, SCIENCE, V290, P1148, DOI 10.1126/science.290.5494.1148; Enquist BJ, 1999, NATURE, V401, P907, DOI 10.1038/44819; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; Hubbell Stephen P., 2001, V32, pi; Monod J., 1971, CHANCE NECESSITY ESS; Moorcroft PR, 2001, ECOL MONOGR, V71, P557, DOI 10.1890/0012-9615(2001)071[0557:AMFSVD]2.0.CO;2; Niklas KJ, 2001, P NATL ACAD SCI USA, V98, P2922, DOI 10.1073/pnas.041590298; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251	10	9	11	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2002	295	5559					1475	1476		10.1126/science.1070130	http://dx.doi.org/10.1126/science.1070130			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11859181				2022-12-28	WOS:000173981300037
J	Oral, EA; Simha, V; Ruiz, E; Andewelt, A; Premkumar, A; Snell, P; Wagner, AJ; DePaoli, AM; Reitman, ML; Taylor, SI; Gorden, P; Garg, A				Oral, EA; Simha, V; Ruiz, E; Andewelt, A; Premkumar, A; Snell, P; Wagner, AJ; DePaoli, AM; Reitman, ML; Taylor, SI; Gorden, P; Garg, A			Leptin-replacement therapy for lipodystrophy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REVERSES INSULIN-RESISTANCE; ADIPOSE-TISSUE; RECOMBINANT LEPTIN; DIABETES-MELLITUS; OBESE GENE; WEIGHT; PROTEIN; FAT; TROGLITAZONE; LIPOATROPHY	Background: The adipocyte hormone leptin is important in regulating energy homeostasis. Since severe lipodystrophy is associated with leptin deficiency, insulin resistance, hypertriglyceridemia, and hepatic steatosis, we assessed whether leptin replacement would ameliorate this condition. Methods: Nine female patients (age range, 15 to 42 years; eight with diabetes mellitus) who had lipodystrophy and serum leptin levels of less than 4 ng per milliliter (0.32 nmol per milliliter) received recombinant methionyl human leptin (recombinant leptin). Recombinant leptin was administered subcutaneously twice a day for four months at escalating doses to achieve low, intermediate, and high physiologic replacement levels of leptin. Results: During treatment with recombinant leptin, the serum leptin level increased from a mean (+/-SE) of 1.3+/-0.3 ng per milliliter to 11.1+/-2.5 ng per milliliter (0.1+/-0.02 to 0.9+/-0.2 nmol per milliliter). The absolute decrease in the glycosylated hemoglobin value was 1.9 percent (95 percent confidence interval, 1.1 to 2.7 percent; P=0.001) in the eight patients with diabetes. Four months of therapy decreased average triglyceride levels by 60 percent (95 percent confidence interval, 43 to 77 percent; P<0.001) and liver volume by an average of 28 percent (95 percent confidence interval, 20 to 36 percent; P=0.002) in all nine patients and led to the discontinuation of or a large reduction in antidiabetes therapy. Self-reported daily caloric intake and the measured resting metabolic rate also decreased significantly with therapy. Overall, recombinant leptin therapy was well tolerated. Conclusions: Leptin-replacement therapy improved glycemic control and decreased triglyceride levels in patients with lipodystrophy and leptin deficiency. Leptin deficiency contributes to the insulin resistance and other metabolic abnormalities associated with severe lipodystrophy. Copyright (C) 2002 Massachusetts Medical Society.	NIDDK, Diabet Branch, NIH, Bethesda, MD 20892 USA; Univ Texas, SW Med Ctr, Dallas, TX USA; Amgen Inc, Thousand Oaks, CA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Amgen	Oral, EA (corresponding author), NIDDK, Diabet Branch, NIH, Bldg 10,Rm 8D20, Bethesda, MD 20892 USA.	elif_arioglu@nih.gov	Reitman, Marc/B-4448-2013	Reitman, Marc/0000-0002-0426-9475; Oral, Elif/0000-0002-9171-1144	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK047022, R01DK054387] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00633] Funding Source: Medline; NIDDK NIH HHS [R01-DK54387] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABATE N, 1994, J LIPID RES, V35, P1490; Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Arioglu E, 2000, ANN INTERN MED, V133, P263, DOI 10.7326/0003-4819-133-4-200008150-00009; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Bolan C, 2002, J CLIN ENDOCR METAB, V87, P380, DOI 10.1210/jc.87.1.380; Burant CF, 1997, J CLIN INVEST, V100, P2900, DOI 10.1172/JCI119839; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Cao H, 2000, HUM MOL GENET, V9, P109, DOI 10.1093/hmg/9.1.109; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Ebihara K, 2001, DIABETES, V50, P1440, DOI 10.2337/diabetes.50.6.1440; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; GARG A, 1992, J CLIN ENDOCR METAB, V75, P358, DOI 10.1210/jc.75.2.358; Garg A, 2000, AM J MED, V108, P143, DOI 10.1016/S0002-9343(99)00414-3; Garg A, 1999, J CLIN ENDOCR METAB, V84, P170, DOI 10.1210/jc.84.1.170; Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901; Gotto AM, 1998, AM J CARDIOL, V82, p22Q; Hahn G., 1991, STAT INTERVALS GUIDE; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; HARRISON LC, 1976, J CLIN INVEST, V58, P1435, DOI 10.1172/JCI108599; Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568; Kreisberg RA, 1998, AM J CARDIOL, V82, p67U, DOI 10.1016/S0002-9149(98)00848-0; Lambrinoudaki I, 1998, METABOLISM, V47, P1379, DOI 10.1016/S0026-0495(98)90309-2; LAWRENCE RD, 1946, LANCET, V250, P773; LAWRENCE RD, 1946, LANCET, V250, P724; Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585; Mantzoros CS, 2000, J CLIN ENDOCR METAB, V85, P4000, DOI 10.1210/jc.85.11.4000; MCKUSICK V, 2001, ONLINE MENDELIAN INH; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Peters Anne L., 1998, American Journal of Medicine, V105, p15S, DOI 10.1016/S0002-9343(98)00206-X; Reitman ML, 2000, TRENDS ENDOCRIN MET, V11, P410, DOI 10.1016/S1043-2760(00)00309-X; Ruhl CE, 2001, AM J CLIN NUTR, V74, P295; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; TRYGSTAD O, 1977, INT J OBESITY, V1, P287; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; Unger RH, 1999, P NATL ACAD SCI USA, V96, P2327, DOI 10.1073/pnas.96.5.2327; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; ZHANG YY, 1995, NATURE, V374, P479, DOI 10.1038/374479a0; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	44	854	891	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2002	346	8					570	578		10.1056/NEJMoa012437	http://dx.doi.org/10.1056/NEJMoa012437			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	522ZK	11856796				2022-12-28	WOS:000173926700005
J	Freedman, A; Afonja, O; Chang, MW; Mostashari, F; Blaser, M; Perez-Perez, G; Lazarus, H; Schacht, R; Guttenberg, J; Traister, M; Borkowsky, W				Freedman, A; Afonja, O; Chang, MW; Mostashari, F; Blaser, M; Perez-Perez, G; Lazarus, H; Schacht, R; Guttenberg, J; Traister, M; Borkowsky, W			Cutaneous anthrax associated with microangiopathic hemolytic anemia and coagulopathy in a 7-month-old infant	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								A 7-month-old infant with cutaneous anthrax developed severe systemic illness despite early treatment with antibiotics. The infant displayed severe microangiopathic hemolytic anemia with renal involvement, coagulopathy, and hyponatremia. These findings are unusual with cutaneous anthrax, but have been described in illness resulting from spider toxin and may delay correct diagnosis. The systemic manisfestations of the disease persisted for nearly a month despite corticosteroid therapy, but resolved.	NYU, Med Ctr, Dept Pediat, Sch Med, New York, NY 10016 USA; NYU, Sch Med, Dept Dermatol, New York, NY USA; NYU, Sch Med, Dept Hlth, New York, NY USA; NYU, Sch Med, Dept Med, New York, NY USA	New York University; New York University; New York University; New York University	Borkowsky, W (corresponding author), NYU, Med Ctr, Dept Pediat, Sch Med, 550 1st Ave, New York, NY 10016 USA.	borkow01@gcrc.med.nyu.edu	Perez, Guillermo Perez/AAJ-3761-2020	Perez Perez, Guillermo/0000-0002-0131-5798				*AM AC PED, 2000, AAP 2000 RED BOOK RE; Arya L S, 1982, Indian J Pediatr, V49, P529, DOI 10.1007/BF02834559; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P909; *CDCP, 1994, MMWR-MORBID MORTAL W, V43, P70; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P82; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P1014; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; DOUST JY, 1968, DIS CHEST, V53, P773; EDWARDS MS, 1998, TXB PEDIAT INFECT DI, V1, P1176; HEYWORTH B, 1975, BMJ-BRIT MED J, V4, P79, DOI 10.1136/bmj.4.5988.79; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; Kassenborg H, 2000, JAMA-J AM MED ASSOC, V284, P1644; Khajehdehi P, 2001, MT SINAI J MED, V68, P213; Mallon E, 1997, AM J DERMATOPATH, V19, P79, DOI 10.1097/00000372-199702000-00014; MANIOS S, 1979, SCAND J INFECT DIS, V11, P203, DOI 10.3109/inf.1979.11.issue-3.05; Roche KJ, 2001, NEW ENGL J MED, V345, P1611, DOI 10.1056/NEJMicm010777; Smego RA, 1998, CLIN INFECT DIS, V26, P97; TAHERNIA AC, 1972, PEDIATRICS, V50, P329; TAHERNIA AC, 1967, ARCH DIS CHILD, V42, P181, DOI 10.1136/adc.42.222.181; Thappa Devinder Mohan, 2001, Indian Journal of Pediatrics, V68, P573, DOI 10.1007/BF02723258; TURNBULL PCB, 1992, EPIDEMIOL INFECT, V108, P299, DOI 10.1017/S0950268800049773; WILLIAMS ST, 1995, AM J CLIN PATHOL, V104, P463; Wright SW, 1997, ANN EMERG MED, V30, P28, DOI 10.1016/S0196-0644(97)70106-9; YORSTON D, 1989, BRIT J OPHTHALMOL, V73, P809, DOI 10.1136/bjo.73.10.809	25	57	61	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2002	287	7					869	874		10.1001/jama.287.7.869	http://dx.doi.org/10.1001/jama.287.7.869			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	522XP	11851579	Bronze			2022-12-28	WOS:000173922500026
J	Rolston, SL; Phillips, WD				Rolston, SL; Phillips, WD			Nonlinear and quantum atom optics	NATURE			English	Review							BOSE-EINSTEIN CONDENSATE; PHASE-COHERENT AMPLIFICATION; STANDING LIGHT-WAVE; MATTER WAVES; OUTPUT COUPLER; SCATTERING; DIFFRACTION; SOLITONS; STATES; LASER		Natl Inst Stand & Technol, Atom Phys Div, Gaithersburg, MD 20899 USA	National Institute of Standards & Technology (NIST) - USA	Rolston, SL (corresponding author), Natl Inst Stand & Technol, Atom Phys Div, 100 Bur Dr, Gaithersburg, MD 20899 USA.		rolston, steven l/L-5175-2013	rolston, steven l/0000-0003-1671-4190				Anderson BP, 2001, PHYS REV LETT, V86, P2926, DOI 10.1103/PhysRevLett.86.2926; Anderson BP, 1998, SCIENCE, V282, P1686, DOI 10.1126/science.282.5394.1686; ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; Bloch I, 1999, PHYS REV LETT, V82, P3008, DOI 10.1103/PhysRevLett.82.3008; Burger S, 1999, PHYS REV LETT, V83, P5198, DOI 10.1103/PhysRevLett.83.5198; Burt EA, 1997, PHYS REV LETT, V79, P337, DOI 10.1103/PhysRevLett.79.337; Dalfovo F, 1999, REV MOD PHYS, V71, P463, DOI 10.1103/RevModPhys.71.463; Deng L, 1999, NATURE, V398, P218, DOI 10.1038/18395; Denschlag J, 2000, SCIENCE, V287, P97, DOI 10.1126/science.287.5450.97; Dos Santos FP, 2001, PHYS REV LETT, V86, P3459, DOI 10.1103/PhysRevLett.86.3459; Dutton Z, 2001, SCIENCE, V293, P663, DOI 10.1126/science.1062527; EVANS M, 1997, MODERN NONLINEAR OPT, V1; Feder DL, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.053606; FRANKEN PA, 1961, PHYS REV LETT, V7, P118, DOI 10.1103/PhysRevLett.7.118; Hagley EW, 1999, SCIENCE, V283, P1706, DOI 10.1126/science.283.5408.1706; Hagley EW, 1999, PHYS REV LETT, V83, P3112, DOI 10.1103/PhysRevLett.83.3112; Helmerson K, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.170402; INGUSCIO M, 1999, BOSEEINSTEIN CONDENS; Inouye S, 1999, NATURE, V402, P641, DOI 10.1038/45194; Inouye S, 1999, SCIENCE, V285, P571, DOI 10.1126/science.285.5427.571; Javanainen J, 1999, PHYS REV A, V59, pR3186, DOI 10.1103/PhysRevA.59.R3186; Ketterle W, 2001, PHYS REV LETT, V86, P4203, DOI 10.1103/PhysRevLett.86.4203; KITAGAWA M, 1993, PHYS REV A, V47, P5138, DOI 10.1103/PhysRevA.47.5138; Kozuma M, 1999, SCIENCE, V286, P2309, DOI 10.1126/science.286.5448.2309; Kozuma M, 1999, PHYS REV LETT, V82, P871, DOI 10.1103/PhysRevLett.82.871; LENS G, 1993, PHYS REV LETT, V71, P3271; Liu C, 2001, NATURE, V409, P490, DOI 10.1038/35054017; MARTIN PJ, 1988, PHYS REV LETT, V60, P515, DOI 10.1103/PhysRevLett.60.515; Mewes MO, 1997, PHYS REV LETT, V78, P582, DOI 10.1103/PhysRevLett.78.582; Migdall A, 1999, PHYS TODAY, V52, P41, DOI 10.1063/1.882570; Moore MG, 2001, PHYS REV LETT, V86, P4199, DOI 10.1103/PhysRevLett.86.4199; Orzel C, 2001, SCIENCE, V291, P2386, DOI 10.1126/science.1058149; Ovchinnikov YB, 1999, PHYS REV LETT, V83, P284, DOI 10.1103/PhysRevLett.83.284; Raithel G, 1998, PHYS REV LETT, V81, P3615, DOI 10.1103/PhysRevLett.81.3615; Robert A, 2001, SCIENCE, V292, P461, DOI 10.1126/science.1060622; RUSSELL JS, 1844, 14TH M BRIT ASS ADV, P331; Shen Y. R., 1984, PRINCIPLES NONLINEAR; Simsarian JE, 2000, PHYS REV LETT, V85, P2040, DOI 10.1103/PhysRevLett.85.2040; Sorensen A, 2001, NATURE, V409, P63, DOI 10.1038/35051038; Sorensen A, 1999, PHYS REV LETT, V83, P2274, DOI 10.1103/PhysRevLett.83.2274; Stenger J, 1999, PHYS REV LETT, V82, P4569, DOI 10.1103/PhysRevLett.82.4569; Trippenbach M, 1998, OPT EXPRESS, V3, P530, DOI 10.1364/OE.3.000530	43	92	96	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2002	416	6877					219	224		10.1038/416219a	http://dx.doi.org/10.1038/416219a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894105				2022-12-28	WOS:000174348100048
J	Angelo, SJ				Angelo, SJ			A wake-up call	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2002	287	10					1227	1227		10.1001/jama.287.10.1227	http://dx.doi.org/10.1001/jama.287.10.1227			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529YU	11886296				2022-12-28	WOS:000174329500001
J	Marchetti, O; Calandra, T				Marchetti, O; Calandra, T			Infections in neutropenic cancer patients	LANCET			English	Editorial Material							FEBRILE PATIENTS; THERAPY; GRANULOCYTOPENIA; CHEMOTHERAPY; PROPHYLAXIS; FEVER		CHU Vaudois, Dept Internal Med, Div Infect Dis, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Calandra, T (corresponding author), CHU Vaudois, Dept Internal Med, Div Infect Dis, CH-1011 Lausanne, Switzerland.		Calandra, Thierry/D-9017-2015	Calandra, Thierry/0000-0003-3051-1285				BOCHUD PY, 1994, AM J MED, V97, P256, DOI 10.1016/0002-9343(94)90009-4; CALANDRA T, 1991, J INFECT DIS, V163, P951; Collin BA, 2001, CLIN INFECT DIS, V33, P947, DOI 10.1086/322604; COMETTA A, 1994, NEW ENGL J MED, V330, P1240, DOI 10.1056/NEJM199404283301717; COMETTA A, 2001, 4 ICAAC CHIC 2001; DEBOCK R, 2001, 4 ICAAC CHIC 2001; Del Favero A, 2001, CLIN INFECT DIS, V33, P1295, DOI 10.1086/322646; Engels EA, 1998, J CLIN ONCOL, V16, P1179, DOI 10.1200/JCO.1998.16.3.1179; *EORTC INT ANT THE, 1978, J INFECT DIS, V137, P14; Freifeld A, 1999, NEW ENGL J MED, V341, P305, DOI 10.1056/NEJM199907293410501; Kern WV, 1999, NEW ENGL J MED, V341, P312, DOI 10.1056/NEJM199907293410502; Klastersky J, 2000, J CLIN ONCOL, V18, P3038, DOI 10.1200/JCO.2000.18.16.3038; Murphy M, 1997, CLIN INFECT DIS, V25, P346, DOI 10.1086/516925; SCHIMPFF S, 1971, NEW ENGL J MED, V284, P1061, DOI 10.1056/NEJM197105132841904; TALCOTT JA, 1992, J CLIN ONCOL, V10, P316, DOI 10.1200/JCO.1992.10.2.316; ZINNER SH, 1994, JAMA-J AM MED ASSOC, V272, P1183, DOI 10.1001/jama.1994.03520150051036	16	25	31	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 2	2002	359	9308					723	725		10.1016/S0140-6736(02)07900-X	http://dx.doi.org/10.1016/S0140-6736(02)07900-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526DZ	11888579				2022-12-28	WOS:000174115200003
J	Lee, J; Kim, H; Kahng, SJ; Kim, G; Son, YW; Ihm, J; Kato, H; Wang, ZW; Okazaki, T; Shinohara, H; Kuk, Y				Lee, J; Kim, H; Kahng, SJ; Kim, G; Son, YW; Ihm, J; Kato, H; Wang, ZW; Okazaki, T; Shinohara, H; Kuk, Y			Bandgap modulation of carbon nanotubes by encapsulated metallofullerenes	NATURE			English	Article							WAVE-FUNCTIONS; C-60	Motivated by the technical and economic difficulties in further miniaturizing silicon-based transistors with the present fabrication technologies, there is a strong effort to develop alternative electronic devices, based, for example, on single molecules(1,2). Recently, carbon nanotubes have been successfully used for nanometre-sized devices such as diodes(3,4), transistors(5,6), and random access memory cells(7). Such nanotube devices are usually very long compared to silicon-based transistors. Here we report a method for dividing a semiconductor nanotube into multiple quantum dots with lengths of about 10 nm by inserting Gd@C-82 endohedral fullerenes. The spatial modulation of the nanotube electronic bandgap is observed with a low-temperature scanning tunnelling microscope. We find that a bandgap of similar to0.5 eV is narrowed down to similar to0.1 eV at sites where endohedral metallofullerenes are inserted. This change in bandgap can be explained by local elastic strain and charge transfer at metallofullerene sites. This technique for fabricating an array of quantum dots could be used for nano-electronics(8) and nano-optoelectronics(9).	Seoul Natl Univ, Sch Phys, Seoul 151747, South Korea; Seoul Natl Univ, Ctr Sci Nanometer Scale, Seoul 151747, South Korea; Soongsil Univ, Dept Phys, Seoul 156743, South Korea; Nagoya Univ, Dept Chem, Nagoya, Aichi 4648602, Japan	Seoul National University (SNU); Seoul National University (SNU); Soongsil University; Nagoya University	Kuk, Y (corresponding author), Seoul Natl Univ, Sch Phys, Seoul 151747, South Korea.	ykuk@phya.snu.ac.kr	Lee, Jhinhwan/I-3727-2012; Lee, Jhinhwan/C-2074-2011; Wang, Zhongwen/F-1353-2010; Kim, Hajin/B-5166-2014; Okazaki, Toshiya/H-9545-2018; Okazaki, Toshiya/U-6757-2019; son, Young-Woo/B-2566-2010	Lee, Jhinhwan/0000-0001-7159-6305; Okazaki, Toshiya/0000-0002-5958-0148; Okazaki, Toshiya/0000-0002-5958-0148; 				Aviram A., 1998, MOL ELECT SCI TECHNO; Bandow S, 2001, CHEM PHYS LETT, V347, P23, DOI 10.1016/S0009-2614(01)01020-X; FAIST J, 1995, APPL PHYS LETT, V67, P3057, DOI 10.1063/1.114863; Hirahara K, 2000, PHYS REV LETT, V85, P5384, DOI 10.1103/PhysRevLett.85.5384; HORNBAKER DJ, 2001, P 11 INT C SCANN TUN, P104; IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0; KIM H, UNPUB PHYS REV LETT; Lemay SG, 2001, NATURE, V412, P617, DOI 10.1038/35088013; Okada S, 2001, PHYS REV LETT, V86, P3835, DOI 10.1103/PhysRevLett.86.3835; Postma HWC, 2001, SCIENCE, V293, P76, DOI 10.1126/science.1061797; Reed MA, 2000, SCI AM, V282, P86, DOI 10.1038/scientificamerican0600-86; Rueckes T, 2000, SCIENCE, V289, P94, DOI 10.1126/science.289.5476.94; Shinohara H, 2000, REP PROG PHYS, V63, P843, DOI 10.1088/0034-4885/63/6/201; Smith BW, 2000, CHEM PHYS LETT, V331, P137, DOI 10.1016/S0009-2614(00)01008-3; Smith BW, 1998, NATURE, V396, P323, DOI 10.1038/24521; Suenaga K, 2000, PHYS REV B, V62, P1627, DOI 10.1103/PhysRevB.62.1627; Suenaga K, 2000, SCIENCE, V290, P2280, DOI 10.1126/science.290.5500.2280; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; Toth G, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.052315; Venema LC, 1999, SCIENCE, V283, P52, DOI 10.1126/science.283.5398.52; Yang L, 2000, PHYS REV LETT, V85, P154, DOI 10.1103/PhysRevLett.85.154; Yao Z, 1999, NATURE, V402, P273, DOI 10.1038/46241; Zhou CW, 2000, SCIENCE, V290, P1552, DOI 10.1126/science.290.5496.1552	23	432	440	3	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2002	415	6875					1005	1008		10.1038/4151005a	http://dx.doi.org/10.1038/4151005a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875563				2022-12-28	WOS:000174075000039
J	Bailey, WC; Gerald, LB; Kimerling, ME; Redden, D; Brook, N; Bruce, F; Tang, SH; Duncan, S; Brooks, CM; Dunlap, NE				Bailey, WC; Gerald, LB; Kimerling, ME; Redden, D; Brook, N; Bruce, F; Tang, SH; Duncan, S; Brooks, CM; Dunlap, NE			Predictive model to identify positive tuberculosis skin test results during contact investigations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MYCOBACTERIUM-TUBERCULOSIS; TRANSMISSION	Context Budgetary constraints in tuberculosis (TB) control programs require streamlining contact investigations without sacrificing disease control. Objective To develop more efficient methods of TB contact investigation by creating a model of TB transmission using variables that best predict a positive tuberculin skin test among contacts of an active TB case. Design, Setting, and Subjects After standardizing the interview and documentation process, data were collected on 292 consecutive TB cases and their 2941 contacts identified by the Alabama Department of Public Health between January and October 1998. Generalized estimating equations were used to create a model for predicting positive skin test results in contacts of active TB cases. The model was then validated using data from a prospective cohort of 366 new TB cases and their 3162 contacts identified between October 1998 and April 2000. Main Outcome Measure Tuberculin skin test result. Results Using generalized estimating equations to build a predictive model, 7 variables were found to significantly predict a positive tuberculin skin test result among contacts of an active TB case. Further testing showed this model to have a sensitivity, specificity, and positive predictive value of approximately 89%, 36%, and 26%, respectively. The false-negative rate was less than 10%, and about 40% of the contact workload could be eliminated using this model. Conclusions Certain characteristics can be used to predict contacts most likely to have a positive tuberculin skin test result. Use of such models can significantly reduce the number of contacts that public health officials need to investigate while still maintaining excellent disease control.	Univ Alabama Birmingham, Lung Hlth Ctr, Div Pulm & Crit Care Med, Birmingham, AL 35233 USA; Univ Alabama Birmingham, Div Gen Internal Med, Birmingham, AL USA; Univ Alabama Birmingham, Div Biostat, Birmingham, AL USA; Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; Univ Alabama Birmingham, Sch Hlth Related Profess, Birmingham, AL USA; Univ Alabama Birmingham, Sch Publ Hlth, Dept Biostat, Birmingham, AL 35294 USA; Alabama Dept Publ Hlth, Div TB Control, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Bailey, WC (corresponding author), Univ Alabama Birmingham, Lung Hlth Ctr, Div Pulm & Crit Care Med, 620 S 20th St,NHB 104, Birmingham, AL 35233 USA.	wcbailey@uab.edu			NHLBI NIH HHS [5 R01 HL55752] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055752] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*ADV COUNC EL TUB, 1999, ADV COUNC ELIMINATE, V48, P1; *AM THOR SOC, 1990, AM REV RESPIR DIS, V142, P724; BAILEY W, 2000, WORLD C LUNG HLTH AU; BAMES PF, 1991, NEW ENGL J MED, V324, P1644; BASS J, 1992, AM REV RESPIR DIS, V146, P1623; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Brook N, 1999, AM J RESP CRIT CARE, V159, pA551; Cantwell MF, 1998, AM J RESP CRIT CARE, V157, P1016, DOI 10.1164/ajrccm.157.4.9704036; *CDCP, 1991, MMWR-MORBID MORTAL W, V40, P649; DIPERRI G, 1989, LANCET, V2, P1502; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; ETKIND SC, 1993, TUBERCULOSIS COMPREH, P275; ETKIND SC, 2000, LUNG BIOL HEALTH DIS, V144, P377; GERALD L, 2000, AM J RESP CRIT CARE, V161, pA305; Gerald LB, 1999, AM J RESP CRIT CARE, V159, pA301; GRZYBOWSKI S, 1975, Bulletin of the International Union Against Tuberculosis, V50, P90; Hennekens CH, 1987, EPIDEMIOLOGY MED, P327; HORWITZ O, 1971, AM REV RESPIR DIS, V104, P22; HOUK V, 1968, ARCH ENVIRON HEALTH, V16, P25; HOUK VN, 1968, ARCH ENVIRON HEALTH, V16, P4, DOI 10.1080/00039896.1968.10665007; *I MED, 2000, END NEGL EL TUB US; Kenyon TA, 1996, NEW ENGL J MED, V334, P933, DOI 10.1056/NEJM199604113341501; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LIIPPO KK, 1993, AM REV RESPIR DIS, V148, P235, DOI 10.1164/ajrccm/148.1.235; MENZIES RI, 2000, LUNG BIOL HEALTH DIS, V144, P279; Moore M, 1999, CLIN INFECT DIS, V28, P52, DOI 10.1086/515089; Preisser JS, 1996, BIOMETRIKA, V83, P551, DOI 10.1093/biomet/83.3.551; ROSE CE, 1979, AM REV RESPIR DIS, V119, P603; SAS Institute Inc, 1999, SAS STAT US GUID VER; SHAW JB, 1954, AM REV TUBERC PULM, V69, P724; van Geuns H A, 1975, Bull Int Union Tuberc, V50, P107; VEEN J, 1992, TUBERCLE LUNG DIS, V73, P73, DOI 10.1016/0962-8479(92)90058-R	32	85	88	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2002	287	8					996	1002		10.1001/jama.287.8.996	http://dx.doi.org/10.1001/jama.287.8.996			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525CX	11866647	Bronze			2022-12-28	WOS:000174052100027
J	Bartlett, LA; Jamieson, DJ; Kahn, T; Sultana, M; Wilson, HG; Duerr, A				Bartlett, LA; Jamieson, DJ; Kahn, T; Sultana, M; Wilson, HG; Duerr, A			Maternal mortality among Afghan refugees in Pakistan, 1999-2000	LANCET			English	Article							VERBAL AUTOPSIES; PREGNANCY	Background Estimated at 3.6 million, Afghans are the largest population of refugees in the world. Information on the magnitude, causes, and preventable factors of maternal deaths among Afghan refugees may yield valuable information for prevention. Methods Deaths were recorded between Jan 20, 1999, and Aug 31, 2000, during a census carried out in 12 Afghan refugee settlements in Pakistan. Deaths among women of reproductive age (15-49 years) were further investigated by verbal autopsy interviews to determine their cause, risk factors, and preventability, and to ascertain the barriers faced to obtaining health care. Findings The census identified 134406 Afghan refugees and 1197 deaths; a crude mortality rate of 5.5 (95% Cl 5.2-5.8) per thousand population. Among the 66 deaths among women of reproductive age, deaths due to maternal causes (n=27) exceeded any other cause 41% [95% CI 29-53]). 16 liveborn and nine stillborn infants were born to women who died of maternal causes: six of the liveborn infants died after birth, Therefore, 60% (15 of 24) of infants born to these women were either born dead or died after birth. Compared with women who died of non-maternal causes. women who died of maternal causes had a greater number of harriers to health care (p=0.001), and their deaths were more likely to be preventable (p<0.05). Interpretation Maternal deaths account for a substantial burden of mortality among Afghan refugee women of reproductive age in Pakistan. The high prevalence of barriers to health care access indicates opportunities for reducing maternal deaths in refugee women and their children.	CDCP, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA; Int Rescue Comm, Pakistan Off, Peshawar, Pakistan	Centers for Disease Control & Prevention - USA	Bartlett, LA (corresponding author), CDCP, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Highway NE,MS-K-23, Atlanta, GA 30341 USA.			Jamieson, Denise/0000-0003-2597-1201				[Anonymous], 1997, REF HLTH APPR EM SIT; *CDCP, 1992, MMWR-MORBID MORTAL W, V41, pRR13; Chandramohan D, 1998, STUD FAMILY PLANN, V29, P414, DOI 10.2307/172253; Chandramohan D, 1998, TROP MED INT HEALTH, V3, P436, DOI 10.1046/j.1365-3156.1998.00255.x; CRIPS J, 2001, UNHCR AFGHAN ASSESSM, V2; FORTNEY JA, 1985, FHEPMM85913 WHO; GRAHAM W, 1996, WHORHTMSM951; Hill K, 2001, B WORLD HEALTH ORGAN, V79, P182; Jamieson DJ, 2000, JAMA-J AM MED ASSOC, V283, P397, DOI 10.1001/jama.283.3.397; MacQueen G, 2000, BRIT MED J, V321, P293, DOI 10.1136/bmj.321.7256.293; MacQueen G, 2001, LANCET, V357, P1460, DOI 10.1016/S0140-6736(00)04668-7; MAINE D, 1999, SAFE MOTHERHOOD INIT; *POP REF BUR, 2001, WORLD POP DAT SHEET; Reed HE, 2001, FORCED MIGRATION MOR; Steketee RW, 1996, AM J TROP MED HYG, V55, P24, DOI 10.4269/ajtmh.1996.55.24; The Sphere Project, 2000, HUM CHART MIN STAND; *UN, 1996, PROGR NAT 1996; *UN HIGH COMM REF, 2001, WOM CHILDR OLD REF S; *UN HIGH COMM REF, 2001, CRIS AFGH; *UN POP FUND, 2001, HUM CRIS AFGH REPR H; *UN POP FUND, 2001, UNFPA RESP AFGH CRIS; Waldman RJ, 2001, LANCET, V357, P1427, DOI 10.1016/S0140-6736(00)04568-2; *WHO, 1998, 030501 EURICPCORD WH; *WHO, 1987, WHOFHE877; *WHO, 1995, WHOFHEMSM9515; *WHO, 2001, WHORHR019 UNICEF UNF; *WHO UNFPA UNHCR, 1999, REPR HLTH REF SETT I; World Health Organization, 2004, ICD 10 INT STAT CLAS, V2nd	28	38	38	1	12	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 23	2002	359	9307					643	649		10.1016/S0140-6736(02)07808-X	http://dx.doi.org/10.1016/S0140-6736(02)07808-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526AZ	11879858				2022-12-28	WOS:000174107400006
J	Cunliffe, NA; Bresee, JS; Gentsch, JR; Glass, RI; Hart, CA				Cunliffe, NA; Bresee, JS; Gentsch, JR; Glass, RI; Hart, CA			The expanding diversity of rotaviruses	LANCET			English	Editorial Material							RNA-RNA HYBRIDIZATION; VACCINE DEVELOPMENT; GENOGROUPS; SEROTYPES; DIARRHEA; CHILDREN; INFANTS; STRAINS		Univ Liverpool, Dept Med Microbiol & Genitourinary Med, Liverpool L69 3GA, Merseyside, England; Ctr Dis Control & Prevent, Viral Gastroenteritis Sect, Atlanta, GA USA	University of Liverpool; Centers for Disease Control & Prevention - USA	Cunliffe, NA (corresponding author), Univ Liverpool, Dept Med Microbiol & Genitourinary Med, Liverpool L69 3GA, Merseyside, England.			Cunliffe, Nigel/0000-0002-5449-4988				Bernstein DI, 1999, LANCET, V354, P287, DOI 10.1016/S0140-6736(98)12106-2; Bresee JS, 1999, VACCINE, V17, P2207, DOI 10.1016/S0264-410X(98)00376-4; Clark HF, 1996, J INFECT DIS, V174, pS73, DOI 10.1093/infdis/174.Supplement_1.S73; Cunliffe NA, 2001, J CLIN MICROBIOL, V39, P836, DOI 10.1128/JCM.39.3.836-843.2001; DUNN SJ, 1993, J CLIN MICROBIOL, V31, P165, DOI 10.1128/JCM.31.1.165-169.1993; FLORES J, 1985, J MED VIROL, V17, P135, DOI 10.1002/jmv.1890170206; Gentsch JR, 1996, J INFECT DIS, V174, pS30, DOI 10.1093/infdis/174.Supplement_1.S30; GOUVEA V, 1994, J CLIN MICROBIOL, V32, P1408, DOI 10.1128/JCM.32.5.1408-1409.1994; Hoshino Y, 2000, J HEALTH POPUL NUTR, V18, P5; Iturriza-Gomara M, 2001, J VIROL, V75, P3696, DOI 10.1128/JVI.75.8.3696-3705.2001; Koshimura Y, 2000, MICROBIOL IMMUNOL, V44, P499, DOI 10.1111/j.1348-0421.2000.tb02525.x; Murphy TV, 2001, NEW ENGL J MED, V344, P564, DOI 10.1056/NEJM200102223440804; NAKAGOMI O, 1989, MOL CELL PROBE, V3, P251, DOI 10.1016/0890-8508(89)90006-6; NAKAGOMI T, 1989, J VIROL, V63, P1431, DOI 10.1128/JVI.63.3.1431-1434.1989; Palombo EA, 1999, FEMS MICROBIOL LETT, V181, P1; Ramachandran M, 2000, VIROLOGY, V278, P436, DOI 10.1006/viro.2000.0682; TANIGUCHI K, 1995, SEMIN VIROL, V6, P123, DOI 10.1006/smvy.1995.0016; Unicomb LE, 1999, J CLIN MICROBIOL, V37, P1885, DOI 10.1128/JCM.37.6.1885-1891.1999; WARD RL, 1990, J VIROL, V64, P3219, DOI 10.1128/JVI.64.7.3219-3225.1990; Watanabe M, 2001, ARCH VIROL, V146, P557, DOI 10.1007/s007050170162; 1990, LANCET, V335, P573	21	49	54	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 23	2002	359	9307					640	642		10.1016/S0140-6736(02)07781-4	http://dx.doi.org/10.1016/S0140-6736(02)07781-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526AZ	11879856				2022-12-28	WOS:000174107400004
J	Haissaguerre, M; Shah, DC; Jais, P; Shoda, M; Kautzner, J; Arentz, T; Kalushe, D; Kadish, A; Griffith, M; Gaita, F; Yamane, T; Garrigue, S; Hocini, M; Clementy, J				Haissaguerre, M; Shah, DC; Jais, P; Shoda, M; Kautzner, J; Arentz, T; Kalushe, D; Kadish, A; Griffith, M; Gaita, F; Yamane, T; Garrigue, S; Hocini, M; Clementy, J			Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation	LANCET			English	Article								Ventricular fibrillation Is the main mechanism of sudden cardiac death, but the source of its spontaneous initiation has not been mapped. 16 patients were Investigated by electrography and radiofrequency ablation after resuscitation from recurrent idiopathic ventricular fibrillation. Triggers of ventricular fibrillation originated from various locations within the Purkinje system in :12 patients and from the ordinary myocardial muscle in four. The accuracy of mapping was confirmed by acute elimination of triggers by radiofrequency delivery, and there was no recurrence of ventricular fibrillation in 14 patients. Long-term follow-up Is necessary to establish that ablation is curative and avoids use of a defibrillator.	Hop Cardiol Haut Leveque, F-33604 Bordeaux, France; Tokyo Womens Med Coll, Tokyo 162, Japan; Inst Clin Med, Prague, Czech Republic; Herz Zentrum, Bad Krozingen, Germany; Northwestern Med Fac, Chicago, IL USA; Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England	CHU Bordeaux; Tokyo Women's Medical University; University of Birmingham	Haissaguerre, M (corresponding author), Hop Cardiol Haut Leveque, Ave Magellan, F-33604 Bordeaux, France.			Gaita, Fiorenzo/0000-0003-3178-6205				BELHASSEN B, 1993, J CARDIOVASC ELECTR, V4, P356, DOI 10.1111/j.1540-8167.1993.tb01236.x; FRIEDMAN PL, 1973, CIRC RES, V33, P612, DOI 10.1161/01.RES.33.5.612; *JOINT COMM UN CAR, 1996, CIRCULATION, V95, P265; MYERBURG RJ, 1970, CIRC RES, V26, P361, DOI 10.1161/01.RES.26.3.361	4	204	210	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 23	2002	359	9307					677	678		10.1016/S0140-6736(02)07807-8	http://dx.doi.org/10.1016/S0140-6736(02)07807-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526AZ	11879868				2022-12-28	WOS:000174107400016
J	Plata, R; Cornejo, A; Arratia, C; Anabaya, A; Perna, A; Dimitrov, BD; Remuzzi, G; Ruggenenti, P				Plata, R; Cornejo, A; Arratia, C; Anabaya, A; Perna, A; Dimitrov, BD; Remuzzi, G; Ruggenenti, P		Commission Global Advancement Neph	Angiotensin-converting-enzyme inhibition therapy in altitude polycythaemia: a prospective randomised trial	LANCET			English	Article							POSTTRANSPLANT ERYTHROCYTOSIS; TRANSPLANT ERYTHROCYTOSIS; ERYTHROID PROGENITORS; ERYTHROPOIESIS	Background Angiotensin-converting-enzyme (ACE) inhibitors reduce packed cell volume and haemoglobin concentration in polycythaemia that follows renal transplantation, which, like altitude polycythaemia, is an erythropoietin-dependent form of polycythaemia. We aimed to establish the effect of ACE-inhibitor treatment in people with altitude polycythaemia. Methods We did a prospective randomised study in 26 people with altitude polycythaemia (packed cell volume greater than or equal to55%) and 24-h rate of urinary protein excretion greater than 150 mg, who had been referred to the Renal Disease Project in La Paz, Bolivia. 13 participants were assigned 5 mg/day enalapril for 2 years (study group), and 13 no treatment (controls). Blood pressure, packed cell volume and haemoglobin concentration, proteinuria, and renal function were compared by intention-to-treat analyses. Findings Baseline packed cell volume and haemoglobin concentration were positively correlated with bodyweight (p=0.02), systolic (p=0.01) and diastolic (p=0.04) blood pressure, serum creatinine (p=0.0009), blood urea (p=0.008), and proteinuria (p=0.003). Systolic and diastolic blood pressure remained stable in the study group, but increased in controls. In study patients, mean (SD) packed cell volume, haemoglobin concentration, and proteinuria fell from 63.5% (4.9) to 56.8% (4.1), p<0.0001; 207 (18) to 164 g/L (13), p<0.0001; and from 358.6 (260.3) to 247.7 mg/24-h (208.2), p<0.002, respectively, but did not change significantly in controls. At 12 and 24 months of follow-up, packed cell volume, haemoglobin concentration, and proteinuria differed significantly between the groups (p<0.0001 for each comparison). In study patients, follow-up changes in packed cell volume (r=0.88, p<0.0001) or haemoglobin concentration (r = 0.83, p<0.0001) and proteinuria were strongly correlated. Enalapril was well tolerated by all patients. Interpretation ACE-inhibition therapy effectively and safely ameliorates altitude polycythaemia and reduces proteinuria.	Renal Dis Project, Biol Lab, La Paz, Bolivia; Mario Negri Inst Pharmacol Res, Clin Res Ctr Rare Dis Aldo & Cele Dacco Villa Cam, Ranica, Italy; Higher Med Inst IP Pavlov, Dept Social Med, Plovdiv, Bulgaria; Azienda Osped Osped Riuniti, Nephrol Unit, Bergamo, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Medical University Plovdiv; Medical University Varna; Ospedali Riuniti di Bergamo	Ruggenenti, P (corresponding author), Mario Negri Inst Pharmacol Res, Clin Res Ctr Aldo & Cele Dacco Villa Camozzi, Via Gavazzeni 11, I-24125 Bergamo, Italy.	ruggenenti@marionegri.it	Perna, Annalisa/AAC-1323-2020; Dimitrov, Borislav D/A-1246-2010; Remuzzi, Giuseppe/V-9766-2017	Perna, Annalisa/0000-0002-9257-0283; Dimitrov, Borislav D/0000-0002-5896-2072; Remuzzi, Giuseppe/0000-0002-6194-3446				Azizi M, 1996, J CLIN INVEST, V97, P839, DOI 10.1172/JCI118484; BLAND JM, 1995, BRIT MED J, V310, P446, DOI 10.1136/bmj.310.6977.446; CAHAN C, 1990, AM J PHYSL R, V258; Cole J, 2000, J CLIN INVEST, V106, P1391, DOI 10.1172/JCI10557; Fine LG, 2000, KIDNEY INT, V57, pS22, DOI 10.1046/j.1523-1755.2000.07512.x; GASTON RS, 1994, AM J KIDNEY DIS, V24, P1; GROVER RF, 1986, EXERCISE SPORT SCI R, V14, P269; Grover RF, 1998, EUR J APPL PHYSIOL, V77, P264, DOI 10.1007/s004210050331; Gupta M, 2000, TRANSPLANTATION, V70, P1188, DOI 10.1097/00007890-200010270-00011; Montanaro D, 2000, CLIN NEPHROL, V53, pB47; Morrone LF, 1997, TRANSPLANTATION, V64, P913, DOI 10.1097/00007890-199709270-00021; Mrug M, 1997, J CLIN INVEST, V100, P2310, DOI 10.1172/JCI119769; MULHERN JG, 1995, AM J NEPHROL, V15, P318, DOI 10.1159/000168856; Ou LC, 1998, J APPL PHYSIOL, V84, P1242, DOI 10.1152/jappl.1998.84.4.1242; PERAZELLA MA, 1993, J AM SOC NEPHROL, V3, P1653; REMUZZI A, 1991, KIDNEY INT, V39, P1267, DOI 10.1038/ki.1991.160; REMUZZI A, 1990, J CLIN INVEST, V85, P541, DOI 10.1172/JCI114470; WINTERBORN MH, 1987, POSTGRAD MED J, V63, P179, DOI 10.1136/pgmj.63.737.179	18	77	83	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 23	2002	359	9307					663	666		10.1016/S0140-6736(02)07812-1	http://dx.doi.org/10.1016/S0140-6736(02)07812-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526AZ	11879862				2022-12-28	WOS:000174107400010
J	Nakahara, K; Hayashi, T; Konishi, S; Miyashita, Y				Nakahara, K; Hayashi, T; Konishi, S; Miyashita, Y			Functional MRI of macaque monkeys performing a cognitive set-shifting task	SCIENCE			English	Article							CARD SORTING TEST; ACTIVATION; CORTEX; CORTICES; MEMORY	Functional brain organization of macaque monkeys and humans was directly compared by functional magnetic resonance imaging. Subjects of both species performed a modified Wisconsin Card Sorting Test that required behavioral flexibility in the form of cognitive set shifting. Equivalent visual stimuli and task sequence were used for the two species. We found transient activation related to cognitive set shifting in focal regions of prefrontal cortex in both monkeys and humans. These functional homologs were Located in cytoarchitectonically equivalent regions in the posterior part of ventrolateral prefrontal cortex. This comparative imaging provides insights into the evolution of cognition in primates.	Univ Tokyo, Dept Physiol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Dept Neurol, Bunkyo Ku, Tokyo 1130033, Japan; Natl Inst Physiol Sci, Okazaki, Aichi 4448585, Japan	University of Tokyo; University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Miyashita, Y (corresponding author), Univ Tokyo, Dept Physiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		Miyashita, Yasushi/B-7171-2019; Hayashi, Toshihiro/A-6028-2008	Miyashita, Yasushi/0000-0003-3496-8637; Hayashi, Toshihiro/0000-0003-4362-7439; Nakahara, Kiyoshi/0000-0001-6701-6216				Ashburner J, 1997, NEUROIMAGE, V6, P209, DOI 10.1006/nimg.1997.0290; BERMAN KF, 1995, NEUROPSYCHOLOGIA, V33, P1027, DOI 10.1016/0028-3932(95)00035-2; Brodmann K., 1910, HDB NEUROLOGIE, V1, P206; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; Damasio H, 1989, LESION ANAL NEUROPSY; Dubowitz DJ, 1998, NEUROREPORT, V9, P2213, DOI 10.1097/00001756-199807130-00012; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; FUSTER JM, 1997, PREFRONTAL CORTEX; Goldman-Rakic P.S., 2011, HDB PHYSL, P373, DOI DOI 10.1002/CPHY.CP010509; Hasegawa I, 1998, SCIENCE, V281, P814, DOI 10.1126/science.281.5378.814; Hayashi T, 1999, EUR J NEUROSCI, V11, P4451, DOI 10.1046/j.1460-9568.1999.00892.x; Konishi S, 1998, NAT NEUROSCI, V1, P80, DOI 10.1038/283; Konishi S, 2001, NEUROIMAGE, V13, P364, DOI 10.1006/nimg.2000.0691; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Milner B., 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI DOI 10.1001/ARCHNEUR.1963.00460070100010; Miyashita Y, 2000, CURR OPIN NEUROBIOL, V10, P187, DOI 10.1016/S0959-4388(00)00071-4; Monchi O, 2001, J NEUROSCI, V21, P7733, DOI 10.1523/JNEUROSCI.21-19-07733.2001; Nagahama Y, 1996, BRAIN, V119, P1667, DOI 10.1093/brain/119.5.1667; Orban GA, 2001, CURR OPIN NEUROL, V14, P47, DOI 10.1097/00019052-200102000-00008; OWEN AM, 1993, BRAIN, V116, P1159, DOI 10.1093/brain/116.5.1159; PASSINGHAM RE, 1972, NEUROPSYCHOLOGIA, V10, P41, DOI 10.1016/0028-3932(72)90041-3; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; Petrides M., 1994, HDB NEUROPSYCHOLOGY, V9, P17; Stefanacci L, 1998, NEURON, V20, P1051, DOI 10.1016/S0896-6273(00)80485-7; Ungerleider LG, 1998, P NATL ACAD SCI USA, V95, P883, DOI 10.1073/pnas.95.3.883; Van Essen DC, 2001, VISION RES, V41, P1359, DOI 10.1016/S0042-6989(01)00045-1; Vanduffel W, 2001, NEURON, V32, P565, DOI 10.1016/S0896-6273(01)00502-5; Walker E.A, 1940, J COMP NEUROL, V73, P59	29	224	226	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2002	295	5559					1532	1536		10.1126/science.1067653	http://dx.doi.org/10.1126/science.1067653			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11859197				2022-12-28	WOS:000173981300056
J	Clark, PU; Pisias, NG; Stocker, TF; Weaver, AJ				Clark, PU; Pisias, NG; Stocker, TF; Weaver, AJ			The role of the thermohaline circulation in abrupt climate change	NATURE			English	Review							ATLANTIC DEEP-WATER; LAST GLACIAL PERIOD; YOUNGER DRYAS EVENT; NORTH-ATLANTIC; ICE CORE; TROPICAL ATLANTIC; ATMOSPHERIC CO2; HEINRICH EVENTS; PACIFIC-OCEAN; RAPID CHANGES	The possibility of a reduced Atlantic thermohaline circulation in response to increases in greenhouse-gas concentrations has been demonstrated in a number of simulations with general circulation models of the coupled ocean-atmosphere system. But it remains difficult to assess the likelihood of future changes in the thermohaline circulation, mainly owing to poorly constrained model parameterizations and uncertainties in the response of the climate system to greenhouse warming. Analyses of past abrupt climate changes help to solve these problems. Data and models both suggest that abrupt climate change during the last glaciation originated through changes in the Atlantic thermohaline circulation in response to small changes in the hydrological cycle. Atmospheric and oceanic responses to these changes were then transmitted globally through a number of feedbacks. The palaeoclimate data and the model results also indicate that the stability of the thermohaline circulation depends on the mean climate state.	Oregon State Univ, Dept Geosci, Corvallis, OR 97331 USA; Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8W 3P6, Canada	Oregon State University; Oregon State University; University of Bern; University of Victoria	Clark, PU (corresponding author), Oregon State Univ, Dept Geosci, Corvallis, OR 97331 USA.	clarkp@ucs.orst.edu	Stocker, Thomas/B-1273-2013; Weaver, Andrew J/E-7590-2011	Weaver, Andrew J/0000-0001-8919-3598				Alley RB, 1999, ANNU REV EARTH PL SC, V27, P149, DOI 10.1146/annurev.earth.27.1.149; Alley RB, 2001, PALEOCEANOGRAPHY, V16, P190, DOI 10.1029/2000PA000518; ALLEY RB, IN PRESS ABRUPT CLIM; Bard E, 2000, SCIENCE, V289, P1321, DOI 10.1126/science.289.5483.1321; Bard E, 1998, RADIOCARBON, V40, P1085, DOI 10.1017/S0033822200019135; Bard E, 1997, NATURE, V385, P707, DOI 10.1038/385707a0; Behl RJ, 1996, NATURE, V379, P243, DOI 10.1038/379243a0; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Bond GC, 1999, GEOPH MONOG SERIES, V112, P35; BROECKER W, 1984, NUCL INSTRUM METH B, V5, P331, DOI 10.1016/0168-583X(84)90538-X; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; Broecker WS, 1997, SCIENCE, V278, P1582, DOI 10.1126/science.278.5343.1582; BRYAN F, 1986, NATURE, V323, P301, DOI 10.1038/323301a0; Charles CD, 1996, EARTH PLANET SC LETT, V142, P19, DOI 10.1016/0012-821X(96)00083-0; Clark PU, 2001, SCIENCE, V293, P283, DOI 10.1126/science.1062517; CLARK PU, UNPUB SCIENCE; Crowley TJ, 1992, PALEOCEANOGRAPHY, V7, P489, DOI 10.1029/92PA01058; Cubasch U., 2001, PROJECTIONS FUTURE C, P525; Cuffey KM, 1997, J GEOPHYS RES-OCEANS, V102, P26383, DOI 10.1029/96JC03981; CUFFEY KM, 1995, SCIENCE, V270, P455, DOI 10.1126/science.270.5235.455; Delworth TL, 2000, J CLIMATE, V13, P3721, DOI 10.1175/1520-0442(2000)013<3721:IOTRTI>2.0.CO;2; DICKSON RR, 1994, J GEOPHYS RES-OCEANS, V99, P12319, DOI 10.1029/94JC00530; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Fanning AF, 1997, PALEOCEANOGRAPHY, V12, P307, DOI 10.1029/96PA03726; Finkel RC, 1997, J GEOPHYS RES-OCEANS, V102, P26699, DOI 10.1029/97JC01282; Frank M, 2000, PHILOS T ROY SOC A, V358, P1089, DOI 10.1098/rsta.2000.0575; Ganachaud A, 2000, NATURE, V408, P453, DOI 10.1038/35044048; Ganopolski A, 2001, NATURE, V409, P153, DOI 10.1038/35051500; GROOTES PM, 1993, NATURE, V366, P552, DOI 10.1038/366552a0; GRUMBINE RW, 1991, J GEOPHYS RES-OCEANS, V96, P22049, DOI 10.1029/91JC00531; Hostetler SW, 1999, J GEOPHYS RES-ATMOS, V104, P3947, DOI 10.1029/1998JD200067; Hughen KA, 1996, NATURE, V380, P51, DOI 10.1038/380051a0; Hughen KA, 2000, SCIENCE, V290, P1951, DOI 10.1126/science.290.5498.1951; JOHNSEN SJ, 1992, NATURE, V359, P311, DOI 10.1038/359311a0; Joos F, 1999, SCIENCE, V284, P464, DOI 10.1126/science.284.5413.464; Jouzel J, 2001, GEOPHYS RES LETT, V28, P3199, DOI 10.1029/2000GL012243; Kienast M, 2001, SCIENCE, V291, P2132, DOI 10.1126/science.1057131; KILLWORTH PD, 1983, REV GEOPHYS, V21, P1, DOI 10.1029/RG021i001p00001; Kitagawa H, 2000, RADIOCARBON, V42, P369; Knutti R, 2002, J CLIMATE, V15, P179, DOI 10.1175/1520-0442(2002)015<0179:LPOTFT>2.0.CO;2; LABEYRIE LD, 1992, QUATERNARY SCI REV, V11, P401, DOI 10.1016/0277-3791(92)90022-Z; Latif M, 2000, J CLIMATE, V13, P1809, DOI 10.1175/1520-0442(2000)013<1809:L>2.0.CO;2; Little MG, 1997, PALEOCEANOGRAPHY, V12, P568, DOI 10.1029/97PA00823; Manabe S, 1988, J CLIMATE, V1, P841, DOI 10.1175/1520-0442(1988)001<0841:TSEOAC>2.0.CO;2; Manabe S, 1997, PALEOCEANOGRAPHY, V12, P321, DOI 10.1029/96PA03932; MANABE S, 1993, NATURE, V364, P215, DOI 10.1038/364215a0; Marchal O, 2001, EARTH PLANET SC LETT, V185, P383, DOI 10.1016/S0012-821X(00)00383-6; MCCARTNEY MS, 1992, PROG OCEANOGR, V29, P283, DOI 10.1016/0079-6611(92)90006-L; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; Meese DA, 1997, J GEOPHYS RES-OCEANS, V102, P26411, DOI 10.1029/97JC00269; Mikolajewicz U, 2000, CLIM DYNAM, V16, P627, DOI 10.1007/s003820000066; MIKOLAJEWICZ U, 1993, PALEOCEANOGRAPHY, V8, P409, DOI 10.1029/93PA00893; MIKOLAJEWICZ U, 1994, J GEOPHYS RES-OCEANS, V99, P22633, DOI 10.1029/94JC01989; Mix AC, 1999, GEOPH MONOG SERIES, V112, P127; Mulvaney R, 2000, GEOPHYS RES LETT, V27, P2673, DOI 10.1029/1999GL011254; Muscheler R, 2000, NATURE, V408, P567, DOI 10.1038/35046041; OESCHGER H, 1984, AM GEOPHYS UNION MON, V29, P299; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pisias NG, 2001, QUATERNARY SCI REV, V20, P1561, DOI 10.1016/S0277-3791(01)00018-X; Rahmstorf S, 1999, CLIMATIC CHANGE, V43, P353, DOI 10.1023/A:1005474526406; Rind D, 2001, J GEOPHYS RES-ATMOS, V106, P27335, DOI 10.1029/2000JD000070; Ruhlemann C, 1999, NATURE, V402, P511, DOI 10.1038/990069; Rutberg RL, 2000, NATURE, V405, P935, DOI 10.1038/35016049; Sachs JP, 2001, SCIENCE, V293, P2077, DOI 10.1126/science.1063584; SARNTHEIN M, 1994, PALEOCEANOGRAPHY, V9, P209, DOI 10.1029/93PA03301; Schiller A, 1997, CLIM DYNAM, V13, P325, DOI 10.1007/s003820050169; Schmittner A, 2001, GEOPHYS RES LETT, V28, P1027, DOI 10.1029/2000GL012410; Schmittner A, 2000, GEOPHYS RES LETT, V27, P1163, DOI 10.1029/1999GL011048; SCHMITTNER A, IN PRESS SCIENCE; Schulz H, 1998, NATURE, V393, P54, DOI 10.1038/31750; Severinghaus JP, 1998, NATURE, V391, P141, DOI 10.1038/34346; Severinghaus JP, 1999, SCIENCE, V286, P930, DOI 10.1126/science.286.5441.930; Sikes EL, 2000, NATURE, V405, P555, DOI 10.1038/35014581; Steig EJ, 1998, SCIENCE, V282, P92, DOI 10.1126/science.282.5386.92; Stocker TF, 1998, SCIENCE, V282, P61, DOI 10.1126/science.282.5386.61; Stocker TF, 2000, QUATERNARY SCI REV, V19, P301, DOI 10.1016/S0277-3791(99)00067-0; STOCKER TF, 1991, NATURE, V351, P729, DOI 10.1038/351729a0; Stocker TF, 1997, NATURE, V388, P862, DOI 10.1038/42224; STOMMEL H, 1961, TELLUS, V13, P224, DOI 10.1111/j.2153-3490.1961.tb00079.x; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; Thompson LG, 1998, SCIENCE, V282, P1858, DOI 10.1126/science.282.5395.1858; THOMPSON LG, 1995, SCIENCE, V269, P46, DOI 10.1126/science.269.5220.46; Timmermann A, 1999, NATURE, V398, P694, DOI 10.1038/19505; Tziperman E, 1997, NATURE, V386, P592, DOI 10.1038/386592a0; Vidal L, 1998, PALEOCEANOGRAPHY, V13, P245, DOI 10.1029/98PA00315; Weaver AJ, 1999, ANNU REV EARTH PL SC, V27, P231, DOI 10.1146/annurev.earth.27.1.231; WEAVER AJ, 1995, NATURAL CLIMATE VARI, P365; Wood RA, 1999, NATURE, V399, P572, DOI 10.1038/21170; Yu EF, 1996, NATURE, V379, P689, DOI 10.1038/379689a0	90	539	575	6	278	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2002	415	6874					863	869		10.1038/415863a	http://dx.doi.org/10.1038/415863a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859359				2022-12-28	WOS:000173941000035
J	Waksman, R; Raizner, AE; Yeung, AC; Lansky, AJ; Vandertie, L				Waksman, R; Raizner, AE; Yeung, AC; Lansky, AJ; Vandertie, L		INHIBIT Investigators	Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial	LANCET			English	Article							CORONARY-ARTERY DISEASE; BALLOON ANGIOPLASTY; INTRAVASCULAR ULTRASOUND; BRACHYTHERAPY; MECHANISMS; RECURRENCE; PLACEMENT; PATTERNS; THERAPY	Background In-stent restenosis is a major limitation of intracoronary stenting. lonising gamma radiation has been shown to reduce recurrence of restenosis after stent placement. We aimed to compare the effects of intracoronary beta radiation treatment with those of placebo for clinical and angiographic outcomes of patients with diffuse in-stent restenosis. Methods 332 patients with in-stent restenosis underwent successful coronary intervention, and were then randomly allocated to intracoronary beta radiation with a phosphorus-32 source (n=166) or placebo (166) delivered into a centreing balloon catheter through an automatic afterloader. Longer lesions (>22 mm of dilated length) were treated with tandem positioning of the study wire. The primary safety endpoint was major adverse cardiac events, defined as death, myocardial infarction, and repeat target-lesion revascularisation at 9 months. The primary efficacy endpoint was binary angiographic restenosis rate in the analysis segment during 9-months' follow-up. Analysis was by intention to treat. Findings Procedural success, and in-hospital and 30-day complications were similar among the two groups. 24 (15%) patients in the radiated group had the primary safety endpoint of death, myocardial infarction, or repeat target-lesion revascularlsation over 290 days compared with 15 (31%) in the placebo group (difference 16% [95% CI 7-25], p=0.0006). Binary angiographic restenosis rate was lower in the radiated group than the placebo group for the entire analysed segment (difference 25% [14-37], p<0.0001). Interpretation Vascular brachytherapy using pure beta-emitter P-32 delivered into a centreing catheter via an automatic afterloader can be used to reduce overall revascularisation in patients undergoing treatment for diffuse in-stent restenosis.	Washington Hosp Ctr, Cardiovasc Brachytherapy Inst, Washington, DC 20010 USA; Baylor Univ, Houston, TX 77030 USA; Stanford Univ, Stanford, CA 94305 USA; Cardiol Res Fdn, New York, NY USA; Guidant Corp, Santa Clara, CA USA	MedStar Washington Hospital Center; Baylor University; Stanford University; Cardiovascular Research Foundation (CRF)	Waksman, R (corresponding author), Washington Hosp Ctr, Cardiovasc Brachytherapy Inst, Washington, DC 20010 USA.	ron.waksman@medstar.net	Webb, Delores D/G-3047-2010					BAIM DS, 1993, AM J CARDIOL, V71, P364, DOI 10.1016/0002-9149(93)90813-R; DUSSAILLANT GR, 1995, J AM COLL CARDIOL, V26, P720, DOI 10.1016/0735-1097(95)00249-4; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; Hoffmann R, 1996, CIRCULATION, V94, P1247, DOI 10.1161/01.CIR.94.6.1247; Kastrati A, 1997, J AM COLL CARDIOL, V30, P1428, DOI 10.1016/S0735-1097(97)00334-3; Kim HS, 2001, J AM COLL CARDIOL, V37, P1026, DOI 10.1016/S0735-1097(01)01112-3; Kleiman NS, 2000, J AM COLL CARDIOL, V36, P310, DOI 10.1016/S0735-1097(00)00805-6; Leon MB, 2001, NEW ENGL J MED, V344, P250, DOI 10.1056/NEJM200101253440402; Mehran R, 1999, CIRCULATION, V100, P1872, DOI 10.1161/01.CIR.100.18.1872; Mehran R, 1997, CIRCULATION, V96, P2183; Raizner AE, 1998, CIRCULATION, V98, P651; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; Sharma SK, 1998, J AM COLL CARDIOL, V32, P1358, DOI 10.1016/S0735-1097(98)00382-9; Teirstein PS, 1997, NEW ENGL J MED, V336, P1697, DOI 10.1056/NEJM199706123362402; VanBelle E, 1997, CIRCULATION, V96, P1454, DOI 10.1161/01.CIR.96.5.1454; Verin V, 2001, NEW ENGL J MED, V344, P243, DOI 10.1056/NEJM200101253440401; Waksman R, 2001, CIRCULATION, V103, P2332; Waksman R, 2000, CIRCULATION, V101, P2165, DOI 10.1161/01.CIR.101.18.2165; Waksman R, 2000, J AM COLL CARDIOL, V36, P65, DOI 10.1016/S0735-1097(00)00681-1; Waksman R, 2000, CIRCULATION, V101, P1895, DOI 10.1161/01.CIR.101.16.1895	20	218	224	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2002	359	9306					551	557		10.1016/S0140-6736(02)07741-3	http://dx.doi.org/10.1016/S0140-6736(02)07741-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523FP	11867107				2022-12-28	WOS:000173943600006
J	Hofmann, WK; de Vos, S; Elashoff, D; Gschaidmeier, H; Hoelzer, D; Koeffler, HP; Ottmann, OG				Hofmann, WK; de Vos, S; Elashoff, D; Gschaidmeier, H; Hoelzer, D; Koeffler, HP; Ottmann, OG			Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor ST1571 and gene-expression profiles: a gene-expression study	LANCET			English	Article							CELL-LINES; MICROARRAY; STI571; SENSITIVITY; ACTIVATION; MECHANISM; LEUKEMIA; CANCER	Background The ABL tyrosine kinase inhibitor STI571 is a promising agent for treatment of advanced Philadelphia-chromosome-positive (Ph+) acute lymphoblastic leukaemia. However, resistance to this drug develops within a few months in most patients. We aimed to predict resistance to STI571. Methods Total RNA was extracted from 25 bone-marrow samples from 19 patients with Ph+ acute lymphoblastic leukaemia who were enrolled into a phase 11 study. 17 samples were obtained before STI571 treatment was started: ten from individuals who were classified as good responders to STI571 (sensitive), and seven from individuals who did not to respond to STI571 (primary resistance). Eight samples were obtained from patients during treatment with STI571. We analysed six matched samples, which were obtained before and during treatment with STI571. Oligonucleotide microarray analysis of samples was done with high-density microarrays. Findings We identified 95 genes whose expression could be used to predict sensitivity of leukaemic cells to STI571. On this basis, all the STI571-sensitive samples could clearly be distinguished from the resistant cases. 56 highly differentially expressed genes were identified in leukaemic cells that were secondarily resistant to STI571. Resistant leukaemic cells expressed high levels of Bruton's tyrosine kinase and two ATP synthetases (ATP5A1 and ATP5C1), and showed significantly reduced expression of the proapoptotic gene BAK1 and the cell-cycle control gene p15 INK4b, Interpretation We have shown the clinical relevance of gene expression data for the pretreatment assessment of acute lymphoblastic leukaemia. Our results have implications for future clinical studies of tyrosine kinase inhibitors.	Univ Hosp, Dept Haematol & Oncol, D-60596 Frankfurt, Germany; Univ Calif Los Angeles, Sch Med, Cedars Sinai Res Inst, Div Haematol & Oncol, Los Angeles, CA USA; Univ Calif Los Angeles, Sch Med, Dept Pathol, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90024 USA; Novartis Pharma AG, Nurnberg, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Novartis	Hofmann, WK (corresponding author), Univ Hosp, Dept Haematol & Oncol, Theodor Stern Kai 7, D-60596 Frankfurt, Germany.	W.K.Hofmann@em.uni-frankfurt.de	Ottmann, Oliver G/D-5007-2016	Ottmann, Oliver G/0000-0001-9559-1330				COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; DeRisi J, 2000, FEBS LETT, V470, P156, DOI 10.1016/S0014-5793(00)01294-1; Desiderio S, 1997, CURR OPIN IMMUNOL, V9, P534, DOI 10.1016/S0952-7915(97)80107-0; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Goldman JM, 2001, NEW ENGL J MED, V344, P1084, DOI 10.1056/NEJM200104053441409; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Hochhaus A, 2001, SCIENCE, V293, P2163; Hofmann WK, 2001, BLOOD, V98, P787, DOI 10.1182/blood.V98.3.787; Honda H, 1998, BLOOD, V91, P2067, DOI 10.1182/blood.V91.6.2067.2067_2067_2075; Huettner CS, 2000, NAT GENET, V24, P57, DOI 10.1038/71691; Kaminski N, 2000, P NATL ACAD SCI USA, V97, P1778, DOI 10.1073/pnas.97.4.1778; Knight ZA, 2000, BLOOD, V96, P4003, DOI 10.1182/blood.V96.12.4003.h8004000d_4003_4005; Komatani H, 2001, CANCER RES, V61, P2827; Kudoh K, 2000, CANCER RES, V60, P4161; le Coutre P, 2000, BLOOD, V95, P1758, DOI 10.1182/blood.V95.5.1758.005a41_1758_1766; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Mahon FX, 2000, BLOOD, V96, P1070, DOI 10.1182/blood.V96.3.1070.015k17_1070_1079; Ottmann OG, 2000, BLOOD, V96, p828A; PUISSANT C, 1990, BIOTECHNIQUES, V8, P148; Satterthwaite AB, 2000, P NATL ACAD SCI USA, V97, P6687, DOI 10.1073/pnas.110146697; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; Voehringer DW, 2000, P NATL ACAD SCI USA, V97, P2680, DOI 10.1073/pnas.97.6.2680; Weisberg E, 2000, BLOOD, V95, P3498, DOI 10.1182/blood.V95.11.3498.011k27_3498_3505; Wilson W, 1999, P NATL ACAD SCI USA, V96, P12833, DOI 10.1073/pnas.96.22.12833	28	163	180	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2002	359	9305					481	486		10.1016/S0140-6736(02)07678-X	http://dx.doi.org/10.1016/S0140-6736(02)07678-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520ML	11853794				2022-12-28	WOS:000173785600011
